ABSTRACT AUTHOR DISCLOSURE INFORMATION · ABSTRACT AUTHOR DISCLOSURE INFORMATION All...

A696

AU

THO

R D

ISCL

OSU

RE

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

Aaboe, Kasper ....................................... Disclosed no confl ict of interest.Aadahl, Mette ....................................... Disclosed no confl ict of interest.Aamodt, Kristie I. ................................. Disclosed no confl ict of interest.Abate, Nicola ........................................ Disclosed no confl ict of interest.Abbas, Malak ........................................ Disclosed no confl ict of interest.Abbasi, Fahim........................................ Disclosed no confl ict of interest.Abbass, Ibrahim .................................... Consultant: Novo Nordisk Inc.Abbott, Akshar B. ................................. Disclosed no confl ict of interest.Abbott, Alice M. ................................... Disclosed no confl ict of interest.Abbott, Scott ......................................... Employee: Valeritas; Stock/Shareholder: Valeritas.Abburi, Nandini ..................................... Disclosed no confl ict of interest.Abcouwer, Steven F. ............................. Disclosed no confl ict of interest.Abdallah Hasan, Ahmed ....................... Disclosed no confl ict of interest.Abdella, Nabilla .................................... Disclosed no confl ict of interest.Abdesselam, Ines .................................. Disclosed no confl ict of interest.Abdul-Ghani, Muhammad ..................... Disclosed no confl ict of interest.Abdulina, Galiya A. .............................. Disclosed no confl ict of interest.Abdullah, Mohamed.............................. Disclosed no confl ict of interest.Abdulrahman, Alif ................................. Disclosed no confl ict of interest.Abdulreda, Midhat H. ........................... Disclosed no confl ict of interest.Abdurrob, Abdurrahman........................ Research Support: Eli Lilly and Company.Abe, Kaori.............................................. Disclosed no confl ict of interest.Abe, Makoto.......................................... Disclosed no confl ict of interest.Abe, Masanori....................................... Disclosed no confl ict of interest.Abe, Megumi......................................... Disclosed no confl ict of interest.Abe, Yoshimi ......................................... Disclosed no confl ict of interest.Abebe, Tsehay ....................................... Disclosed no confl ict of interest.Abel, E. Dale.......................................... Disclosed no confl ict of interest.Abellán, Pablo ....................................... Advisory Panel: Abbott, Almirall, AstraZeneca (Spouse/

Partner), AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner), Esteve (Spouse/Partner), Esteve, Janssen Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis; Consultant: Abbott, Almirall, AstraZeneca (Spouse/Partner), AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner), Esteve (Spouse/Partner), Esteve, Janssen Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis; Research Support: Esteve, Ferrer, Novo Nordisk Inc., Sanofi -Aventis.

Aberer, Felix .......................................... Disclosed no confl ict of interest.Abitbol, Alexander ................................ Disclosed no confl ict of interest.Abou Samra, Abdel Badi ....................... Disclosed no confl ict of interest.Abouhossein, Mariam ........................... Employee: Sanofi U.S.Abrahamsen, Trine J. ........................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Abrahamsson, Niclas ............................ Disclosed no confl ict of interest.Abuaysheh, Sanaa ................................ Disclosed no confl ict of interest.Abulizi, Abudukadier ............................. Disclosed no confl ict of interest.Aburatani, Hiroyuki ............................... Disclosed no confl ict of interest.Abusnana, Salah ................................... Advisory Panel: AstraZeneca, Novartis AG, Novo Nordisk A/S;

Consultant: AstraZeneca, Novartis AG, Novo Nordisk A/S; Research Support: Johnson & Johnson, Novo Nordisk A/S, Sanofi -Aventis; Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Novartis AG, Novo Nordisk A/S.

Accili, Domenico ................................... Disclosed no confl ict of interest.Accurso, Anthony D. ............................. Disclosed no confl ict of interest.Acevedo, Maria ..................................... Disclosed no confl ict of interest.Acharya, Anita Prem ............................. Disclosed no confl ict of interest.Acharya, Runa ....................................... Disclosed no confl ict of interest.Ackart, David F. .................................... Disclosed no confl ict of interest.Ackermann, Ronald T. .......................... Disclosed no confl ict of interest.Ackermans, Mariette T. ........................ Disclosed no confl ict of interest.Acosta, Carolina .................................... Disclosed no confl ict of interest.Acton, Anthony J. ................................. Disclosed no confl ict of interest.Acuff, S. Will ......................................... Disclosed no confl ict of interest.Acuña-Ortega, Natalhie ........................ Disclosed no confl ict of interest.Acusta, Andre........................................ Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Adachi, Yusuke ...................................... Employee: Ajinomoto Group.Adam, Julie ........................................... Disclosed no confl ict of interest.Adamo, Michela .................................... Disclosed no confl ict of interest.Adams, Alyce ........................................ Disclosed no confl ict of interest.

Adams, Alyssa....................................... Disclosed no confl ict of interest.Adams, David B. ................................... Disclosed no confl ict of interest.Adams, John ......................................... Disclosed no confl ict of interest.Adams, Linda......................................... Disclosed no confl ict of interest.Adams, Michael W. .............................. Disclosed no confl ict of interest.Adams, Rachel ...................................... Disclosed no confl ict of interest.Adams, Sara R. ..................................... Disclosed no confl ict of interest.Adamson, Karen .................................... Disclosed no confl ict of interest.Adeli, Khosrow ...................................... Disclosed no confl ict of interest.Adhami, Anwar ..................................... Disclosed no confl ict of interest.Adhikari, Pramisha ................................ Disclosed no confl ict of interest.Adhikary, Till .......................................... Disclosed no confl ict of interest.Adi, Saleh .............................................. Advisory Panel: Tandem Diabetes Care, Inc., Tidepool; Board

Member: Tidepool; Stock/Shareholder: Dexcom, Inc., Tandem Diabetes Care, Inc.

Adili, Fatemeh ....................................... Disclosed no confl ict of interest.Adkins, Laura......................................... Disclosed no confl ict of interest.Advani, Andrew..................................... Other Relationship: Boehringer Ingelheim Pharmaceuticals,

Inc.; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc.

Aeby, Sébastien .................................... Disclosed no confl ict of interest.Aerni, Hans R. ...................................... Disclosed no confl ict of interest.Affi nati, Alison ...................................... Disclosed no confl ict of interest.Afrin, M.S.T. Rejina ............................... Disclosed no confl ict of interest.Agarwal, Rishi ....................................... Employee: Accenture; Other Relationship: Sanofi U.S., Inc.Agarwal, Shivani ................................... Disclosed no confl ict of interest.Aggarwal, Naresh ................................. Advisory Panel: Janssen Canada.Ági, Tamás ............................................. Employee: 77 Electronics Co., Ltd.Agolory, Joseph..................................... Disclosed no confl ict of interest.Agrawal, Madhur .................................. Disclosed no confl ict of interest.Agrawal, Pratik J. ................................. Employee: Medtronic, Inc.Agrawal, Rahul...................................... Disclosed no confl ict of interest.Agrawal, Rajendra P. ............................ Disclosed no confl ict of interest.Aguayo-Mazzucato, Cristina ................. Disclosed no confl ict of interest.Aguilar, Richard ..................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited; Other Relationship: Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Scientifi c Affairs, LLC; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.

Agus, Michael ....................................... Disclosed no confl ict of interest.Agyin, Christina ..................................... Disclosed no confl ict of interest.Ahad, Abdul........................................... Disclosed no confl ict of interest.Ahlqvist, Emma ..................................... Disclosed no confl ict of interest.Ahmad Suhaimi, Farhanah .................... Disclosed no confl ict of interest.Ahmad, Faiyaz ....................................... Disclosed no confl ict of interest.Ahmad, Iram .......................................... Disclosed no confl ict of interest.Ahmad, Rasheed ................................... Disclosed no confl ict of interest.Ahmadi, Neeki....................................... Disclosed no confl ict of interest.Ahmann, Andrew J. ............................. Advisory Panel: Eli Lilly and Company, Sanofi U.S.; Consultant:

Dexcom, Inc., Novo Nordisk A/S; Research Support: Dexcom, Inc., Medtronic, Inc., Novo Nordisk A/S, Sanofi U.S.

Ahmed, Simi .......................................... Disclosed no confl ict of interest.Ahmedani, M. Yakoob ........................... Disclosed no confl ict of interest.Ahn, Byul-Nim ....................................... Disclosed no confl ict of interest.Ahn, Chang Ho ...................................... Disclosed no confl ict of interest.Ahn, Chul Woo ...................................... Disclosed no confl ict of interest.Ahn, Jin Hee.......................................... Disclosed no confl ict of interest.Ahn, Kyu Jeung ..................................... Disclosed no confl ict of interest.Ahn, Sylvie A. ....................................... Disclosed no confl ict of interest.Ahn, Yu-Bae ........................................... Disclosed no confl ict of interest.Ahrén, Bo............................................... Advisory Panel: Bristol-Myers Squibb Company, Eli Lilly and

Company, GlaxoSmithKline, Merck & Co., Inc., Novartis AG, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Inc., Novartis AG, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH.

Ahroni, Jessie H. .................................. Disclosed no confl ict of interest.Ai, Masumi ............................................ Speaker’s Bureau: Merck & Co., Inc., Sanofi K.K.Aiello, Lloyd Paul................................... Consultant: Eisai Co., Ltd., Eli Lilly and Company, EyeGate,

Foreseehome, Genentech, Inc., Genzyme Corporation, KalVista Pharmaceuticals Inc., Momenta, PureTech,

ABSTRACT AUTHOR DISCLOSURE INFORMATION

All presenters/authors are required to disclose to the program audience any fi nancial relationships related to the subject matter of this program. The intent of this disclosure is not to prevent a presenter or author from being involved in the activity, but rather to provide participants with information on which they may make their own judgments.

A697


AU

THO

R D

ISCL

OSU

RE

Santen Pharmaceutical, SciFluor, ThromboGenics NV; Research Support: KalVista Pharmaceuticals Inc., Optos.

Aiello, Vito ............................................. Disclosed no confl ict of interest.Aikawa, Masanori ................................. Disclosed no confl ict of interest.Aitken, Moira L. .................................... Disclosed no confl ict of interest.Aizawa, Toru .......................................... Disclosed no confl ict of interest.Ajalat, Mark .......................................... Disclosed no confl ict of interest.Ajami, Nadim ........................................ Disclosed no confl ict of interest.Ajeeb, Tamara ....................................... Disclosed no confl ict of interest.Ajmera, Mayank .................................... Other Relationship: Sanofi U.S.Akanuma, Yasuo.................................... Disclosed no confl ict of interest.Akcicek, Fehmi ...................................... Disclosed no confl ict of interest.Akehi, Yuko ............................................ Disclosed no confl ict of interest.Akella, Syamala .................................... Employee: Berg Health; Stock/Shareholder: Berg Health.Akeroyd, Julia M. ................................. Disclosed no confl ict of interest.Akhmetova, Saule B. ............................ Disclosed no confl ict of interest.Akhrass, Firas ........................................ Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Bristol-Myers Squibb Company, Eli Lilly and Company; Speaker’s Bureau: Amarin Pharma, Inc., Amgen Inc., AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company.

Aki, Nanako ........................................... Disclosed no confl ict of interest.Akiyama, Noriko .................................... Employee: Astellas Pharma Inc.Akiyama, Yoshitaka ............................... Disclosed no confl ict of interest.Akkari, Patrick Anthony ......................... Other Relationship: Eli Lilly and Company.Akkireddy, Padmaja ............................... Disclosed no confl ict of interest.Akolkar, Beena ...................................... Disclosed no confl ict of interest.Akoumianakis, Ioannis .......................... Research Support: Sanofi -Aventis Deutschland GmbH.Akturk, Halis K. ..................................... Disclosed no confl ict of interest.Akueson, Cecelia E. .............................. Disclosed no confl ict of interest.Al Jobori, Hussein ................................. Disclosed no confl ict of interest.Al Khaldi, Rasha .................................... Disclosed no confl ict of interest.Ala-Korpela, Mika ................................. Disclosed no confl ict of interest.Alarcón, Javier ...................................... Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.Alarcon, Maria Lis ................................. Disclosed no confl ict of interest.Alatrach, Mariam .................................. Disclosed no confl ict of interest.Al-Atrash, Fida ...................................... Disclosed no confl ict of interest.Alaupovic, Petar .................................... Disclosed no confl ict of interest.Alba, Maria ........................................... Employee: Janssen Research & Development, LLC.Albarello, Luca ...................................... Disclosed no confl ict of interest.Albert, Paul............................................ Disclosed no confl ict of interest.Albrechtsen, Reidar............................... Disclosed no confl ict of interest.Albright, Ann L. .................................... Disclosed no confl ict of interest.Alcaide-Torres, Juan ............................. Disclosed no confl ict of interest.Aldana, Paola C. ................................... Disclosed no confl ict of interest.Alderisio, Antonio ................................. Disclosed no confl ict of interest.Aldhalimy, Nadia ................................... Disclosed no confl ict of interest.Aldigeri, Raffaella ................................. Disclosed no confl ict of interest.Aldini, Giancarlo.................................... Disclosed no confl ict of interest.Alejandro, Rodolfo ................................ Disclosed no confl ict of interest.Alemayehu, Berhanu ............................. Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Aleppo, Grazia ....................................... Advisory Panel: Diasend; Consultant: Dexcom, Inc.; Research

Support: Novo Nordisk Inc.Alessandrelli, Maria Cristina ................ Disclosed no confl ict of interest.Alessi, Tom ............................................ Employee: Intarcia Therapeutics, Inc.Alexander, Andrea H. ........................... Employee: Pfi zer Inc.; Stock/Shareholder: Amgen Inc., Gilead

Sciences, Inc., Johnson & Johnson, Pfi zer Inc.Alexander, Jacqueline ........................... Disclosed no confl ict of interest.Alexander, Michael ............................... Disclosed no confl ict of interest.Alexiadou, Kleopatra............................. Disclosed no confl ict of interest.Alexopoulos, Anastasia-Stefania ......... Disclosed no confl ict of interest.Alghamdi, Tamadher A. ........................ Disclosed no confl ict of interest.Alharbi, Majed ...................................... Disclosed no confl ict of interest.Al-Harbi, Mohammed Yahia.................. Disclosed no confl ict of interest.Al-Hasani, Hadi ..................................... Disclosed no confl ict of interest.Alhumaid, Haidar .................................. Disclosed no confl ict of interest.Alhusseini, Maha .................................. Disclosed no confl ict of interest.Ali, Ayad K. ........................................... Employee: Eli Lilly and Company.Ali, Mohammed K. ............................... Disclosed no confl ict of interest.Ali, Safi na .............................................. Employee: MedImmune, LLC.Alicandro, Gianfranco ........................... Disclosed no confl ict of interest.Alina, Bentkowska-Prokop .................... Disclosed no confl ict of interest.Alkaf, Budour......................................... Disclosed no confl ict of interest.Alkanani, Aimon .................................... Disclosed no confl ict of interest.Alkasem, Meis ...................................... Disclosed no confl ict of interest.Alkhatib, Einas ...................................... Disclosed no confl ict of interest.Allard, Camille....................................... Disclosed no confl ict of interest.Allard, Catherine ................................... Disclosed no confl ict of interest.Allebrandt, Karla ................................... Disclosed no confl ict of interest.Allegretto, Stephen ............................... Other Relationship: Strata Decision Technology.Allen, Elsie ............................................ Employee: Novo Nordisk Inc.Allen, Eric .............................................. Disclosed no confl ict of interest.Allen, Janet M. .................................... Disclosed no confl ict of interest.Allen, Jason W. .................................... Disclosed no confl ict of interest.

Allen, Norrina B. ................................... Disclosed no confl ict of interest.Allen, Ron .............................................. Disclosed no confl ict of interest.Aller, Rocio ............................................ Disclosed no confl ict of interest.Allison, Matthew .................................. Disclosed no confl ict of interest.Allister Price, Candice ........................... Disclosed no confl ict of interest.Allred, Nicholette D. ............................ Disclosed no confl ict of interest.Allsop, David ......................................... Disclosed no confl ict of interest.Alluis, Bertrand ..................................... Employee: ADOCIA; Stock/Shareholder: ADOCIA.Al-Mardini, Claudia ............................... Disclosed no confl ict of interest.Al-Mass, Anfal ...................................... Disclosed no confl ict of interest.Almeida-Pititto, Bianca ......................... Disclosed no confl ict of interest.Almgren, Peter ...................................... Disclosed no confl ict of interest.Al-Mrabeh, Ahmad................................ Disclosed no confl ict of interest.Alonso, G. Todd ..................................... Disclosed no confl ict of interest.Alonzo, Ryan.......................................... Disclosed no confl ict of interest.Alpers, Charles E. ................................. Disclosed no confl ict of interest.Alskaer, Oskar ....................................... Consultant: Merck & Co., Inc; Employee: Pharmetheus.Altaf, Quratulain.................................... Disclosed no confl ict of interest.Altaye, Mekibib ..................................... Disclosed no confl ict of interest.Altindis, Emrah ...................................... Disclosed no confl ict of interest.Altman, Jean-Jacques .......................... Disclosed no confl ict of interest.Altomare, Maria .................................... Disclosed no confl ict of interest.Altpeter, Bernd ...................................... Research Support: Boehringer Ingelheim GmbH.Altschuler, Andrea ................................. Disclosed no confl ict of interest.Altun Ensari, Tugba ............................... Disclosed no confl ict of interest.Alva, Maria............................................ Disclosed no confl ict of interest.Álvarez Hernández, Elisa....................... Disclosed no confl ict of interest.Alvarez, Ana M. .................................... Disclosed no confl ict of interest.Alvarez-Perez, Juan Carlos ................... Disclosed no confl ict of interest.Álvarez-Sintes, Rogelio ......................... Consultant: Abbott, Almirall, AstraZeneca, Bayer HealthCare,

Boehringer Ingelheim Pharmaceuticals, Inc., Chiesi, Eli Lilly and Company, Ferrer, GlaxoSmithKline, Grünenthal, Janssen Pharmaceuticals, Inc., Menarini Group, Mundipharma, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Ordesa, Pfi zer Inc., Recordati, Rovi, Sanofi -Aventis, Tedec-Meiji Farma, Zambom.

Alves, Beatriz C. ................................... Disclosed no confl ict of interest.Alves, Michaela L. ................................ Disclosed no confl ict of interest.Alves-Guerra, Clotilde ........................... Disclosed no confl ict of interest.Al-Wahab, Uns ...................................... Disclosed no confl ict of interest.Alyahyawi, Naseem Y. ......................... Disclosed no confl ict of interest.Alzohaili, Opdada .................................. Research Support: Valeritas; Speaker’s Bureau: Valeritas.Amadov, Gunduz.................................... Disclosed no confl ict of interest.Amar, Meera ......................................... Research Support: Alere Inc.Ambady, Ramachandran ....................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Merck Sharp

& Dohme Corp.; Research Support: Merck Sharp & Dohme Corp.; Speaker’s Bureau: Bayer HealthCare, Boehringer, Eli Lilly and Company, Johnson & Johnson, Merck Sharp & Dohme Corp., Novartis AG, Novo Nordisk A/S, Sanofi U.S.

Ambrosius, Walter T. ............................ Disclosed no confl ict of interest.Ames, Ryan ........................................... Disclosed no confl ict of interest.Amiel, Stephanie A. ............................. Disclosed no confl ict of interest.Amin, Nikhil........................................... Employee: MannKind Corporation.Amini, Sam E. ....................................... Disclosed no confl ict of interest.Aminian, Ali........................................... Disclosed no confl ict of interest.Amnakkittikul, Somvang ....................... Disclosed no confl ict of interest.Amorosa, Louis F. ................................. Disclosed no confl ict of interest.Ampudia-Blasco, F. Javier ..................... Advisory Panel: AstraZeneca, Boehringer Ingelheim, Janssen,

Merck Sharp & Dohme, Novo Nordisk, Sanofi , Takeda; Board Member: AstraZeneca, Janssen, Merck Sharp & Dohme, Sanofi ; Consultant: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novo Nordisk, Sanofi ; Research Support: Novo Nordisk, Sanofi ; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Janssen, Merck Sharp & Dohme, Novo Nordisk, Sanofi , Takeda.

An, Hyun-Ju........................................... Disclosed no confl ict of interest.An, Jee Hyun ......................................... Disclosed no confl ict of interest.An, Ling-Wang ...................................... Disclosed no confl ict of interest.An, Yali .................................................. Disclosed no confl ict of interest.Anabtawi, Abeer ................................... Disclosed no confl ict of interest.Ancel, Patricia ....................................... Disclosed no confl ict of interest.Anda, Naciu........................................... Disclosed no confl ict of interest.Andag, Uwe........................................... Employee: Evotec.Andersen, Birgitte ................................. Employee: Novo Nordisk A/S.Andersen, Gregers S. ........................... Employee: Steno Diabetes Center A/S.Andersen, Grit ....................................... Employee: Profi l Institut für Stoffwechselforschung GmbH.Andersen, Henrik U. ............................. Advisory Panel: Abbott; Stock/Shareholder: Novo Nordisk A/S.Andersen, Jens R. ................................ Disclosed no confl ict of interest.Andersen, Knut Robert .......................... Employee: Boehringer Ingelheim Norway KS.Andersen, Tue H. .................................. Disclosed no confl ict of interest.Anderson, Amy J. ................................. Employee: Optum, Inc.Anderson, Barbara J. ........................... Disclosed no confl ict of interest.Anderson, Brian..................................... Disclosed no confl ict of interest.Anderson, James H. ............................. Board Member: Generex Biotechnology; Employee: PTS

Diagnostics; Other Relationship: Eli Lilly and Company.

A698


AU

THO

R D

ISCL

OSU

RE

Anderson, Julie D. ................................ Disclosed no confl ict of interest.Anderson, Leigh .................................... Disclosed no confl ict of interest.Anderson, Nancy ................................... Disclosed no confl ict of interest.Anderson, Ryan M. ............................... Disclosed no confl ict of interest.Anderson, Simon G. ............................. Disclosed no confl ict of interest.Anderson, Stacey M. ............................ Research Support: Animas Corporation, Dexcom, Inc., InSpark

Technologies, Medtronic, Inc., Roche Diagnostics, Senseonics, Inc.

Andersson, Ehm .................................... Disclosed no confl ict of interest.Andersson, Eva-Marie........................... Employee: AstraZeneca.Anderten, Helmut .................................. Advisory Panel: Abbott, AstraZeneca, Bayer HealthCare,

Berlin-Chemie, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., LifeScan, Inc., Lilly Deutschland GmbH, Merck Sharp & Dohme Corp., Novartis Pharma AG, Novo Nordisk A/S, Pfi zer Inc., Roche Pharmaceuticals, Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited; Board Member: Sanofi -Aventis Deutschland GmbH; Research Support: GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Lilly Deutschland GmbH, Merck Sharp & Dohme Corp., Novartis Pharma AG, Novo Nordisk A/S, Pfi zer Inc., Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca, Bayer HealthCare, Berlin-Chemie, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., LifeScan, Inc., Lilly Deutschland GmbH, Merck Sharp & Dohme Corp., Novartis Pharma AG, Novo Nordisk A/S, Pfi zer Inc., Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited.

Ando, Osamu ......................................... Disclosed no confl ict of interest.Ando, Yasuyo......................................... Disclosed no confl ict of interest.Andoh, Daiki .......................................... Disclosed no confl ict of interest.Andolfo, Annapaola .............................. Disclosed no confl ict of interest.Andrade-Gordon, Patricia...................... Employee: Janssen Pharmaceuticals, Inc.Andreadi, Aikaterini .............................. Disclosed no confl ict of interest.Andreasen, Camilla ............................... Disclosed no confl ict of interest.Andreassen, Kim V. .............................. Employee: Nordic Bioscience.Andrews, James C. .............................. Disclosed no confl ict of interest.Andriankaja, Oelisoa M. ...................... Disclosed no confl ict of interest.Andrikopoulos, Sof ................................ Disclosed no confl ict of interest.Andros, Victoria ..................................... Disclosed no confl ict of interest.Aneja, Pankaj ........................................ Disclosed no confl ict of interest.Ang, Li Chang Alcey .............................. Disclosed no confl ict of interest.Ang, Lynn ............................................... Disclosed no confl ict of interest.Angelidi, Angeliki .................................. Disclosed no confl ict of interest.Angelopoulou, Stella-Maria.................. Disclosed no confl ict of interest.Anghel, Ersilia L. .................................. Disclosed no confl ict of interest.Angin, Yeliz............................................ Disclosed no confl ict of interest.Anichini, Roberto................................... Disclosed no confl ict of interest.Annamalai, Mani................................... Disclosed no confl ict of interest.Annicotte, Jean-Sebastien ................... Disclosed no confl ict of interest.Annuzzi, Giovanni .................................. Disclosed no confl ict of interest.Anson, Blake ......................................... Employee: Cellular Dynamics International.Antal, Ivana ........................................... Disclosed no confl ict of interest.Antal, Maria Cristina............................. Disclosed no confl ict of interest.Anthony, Joseph.................................... Disclosed no confl ict of interest.Antinozzi, Peter ..................................... Disclosed no confl ict of interest.Antonetti, David A. ............................... Disclosed no confl ict of interest.Antoniades, Charalambos ..................... Research Support: Sanofi -Aventis Deutschland GmbH.Antuna, Ramiro ..................................... Consultant: Abbott Diabetes Care Inc.; Speaker’s Bureau:

Abbott Diabetes Care Inc.Anuar Zaini, Azriyanti............................ Disclosed no confl ict of interest.Anupindi, Raghuram.............................. Disclosed no confl ict of interest.Anusree, N.V. ........................................ Disclosed no confl ict of interest.Anyanwagu, Uchenna C. ...................... Disclosed no confl ict of interest.Anzai, Keizo ........................................... Disclosed no confl ict of interest.Anzola, Isabel ........................................ Disclosed no confl ict of interest.Aoki, Chie .............................................. Disclosed no confl ict of interest.Aoki, Masako ........................................ Disclosed no confl ict of interest.Aoki, Yoko.............................................. Disclosed no confl ict of interest.Aoki, Yudai ............................................ Disclosed no confl ict of interest.Aouadi, Myriam..................................... Disclosed no confl ict of interest.Aoun, Charlie......................................... Disclosed no confl ict of interest.Aoyama, Natsuyo .................................. Employee: Cellular Dynamics International.Aoyama, Tomohisa ................................ Disclosed no confl ict of interest.Apolzan, John W. ................................. Disclosed no confl ict of interest.Apostolopoulou, Maria ......................... Disclosed no confl ict of interest.Apostolou, Ourania ............................... Disclosed no confl ict of interest.Apparsundaram, Subbu......................... Disclosed no confl ict of interest.Appelhans, Bradley ............................... Disclosed no confl ict of interest.Araki, Atsushi ........................................ Disclosed no confl ict of interest.Araki, Shin-Ichi ...................................... Disclosed no confl ict of interest.Aramandla, Mounika............................. Disclosed no confl ict of interest.Aramandla, Radhika .............................. Disclosed no confl ict of interest.

Aranda, Cristina .................................... Employee: Sanofi -Aventis.Aranda-Reneo, Isaac ............................. Disclosed no confl ict of interest.Araneta, Maria Rosario G. ................... Disclosed no confl ict of interest.Aranguren, Marcela .............................. Disclosed no confl ict of interest.Arani, Ramin.......................................... Employee: AstraZeneca Pharmaceuticals LP.Aranzo, Jose.......................................... Disclosed no confl ict of interest.Araque, Katherine A. ............................ Disclosed no confl ict of interest.Araz, Mustafa........................................ Research Support: Eli Lilly and Company.Arbeeny, Cynthia ................................... Employee: Genzyme Corporation.Arbiter, Brandon .................................... Employee: Tidepool.Arble, Danna ......................................... Disclosed no confl ict of interest.Arble, Deanna ....................................... Disclosed no confl ict of interest.Aregbesola, Alex ................................... Disclosed no confl ict of interest.Arena, Vincent C. ................................. Disclosed no confl ict of interest.Arends, Valerie ...................................... Disclosed no confl ict of interest.Arevalo, Sandra..................................... Disclosed no confl ict of interest.Argeseanu Cunningham, Solveig .......... Disclosed no confl ict of interest.Argyrakopoulou, Georgia ...................... Disclosed no confl ict of interest.Ari, Csilla ............................................... Disclosed no confl ict of interest.Arias, Edward ........................................ Disclosed no confl ict of interest.Arima, Naoaki ....................................... Employee: Kowa Company, Ltd.Arlotto, Michelle ................................... Disclosed no confl ict of interest.Armah, Seth M. .................................... Disclosed no confl ict of interest.Armbrecht, Eric...................................... Disclosed no confl ict of interest.Armian, Haleh ....................................... Disclosed no confl ict of interest.Armistead, Niti ...................................... Disclosed no confl ict of interest.Armstrong, David G. ............................. Disclosed no confl ict of interest.Armstrong, Paul W. .............................. Consultant: Merck & Co., Inc; Other Relationship: Merck &

Co., Inc; Research Support: AstraZeneca, Merck & Co., Inc.

Arnaldi, Claudia..................................... Disclosed no confl ict of interest.Arner, Peter ........................................... Disclosed no confl ict of interest.Ärnlöv, Johan ........................................ Disclosed no confl ict of interest.Arnold, Suzanne V. ............................... Disclosed no confl ict of interest.Arnold, William ..................................... Employee: Alere Inc.Arnolds, Sabine ..................................... Disclosed no confl ict of interest.Aroda, Vanita R. ................................... Advisory Panel: Janssen Biotech, Inc., Novo Nordisk A/S,

Sanofi -Aventis Deutschland GmbH; Consultant: Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH; Employee: MedStar Health Research Institute; Research Support: Amylin Pharmaceuticals, LLC., AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Calibra, GI Dynamics, Inc., GlaxoSmithKline, N-Gene, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited.

Aron, David C. ...................................... Disclosed no confl ict of interest.Aroner, Sarah ........................................ Disclosed no confl ict of interest.Aronson, Ronnie .................................... Advisory Panel: AstraZeneca, Janssen Pharmaceuticals,

Inc., Medtronic, Inc., Novo Nordisk A/S, Sanofi U.S.; Consultant: AstraZeneca, Janssen Pharmaceuticals, Inc., Medtronic, Inc., Novo Nordisk A/S, Sanofi U.S.; Other Relationship: Sanofi U.S.; Research Support: AbbVie Inc., AstraZeneca, BD Medical-Diabetes Care, Covance, Eli Lilly and Company, Genkyotex, GlaxoSmithKline, ICON, Plc., inVentiv Health, Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Medtronic, Inc., Merck & Co., Inc., Novo Nordisk A/S, PAREXEL International Corp., Pfi zer Inc., Quintiles Inc., Sanofi U.S.

Aroor, Annayya ...................................... Disclosed no confl ict of interest.Arora, Millie .......................................... Disclosed no confl ict of interest.Arora, Sanjeev....................................... Disclosed no confl ict of interest.Arriga, Roberto ...................................... Disclosed no confl ict of interest.Arroyo-Díez, Francisco J. ..................... Disclosed no confl ict of interest.Arslanian, Silva A. ................................ Research Support: National Institutes of Health.Arumugam, Premilla Arul ...................... Disclosed no confl ict of interest.Arumugam, Ramamani.......................... Disclosed no confl ict of interest.Arumugam, Somasundaram.................. Disclosed no confl ict of interest.Arun, Nanditha ...................................... Disclosed no confl ict of interest.Aryal, Pratik ........................................... Disclosed no confl ict of interest.Asahina, Seitaro.................................... Employee: Astellas Pharma Inc.Asakawa, Masahiro .............................. Disclosed no confl ict of interest.Asano, Mai ............................................ Research Support: Astellas Pharma Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Takeda Pharmaceutical Company Limited.

Asano, Motochika ................................. Disclosed no confl ict of interest.Asao, Keiko ........................................... Disclosed no confl ict of interest.Asare Bediako, Isaac............................. Disclosed no confl ict of interest.Ásbjörnsdóttir, Björg ............................. Disclosed no confl ict of interest.Asche, Stephen E. ................................ Disclosed no confl ict of interest.

A699


AU

THO

R D

ISCL

OSU

RE

Aschemeier, Baerbel ............................. Disclosed no confl ict of interest.Ascher-Svanum, Haya ........................... Employee: Eli Lilly and Company.Asghari, Shabnam ................................. Disclosed no confl ict of interest.Ashcraft, Jordan.................................... Disclosed no confl ict of interest.Ashford, Michael L. .............................. Disclosed no confl ict of interest.Ashok, Ashwin David ............................ Disclosed no confl ict of interest.Aslamy, Arianne .................................... Disclosed no confl ict of interest.Asmar, Ali .............................................. Disclosed no confl ict of interest.Asmar, Meena ....................................... Disclosed no confl ict of interest.Aso, Yoshimasa ..................................... Disclosed no confl ict of interest.Asp, Lauren L. ....................................... Disclosed no confl ict of interest.Asrani, Varsha ....................................... Disclosed no confl ict of interest.Assanelli, Alice ..................................... Disclosed no confl ict of interest.Assari, Shervin ...................................... Disclosed no confl ict of interest.Asseburg, Christian ............................... Employee: The Swedish Institute for Health Economics.Assemi, Parisa....................................... Disclosed no confl ict of interest.Astley, Christina .................................... Disclosed no confl ict of interest.Aston, Christopher E. ........................... Disclosed no confl ict of interest.Astrugue, Cyril....................................... Disclosed no confl ict of interest.Astrup, Arne .......................................... Consultant: Arena Pharmaceuticals, Inc., Biocare Copenhagen,

Gelesis, Global Dairy Platform, Novo Nordisk A/S, Orexigen Therapeutics, Inc., S-biotek, Weight Watchers International, Inc.

Asztalos, Bela F. ................................... Disclosed no confl ict of interest.Atageldiyeva, Kuralay K. ...................... Disclosed no confl ict of interest.Atherley, Anique E. ............................... Disclosed no confl ict of interest.Atigadda, Venkatram R. ....................... Disclosed no confl ict of interest.Atkin, Stephen L. .................................. Speaker’s Bureau: Novo Nordisk A/S.Atkinson, Mark A. ................................ Disclosed no confl ict of interest.Atsumi, Yoshihito .................................. Disclosed no confl ict of interest.Atsushi, Ishikado ................................... Disclosed no confl ict of interest.Attai, Chris ............................................ Disclosed no confl ict of interest.Attané, Camille ..................................... Disclosed no confl ict of interest.Attaoua, Redha ..................................... Disclosed no confl ict of interest.Attinger, Christopher E. ........................ Disclosed no confl ict of interest.Audet, Annick ........................................ Disclosed no confl ict of interest.Auger, Cyril ............................................ Disclosed no confl ict of interest.Augustin, Livia S. ................................. Disclosed no confl ict of interest.Augustin, Thomas ................................. Disclosed no confl ict of interest.Auld, Corinth A. .................................... Disclosed no confl ict of interest.Auriola, Seppo....................................... Disclosed no confl ict of interest.Autier, Philippe ...................................... Disclosed no confl ict of interest.Autier, Valérie........................................ Disclosed no confl ict of interest.Avery, Elizabeth ..................................... Disclosed no confl ict of interest.Avery, Erin ............................................. Disclosed no confl ict of interest.Avilés-Santa, Larissa ............................ Disclosed no confl ict of interest.Avni, Yuval ............................................. Disclosed no confl ict of interest.Axelgaard, Esben .................................. Disclosed no confl ict of interest.Axelsen, Mads Buhl .............................. Employee: Novo Nordisk A/S.Axen, Kathleen V. ................................. Disclosed no confl ict of interest.Axen, Kenneth ....................................... Disclosed no confl ict of interest.Axon, Robert N. .................................... Disclosed no confl ict of interest.Ayala, Jennifer E. ................................. Disclosed no confl ict of interest.Ayala, Julio E. ...................................... Disclosed no confl ict of interest.Aye, Tandy ............................................. Disclosed no confl ict of interest.Aylor, Kevin ........................................... Disclosed no confl ict of interest.Ayutyanont, Napatkamon ..................... Disclosed no confl ict of interest.Azalis, Ligia A. ...................................... Disclosed no confl ict of interest.Azam, Laila ............................................ Disclosed no confl ict of interest.Azamian, Bobak R. ............................... Employee: Metavention; Stock/Shareholder: Metavention.Azancot, Isaac ....................................... Disclosed no confl ict of interest.Azar, Madona G. ................................... Disclosed no confl ict of interest.Azeem, Rehan ....................................... Employee: Intarcia Therapeutics, Inc.Azinheira, Jorge .................................... Disclosed no confl ict of interest.Aziz, Umaira .......................................... Disclosed no confl ict of interest.Azmi, Shazli ........................................... Disclosed no confl ict of interest.Azpelicueta, A. ..................................... Disclosed no confl ict of interest.Azuma, Koichiro .................................... Disclosed no confl ict of interest.Azuma, Rikka ......................................... Disclosed no confl ict of interest.Baack, Michelle L. ................................ Disclosed no confl ict of interest.Baasov, Timor ........................................ Disclosed no confl ict of interest.Babra, Deshveer Singh.......................... Disclosed no confl ict of interest.Baccara-Dinet, Marie T. ....................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi U.S.Bacci, Marcelo R. ................................. Disclosed no confl ict of interest.Bach, Leon ............................................. Disclosed no confl ict of interest.Bacha, Fida ............................................ Disclosed no confl ict of interest.Bachman, Nicola ................................... Disclosed no confl ict of interest.Bäckhed, Fredrik .................................... Disclosed no confl ict of interest.Bader, Giovanni ..................................... Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG.Bae, Jae Hyun ....................................... Disclosed no confl ict of interest.Bae, Jay................................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Bae, Ji Cheol ......................................... Disclosed no confl ict of interest.Bae, Myung Ae...................................... Disclosed no confl ict of interest.Baek, Jongha......................................... Disclosed no confl ict of interest.

Baetscher, Eric ....................................... Disclosed no confl ict of interest.Baez, Santiago ...................................... Disclosed no confl ict of interest.Bagger, Jonatan I. ................................ Speaker’s Bureau: AstraZeneca.Bagger, Malene ..................................... Employee: Novo Nordisk A/S.Baggesen, Lisbeth M. .......................... Disclosed no confl ict of interest.Bagre, Variyata ...................................... Disclosed no confl ict of interest.Bahendeka, Silver K. ............................ Speaker’s Bureau: AstraZeneca, Novartis Pharmaceuticals

Corporation.Bahne, Emilie ........................................ Disclosed no confl ict of interest.Bai, Johnny-Wei .................................... Disclosed no confl ict of interest.Bai, Juli ................................................. Disclosed no confl ict of interest.Baidal, David A. .................................... Disclosed no confl ict of interest.Baier, Leslie J. ...................................... Disclosed no confl ict of interest.Baier, Rosa R. ....................................... Disclosed no confl ict of interest.Baig, Sonia ............................................ Disclosed no confl ict of interest.Baiguzhina, Sara K. .............................. Disclosed no confl ict of interest.Baik, Sei Hyun ....................................... Disclosed no confl ict of interest.Bailey Callahan, Robin .......................... Disclosed no confl ict of interest.Bailey, Clifford J. .................................. Advisory Panel: Abbott Diabetes Care Inc., American Diabetes

Association, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH.

Bailey, Jennifer L. ................................. Disclosed no confl ict of interest.Bailey, Marilyn ...................................... Disclosed no confl ict of interest.Bailey, Robert A. ................................... Employee: Janssen Scientifi c Affairs, LLC; Stock/Shareholder:

Johnson & Johnson.Bailey, Timothy S. ................................. Consultant: AstraZeneca Pharmaceuticals LP, Bayer

HealthCare, Becton, Dickinson and Company, Eli Lilly and Company, Medtronic, Inc., Novo Nordisk Inc., Sanofi U.S.; Research Support: Abbott, ACON Laboratories, Inc., Bayer HealthCare, Bristol-Myers Squibb Company, Dexcom, Inc., Eli Lilly and Company, GlaxoSmithKline, Insulet Corporation, Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., LifeScan, Inc., Medtronic, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: Abbott, Insulet Corporation, Novo Nordisk Inc., Sanofi U.S.

Bain, James........................................... Disclosed no confl ict of interest.Bain, Stephen C. ................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim GmbH,

Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH; Board Member: Glycosmedia; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Medscape, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Omnia-Med, Ltd., Sanofi -Aventis Deutschland GmbH.

Bainbridge, Veronica ............................. Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmithKline.

Bajaj, Harpreet S. ................................. Advisory Panel: AstraZeneca, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Canada Inc., Genkyotex, Janssen Biotech, Inc., Merck & Co., Inc., Novo Nordisk Inc., Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S.; Speaker’s Bureau: Abbott, AstraZeneca, Bayer Health Care, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Biotech, Inc., Medtronic, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S., Valeant Pharmaceuticals.

Bajpeyi, Sudip ....................................... Disclosed no confl ict of interest.Bajwa, Hammad A. .............................. Disclosed no confl ict of interest.Bakaj, Ivona ........................................... Employee: Janssen Pharmaceuticals, Inc.Baker, Chris ........................................... Disclosed no confl ict of interest.Baker, David .......................................... Employee: MedImmune, LLC.Baker II, Peter R. ................................... Disclosed no confl ict of interest.Baker, Rocky L. ..................................... Disclosed no confl ict of interest.Baki, Salwa ........................................... Disclosed no confl ict of interest.Bakomitrou, Florentia ............................ Disclosed no confl ict of interest.Bakris, George L. .................................. Other Relationship: Boehringer Ingelheim GmbH, Janssen

Pharmaceuticals, Inc., NxStage; Research Support: AbbVie Inc., Bayer HealthCare, Medtronic, Inc., Relypsa, Inc., Takeda Development Center Americas, Inc.

Baksh, Ali .............................................. Disclosed no confl ict of interest.Balaji, Prathab ....................................... Disclosed no confl ict of interest.Balakrishnan, Vijay ................................ Disclosed no confl ict of interest.Balashanmugam, Ponjayanthi............... Disclosed no confl ict of interest.Balasubramanyam, Ashok..................... Disclosed no confl ict of interest.Balcezak, Thomas J. ............................. Other Relationship: Strata Decision Technology.Baldelli, Luke T. .................................... Disclosed no confl ict of interest.Baldi, Simona ........................................ Disclosed no confl ict of interest.Balducci, Stefano .................................. Disclosed no confl ict of interest.Balinski, Brenda .................................... Disclosed no confl ict of interest.Balis, Dainius ........................................ Employee: Janssen Research & Development, LLC.Balkau, Beverley.................................... Advisory Panel: AstraZeneca, Bristol-Myers Squibb, Novo

Nordisk, Sanofi .

A700


AU

THO

R D

ISCL

OSU

RE

Ballantyne, Christie M. ........................ Consultant: Abbott, Amarin Pharma, Inc., Amgen Inc., AstraZeneca, Eli Lilly and Company, Esperion Therapeutics, Inc., Genzyme Corporation, Isis Pharmaceuticals, Inc., Matinas BioPharma Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Roche Pharmaceuticals, Sanofi U.S.; Research Support: Abbott, Amarin Pharma, Inc., American Diabetes Association, American Heart Association, Amgen Inc., Eli Lilly and Company, Esperion Therapeutics, Inc., National Institutes of Health, Novartis Pharmaceuticals Corporation, Otsuka Pharmaceutical Co., Ltd., Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Roche Diagnostics, Sanofi U.S., Taisho Pharmaceutical Co., Ltd.

Balliro, Courtney.................................... Disclosed no confl ict of interest.Balo, Andy ............................................. Employee: Dexcom, Inc.Baltzinger, Philippe ................................ Disclosed no confl ict of interest.Baltzis, Dimitrios ................................... Disclosed no confl ict of interest.Ban, Noriko............................................ Disclosed no confl ict of interest.Banal, Claudine ..................................... Disclosed no confl ict of interest.Bandi, Archana ...................................... Disclosed no confl ict of interest.Banerjee, Pinaki .................................... Disclosed no confl ict of interest.Banerjee, Somalee ................................ Disclosed no confl ict of interest.Bang, Rikke Beck ................................... Employee: Novo Nordisk A/S.Banke Nordbeck, Elin ............................ Disclosed no confl ict of interest.Bankhead, Emily .................................... Disclosed no confl ict of interest.Bankir, Lise ............................................ Disclosed no confl ict of interest.Banks, Jaminelli .................................... Disclosed no confl ict of interest.Banks, Phillip L. .................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc.Banning, Friederike ............................... Disclosed no confl ict of interest.Bansal, Nidhi ......................................... Disclosed no confl ict of interest.Bantle, Anne.......................................... Disclosed no confl ict of interest.Banu, Isabela......................................... Consultant: Roche Diagnostics; Other Relationship: Novo

Nordisk Inc.Bao, Wei ................................................ Disclosed no confl ict of interest.Bao, Yuqian ........................................... Disclosed no confl ict of interest.Bar Ilan, Ahuva ...................................... Disclosed no confl ict of interest.Barabanov, Valeriy M. .......................... Disclosed no confl ict of interest.Barakat, Maha T. .................................. Disclosed no confl ict of interest.Baranowski, Tom ................................... Disclosed no confl ict of interest.Barbara, Idzior-Walus............................ Disclosed no confl ict of interest.Barber, Karl W. ..................................... Disclosed no confl ict of interest.Barber, Roz ............................................ Disclosed no confl ict of interest.Barbero, Simone.................................... Disclosed no confl ict of interest.Barbour, April M. .................................. Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Barbour, Linda ....................................... Disclosed no confl ict of interest.Bardenheier, Barbara ............................ Disclosed no confl ict of interest.Bardova, Kristyna .................................. Disclosed no confl ict of interest.Bardtrum, Lars ....................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Baretto, Carol ........................................ Disclosed no confl ict of interest.Barger, Kelly .......................................... Disclosed no confl ict of interest.Barkai, Laszlo Jozsef ............................. Disclosed no confl ict of interest.Barkai, Uriel........................................... Disclosed no confl ict of interest.Barker, Natalie ...................................... Disclosed no confl ict of interest.Barkholt, Pernille ................................... Employee: Gubra ApS.Barlow, Sarah ........................................ Disclosed no confl ict of interest.Barnard, Katharine ................................ Advisory Panel: Animas Corporation, EUIDS, Roche

Diagnostics; Speaker’s Bureau: AbbVie Inc., Animas Corporation, AstraZeneca, Janssen, LifeScan, Inc., Novo Nordisk Inc., Roche Diagnostics, Sanofi .

Barnes, Catherine S. ............................ Disclosed no confl ict of interest.Barnes, Dennis ...................................... Disclosed no confl ict of interest.Barnett, Anthony H. .............................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company.

Baron, Michelle ..................................... Employee: Intarcia Therapeutics, Inc.Barone, Francesca ................................. Disclosed no confl ict of interest.Barquiel, Beatriz .................................... Disclosed no confl ict of interest.Barquissau, Valentin ............................. Disclosed no confl ict of interest.Barreto, Sandhi ..................................... Disclosed no confl ict of interest.Barrett, Amy .......................................... Disclosed no confl ict of interest.Barrett, Eugene J. ................................ Disclosed no confl ict of interest.Barrett-Connor, Elizabeth L. ................. Disclosed no confl ict of interest.Barron, John .......................................... Other Relationship: HealthCore, Inc., Sanofi U.S. Inc.Barroso, Inês ......................................... Disclosed no confl ict of interest.Barry, Courtney ...................................... Disclosed no confl ict of interest.Barry, Natasha....................................... Disclosed no confl ict of interest.Barry, Samantha .................................... Disclosed no confl ict of interest.Barry, Yaya............................................. Disclosed no confl ict of interest.Barsnes, Harald ..................................... Disclosed no confl ict of interest.Bartels, Dorothee .................................. Employee: Boehringer Ingelheim GmbH.

Barton, Kristen ...................................... Disclosed no confl ict of interest.Barzilay, Joshua I. ................................ Disclosed no confl ict of interest.Basaraba, Randall J. ............................ Disclosed no confl ict of interest.Baschiera, Fabio .................................... Employee: Novartis Pharma AG.Baser, Onur ............................................ Consultant: Janssen Scientifi c Affairs LLC., STATinMED

Research.Basina, Marina ...................................... Disclosed no confl ict of interest.Bassetti, Matteo ................................... Disclosed no confl ict of interest.Bassi, Roberto ....................................... Disclosed no confl ict of interest.Bassyouni, Atef A. ................................ Disclosed no confl ict of interest.Basta, Giuseppe .................................... Disclosed no confl ict of interest.Bastian, Lori .......................................... Disclosed no confl ict of interest.Basu, Ananda ........................................ Disclosed no confl ict of interest.Basu, Anirban ........................................ Disclosed no confl ict of interest.Basu, Arpita........................................... Disclosed no confl ict of interest.Basu, Rita .............................................. Disclosed no confl ict of interest.Batayyah, Esam ..................................... Disclosed no confl ict of interest.Batchu, Sri N. ....................................... Disclosed no confl ict of interest.Batchuluun, Battsetseg ......................... Disclosed no confl ict of interest.Batish, Sat Dev...................................... Employee: Quest Diagnostics.Batista, Rodolfo..................................... Disclosed no confl ict of interest.Batlle, Eduard ........................................ Disclosed no confl ict of interest.Batorsky, Anna ...................................... Disclosed no confl ict of interest.Batra, Manav......................................... Disclosed no confl ict of interest.Battezzati, Alberto................................. Disclosed no confl ict of interest.Bauer, Douglas C. ................................. Disclosed no confl ict of interest.Bauer, John A. ...................................... Disclosed no confl ict of interest.Bauer, Timothy A. ................................. Employee: Somalogic, Inc.Baughman, Robert................................. Employee: MannKind Corporation.Bauman, Janine M. .............................. Research Support: Merck & Co., Inc., Novo Nordisk Inc.Bauman, Viviana ................................... Disclosed no confl ict of interest.Baumann, Johannes.............................. Disclosed no confl ict of interest.Baumgartner, Amy ................................. Disclosed no confl ict of interest.Baumgartner, Iris ................................... Disclosed no confl ict of interest.Baumstark, Annette .............................. Disclosed no confl ict of interest.Baverel, Gabriel..................................... Stock/Shareholder: Metabolys Inc.Baxter, Judith ........................................ Disclosed no confl ict of interest.Bayatli, Nur ........................................... Disclosed no confl ict of interest.Bays, Harold E. ..................................... Advisory Panel: Alnylam, Amgen Inc., Eli Lilly and Company,

Isis Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, Regeneron Pharmaceuticals, Inc., Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited; Consultant: Alnylam, Amgen Inc., Eli Lilly and Company, Isis Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, Regeneron Pharmaceuticals, Inc., Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited; Research Support: Amarin Pharma, Inc., Amgen Inc., Ardea, Arisaph Pharmaceuticals, AstraZeneca, Bristol-Myers Squibb Company, Catabasis Pharmaceuticals, Inc., CymaBay Therapeutics, Eisai Co., Ltd., Elcelyx Therapeutics, Inc., Eli Lilly and Company, Esperion Therapeutics, Inc., Gilead Sciences, Inc., GlaxoSmithKline, Hanmi Pharmaceutical Co., Ltd., Hisun, Hoffman-La Roche Limited, Home Access, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co., Inc., Nektar, Novartis AG, Novo Nordisk A/S, Omthera, Orexigen Therapeutics, Inc., Pfi zer Inc., ProNova Solutions, LLC, Regeneron Pharmaceuticals, Inc., Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited, TIMI; Speaker’s Bureau: Amarin Pharma, Inc., Amgen Inc., AstraZeneca, Eisai Co., Ltd., Regeneron Pharmaceuticals, Inc., Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited.

Baysal, Nihat ......................................... Disclosed no confl ict of interest.Baz, Baz ................................................. Disclosed no confl ict of interest.Bazán, Cristina ...................................... Disclosed no confl ict of interest.Bazinet, Richard P. ................................ Disclosed no confl ict of interest.Bazzigaluppi, Elena ............................... Disclosed no confl ict of interest.Beam, Craig ........................................... Disclosed no confl ict of interest.Beard, K. Scott ...................................... Disclosed no confl ict of interest.Beato-Víbora, Pilar I. ............................ Disclosed no confl ict of interest.Beauchamp, Giovanna .......................... Disclosed no confl ict of interest.Beaumont, Robin ................................... Disclosed no confl ict of interest.Becerra, Pablo ....................................... Research Support: Fractyl.Beck Jensen, Rikke ............................... Other Relationship: Novo Nordisk A/S.Beck, Joni K. ......................................... Disclosed no confl ict of interest.Beck, Peter ............................................ Disclosed no confl ict of interest.Beck, Roy W. ........................................ Consultant: Animas Corporation, Bigfoot Biomedical,

Tandem Diabetes Care, Inc.; Research Support: Animas Corporation, Bigfoot Biomedical, Juvenile Diabetes Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases, Tandem Diabetes Care, Inc.

Beck, Stephan ....................................... Disclosed no confl ict of interest.Becker, Dorothy J. ................................ Disclosed no confl ict of interest.Becker, Laura K. .................................... Disclosed no confl ict of interest.

A701


AU

THO

R D

ISCL

OSU

RE

Becker, Mary T. ..................................... Disclosed no confl ict of interest.Becker, Thomas C. ................................ Disclosed no confl ict of interest.Beckers, Johannes ................................ Disclosed no confl ict of interest.Beckles, Gloria L. .................................. Disclosed no confl ict of interest.Beckman, Darrick J. ............................. Disclosed no confl ict of interest.Beck-Nielsen, Henning.......................... Disclosed no confl ict of interest.Becvar, Sebastian .................................. Disclosed no confl ict of interest.Bednarek, Maria.................................... Employee: MedImmune, LLC.Bednarik, Petr ........................................ Disclosed no confl ict of interest.Bedogni, Giorgio.................................... Disclosed no confl ict of interest.Bedoya, Juan Jose ................................ Disclosed no confl ict of interest.Bedrick, Edward .................................... Disclosed no confl ict of interest.Bee, Yong M. ........................................ Advisory Panel: Abbott, Janessen, Merck Sharp & Dohme

Corp., Novo Nordisk A/S.Bee, Yong Mong .................................... Disclosed no confl ict of interest.Beer, Nicola L. ...................................... Disclosed no confl ict of interest.Befroy, Douglas E. ................................ Disclosed no confl ict of interest.Begtrup, Kamilla.................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Behar, Kevin .......................................... Disclosed no confl ict of interest.Behbahani, Keywan .............................. Disclosed no confl ict of interest.Beig, Mohammad Imran........................ Disclosed no confl ict of interest.Beilman, Gregory................................... Disclosed no confl ict of interest.Bekaert, Marlies.................................... Disclosed no confl ict of interest.Belakhov, Valery .................................... Disclosed no confl ict of interest.Beleigoli, Alline ..................................... Disclosed no confl ict of interest.Belfort-DeAguiar, Renata ...................... Disclosed no confl ict of interest.Beli, Eleni .............................................. Disclosed no confl ict of interest.Bell, Christopher.................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Bell, Kelly .............................................. Employee: AstraZeneca; Stock/Shareholder: AstraZeneca,

Bristol-Myers Squibb.Bell, Ronny A. ....................................... Disclosed no confl ict of interest.Bellan, Mattia ....................................... Disclosed no confl ict of interest.Bellante, Rosalia ................................... Disclosed no confl ict of interest.Bellary, Srikanth .................................... Advisory Panel: Merck Sharp & Dohme Corp., Novo

Nordisk Inc.; Research Support: Novo Nordisk Inc., The Binding Site; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH.

Bellia, Alfonso ....................................... Disclosed no confl ict of interest.Bellido, Diego ........................................ Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Nestlé, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis; Consultant: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis.

Bellili-Muñoz, Naïma ............................ Disclosed no confl ict of interest.Bellin, Melena D. ................................. Research Support: Dompé Pharmaceutical, Medtronic

MiniMed, Inc., Merck & Co., Inc.Belongie, Kirstine J. ............................. Employee: Janssen Pharmaceuticals, Inc.Belsley, Scott......................................... Disclosed no confl ict of interest.Belton, Anne.......................................... Consultant: LifeScan Canada Ltd.Bem, Robert........................................... Disclosed no confl ict of interest.Ben Fradj, Selma ................................... Disclosed no confl ict of interest.Ben Nasr, Moufi da ................................ Disclosed no confl ict of interest.Bender, Diane ........................................ Disclosed no confl ict of interest.Bendlin, Barbara B. .............................. Research Support: AG033514, National Institutes of Health.Benedini, Stefano.................................. Disclosed no confl ict of interest.Benes, Marek ........................................ Disclosed no confl ict of interest.Benesch, Carsten .................................. Disclosed no confl ict of interest.Benetti, Alberto ..................................... Disclosed no confl ict of interest.Benford, Michael................................... Disclosed no confl ict of interest.Benite-Ribeiro, Sandra A. .................... Disclosed no confl ict of interest.Benitez-Aguirre, Paul Z. ....................... Disclosed no confl ict of interest.Benjamin, Tonya R. ............................... Disclosed no confl ict of interest.Bennett, Denise..................................... Disclosed no confl ict of interest.Bennett, Hayley ..................................... Research Support: AstraZeneca.Bennett, Peter H. .................................. Advisory Panel: International Diabetes Federation, World

Health Organization; Stock/Shareholder: American Heart Association, CVS Health Corporation, Gilead Sciences, Inc., Johnson & Johnson, UnitedHealth Group.

Bennett, Robert G. ................................ Disclosed no confl ict of interest.Benninger, Richard K. ........................... Disclosed no confl ict of interest.Benninghoff, Tim ................................... Disclosed no confl ict of interest.Benrick, Anna ........................................ Disclosed no confl ict of interest.Ben-Skowronek, Iwona ......................... Disclosed no confl ict of interest.Bentata, Rabia....................................... Disclosed no confl ict of interest.Bentley, John......................................... Disclosed no confl ict of interest.Bentley-Lewis, Rhonda ......................... Consultant: Merck Sharp & Dohme Corp., Sanofi U.S.;

Research Support: Amgen Inc. (Spouse/Partner), Novartis Pharmaceuticals Corporation (Spouse/Partner), Sanofi U.S., Sanofi U.S. (Spouse/Partner).

Benware, Sheila .................................... Employee: Pacifi c Diabetes Technologies, Inc.; Stock/Shareholder: Pacifi c Diabetes Technologies, Inc.

Bequette, B. Wayne .............................. Disclosed no confl ict of interest.Beraldo, Rebeca A. ............................... Disclosed no confl ict of interest.Berard, Lori D. ...................................... Advisory Panel: Abbott, AstraZeneca, Becton, Dickinson and

Company, Eli Lilly and Company, Janssen, Lifescan, Novo Nordisk, Sanofi ; Consultant: Abbott, AstraZeneca, Bayer, Becton, Dickinson and Company, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Lifescan, Merck, Novo Nordisk, Sanofi ; Speaker’s Bureau: Abbott, AstraZeneca, Bayer, Becton, Dickinson and Company, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Lifescan, Merck, Novo Nordisk, Sanofi .

Berencsi, Klara ...................................... Disclosed no confl ict of interest.Beresford, Shirley.................................. Disclosed no confl ict of interest.Berg, Cynthia A. ................................... Disclosed no confl ict of interest.Berg, Gabriela ....................................... Disclosed no confl ict of interest.Berg, Sofi a ............................................. Disclosed no confl ict of interest.Bergen, Karin......................................... Disclosed no confl ict of interest.Bergenheim, Klas .................................. Employee: AstraZeneca.Bergenstal, Richard M. ........................ Advisory Panel: Boehringer Ingelheim GmbH, Bristol-Meyers

Squibb/Astrazeneca, Eli Lilly and Company, Halozyme Therapeutics, Johnson & Johnson, Novo Nordisk Inc., Roche Pharmaceuticals, Sanofi U.S., Takeda Pharmaceutical Company Limited; Consultant: Boehringer Ingelheim GmbH, Bristol-Meyers Squibb/Astrazeneca, Eli Lilly and Company, Halozyme Therapeutics, Johnson & Johnson, Novo Nordisk Inc., Roche Pharmaceuticals, Sanofi U.S., Takeda Pharmaceutical Company Limited; Research Support: Boehringer Ingelheim GmbH, Bristol-Meyers Squibb/Astrazeneca, Eli Lilly and Company, Halozyme Therapeutics, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Roche Pharmaceuticals, Sanofi U.S., Takeda Pharmaceutical Company Limited.

Berger, Janine ....................................... Disclosed no confl ict of interest.Berger, Kimberly M. ............................. Disclosed no confl ict of interest.Berget, Cari ........................................... Disclosed no confl ict of interest.Berggren, Per-Olof ................................. Disclosed no confl ict of interest.Bergin, Stephen..................................... Disclosed no confl ict of interest.Bergis-Jurgan, Nikola ........................... Speaker’s Bureau: Berlin-Chemie.Bergman, Arthur .................................... Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc.Bergman, Richard N. ............................ Advisory Panel: GI Dynamics, Inc., Ingredion Incorporated,

Novo Nordisk Inc; Consultant: GI Dynamics, Inc., Ingredion Incorporated, Novo Nordisk Inc; Research Support: GI Dynamics, Inc., Janssen Pharmaceuticals, Inc., Novo Nordisk Inc.

Bergmann, Karin.................................... Employee: Sanofi -Aventis Deutschland GmbH.Bergner, Erin M. ................................... Disclosed no confl ict of interest.Bergwitz, Clemens ................................ Disclosed no confl ict of interest.Berhanu, Paulos .................................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi .Berker, Dilek .......................................... Disclosed no confl ict of interest.Berman, Dora M. .................................. Disclosed no confl ict of interest.Bermick, Jennifer .................................. Disclosed no confl ict of interest.Bernal-Lopez, M. Rosa .......................... Disclosed no confl ict of interest.Bernal-Mizrachi, Ernesto....................... Disclosed no confl ict of interest.Bernard, Elise ........................................ Employee: MedImmune, LLC.Bernard, Monique ................................. Disclosed no confl ict of interest.Berne, Christian..................................... Disclosed no confl ict of interest.Berni, Ellen ............................................ Employee: Pharmatelligence.Bernjak, Alan ......................................... Disclosed no confl ict of interest.Bernlohr, David A. ................................ Disclosed no confl ict of interest.Berria, Rachele ...................................... Employee: Sanofi U.S.Berrigan, David...................................... Disclosed no confl ict of interest.Berryman, Darlene E. ........................... Disclosed no confl ict of interest.Berthold, Carolyn................................... Disclosed no confl ict of interest.Bertoli, Simona...................................... Disclosed no confl ict of interest.Bertolini, Monica................................... Employee: Sanofi U.S.Bertoni, Alain G. ................................... Disclosed no confl ict of interest.Besançon, Stéphane ............................. Disclosed no confl ict of interest.Beshyah, Salem A. ............................... Advisory Panel: AstraZeneca, Eli Lilly and Company, Merck

Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis; Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis, Servier.

Besser, Rachel ....................................... Disclosed no confl ict of interest.Bessho, Ryoichi ..................................... Disclosed no confl ict of interest.Best, Conor J. ....................................... Disclosed no confl ict of interest.Bethea, Maigen..................................... Disclosed no confl ict of interest.Bethel, M. Angelyn ............................... Research Support: Bayer HealthCare, Novartis

Pharmaceuticals Corporation.Betonico, Carolina Castro Rocha .......... Disclosed no confl ict of interest.Betriu, Angels........................................ Disclosed no confl ict of interest.Bettinger, Dominik ................................. Disclosed no confl ict of interest.Bettini, Maria ........................................ Disclosed no confl ict of interest.Bettini, Matthew L. .............................. Disclosed no confl ict of interest.Beverly, Elizabeth A. ............................. Disclosed no confl ict of interest.

A702


AU

THO

R D

ISCL

OSU

RE

Bevier, Wendy ....................................... Disclosed no confl ict of interest.Bhagat, Abhijeet ................................... Disclosed no confl ict of interest.Bhagyalakshmy, U ................................. Disclosed no confl ict of interest.Bhalla, Sandeep .................................... Disclosed no confl ict of interest.Bhalshankar, Jaydutt Digambar ............ Disclosed no confl ict of interest.Bhansali, Anil ........................................ Disclosed no confl ict of interest.Bhansali, Shipra .................................... Disclosed no confl ict of interest.Bhansali, Shobhit .................................. Disclosed no confl ict of interest.Bharara, Manish.................................... Disclosed no confl ict of interest.Bhat, Owais Mohammad ...................... Disclosed no confl ict of interest.Bhatnagar, Pallav .................................. Employee: Eli Lilly and Company.Bhatt, Deepak........................................ Disclosed no confl ict of interest.Bhattacharyya, Amit.............................. Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Bhattarai, Bikash ................................... Disclosed no confl ict of interest.Bhatwadekar, Ashay ............................. Disclosed no confl ict of interest.Bhoi, Bibhuti B. ..................................... Employee: Zydus Research Centre, Cadila Healthcare Limited,

Ahmedabad, India.Bhosekar, Vaishali ................................. Employee: Novartis Healthcare Private Limited.Bhosle, Deepak ..................................... Disclosed no confl ict of interest.Bhosle, Vandana ................................... Disclosed no confl ict of interest.Bi, Yan ................................................... Disclosed no confl ict of interest.Bi, Yufang .............................................. Disclosed no confl ict of interest.Bian, Rongwen ...................................... Disclosed no confl ict of interest.Bianchi, Elena........................................ Disclosed no confl ict of interest.Bibok, György ........................................ Employee: 77 Electronics Co., Ltd.Bicciato, Silvio....................................... Disclosed no confl ict of interest.Bickel, Perry........................................... Disclosed no confl ict of interest.Biel, Beth ............................................... Other Relationship: Anthem, Inc.Bielohuby, Maximilian........................... Employee: Sanofi -Aventis Deutschland GmbH.Bierbrauer, Mary ................................... Disclosed no confl ict of interest.Bierman, Arlene S. ............................... Disclosed no confl ict of interest.Bierwagen, Alessandra ......................... Disclosed no confl ict of interest.Biester, Torben ...................................... Disclosed no confl ict of interest.Bieszk, Nella.......................................... Employee: Sanofi U.S.Bijos, Pawel........................................... Employee: Teva Pharmaceutical Industries Ltd.Bilal, Usama .......................................... Disclosed no confl ict of interest.Bilic-Curcic, Ines.................................... Disclosed no confl ict of interest.Bilir, Bülent ............................................ Disclosed no confl ict of interest.Billings, John C. ................................... Disclosed no confl ict of interest.Billings, Liana K. ................................... Consultant: Dexcom, Inc., Novo Nordisk Inc.Billionnet, Cécile ................................... Disclosed no confl ict of interest.Billy, D’Izraiel......................................... Disclosed no confl ict of interest.Bingham, Brianna A. ............................ Disclosed no confl ict of interest.Bingley, Polly J. .................................... Disclosed no confl ict of interest.Bini, Jason............................................. Disclosed no confl ict of interest.Binikos, Isidoros .................................... Disclosed no confl ict of interest.Binns-Hall, Oliver .................................. Disclosed no confl ict of interest.Biondi, Giuseppina ................................ Disclosed no confl ict of interest.Birch, Lewis ........................................... Disclosed no confl ict of interest.Birk Østerskov, Anne ............................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Birkeland, Kare ...................................... Disclosed no confl ict of interest.Birkenfeld, Andreas L. .......................... Disclosed no confl ict of interest.Birnbaum, Howard ................................ Employee: Analysis Group; Research Support: Eli Lilly and

Company.Birtles, Linda ......................................... Disclosed no confl ict of interest.Bishop, Nicholas H. .............................. Disclosed no confl ict of interest.Biten, Hilal............................................. Disclosed no confl ict of interest.Bittner, Ava K. ...................................... Research Support: Adaptive Sensory Technology, LLC.Biunno, Ida ............................................ Disclosed no confl ict of interest.Bjerre, Mette ......................................... Disclosed no confl ict of interest.Bjerre-Christensen, Ulla ........................ Employee: Steno Diabetes Center A/S.Bjørner, Jakob B. .................................. Consultant: Novo Nordisk A/S; Employee:

OptumInsight.Bjornstad, Petter ................................... Disclosed no confl ict of interest.Black, Kristin ......................................... Disclosed no confl ict of interest.Black, Mary Helen ................................. Disclosed no confl ict of interest.Blackburn, Geroge ................................. Disclosed no confl ict of interest.Blaha, Michael J. ................................. Disclosed no confl ict of interest.Blahnik, Gabriele ................................... Disclosed no confl ict of interest.Blair, Steven N. .................................... Disclosed no confl ict of interest.Blakeney, Tamara .................................. Disclosed no confl ict of interest.Blanchard, Jeanine ............................... Disclosed no confl ict of interest.Blanchet, Emilie .................................... Disclosed no confl ict of interest.Blanco Mejia, Sonia .............................. Disclosed no confl ict of interest.Blanco, Laurence ................................... Disclosed no confl ict of interest.Blankstein, Ron ..................................... Disclosed no confl ict of interest.Blaslov, Kristina..................................... Disclosed no confl ict of interest.Blaszczak, Alecia ................................... Disclosed no confl ict of interest.Blau, Jenny E. ....................................... Disclosed no confl ict of interest.Bletsa, Evdoxia ...................................... Disclosed no confl ict of interest.Bliss, Karen ........................................... Disclosed no confl ict of interest.Blobel, Gerd A. ..................................... Disclosed no confl ict of interest.Blodgett, David M. ............................... Disclosed no confl ict of interest.Bloise, Donatella ................................... Disclosed no confl ict of interest.

Blonde, Lawrence.................................. Consultant: AstraZeneca, GlaxoSmithKline, Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Quest Diagnostics, Sanofi U.S.; Research Support: Eli Lilly and Company, Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: AstraZeneca, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S.

Bloom, Jonathan D. .............................. Board Member: Podimetrics, Inc.; Employee: Podimetrics, Inc.; Stock/Shareholder: Podimetrics, Inc.

Blot, William J. .................................... Disclosed no confl ict of interest.Bloudek, Lisa ......................................... Consultant: Novo Nordisk Inc.Blouin, Jean-Louis................................. Disclosed no confl ict of interest.Blueher, Matthias .................................. Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Lilly, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Consultant: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Lilly, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., RIEMSER Pharma GmbH; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Lilly, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi .

Bluestone, Jeffrey A. ........................... Disclosed no confl ict of interest.Blum, Janice.......................................... Disclosed no confl ict of interest.Blumensatt, Marcel............................... Disclosed no confl ict of interest.Blumer, Ian ............................................ Advisory Panel: BD Medical-Diabetes Care, Eli Lilly and

Company, Insulet Corporation, Janssen Global Services, LLC, Medtronic, Inc., Novo Nordisk Inc., Sanofi U.S.

Blundell, John ....................................... Advisory Panel: Novo Nordisk A/S; Consultant: Novo Nordisk A/S; Research Support: Novo Nordisk A/S.

Blustein, Erica C. .................................. Disclosed no confl ict of interest.Boa, Beatriz C. ...................................... Disclosed no confl ict of interest.Boada, Merce ........................................ Disclosed no confl ict of interest.Boatright, Steven M. ............................ Disclosed no confl ict of interest.Boban, Saja ........................................... Disclosed no confl ict of interest.Bobde, Jyoti .......................................... Disclosed no confl ict of interest.Bobelu, Jeanette ................................... Disclosed no confl ict of interest.Bocian, Carla ......................................... Disclosed no confl ict of interest.Bock, Christopher .................................. Disclosed no confl ict of interest.Bode, Bruce W. ..................................... Consultant: AstraZeneca, Biodel, Biodel Inc., Janssen

Pharmaceuticals, Inc., Medtronic, Inc., Novo Nordisk A/S, Sanofi , Valeritas; Employee: Atlanta Diabetes Associates; Research Support: Abbott, Becton, Dickinson and Company, Biodel Inc., Dexcom, Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Juvenile Diabetes Research Foundation, Lexicon Pharmaceuticals, Inc., Lilly/Boehringer Ingelheim, MannKind Corporation, Medtronic, Inc., National Institutes of Health, Novo Nordisk Inc., Pfi zer Inc., Sanofi ; Speaker’s Bureau: Astellas Pharma Inc., GlaxoSmithKline, Insulet Corporation, Janssen Pharmaceuticals, Inc., Lilly/Boehringer Ingelheim, Medtronic, Inc., Merck, Novo Nordisk A/S, Sanofi , Valeritas; Stock/Shareholder: Aseko.

Bódis, Kálmán ....................................... Disclosed no confl ict of interest.Bodnar, Timothy ..................................... Disclosed no confl ict of interest.Boehm, Anja .......................................... Disclosed no confl ict of interest.Boehm, Marcus ..................................... Employee: Receptos.Boelen, Anita......................................... Disclosed no confl ict of interest.Boëlle-Le Corfec, Emmanuelle .............. Employee: Sanofi .Boero, Laura .......................................... Disclosed no confl ict of interest.Bogachus, Lindsey................................. Disclosed no confl ict of interest.Bogardus, Clifton................................... Disclosed no confl ict of interest.Bogart, Michael..................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Bogdanet, Delia..................................... Disclosed no confl ict of interest.Bogdanov, Patricia................................. Disclosed no confl ict of interest.Bogun, Magdalena M. ......................... Disclosed no confl ict of interest.Bohren, Kurt .......................................... Disclosed no confl ict of interest.Bois, Timothée....................................... Disclosed no confl ict of interest.Boisseau, Nathalie ................................ Board Member: Valbiotis.Bojsen-Møller, Kirstine N. .................... Speaker’s Bureau: Eli Lilly and Company.Bokvist, Krister ...................................... Employee: Eli Lilly and Company.Boland, Brandon .................................... Employee: MedImmune, LLC.Bolick, Natasha G. ................................ Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.Bolinder, Jan ......................................... Advisory Panel: Abbott Diabetes Care Inc., Integrity

Applications Ltd., Sanofi Sweden; Employee: Pfi zer Inc. (Spouse/Partner); Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Sanofi Sweden.

Bollanti, Lucilla...................................... Disclosed no confl ict of interest.Bollhalter, Linda .................................... Disclosed no confl ict of interest.Bolli, Geremia B. .................................. Advisory Panel: Sanofi -Aventis Deutschland GmbH;

Board Member: Eli Lilly and Company, Sanofi -Aventis Deutschland GmbH; Consultant: Eli Lilly and Company, Sanofi -Aventis Deutschland GmbH.

Bolo, Nicolas R. .................................... Disclosed no confl ict of interest.

A703


AU

THO

R D

ISCL

OSU

RE

Bolze, Sebastien.................................... Employee: Poxel Pharmaceutical Company.Bompada, Pradeep ................................ Disclosed no confl ict of interest.Bonab, Elmira ........................................ Disclosed no confl ict of interest.Bonaccorso, Antoinette......................... Disclosed no confl ict of interest.Bonadonna, Riccardo C. ....................... Advisory Panel: Amgen Inc., Eli Lilly and Company, Johnson

& Johnson, Merck Sharp & Dohme Corp., Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Sanofi -Aventis Deutschland GmbH.

Bondarenko, Natalia A. ........................ Disclosed no confl ict of interest.Bonde Jacobsen, Jacob ........................ Employee: Novo Nordisk A/S.Bonde, Lisbeth....................................... Disclosed no confl ict of interest.Bondia, Jorge ........................................ Disclosed no confl ict of interest.Bonds, Denise E. .................................. Disclosed no confl ict of interest.Bonfadini, Silvia .................................... Disclosed no confl ict of interest.Bönhof, Gidon........................................ Disclosed no confl ict of interest.Bonhomme, Keisha ............................... Disclosed no confl ict of interest.Boniol, Mathieu..................................... Disclosed no confl ict of interest.Bonnell, Ric ........................................... Disclosed no confl ict of interest.Bonnemaire, Mireille ............................ Employee: Sanofi .Bonner, Caroline .................................... Disclosed no confl ict of interest.Bonner-Weir, Susan .............................. Disclosed no confl ict of interest.Bonnyman, Claire W. ............................ Disclosed no confl ict of interest.Bonora, Enzo.......................................... Disclosed no confl ict of interest.Bonsignore, Patricia J. ......................... Disclosed no confl ict of interest.Boonin, Alan .......................................... Disclosed no confl ict of interest.Booth, Gillian L. .................................... Disclosed no confl ict of interest.Booth, Robby ......................................... Disclosed no confl ict of interest.Boothby, Mark ....................................... Disclosed no confl ict of interest.Borchert, Kristen M. ............................. Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.Borck, Anja ............................................ Employee: Sanofi -Aventis Deutschland GmbH.Borg, Hermann ...................................... Disclosed no confl ict of interest.Borkowska, Anna .................................. Disclosed no confl ict of interest.Bornfeldt, Karin E. ................................ Disclosed no confl ict of interest.Bornstein, Stefan R. ............................. Disclosed no confl ict of interest.Bortell, Rita ........................................... Disclosed no confl ict of interest.Bosch, Tyler A. ...................................... Disclosed no confl ict of interest.Bose, Rupan .......................................... Disclosed no confl ict of interest.Boselli, Maria Linda .............................. Disclosed no confl ict of interest.Bosi, Emanuele...................................... Disclosed no confl ict of interest.Boss, Anders ......................................... Employee: Sanofi .Bossowski, Artur ................................... Disclosed no confl ict of interest.Boston, Ray ........................................... Disclosed no confl ict of interest.Bota, Maria ........................................... Disclosed no confl ict of interest.Botchway, Albert ................................... Disclosed no confl ict of interest.Botros, Diana......................................... Disclosed no confl ict of interest.Botros, Fady T. ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Botta, Eliana .......................................... Disclosed no confl ict of interest.Bottino, Rita .......................................... Disclosed no confl ict of interest.Botvinick, Elliot...................................... Disclosed no confl ict of interest.Bouby, Nadine ....................................... Disclosed no confl ict of interest.Bouça, Bruno ......................................... Disclosed no confl ict of interest.Bouchard, Guy ....................................... Disclosed no confl ict of interest.Bouchard, Jonathan .............................. Employee: Novo Nordisk Inc.Bouchard, Luigi...................................... Disclosed no confl ict of interest.Bouché, Clara ........................................ Disclosed no confl ict of interest.Boucher, Jeremie .................................. Disclosed no confl ict of interest.Bouchi, Ryotaro ..................................... Disclosed no confl ict of interest.Bouchonville, Matthew F. .................... Disclosed no confl ict of interest.Bouhairie, Victoria E. ............................ Disclosed no confl ict of interest.Boulet, Genevieve ................................. Disclosed no confl ict of interest.Boulton, Andrew J.M. .......................... Disclosed no confl ict of interest.Boulton, David W. ................................ Stock/Shareholder: AstraZeneca, Bristol-Myers Squibb

Company.Boulton, Michael E. .............................. Disclosed no confl ict of interest.Boulware, David .................................... Disclosed no confl ict of interest.Bousboulas, Stavros.............................. Disclosed no confl ict of interest.Bouskela, Eliete..................................... Disclosed no confl ict of interest.Boutati, Eleni ......................................... Disclosed no confl ict of interest.Bouxsein, Mary ..................................... Disclosed no confl ict of interest.Bouzakri, Karim ..................................... Disclosed no confl ict of interest.Bouziana, Stella .................................... Disclosed no confl ict of interest.Bovbjerg, Marit L. ................................. Disclosed no confl ict of interest.Bowden, Donald W. ............................. Disclosed no confl ict of interest.Bowden, Sasigarn ................................. Disclosed no confl ict of interest.Bowering, Keith..................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck, Novo Nordisk A/S, Sanofi ; Consultant: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck; Research Support: AstraZeneca, Eli Lilly and Company, Merck, Novo Nordisk A/S, Sanofi .

Bowman, Christopher R. ...................... Disclosed no confl ict of interest.Bowyer, Vicky ........................................ Disclosed no confl ict of interest.Boyd, Kelly............................................. Disclosed no confl ict of interest.Boye, Kristina S. ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Boyko, Edward J. .................................. Disclosed no confl ict of interest.Boyle, Claire T. ..................................... Disclosed no confl ict of interest.Boyle, Kristen E. ................................... Disclosed no confl ict of interest.Boyle, Mary E. ...................................... Disclosed no confl ict of interest.Boyle, Peter ........................................... Disclosed no confl ict of interest.Boyuk, Gulbahar .................................... Disclosed no confl ict of interest.Bozadjieva, Nadejda I. ......................... Disclosed no confl ict of interest.Bozkaya, Giray ....................................... Disclosed no confl ict of interest.Bozovic, Andrea..................................... Disclosed no confl ict of interest.Bozzetto, Lutgarda................................. Disclosed no confl ict of interest.Bozzo, Janis E. ...................................... Other Relationship: Strata Decision Technology.Brabec, Marek ....................................... Disclosed no confl ict of interest.Brachs, Sebastian ................................. Disclosed no confl ict of interest.Bracy, Deanna P. ................................... Disclosed no confl ict of interest.Bradford, John....................................... Employee: Calibra Medical; Stock/Shareholder: Johnson &

Johnson.Bradley, David ....................................... Disclosed no confl ict of interest.Bradley, Paige K. .................................. Disclosed no confl ict of interest.Brady, Cassandra................................... Disclosed no confl ict of interest.Brahmachary, Enugurthi ........................ Disclosed no confl ict of interest.Brain, Joseph ........................................ Consultant: MannKind Corporation, Sanofi U.S.Bramer, Lisa ........................................... Disclosed no confl ict of interest.Bramlage, Peter..................................... Consultant: AstraZeneca, Berlin-Chemie, Boehringer

Ingelheim GmbH, Novartis Pharma GmbH, Sanofi -Aventis Deutschland GmbH.

Brancale, Joseph................................... Disclosed no confl ict of interest.Brancato, Davide ................................... Disclosed no confl ict of interest.Brandon, Amanda E. ............................. Disclosed no confl ict of interest.Brandslund, Ivan.................................... Disclosed no confl ict of interest.Brandtner, Eva M. ................................. Disclosed no confl ict of interest.Branigan, Deborah ................................ Disclosed no confl ict of interest.Brantly, Mark ......................................... Disclosed no confl ict of interest.Brathwaite, Collin ................................. Disclosed no confl ict of interest.Braun, Ursula......................................... Disclosed no confl ict of interest.Bray, George A. .................................... Disclosed no confl ict of interest.Brayman, Kenneth L. ............................ Disclosed no confl ict of interest.Brazg, Ron ............................................. Research Support: Medtronic, Inc.Brazil, Derek P. ...................................... Disclosed no confl ict of interest.Breault, David........................................ Disclosed no confl ict of interest.Bredefeld, Cindy L. ............................... Disclosed no confl ict of interest.Bree, Mark............................................. Employee: Genzyme Corporation.Breen, Matthew .................................... Employee: Pacifi c Diabetes Technologies, Inc.; Stock/

Shareholder: Pacifi c Diabetes Technologies, Inc.Breitschopf, Kristin................................ Employee: Sanofi -Aventis Deutschland GmbH.Bremer, Andrew A. ............................... Disclosed no confl ict of interest.Bremholm, Lasse ................................... Disclosed no confl ict of interest.Brennan, Julie ....................................... Disclosed no confl ict of interest.Brennan, Meghan.................................. Disclosed no confl ict of interest.Brenner, Jeffrey ..................................... Disclosed no confl ict of interest.Brennon, Ursula..................................... Disclosed no confl ict of interest.Brent, Michael H. ................................. Disclosed no confl ict of interest.Brethauer, Stacy A. .............................. Disclosed no confl ict of interest.Bretler, Ditte-Marie ............................... Employee: Novo Nordisk A/S.Breton, Marc D. .................................... Research Support: Becton, Dickinson and Company, Roche

Diagnostics, Sanofi U.S., Tandem Diabetes Care, Inc.; Stock/Shareholder: TypeZero Technologies.

Brewer, Paul Duffi eld ............................ Disclosed no confl ict of interest.Brewster, Luke ....................................... Disclosed no confl ict of interest.Briad, Francois....................................... Employee: Physiogenex.Brideau, Lisa.......................................... Employee: Pfi zer Inc.Bright, Tamis ......................................... Disclosed no confl ict of interest.Brigstock, David R. ............................... Disclosed no confl ict of interest.Bril, Fernando ........................................ Disclosed no confl ict of interest.Bril, Vera ................................................ Disclosed no confl ict of interest.Brinton, Eliot A. .................................... Advisory Panel: Amarin Pharma, Inc.; Consultant: Alexion

Pharmaceuticals, Amarin Pharma, Inc., Amgen Inc., Janssen Pharmaceuticals, Inc., Kowa Pharmaceuticals America, Inc., Merck & Co., Inc., Sanofi U.S.; Speaker’s Bureau: Alexion Pharmaceuticals, Amarin Pharma, Inc., Amgen Inc., Janssen Pharmaceuticals, Inc., Kowa Pharmaceuticals America, Inc., Merck & Co., Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited.

Brissova, Marcela ................................. Disclosed no confl ict of interest.Brites, Fernando .................................... Disclosed no confl ict of interest.Brito, Luciano A. ................................... Disclosed no confl ict of interest.Broberg, Malin ...................................... Employee: AstraZeneca.Broche, Benjamin .................................. Disclosed no confl ict of interest.Brock, Birgitte........................................ Disclosed no confl ict of interest.Brock, Christina ..................................... Disclosed no confl ict of interest.Brodovicz, Kimberly ............................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Brodsky, Irwin ........................................ Disclosed no confl ict of interest.

A704


AU

THO

R D

ISCL

OSU

RE

Brodsky, Michael ................................... Disclosed no confl ict of interest.Brody, Jennifer ...................................... Disclosed no confl ict of interest.Broeckling, Corey D. ............................. Disclosed no confl ict of interest.Broedl, Uli C. ........................................ Employee: Boehringer Ingelheim GmbH.Brokaw, Sarah M. ................................. Disclosed no confl ict of interest.Bronas, Ulf............................................. Disclosed no confl ict of interest.Brønden, Andreas.................................. Disclosed no confl ict of interest.Brooks, Ashley....................................... Disclosed no confl ict of interest.Brooks, Belinda A. ................................ Disclosed no confl ict of interest.Brooks, Jennifer .................................... Employee: Receptos (Celgene).Brousseau, Emmanuel........................... Employee: Physiogenex.Brown, Adam S. ................................... Disclosed no confl ict of interest.Brown, Anne.......................................... Disclosed no confl ict of interest.Brown, James B. .................................. Disclosed no confl ict of interest.Brown, Jo Ann....................................... Disclosed no confl ict of interest.Brown, Lee ............................................ Disclosed no confl ict of interest.Brown, Mark S. .................................... Disclosed no confl ict of interest.Brown, Nicholas F. ............................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Brown, Rebecca J. ............................... Disclosed no confl ict of interest.Brown, Simon H. .................................. Disclosed no confl ict of interest.Brown, Steven ....................................... Disclosed no confl ict of interest.Brown, Sue ............................................ Research Support: Animas Corporation, ConAgra, Dexcom,

Inc., LifeScan, Inc., Medtronic, Inc., Roche Diagnostics.Brown, Susan D. ................................... Disclosed no confl ict of interest.Brown, Talia L. ...................................... Disclosed no confl ict of interest.Broyles, Stephanie T. ........................... Disclosed no confl ict of interest.Brož, Jan................................................ Disclosed no confl ict of interest.Brozinick, Joseph T. .............................. Disclosed no confl ict of interest.Brubaker, Patricia L. ............................. Research Support: Novo Nordisk A/S.Bruce, Kimberley D. .............................. Disclosed no confl ict of interest.Bruce, Simon ......................................... Employee: ADOCIA; Stock/Shareholder: ADOCIA.Bruder, Jan ............................................ Disclosed no confl ict of interest.Bruggeman, Emily C. ............................ Disclosed no confl ict of interest.Brulle-Wohlhueter, Claire ..................... Employee: Sanofi .Brumm, Susan D. .................................. Disclosed no confl ict of interest.Brun, Jean-Frederic ............................... Disclosed no confl ict of interest.Brunelle, Rocco ..................................... Consultant: PTS Diagnostics; Employee: B2S Consulting.Brüning, Jens C. ................................... Disclosed no confl ict of interest.Brunner, Eric J. ..................................... Disclosed no confl ict of interest.Brunner, Hermine .................................. Disclosed no confl ict of interest.Brunt, Elizabeth M. ............................... Disclosed no confl ict of interest.Brusko, Cynthia S. ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Brusko, Todd M. ................................... Disclosed no confl ict of interest.Bry, Lynn ................................................ Disclosed no confl ict of interest.Bryhn, Morten ....................................... Disclosed no confl ict of interest.Bu, Le..................................................... Disclosed no confl ict of interest.Bu, So Young ......................................... Disclosed no confl ict of interest.Buchanan, Thomas A. .......................... Disclosed no confl ict of interest.Buchwald, Peter .................................... Disclosed no confl ict of interest.Buck Louis, Germaine............................ Disclosed no confl ict of interest.Buckingham, Bruce A. .......................... Consultant: Medtronic MiniMed, Inc., Novo-Nordisk, Sanofi ,

Tandem Diabetes Care, Inc.; Research Support: Dexcom, Inc., Medtronic MiniMed, Inc.

Buckner, Jane H. .................................. Disclosed no confl ict of interest.Buettner, Christoph ............................... Disclosed no confl ict of interest.Buffi ngton, Cynthia K. .......................... Disclosed no confl ict of interest.Bugajski, Maciej.................................... Disclosed no confl ict of interest.Bugliani, Marco ..................................... Disclosed no confl ict of interest.Buhl, Esben S. ...................................... Employee: Novo Nordisk A/S.Buhl, Thora ............................................ Disclosed no confl ict of interest.Bujalance, M. Jose ............................... Disclosed no confl ict of interest.Bukys, Michael A. ................................ Disclosed no confl ict of interest.Bulanda, Malgorzata ............................. Disclosed no confl ict of interest.Bull, Shelley B. ..................................... Disclosed no confl ict of interest.Bullard, Kai M. ..................................... Disclosed no confl ict of interest.Buller, Gregory ....................................... Disclosed no confl ict of interest.Bülow, Jens ........................................... Disclosed no confl ict of interest.Bulur, Sule ............................................. Disclosed no confl ict of interest.Bumrungphuet, Sommart ...................... Disclosed no confl ict of interest.Bundy, Brian .......................................... Disclosed no confl ict of interest.Bunnag, Pongamorn .............................. Advisory Panel: Abbott, AstraZeneca, Boehringer Ingelheim,

Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis, Novo Nordisk, Pfi zer, Sanofi , Takeda; Speaker’s Bureau: Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck, Merck Sharp & Dohme Corp., Novartis, Novo Nordisk, Pfi zer, Sanofi , Takeda, Thai Otsuka.

Buranasupkajorn, Patinut ...................... Disclosed no confl ict of interest.Burant, Charles F. ................................. Board Member: Metabolic Solutions Development Company,

LLC., Zydus Cadila; Consultant: Takeda Pharmaceutical Company Limited; Stock/Shareholder: Metabolic Solutions Development Company, LLC.

Burcelin, Remy ...................................... Disclosed no confl ict of interest.Burdett, Elena........................................ Disclosed no confl ict of interest.Burg, Ashley R. ..................................... Disclosed no confl ict of interest.

Burgard, Gunther ................................... Board Member: PharmACT Egypt; Employee: PharmACT Egypt.Burge, Mark R. ..................................... Disclosed no confl ict of interest.Burgess, Anthony .................................. Disclosed no confl ict of interest.Burghardt, Danielle ............................... Disclosed no confl ict of interest.Burini, Roberto ...................................... Disclosed no confl ict of interest.Burkart, Alison....................................... Disclosed no confl ict of interest.Burkart, Volker ....................................... Disclosed no confl ict of interest.Burmeister, Melissa A. ......................... Disclosed no confl ict of interest.Burroughs, Thomas ............................... Disclosed no confl ict of interest.Bursill, Christina A. .............................. Disclosed no confl ict of interest.Burtman, Elizabeth ................................ Disclosed no confl ict of interest.Burton, Kathryn J. ................................ Disclosed no confl ict of interest.Buse, John B. ....................................... Consultant: PhaseBio Pharmaceuticals, Inc.; Other

Relationship: AstraZeneca, Dance Biopharm, Elcelyx Therapeutics, Inc., Eli Lilly and Company, GI Dynamics, Inc., Lexicon Pharmaceuticals, Inc., Merck & Co., Inc., Metavention, Novo Nordisk A/S, Orexigen Therapeutics, Inc., vTv Therapeutics; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GI Dynamics, Inc., Johnson & Johnson, Lexicon Pharmaceuticals, Inc., Novo Nordisk Inc., Orexigen Therapeutics, Inc.; Stock/Shareholder: PhaseBio Pharmaceuticals, Inc.

Busik, Julia V. ....................................... Disclosed no confl ict of interest.Butalia, Sonia ........................................ Disclosed no confl ict of interest.Butcher, Marcene .................................. Disclosed no confl ict of interest.Butikofer, Ueli ........................................ Disclosed no confl ict of interest.Butler, Alexandra ................................... Disclosed no confl ict of interest.Butler, Ashley ........................................ Disclosed no confl ict of interest.Butler, Deborah A. ................................ Disclosed no confl ict of interest.Butler, Kenneth ...................................... Disclosed no confl ict of interest.Butler, Peter ........................................... Disclosed no confl ict of interest.Butler, Scott ........................................... Disclosed no confl ict of interest.Butler, Simona O. ................................. Disclosed no confl ict of interest.Butrico, Gina.......................................... Disclosed no confl ict of interest.Butte, Atul ............................................. Disclosed no confl ict of interest.Butterworth, Elizabeth A. ..................... Disclosed no confl ict of interest.Butterworth, John ................................. Disclosed no confl ict of interest.Butterworth, Martha ............................. Disclosed no confl ict of interest.Buus, Niels H. ....................................... Disclosed no confl ict of interest.Buyken, Anette E. ................................. Disclosed no confl ict of interest.Buysman, Erin K. .................................. Employee: Optum, Inc.Bužga, Marek ........................................ Disclosed no confl ict of interest.Bychkova, Ielizaveta .............................. Disclosed no confl ict of interest.Bydon, Mohamad .................................. Disclosed no confl ict of interest.Byers, Timothy ....................................... Disclosed no confl ict of interest.Bynoe, Karen A. .................................... Disclosed no confl ict of interest.Byrne, Enda M. ..................................... Disclosed no confl ict of interest.Bysted, Britta V. .................................... Employee: Zealand Pharma A/S.Bytoft, Birgitte ....................................... Disclosed no confl ict of interest.Caballero, A. Enrique ............................ Disclosed no confl ict of interest.Caballero, Daniel................................... Disclosed no confl ict of interest.Cabrera, Francisco................................. Disclosed no confl ict of interest.Caccioppoli, Cristina ............................. Disclosed no confl ict of interest.Caceres, Elena....................................... Disclosed no confl ict of interest.Cadenhead, Heather ............................. Disclosed no confl ict of interest.Caga-Anan, Christina ............................ Disclosed no confl ict of interest.Cagide, Ana L. ...................................... Advisory Panel: Teva Pharmaceutical Industries Ltd.; Speaker’s

Bureau: AstraZeneca, Novartis Pharma AG, Novo Nordisk Inc., Sanofi U.S.

Cai, Huan ............................................... Disclosed no confl ict of interest.Cai, Jennifer .......................................... Employee: Janssen Scientifi c Affairs, LLC.Cai, Jianwen ......................................... Disclosed no confl ict of interest.Cai, Lu.................................................... Disclosed no confl ict of interest.Cai, Mengyin ......................................... Disclosed no confl ict of interest.Cai, Weikang ......................................... Disclosed no confl ict of interest.Cai, Xiaoling .......................................... Disclosed no confl ict of interest.Caicedo, Alejandro ................................ Disclosed no confl ict of interest.Cain, Cindy ............................................ Disclosed no confl ict of interest.Calabro, Paolo ....................................... Disclosed no confl ict of interest.Calafi ore, Riccardo ................................ Disclosed no confl ict of interest.Calan, Mehmet...................................... Disclosed no confl ict of interest.Caldwell, Ellen S. ................................. Disclosed no confl ict of interest.Caldwell, Gary W. ................................ Disclosed no confl ict of interest.Cali, Anna M. ....................................... Employee: Sanofi .Caligiuri, Michael .................................. Disclosed no confl ict of interest.Callan, Judith A. ................................... Disclosed no confl ict of interest.Calle, Roberto A. .................................. Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc.Callender, Matthew .............................. Disclosed no confl ict of interest.Calle-Pascual, Alfonso L. ..................... Disclosed no confl ict of interest.Calosing, Cyrus...................................... Employee: Resverlogix Corp.; Stock/Shareholder: Resverlogix

Corp.Camacho, Raul ...................................... Employee: Janssen Pharmaceuticals, Inc.Cameron, Faye....................................... Disclosed no confl ict of interest.Cameron, Hilary..................................... Employee: LifeScan scotland Ltd.Campbell, Archie ................................... Disclosed no confl ict of interest.

A705


AU

THO

R D

ISCL

OSU

RE

Campbell, Fiona..................................... Disclosed no confl ict of interest.Campbell, Latoya E. .............................. Disclosed no confl ict of interest.Campbell, Paul ...................................... Disclosed no confl ict of interest.Campbell-Thompson, Martha ............... Disclosed no confl ict of interest.Campelo, Allison ................................... Disclosed no confl ict of interest.Camporez, Joao-Paulo G. ..................... Disclosed no confl ict of interest.Campos-Nanez, Enrique ........................ Consultant: The Epsilon Group; Research Support: Bayer

HealthCare, Insulet Corporation, Roche Diagnostics.Can Tamer, Søren .................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Candeloro, Paola ................................... Disclosed no confl ict of interest.Cane, Matthew C. ................................ Disclosed no confl ict of interest.Canel, Clémence ................................... Disclosed no confl ict of interest.Cann, Jennifer ....................................... Employee: MedImmune, LLC.Cannon, Christopher P. ......................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Bristol-Myers Squibb Company, CSL Behring, Essentialis, Inc., GlaxoSmithKline, Kowa Pharmaceuticals America, Inc., LipoMedix, Merck & Co., Inc., Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S., Takeda Development Center Americas, Inc.; Research Support: Accumetrics, Inc., Arisaph Pharmaceuticals, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Takeda Development Center Americas, Inc.

Canovatchel, William ............................ Employee: Janssen Global Services, LLC.Cao, Anjun ............................................. Employee: Janssen Research & Development, LLC.Cao, Dachuang ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Cao, Han ................................................ Disclosed no confl ict of interest.Cao, Ting................................................ Disclosed no confl ict of interest.Cao, Xuemei .......................................... Disclosed no confl ict of interest.Capehorn, Matthew S. ......................... Consultant: Boehringer Ingelheim GmbH, Eli Lilly and

Company, Merck Sharp & Dohme Limited, Novo Nordisk A/S; Research Support: Cambridge Weight Plan, Lighter Life, Novo Nordisk A/S; Speaker’s Bureau: Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme Limited; Stock/Shareholder: RIO Weight Management Ltd.

Caplan, Jay............................................ Board Member: Fractyl; Employee: Fractyl.Cappell, Katherine................................. Employee: Truven Health Analytics, Inc.Cappelleri, Joseph C. ........................... Employee: Pfi zer Inc.Caprio, Sonia ......................................... Disclosed no confl ict of interest.Caprioli, Raffaele .................................. Disclosed no confl ict of interest.Capuani, Barbara................................... Disclosed no confl ict of interest.Carandang, Kristine............................... Disclosed no confl ict of interest.Caratelli, Sara ....................................... Disclosed no confl ict of interest.Carbajales-Dale, Patricia ...................... Disclosed no confl ict of interest.Carballo, Dolores................................... Employee: Locemia Solutions; Stock/Shareholder: Locemia

Solutions.Carbillon, Lionel .................................... Disclosed no confl ict of interest.Cardelli, Patrizia .................................... Disclosed no confl ict of interest.Cardi, Christine...................................... Employee: VeroScience, LLC.Cardona, Ernesto ................................... Disclosed no confl ict of interest.Cardona, Fernando ................................ Disclosed no confl ict of interest.Careddu, Giovanni ................................. Disclosed no confl ict of interest.Carey, Michelle ..................................... Disclosed no confl ict of interest.Cargill, Robert S. .................................. Board Member: Pacifi c Diabetes Technologies, Inc.; Employee:

Pacifi c Diabetes Technologies, Inc.; Stock/Shareholder: Pacifi c Diabetes Technologies, Inc.

Caricato, Valentina ................................ Disclosed no confl ict of interest.Cariou, Bertrand .................................... Advisory Panel: Amgen Inc., DebioPharm, Eli Lilly and

Company, Novo Nordisk Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S.; Other Relationship: AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Pierre Fabre, Sanofi U.S., Taisho Pharmaceutical Co., Ltd.; Research Support: Sanofi U.S.

Caritis, Steve N. ................................... Disclosed no confl ict of interest.Cariuk, Peter .......................................... Disclosed no confl ict of interest.Carley, David W. ................................... Disclosed no confl ict of interest.Carls, Ginger S. .................................... Consultant: Intarcia Therapeutics, Inc.Carlson, Coby ........................................ Employee: Cellular Dynamics International.Carlsson, Annika ................................... Disclosed no confl ict of interest.Carlyle, Kellie ........................................ Disclosed no confl ict of interest.Carmichael, Kim A. ............................... Speaker’s Bureau: Janssen Pharmaceuticals, Inc., Merck &

Co., Inc.Carmine, Brian....................................... Disclosed no confl ict of interest.Carmody, David ..................................... Disclosed no confl ict of interest.Carmody, Jill S. .................................... Disclosed no confl ict of interest.Carmody, Louise .................................... Disclosed no confl ict of interest.Carmon, Mark........................................ Employee: Valeritas; Stock/Shareholder: Valeritas.Carnethon, Mercedes R. ...................... Disclosed no confl ict of interest.Carnevale Schianca, Gian P. ................. Disclosed no confl ict of interest.Carofano, Wendy .................................. Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co., Inc.Carolan, Eirin ......................................... Disclosed no confl ict of interest.Carolan, Padraig .................................... Disclosed no confl ict of interest.

Carpéné, Christian................................. Disclosed no confl ict of interest.Carpenedo, Dorota ................................ Disclosed no confl ict of interest.Carpenter, Christopher .......................... Disclosed no confl ict of interest.Carpenter, Thomas ................................ Disclosed no confl ict of interest.Carr, Christin .......................................... Disclosed no confl ict of interest.Carr, Jeffrey ........................................... Disclosed no confl ict of interest.Carr, Molly C. ........................................ Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Carranza-Leon, Barbara (Gisella) .......... Disclosed no confl ict of interest.Carrasco, Javier .................................... Disclosed no confl ict of interest.Carraway, Marissa ................................ Disclosed no confl ict of interest.Carreon, Marco ..................................... Disclosed no confl ict of interest.Carretero, Juana ................................... Disclosed no confl ict of interest.Carrion-Petersen, Marylou .................... Disclosed no confl ict of interest.Carroll, Chad C. .................................... Disclosed no confl ict of interest.Carroll, Rachel B. .................................. Disclosed no confl ict of interest.Carson, April P. ..................................... Research Support: Asahi Kasei Corporation, GlycoMark, Inc.,

National Institute of Diabetes and Digestive and Kidney Diseases.

Carson, Beau ......................................... Disclosed no confl ict of interest.Carson, Kathryn A. ............................... Disclosed no confl ict of interest.Carson, Richard E. ................................ Research Support: AstraZeneca, Eli Lilly and Company, Pfi zer

Inc., Taisho Pharmaceutical Co., Ltd.Carstensen, Bendix ............................... Employee: Steno Diabetes Center A/S; Stock/Shareholder:

Novo Nordisk A/S.Carstensen-Kirberg, Maren................... Disclosed no confl ict of interest.Cartee, Amanda K. ............................... Disclosed no confl ict of interest.Cartee, Gregory ..................................... Disclosed no confl ict of interest.Carter, Andrea ....................................... Disclosed no confl ict of interest.Carter, Sharayah .................................... Disclosed no confl ict of interest.Caruso, Irene ......................................... Disclosed no confl ict of interest.Caruso, Michael .................................... Disclosed no confl ict of interest.Carvajal-Gonzalez, Santos .................... Employee: Pfi zer Inc.Carvalho, Davide ................................... Disclosed no confl ict of interest.Carvalho, Francisco Herlânio ................ Disclosed no confl ict of interest.Casagran, Oriol...................................... Disclosed no confl ict of interest.Casas, Mariana ..................................... Disclosed no confl ict of interest.Casciano, Roman................................... Consultant: Janssen Pharmaceuticals, Inc., Novartis

Pharmaceuticals Corporation, Sanofi U.S.Case, Christopher .................................. Research Support: AstraZeneca, Janssen Pharmaceuticals,

Inc., Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Janssen Pharmaceuticals, Inc., Novo Nordisk A/S, Sanofi .

Case, Laure............................................ Disclosed no confl ict of interest.Case, Martin.......................................... Employee: Janssen Pharmaceuticals, Inc.Casey, John ........................................... Disclosed no confl ict of interest.Casiraghi, Francesca ............................. Disclosed no confl ict of interest.Castelo, Maria Helane .......................... Disclosed no confl ict of interest.Castle, Jessica R. ................................. Disclosed no confl ict of interest.Casucci, Simone .................................... Disclosed no confl ict of interest.Cataldo, Luis R. .................................... Disclosed no confl ict of interest.Catanzaro, Rosemary B. ....................... Disclosed no confl ict of interest.Cates, Courtney A. ............................... Disclosed no confl ict of interest.Cato, Janet M. ..................................... Disclosed no confl ict of interest.Catoira, Natalia ..................................... Disclosed no confl ict of interest.Catov, Janet .......................................... Disclosed no confl ict of interest.Cattaneo, Monica.................................. Disclosed no confl ict of interest.Caudle, Jane M. ................................... Disclosed no confl ict of interest.Cavallerano, Jerry D. ............................ Disclosed no confl ict of interest.Cavallo, Massimiliano........................... Disclosed no confl ict of interest.Cavan, David ......................................... Disclosed no confl ict of interest.Cavanaugh, Joseph ............................... Disclosed no confl ict of interest.Cazzell, Shawn M. ................................ Research Support: Podimetrics, Inc.Cechin, Sirlene R. ................................. Disclosed no confl ict of interest.Ceesay, Paulette.................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Cefalu, William T. ................................. Consultant: Intarcia Therapeutics, Inc., Sanofi U.S.; Research

Support: AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Sanofi U.S.

Ceglarek, Uta......................................... Disclosed no confl ict of interest.Cela, Suela ............................................ Disclosed no confl ict of interest.Çelik, Hüseyin........................................ Disclosed no confl ict of interest.Cellini, Joseph....................................... Disclosed no confl ict of interest.Cengiz, Eda ............................................ Advisory Panel: Lexicon Pharmaceuticals, Inc.; Speaker’s

Bureau: Novo Nordisk Inc.Cengiz, Tugba ........................................ Disclosed no confl ict of interest.Ceperuelo-Mallafre, Victoria ................ Disclosed no confl ict of interest.Cereijo, Rubén ....................................... Disclosed no confl ict of interest.Ceriani, Valerio ...................................... Disclosed no confl ict of interest.Ceriello, Antonio ................................... Disclosed no confl ict of interest.Cerny, Matthew A. ............................... Disclosed no confl ict of interest.Cersosimo, Eugenio............................... Advisory Panel: Takeda Pharmaceutical Company Limited;

Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Sanofi U.S.

Cervantes, Christopher.......................... Disclosed no confl ict of interest.Cervantes, Francisco J. ........................ Disclosed no confl ict of interest.

A706


AU

THO

R D

ISCL

OSU

RE

Cetta, Francesco.................................... Disclosed no confl ict of interest.Ceulemans, Laurens .............................. Disclosed no confl ict of interest.Cha, Bong Soo ....................................... Disclosed no confl ict of interest.Cha, Bong-Yun ....................................... Disclosed no confl ict of interest.Cha, Dae Ryong ..................................... Disclosed no confl ict of interest.Cha, Eun Seok ....................................... Disclosed no confl ict of interest.Cha, Seon Ah......................................... Disclosed no confl ict of interest.Cha, Sun-Ah .......................................... Disclosed no confl ict of interest.Chabay, Simon....................................... Disclosed no confl ict of interest.Chabenne, Joseph................................. Employee: AIT Bioscience.Chachkhiani, David................................ Disclosed no confl ict of interest.Chadha, Chhavi ..................................... Disclosed no confl ict of interest.Chadha, Manoj ...................................... Disclosed no confl ict of interest.Chadid, Tatiana ..................................... Disclosed no confl ict of interest.Chae, Jeesoo......................................... Disclosed no confl ict of interest.Chae, Yu Na ........................................... Employee: Dong-A ST.Chagin, Kevin M. .................................. Research Support: Merck & Co., Inc., Novo Nordisk Inc.Chahar, Chitresh .................................... Disclosed no confl ict of interest.Chai, Shangyu ....................................... Disclosed no confl ict of interest.Chaiyakunapruk, Nathorn...................... Disclosed no confl ict of interest.Chakrabarti, Subrata ............................. Disclosed no confl ict of interest.Chakravorty, Sangeeta .......................... Disclosed no confl ict of interest.Chalasani, Naga .................................... Consultant: AbbVie Inc., DS Biopharma, Eli Lilly and Company,

NuSirt Biopharma, Takeda Pharmaceutical Company Limited, Tobira Therapeutics; Research Support: Eli Lilly and Company, Galectin Therapeutics, Gilead Sciences, Inc., Intercept Pharmaceuticals.

Chalaye, Margot.................................... Disclosed no confl ict of interest.Chalew, Stuart....................................... Disclosed no confl ict of interest.Chamarthi, Bindu................................... Consultant: VeroScience, LLC.Chambers, John C. ............................... Disclosed no confl ict of interest.Chamukuttan, Snehalatha..................... Disclosed no confl ict of interest.Chan, Albert K. ..................................... Disclosed no confl ict of interest.Chan, Carina .......................................... Disclosed no confl ict of interest.Chan, Edmond ....................................... Employee: Janssen-Cilag Ltd.Chan, Juliana ........................................ Consultant: AstraZeneca, Bayer HealthCare, Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Corp., Novo Nordisk Inc., Pfi zer Inc., Sanofi U.S.; Research Support: AstraZeneca, Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, GlaxoSmithKline, Merck Sharp & Dohme Corp., Novo Nordisk Inc., Pfi zer Inc., Sanofi U.S.

Chan, Ka-Hei ......................................... Disclosed no confl ict of interest.Chan, Kwun ........................................... Disclosed no confl ict of interest.Chan, Luisa ............................................ Disclosed no confl ict of interest.Chan, Michael H. .................................. Disclosed no confl ict of interest.Chan, Owen ........................................... Disclosed no confl ict of interest.Chan, Siew Pheng ................................. Advisory Panel: AstraZeneca, Boehringer Ingelheim, Eli Lilly

and Company, Merck Sharp & Dohme Corp., Novartis, Novo Nordisk, Servier; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis, Novo Nordisk, Servier.

Chan, Vicky ............................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S.

Chan, Weng Hoong ............................... Disclosed no confl ict of interest.Chanan, Neha........................................ Research Support: Parexel International.Chanclon Garcia, Belen ......................... Disclosed no confl ict of interest.Chandalia, Manisha .............................. Disclosed no confl ict of interest.Chandarana, Keval ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Chandler, LuWanda C. .......................... Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.Chandni, Radhakrishnan ....................... Disclosed no confl ict of interest.Chandramani-Shivalingappa, Prashanth Disclosed no confl ict of interest.Chandramohan, Suganya ...................... Disclosed no confl ict of interest.Chang, Amy ........................................... Disclosed no confl ict of interest.Chang, Baocheng .................................. Disclosed no confl ict of interest.Chang, Charles ...................................... Disclosed no confl ict of interest.Chang, Chia-Hsuin................................. Disclosed no confl ict of interest.Chang, Denise ....................................... Employee: Novo Nordisk Inc; Stock/Shareholder: Novo

Nordisk Inc.Chang, Douglas C. ................................ Disclosed no confl ict of interest.Chang, Healani K. ................................. Disclosed no confl ict of interest.Chang, Ji Suk ........................................ Disclosed no confl ict of interest.Chang, Silvia D. .................................... Disclosed no confl ict of interest.Chang, Wan-Jung ................................. Disclosed no confl ict of interest.Chang, Yuan .......................................... Employee: MedImmune, LLC.Change, Peiyao...................................... Disclosed no confl ict of interest.Chang-Hsun, Hsieh................................ Disclosed no confl ict of interest.Channon, Keith ...................................... Research Support: Sanofi -Aventis Deutschland GmbH.Chanprasert, Chutima ........................... Disclosed no confl ict of interest.Chantanis, Stilianos .............................. Disclosed no confl ict of interest.Chao, Jason........................................... Employee: Sanofi U.S., Xinyl Inc. Charbonnel, Bernard ............................. Advisory Panel: AstraZeneca; Consultant: AstraZeneca,

Boehringer Ingelheim, Janssen, Lilly, Merck, Sharp &

Dohme, Novartis, Novo Nordisk, Sanofi -Aventis, Takeda; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Lilly, Merck, Sharp & Dohme, Novartis, Novo Nordisk, Sanofi , Takeda.

Charemska, Dorota................................ Disclosed no confl ict of interest.Charlton, Elizabeth ................................ Disclosed no confl ict of interest.Charlton, Rodger ................................... Disclosed no confl ict of interest.Charoensri, Suranut .............................. Disclosed no confl ict of interest.Charon, Christine................................... Disclosed no confl ict of interest.Charpentier, Guillaume ......................... Disclosed no confl ict of interest.Charrier, Alyssa ..................................... Disclosed no confl ict of interest.Charron-Prochownik, Denise C. ........... Disclosed no confl ict of interest.Charytan, David M. .............................. Research Support: Janssen Pharmaceuticals, Inc., Medtronic,

Inc.Chase, H. Peter...................................... Research Support: Dexcom, Inc.Chasens, Eileen ..................................... Disclosed no confl ict of interest.Chatbenjanan, Theetanittha ................. Disclosed no confl ict of interest.Chatha, Sheena ..................................... Disclosed no confl ict of interest.Chatterjee, Piyali ................................... Disclosed no confl ict of interest.Chatterjee, Ranee ................................. Research Support: Sanofi U.S.Chatterjee, Sanjay................................. Disclosed no confl ict of interest.Chattopadhyay, Munmun ...................... Disclosed no confl ict of interest.Chatziangelaki, Erifyli............................ Disclosed no confl ict of interest.Chau, Larissa ......................................... Disclosed no confl ict of interest.Chaudhari, Paresh ................................. Employee: Takeda Development Center Americas, Inc.; Stock/

Shareholder: Takeda Development Center Americas, Inc.Chaudhary, Archana .............................. Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company (Spouse/Partner).

Chaudhry, Zunaira ................................. Disclosed no confl ict of interest.Chaudhuri, Ajay ..................................... Speaker’s Bureau: AstraZeneca.Chavan, Bhakti ...................................... Disclosed no confl ict of interest.Chavanelle, Vivien ................................. Employee: Valbiotis.Chavarro, Jorge E. ................................ Disclosed no confl ict of interest.Chavez, Julia ......................................... Disclosed no confl ict of interest.Chavez-Velazquez, Alberto .................... Disclosed no confl ict of interest.Chawla, Aastha ..................................... Disclosed no confl ict of interest.Chawla, Manoj ...................................... Research Support: Eli Lilly and Company.Chawla, Rajeev ..................................... Disclosed no confl ict of interest.Cheah, Seong Keat................................ Disclosed no confl ict of interest.Cheesman, Khadeen C. ........................ Disclosed no confl ict of interest.Chehter, Ethel Z. ................................... Disclosed no confl ict of interest.Chen, Chang-Yi ...................................... Disclosed no confl ict of interest.Chen, Chen-Yi ........................................ Disclosed no confl ict of interest.Chen, Chiung-Tong ................................ Disclosed no confl ict of interest.Chen, Dawei .......................................... Disclosed no confl ict of interest.Chen, Guilin ........................................... Disclosed no confl ict of interest.Chen, Guoxia X. .................................... Disclosed no confl ict of interest.Chen, Haiying ........................................ Disclosed no confl ict of interest.Chen, Harn-Shen ................................... Disclosed no confl ict of interest.Chen, Hong ............................................ Disclosed no confl ict of interest.Chen, Hongzhi ....................................... Disclosed no confl ict of interest.Chen, Hua Fen ....................................... Disclosed no confl ict of interest.Chen, Hui ............................................... Disclosed no confl ict of interest.Chen, Hungta......................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP.Chen, Jiaqi ............................................ Disclosed no confl ict of interest.Chen, Jieling ......................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Chen, Jihai ............................................ Disclosed no confl ict of interest.Chen, Jing ............................................. Disclosed no confl ict of interest.Chen, Jun .............................................. Disclosed no confl ict of interest.Chen, Junqin ......................................... Disclosed no confl ict of interest.Chen, Keyang ........................................ Disclosed no confl ict of interest.Chen, Laigao.......................................... Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc.Chen, Li.................................................. Disclosed no confl ict of interest.Chen, Lihua............................................ Disclosed no confl ict of interest.Chen, Liming.......................................... Disclosed no confl ict of interest.Chen, Liwei............................................ Disclosed no confl ict of interest.Chen, Lulu.............................................. Research Support: Medtronic, Inc.Chen, Ming ............................................ Disclosed no confl ict of interest.Chen, Mu ............................................... Disclosed no confl ict of interest.Chen, Peng ............................................ Disclosed no confl ict of interest.Chen, Qian ............................................. Disclosed no confl ict of interest.Chen, Roger C. ...................................... Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly and

Company; Speaker’s Bureau: Amgen Inc., AstraZeneca (Spouse/Partner), AstraZeneca, Boehringer Ingelheim GmbH, Boehringer Ingelheim GmbH (Spouse/Partner), Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner), Janssen-Cilag Ltd (Spouse/Partner), Janssen-Cilag Ltd., Merck Sharp & Dohme Corp., Merck Sharp & Dohme Corp. (Spouse/Partner), Novo Nordisk A/S (Spouse/Partner), Novo Nordisk A/S, Servier, Servier (Spouse/Partner).

Chen, Rongping ..................................... Disclosed no confl ict of interest.Chen, Ruihua ......................................... Disclosed no confl ict of interest.

A707


AU

THO

R D

ISCL

OSU

RE

Chen, Sanjian ........................................ Disclosed no confl ict of interest.Chen, Shali ............................................ Disclosed no confl ict of interest.Chen, Shuru ........................................... Disclosed no confl ict of interest.Chen, Stephanie .................................... Employee: AstraZeneca.Chen, Su ................................................ Disclosed no confl ict of interest.Chen, Wanling ....................................... Disclosed no confl ict of interest.Chen, Weena J. .................................... Disclosed no confl ict of interest.Chen, Wei .............................................. Disclosed no confl ict of interest.Chen, Wei-Min ...................................... Disclosed no confl ict of interest.Chen, Wei-Ming .................................... Disclosed no confl ict of interest.Chen, Wenbiao ...................................... Disclosed no confl ict of interest.Chen, Wenwen ...................................... Disclosed no confl ict of interest.Chen, Xi ................................................. Disclosed no confl ict of interest.Chen, Xian ............................................. Employee: Pfi zer Inc.Chen, Xiaoxiao ...................................... Employee: Senseonics, Inc.Chen, Xiaoying ...................................... Disclosed no confl ict of interest.Chen, Xin ............................................... Disclosed no confl ict of interest.Chen, Xinhua ......................................... Disclosed no confl ict of interest.Chen, Xuqing ......................................... Disclosed no confl ict of interest.Chen, Y. Stefanie ................................... Disclosed no confl ict of interest.Chen, Yanming ...................................... Disclosed no confl ict of interest.Chen, Yanyan......................................... Research Support: Medtronic, Inc.Chen, Yi Jun .......................................... Disclosed no confl ict of interest.Chen, Yifei ............................................. Disclosed no confl ict of interest.Chen, Yi-Guang ..................................... Disclosed no confl ict of interest.Chen, Yii-Der Ida ................................... Disclosed no confl ict of interest.Chen, Yongsong..................................... Disclosed no confl ict of interest.Chen, Yue .............................................. Disclosed no confl ict of interest.Chen, Yu-Han ......................................... Disclosed no confl ict of interest.Chen, Yumay .......................................... Disclosed no confl ict of interest.Chen, Yushu ........................................... Disclosed no confl ict of interest.Chen, Zheng .......................................... Disclosed no confl ict of interest.Cheng, Anton......................................... Disclosed no confl ict of interest.Cheng, Li................................................ Disclosed no confl ict of interest.Cheng, Peiyao........................................ Disclosed no confl ict of interest.Cheng, Shi Hui....................................... Disclosed no confl ict of interest.Cheng, Tsz Wai ...................................... Disclosed no confl ict of interest.Cheng, Xi ............................................... Employee: Sanofi .Cheng, Xiaoyun ..................................... Disclosed no confl ict of interest.Cheng, Yanli .......................................... Disclosed no confl ict of interest.Cheng, Yiling J. .................................... Disclosed no confl ict of interest.Cheng, Yu-Chien .................................... Disclosed no confl ict of interest.Cheong, Ye-Hwang................................ Employee: Dong-A ST.Chera, Simona ....................................... Disclosed no confl ict of interest.Chernatynskaya, Anna V. ..................... Disclosed no confl ict of interest.Chernausek, Steven D. ......................... Disclosed no confl ict of interest.Chernavvsky, Daniel .............................. Disclosed no confl ict of interest.Cherney, David ...................................... Research Support: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Merck Foundation; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Canada Inc., Janssen Pharmaceuticals, Inc., Merck Foundation.

Chernoff, Jonathan ............................... Disclosed no confl ict of interest.Chernyaeva, Anna ................................. Disclosed no confl ict of interest.Chernyavskaya, Iryna ............................ Disclosed no confl ict of interest.Cherrington, Alan D. ............................. Advisory Panel: Biocon, Fractyl, Hanmi Pharmaceutical Co., Ltd

(Spouse/Partner), Merck & Co., Inc., Metavention, NuSirt Biopharma, Sensulin, LLC, Zafgen; Consultant: Eli Lilly and Company, Islet Sciences, Novo Nordisk A/S, Profi l Institute for Clinical Research, Inc., Silver Lake, Thermalin Diabetes, LLC, Thetis Pharmaceuticals, ViaCyte, Inc., Viking, vTv Therapeutics; Research Support: Eli Lilly and Company, Merck & Co., Inc., Metavention, Novo Nordisk A/S, Silver Lake, Thermalin Diabetes, LLC; Stock/Shareholder: Fractyl, Metavention, Sensulin, LLC, Thetis Pharmaceuticals, Zafgen.

Cherubini, Valentino .............................. Disclosed no confl ict of interest.Chesi, Alessandra ................................. Disclosed no confl ict of interest.Chesla, Catherine A. ............................ Disclosed no confl ict of interest.Cheung, Bernard M. ............................. Disclosed no confl ict of interest.Cheung, Clement C. .............................. Disclosed no confl ict of interest.Cheung, Deanna .................................... Research Support: Abbott Diabetes Care Inc.Cheung, Grace ....................................... Disclosed no confl ict of interest.Cheung, Kitty K. .................................... Disclosed no confl ict of interest.Chevalier, Soazig ................................... Employee: Sanofi ; Stock/Shareholder: Sanofi .Chew, Emily Y. ...................................... Disclosed no confl ict of interest.Chhabra, Mohinish ................................ Disclosed no confl ict of interest.Chhay, Vanna ......................................... Disclosed no confl ict of interest.Chi, Ellen ............................................... Employee: Janssen Pharmaceuticals, Inc.Chi, Han-Lin ........................................... Disclosed no confl ict of interest.Chiang, Chern-En................................... Disclosed no confl ict of interest.Chiang, Yu-Ting Alex ............................. Disclosed no confl ict of interest.Chiavaroli, Laura ................................... Employee: Glycemic Index Laboratories.Chiba, Katsuyoshi.................................. Disclosed no confl ict of interest.Chiba, Yasuko ........................................ Disclosed no confl ict of interest.Chidsey, Kristin...................................... Employee: Pfi zer Inc.

Chiguluri, Vinay ..................................... Employee: Humana Inc.Chiheb, Sabrina ..................................... Disclosed no confl ict of interest.Chikazawa, Shinji .................................. Disclosed no confl ict of interest.Chin, Eugene ......................................... Disclosed no confl ict of interest.Chin, Sherry ........................................... Employee: Pfi zer Inc.Chin, Vivian ........................................... Disclosed no confl ict of interest.Ching, Jenny.......................................... Disclosed no confl ict of interest.Ching, Judy E. ....................................... Disclosed no confl ict of interest.Chinnakotla, Srinath.............................. Disclosed no confl ict of interest.Chinnici, Daniela ................................... Disclosed no confl ict of interest.Chirakalwasan, Naricha ........................ Disclosed no confl ict of interest.Chiu, Abraham....................................... Disclosed no confl ict of interest.Chiu, Wei-Ling ....................................... Disclosed no confl ict of interest.Chmelnik, Sandra .................................. Disclosed no confl ict of interest.Chng, Keefe ........................................... Disclosed no confl ict of interest.Cho, Jae Hyoung ................................... Disclosed no confl ict of interest.Cho, Jeonghwa ..................................... Disclosed no confl ict of interest.Cho, Nam H. ......................................... Disclosed no confl ict of interest.Cho, Pyone............................................. Disclosed no confl ict of interest.Cho, Yong Wook .................................... Disclosed no confl ict of interest.Cho, Yoon Hi .......................................... Disclosed no confl ict of interest.Cho, Young Min ..................................... Disclosed no confl ict of interest.Chodick, Gabriel .................................... Research Support: Merck & Co., Inc.Choe, Eun Yeong ................................... Disclosed no confl ict of interest.Choe, Wonchae ..................................... Disclosed no confl ict of interest.Choi, Byung H. ...................................... Employee: Yuhan Co.Choi, Byung-Jun .................................... Disclosed no confl ict of interest.Choi, Dong Seop.................................... Disclosed no confl ict of interest.Choi, Doo Ah ......................................... Disclosed no confl ict of interest.Choi, Haysook........................................ Disclosed no confl ict of interest.Choi, Hyun H. ........................................ Employee: Yuhan Co.Choi, In Young ....................................... Employee: Hanmi Pharmaceutical Co., Ltd.Choi, Jessica ......................................... Disclosed no confl ict of interest.Choi, Jinkuk ........................................... Disclosed no confl ict of interest.Choi, Ju Hee .......................................... Disclosed no confl ict of interest.Choi, Kyung Jin ..................................... Disclosed no confl ict of interest.Choi, Kyung Mook ................................. Disclosed no confl ict of interest.Choi, Seung Hee.................................... Disclosed no confl ict of interest.Choi, Soo Bong ...................................... Disclosed no confl ict of interest.Choi, Sung E. ........................................ Disclosed no confl ict of interest.Choi, Sung Hee...................................... Disclosed no confl ict of interest.Choi, Su-Yeon ........................................ Disclosed no confl ict of interest.Choi, Yoon-Hee...................................... Disclosed no confl ict of interest.Chokr, Nora ............................................ Disclosed no confl ict of interest.Chon, James.......................................... Disclosed no confl ict of interest.Chon, Suk .............................................. Disclosed no confl ict of interest.Chon, W. James .................................... Disclosed no confl ict of interest.Chong, Anthony ..................................... Disclosed no confl ict of interest.Chong, Elizabeth Y. ............................... Disclosed no confl ict of interest.Chongjaroen, Nalinee ........................... Disclosed no confl ict of interest.Chou, Danny Hung-Chieh ...................... Disclosed no confl ict of interest.Chou, Jeff .............................................. Disclosed no confl ict of interest.Chou, Shengpu ...................................... Disclosed no confl ict of interest.Choudhary, Pratik .................................. Advisory Panel: Abbott, Lilly Deutschland GmbH, Medtronic,

Inc., Novo Nordisk Inc., Sanofi U.S.; Research Support: Medtronic, Inc.; Speaker’s Bureau: Abbott, Johnson & Johnson, Lilly Deutschland GmbH, Medtronic, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Sanofi U.S.

Choudhurry, Roos .................................. Disclosed no confl ict of interest.Choung, Sorim ....................................... Disclosed no confl ict of interest.Chovanes, Christina .............................. Disclosed no confl ict of interest.Chow, Elaine.......................................... Disclosed no confl ict of interest.Chow, Francis ........................................ Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S.

Chow, Lisa ............................................. Disclosed no confl ict of interest.Chow, Wing ........................................... Employee: Janssen Scientifi c Affairs, LLC; Stock/Shareholder:

Janssen Scientifi c Affairs, LLC.Chowdhury, Golam M. .......................... Disclosed no confl ict of interest.Christen, Alejandra ............................... Disclosed no confl ict of interest.Christensen, Dirk L. .............................. Disclosed no confl ict of interest.Christensen, Kent L. ............................. Disclosed no confl ict of interest.Christensen, Mikkel .............................. Disclosed no confl ict of interest.Christensen, Sidsel B. .......................... Employee: Novo Nordisk A/S.Christiansen, Jens S. ........................... Disclosed no confl ict of interest.Christiansen, Liselotte K. ..................... Disclosed no confl ict of interest.Christiansen, Mark ................................ Research Support: Medtronic, Inc.Christiansen, Michael ........................... Disclosed no confl ict of interest.Christofi lidis, George............................. Disclosed no confl ict of interest.Christopher, Theodore ........................... Disclosed no confl ict of interest.Christopherson, Jenica ......................... Disclosed no confl ict of interest.Christophi, Costas ................................. Disclosed no confl ict of interest.Chu, Audrey Y. ...................................... Disclosed no confl ict of interest.Chu, Bong-Chul...................................... Other Relationship: Truven Health Analytics, Inc.

A708


AU

THO

R D

ISCL

OSU

RE

Chu, Chin-Fun ........................................ Disclosed no confl ict of interest.Chu, James............................................ Consultant: Sanofi U.S.; Research Support: Novo Nordisk Inc;

Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Sanofi U.S.

Chu, Zili David ....................................... Disclosed no confl ict of interest.Chua, Jia Min ........................................ Disclosed no confl ict of interest.Chua, Siew Siang .................................. Disclosed no confl ict of interest.Chuang, Lee-Ming ................................. Disclosed no confl ict of interest.Chudleigh, Richard ................................ Disclosed no confl ict of interest.Chun, Kevin M. ..................................... Disclosed no confl ict of interest.Chun, Ki Hong........................................ Disclosed no confl ict of interest.Chung, Choon Hee................................. Disclosed no confl ict of interest.Chung, Hye Soo ..................................... Disclosed no confl ict of interest.Chung, Hyewon ..................................... Disclosed no confl ict of interest.Chung, Janice K. .................................. Employee: Medtronic MiniMed, Inc.Chung, Michelle .................................... Disclosed no confl ict of interest.Chung, Stephanie T. ............................. Disclosed no confl ict of interest.Chung, Youn Wook ................................ Disclosed no confl ict of interest.Church, Timothy S. ............................... Disclosed no confl ict of interest.Churilov, Leonid ..................................... Disclosed no confl ict of interest.Chytilova, Eva ........................................ Disclosed no confl ict of interest.Ciancio, Gaetano ................................... Disclosed no confl ict of interest.Ciaraldi, Theodore P. ............................ Disclosed no confl ict of interest.Ciardi, Alicia .......................................... Disclosed no confl ict of interest.Ciardullo, Anna Vittoria ......................... Disclosed no confl ict of interest.Ciarkowski, Scott .................................. Disclosed no confl ict of interest.Cibula, Donald ....................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases.Ciecko, Ashley ....................................... Disclosed no confl ict of interest.Cieniawski, Dominik.............................. Disclosed no confl ict of interest.Cignarelli, Angelo.................................. Disclosed no confl ict of interest.Cigolle, Christine ................................... Disclosed no confl ict of interest.Cigrovski Berkovic, Maja....................... Disclosed no confl ict of interest.Cigrovski, Vjekoslav .............................. Disclosed no confl ict of interest.Cimino, Antonino................................... Disclosed no confl ict of interest.Cimino, Elena ........................................ Disclosed no confl ict of interest.Cinar, Ali ................................................ Disclosed no confl ict of interest.Cinar, Resat ........................................... Disclosed no confl ict of interest.Cincotta, Anthony H. ............................ Employee: VeroScience, LLC.Cinkajzlova, Anna .................................. Disclosed no confl ict of interest.Ciociaro, Demetrio ................................ Disclosed no confl ict of interest.Cioli, Patrizia ......................................... Disclosed no confl ict of interest.Ciotola, Miryam..................................... Disclosed no confl ict of interest.Cipolloni, Laura ..................................... Disclosed no confl ict of interest.Cipriano, Paola ...................................... Disclosed no confl ict of interest.Cirulli, Vincenzo ..................................... Disclosed no confl ict of interest.Cistola, David P. .................................... Disclosed no confl ict of interest.Cito, Monia............................................ Disclosed no confl ict of interest.Ciudin, Andreea..................................... Disclosed no confl ict of interest.Claggett, Brian ...................................... Disclosed no confl ict of interest.Claringbould, Annique........................... Disclosed no confl ict of interest.Clark, Anne ............................................ Disclosed no confl ict of interest.Clark, Douglas ....................................... Employee: Boehringer Ingelheim GmbH.Clark, James.......................................... Disclosed no confl ict of interest.Clark, Jeanne M. .................................. Disclosed no confl ict of interest.Clark, Pamela ........................................ Disclosed no confl ict of interest.Clark, Taylor ........................................... Disclosed no confl ict of interest.Clary, Dawn ........................................... Disclosed no confl ict of interest.Clausen, Tine D. ................................... Disclosed no confl ict of interest.Cleal, Bryan ........................................... Employee: Steno Diabetes Center.Clegg, Deborah J. ................................. Disclosed no confl ict of interest.Clemente, Gennaro ............................... Disclosed no confl ict of interest.Clemente-Postigo, Mercedes................ Disclosed no confl ict of interest.Clements, Mark A. ............................... Disclosed no confl ict of interest.Clemons, Bryan ..................................... Employee: Receptos, Celgene.Clifford, C. Robin ................................... Disclosed no confl ict of interest.Clifford, Holly E. ................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Clifton, Peter M. ................................... Disclosed no confl ict of interest.Cline, Gary W. ...................................... Research Support: Pfi zer Inc.Clinton, Paula ........................................ Consultant: Johnson & Johnson Diabetes Institute.Clish, Clary ............................................ Disclosed no confl ict of interest.Clodfelter, Jason ................................... Disclosed no confl ict of interest.Close, Kelly L. ....................................... Disclosed no confl ict of interest.Clougherty, Marilyn ............................... Disclosed no confl ict of interest.Clouse, Melvin ...................................... Research Support: National Heart Lung and Blood Institue,

National Institutes of Health.Cloutier, Marie-Pier ............................... Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Cn, Krishnan .......................................... Disclosed no confl ict of interest.Cobas, Roberta A. ................................ Disclosed no confl ict of interest.Cobb, Ellen ............................................ Disclosed no confl ict of interest.Cobelli, Claudio ..................................... Disclosed no confl ict of interest.Cobo-Vuilleumier, Nadia ....................... Disclosed no confl ict of interest.Cochran, Elaine ..................................... Disclosed no confl ict of interest.Cocks Eschler, Deirdre ........................... Disclosed no confl ict of interest.Coculescu, Mihai................................... Disclosed no confl ict of interest.

Codario, Ronald ..................................... Disclosed no confl ict of interest.Codella, Roberto.................................... Disclosed no confl ict of interest.Coe, Gregory.......................................... Disclosed no confl ict of interest.Cogan, Derek A. ................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Coghlan, Matthew ................................ Employee: MedImmune, LLC.Cogne, Yannick ...................................... Disclosed no confl ict of interest.Cohen, Ashley ....................................... Disclosed no confl ict of interest.Cohen, Cheli Melzer .............................. Research Support: Merck & Co., Inc.Cohen, Coraal ........................................ Disclosed no confl ict of interest.Cohen, Joshua L. .................................. Disclosed no confl ict of interest.Colca, Jerry R. ...................................... Board Member: Metabolic Solutions Development Company,

LLC.; Employee: Metabolic Solutions Development Company, LLC.; Stock/Shareholder: Metabolic Solutions Development Company, LLC.

Colclough, Kevin.................................... Disclosed no confl ict of interest.Coldren, Anastasia ................................ Disclosed no confl ict of interest.Coleman, Deidra.................................... Disclosed no confl ict of interest.Coletta, Dawn K. .................................. Disclosed no confl ict of interest.Coletta, Richard L. ................................ Disclosed no confl ict of interest.Colhoun, Helen M. ............................... Disclosed no confl ict of interest.Colip, Leslie ........................................... Disclosed no confl ict of interest.Coll, Anthony P. .................................... Disclosed no confl ict of interest.Collazo-Clavell, Maria ........................... Disclosed no confl ict of interest.Collier, Izabela A. ................................. Disclosed no confl ict of interest.Collins, Jenna........................................ Consultant: Novo Nordisk Inc.Collins, Michael T. ................................ Disclosed no confl ict of interest.Collinson, Andie .................................... Employee: MedImmune, LLC.Collombat, Patrick ................................. Disclosed no confl ict of interest.Colman, Peter G. .................................. Consultant: Australian Medical and Scientifi c; Research

Support: AstraZeneca, Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Biotech, Inc., Medtronic, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: Eli Lilly and Company, Ipsen Bioscience, Inc., Novo Nordisk Inc.

Colombo, Carla ...................................... Disclosed no confl ict of interest.Colon-Emeric, Cathleen......................... Disclosed no confl ict of interest.Colosimo, Enrico.................................... Disclosed no confl ict of interest.Colton, Clark K. ..................................... Disclosed no confl ict of interest.Coluzzi, Sara .......................................... Disclosed no confl ict of interest.Comas, Anna ......................................... Disclosed no confl ict of interest.Comas, Luis Masmiquel ........................ Advisory Panel: Janssen Pharmaceuticals, Inc., Novo Nordisk

A/S; Research Support: Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: Abbott, AstraZeneca, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH.

Comba, Rebecca W. ............................. Disclosed no confl ict of interest.Commissariat, Persis V. ........................ Disclosed no confl ict of interest.Commodore-Mensah, Yvonne Y. .......... Disclosed no confl ict of interest.Comyn, Oliver ........................................ Research Support: Novartis Pharmaceuticals Corporation.Concannon, Patrick................................ Disclosed no confl ict of interest.Concha, Alyssa ...................................... Disclosed no confl ict of interest.Confi des, Amy L. ................................... Disclosed no confl ict of interest.Conget, Ignacio ..................................... Disclosed no confl ict of interest.Conley, Kevin ......................................... Disclosed no confl ict of interest.Conley, Sean.......................................... Employee: ALPCO.Connell, Anna R. ................................... Disclosed no confl ict of interest.Connell, Frederick A. ............................ Disclosed no confl ict of interest.Connelly, Kim A. ................................... Advisory Panel: AstraZeneca, Eli Lilly and Company, Merck

& Co., Inc., Servier; Research Support: AstraZeneca, Boehringer Ingelheim GmbH.

Connelly, Margery A. ............................ Disclosed no confl ict of interest.Connelly, Philip W. ............................... Disclosed no confl ict of interest.Connon, Chelsea A. .............................. Disclosed no confl ict of interest.Connor, Crystal G. ................................. Disclosed no confl ict of interest.Conrad, Barry......................................... Disclosed no confl ict of interest.Constable, Robert T. ............................. Disclosed no confl ict of interest.Constantino, Maria I. ........................... Disclosed no confl ict of interest.Conte, Caterina ..................................... Disclosed no confl ict of interest.Conti, Francesco G. .............................. Disclosed no confl ict of interest.Contreras-Ferrat, Ariel .......................... Disclosed no confl ict of interest.Conway, Baqiyyah N. ........................... Disclosed no confl ict of interest.Cook, Curtiss B. .................................... Disclosed no confl ict of interest.Cook, John............................................. Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Cook, Shelly........................................... Disclosed no confl ict of interest.Cook, William ........................................ Employee: MedImmune, LLC.Coolman, Tyler ....................................... Disclosed no confl ict of interest.Cooney, Gregory .................................... Disclosed no confl ict of interest.Cooper, Blake A. ................................... Disclosed no confl ict of interest.Cooper, Jennifer .................................... Disclosed no confl ict of interest.Cooper, Mark E. .................................... Disclosed no confl ict of interest.Coppelli, Alberto ................................... Disclosed no confl ict of interest.Coppola, Andrea.................................... Disclosed no confl ict of interest.Copps, Kyle............................................ Disclosed no confl ict of interest.Corbeels, Katrien................................... Disclosed no confl ict of interest.Corbin, Adele E. .................................... Disclosed no confl ict of interest.

A709


AU

THO

R D

ISCL

OSU

RE

Corbin, Karen D. ................................... Disclosed no confl ict of interest.Cordeiro, Alessandra S. ....................... Disclosed no confl ict of interest.Cordeiro, Gabriela ................................. Disclosed no confl ict of interest.Cordoba-Chacon, Jose .......................... Disclosed no confl ict of interest.Coresh, Josef ........................................ Disclosed no confl ict of interest.Cornelis, Marilyn ................................... Disclosed no confl ict of interest.Cornu, Marion ....................................... Disclosed no confl ict of interest.Corradi, Domenico................................. Disclosed no confl ict of interest.Corraliza, Lidia....................................... Disclosed no confl ict of interest.Correa, Adolfo ....................................... Disclosed no confl ict of interest.Corrêa-Giannella, Maria Lúcia .............. Disclosed no confl ict of interest.Correia, Marcia R. ................................ Disclosed no confl ict of interest.Corrente, Jose Eduardo......................... Disclosed no confl ict of interest.Corsi Romanelli, Massimiliano ............. Disclosed no confl ict of interest.Cortez-Navarrete, Marisol .................... Disclosed no confl ict of interest.Coshway, Loyal...................................... Disclosed no confl ict of interest.Cosson, Emmanuel ................................ Advisory Panel: AstraZeneca, Janssen Pharmaceuticals, Inc.,

LifeScan, Inc., Lilly Deutschland GmbH, Menarini Group, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Roche Diagnostics, Sanofi -Aventis Deutschland GmbH; Research Support: Lilly Deutschland GmbH, Roche Diagnostics.

Costa Gil, José Esteban ........................ Disclosed no confl ict of interest.Costa, Diana K. ..................................... Disclosed no confl ict of interest.Costa, Rafaela A. ................................. Disclosed no confl ict of interest.Costabile, Giuseppina ........................... Disclosed no confl ict of interest.Costacou, Tina ....................................... Disclosed no confl ict of interest.Costantino, Francesco ........................... Disclosed no confl ict of interest.Costigan, Timothy.................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Coston, Taylor D. .................................. Disclosed no confl ict of interest.Cotch, Mary Frances ............................. Disclosed no confl ict of interest.Cote, Josee ........................................... Employee: Merck & Co., Inc.Coudriet, Gina M. ................................. Disclosed no confl ict of interest.Coue, Marine......................................... Disclosed no confl ict of interest.Cougnard-Gregoire, Audrey .................. Disclosed no confl ict of interest.Courtney, Michael ................................. Employee: Vaiomer.Courtney, Monica .................................. Disclosed no confl ict of interest.Courville, Amber.................................... Disclosed no confl ict of interest.Covington, Jeffrey ................................. Disclosed no confl ict of interest.Cowie, Catherine................................... Disclosed no confl ict of interest.Cox, Aaron R. ........................................ Disclosed no confl ict of interest.Cox, Catherine ....................................... Disclosed no confl ict of interest.Coyle, Sussete....................................... Disclosed no confl ict of interest.Cozar-Castellano, Irene ......................... Disclosed no confl ict of interest.Craig, Colleen M. ................................. Consultant: Eiger Biopharmaceuticals; Stock/Shareholder:

Eiger Biophparmaceuticals.Craig, Maria E. ..................................... Disclosed no confl ict of interest.Crain, A.L. ............................................. Disclosed no confl ict of interest.Crain, Lauren A. .................................... Disclosed no confl ict of interest.Craven, Timothy E. ................................ Disclosed no confl ict of interest.Crawford, Caitlin ................................... Disclosed no confl ict of interest.Crawford, Sam ...................................... Employee: Calibra Medical; Stock/Shareholder: Johnson &

Johnson.Cree-Green, Melanie............................. Disclosed no confl ict of interest.Cretu, Adina Mihaela ............................ Disclosed no confl ict of interest.Crick, Kent ............................................. Disclosed no confl ict of interest.Crickmore, Kim ...................................... Disclosed no confl ict of interest.Crimmins, Dan ....................................... Disclosed no confl ict of interest.Crimmins, Sarah .................................... Disclosed no confl ict of interest.Crisa, Laura ........................................... Disclosed no confl ict of interest.Cristol, Jean-Paul .................................. Disclosed no confl ict of interest.Crites, Yvonne ....................................... Disclosed no confl ict of interest.Crivano, Bruna M. ................................ Disclosed no confl ict of interest.Cromwell, William ................................ Consultant: Amarin Pharma, Inc.; Employee: LabCorp;

Speaker’s Bureau: Amarin Pharma, Inc.Cron, Stanley ......................................... Disclosed no confl ict of interest.Crookston, Robert.................................. Disclosed no confl ict of interest.Crull, Matthew R. ................................. Disclosed no confl ict of interest.Crume, Tessa L. .................................... Disclosed no confl ict of interest.Crutchlow, Michael ............................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Cuchel, Marina ...................................... Disclosed no confl ict of interest.Cuddihy, Robert ..................................... Employee: Janssen Global Services, LLC.Cuesta-Hernandez, Martin .................... Disclosed no confl ict of interest.Cui, Aoyuan ........................................... Disclosed no confl ict of interest.Cui, Jingqiu ........................................... Disclosed no confl ict of interest.Cui, Ran ................................................. Disclosed no confl ict of interest.Cui, Wenjie ............................................ Disclosed no confl ict of interest.Cui, Xuewei ........................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Cull, Melissa L. ..................................... Disclosed no confl ict of interest.Culley, Amanda A. ................................ Disclosed no confl ict of interest.Cummings, David E. ............................. Research Support: Jonhson & Johnson.Cummings, Doyle M. ............................ Disclosed no confl ict of interest.Cummings, Elizabeth ............................. Disclosed no confl ict of interest.

Cummings, Michael .............................. Other Relationship: Speaker’s Event, Eli Lilly and Company.Cunha-Neto, Edecio .............................. Disclosed no confl ict of interest.Cunningham, Tyler J. ............................ Disclosed no confl ict of interest.Cupples, L. Adrienne ............................. Disclosed no confl ict of interest.Cureau, Felipe V. ................................... Disclosed no confl ict of interest.Currie, Craig J. ..................................... Research Support: Abbott, Astra Zeneca, Grunenthal, KRKA,

Merck, Norgine, Novartis, Pfi zer, Sanofi , Takeda; Stock/Shareholder: Pharmatelligence.

Curtis, Bradley H. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Curtis, Sarah.......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Cushman, Samuel ................................. Disclosed no confl ict of interest.Cushman, William C. ............................ Other Relationship: Takeda Development Center Americas,

Inc.; Research Support: Eli Lilly and Company, Merck & Co., Inc.

Cusi, Kenneth ........................................ Disclosed no confl ict of interest.Cussac-Pillegand, Camille..................... Disclosed no confl ict of interest.Cusumano, Janine................................. Disclosed no confl ict of interest.Cwenar, Elizabeth .................................. Disclosed no confl ict of interest.Cyganek, Katarzyna ............................... Consultant: Medtronic MiniMed, Inc.Cypess, Aaron M. ................................. Disclosed no confl ict of interest.Czech, Michael P. ................................. Disclosed no confl ict of interest.Czerwinska, Margerita .......................... Disclosed no confl ict of interest.Czupryniak, Leszek ................................ Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly and

Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Wörwag Pharma GmbH & Co. KG; Speaker’s Bureau: Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., LifeScan, Inc., Polpharma SA Pharmaceutical Works, Servier, Teva Pharmaceutical Industries Ltd.

da Rocha Fernandes, Joao Diogo ......... Disclosed no confl ict of interest.da Silva Xavier, Gabriela ....................... Disclosed no confl ict of interest.Dabelea, Dana....................................... Disclosed no confl ict of interest.Dabra, Shakun ....................................... Disclosed no confl ict of interest.D’Addio, Francesca ............................... Disclosed no confl ict of interest.Dadi, Prasanna ...................................... Disclosed no confl ict of interest.Dadlani, Vikash ..................................... Disclosed no confl ict of interest.Dagdeviren, Sezin ................................. Disclosed no confl ict of interest.Dagogo-Jack, Samuel ........................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Novo Nordisk Inc.

D’Agostino McGowan, Lucy.................. Disclosed no confl ict of interest.D’Agostino, Ralph B. ............................ Disclosed no confl ict of interest.Dahgam, Santosh .................................. Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Dahl, Kirsten.......................................... Employee: Novo Nordisk A/S.Dahlin, Lars ........................................... Disclosed no confl ict of interest.Dahl-Jorgensen, Knut ........................... Disclosed no confl ict of interest.Dahlström, Emma .................................. Disclosed no confl ict of interest.Dahmen, Raphael .................................. Employee: Sanofi .Dai, Chunhua ......................................... Disclosed no confl ict of interest.Dai, Jiannong ........................................ Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Dai, Meng.............................................. Disclosed no confl ict of interest.Dai, Xiao-Qing ....................................... Disclosed no confl ict of interest.Dai, Xiaozhen ........................................ Disclosed no confl ict of interest.Dai, Zhe ................................................. Disclosed no confl ict of interest.Daiber, Andreas ..................................... Research Support: Boehringer Ingelheim GmbH.Daiello, Lori ........................................... Research Support: National Institutes of Health.Daigle, Lauren G. .................................. Disclosed no confl ict of interest.Dailey, George ....................................... Advisory Panel: Sanofi U.S.; Consultant: Sanofi U.S.;

Employee: Scripps Whittier Diabetes Institute; Research Support: Eli Lilly and Company, Lexicon Pharmaceuticals, Inc., Mylan, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca, Sanofi U.S.

Daimon, Makoto.................................... Disclosed no confl ict of interest.Dalal, Mehul R. .................................... Other Relationship: Sanofi U.S.Dalbøge, Louise S. ............................... Employee: Gubra.D’Alessio, David A. .............................. Disclosed no confl ict of interest.DallaMan, Chiara .................................. Disclosed no confl ict of interest.Dalton, R. Neil ....................................... Disclosed no confl ict of interest.Dalton-Bakes, Cornelia ......................... Disclosed no confl ict of interest.D’Alva, Catarina .................................... Disclosed no confl ict of interest.Damacharla, Divyasri ............................ Disclosed no confl ict of interest.Damiano, Edward R. ............................. Other Relationship: Beta Bionics, Dexcom, Inc., Eli Lilly and

Company, Tandem Diabetes Care, Inc.; Research Support: Dexcom, Inc., Eli Lilly and Company, NOVA Biomedical, Sweetspot Diabetes, Tandem Diabetes Care, Inc.

Damm, Peter.......................................... Other Relationship: Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S.

D’Amours, Martin.................................. Disclosed no confl ict of interest.Dan, Meixia ........................................... Disclosed no confl ict of interest.Dan, Olivia ............................................. Disclosed no confl ict of interest.

A710


AU

THO

R D

ISCL

OSU

RE

Danaei, Goodarz .................................... Disclosed no confl ict of interest.Dandona, Paresh ................................... Speaker’s Bureau: AstraZeneca.Daniel, Timothy D. ................................ Advisory Panel: Abbott Diabetes Care Inc.; Research Support:

Abbott Diabetes Care Inc., Valeritas.Daniele, Giuseppe ................................. Disclosed no confl ict of interest.Daniels, Mark J. ................................... Disclosed no confl ict of interest.Daniels, Martin A. ................................ Disclosed no confl ict of interest.Daniels, Martin M. ............................... Disclosed no confl ict of interest.Daniels, Stephen R. .............................. Disclosed no confl ict of interest.Danielson, Kirstie K. ............................. Disclosed no confl ict of interest.Daniilidis, Michael ................................ Disclosed no confl ict of interest.Danne, Thomas ..................................... Consultant: Abbott, AstraZeneca, Bayer HealthCare,

Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Dexcom, Inc., Eli Lilly and Company, Medtronic, Novo Nordisk A/S, Roche, Sanofi ; Research Support: Abbott, AstraZeneca, Bayer HealthCare, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Dexcom, Inc., Eli Lilly and Company, Medtronic, Novo Nordisk A/S, Roche, Sanofi ; Stock/Shareholder: DreaMed Diabetes, Ltd.

Dao, Lisa................................................ Disclosed no confl ict of interest.Dao-Ming, Chang .................................. Disclosed no confl ict of interest.Daoudi, Ahmed...................................... Disclosed no confl ict of interest.Daphna-Iken, Dorit ................................ Disclosed no confl ict of interest.Dar, Shujah ............................................ Disclosed no confl ict of interest.Dardano, Angela ................................... Disclosed no confl ict of interest.Dardari, Dured ....................................... Disclosed no confl ict of interest.Darden, Carly......................................... Disclosed no confl ict of interest.Darmon, Patrice..................................... Disclosed no confl ict of interest.Darshi, Manjula..................................... Disclosed no confl ict of interest.Dart, Allison .......................................... Disclosed no confl ict of interest.Darwish Murad, Sarwa ......................... Disclosed no confl ict of interest.Darzy, Ken.............................................. Disclosed no confl ict of interest.Das, Romita ........................................... Employee: Merck Sharp & Dohme Corp.Das, Shaonli .......................................... Disclosed no confl ict of interest.Das, Swapan K. .................................... Disclosed no confl ict of interest.Dasgupta, Kaberi................................... Disclosed no confl ict of interest.Dasgupta, Riddhi ................................... Disclosed no confl ict of interest.Dash, Rajesh ......................................... Disclosed no confl ict of interest.Dash, Satya ........................................... Disclosed no confl ict of interest.Daskalova, Ivona ................................... Disclosed no confl ict of interest.Dassau, Eyal .......................................... Consultant: Animas Corporation, Insulet Corporation.Datye, Karishma .................................... Disclosed no confl ict of interest.Dauriz, Marco ........................................ Disclosed no confl ict of interest.Davenport, Clemontina A. .................... Disclosed no confl ict of interest.Davey, Peter .......................................... Disclosed no confl ict of interest.Davidson, Jaime.................................... Advisory Panel: Amgen Inc., Aspire Bariatrics, AstraZeneca,

Boston Therapeutics, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc; Speaker’s Bureau: AstraZeneca, Janssen Pharmaceuticals, Inc., Merck Serono, Novo Nordisk Inc., Takeda Pharmaceutical Company Limited.

Davies, Melanie .................................... Advisory Panel: AstraZeneca, Boehringer Ingleheim, Janssen, Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi -Aventis; Board Member: AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi -Aventis; Consultant: AstraZeneca, Boehringer Ingleheim, Janssen, Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi -Aventis; Research Support: GlaxoSmithKline, Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Pfi zer, Sanofi -Aventis; Speaker’s Bureau: AstraZeneca, Boehringer Ingleheim, Janssen, Lilly, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk, Sanofi -Aventis.

Davies, Michael J. ............................... Employee: Janssen Scientifi c Affairs, LLC.Davies, Steve ........................................ Disclosed no confl ict of interest.Davis, Brian ........................................... Other Relationship: Truven Health Analytics, Inc.Davis, Crystal ........................................ Disclosed no confl ict of interest.Davis, Elizabeth ..................................... Disclosed no confl ict of interest.Davis, Fred............................................. Disclosed no confl ict of interest.Davis, Georgia ....................................... Disclosed no confl ict of interest.Davis, Keith ........................................... Other Relationship: Sanofi U.S.Davis, Lindsey E. .................................. Disclosed no confl ict of interest.Davis, Melanie L. ................................. Disclosed no confl ict of interest.Davis, Nicholas A. ................................ Disclosed no confl ict of interest.Davis, Stephen N. ................................ Disclosed no confl ict of interest.Davis, Timothy ....................................... Advisory Panel: Merck Sharp & Dohme Corp., Novo Nordisk

A/S; Other Relationship: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc.; Research Support: Merck Sharp & Dohme Corp., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Abbott, AstraZeneca, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Pfi zer Inc.

Davis, Wendy A. ................................... Research Support: Merck Sharp & Dohme Corp., Novo Nordisk A/S, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Eli Lilly and Company.

Dawn, Buddhadeb ................................. Disclosed no confl ict of interest.

Dawoud, Hazem .................................... Disclosed no confl ict of interest.Dawson, Philip E. ................................. Disclosed no confl ict of interest.Day, Samantha E. ................................. Disclosed no confl ict of interest.De Amicis, Ramona ............................... Disclosed no confl ict of interest.de Andrade, Mariza............................... Disclosed no confl ict of interest.De Bellis, Alessandra ............................ Disclosed no confl ict of interest.De Block, Christophe ............................. Advisory Panel: A. Menarini Diagnostics, Abbott, Eli Lilly

and Company, Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi , Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited.

De Bock, Martin .................................... Other Relationship: Pfi zer Inc., Sanofi U.S.; Research Support: Novo Nordisk Inc.

de Boer, Ian H. ...................................... Disclosed no confl ict of interest.De Carli, Elisa ........................................ Disclosed no confl ict of interest.De Cosmo, Salvatore............................. Disclosed no confl ict of interest.de Courten, Barbora .............................. Disclosed no confl ict of interest.De Escalante, Begoña ........................... Disclosed no confl ict of interest.De Filippis, Elena A. ............................. Disclosed no confl ict of interest.De Francesco, Maria ............................. Consultant: IMS Health Consulting.De Giglio, Roberto ................................. Disclosed no confl ict of interest.de Groot, Mary K. ................................. Disclosed no confl ict of interest.De Jesus, Dario F. ................................. Disclosed no confl ict of interest.de la Cruz, Marie ................................... Consultant: Icon, Plc.De La Fuente, Adriana........................... Disclosed no confl ict of interest.De la Houssaye, Rebecca...................... Disclosed no confl ict of interest.De Leon, Diva D. ................................... Disclosed no confl ict of interest.de Luis, Daniel....................................... Disclosed no confl ict of interest.de Lusignan, Simon ............................... Research Support: Eli Lilly and Company.De Maar, Josanne S. ............................ Disclosed no confl ict of interest.De Marinis, Yang................................... Disclosed no confl ict of interest.de Mello Laaksonen, Vanessa .............. Disclosed no confl ict of interest.De Miguel, Jose María ......................... Disclosed no confl ict of interest.De Nigris, Valeria .................................. Disclosed no confl ict of interest.De Santis, Michele................................ Disclosed no confl ict of interest.De Solis, Marco..................................... Disclosed no confl ict of interest.de Valk, Harold W. ............................... Disclosed no confl ict of interest.de Vos, Paul ........................................... Disclosed no confl ict of interest.de Weijer, Barbara A. ........................... Disclosed no confl ict of interest.de Wit, Helena M. ................................ Disclosed no confl ict of interest.de Wit, Maartje..................................... Advisory Panel: Sanofi -Aventis Deutschland GmbH; Research

Support: Sanofi -Aventis Deutschland GmbH.Deacon, Carolyn .................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Lilly

Deutschland GmbH, Merck Sharp & Dohme Corp., Novo Nordisk A/S; Employee: Merck Sharp & Dohme Corp. (Spouse/Partner); Stock/Shareholder: Merck & Co., Inc. (Spouse/Partner).

Dean, E. Danielle................................... Disclosed no confl ict of interest.Deb Majumdar, Ishita ............................ Employee: Berg Health; Stock/Shareholder: Berg Health.DeBoer, Mark D. ................................... Disclosed no confl ict of interest.Dedman, Harry ...................................... Employee: Receptos (Celgene).Dedousis, Nicolas ................................. Disclosed no confl ict of interest.Deeg, Mark A. ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Defoba, Elisabeth .................................. Employee: Sanofi -Aventis Deutschland GmbH.DeForest, Cole A. ................................. Disclosed no confl ict of interest.DeFronzo, Ralph A. ............................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Novo Nordisk Inc; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol Myers Squibb, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca, Novo Nordisk Inc.

Degnan, Bernard ................................... Disclosed no confl ict of interest.Deguchi, Tsuneo .................................... Disclosed no confl ict of interest.Dehennis, Andrew D. ........................... Employee: Senseonics, Inc.Dehghan, Abbas .................................... Disclosed no confl ict of interest.Dehn, Clayton A. .................................. Disclosed no confl ict of interest.Dei Cas, Alessandra .............................. Speaker’s Bureau: AstraZeneca, Merck Sharp & Dohme Corp.Dejene, Eden ......................................... Disclosed no confl ict of interest.Dejgaard, Thomas F. ............................. Research Support: Novo Nordisk A/S; Speaker’s Bureau: Novo

Nordisk A/S.DeJournett, Jeremy .............................. Stock/Shareholder: Ideal Medical Technologies Inc.DeJournett, Leon................................... Stock/Shareholder: Ideal Medical Technologies Inc.Dekeryte, Ruta....................................... Disclosed no confl ict of interest.Dekkers, Olaf M. .................................. Disclosed no confl ict of interest.Del Greco, Fabiola ................................. Disclosed no confl ict of interest.del Parigi, Angelo .................................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Del Prato, Stefano ................................. Advisory Panel: AstraZeneca, Boehringer Ingelheim GmbH,

Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi , Takeda Pharmaceutical Company Limited; Research Support: Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S.

del Re, Luigi........................................... Disclosed no confl ict of interest.

A711


AU

THO

R D

ISCL

OSU

RE

Del Toro, Rossella ................................. Disclosed no confl ict of interest.Dela Cruz, Amanda................................ Disclosed no confl ict of interest.Delahanty, Linda M. ............................. Advisory Panel: Eli Lilly and Company, Janssen

Pharmaceuticals, Inc., Nutrisystem, Omada Health, Inc.; Consultant: JanaCare.

Delamater, Alan M. .............................. Disclosed no confl ict of interest.Delcourt, Cécile ..................................... Disclosed no confl ict of interest.Delgado, Luís......................................... Disclosed no confl ict of interest.Delgado-García, Esther ......................... Disclosed no confl ict of interest.Delibegovic, Mirela ............................... Disclosed no confl ict of interest.Delivanis, Danae A. .............................. Disclosed no confl ict of interest.Della-Morte, David................................ Disclosed no confl ict of interest.Dellweg, Sibylle .................................... Disclosed no confl ict of interest.Delong, Thomas .................................... Disclosed no confl ict of interest.DeLozier, Amy ........................................ Employee: Eli Lilly and Company.DeLuzio, Tony ........................................ Employee: Novo Nordisk Inc.Delyfer, Marie Noelle ............................ Disclosed no confl ict of interest.Demant, Mia G. .................................... Disclosed no confl ict of interest.DeMarco, George J. ............................. Employee: Pfi zer Inc.DeMarco, Vincent G. ............................ Research Support: Boehringer Ingelheim Pharmaceuticals, Inc.Demarest, Keith .................................... Employee: Janssen Pharmaceuticals, Inc.DeMenna, Jacob T. .............................. Disclosed no confl ict of interest.Demircik, Filiz ........................................ Disclosed no confl ict of interest.Demissie, Marek ................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.den Hartigh, Laura................................. Disclosed no confl ict of interest.Deng, Hongrong .................................... Disclosed no confl ict of interest.Deng, Tuo .............................................. Disclosed no confl ict of interest.Deng, Wanping ..................................... Disclosed no confl ict of interest.Deng, Wei ............................................. Research Support: Medtronic, Inc.Deng, Yanru ........................................... Disclosed no confl ict of interest.Denham, Douglas .................................. Research Support: Intarcia Therapeutics, Inc.Denic, Hristina....................................... Disclosed no confl ict of interest.Denis, Amado E. ................................... Disclosed no confl ict of interest.Dennis, John M. ................................... Disclosed no confl ict of interest.Dennis, Michael D. ............................... Disclosed no confl ict of interest.Deodhar, Sneha ..................................... Disclosed no confl ict of interest.D’Eon, Stephanie................................... Disclosed no confl ict of interest.Derby, Teresa ......................................... Disclosed no confl ict of interest.Derdeyn, Colin ....................................... Disclosed no confl ict of interest.Derlindati, Eleonora .............................. Disclosed no confl ict of interest.D’Errico, Valeria .................................... Disclosed no confl ict of interest.DeRubertis, Frederick ............................ Disclosed no confl ict of interest.Der-Wei, Hwu........................................ Disclosed no confl ict of interest.Desai, Akshata ...................................... Disclosed no confl ict of interest.Desai, Jay R. ........................................ Disclosed no confl ict of interest.Desai, Mehul ......................................... Employee: Janssen Research and Development, LLC.Desai, Niraj ........................................... Disclosed no confl ict of interest.Desai, Sonali P. ..................................... Disclosed no confl ict of interest.Desai, Tanvi ........................................... Disclosed no confl ict of interest.Desai, Tejas ........................................... Disclosed no confl ict of interest.Desai, Urvi ............................................. Research Support: AstraZeneca, Bristol-Myers Squibb

Company, Eli Lilly and Company, GlaxoSmithKline.Desale, Hans ......................................... Employee: Receptos.DeSalvo, Daniel J. ................................ Disclosed no confl ict of interest.Desantis, Andrea................................... Research Support: Merck Sharp & Dohme Corp.Deshmukh, Harshal A. .......................... Disclosed no confl ict of interest.Desouza, Cyrus V. ................................. Advisory Panel: Novo Nordisk Inc; Consultant: Merck & Co.,

Inc.Desviat, Ivan.......................................... Employee: Eli Lilly and Company.Deswal, Anita........................................ Disclosed no confl ict of interest.Deusenbery, Carly ................................. Disclosed no confl ict of interest.Deutz, Nicolaas E. ................................ Disclosed no confl ict of interest.Devaraj, Sridevi ..................................... Disclosed no confl ict of interest.Devarajan, Meera ................................. Disclosed no confl ict of interest.DeVries, J. Hans .................................... Advisory Panel: Johnson & Johnson, Merck Sharp & Dohme

Corp., Novo Nordisk A/S, Roche Diagnostics; Research Support: Abbott Diabetes Care Inc., Dexcom, Inc., Medtronic, Inc., Sanofi U.S., Senseonics, Inc; Speaker’s Bureau: Becton, Dickinson and Company, Novo Nordisk A/S, Roche Diagnostics, Roche USA, Senseonics, Inc.

Dex, Terry .............................................. Employee: Sanofi U.S.; Stock/Shareholder: Merck & Co., Inc., Pfi zer Inc., Proctor and Gamble, Sanofi U.S., Teva Pharmaceutical Industries Ltd.

Dezube, Milana ..................................... Disclosed no confl ict of interest.Dhawan, Sangeeta................................ Disclosed no confl ict of interest.Dhawan, Veena ..................................... Disclosed no confl ict of interest.Dhindsa, Sandeep ................................. Disclosed no confl ict of interest.Dhyani, Vaneeta .................................... Disclosed no confl ict of interest.Di Caprio, Giovanni ............................... Disclosed no confl ict of interest.Di Mauro, Antonio................................. Disclosed no confl ict of interest.Di Noto, Anna........................................ Disclosed no confl ict of interest.Di Salvo, Jerry ....................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Diallo, Abdourahmane .......................... Disclosed no confl ict of interest.Diamandis, Eleftherios .......................... Disclosed no confl ict of interest.

Diamant, Michaela................................ Consultant: Abbott, AstraZeneca, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, GI Dynamics, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S, Poxel Pharmaceutical Company, Sanofi -Aventis Deutschland GmbH; Research Support: Abbott, AstraZeneca, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Medtronic, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH.

Diamantis, Theodoros ........................... Disclosed no confl ict of interest.Dias-da-Silva, Magnus R. .................... Disclosed no confl ict of interest.Diaz Coranguez, Monica ....................... Disclosed no confl ict of interest.Diaz, Ana ............................................... Disclosed no confl ict of interest.Diaz, Jesus ............................................ Disclosed no confl ict of interest.Diaz, Lars J. .......................................... Employee: Steno Diabetes Center A/S.Diaz, Paula............................................. Disclosed no confl ict of interest.Diaz, Rafael ........................................... Disclosed no confl ict of interest.Díaz-Cruz, Cristal ................................... Disclosed no confl ict of interest.Díaz-Roque, Lizbeth............................... Disclosed no confl ict of interest.Dib, Sergio A. ....................................... Disclosed no confl ict of interest.Dickerson, Matthew.............................. Disclosed no confl ict of interest.Dickstein, Kenneth ................................ Advisory Panel: Sanofi U.S.Diels, Joris ............................................ Employee: Janssen Global Services, LLC.Dietrich, Maren G. ................................ Disclosed no confl ict of interest.Dietze-Schroeder, Daniela .................... Disclosed no confl ict of interest.DiFrancesco, Mark ................................ Disclosed no confl ict of interest.DiGangi, Caralyn M. ............................. Disclosed no confl ict of interest.DiGruccio, Michael R. .......................... Disclosed no confl ict of interest.Dikovskaya, M.A. ................................. Disclosed no confl ict of interest.Dilisio, James........................................ Disclosed no confl ict of interest.Dilla, Tatiana ......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Dillinger, Jean-Guillaume ..................... Disclosed no confl ict of interest.DiMarchi, Richard O. ............................ Board Member: Calibrium LLC.; Other Relationship: Calibrium

LLC.; Research Support: Calibrium LLC.Dimasi, Paola ........................................ Disclosed no confl ict of interest.Dimasuay, Genelyn................................ Disclosed no confl ict of interest.Dimcevski, Georg .................................. Disclosed no confl ict of interest.DiMeglio, Linda A. ............................... Disclosed no confl ict of interest.Dimitriadis, Georgios K. ....................... Disclosed no confl ict of interest.Dimmock, Jacqueline ............................ Research Support: National Institutes of Health.Dimosthenopoulos, Charilaos ............... Disclosed no confl ict of interest.Diner, Jaimie ......................................... Disclosed no confl ict of interest.Dines, Kevin .......................................... Employee: Receptos.Ding, Christopher .................................. Disclosed no confl ict of interest.Ding, Ding.............................................. Disclosed no confl ict of interest.Ding, Jingzhong..................................... Disclosed no confl ict of interest.Ding, Lin ................................................ Disclosed no confl ict of interest.Ding, Mingge......................................... Disclosed no confl ict of interest.Ding, Su-Ann ......................................... Disclosed no confl ict of interest.Ding, Xiaofeng....................................... Disclosed no confl ict of interest.Ding, Xiaoying ....................................... Disclosed no confl ict of interest.Ding, Yanhua ......................................... Disclosed no confl ict of interest.Ding, Yishu ............................................ Disclosed no confl ict of interest.Diniz, Maria de Fátima .......................... Disclosed no confl ict of interest.DiNuzzo, Mauro..................................... Disclosed no confl ict of interest.Dion, Francois........................................ Disclosed no confl ict of interest.Dionne, Derek A. .................................. Disclosed no confl ict of interest.Direlwanger, Mirjam ............................. Disclosed no confl ict of interest.Dirice, Ercument .................................... Disclosed no confl ict of interest.Dirksen, Carsten .................................... Speaker’s Bureau: Eli Lilly and Company.Dismuke, Clara E. ................................. Disclosed no confl ict of interest.Disoteo, Olga E. .................................... Disclosed no confl ict of interest.Disotuar, Maria ..................................... Disclosed no confl ict of interest.Dissanayake, Waruni C. ....................... Disclosed no confl ict of interest.Distin, Tashanne .................................... Disclosed no confl ict of interest.Divakaruni, Monica ............................... Disclosed no confl ict of interest.Divers, Jasmin....................................... Disclosed no confl ict of interest.Dixon, Jane ........................................... Disclosed no confl ict of interest.Djakbarova, Umidahan .......................... Disclosed no confl ict of interest.Długaszek, Michał ................................. Disclosed no confl ict of interest.Do, Oanh H. .......................................... Disclosed no confl ict of interest.Doan, John ............................................ Disclosed no confl ict of interest.Dobrecky-Mery, Idit ............................... Advisory Panel: Merck & Co., Inc; Research Support: Novartis

Pharmaceuticals Corporation.Dobs, Adrian S. .................................... Disclosed no confl ict of interest.Docan, Mihaela ..................................... Disclosed no confl ict of interest.Dohrmann, Cord .................................... Employee: Evotec.Doi, Ayano ............................................. Disclosed no confl ict of interest.Doi, Misaki ............................................ Disclosed no confl ict of interest.Dolan, Lawrence M. ............................. Disclosed no confl ict of interest.Dolleman, Sophie .................................. Disclosed no confl ict of interest.Dollet, Lucile ......................................... Disclosed no confl ict of interest.

A712


AU

THO

R D

ISCL

OSU

RE

Dolzan, Vita ........................................... Disclosed no confl ict of interest.Domingo-Espin, Joan ............................ Disclosed no confl ict of interest.Domingues, Cleyton .............................. Disclosed no confl ict of interest.Dominquez, James ................................ Disclosed no confl ict of interest.Donadel, Giulia...................................... Disclosed no confl ict of interest.Donaghue, Kim C. ................................. Disclosed no confl ict of interest.Donahue, E. Patrick ............................... Disclosed no confl ict of interest.Donahue, Jimmy D. .............................. Disclosed no confl ict of interest.Donahue, Katrina E. ............................. Disclosed no confl ict of interest.Donaldson, Cynthia J. .......................... Disclosed no confl ict of interest.Donavan, Lois ........................................ Disclosed no confl ict of interest.Dong, Daoyin ......................................... Disclosed no confl ict of interest.Dong, Feng ............................................ Disclosed no confl ict of interest.Dong, Fran ............................................. Disclosed no confl ict of interest.Dong, Hengjin........................................ Disclosed no confl ict of interest.Dong, Henry........................................... Disclosed no confl ict of interest.Dong, Kun .............................................. Disclosed no confl ict of interest.Dong, Lily Q. ......................................... Disclosed no confl ict of interest.Dong, Sicong ......................................... Disclosed no confl ict of interest.Dong, Sisi .............................................. Disclosed no confl ict of interest.Dong, Yanting ........................................ Employee: Humana Inc.Dongre, Neelesh ................................... Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG.Doni Ova, Viera ..................................... Disclosed no confl ict of interest.Donihi, Amy C. ...................................... Disclosed no confl ict of interest.Donnelly, Louise .................................... Disclosed no confl ict of interest.Donnelly, Peter ...................................... Disclosed no confl ict of interest.Donnelly, Richard .................................. Speaker’s Bureau: AstraZeneca, Eli Lilly and Company,

Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc.

Donnelly, Rosemary............................... Disclosed no confl ict of interest.Donovan, Casey M. .............................. Disclosed no confl ict of interest.Donovan, Lois ........................................ Disclosed no confl ict of interest.Donovan, Peter ...................................... Disclosed no confl ict of interest.Donsa, Klaus ......................................... Disclosed no confl ict of interest.Dore, David D. ...................................... Employee: Optum, Inc.Doria, Alessandro.................................. Research Support: National Institutes of Health.D’Oria, Rossella..................................... Disclosed no confl ict of interest.Doridot, Ludivine ................................... Employee: Shire (Spouse/Partner).Dornadula, Sireesh................................ Disclosed no confl ict of interest.Doros, Gheorghe ................................... Other Relationship: Bayer HealthCare.Dorosh, Helen........................................ Disclosed no confl ict of interest.Dorothee, Kieninger-Baum .................... Disclosed no confl ict of interest.Dos Santos, Laila R. ............................. Disclosed no confl ict of interest.Dostalova, Gabriela............................... Disclosed no confl ict of interest.Dotta, Francesco ................................... Board Member: Merck Sharp & Dohme Corp., Novo Nordisk

A/S.Dotto, Renata P. .................................... Disclosed no confl ict of interest.Doty, Tasha ............................................ Disclosed no confl ict of interest.Dou, Jingtao .......................................... Disclosed no confl ict of interest.Doupis, John ......................................... Disclosed no confl ict of interest.Dowlat, Hoss A. ................................... Consultant: Marvel Life Sciences Ltd.Down, Susan ......................................... Consultant: Abbott Diabetes Care Inc., AstraZeneca/Bristol-

Meyers Squibb, Boehringer Ingelheim GmbH, Eli Lilly and Company, Johnson & Johnson, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: Omnia-Med, Ltd., SB Communications.

Downing, Janelle .................................. Consultant: Livongo Health.Downs, Julie S. .................................... Disclosed no confl ict of interest.Doyle III, Francis J. ............................... Disclosed no confl ict of interest.Doyle, Ralph T. ..................................... Employee: Amarin Pharma, Inc.; Stock/Shareholder: Amarin

Pharma, Inc.Dozio, Elena........................................... Disclosed no confl ict of interest.Dragomir, Miruna .................................. Disclosed no confl ict of interest.Drake, Isabel ......................................... Disclosed no confl ict of interest.Dreon, Darlene ...................................... Employee: Calibra Medical; Stock/Shareholder: Johnson &

Johnson.Dreval, A.V. ........................................... Disclosed no confl ict of interest.Drevon, Christian................................... Disclosed no confl ict of interest.Drewes, Asbjørn M. ............................. Disclosed no confl ict of interest.Drexel, Carole........................................ Disclosed no confl ict of interest.Drexel, Heinz ......................................... Disclosed no confl ict of interest.Dreyfuss, Jonathan M. ......................... Disclosed no confl ict of interest.Driscoll, Henry K. .................................. Disclosed no confl ict of interest.Driscoll, Kimberly A. ............................. Disclosed no confl ict of interest.Driver, John P. ....................................... Disclosed no confl ict of interest.Drobny, Jessica ..................................... Disclosed no confl ict of interest.Dropkin, Jess......................................... Disclosed no confl ict of interest.Drucker, Daniel J. ................................. Advisory Panel: Arisaph Pharmaceuticals, Intarcia

Therapeutics, Inc., MedImmune, LLC., Merck & Co., Inc., Novo Nordisk Inc., NPS Pharmaceuticals, Receptos, Sanofi U.S.

Drummond, Russell S. .......................... Disclosed no confl ict of interest.du Plessis, Cristina ................................ Disclosed no confl ict of interest.Du, Fuyong............................................. Employee: Janssen Pharmaceuticals, Inc.Du, Hong................................................ Disclosed no confl ict of interest.Du, Jin ................................................... Disclosed no confl ict of interest.

Du, Jing ................................................. Disclosed no confl ict of interest.Du, Liang ............................................... Disclosed no confl ict of interest.Duan, Ran .............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Duanne, Catherine ................................ Disclosed no confl ict of interest.Dubé, John J. ....................................... Disclosed no confl ict of interest.Dube, Marie-Christine........................... Disclosed no confl ict of interest.DuBose, Stephanie N. .......................... Disclosed no confl ict of interest.Dubroca, Caroline.................................. Disclosed no confl ict of interest.Dubsky, Michal ...................................... Disclosed no confl ict of interest.Duca, Lindsey M. .................................. Disclosed no confl ict of interest.Dufour, Sylvie ........................................ Disclosed no confl ict of interest.Duggal, Ashima ..................................... Disclosed no confl ict of interest.Duh, Mei Sheng .................................... Research Support: Janssen Scientifi c Affairs, LLC.Dujic, Tanja ............................................ Disclosed no confl ict of interest.Duke, Danny C. ..................................... Disclosed no confl ict of interest.Dulude, Helene...................................... Employee: Locemia Solutions; Stock/Shareholder: Locemia

Solutions.Dumayne, Christopher........................... Disclosed no confl ict of interest.Dunagan, Kelly T. ................................. Disclosed no confl ict of interest.Dunayeva, Inna...................................... Disclosed no confl ict of interest.Duncan, Bruce B. .................................. Research Support: Eli Lilly and Company.Duncan, F. Jason ................................... Disclosed no confl ict of interest.Duncan, Ian ........................................... Disclosed no confl ict of interest.Duncan, Stephen ................................... Disclosed no confl ict of interest.Dungan, Kathleen M. ........................... Advisory Panel: Eli Lilly and Company, GlaxoSmithKline;

Research Support: AstraZeneca, GlaxoSmithKline, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.

Dunger, David B. ................................... Disclosed no confl ict of interest.Duni, Janet ............................................ Disclosed no confl ict of interest.Dunn, Andrea L. .................................... Disclosed no confl ict of interest.Dunn, George ........................................ Disclosed no confl ict of interest.Dunn, Imogene ...................................... Employee: vTv Therapeutics LLC.Dunn, Jennifer C. ................................. Disclosed no confl ict of interest.Dunn, Ty ................................................. Disclosed no confl ict of interest.Dunne, Fidelma ..................................... Disclosed no confl ict of interest.Dunwoodie, Sally .................................. Disclosed no confl ict of interest.Duong, Michelle T. ............................... Disclosed no confl ict of interest.Dupont-Versteegden, Esther E. ............ Disclosed no confl ict of interest.Dupuis, Josee........................................ Disclosed no confl ict of interest.Durak, Abigail........................................ Disclosed no confl ict of interest.Durkan, Maeve C. ................................. Advisory Panel: Amgen Inc., Boehringer Ingelheim GmbH, Eli

Lilly and Company, Janssen Scientifi c Affairs, LLC, Merck & Co., Inc., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Other Relationship: Menarini Group.

Durkin, Nowella .................................... Disclosed no confl ict of interest.Durksen, Anita....................................... Disclosed no confl ict of interest.Durst, Ronen.......................................... Disclosed no confl ict of interest.Duru, Kenrick ......................................... Disclosed no confl ict of interest.Dutia, Roxanne ...................................... Disclosed no confl ict of interest.Dutour, Anne ......................................... Disclosed no confl ict of interest.Duvall, Craig L. ..................................... Disclosed no confl ict of interest.Duvillie, Bertrand .................................. Disclosed no confl ict of interest.Duvnjak, Lea .......................................... Disclosed no confl ict of interest.Duvvuru, Suman .................................... Employee: Eli Lilly and Company.Dvorak, Justin ....................................... Disclosed no confl ict of interest.Dvorak, Lisa ........................................... Employee: Receptos, Receptos (Celgene).Dybala, Claire ........................................ Employee: Takeda Pharmaceutical Company Limited.Dye, Amanda S. .................................... Disclosed no confl ict of interest.Dzygalo, Katarzyna ................................ Disclosed no confl ict of interest.Eather, Samuel R. ................................. Disclosed no confl ict of interest.Eaton, Charles B. .................................. Disclosed no confl ict of interest.Eberly, Lynn E. ...................................... Disclosed no confl ict of interest.Ebihara, Chihiro ..................................... Disclosed no confl ict of interest.Ebihara, Ken .......................................... Disclosed no confl ict of interest.Ebner, Eric .............................................. Employee: Dexcom, Inc.Ebner, Karl-Martin ................................. Disclosed no confl ict of interest.Ebrahimi, Aref ....................................... Disclosed no confl ict of interest.Echague, Carmen .................................. Disclosed no confl ict of interest.Echouffo-Tcheugui, Justin B. ............... Disclosed no confl ict of interest.Eckardt, Kristin ...................................... Disclosed no confl ict of interest.Eckel, Juergen ....................................... Research Support: Profi l Institute for Clinical Research, Inc.Eckel, Robert H. .................................... Disclosed no confl ict of interest.Edden, Richard ...................................... Disclosed no confl ict of interest.Eddie, James ......................................... Disclosed no confl ict of interest.Eddings, Wesley .................................... Research Support: Eli Lilly and Company.Edelman, David ..................................... Disclosed no confl ict of interest.Edelman, Steven V. ............................... Consultant: Boehringer Ingelheim GmbH, Eli Lilly and

Company; Speaker’s Bureau: Boehringer Ingelheim GmbH, Eli Lilly and Company.

Edelstein, Sharon L. ............................. Disclosed no confl ict of interest.Eder, Véronique ..................................... Disclosed no confl ict of interest.Ederveen, Twan ..................................... Employee: Merck & Co., Inc.Edgerton, Dale S. ................................. Disclosed no confl ict of interest.Edwards, Alun ....................................... Disclosed no confl ict of interest.Edwards, Robert .................................... Disclosed no confl ict of interest.

A713


AU

THO

R D

ISCL

OSU

RE

Edwards, Sheila .................................... Disclosed no confl ict of interest.Efanov, Alexander M. ........................... Employee: Eli Lilly and Company.Effoe, Valery S. ..................................... Disclosed no confl ict of interest.Egan, Aoife M. ..................................... Disclosed no confl ict of interest.Egan, Josephine M. ............................. Disclosed no confl ict of interest.Egede, Leonard...................................... Disclosed no confl ict of interest.Egerman, Robert S. .............................. Disclosed no confl ict of interest.Eggink, Hannah M. ............................... Disclosed no confl ict of interest.Egidi, Maria F. ....................................... Disclosed no confl ict of interest.Ehrlich, Michelle ................................... Disclosed no confl ict of interest.Ehrlich, Samantha F. ............................. Disclosed no confl ict of interest.Ehrman, Dominic ................................... Speaker’s Bureau: AstraZeneca, Berlin-Chemie.Ehrmann, David A. ................................ Board Member: Aastrom Biosciences, Inc.Ehses, Jan A. ........................................ Disclosed no confl ict of interest.Eichholz, Martin .................................... Disclosed no confl ict of interest.Eiermann, George.................................. Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Einhorn, Daniel ...................................... Consultant: AstraZeneca, Eli Lilly and Company, Halozyme

Therapeutics, Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi U.S., Takeda Development Center Americas, Inc.; Research Support: Eisai Co., Ltd., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Mylan, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc.; Speaker’s Bureau: Takeda Development Center Americas, Inc.; Stock/Shareholder: Halozyme Therapeutics.

Einig, Christine ...................................... Employee: Sanofi -Aventis Deutschland GmbH.Eisenberg, Stephen ............................... Employee: AmideBio; Stock/Shareholder: AmideBio.Ejarque, Miriam..................................... Disclosed no confl ict of interest.Ejzykowicz, Flavia .................................. Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Eke, Ransome ........................................ Disclosed no confl ict of interest.Ekhaese, Obos ....................................... Disclosed no confl ict of interest.Ekhlaspour, Laya .................................... Disclosed no confl ict of interest.Ekinci, Elif .............................................. Disclosed no confl ict of interest.Ekiz-Bilir, Betül ...................................... Disclosed no confl ict of interest.Ekstrom, Heidi L. .................................. Disclosed no confl ict of interest.Ekström, Marie ...................................... Disclosed no confl ict of interest.El Ansari, Nawal ................................... Disclosed no confl ict of interest.El Boustany, Ray .................................... Disclosed no confl ict of interest.El Ghormli, Laure ................................... Disclosed no confl ict of interest.El Hefnawy, Hesham ............................. Disclosed no confl ict of interest.El Makni, Mouna ................................... Disclosed no confl ict of interest.El Mghari, Ghizlane ............................... Disclosed no confl ict of interest.El Mokhtari, Mohammed ...................... Disclosed no confl ict of interest.El Ouaamari, Abdelfattah...................... Disclosed no confl ict of interest.El Youssef, Joseph ................................ Disclosed no confl ict of interest.Elango, Bhakkiyalakshmi....................... Disclosed no confl ict of interest.Elasy, Thomas A. .................................. Disclosed no confl ict of interest.ElBach, Jessica L. ................................. Disclosed no confl ict of interest.Elbez, Yedid ........................................... Disclosed no confl ict of interest.Eldor, Roy ............................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Elghazi, Lynda ........................................ Disclosed no confl ict of interest.Eliasson, Bjorn....................................... Advisory Panel: Amgen Inc., AstraZeneca, Boehringer

Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi .

Eliot, Kathrin A. .................................... Disclosed no confl ict of interest.El-Khatib, Firas ...................................... Disclosed no confl ict of interest.Elkind-Hirsch, Karen .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP; Research

Support: AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Merck & Co., Inc., Novo Nordisk A/S.

Elks, Carrie M. ...................................... Disclosed no confl ict of interest.Ellard, Sian ............................................ Disclosed no confl ict of interest.Elliott, Matthew R. ............................... Disclosed no confl ict of interest.Elmarsafi , Tammer ................................. Disclosed no confl ict of interest.Elmendorf, Jeffrey S. ........................... Disclosed no confl ict of interest.El-Sayed, Hesham ................................. Disclosed no confl ict of interest.El-Zein, Karla ......................................... Disclosed no confl ict of interest.Emerson, Julia....................................... Disclosed no confl ict of interest.Emirova, Aida ........................................ Employee: Novartis Pharma LLC.Emmert, Alison R. ................................. Disclosed no confl ict of interest.Emond, Bruno ........................................ Research Support: Janssen Scientifi c Affairs, LLC.Emral, Rifat............................................ Advisory Panel: AstraZeneca, Boehringer Ingelheim

GmbH, Novo Nordisk A/S, Sanofi -Aventis; Consultant: AstraZeneca, Boehringer Ingelheim GmbH, Novo Nordisk A/S, Sanofi -Aventis; Speaker’s Bureau: AstraZeneca, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis.

Ena, Javier............................................. Disclosed no confl ict of interest.Endo, Kei ............................................... Disclosed no confl ict of interest.Eng, Alvin .............................................. Disclosed no confl ict of interest.Engel, Felix ............................................ Disclosed no confl ict of interest.Engel, Samuel ....................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Engel, Taly ............................................. Disclosed no confl ict of interest.Engelbrechtsen, Line ............................. Disclosed no confl ict of interest.

Engelgau, Michael ................................ Disclosed no confl ict of interest.Engeli, Stefan ........................................ Disclosed no confl ict of interest.Engle, Courtney ..................................... Disclosed no confl ict of interest.Ennassiri, Wiam .................................... Disclosed no confl ict of interest.Ennis, Gilda E. ...................................... Disclosed no confl ict of interest.Enomoto, Laura ..................................... Disclosed no confl ict of interest.Enriquez, Ana ........................................ Disclosed no confl ict of interest.Eom, Young Sil ...................................... Disclosed no confl ict of interest.Erichsen, Lars ........................................ Employee: Novo Nordisk A/S.Ericson, Ulrika ....................................... Disclosed no confl ict of interest.Ericsson, Hans ....................................... Employee: AstraZeneca.Eriksson, Jan W. ................................... Advisory Panel: Merck & Co., Inc., Novo Nordisk Inc.;

Consultant: Merck & Co., Inc., Novo Nordisk Inc., Piramal Life Sciences; Employee: Amgen Inc. (Spouse/Partner); Other Relationship: AstraZeneca; Research Support: AstraZeneca; Stock/Shareholder: Amgen Inc. (Spouse/Partner).

Eringa, Ed E. ......................................... Disclosed no confl ict of interest.Eringa, Etto C. ....................................... Disclosed no confl ict of interest.Erion, Derek ........................................... Disclosed no confl ict of interest.Ermetice, Mariana N. ........................... Employee: Novo Nordisk A/S.Ersoz Gulcelik, Nese.............................. Disclosed no confl ict of interest.Escalada, Javier .................................... Advisory Panel: Merck Sharp & Dohme, Sanofi ; Speaker’s

Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk, Sanofi .

Escobar-Curbelo, Luis ............................ Disclosed no confl ict of interest.Eshtehardi, Sahar S. ............................. Disclosed no confl ict of interest.Eskelinen, Jari-Joonas .......................... Disclosed no confl ict of interest.Eskildsen, Tilde...................................... Disclosed no confl ict of interest.Esmaeili, Aryan ..................................... Disclosed no confl ict of interest.Espadero, Rosa-Maria........................... Employee: Boehringer Ingelheim GmbH.Espeland, Mark A. ................................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Janssen Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Terumo Corporation.

Espinosa DeYcaza, Ana......................... Disclosed no confl ict of interest.Espinosa, Carolina................................. Disclosed no confl ict of interest.Esponda, Raul R. .................................. Disclosed no confl ict of interest.Estes, Shanea K. .................................. Disclosed no confl ict of interest.Eto, Takashi ........................................... Disclosed no confl ict of interest.Ettela, Abora ......................................... Disclosed no confl ict of interest.Ettner, Susan L. .................................... Disclosed no confl ict of interest.Eurich, Dean .......................................... Disclosed no confl ict of interest.Evans, Charles R. .................................. Disclosed no confl ict of interest.Evans, Marc........................................... Advisory Panel: Merck Sharp & Dohme Corp., Novartis Pharma

AG, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: Merck Sharp & Dohme Corp., Novartis Pharma AG, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH.

Evans, Meredyth A. .............................. Disclosed no confl ict of interest.Evans-Molina, Carmella ........................ Disclosed no confl ict of interest.Eversley, Judith A. ................................ Disclosed no confl ict of interest.Evron, Yoav ............................................ Disclosed no confl ict of interest.Ewa, Ignacak ......................................... Disclosed no confl ict of interest.Ewen, Marg ........................................... Disclosed no confl ict of interest.Ezrokhi, Michael .................................... Employee: VeroScience, LLC.Ezzy, Stephen......................................... Disclosed no confl ict of interest.Faber, Jens ............................................ Disclosed no confl ict of interest.Fabris, Chiara ........................................ Disclosed no confl ict of interest.Fadavi, Hassan ...................................... Disclosed no confl ict of interest.Faerch, Kristine ..................................... Employee: Steno Diabetes Center A/S; Stock/Shareholder:

Novo Nordisk A/S.Færgeman, Nils ..................................... Disclosed no confl ict of interest.Faessler, Julia ....................................... Employee: Boehringer Ingelheim GmbH.Fagher, Katrina ...................................... Disclosed no confl ict of interest.Fahlbusch, Pia ....................................... Disclosed no confl ict of interest.Fahrmann, Elke ...................................... Disclosed no confl ict of interest.Fain, Pamela R. ..................................... Disclosed no confl ict of interest.Fajardo, Carmen .................................... Disclosed no confl ict of interest.Fajas, Lluis............................................. Disclosed no confl ict of interest.Falciglia, Mercedes ............................... Disclosed no confl ict of interest.Falkenhahn, Mechthilde........................ Employee: Sanofi -Aventis Deutschland GmbH.Fall, Tove ............................................... Disclosed no confl ict of interest.Fallucca, Sara ........................................ Disclosed no confl ict of interest.Famulla, Susanne .................................. Disclosed no confl ict of interest.Fan, Fan ................................................. Disclosed no confl ict of interest.Fan, Fangfang ........................................ Disclosed no confl ict of interest.Fan, Hongqi ........................................... Disclosed no confl ict of interest.Fan, Jing ................................................ Employee: Humana Inc.Fan, Ludi ................................................ Employee: Eli Lilly and Company.Fan, Mengdi .......................................... Disclosed no confl ict of interest.Fan, Michelle......................................... Disclosed no confl ict of interest.Fan, Tao ................................................. Employee: Sanofi U.S.; Stock/Shareholder: Sanofi U.S.Fan, Wenjun .......................................... Disclosed no confl ict of interest.Fanelli, Carmine G. ............................... Advisory Panel: Sanofi U.S.; Board Member: Sanofi -Aventis

Deutschland GmbH.Fang, Anna ............................................ Employee: Analysis Group, Inc.

A714


AU

THO

R D

ISCL

OSU

RE

Fang, Chen............................................. Disclosed no confl ict of interest.Fang, Han .............................................. Disclosed no confl ict of interest.Fang, Hui ............................................... Disclosed no confl ict of interest.Fang, Mei .............................................. Disclosed no confl ict of interest.Fang, Zhenwei ....................................... Disclosed no confl ict of interest.Fanghanel, Joelle .................................. Disclosed no confl ict of interest.Fanin, Alice............................................ Disclosed no confl ict of interest.Fantus, George I. .................................. Disclosed no confl ict of interest.Fantuzzi, Federica .................................. Disclosed no confl ict of interest.Farabi, Sarah S. .................................... Disclosed no confl ict of interest.Farag, Matthew..................................... Disclosed no confl ict of interest.Farahbakhshian, Sepehr........................ Employee: AstraZeneca Pharmaceuticals LP.Farb, Melissa G. ................................... Disclosed no confl ict of interest.Farese, Robert ....................................... Disclosed no confl ict of interest.Farese-Higgs, Margaret ........................ Disclosed no confl ict of interest.Farges, Blandine.................................... Disclosed no confl ict of interest.Fargo, Ramiz .......................................... Disclosed no confl ict of interest.Farhy, Leon S. ....................................... Disclosed no confl ict of interest.Farias, Ana Gardenia............................. Disclosed no confl ict of interest.Farias, Javier M. .................................. Disclosed no confl ict of interest.Farias, Monica....................................... Disclosed no confl ict of interest.Farmer, Adam D. ................................... Disclosed no confl ict of interest.Farmer, Ben ........................................... Disclosed no confl ict of interest.Farnsworth, Nikki .................................. Disclosed no confl ict of interest.Farooqi, Mohammed A. ........................ Disclosed no confl ict of interest.Farr, Sarah L. ........................................ Disclosed no confl ict of interest.Farrar, Alexandria .................................. Disclosed no confl ict of interest.Fath, Maryam ........................................ Disclosed no confl ict of interest.Faulds, Eileen ........................................ Disclosed no confl ict of interest.Faulkner, Melissa .................................. Disclosed no confl ict of interest.Faurschou, Annesofi e ............................ Disclosed no confl ict of interest.Faus, Ignacio ......................................... Employee: Genmedica Therapeutics; Stock/Shareholder:

Genmedica Therapeutics.Faustman, Denise L. ............................. Disclosed no confl ict of interest.Fava, Genevieve E. ............................... Disclosed no confl ict of interest.Favretto, Serena .................................... Disclosed no confl ict of interest.Fawdry, Robert A. ................................. Disclosed no confl ict of interest.Fawwad, Asher ..................................... Disclosed no confl ict of interest.Fayfman, Maya...................................... Disclosed no confl ict of interest.Fazli, Ghazal S. ..................................... Disclosed no confl ict of interest.Fealy, Ciarán E. ..................................... Disclosed no confl ict of interest.Federici, Massimo ................................. Disclosed no confl ict of interest.Federspiel, Cecilie A. ........................... Disclosed no confl ict of interest.Feener, Edward ...................................... Disclosed no confl ict of interest.Fegan-Bohm, Kelly ................................ Disclosed no confl ict of interest.Feghali, Maisa....................................... Disclosed no confl ict of interest.Fehlert, Ellen ......................................... Disclosed no confl ict of interest.Feig, Denice S. ..................................... Disclosed no confl ict of interest.Feig, Peter ............................................. Disclosed no confl ict of interest.Feigh, Michael....................................... Disclosed no confl ict of interest.Feinglass, Joseph.................................. Disclosed no confl ict of interest.Fejfarova, Vladimira .............................. Disclosed no confl ict of interest.Feldman, Anna ...................................... Disclosed no confl ict of interest.Feldman, Eva L. .................................... Disclosed no confl ict of interest.Fellows, Jonathan ................................. Research Support: AstraZeneca.Felton, Alexandra .................................. Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Fend, Falko ............................................ Disclosed no confl ict of interest.Feng, Biao.............................................. Disclosed no confl ict of interest.Feng, Jianyuan ...................................... Disclosed no confl ict of interest.Feng, Juanran........................................ Disclosed no confl ict of interest.Feng, Zhonggang ................................... Disclosed no confl ict of interest.Fenici, Peter........................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Fenutria, Rafael ..................................... Disclosed no confl ict of interest.Feoktistov, Vitaliy A. ............................. Disclosed no confl ict of interest.Feo-Ortega, Gara ................................... Disclosed no confl ict of interest.Feraldi, Alessandro ............................... Disclosed no confl ict of interest.Ferdaoussi, Mourad .............................. Disclosed no confl ict of interest.Ferdousi, Maryam ................................. Disclosed no confl ict of interest.Feretic, Brian ......................................... Employee: Receptos (Celgene).Ferguson-Smith, Anne........................... Disclosed no confl ict of interest.Fernadez-Diaz, Cristina M. ................... Disclosed no confl ict of interest.Fernandes, Gabriel R. ........................... Disclosed no confl ict of interest.Fernandes, Gail ..................................... Employee: Merck & Co., Inc.Fernandes, Virginia ............................... Research Support: Eli Lilly and Company.Fernández, Elvira ................................... Disclosed no confl ict of interest.Fernandez, Megan................................. Disclosed no confl ict of interest.Fernandez-Cachon, MariaLuisa............. Employee: Sanofi -Aventis Deutschland GmbH.Fernandez-Garcia, Jose Carlos ............. Disclosed no confl ict of interest.Fernandez-Montero, Alejandro ............. Disclosed no confl ict of interest.Fernandez-Veledo, Sonia ...................... Disclosed no confl ict of interest.Fernando, Sumali .................................. Disclosed no confl ict of interest.Feron, Florine......................................... Disclosed no confl ict of interest.Ferrannini, Ele ....................................... Consultant: Janssen Pharmaceuticals, Inc.Ferrara, Assiamira ................................. Disclosed no confl ict of interest.Ferrara, Christine T. .............................. Disclosed no confl ict of interest.

Ferrari, Uta ............................................ Disclosed no confl ict of interest.Ferreira, Ludmila R. .............................. Disclosed no confl ict of interest.Ferreira, Sandra R. ............................... Disclosed no confl ict of interest.Ferris, Heather A. ................................. Disclosed no confl ict of interest.Ferrito, Lucia.......................................... Disclosed no confl ict of interest.Ferrulli, Anna ......................................... Disclosed no confl ict of interest.Festa, Andreas ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Fiaschi-Taesch, Nathalie M. ................ Disclosed no confl ict of interest.Fieldhouse, Abigail................................ Disclosed no confl ict of interest.Fielding, Robert ..................................... Consultant: Intarcia Therapeutics, Inc.Figueiredo, Roberta ............................... Disclosed no confl ict of interest.Filice, Emanuele .................................... Disclosed no confl ict of interest.Finck, Brian N. ...................................... Disclosed no confl ict of interest.Findley, Mary K. .................................... Disclosed no confl ict of interest.Fingberg, Waltraud ............................... Disclosed no confl ict of interest.Fingerlin, Tasha E. ................................ Disclosed no confl ict of interest.Finkelstein, Netanel .............................. Disclosed no confl ict of interest.Finlayson, Graham................................. Research Support: Novo Nordisk A/S.Finlin, Brian ........................................... Disclosed no confl ict of interest.Finney, Krystal ....................................... Disclosed no confl ict of interest.Fino, Nora .............................................. Disclosed no confl ict of interest.Finzi, Giovanna ...................................... Disclosed no confl ict of interest.Fiorentino, Vanessa ............................... Disclosed no confl ict of interest.Fiorina, Paolo......................................... Disclosed no confl ict of interest.Fioriti, Elvira .......................................... Disclosed no confl ict of interest.Fischer, Annelie ..................................... Employee: Profi l Institut für Stoffwechselforschung.Fischer-Posovszky, Pamela .................... Disclosed no confl ict of interest.Fischl, Andrea F. ................................... Disclosed no confl ict of interest.Fiserova, Eva ......................................... Disclosed no confl ict of interest.Fisher, Edwin B. .................................... Consultant: Novo Nordisk Inc; Speaker’s Bureau: Sanofi K.K.Fisher, Gordon ....................................... Disclosed no confl ict of interest.Fisher, Lawrence ................................... Consultant: Abbott, Eli Lilly and Company, Roche Diagnostics.Fisher, Simon J. .................................... Consultant: Merck Sharp & Dohme Corp., Novo Nordisk Inc;

Speaker’s Bureau: Merck Sharp & Dohme Corp.Fitchett, David ....................................... Advisory Panel: AstraZeneca, Merck & Co., Inc., Sanofi -Aventis

Deutschland GmbH; Other Relationship: DSMB, Novo Nordisk Inc; Speaker’s Bureau: Boehringer Ingelheim GmbH.

Fitzgerald, Ryan H. ............................... Research Support: Podimetrics, Inc.Fitzpatrick, Annette ............................... Disclosed no confl ict of interest.Flachs, Pavel.......................................... Disclosed no confl ict of interest.Flacke, Frank.......................................... Employee: Sanofi -Aventis Deutschland GmbH.Flak, Jonathan N. ................................. Disclosed no confl ict of interest.Flannery, Clare A. ................................. Disclosed no confl ict of interest.Flannick, Jason A. ................................ Disclosed no confl ict of interest.Fleck, Penny........................................... Employee: Takeda Development Center Americas, Inc.Flekac, Milan ......................................... Disclosed no confl ict of interest.Fleming, Victoria ................................... Disclosed no confl ict of interest.Fleres, Mattia ........................................ Disclosed no confl ict of interest.Flint, Anne ............................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S, Novo Nordisk A/S (Spouse/Partner).Flitter, Ben A. ........................................ Disclosed no confl ict of interest.Flögel, Ulrich ......................................... Disclosed no confl ict of interest.Flood, Emuella ....................................... Consultant: Icon, Plc.Florczyk, Iga ........................................... Disclosed no confl ict of interest.Florea, Liliana ........................................ Disclosed no confl ict of interest.Florez, Jose C. ...................................... Disclosed no confl ict of interest.Flowers, Elena ....................................... Disclosed no confl ict of interest.Flynn, Maxfi eld ...................................... Disclosed no confl ict of interest.Foga, Irene............................................. Employee: Eli Lilly Canada Inc.; Stock/Shareholder: Eli Lilly

Canada Inc.Fogelfeld, Leon ...................................... Disclosed no confl ict of interest.Foghsgaard, Signe................................. Research Support: Novo Nordisk A/S.Foley, James E. ..................................... Employee: Novartis Pharmaceuticals Corporation; Stock/

Shareholder: Novartis Pharmaceuticals Corporation.Folini, Laura ........................................... Disclosed no confl ict of interest.Folli, Franco ........................................... Disclosed no confl ict of interest.Fonda, Stephanie .................................. Employee: Estenda.Fong, Carol H. ....................................... Disclosed no confl ict of interest.Fonseca’, Fernando Luiz A. ................... Disclosed no confl ict of interest.Fonseca, Maria de Jesus ...................... Disclosed no confl ict of interest.Fonseca, Vivian A. ................................ Disclosed no confl ict of interest.Fontana, Alessia.................................... Disclosed no confl ict of interest.Foos, Volker ........................................... Disclosed no confl ict of interest.Forbes, Josephine M. ........................... Disclosed no confl ict of interest.Forbes, Shareen .................................... Disclosed no confl ict of interest.Forero-Schwanhaeuser, Sergio ............. Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Foretz, Marc .......................................... Disclosed no confl ict of interest.Forken, Patricia...................................... Research Support: National Institutes of Health.Forlenza, Gregory P. .............................. Consultant: Abbott Diabetes Care Inc.; Research Support:

Medtronic MiniMed, Inc.Formiga, Frances ................................... Disclosed no confl ict of interest.Forsblom, Carol ..................................... Disclosed no confl ict of interest.Forst, Thomas A. .................................. Advisory Panel: AstraZeneca, Boehringer Ingelheim GmbH,

Bristol-Myers Squibb Company, Eli Lilly and Company,

A715


AU

THO

R D

ISCL

OSU

RE

Sanofi U.S.; Research Support: AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Novartis Pharma GmbH, Sanofi U.S.; Speaker’s Bureau: AstraZeneca, Berlin-Chemie, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis Pharma GmbH, Novo Nordisk Inc., Sanofi U.S.

Fortmann, Addie L. ............................... Advisory Panel: AstraZeneca Pharmaceuticals LP.Foss, Milton C. ..................................... Disclosed no confl ict of interest.Fosse-Edorh, Sandrine .......................... Disclosed no confl ict of interest.Foss-Freitas, Maria Cristina .................. Disclosed no confl ict of interest.Foster, Kathleen .................................... Disclosed no confl ict of interest.Foster, Nicole C. ................................... Disclosed no confl ict of interest.Foster, Wendra M. ............................... Employee: Eli Lilly and Company.Founds, Sandra...................................... Disclosed no confl ict of interest.Fourcaudot, Marcel ............................... Disclosed no confl ict of interest.Fousas, Stefanos ................................... Disclosed no confl ict of interest.Fousteris, Evangelos ............................. Disclosed no confl ict of interest.Fouts, Alexandra R. .............................. Disclosed no confl ict of interest.Fowler, Kristen ...................................... Disclosed no confl ict of interest.Fowler, Susan ........................................ Disclosed no confl ict of interest.Fox, Charles ........................................... Disclosed no confl ict of interest.Fox, Peter............................................... Disclosed no confl ict of interest.Fradera, Rosa ........................................ Disclosed no confl ict of interest.Fraga, Daniel W. ................................... Disclosed no confl ict of interest.Franc, Sylvia .......................................... Disclosed no confl ict of interest.Francia, Piergiorgio ............................... Disclosed no confl ict of interest.Francis, Sheila ....................................... Disclosed no confl ict of interest.Francisco, Rossana P. ........................... Disclosed no confl ict of interest.Franco, Luciana F. ................................. Disclosed no confl ict of interest.Franco, Oscar......................................... Disclosed no confl ict of interest.Frandsen, Christian S. .......................... Research Support: Novo Nordisk A/S; Speaker’s Bureau: Novo

Nordisk A/S.Franek, Edward...................................... Advisory Panel: AstraZeneca, Merck & Co., Inc., Novo

Nordisk A/S; Consultant: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca, Bioton SA, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Johnson & Johnson Diabetes Institute, Merck & Co., Inc., Merck KGaA, Novo Nordisk A/S, Sanofi , Servier, Teva Pharmaceutical Industries Ltd.

Frank, Eliana .......................................... Disclosed no confl ict of interest.Frank, Sabine......................................... Disclosed no confl ict of interest.Franklin, Jessica.................................... Disclosed no confl ict of interest.Franks, Stephen..................................... Disclosed no confl ict of interest.Franzén, Stefan ..................................... Research Support: AstraZeneca.Frascerra, Silvia..................................... Disclosed no confl ict of interest.Fraunberger, Peter ................................. Disclosed no confl ict of interest.Frayling, Timothy M. ............................. Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.Fraysse, Jeremy .................................... Research Support: AstraZeneca.Freathy, Rachel ...................................... Disclosed no confl ict of interest.Freckmann, Guido.................................. Advisory Panel: Abbott Diabetes Care Inc., Sanofi -Aventis

Deutschland GmbH; Consultant: Becton, Dickinson and Company, Novo Nordisk A/S; Speaker’s Bureau: Abbott Diabetes Care Inc., Bayer HealthCare, Berlin-Chemie, Hoffman-La Roche Limited, Menarini Group, Sanofi -Aventis Deutschland GmbH, Ypsomed.

Free, Colette .......................................... Disclosed no confl ict of interest.Freedman, Barry I. ................................ Disclosed no confl ict of interest.Freeman, Dilys J. .................................. Disclosed no confl ict of interest.Freeman, Jennifer ................................. Employee: vTv Therapeutics LLC; Stock/Shareholder: vTv

Therapeutics LLC, vTv Therapeutics LLC (Spouse/Partner).Freeman, Kurt A. .................................. Disclosed no confl ict of interest.Freemantle, Nick ................................... Consultant: Novo Nordisk Inc., Sanofi U.S.Freemark, Michael ................................ Disclosed no confl ict of interest.Frego, Roberto ....................................... Disclosed no confl ict of interest.Freibothe, Ines....................................... Disclosed no confl ict of interest.Freude, Susanna.................................... Employee: Boehringer Ingelheim GmbH.Frey, Marcel........................................... Disclosed no confl ict of interest.Frias, Juan P. ........................................ Consultant: AstraZeneca, CeQur, Ltd., Johnson & Johnson;

Research Support: AbbVie Inc., Amgen Inc., Asahi Kasei Corporation, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Elcelyx Therapeutics, Inc., Isis Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Lilly Deutschland GmbH, Merck & Co., Inc., Novo Nordisk Inc., Pfi zer Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited.

Friberg, Lena E. ..................................... Consultant: Merck & Co., Inc; Employee: Pharmetheus, Inc.Friborg, Søren ........................................ Disclosed no confl ict of interest.Frid, Anders ........................................... Disclosed no confl ict of interest.Fridlyand, Leonid ................................... Disclosed no confl ict of interest.Friedline, Randall H. ............................. Disclosed no confl ict of interest.Friedman, Jacob E. (Jed) ....................... Disclosed no confl ict of interest.Friedman, Miriam .................................. Disclosed no confl ict of interest.Friedrich, Stefanie ................................. Disclosed no confl ict of interest.Frier, Brian M. ....................................... Advisory Panel: Eli Lilly and Company, Johnson & Johnson,

Locemia Solutions, LP, Merck Sharp & Dohme Corp.;

Speaker’s Bureau: Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Takeda Pharmaceutical Company Limited.

Friis, Steffen U. .................................... Disclosed no confl ict of interest.Frisvold, Rune ........................................ Employee: LifeCare; Stock/Shareholder: LifeCare.Fritsche, Andreas .................................. Consultant: Sanofi -Aventis Deutschland GmbH.Fritsche, Louise ..................................... Disclosed no confl ict of interest.Fritschi, Cynthia..................................... Disclosed no confl ict of interest.Fröhlich-Reiterer, Elke ........................... Disclosed no confl ict of interest.Frohnert, Brigitte ................................... Disclosed no confl ict of interest.Fronczyk, Aneta ..................................... Disclosed no confl ict of interest.Frontoni, Simona ................................... Disclosed no confl ict of interest.Frosio, Christiana .................................. Employee: Sanofi -Aventis Deutschland GmbH.Frost, Carrie ........................................... Disclosed no confl ict of interest.Frost, Morten......................................... Disclosed no confl ict of interest.Fruecht, Molly ....................................... Disclosed no confl ict of interest.Fry, Jessica ............................................ Disclosed no confl ict of interest.Frykberg, Robert G. ............................... Research Support: Podimetrics, Inc.Frystyk, Jan ........................................... Advisory Panel: Novo Nordisk A/S.Fu, Alex Z. ............................................. Research Support: AstraZeneca.Fu, An-Chen ........................................... Employee: HealthCore.Fu, Chaowei........................................... Disclosed no confl ict of interest.Fu, Dongxu............................................. Disclosed no confl ict of interest.Fu, Feng ................................................. Disclosed no confl ict of interest.Fu, Haiyan.............................................. Disclosed no confl ict of interest.Fu, Han-Jing .......................................... Disclosed no confl ict of interest.Fu, Haoda .............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Fu, Jinxiang ........................................... Disclosed no confl ict of interest.Fu, Junlin ............................................... Disclosed no confl ict of interest.Fu, Zhenzhen ......................................... Disclosed no confl ict of interest.Fu, Zhuo ................................................. Disclosed no confl ict of interest.Fuchs, Matthias..................................... Employee: Boehringer Ingelheim GmbH; Stock/Shareholder:

Novartis AG.Fuente-Martin, Esther ........................... Disclosed no confl ict of interest.Fuentes, Ruth ........................................ Disclosed no confl ict of interest.Fufaa, Gudeta D. .................................. Disclosed no confl ict of interest.Fujihara, Kazuya .................................... Disclosed no confl ict of interest.Fujikura, Junji ........................................ Disclosed no confl ict of interest.Fujimaki, Yuko ....................................... Disclosed no confl ict of interest.Fujimori, Shin ........................................ Disclosed no confl ict of interest.Fujimoto, Hiroyuki ................................. Disclosed no confl ict of interest.Fujimoto, Shimpei ................................. Research Support: Astellas Pharma Inc., AstraZeneca,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Japan K.K., Merck & Co., Inc., Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Ono Pharmaceutical Co., Ltd.

Fujimoto, Shuji ...................................... Disclosed no confl ict of interest.Fujimoto, Wilfred .................................. Disclosed no confl ict of interest.Fujioka, Kei ............................................ Disclosed no confl ict of interest.Fujisaka, Shiho ...................................... Disclosed no confl ict of interest.Fujita, Naotaka ...................................... Disclosed no confl ict of interest.Fujita, Nobuya ....................................... Disclosed no confl ict of interest.Fujita, Yukihiro ....................................... Disclosed no confl ict of interest.Fujitani, Yoshio ...................................... Research Support: Eli Lilly Japan K.K., Merck & Co., Inc.,

Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Merck & Co., Inc., Novartis Pharma K.K., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Fukagawa, Masafumi............................ Disclosed no confl ict of interest.Fukuda, Takuya ...................................... Disclosed no confl ict of interest.Fukuda, Yukiko ....................................... Disclosed no confl ict of interest.Fukui, Michiaki ...................................... Research Support: Astellas Pharma Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Takeda Pharmaceutical Company Limited.

Fukui, Rosa ............................................ Disclosed no confl ict of interest.Fukui, Tomoyasu .................................... Disclosed no confl ict of interest.Fukumi, Fukumi...................................... Disclosed no confl ict of interest.Fukutani, Tomoka .................................. Disclosed no confl ict of interest.Fulcher, Gregory .................................... Advisory Panel: Amgen Inc., Boehringer Ingelheim GmbH,

Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Boehringer Ingelheim GmbH, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S.

Fulkerson, Candice ................................ Disclosed no confl ict of interest.Fullmer, Rodney ..................................... Disclosed no confl ict of interest.Fumeron, Frédéric.................................. Disclosed no confl ict of interest.

A716


AU

THO

R D

ISCL

OSU

RE

Funaki, Makoto...................................... Board Member: Mechanogenic, K.K.; Research Support: Mechanogenic, K.K.; Stock/Shareholder: Mechanogenic, K.K.

Funakoshi, Satoshi ................................ Disclosed no confl ict of interest.Funayama, Takashi ................................ Disclosed no confl ict of interest.Funck, Kristian ....................................... Disclosed no confl ict of interest.Fung, Albert ........................................... Employee: Janssen Research & Development, LLC.Funnell, Martha ..................................... Advisory Panel: AstraZeneca, Bristol Myers Squibb, Eli Lilly

and Company, Hygieia, Johnson & Johnson, Novo Nordisk Inc., Omada Health, Inc., Sanofi U.S.

Funsten, Matthew ................................. Disclosed no confl ict of interest.Furie, Karen L. ...................................... Disclosed no confl ict of interest.Furman, Elise ......................................... Disclosed no confl ict of interest.Furman, Roy........................................... Disclosed no confl ict of interest.Furuie, Hidetoshi ................................... Disclosed no confl ict of interest.Furukawa, Shinya .................................. Disclosed no confl ict of interest.Furukawa, Yasuhiko .............................. Disclosed no confl ict of interest.Furukoshi, Michiaki ............................... Disclosed no confl ict of interest.Furusyo, Norihiro ................................... Disclosed no confl ict of interest.Furuta, Yoshihiko ................................... Disclosed no confl ict of interest.Fysekidis, Marinos ................................ Disclosed no confl ict of interest.Gaarsdal Holst, Anders ......................... Employee: Novo Nordisk A/S.Gaba, Ruchi ........................................... Disclosed no confl ict of interest.Gabbay, Robert A. ................................ Disclosed no confl ict of interest.Gaber, Osama O. .................................. Disclosed no confl ict of interest.Gaborit, Bénédicte ................................ Disclosed no confl ict of interest.Gabriele, Jeanne ................................... Disclosed no confl ict of interest.Gabriele, Morena .................................. Disclosed no confl ict of interest.Gabriely, Ilan ......................................... Disclosed no confl ict of interest.Gadgil, Meghana D. ............................. Disclosed no confl ict of interest.Gaggini, Melania................................... Disclosed no confl ict of interest.Gagliardino, Juan Jose ......................... Advisory Panel: Eli Lilly and Company.Gagnon, Lyne ......................................... Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Gagnon, William ................................... Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Gaillard, Trudy R. .................................. Disclosed no confl ict of interest.Gaisano, Herbert Y. .............................. Disclosed no confl ict of interest.Gal, Robin L. ......................................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Novo Nordisk Inc.Galán-Bueno, Laura............................... Disclosed no confl ict of interest.Galassetti, Pietro................................... Disclosed no confl ict of interest.Galgani, Jose E. ................................... Disclosed no confl ict of interest.Galindo, Rodolfo J. ............................... Disclosed no confl ict of interest.Gallagher, Emily J. ............................... Disclosed no confl ict of interest.Gallagher, Katherine ............................. Disclosed no confl ict of interest.Gallen, Ian W. ....................................... Disclosed no confl ict of interest.Galli, Angelica ....................................... Disclosed no confl ict of interest.Gallo, Linda C. ...................................... Disclosed no confl ict of interest.Galloway, Jamie.................................... Disclosed no confl ict of interest.Gallwitz, Baptist .................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc.; Speaker’s Bureau: Abbott, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Sanofi U.S.

Galván-Díaz, Beatriz .............................. Disclosed no confl ict of interest.Galvao Neto, Manoel ............................ Advisory Panel: Fractyl, GI Dynamics, Inc.; Consultant: Fractyl,

GI Dynamics, Inc.; Research Support: Fractyl.Gamerman, Victoria .............................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Gan, Dongmei........................................ Disclosed no confl ict of interest.Gan, Lixia............................................... Disclosed no confl ict of interest.Ganachari, M. ....................................... Disclosed no confl ict of interest.Ganapathy, Vinutha ............................... Disclosed no confl ict of interest.Gancheva, Sofi ya................................... Disclosed no confl ict of interest.Gandhi, Alka .......................................... Disclosed no confl ict of interest.Gandhi, Kajal ......................................... Disclosed no confl ict of interest.Gandhi, Rajiv ......................................... Disclosed no confl ict of interest.Gandhi, Shruti ....................................... Disclosed no confl ict of interest.Gandy, Sam ........................................... Disclosed no confl ict of interest.Ganesan, Goutham................................ Disclosed no confl ict of interest.Ganetsky, Valerie .................................. Disclosed no confl ict of interest.Gangadhara, Praveen ............................ Disclosed no confl ict of interest.Ganguly, Sonali ..................................... Disclosed no confl ict of interest.Ganna, Andrea ...................................... Disclosed no confl ict of interest.Gannon, Maureen A. ............................ Disclosed no confl ict of interest.Ganotopoulou, Asimina......................... Disclosed no confl ict of interest.Gantz, Ira ............................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Gao, Beibei ............................................ Disclosed no confl ict of interest.Gao, Fabao ............................................ Disclosed no confl ict of interest.Gao, He.................................................. Disclosed no confl ict of interest.Gao, Hong.............................................. Disclosed no confl ict of interest.Gao, Hongkai ......................................... Disclosed no confl ict of interest.

Gao, Jing ............................................... Disclosed no confl ict of interest.Gao, Lili ................................................. Disclosed no confl ict of interest.Gao, Ling ............................................... Other Relationship: Consultant Sanofi U.S., Inc.Gao, Shan .............................................. Disclosed no confl ict of interest.Gao, Weiguo ......................................... Disclosed no confl ict of interest.Gao, Xianfu............................................ Disclosed no confl ict of interest.Gao, Xin ................................................. Disclosed no confl ict of interest.Gao, Xueying ......................................... Disclosed no confl ict of interest.Garcia Rodriguez, Noelia ...................... Disclosed no confl ict of interest.García Vicente, Silvia ............................ Employee: Genmedica Therapeutics.Garcia, Katelyn ...................................... Disclosed no confl ict of interest.Garcia, Mar ........................................... Disclosed no confl ict of interest.Garcia, Maria Isabel.............................. Disclosed no confl ict of interest.Garcia, Nadia ........................................ Disclosed no confl ict of interest.Garcia, Stephanie C. ............................ Disclosed no confl ict of interest.Garcia-Dolagaray, Gabriela ................... Disclosed no confl ict of interest.García-Lobato, Claudia.......................... Disclosed no confl ict of interest.Garcia-Ocana, Adolfo ............................ Research Support: Pfi zer Inc.Garcia-Perez, Luis-Emilio ...................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.García-Ramírez, Marta .......................... Disclosed no confl ict of interest.Gardner, Christopher D. ........................ Disclosed no confl ict of interest.Gardner, Daphne ................................... Disclosed no confl ict of interest.Gardner, Thomas W. ............................. Disclosed no confl ict of interest.Gäredal, Carolina .................................. Disclosed no confl ict of interest.Garg, Manisha....................................... Disclosed no confl ict of interest.Garg, Rajesh .......................................... Disclosed no confl ict of interest.Garg, Ranjna.......................................... Disclosed no confl ict of interest.Garg, Satish K. ..................................... Advisory Panel: Eli Lilly and Company, Lexicon

Pharmaceuticals, Inc., Medtronic, Inc., Merck & Co., Inc., Novo Nordisk Inc., Roche Pharmaceuticals, Sanofi U.S.; Research Support: Dario, Eli Lilly and Company, Juvenile Diabetes Research Foundation, Lexicon Pharmaceuticals, Inc., Medtronic, Inc., Merck & Co., Inc., National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Novo Nordisk Inc., Sanofi U.S., T1D Exchange.

Garhyan, Parag ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Garmey, James C. ................................ Disclosed no confl ict of interest.Garofolo, Monia .................................... Disclosed no confl ict of interest.Garraffo, Martin .................................... Disclosed no confl ict of interest.Garrett, Alan.......................................... Disclosed no confl ict of interest.Garrett, J.E. .......................................... Disclosed no confl ict of interest.Garrido Santos, Natalia ........................ Disclosed no confl ict of interest.Garrison, Roger ..................................... Disclosed no confl ict of interest.Garro, M.P. ............................................ Disclosed no confl ict of interest.Garro, Mona .......................................... Disclosed no confl ict of interest.Garst, Jilde ............................................ Disclosed no confl ict of interest.Gärtner, Babette .................................... Research Support: Boehringer Ingelheim GmbH.Garvey, Cindy......................................... Disclosed no confl ict of interest.Garvey, Katharine C. ............................. Disclosed no confl ict of interest.Garvey, W. Timothy ............................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eisai Co., Ltd., Janssen Pharmaceuticals, Inc., LipoScience, Inc., Novo Nordisk Inc., Takeda Pharmaceutical Company Limited, Vivus Inc.; Research Support: AstraZeneca, Eisai Co., Ltd., Lexicon Pharmaceuticals, Inc., Merck & Co., Inc., Pfi zer Inc., Sanofi U.S., Weight Watchers International, Inc.; Stock/Shareholder: Bristol-Myers Squibb Company, Eli Lilly and Company, Isis Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfi zer Inc.

Gary, Françoise ...................................... Disclosed no confl ict of interest.Gassaway, Brandon M. ........................ Disclosed no confl ict of interest.Gastaldelli, Amalia................................ Consultant: Eli Lilly and Company, Roche Pharmaceuticals,

Sanofi U.S.; Research Support: Amylin Pharmaceuticals, LLC., AstraZeneca.

Gastecki, Michelle L. ............................ Disclosed no confl ict of interest.Gaster, Michael ..................................... Disclosed no confl ict of interest.Gaster, Natascha ................................... Disclosed no confl ict of interest.Gately, Robert........................................ Disclosed no confl ict of interest.Gatlin, Peggy ......................................... Disclosed no confl ict of interest.Gaudier, Martin ..................................... Employee: ADOCIA; Stock/Shareholder: ADOCIA.Gaul, Michael D. .................................. Employee: Janssen Pharmaceuticals, Inc.Gaulton, Kyle J. .................................... Disclosed no confl ict of interest.Gautam, Shiva ....................................... Disclosed no confl ict of interest.Gautham, Raghavendhar....................... Disclosed no confl ict of interest.Gauthier, Benoit R. ............................... Disclosed no confl ict of interest.Gautier, Jean-François .......................... Disclosed no confl ict of interest.Gavard, Jeffrey A. ................................ Disclosed no confl ict of interest.Gay, Caryl L. .......................................... Disclosed no confl ict of interest.Gazaliyeva, Meruert A. ........................ Disclosed no confl ict of interest.Gazdzik, Maciej ..................................... Disclosed no confl ict of interest.Ge, Yan .................................................. Disclosed no confl ict of interest.Gebregzoabher, Mulugeta ..................... Disclosed no confl ict of interest.Gebretsadik, Tebeb ............................... Disclosed no confl ict of interest.

A717


AU

THO

R D

ISCL

OSU

RE

Gedulin, Bronislava ............................... Consultant: Satiogen Pharmaceuticals, Inc.Geelhoed-Duijvestijn, Nel ..................... Advisory Panel: Medtronic, Inc., Novo Nordisk A/S; Speaker’s

Bureau: Abbott Diabetes Care Inc.Geerts, Lilianne ..................................... Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Gehrman, Philip ..................................... Disclosed no confl ict of interest.Geiss, Linda S. ...................................... Disclosed no confl ict of interest.Gelrud, Andres ...................................... Disclosed no confl ict of interest.Genovese, Stefano ................................ Disclosed no confl ict of interest.Gentile, Michela.................................... Disclosed no confl ict of interest.Gentry, Chad K. ..................................... Disclosed no confl ict of interest.George, Cindy ........................................ Disclosed no confl ict of interest.Gerard Gonzalez, Andrea ...................... Disclosed no confl ict of interest.Gerards, Maaike C. .............................. Research Support: AstraZeneca.Gerdes, Victor E. ................................... Disclosed no confl ict of interest.Gerling, Ivan C. ..................................... Disclosed no confl ict of interest.Gerst, Felicia ......................................... Disclosed no confl ict of interest.Gerstein, Hertzel C. .............................. Advisory Panel: Sanofi U.S.; Consultant: Abbott, AstraZeneca,

Berlin Chemie, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, GlaxoSmithKline, Kaneq Bioscience, Merck & Co., Inc., Roche Pharmaceuticals; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.

Gerszten, Robert E. ............................... Disclosed no confl ict of interest.Gerth, Suvadra S. ................................. Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.Gervais, Liette ....................................... Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Gessler, Julie ......................................... Disclosed no confl ict of interest.Gesta, Stephane.................................... Employee: Berg Health; Stock/Shareholder: Berg Health.Getaneh, Asqual.................................... Disclosed no confl ict of interest.Geurts, Aron .......................................... Disclosed no confl ict of interest.Geyer, Susan ......................................... Disclosed no confl ict of interest.Gezzar, Sari ............................................ Disclosed no confl ict of interest.Ghahate, Donica.................................... Disclosed no confl ict of interest.Ghanim, Husam ..................................... Disclosed no confl ict of interest.Gharib, Ahmed M. ................................ Disclosed no confl ict of interest.Ghipetenanu, Gabriela .......................... Employee: Eli Lilly and Company.Gholap, Nitin ......................................... Disclosed no confl ict of interest.Ghosh, Shreeparna................................ Disclosed no confl ict of interest.Ghosh, Sujoy ......................................... Disclosed no confl ict of interest.Giacaglia, Luciano ................................. Disclosed no confl ict of interest.Giacca, Adria ......................................... Disclosed no confl ict of interest.Giaccari, Andrea.................................... Disclosed no confl ict of interest.Giacco, Angela ...................................... Disclosed no confl ict of interest.Giampatzis, Vasilios .............................. Disclosed no confl ict of interest.Gianani, Roberto ................................... Disclosed no confl ict of interest.Gianchandani, Roma Y. ........................ Disclosed no confl ict of interest.Gianferante, Danielle ............................ Disclosed no confl ict of interest.Giani, Elisa ............................................ Disclosed no confl ict of interest.Gibbin, Antonello .................................. Disclosed no confl ict of interest.Gibbons, Catherine................................ Disclosed no confl ict of interest.Gibson, Ronald ...................................... Disclosed no confl ict of interest.Giedraitis, Vilmantas ............................. Disclosed no confl ict of interest.Giese, Karla K. ...................................... Other Relationship: Eli Lilly and Company.Gifford, David R. ................................... Employee: American Health Care Association.Gifford, Robert M. ................................ Disclosed no confl ict of interest.Gigauri, Nino ......................................... Disclosed no confl ict of interest.Gil, Victoria ............................................ Disclosed no confl ict of interest.Gilboa, Suzanne M. .............................. Disclosed no confl ict of interest.Gilden, Janice L. ................................... Research Support: Novo Nordisk Inc.Gilham, Dean......................................... Employee: Resverlogix Corp.; Stock/Shareholder: Resverlogix

Corp.Gilijamse, Pim W. ................................. Disclosed no confl ict of interest.Giljanovic Kîs, Sanja ............................. Employee: Eli Lilly and Company.Gill, Max S. ........................................... Employee: Medtronic MiniMed, Inc.Gill, Ronald G. ...................................... Disclosed no confl ict of interest.Gill, Thomas M. .................................... Disclosed no confl ict of interest.Gillard, Pieter ........................................ Disclosed no confl ict of interest.Gillespie, Alexander .............................. Disclosed no confl ict of interest.Gillespie, Mark ...................................... Disclosed no confl ict of interest.Gillis, Bonnie P. ..................................... Disclosed no confl ict of interest.Giménez, Marga .................................... Disclosed no confl ict of interest.Gimeno, Ruth E. .................................... Employee: Eli Lilly and Company.Gin, Henri .............................................. Disclosed no confl ict of interest.Giordani, Ilaria....................................... Disclosed no confl ict of interest.Giorgini, Alessia .................................... Disclosed no confl ict of interest.Giorgini, Marisa .................................... Disclosed no confl ict of interest.Giorgino, Francesco............................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, LifeScan, Inc., Novo Nordisk A/S, Roche Diagnostics, Sanofi U.S., Takeda Pharmaceutical Company Limited; Research Support: AstraZeneca, Eli Lilly and Company, LifeScan, Inc., Takeda Pharmaceutical Company Limited.

Giralt, Albert.......................................... Disclosed no confl ict of interest.

Girelli, Angela ....................................... Disclosed no confl ict of interest.Giri, Smith ............................................. Disclosed no confl ict of interest.Giri, Suresh R. ...................................... Employee: Zydus Research Centre, Cadila Healthcare Limited,

Ahmedabad, India.Giroux, Isabelle ..................................... Disclosed no confl ict of interest.Gitelman, Stephen E. ........................... Disclosed no confl ict of interest.Giuffrida, Fernando M. ......................... Disclosed no confl ict of interest.Giunta, Diego H. ................................... Disclosed no confl ict of interest.Giuseppe, Daniele A. ........................... Disclosed no confl ict of interest.Giusti, Laura .......................................... Disclosed no confl ict of interest.Gjelsvik, Annie ...................................... Disclosed no confl ict of interest.Glantschnig, Christina ........................... Disclosed no confl ict of interest.Glasheen, William................................. Employee: Humana Inc.Glass, Thomas A. ................................. Disclosed no confl ict of interest.Glastras, Sarah...................................... Disclosed no confl ict of interest.Glatz, Jan .............................................. Disclosed no confl ict of interest.Gletsu-Miller, Nana ............................... Disclosed no confl ict of interest.Glezer, Eli N. ......................................... Disclosed no confl ict of interest.Glicksman, Robin................................... Disclosed no confl ict of interest.Gloyn, Anna L. ...................................... Disclosed no confl ict of interest.Glueck, Deborah H. .............................. Disclosed no confl ict of interest.Gluud, Lise L. ........................................ Disclosed no confl ict of interest.Gmitrov, Juraj ........................................ Disclosed no confl ict of interest.Gnasso, Agostino .................................. Disclosed no confl ict of interest.Godfrey, Lynn W. .................................. Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.Godlewski, Grzegorz.............................. Disclosed no confl ict of interest.Goebel-Fabbri, Ann E. .......................... Disclosed no confl ict of interest.Goedecke, Julia..................................... Disclosed no confl ict of interest.Goel, Om................................................ Employee: Jiva Pharma Inc.Goellnitz, Jason..................................... Disclosed no confl ict of interest.Goertzen, Katelyn .................................. Disclosed no confl ict of interest.Goh, Su-Yen........................................... Advisory Panel: Boehringer Ingelheim GmbH, Merck Sharp &

Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis.Gohlke, Sabrina ..................................... Disclosed no confl ict of interest.Gohs, Frank............................................ Research Support: Merck Sharp & Dohme Corp.Gokce, Noyan ........................................ Disclosed no confl ict of interest.Golab, Karolina...................................... Disclosed no confl ict of interest.Goland, Robin S. ................................... Disclosed no confl ict of interest.Goldberg, Ronald B. ............................. Disclosed no confl ict of interest.Golden, Sherita H. ................................ Disclosed no confl ict of interest.Goldfi ne, Allison B. ............................... Other Relationship: Amneal Pharmaceuticals, Boston Heart

Diagnostics, Caraco Pharmaceuticals, Joslin Diabetes Center Philanthropic Donors; Research Support: National Heart Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.

Goldis, Marina....................................... Disclosed no confl ict of interest.Goldman, Tali ........................................ Disclosed no confl ict of interest.Goł biewska, Justyna ............................ Disclosed no confl ict of interest.Golm, Gregory ....................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Golor, Georg .......................................... Consultant: Sanofi -Aventis Deutschland GmbH; Research

Support: Sanofi -Aventis Deutschland GmbH.Gombos, Timea...................................... Disclosed no confl ict of interest.Gomes, Everton P. ................................. Disclosed no confl ict of interest.Gomes, Karla Fabiana B. ...................... Disclosed no confl ict of interest.Gomes, Marilia B. ................................ Advisory Panel: AstraZeneca.Gomes, Patricia M. ............................... Disclosed no confl ict of interest.Gomez Medina, Ana Maria ................... Research Support: Abbott, Medtronic, Inc., Novartis AG;

Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Medtronic, Inc., Merck Sharp & Dohme Corp., Novartis AG, Novo Nordisk A/S.

Gomez, Alicia ........................................ Disclosed no confl ict of interest.Gomez, Carmen ..................................... Disclosed no confl ict of interest.Gomez, David ........................................ Disclosed no confl ict of interest.Gomez, Guillermo .................................. Disclosed no confl ict of interest.Gomez, Patricia ..................................... Disclosed no confl ict of interest.Gomez, Ricardo ..................................... Disclosed no confl ict of interest.Gomez, Yvette ....................................... Disclosed no confl ict of interest.Gomez-Hoyos, Emilia ............................ Disclosed no confl ict of interest.Gómez-Huelgas, Ricardo ....................... Disclosed no confl ict of interest.Gomis, Ramon ....................................... Disclosed no confl ict of interest.Gondhalekar, Ravi ................................. Disclosed no confl ict of interest.Gong, Li ................................................. Disclosed no confl ict of interest.Gong, Qi................................................. Disclosed no confl ict of interest.Gong, Qiuhong....................................... Disclosed no confl ict of interest.Gong, Siqian .......................................... Disclosed no confl ict of interest.Gong, Yanping ....................................... Disclosed no confl ict of interest.Gong, Yingyun ....................................... Disclosed no confl ict of interest.Gonynor, Caroline .................................. Disclosed no confl ict of interest.Gonzalez Galvez, Guillermo................... Advisory Panel: Amgen, AstraZeneca, Boehringer Ingelheim,

Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novo Nordisk, Sanofi , Sanofi (Spouse/Partner), Stendhal (Spouse/Partner), Stendhal, Takeda; Board Member: Amgen, AstraZeneca, Novo Nordisk; Speaker’s Bureau:

A718


AU

THO

R D

ISCL

OSU

RE

Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novo Nordisk, Sanofi , Stendhal, Takeda.

Gonzalez Mariscal, Isabel ..................... Disclosed no confl ict of interest.Gonzalez Villalpando, Clicerio ............... Disclosed no confl ict of interest.Gonzalez Villalpando, Maria Elena ....... Disclosed no confl ict of interest.Gonzalez, Claudio .................................. Disclosed no confl ict of interest.Gonzalez, Jeffrey S. ............................. Disclosed no confl ict of interest.Gonzalez, Jorge ..................................... Disclosed no confl ict of interest.Gonzalez, Manuel.................................. Disclosed no confl ict of interest.Gonzalez, Mayra.................................... Disclosed no confl ict of interest.Gonzalez, Noemi ................................... Disclosed no confl ict of interest.González-Ortiz, Manuel ......................... Disclosed no confl ict of interest.Goodman, Andrew L. ............................ Disclosed no confl ict of interest.Goodman, Keith..................................... Disclosed no confl ict of interest.Goodpaster, Bret H. .............................. Disclosed no confl ict of interest.Goodspeed, Leela.................................. Disclosed no confl ict of interest.Goodwin, Bryan ..................................... Employee: Pfi zer Inc.Gopal, Vipin ........................................... Employee: Humana Inc.Gopalakrishnan, Chandrasekar ............. Disclosed no confl ict of interest.Gorden, Phillip ....................................... Disclosed no confl ict of interest.Gordon, Andrew .................................... Disclosed no confl ict of interest.Gordon, Ian L. ....................................... Research Support: Podimetrics, Inc.Gordon, Jason P. ................................... Research Support: Amgen Inc., AstraZeneca, Boehringer

Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Genzyme Corporation, GlaxoSmithKline, Novo Nordisk A/S, Otsuka Pharmaceutical Co., Ltd., Pfi zer Inc., Sanofi U.S., Takeda Development Centre Europe Ltd.

Gordon, Katrina V. ................................ Disclosed no confl ict of interest.Goretti, Chiara ....................................... Disclosed no confl ict of interest.Görgens, Sven W. ................................. Disclosed no confl ict of interest.Gorgojo-Martinez, Juan J. ................... Advisory Panel: AstraZeneca, Eli Lilly and Company, Merck

Sharp & Dohme Corp., Novo Nordisk Inc; Consultant: AstraZeneca, Eli Lilly and Company, Novo Nordisk Inc; Other Relationship: Sanofi .

Goricar, Katja ......................................... Disclosed no confl ict of interest.Gorkhali, Sachi ...................................... Disclosed no confl ict of interest.Gorman, Mark ....................................... Disclosed no confl ict of interest.Gosdin, Lucas ........................................ Disclosed no confl ict of interest.Gosho, Masahiko .................................. Consultant: Kowa Company, Ltd.Gosiewski, Tomasz ................................ Disclosed no confl ict of interest.Gospin, Rebekah ................................... Disclosed no confl ict of interest.Goss, Amy ............................................. Disclosed no confl ict of interest.Goss, Christopher H. ............................ Disclosed no confl ict of interest.Goto, Hiromasa ..................................... Disclosed no confl ict of interest.Goto, Nobuko ........................................ Disclosed no confl ict of interest.Goto, Seiji.............................................. Disclosed no confl ict of interest.Goto, Toshio .......................................... Disclosed no confl ict of interest.Gottlieb, Peter A. .................................. Disclosed no confl ict of interest.Götz, Sophia .......................................... Employee: Boehringer Ingelheim GmbH.Gou, Fang .............................................. Disclosed no confl ict of interest.Gounko, Natalia .................................... Disclosed no confl ict of interest.Goustin, Anton Scott ............................. Disclosed no confl ict of interest.Gower, Barbara ..................................... Disclosed no confl ict of interest.Goyal, Abhinav ...................................... Disclosed no confl ict of interest.Goyal, Akankasha.................................. Disclosed no confl ict of interest.Goyal, Ramesh K. ................................. Disclosed no confl ict of interest.Grabner, Michael ................................... Other Relationship: HealthCore, Inc., Sanofi U.S. Inc.Grabowski, Dan ..................................... Employee: Steno Diabetes Center A/S.Gracia, Jesus......................................... Disclosed no confl ict of interest.Gradišer, Marina ................................... Disclosed no confl ict of interest.Grady, Mike ........................................... Employee: LifeScan Scotland Ltd.Graefe-Mody, Ulrike .............................. Employee: Boehringer Ingelheim GmbH.Graff, Emily C. ...................................... Disclosed no confl ict of interest.Graff, Jonathan M. ............................... Disclosed no confl ict of interest.Graffi gna, Mabel ................................... Disclosed no confl ict of interest.Graham, James L. ................................ Disclosed no confl ict of interest.Graham, Mark ....................................... Employee: Ionis Pharmaceuticals.Graja, Antonia ....................................... Disclosed no confl ict of interest.Grallert, Harald...................................... Disclosed no confl ict of interest.Grammatiki, Maria ................................ Disclosed no confl ict of interest.Granados-Silvestre, María de los Ángeles .................... Disclosed no confl ict of interest.Grancini, Valeria .................................... Disclosed no confl ict of interest.Grande, Cristina .................................... Disclosed no confl ict of interest.Grando, Maria Adela............................. Disclosed no confl ict of interest.Grandy, Susan ....................................... Employee: AstraZeneca.Grant, Maria B. ..................................... Disclosed no confl ict of interest.Grant, Marshall ..................................... Employee: Mannkind Corporation.Grant, Richard W. ................................. Disclosed no confl ict of interest.Grant, Struan F. ..................................... Disclosed no confl ict of interest.Grarup, Niels ......................................... Disclosed no confl ict of interest.Graungaard, Tina ................................... Employee: Novo Nordisk A/S.Graves, Leland....................................... Disclosed no confl ict of interest.Gravholt, Claus H. ................................ Other Relationship: PNovo Nordisk A/S, Pfi zer.Gray, Kristen E. ..................................... Disclosed no confl ict of interest.

Gray, Sarah M. ..................................... Disclosed no confl ict of interest.Gray, Stephen P. ................................... Disclosed no confl ict of interest.Grayson, Truman ................................... Disclosed no confl ict of interest.Green, Jennifer B. ................................ Consultant: Bioscientifi ca, Merck Sharp & Dohme Corp.,

The Endocrine Society; Other Relationship: Boehringer Ingelheim GmbH; Research Support: AstraZeneca, GlaxoSmithKline, Merck Sharp & Dohme Corp.

Green, Kelly ........................................... Disclosed no confl ict of interest.Greenaway, Tim .................................... Disclosed no confl ict of interest.Greenbaum, Carla J. ............................ Disclosed no confl ict of interest.Greenberg, Andrew S. .......................... Disclosed no confl ict of interest.Greenberg-Shushlav, Yael ..................... Consultant: Oramed Pharmaceuticals.Greene, Michael.................................... Disclosed no confl ict of interest.Greene, Ted ........................................... Board Member: Satiogen Pharmaceuticals, Inc.Greenfi eld, Helena ................................ Disclosed no confl ict of interest.Greenspan, Susan L. ............................ Research Support: National Institutes of Health.Greenwald, Esther................................. Disclosed no confl ict of interest.Greevy, Robert ....................................... Disclosed no confl ict of interest.Gregg, Edward W. ................................ Disclosed no confl ict of interest.Gregory, Becky P. .................................. Disclosed no confl ict of interest.Gregory, Ismail ...................................... Disclosed no confl ict of interest.Gregory, Justin M. ................................ Disclosed no confl ict of interest.Gregory, Tamara .................................... Disclosed no confl ict of interest.Greiner, Dale ......................................... Consultant: Jackson Laboratory.Greinix, Hildegard ................................. Disclosed no confl ict of interest.Greub, Gilbert ........................................ Disclosed no confl ict of interest.Grewal, Jagteshwar.............................. Disclosed no confl ict of interest.Griciunas, Fabiano................................. Employee: Novo Nordisk A/S.Griffi n, Marie ......................................... Disclosed no confl ict of interest.Griffi ths, Robert ..................................... Research Support: Boston Health Economics.Grigorescu, Florin .................................. Disclosed no confl ict of interest.Grijalva, Carlos ...................................... Disclosed no confl ict of interest.Grimm, Kimberlea ................................. Disclosed no confl ict of interest.Grimsby, Joseph .................................... Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Grimsrud, Paul A. ................................. Disclosed no confl ict of interest.Grioni, Sara ........................................... Disclosed no confl ict of interest.Gritsenko, Maria A. .............................. Disclosed no confl ict of interest.Gritzapis, Angelos ................................. Disclosed no confl ict of interest.Groat, Danielle ...................................... Disclosed no confl ict of interest.Grobbee, Diederick E. ........................... Consultant: Julius Clinical, Roche USA; Research Support:

Roche USA.Grobman, William ................................. Disclosed no confl ict of interest.Groen, Albert K. .................................... Disclosed no confl ict of interest.Groleau, Melanie .................................. Advisory Panel: Sanofi -Aventis Canada; Consultant: Sanofi -

Aventis Canada; Employee: Sanofi -Aventis Canada; Research Support: Sanofi -Aventis Canada; Stock/Shareholder: Sanofi -Aventis Canada.

Grøndahl, Magnus F. ............................ Stock/Shareholder: Zealand Pharma A/S.Groop, Leif ............................................. Disclosed no confl ict of interest.Groop, Per-Henrik .................................. Disclosed no confl ict of interest.Grosman, Benyamin .............................. Employee: Medtronic, Inc.Gross, Jorge L. ..................................... Advisory Panel: Boehringer Ingelheim, Eli Lilly and Company,

Novo Nordisk; Research Support: Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, MannKind Corporation, Novo Nordisk; Speaker’s Bureau: Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk.

Gross, Myron D. ................................... Disclosed no confl ict of interest.Grouix, Brigitte ...................................... Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Groves, Christopher J. .......................... Disclosed no confl ict of interest.Grozou, Anna ......................................... Disclosed no confl ict of interest.Grunberger, George ............................... Research Support: AstraZeneca, Eli Lilly and Company,

Lexicon, Medtronic, Merck, Novo Nordisk, Sanofi ; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Merck, Novo Nordisk, Sanofi .

Gründer, Diana ...................................... Disclosed no confl ict of interest.Gründer, Malte ...................................... Disclosed no confl ict of interest.Grzeszczak, Władysław ......................... Advisory Panel: Bayer HealthCare, Bioton SA, Eli Lilly

and Company, Merck & Co., Inc., Merck & Co., Inc., Novo Nordisk A/S; Consultant: Bayer HealthCare, Eli Lilly and Company, Merck & Co., Inc., Polpharma SA Pharmaceutical Works; Speaker’s Bureau: Bioton SA, Eli Lilly and Company, Merck & Co., Inc., Merck & Co., Inc., Novo Nordisk A/S.

Grzybowski, Michael ............................. Disclosed no confl ict of interest.Gu, Haihua............................................. Disclosed no confl ict of interest.Gu, Hui................................................... Disclosed no confl ict of interest.Gu, Liubao ............................................. Disclosed no confl ict of interest.Gu, Ping ................................................. Disclosed no confl ict of interest.Gu, Shuyan ............................................ Disclosed no confl ict of interest.Gu, Suping ............................................. Disclosed no confl ict of interest.Gu, Tianwei ........................................... Disclosed no confl ict of interest.Gu, Wei ................................................. Employee: Amgen Inc.Gu, Weijun ............................................ Research Support: Medtronic, Inc.Gu, Xue .................................................. Disclosed no confl ict of interest.

A719


AU

THO

R D

ISCL

OSU

RE

Gu, Yunzi ................................................ Disclosed no confl ict of interest.Gualerzi, Alessandro ............................. Disclosed no confl ict of interest.Guan, Weihua ....................................... Disclosed no confl ict of interest.Guang, Wang ........................................ Disclosed no confl ict of interest.Guardiola, Jose H. ................................ Disclosed no confl ict of interest.Gubitosi-Klug, Rose............................... Disclosed no confl ict of interest.Gubkin, V.A. .......................................... Disclosed no confl ict of interest.Gudipaty, Lalitha ................................... Disclosed no confl ict of interest.Gueneva-Boucheva, Kristina K. ............ Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Guerci, Bruno......................................... Advisory Panel: Abbott, AstraZeneca, Boehringer Ingleheim,

Eli Lilly and Company, GlaxoSmithKline, Medtronic, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Sanofi ; Other Relationship: Abbott, AstraZeneca, Boehringher Ingleheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Janssen, Medtronic, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Sanofi ; Research Support: Eli Lilly and Company, Medtronic, Novo Nordisk, Sanofi , VitalAire.

Guerrero, Alba ....................................... Disclosed no confl ict of interest.Guerrero, Angelica ................................ Disclosed no confl ict of interest.Guerrero, German.................................. Employee: Novo Nordisk Inc; Stock/Shareholder: Novo

Nordisk Inc.Guglielmi, Chiara................................... Disclosed no confl ict of interest.Guillen, Kevin ........................................ Disclosed no confl ict of interest.Guillermo, Jasso-Mosqueda Juan ........ Employee: Sanofi .Guinguing, Lucien.................................. Disclosed no confl ict of interest.Guinter, Mark A. ................................... Disclosed no confl ict of interest.Guionaud, Silvia .................................... Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Guler, Serhat ......................................... Disclosed no confl ict of interest.Gulisano, Massimo ............................... Disclosed no confl ict of interest.Gulko, Tatiana ....................................... Disclosed no confl ict of interest.Gultyaev, Dmitry .................................... Consultant: Amgen Inc., Sanofi U.S.Gummidi, Balaji ..................................... Disclosed no confl ict of interest.Gumprecht, Janusz................................ Consultant: Eli Lilly and Company, Merck & Co., Inc.,

Polpharma SA Pharmaceutical Works; Speaker’s Bureau: Bayer HealthCare, Bioton SA, Bioton SA, Eli Lilly and Company, Merck & Co., Inc., Merck & Co., Inc., Novo Nordisk A/S.

Gunasekaran, Uma ................................ Disclosed no confl ict of interest.Gunnet, Joseph ..................................... Employee: Janssen Pharmaceuticals, Inc.Gunnink, Stephen .................................. Disclosed no confl ict of interest.Guntur, Kalyani V. ................................. Disclosed no confl ict of interest.Guo, Feifan ............................................ Disclosed no confl ict of interest.Guo, Hailing........................................... Consultant: Sanofi .Guo, Heming.......................................... Disclosed no confl ict of interest.Guo, Jingli ............................................. Disclosed no confl ict of interest.Guo, Rui ................................................. Disclosed no confl ict of interest.Guo, Wen .............................................. Disclosed no confl ict of interest.Guo, Xiaohui .......................................... Disclosed no confl ict of interest.Guo, Xin ................................................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Guo, Yumeng ......................................... Disclosed no confl ict of interest.Guo, Zhiguang ....................................... Disclosed no confl ict of interest.Guo, Zijing ............................................. Disclosed no confl ict of interest.Gupta, Kamal......................................... Disclosed no confl ict of interest.Gupta, Lavanya...................................... Disclosed no confl ict of interest.Gupta, Manoj ........................................ Disclosed no confl ict of interest.Gupta, Megha ....................................... Disclosed no confl ict of interest.Gupta, Rishab ........................................ Employee: Accenture; Other Relationship: Under contract with

Sanofi U.S., Inc.Gupta, Ruby ........................................... Disclosed no confl ict of interest.Gupta, Shaloo........................................ Research Support: Kantar Health.Gupta, Simone....................................... Employee: Eli Lilly and Company, Eli Lilly and Company


Gupta, Sunil........................................... Disclosed no confl ict of interest.Gupta, Suruchi....................................... Disclosed no confl ict of interest.Gur, Serap .............................................. Disclosed no confl ict of interest.Gurka, Matthew J. ............................... Disclosed no confl ict of interest.Gurley, Jami .......................................... Disclosed no confl ict of interest.Gurney, Mark ......................................... Disclosed no confl ict of interest.Gustafsson, Stefan................................ Disclosed no confl ict of interest.Gustavson, Stephanie ........................... Employee: AstraZeneca.Guthalu Kondegowda, Nagesha ........... Disclosed no confl ict of interest.Gutierrez, Juan ...................................... Disclosed no confl ict of interest.Gutman, Roee........................................ Research Support: Patient-Centered Outcomes Research

Institute.Gutowski, Hanh ..................................... Disclosed no confl ict of interest.Guttmann-Bauman, Ines ....................... Disclosed no confl ict of interest.Guyer, Laura .......................................... Disclosed no confl ict of interest.Guzman, Cristina ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Gwon, A-Ryeong ................................... Disclosed no confl ict of interest.Gyawali, Prabin ..................................... Disclosed no confl ict of interest.Gydesen, Sofi e ...................................... Employee: Nordic Bioscience.Gyldenløve, Mette................................. Disclosed no confl ict of interest.

Ha, Chae-Myeong ................................. Disclosed no confl ict of interest.Ha, Joohun ............................................ Disclosed no confl ict of interest.Ha, Joon ................................................ Disclosed no confl ict of interest.Haahr, Hanne ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Haak, Thomas J. ................................... Advisory Panel: Abbott Diabetes Care Inc., Lilly Deutschland

GmbH; Speaker’s Bureau: Abbott Diabetes Care Inc., Berlin-Chemie.

Haapakoski, Rita ................................... Disclosed no confl ict of interest.Haase, Christiane L. ............................. Employee: Novo Nordisk A/S.Habegger, Kirk M. ................................ Disclosed no confl ict of interest.Habib, Samy L. ..................................... Disclosed no confl ict of interest.Habibi, Javad ........................................ Disclosed no confl ict of interest.Hachiya, Mayo ...................................... Disclosed no confl ict of interest.Hackley, Barbara ................................... Disclosed no confl ict of interest.Hackstadt, Amber.................................. Disclosed no confl ict of interest.Haddad, Fadia ....................................... Disclosed no confl ict of interest.Hadi, Jean-Christophe .......................... Disclosed no confl ict of interest.Hadi, Laila ............................................. Disclosed no confl ict of interest.Hadjadj, Samy ....................................... Disclosed no confl ict of interest.Hadjiliadis, Denis .................................. Disclosed no confl ict of interest.Hadjiyianni, Irene .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Haenel, Heinz ........................................ Employee: Sanofi -Aventis Deutschland GmbH.Haering, Hans-Ulrich ............................. Disclosed no confl ict of interest.Hafez, Elsayed ....................................... Consultant: PharmACT Egypt.Haffner, Steven ..................................... Disclosed no confl ict of interest.Hagelund, Lise....................................... Consultant: Novo Nordisk A/S, Steno Diabetes Center A/S.Hagenbeek, Fiona.................................. Disclosed no confl ict of interest.Hager, Brandon ...................................... Disclosed no confl ict of interest.Hagerimana, Aline ................................ Employee: Pro Metic Bio Sciences Inc.; Stock/Shareholder: Pro

Metic Bio Sciences Inc.Hagopian, William ................................ Research Support: National Institutes of Health.Hahn, Seokyeong .................................. Disclosed no confl ict of interest.Haidar, Ahmad ....................................... Consultant: SNEL Medical Communication; Other

Relationship: Diabetic Children’s Foundation.Haile, Zelalem T. .................................. Disclosed no confl ict of interest.Haimovich, Beatrice .............................. Disclosed no confl ict of interest.Haire-Joshu, Debra ............................... Disclosed no confl ict of interest.Hairston, Kristen G. .............................. Disclosed no confl ict of interest.Hajizadeh, Ian........................................ Disclosed no confl ict of interest.Hajji, Ibtissam ....................................... Disclosed no confl ict of interest.Hajmrle, Catherine ................................ Disclosed no confl ict of interest.Hajnsek, Martin..................................... Disclosed no confl ict of interest.Hakeam, Hakeam A. ............................. Disclosed no confl ict of interest.Haldeman, Jonathan ............................. Disclosed no confl ict of interest.Halimi, Serge......................................... Disclosed no confl ict of interest.Haliyur, Rachana ................................... Disclosed no confl ict of interest.Hall, Christopher E. .............................. Disclosed no confl ict of interest.Hall, Erica .............................................. Disclosed no confl ict of interest.Hall, Joseph .......................................... Disclosed no confl ict of interest.Hallakou-Bozec, Sophie ........................ Employee: Poxel Pharmaceutical Company.Haller, Michael J. ................................. Disclosed no confl ict of interest.Halliday, Christopher ............................. Employee: Resverlogix Corp.; Stock/Shareholder: Resverlogix

Corp.Hallowell, Peter..................................... Disclosed no confl ict of interest.Halperin, Florencia ................................ Disclosed no confl ict of interest.Haluzik, Martin ...................................... Advisory Panel: AstraZeneca, Eli Lilly and Company, Novartis

Pharma AG, Novo Nordisk A/S.Haluzikova, Denisa ................................ Advisory Panel: AstraZeneca (Spouse/Partner), Eli Lilly and

Company (Spouse/Partner), Novartis AG (Spouse/Partner), Novo Nordisk A/S (Spouse/Partner).

Ham, Hye Jin ......................................... Disclosed no confl ict of interest.Hamaguchi, Masahide .......................... Disclosed no confl ict of interest.Hamaguchi, Yuriko ................................ Disclosed no confl ict of interest.Hamamatsu, Keita................................. Disclosed no confl ict of interest.Hamamoto, Yoshiyuki............................ Disclosed no confl ict of interest.Hamasaki, Akihiro ................................. Disclosed no confl ict of interest.Hambidge, Bertha ................................. Disclosed no confl ict of interest.Hamdy, Osama ...................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Metagenics, Inc., Novo Nordisk Inc; Consultant: Merck & Co., Inc; Research Support: Metagenics, Inc.

Hamel, Frederick G. .............................. Disclosed no confl ict of interest.Hamid, Azizah........................................ Disclosed no confl ict of interest.Hamilton, Bruce..................................... Disclosed no confl ict of interest.Hammad, Samar M. ............................. Disclosed no confl ict of interest.Hamman, Richard F. ............................. Disclosed no confl ict of interest.Hammar, Niklas ..................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Hammarlund, Christer ........................... Disclosed no confl ict of interest.Hampton, Rollie..................................... Disclosed no confl ict of interest.Hamrén, Bengt ...................................... Stock/Shareholder: AstraZeneca.Hamza, Muhammad .............................. Disclosed no confl ict of interest.Han, Bing ............................................... Disclosed no confl ict of interest.Han, Bomie ............................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.

A720


AU

THO

R D

ISCL

OSU

RE

Han, Boram............................................ Disclosed no confl ict of interest.Han, Byoung Geun................................. Disclosed no confl ict of interest.Han, Eugene .......................................... Disclosed no confl ict of interest.Han, Feifei ............................................. Disclosed no confl ict of interest.Han, Je Ho............................................. Disclosed no confl ict of interest.Han, Jenny ............................................ Consultant: AstraZeneca.Han, Jingyan ......................................... Disclosed no confl ict of interest.Han, Kyung Ah....................................... Disclosed no confl ict of interest.Han, Kyungdo ........................................ Disclosed no confl ict of interest.Han, Sang Youb ..................................... Disclosed no confl ict of interest.Han, Seung Jin ...................................... Disclosed no confl ict of interest.Han, Stella............................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP.Han, Weiping ........................................ Disclosed no confl ict of interest.Han, Xueyao .......................................... Disclosed no confl ict of interest.Han, Yamei ............................................ Disclosed no confl ict of interest.Han, Yong .............................................. Disclosed no confl ict of interest.Hanada, Hiroyuki ................................... Disclosed no confl ict of interest.Hanafusa, Toshiaki ................................ Disclosed no confl ict of interest.Hanas, Ragnar ....................................... Disclosed no confl ict of interest.Hancock, Mike....................................... Employee: Cellular Dynamics International.Handelsman, Yehuda ............................ Consultant: Amarin, Amgen, Boehringer Ingleheim, Bristol-

Myers Squibb, DiaDeux, Eisai, GlaxoSmithKline, Janssen, LipoScience, Merck, Novo Nordisk, Regeneron, Sanofi , Takeda, Vivus; Other Relationship: IP-President American College of Endocrinology; Research Support: Amgen, AstraZeneca, Boehringer Ingleheim, Bristol-Myers Squibb, GlaxoSmithKline, Grifolis, Hamni, Intarcia, Lexicon, Merck, Novo Nordisk, Sanofi ; Speaker’s Bureau: Amarin, Amgen, AstraZeneca, Boehringer Ingleheim, Janssen, Lilly, Novo Nordisk, Regeneron, Sanofi , Vivus.

Haneda, Masakazu................................ Research Support: Astellas Pharma Inc., Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Novo Nordisk Inc., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Kowa Company, Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Sanofi K.K., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Hanefeld, Markolf ................................. Advisory Panel: Bristol-Myers Squibb, GlaxoSmithKline, Sanofi , Takeda; Speaker’s Bureau: Bayer Health Care, Eli Lilly and Company, GlaxoSmithKline, Roche, Sanofi , Takeda.

Hanes, Sarah ......................................... Disclosed no confl ict of interest.Hang, Hardy........................................... Disclosed no confl ict of interest.Hang, Yan .............................................. Disclosed no confl ict of interest.Hangaard, Sine...................................... Other Relationship: Novo Nordisk A/S.Hanhineva, Kati ..................................... Disclosed no confl ict of interest.Hanley, Anthony J. ............................... Disclosed no confl ict of interest.Hanna, Amir .......................................... Advisory Panel: Amgen Inc., AstraZeneca Pharmaceuticals LP,

Sanofi U.S.; Other Relationship: Sanofi U.S.Hannon, Tamara S. ............................... Advisory Panel: Eli Lilly and Company; Research Support:

National Institutes of Health.Hannukainen, Jarna C. ......................... Disclosed no confl ict of interest.Hansen, Barbara C. .............................. Disclosed no confl ict of interest.Hansen, Bo F. ........................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Hansen, Carsten P. ............................... Advisory Panel: Ipsen Bioscience, Inc., Novartis

Pharmaceuticals Corporation.Hansen, Gitte ........................................ Employee: Gubra.Hansen, Jakob B. ................................. Disclosed no confl ict of interest.Hansen, Katrine B. ............................... Disclosed no confl ict of interest.Hansen, Michael ................................... Employee: Janssen Pharmaceuticals, Inc.Hansen, Morten .................................... Employee: Novo Nordisk A/S.Hansen, Torben ..................................... Disclosed no confl ict of interest.Hansen, Troels K. ................................. Advisory Panel: Abbott, Amgen Inc., AstraZeneca, Novo

Nordisk A/S, Sanofi A/S; Speaker’s Bureau: Abbott, AstraZeneca, Takeda Pharmaceutical Company Limited.

Hansen, Ulla Møller .............................. Employee: Diabetes Center A/S.Hanseree, Preaw ................................... Disclosed no confl ict of interest.Hanson, Robert L. ................................. Disclosed no confl ict of interest.Hanssen, Kristian F. .............................. Disclosed no confl ict of interest.Hantel, Stefan ....................................... Employee: Boehringer Ingelheim GmbH.Hanyu, Osamu ....................................... Disclosed no confl ict of interest.Hao, Yaping ........................................... Disclosed no confl ict of interest.Hara, Noriko .......................................... Disclosed no confl ict of interest.Hara, Taiki ............................................. Employee: Mitsubishi Tanabe Pharma Corporation.Harada, Marina ..................................... Disclosed no confl ict of interest.Harada, Takashi ..................................... Disclosed no confl ict of interest.Harada, Yukari ....................................... Disclosed no confl ict of interest.Harashima, Shin-Ichi ............................. Disclosed no confl ict of interest.Hardee, Sandra ..................................... Disclosed no confl ict of interest.

Harding, Jessica L. ............................... Disclosed no confl ict of interest.Harding, Joe .......................................... Disclosed no confl ict of interest.Hardy, Elise............................................ Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Hardy, Thomas A. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Hare, Kristine J. ................................... Disclosed no confl ict of interest.Harfmann, Brianna D. ........................... Disclosed no confl ict of interest.Hargrove, Emily ..................................... Disclosed no confl ict of interest.Harima, Meilei ...................................... Disclosed no confl ict of interest.Harindhanavudhi, Tasma ....................... Disclosed no confl ict of interest.Häring, Hans-Ulrich ............................... Disclosed no confl ict of interest.Harjutsalo, Valma .................................. Disclosed no confl ict of interest.Harlan, David M. .................................. Disclosed no confl ict of interest.Harlow, Sioban ...................................... Disclosed no confl ict of interest.Harman, Chris........................................ Disclosed no confl ict of interest.Harmon, Daniel ..................................... Disclosed no confl ict of interest.Haro, Heidi ............................................ Disclosed no confl ict of interest.Harper, Kryseana J. .............................. Disclosed no confl ict of interest.Harper, Marianna .................................. Disclosed no confl ict of interest.Harper, Roy ............................................ Disclosed no confl ict of interest.Harrington, Kara .................................... Disclosed no confl ict of interest.Harris, Claire ......................................... Disclosed no confl ict of interest.Harris, Cynthia J. .................................. Employee: Eli Lilly and Company.Harris, Jonah ......................................... Disclosed no confl ict of interest.Harris, Michael A. ................................ Disclosed no confl ict of interest.Harris, Raymond C. ............................... Disclosed no confl ict of interest.Harris, Stewart B. ................................. Advisory Panel: Abbott, AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Consultant: Abbott, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Research Support: Abbott, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi U.S.

Harris, Tabitha ....................................... Disclosed no confl ict of interest.Harris, Tamara B. .................................. Disclosed no confl ict of interest.Harrison, Leonard C. ............................. Disclosed no confl ict of interest.Harrison, Victor S. ................................ Disclosed no confl ict of interest.Harrold, Christopher .............................. Disclosed no confl ict of interest.Hart, Gili ................................................ Disclosed no confl ict of interest.Hart, Juliet ............................................ Employee: Janssen Pharmaceuticals, Inc.Hart, Nathaniel...................................... Disclosed no confl ict of interest.Hart, Peter ............................................. Disclosed no confl ict of interest.Harteneck, Debra .................................. Disclosed no confl ict of interest.Hartigan, Celia ...................................... Disclosed no confl ict of interest.Hartline, Lee .......................................... Disclosed no confl ict of interest.Hartman, Alexandra .............................. Disclosed no confl ict of interest.Hartmann, Bolette ................................. Disclosed no confl ict of interest.Hartmann, Thorsten M. ........................ Disclosed no confl ict of interest.Hartnell, Sara ........................................ Consultant: Novo Nordisk A/S; Speaker’s Bureau: Medtronic

MiniMed, Inc.Hartos, Jessica...................................... Disclosed no confl ict of interest.Harvey, John.......................................... Advisory Panel: Novo Nordisk A/S.Harvey, Raymond................................... Consultant: Novo Nordisk Inc.Harville, Emily ....................................... Disclosed no confl ict of interest.Harwell, Todd S. ................................... Disclosed no confl ict of interest.Hasan, Farhad ....................................... Disclosed no confl ict of interest.Hasegawa, Machiko ............................. Disclosed no confl ict of interest.Hasenour, Clinton M. ........................... Disclosed no confl ict of interest.Hashigami, Kiyoshi................................ Employee: AstraZeneca.Hashiguchi, Junichiro............................ Disclosed no confl ict of interest.Hashimoto, Hideki ................................. Disclosed no confl ict of interest.Hashimoto, Koshi .................................. Disclosed no confl ict of interest.Hashimoto, Miyuki ................................ Disclosed no confl ict of interest.Hashimoto, Taeko .................................. Disclosed no confl ict of interest.Hashimoto, Yoshitaka ........................... Disclosed no confl ict of interest.Haskins, Kathryn ................................... Disclosed no confl ict of interest.Hassan Bayoumi, Aly ............................ Disclosed no confl ict of interest.Hassan, Iraj ........................................... Disclosed no confl ict of interest.Hassan, Kamal ...................................... Disclosed no confl ict of interest.Hassanali, Neelam ................................ Disclosed no confl ict of interest.Hassoon, Ahmed ................................... Disclosed no confl ict of interest.Hassoun, Shaimaa ................................ Disclosed no confl ict of interest.Hastings, Jon ........................................ Disclosed no confl ict of interest.Hastings, Timothy.................................. Disclosed no confl ict of interest.Hastoy, Benoit ....................................... Disclosed no confl ict of interest.Hata, Akiko ............................................ Disclosed no confl ict of interest.Hata, Jun ............................................... Disclosed no confl ict of interest.Hatae, Chie............................................ Disclosed no confl ict of interest.Hatanaka, Masayuki ............................. Disclosed no confl ict of interest.Hathiramani, Sumitha S. ...................... Disclosed no confl ict of interest.Hatoum, Ida J. ...................................... Disclosed no confl ict of interest.Hatta, Mariko ........................................ Disclosed no confl ict of interest.Hattersley, Andrew T. ........................... Disclosed no confl ict of interest.

A721


AU

THO

R D

ISCL

OSU

RE

Hattori, Yutaka ...................................... Disclosed no confl ict of interest.Hatzitolios, Apostolos I. ....................... Disclosed no confl ict of interest.Hauck, Stefanie ..................................... Disclosed no confl ict of interest.Haufe, Sven ........................................... Disclosed no confl ict of interest.Haug, Cornelia....................................... Disclosed no confl ict of interest.Haugaard, Steen B. .............................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Novo Nordisk A/S.Haukka, Jani.......................................... Disclosed no confl ict of interest.Hauser, Elizabeth ................................... Disclosed no confl ict of interest.Hauser, Thomas ..................................... Consultant: Harvard Cardiovascular Research Institute;

Research Support: National Institutes of Health.Have, Christian ...................................... Disclosed no confl ict of interest.Havel, Peter J. ...................................... Disclosed no confl ict of interest.Haw, J. Sonya ....................................... Disclosed no confl ict of interest.Hawa, Mohammed I. ............................ Disclosed no confl ict of interest.Hawkins, Meredith................................ Disclosed no confl ict of interest.Hawlitschek, Christina .......................... Disclosed no confl ict of interest.Haxhi, Jonida ........................................ Disclosed no confl ict of interest.Hayami, Tomohide ................................. Disclosed no confl ict of interest.Hayasaka, Kiyoshi ................................. Disclosed no confl ict of interest.Hayashi, Tomohito ................................. Disclosed no confl ict of interest.Hayashi, Toshiyuki ................................. Disclosed no confl ict of interest.Haydar, Sara .......................................... Disclosed no confl ict of interest.Hayes, Heather...................................... Disclosed no confl ict of interest.Hayes, John........................................... Disclosed no confl ict of interest.Hayme, Serhat....................................... Disclosed no confl ict of interest.Haymond, Morey W. ............................ Disclosed no confl ict of interest.Haythorne, Elizabeth A. ........................ Disclosed no confl ict of interest.Hayward, Caroline................................. Disclosed no confl ict of interest.Hazra, Sugata ........................................ Disclosed no confl ict of interest.He, Jianghua ......................................... Disclosed no confl ict of interest.He, Jingrui ............................................. Disclosed no confl ict of interest.He, Mengdong....................................... Research Support: Eli Lilly and Company.He, Rui ................................................... Disclosed no confl ict of interest.He, Sijia ................................................. Disclosed no confl ict of interest.He, Yu-Lian ............................................ Disclosed no confl ict of interest.He, Zhi-Min ........................................... Disclosed no confl ict of interest.Heald, Adrian H. ................................... Disclosed no confl ict of interest.Healy, Colleen S. .................................. Disclosed no confl ict of interest.Hebda-Szydlo, Alicja ............................. Disclosed no confl ict of interest.Hebert, Caitlin ....................................... Disclosed no confl ict of interest.Hébert, James ....................................... Disclosed no confl ict of interest.Hebrok, Matthias .................................. Disclosed no confl ict of interest.Hedderson, Monique M. ...................... Disclosed no confl ict of interest.Hediger, Mary ........................................ Disclosed no confl ict of interest.Hedlund, Sara........................................ Disclosed no confl ict of interest.Heerspink, Hiddo J. .............................. Consultant: AbbVie Inc., Astellas Pharma Inc., AstraZeneca,

Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., ZN-Pharma; Research Support: AstraZeneca.

Hegelund, Maria H. .............................. Disclosed no confl ict of interest.Heianza, Yoriko...................................... Disclosed no confl ict of interest.Heidtmann, Bettina ............................... Disclosed no confl ict of interest.Heijster, Jack ......................................... Disclosed no confl ict of interest.Heilmann, Cory ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Heine, Robert J. ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Heinrich, Gabriel ................................... Employee: Pacifi c Diabetes Technologies, Inc.; Stock/

Shareholder: Pacifi c Diabetes Technologies, Inc.Heintz, Audrey ....................................... Disclosed no confl ict of interest.Heinze, Jaana M. ................................. Disclosed no confl ict of interest.Heise, Tim.............................................. Advisory Panel: Novo Nordisk Inc; Consultant: ADOCIA;

Research Support: ADOCIA, AstraZeneca, Becton, Dickinson and Company, Biocon, Boehringer Ingelheim Pharmaceuticals, Inc., Dance Biopharm, Eli Lilly and Company, Grünenthal GmbH, Gulf Pharmaceuticals, Johnson & Johnson, Marvel, MedImmune, LLC., Medtronic MiniMed, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S., Senseonics, Inc., Zealand Pharma A/S; Speaker’s Bureau: Eli Lilly and Company, Mylan, Novo Nordisk A/S.

Heisler, Michele .................................... Disclosed no confl ict of interest.Heiss, Gerardo....................................... Disclosed no confl ict of interest.Heitkemper, Elizabeth M. ..................... Disclosed no confl ict of interest.Hejna, Jeanne ....................................... Disclosed no confl ict of interest.Helgerson, Steven D. ........................... Disclosed no confl ict of interest.Helgeson, Vicki ...................................... Disclosed no confl ict of interest.Heller, Simon ......................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited; Consultant: Eli Lilly and Company; Research Support: Medtronic, Inc.; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis

Deutschland GmbH, Takeda Pharmaceutical Company Limited.

Hellstern, Michael................................. Research Support: AstraZeneca, Bristol-Myers Squibb Company.

Helmer, Catherine ................................. Disclosed no confl ict of interest.Helms Andersen, Tue ............................ Disclosed no confl ict of interest.Helms, Ariel........................................... Disclosed no confl ict of interest.Helmy, Ahmed ....................................... Disclosed no confl ict of interest.Hempe, James ...................................... Disclosed no confl ict of interest.Hempler, Nana F. .................................. Employee: Steno Diabetes Center A/S.Henao-Tamayo, Marcela ....................... Disclosed no confl ict of interest.Henderson, Courtney............................. Disclosed no confl ict of interest.Hendrickson, Karrie C. .......................... Other Relationship: Strata Decision Technology.Hendrieckx, Christel .............................. Disclosed no confl ict of interest.Heni, Martin .......................................... Disclosed no confl ict of interest.Henk, Henry J. ...................................... Employee: Optum, Inc.Henkel, Elena ........................................ Disclosed no confl ict of interest.Henley, Nathalie.................................... Disclosed no confl ict of interest.Henley, William E. ................................ Disclosed no confl ict of interest.Hennayake, Chandani ........................... Disclosed no confl ict of interest.Henriksen, Kim ...................................... Stock/Shareholder: Nordic Bioscience.Henry, Brooke ........................................ Disclosed no confl ict of interest.Henry, Patrick ........................................ Disclosed no confl ict of interest.Henry, Robert R. ................................... Advisory Panel: Amgen Inc., AstraZeneca, Boehringer

Ingelheim Pharmaceuticals, Inc., Elcelyx Therapeutics, Inc., Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH; Consultant: Alere Inc., Intarcia Therapeutics, Inc.; Research Support: Eli Lilly and Company, Hitachi Ltd., Isis Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Sanofi -Aventis Deutschland GmbH, ViaCyte, Inc.

Heptulla, Rubina A. .............................. Advisory Panel: Lexicon Pharmaceuticals, Inc.; Research Support: Lexicon Pharmaceuticals, Inc.

Herath, Meththananda.......................... Disclosed no confl ict of interest.Hercules, Erin ........................................ Disclosed no confl ict of interest.Herder, Christian ................................... Disclosed no confl ict of interest.Herdman, Laura ..................................... Disclosed no confl ict of interest.Hergenrooder, Andrea ........................... Disclosed no confl ict of interest.Hering, Bernhard ................................... Disclosed no confl ict of interest.Herman Mahecic, Davorka.................... Disclosed no confl ict of interest.Herman, Mark A. .................................. Disclosed no confl ict of interest.Herman, William H. .............................. Disclosed no confl ict of interest.Hermann, Anne Pernille ........................ Disclosed no confl ict of interest.Hermanns, Norbert................................ Advisory Panel: Abbott Diabetes Care Inc., Ypsomed; Research

Support: Abbott Diabetes Care Inc., Berlin-Chemie, Roche Diagnostics, Ypsomed; Speaker’s Bureau: Abbott Diabetes Care Inc., Berlin-Chemie, Novo Nordisk A/S.

Hermans, Michel P. .............................. Disclosed no confl ict of interest.Hermansen, Kjeld .................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis.

Hernandez Pascual, Cristina ................. Disclosed no confl ict of interest.Hernandez, Adrian F. ............................ Consultant: Bristol-Myers Squibb Company, Janssen

Pharmaceuticals, Inc.; Research Support: AstraZeneca, Bristol-Myers Squibb, Janssen Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation.

Hernandez, Alexis ................................. Disclosed no confl ict of interest.Hernández, Cristina ............................... Disclosed no confl ict of interest.Hernandez, Diego .................................. Disclosed no confl ict of interest.Hernandez, Lenore ................................ Disclosed no confl ict of interest.Hernandez, Magdalena ......................... Disclosed no confl ict of interest.Hernández, Marta ................................. Disclosed no confl ict of interest.Hernandez, Teri L. ................................. Disclosed no confl ict of interest.Hernandez-Perez, Marimar ................... Disclosed no confl ict of interest.Herold, Kevan ........................................ Disclosed no confl ict of interest.Herranz, Lucrecia................................... Disclosed no confl ict of interest.Herrera, Pedro L. .................................. Disclosed no confl ict of interest.Herrin, Jeph........................................... Disclosed no confl ict of interest.Herrington, David .................................. Disclosed no confl ict of interest.Herriott, Denise ..................................... Disclosed no confl ict of interest.Herrmann, Nicholas D. ......................... Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.Hershey, Tamara .................................... Disclosed no confl ict of interest.Hershkovitz, Oren .................................. Disclosed no confl ict of interest.Herszenson, David S. ........................... Disclosed no confl ict of interest.Hertenberger, Carina ............................. Employee: Boehringer Ingelheim GmbH.Hertzel, Ann........................................... Disclosed no confl ict of interest.Herz, Carsten ......................................... Disclosed no confl ict of interest.Herz, Jonathan ...................................... Employee: AstraZeneca Pharmaceuticals LP.Herzfeld de Wiza, Daniella ................... Disclosed no confl ict of interest.Herzig, Stephan ..................................... Disclosed no confl ict of interest.

A722


AU

THO

R D

ISCL

OSU

RE

Herzog, Lee............................................ Disclosed no confl ict of interest.Hess, Donald T. .................................... Disclosed no confl ict of interest.Hess, Sibylle.......................................... Employee: Sanofi -Aventis Deutschland GmbH.Hesse, Dan ............................................ Other Relationship: Steno Diabetes Center.Hesselbacher, Sean ............................... Disclosed no confl ict of interest.Hesseldal, Louise .................................. Employee: Novo Nordisk A/S.Hesse-Wilting, Deike ............................ Disclosed no confl ict of interest.Hessler, Danielle M. ............................. Consultant: Eli Lilly and Company, Sanofi U.S.Hetterich, Holger ................................... Disclosed no confl ict of interest.Heywood, Matthew .............................. Disclosed no confl ict of interest.Hiasa, Yoichi.......................................... Disclosed no confl ict of interest.Hibner, Brooks ....................................... Disclosed no confl ict of interest.Hicks, Andrew ....................................... Disclosed no confl ict of interest.Hidaka, Yoh ........................................... Disclosed no confl ict of interest.Hidalgo, Bertha ..................................... Disclosed no confl ict of interest.Hidalgo, Mariana .................................. Disclosed no confl ict of interest.Higa, Mariko.......................................... Disclosed no confl ict of interest.Higashi, Kaho ........................................ Disclosed no confl ict of interest.Higdon, Charissa ................................... Research Support: Valeritas.Higgins, Isabel....................................... Disclosed no confl ict of interest.Higgins, Joseph J. ................................ Employee: Quest Diagnostics.Higgins, Laurie ...................................... Disclosed no confl ict of interest.Higgins, Victoria .................................... Disclosed no confl ict of interest.Higo, Naoko........................................... Disclosed no confl ict of interest.Hijazi, Youssef ....................................... Employee: Sanofi .Hijikata, Mai.......................................... Disclosed no confl ict of interest.Hilgers, Rebecca ................................... Disclosed no confl ict of interest.Hilkin, Allison ........................................ Disclosed no confl ict of interest.Hill Golden, Sherita ............................... Disclosed no confl ict of interest.Hillard, Mallory ..................................... Disclosed no confl ict of interest.Hiller, Josh ............................................ Employee: IMS Health.Hilliard, Marisa E. ................................ Disclosed no confl ict of interest.Hillman, Natalia .................................... Disclosed no confl ict of interest.Hilsted, Linda ........................................ Disclosed no confl ict of interest.Himeno, Tatsuhito ................................. Disclosed no confl ict of interest.Hince, Kathy .......................................... Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Hinder, Lucy M. .................................... Disclosed no confl ict of interest.Hindy, George ........................................ Disclosed no confl ict of interest.Hine, Julia ............................................. Research Support: Eli Lilly and Company.Hinke, Simon A. .................................... Employee: Janssen Pharmaceuticals, Inc.Hinkle, Stefanie..................................... Disclosed no confl ict of interest.Hinshaw, Ling ........................................ Disclosed no confl ict of interest.Hinton, William ..................................... Research Support: Eli Lilly and Company.Hirabayashi, Kazuko .............................. Disclosed no confl ict of interest.Hirabayashi, Naoki ................................ Disclosed no confl ict of interest.Hirai, Aizan ............................................ Disclosed no confl ict of interest.Hiraike, Yuta .......................................... Disclosed no confl ict of interest.Hiraki, Linda T. ...................................... Disclosed no confl ict of interest.Hirano, Tsutomu .................................... Research Support: AstraZeneca, Ono Pharmaceutical Co., Ltd.Hirashima, Nao ..................................... Disclosed no confl ict of interest.Hirata, Fumihiko .................................... Disclosed no confl ict of interest.Hirate, Mitsuru ...................................... Disclosed no confl ict of interest.Hirikawa, Chika ..................................... Disclosed no confl ict of interest.Hiromura, Munenori .............................. Disclosed no confl ict of interest.Hirooka, Masashi .................................. Disclosed no confl ict of interest.Hirose, Hiroshi....................................... Disclosed no confl ict of interest.Hirose, Kenzo ........................................ Disclosed no confl ict of interest.Hirose, Takahisa .................................... Research Support: Astellas Pharma Inc., AstraZeneca,

Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson, Kissei Pharmaceutical Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited.

Hirota, Yusuke ....................................... Disclosed no confl ict of interest.Hiroyuki, Hanada ................................... Disclosed no confl ict of interest.Hirsch, Irl B. .......................................... Disclosed no confl ict of interest.Hirschhorn, Joel N. .............................. Disclosed no confl ict of interest.Hirschler, Valeria ................................... Disclosed no confl ict of interest.Hirschman Miller, Ellen ......................... Speaker’s Bureau: AstraZeneca.Hirshberg, Boaz ..................................... Employee: MedImmune, LLC.Hirukawa, Hidenori ............................... Disclosed no confl ict of interest.Hishida, Ai ............................................. Disclosed no confl ict of interest.Hitomi, Mamiko..................................... Disclosed no confl ict of interest.Hivert, Marie-France ............................. Disclosed no confl ict of interest.Hjerpsted, Julie ..................................... Employee: Novo Nordisk A/S.

Hjuler, Sara T. ....................................... Employee: Nordic Bioscience.Hlavacek, Patrick ................................... Employee: Pfi zer Inc.Ho, Bing ................................................. Disclosed no confl ict of interest.Ho, Ching An ......................................... Disclosed no confl ict of interest.Ho, Sam ................................................. Disclosed no confl ict of interest.Hoang, Jonathan ................................... Disclosed no confl ict of interest.Hoang, Monica ...................................... Disclosed no confl ict of interest.Höbaus, Clemens .................................. Disclosed no confl ict of interest.Hocher, Berthold .................................... Disclosed no confl ict of interest.Hockett, Christine W. ........................... Disclosed no confl ict of interest.Hocking, Samantha L. .......................... Disclosed no confl ict of interest.Hockman, Allison L. .............................. Disclosed no confl ict of interest.Hockman, Steven C. ............................. Disclosed no confl ict of interest.Hodish, Israel ........................................ Stock/Shareholder: Hygieia.Hodson, David J. .................................. Disclosed no confl ict of interest.Hoeks, Lette Bea ................................... Disclosed no confl ict of interest.Hoekstra, Joost B. ................................ Research Support: AstraZeneca.Hoekstra, Trynke .................................... Disclosed no confl ict of interest.Hoell, Bernhard ..................................... Disclosed no confl ict of interest.Hoene, Miriam ...................................... Disclosed no confl ict of interest.Hoerger, Thomas J. .............................. Disclosed no confl ict of interest.Hoerster, Katherine D. .......................... Disclosed no confl ict of interest.Hoevelmann, Ulrike ............................... Employee: Profi l Institut für Stoffwechselforschung GmbH.Hoffman, Nolan J. ................................ Disclosed no confl ict of interest.Hoffman, Robert P. ............................... Disclosed no confl ict of interest.Hoffmann, Christoph ............................. Disclosed no confl ict of interest.Hoffmann-Petersen, Ingeborg T. .......... Disclosed no confl ict of interest.Hofman, Albert ...................................... Disclosed no confl ict of interest.Hogan, Meghan F. ................................ Disclosed no confl ict of interest.Hogrefe, Louis ....................................... Disclosed no confl ict of interest.Hohenadel, Maximilian G. ................... Disclosed no confl ict of interest.Hohendorff, Jerzy .................................. Disclosed no confl ict of interest.Hohmeier, Hans-Ewald .......................... Disclosed no confl ict of interest.Hoidal, Mallary...................................... Disclosed no confl ict of interest.Højlund, Kurt ......................................... Disclosed no confl ict of interest.Holbrook, Tim ........................................ Research Support: Merck & Co., Inc.Holden, Sarah E. ................................... Employee: Pharmatelligence, Walgreens Alliance Boots.Holder, Martin ....................................... Disclosed no confl ict of interest.Höll, Bernhard ....................................... Disclosed no confl ict of interest.Holl, Jane .............................................. Disclosed no confl ict of interest.Holl, Reinhard W. ................................. Disclosed no confl ict of interest.Holland, Melanie................................... Disclosed no confl ict of interest.Holland, Scott........................................ Disclosed no confl ict of interest.Hollanda-Miranda, Wallace R. ............ Disclosed no confl ict of interest.Hollander, Abby ..................................... Disclosed no confl ict of interest.Hollander, Priscilla A. ........................... Other Relationship: Eli Lilly & Company, Merck & Co., Novo

Nordisk, Sanofi .Holleman, Cassie .................................. Disclosed no confl ict of interest.Hollenbeak, Christopher S. .................. Disclosed no confl ict of interest.Hollinger, Meredith ............................... Disclosed no confl ict of interest.Hollingsworth, Kieren G. ...................... Disclosed no confl ict of interest.Hollister-Lock, Jennifer ......................... Disclosed no confl ict of interest.Holman, Naomi ..................................... Disclosed no confl ict of interest.Holman, Rury R. .................................... Consultant: Amgen Inc., Bayer HealthCare, Intarcia

Therapeutics, Inc., Merck & Co., Inc., Novartis AG, Novo Nordisk Inc.; Other Relationship: GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited; Research Support: AstraZeneca, Bayer HealthCare, Bristol-Myers Squibb Company, Merck & Co., Inc.

Holmes, Valerie A. ............................... Disclosed no confl ict of interest.Holmes-Truscott, Elizabeth ................... Disclosed no confl ict of interest.Holst, Jens Juul .................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim Pharmaceuticals, Inc., Intarcia Therapeutics, Inc., MannKind Corporation, Merck Sharp & Dohme Corp., Novartis Pharma, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi -Aventis, Zealand Pharma A/S; Consultant: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi -Aventis.

Holst, Line M. ....................................... Disclosed no confl ict of interest.Holt, Charlotte B. .................................. Disclosed no confl ict of interest.Holt, Richard I. ...................................... Advisory Panel: Novo Nordisk; Research Support: Novo

Nordisk; Speaker’s Bureau: Novo Nordisk A/S, speaker for Sanofi -Aventis, Eli Lilly and Company, Otsuka and Bristol-Myers Squibb.

Holter, Marlena ..................................... Disclosed no confl ict of interest.Holzer, Manuel ...................................... Disclosed no confl ict of interest.Holzman, Gregory L. ............................. Disclosed no confl ict of interest.Homan, Erica ......................................... Disclosed no confl ict of interest.Home, Philip D. ..................................... Advisory Panel: AntriaBio, AstraZeneca, GlaxoSmithKline,

Hanmi Pharmaceutical Co., Ltd., Merck KGaA, Novo Nordisk Inc., Roche Diagnostics, Sanofi -Aventis Deutschland GmbH, Skyepharma, Plc; Research

A723


AU

THO

R D

ISCL

OSU

RE

Support: AstraZeneca, Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: AstraZeneca, Biocon, Boehringer Ingelheim GmbH, GlaxoSmithKline, Merck KGaA, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH.

Hompesch, Marcus ............................... Employee: Profi l Institute for Clinical Research, Inc.Hong, Eun Shil ....................................... Disclosed no confl ict of interest.Hong, Janet Yeow Hua ......................... Disclosed no confl ict of interest.Hong, Mihee.......................................... Disclosed no confl ict of interest.Hong, Nam-Ki ........................................ Disclosed no confl ict of interest.Hong, Sangmo ....................................... Disclosed no confl ict of interest.Hong, Sean ............................................ Employee: ConjuChem, LLC.Hong, So-Hyeon .................................... Disclosed no confl ict of interest.Hong, Soo Hyun..................................... Disclosed no confl ict of interest.Hong, Soo Min ...................................... Disclosed no confl ict of interest.Hong, Wanjin ........................................ Disclosed no confl ict of interest.Hong, Won-Jung ................................... Disclosed no confl ict of interest.Hong, Xu ................................................ Disclosed no confl ict of interest.Hong, Young Sun ................................... Disclosed no confl ict of interest.Hong, Zhenzhen..................................... Disclosed no confl ict of interest.Honjo, Sachiko ...................................... Disclosed no confl ict of interest.Honkala, Sanna M. ............................... Disclosed no confl ict of interest.Honma, Hiroyuki .................................... Disclosed no confl ict of interest.Hood, Gillian.......................................... Advisory Panel: Novo Nordisk Research Foundation UK.Hood, Korey K. ...................................... Consultant: Bigfoot Biomedical, Johnson & Johnson Diabetes

Institute.Hookham, Michelle ............................... Disclosed no confl ict of interest.Hoon, Shawn ......................................... Disclosed no confl ict of interest.Hopewell, Jemma C. ............................ Disclosed no confl ict of interest.Hor, Chee Peng ...................................... Disclosed no confl ict of interest.Hora, Israel A. ...................................... Disclosed no confl ict of interest.Hörbelt, Tina .......................................... Disclosed no confl ict of interest.Horii, Takeshi ......................................... Disclosed no confl ict of interest.Horikawa, Chika .................................... Disclosed no confl ict of interest.Horikawa, Yukio .................................... Disclosed no confl ict of interest.Horitani, Keita ....................................... Disclosed no confl ict of interest.Hornick, Doug ........................................ Disclosed no confl ict of interest.Hornigold, David.................................... Employee: MedImmune, LLC.Horowitz, Barry...................................... Research Support: Alere Inc.Horsburgh, Jodie C. .............................. Research Support: Medtronic, Inc.Horton, Edward S. ................................ Advisory Panel: Amgen Inc., AstraZeneca, PTS Diagnostics,

Sanofi U.S., Takeda Development Center Americas, Inc., Theracos, Inc.; Consultant: Axon Advisors; Speaker’s Bureau: Merck & Co., Inc., Platform Q Health.

Horton, Mark B. .................................... Disclosed no confl ict of interest.Horvath, Peter ....................................... Disclosed no confl ict of interest.Hosaka, Toshio ...................................... Disclosed no confl ict of interest.Hoshizawa, Saki .................................... Disclosed no confl ict of interest.Hoskin, Mary A. .................................... Disclosed no confl ict of interest.Hosoda, Kiminori ................................... Disclosed no confl ict of interest.Hosoe, Shigero ...................................... Disclosed no confl ict of interest.Hosomura, Naoshi................................. Disclosed no confl ict of interest.Hossain, Munir ...................................... Disclosed no confl ict of interest.Hosszufalusi, Nora ................................ Disclosed no confl ict of interest.Hotta, Asami ......................................... Disclosed no confl ict of interest.Hottenstein, Charles S. ........................ Employee: GlaxoSmithKline.Hou, Wolin ............................................ Disclosed no confl ict of interest.Hou, Yi ................................................... Disclosed no confl ict of interest.Houe, Susanne Myrup........................... Disclosed no confl ict of interest.Hourigan, Samuel T. ............................. Disclosed no confl ict of interest.Houston, Barbara .................................. Disclosed no confl ict of interest.Hövelmann, Ulrike ................................. Disclosed no confl ict of interest.Hovind, Peter ......................................... Disclosed no confl ict of interest.Hovorka, Roman .................................... Advisory Panel: Eli Lilly and Company; Consultant: B. Braun

Melsungen AG, Profi l Institute for Clinical Research, Inc., Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: B. Braun Melsungen AG, Eli Lilly and Company, Medtronic MiniMed, Inc., Novo Nordisk A/S.

Howard, Waylon ................................... Disclosed no confl ict of interest.Howells, Jacqueline.............................. Disclosed no confl ict of interest.Howitt, Heena ....................................... Employee: Takeda UK Ltd.Howsmon, Daniel .................................. Disclosed no confl ict of interest.Høyem, Pernille ..................................... Disclosed no confl ict of interest.Hrabe de Angelis, Martin...................... Disclosed no confl ict of interest.Hramiak, Irene ....................................... Disclosed no confl ict of interest.Hruby, Adela .......................................... Disclosed no confl ict of interest.Hsia, Daniel S. ...................................... Disclosed no confl ict of interest.Hsieh, Wilson ........................................ Disclosed no confl ict of interest.Hsu, Chien-Yi ......................................... Disclosed no confl ict of interest.Hsu, Hui-Chun ....................................... Disclosed no confl ict of interest.Hsu, Jean W. ........................................ Disclosed no confl ict of interest.Hsu, Liana.............................................. Disclosed no confl ict of interest.Hsu, William C. .................................... Advisory Panel: Novo Nordisk Inc.Hsueh, Wen-Chi .................................... Disclosed no confl ict of interest.Hsueh, Willa A. .................................... Advisory Panel: AstraZeneca, Merck & Co., Inc., Novo Nordisk

Inc.

Htun, Wynn ........................................... Disclosed no confl ict of interest.Hu, Alice ................................................ Disclosed no confl ict of interest.Hu, Cheng .............................................. Disclosed no confl ict of interest.Hu, Chunxiu ........................................... Disclosed no confl ict of interest.Hu, Derong ............................................ Disclosed no confl ict of interest.Hu, Fang ................................................ Disclosed no confl ict of interest.Hu, Frank B. .......................................... Disclosed no confl ict of interest.Hu, Gang................................................ Disclosed no confl ict of interest.Hu, Guo-Tao ........................................... Disclosed no confl ict of interest.Hu, Ji ..................................................... Disclosed no confl ict of interest.Hu, Jiang ............................................... Disclosed no confl ict of interest.Hu, Jiani ................................................ Disclosed no confl ict of interest.Hu, Li ..................................................... Disclosed no confl ict of interest.Hu, Nan ................................................. Disclosed no confl ict of interest.Hu, Tianxin............................................. Disclosed no confl ict of interest.Hu, Xiang ............................................... Disclosed no confl ict of interest.Hu, Xiaodi .............................................. Disclosed no confl ict of interest.Hu, Xiaoke ............................................. Disclosed no confl ict of interest.Hu, Xingyun ........................................... Disclosed no confl ict of interest.Hu, Yan .................................................. Disclosed no confl ict of interest.Hu, Yanjin .............................................. Disclosed no confl ict of interest.Hu, Yanyun ............................................ Disclosed no confl ict of interest.Hu, Yinghua ........................................... Disclosed no confl ict of interest.Hu, Zhimin ............................................. Disclosed no confl ict of interest.Hua, Fei ................................................. Disclosed no confl ict of interest.Hua, Xiaohan ......................................... Disclosed no confl ict of interest.Hua, Yinan ............................................. Disclosed no confl ict of interest.Huang, Chao .......................................... Disclosed no confl ict of interest.Huang, Cheng ........................................ Disclosed no confl ict of interest.Huang, Chien-Ning ................................ Disclosed no confl ict of interest.Huang, Chunhong .................................. Disclosed no confl ict of interest.Huang, Elbert S. ................................... Disclosed no confl ict of interest.Huang, Fengyuan................................... Disclosed no confl ict of interest.Huang, Gavin ......................................... Disclosed no confl ict of interest.Huang, Hazel ......................................... Disclosed no confl ict of interest.Huang, Holly .......................................... Employee: Intarcia Therapeutics, Inc.Huang, Hong.......................................... Disclosed no confl ict of interest.Huang, Huan.......................................... Research Support: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc.Huang, Hui............................................. Employee: Janssen Pharmaceuticals, Inc.Huang, Jian ........................................... Disclosed no confl ict of interest.Huang, Jun-Yuan ................................... Disclosed no confl ict of interest.Huang, Liming ....................................... Disclosed no confl ict of interest.Huang, Min............................................ Disclosed no confl ict of interest.Huang, Peggy ........................................ Disclosed no confl ict of interest.Huang, Peng .......................................... Disclosed no confl ict of interest.Huang, Suiying ...................................... Employee: Medtronic, Inc.Huang, Tao ............................................ Disclosed no confl ict of interest.Huang, Tian Lian.................................... Disclosed no confl ict of interest.Huang, Wei ........................................... Disclosed no confl ict of interest.Huang, Xingyue ..................................... Employee: Merck & Co., Inc.Huang, Yueye ........................................ Disclosed no confl ict of interest.Huang, Yun ............................................ Disclosed no confl ict of interest.Huang, Zhengjing .................................. Disclosed no confl ict of interest.Huang, Zhimin ....................................... Disclosed no confl ict of interest.Hubbard, Stevan R. .............................. Disclosed no confl ict of interest.Huber, Jörg W. ..................................... Disclosed no confl ict of interest.Hübschle, Thomas ................................. Employee: Sanofi -Aventis Deutschland GmbH.Huckestein, Brydie R. ........................... Disclosed no confl ict of interest.Hudemann, Jens ................................... Disclosed no confl ict of interest.Hudkins, Kelly L. ................................... Disclosed no confl ict of interest.Huebschmann, Amy G. ......................... Research Support: Merck & Co., Inc.Hueser, Andreas .................................... Consultant: Sanofi -Aventis Deutschland GmbH; Research

Support: Sanofi -Aventis Deutschland GmbH.Huffhines, Lindsay................................. Disclosed no confl ict of interest.Hughes, Jing W. ................................... Disclosed no confl ict of interest.Hughey, Curtis C. .................................. Disclosed no confl ict of interest.Hugo, Marie .......................................... Disclosed no confl ict of interest.Hui-Chun, Hsu ....................................... Disclosed no confl ict of interest.Huising, Mark O. .................................. Disclosed no confl ict of interest.Hull, Rebecca L. .................................... Research Support: Eli Lilly and Company.Hulme, Maigan...................................... Disclosed no confl ict of interest.Humphrey, Lauren ................................. Disclosed no confl ict of interest.Hung, Adriana ....................................... Disclosed no confl ict of interest.Hunt, Kelly J. ........................................ Research Support: Bristol-Myers Squibb Company.Hunt, Phillip R. ...................................... Consultant: AstraZeneca.Hunter, Anna ......................................... Disclosed no confl ict of interest.Hunter, Chad S. .................................... Disclosed no confl ict of interest.Huo, Lili ................................................. Disclosed no confl ict of interest.Huo, Yong .............................................. Disclosed no confl ict of interest.Hur, Dae Young ...................................... Disclosed no confl ict of interest.Hur, Junguk ........................................... Disclosed no confl ict of interest.Hur, Kyu Yeon ........................................ Disclosed no confl ict of interest.Hurley, Thomas...................................... Disclosed no confl ict of interest.Hursh, Brenden E. ................................. Disclosed no confl ict of interest.Husain, Mansoor ................................... Disclosed no confl ict of interest.

A724


AU

THO

R D

ISCL

OSU

RE

Husain, Raghib ...................................... Disclosed no confl ict of interest.Hussain, Mahmood ............................... Disclosed no confl ict of interest.Hussein, Zanariah ................................. Disclosed no confl ict of interest.Hutchinson, Daria.................................. Disclosed no confl ict of interest.Huyett, Lauren ....................................... Disclosed no confl ict of interest.Huynh, Johnny....................................... Consultant: Intarcia Therapeutics, Inc.Hvid, Henning ........................................ Employee: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/

Partner).Hwang, Eun Sook .................................. Disclosed no confl ict of interest.Hwang, Janice J. ................................. Disclosed no confl ict of interest.Hwang, Jiang-Shiang............................ Disclosed no confl ict of interest.Hwang, Sang Youn ................................ Disclosed no confl ict of interest.Hwu, Katherine ..................................... Disclosed no confl ict of interest.Hyett, Jon .............................................. Disclosed no confl ict of interest.Hykin, Philip........................................... Consultant: Allergan, Inc., Bayer HealthCare, Novartis

Pharmaceuticals Corporation; Research Support: Allergan, Inc., Bayer HealthCare, Novartis Pharmaceuticals Corporation.

Hyles, Kelly............................................ Disclosed no confl ict of interest.Hyltén-Cavallius, Louise........................ Disclosed no confl ict of interest.Hyun, Young Youl .................................. Disclosed no confl ict of interest.Iacopi, Elisabetta................................... Disclosed no confl ict of interest.Iannilli, Antonio ..................................... Disclosed no confl ict of interest.Ibarra, Zumilda ...................................... Disclosed no confl ict of interest.Ibrahim, Luqman.................................... Disclosed no confl ict of interest.Ichijo, Takamasa .................................... Disclosed no confl ict of interest.Ichinose, Hiroshi.................................... Disclosed no confl ict of interest.Idris, Iskandar ........................................ Speaker’s Bureau: AstraZeneca, Eli Lilly and Company,

Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc.

Iepsen, Eva ............................................ Disclosed no confl ict of interest.Iga, Ryo.................................................. Disclosed no confl ict of interest.Igarashi, Masahiko................................ Disclosed no confl ict of interest.Igarashi, Risa......................................... Disclosed no confl ict of interest.Iglay Reger, Heidi B. ............................. Disclosed no confl ict of interest.Iglay, Kristy ............................................ Employee: Merck & Co., Inc.Iglesias, José A. ................................... Disclosed no confl ict of interest.Iijima, Kaori ........................................... Disclosed no confl ict of interest.Iijima, Saeka.......................................... Disclosed no confl ict of interest.Iijima, Toshie ......................................... Disclosed no confl ict of interest.Iizuka, Katsumi ...................................... Disclosed no confl ict of interest.Ijima, Toshie .......................................... Disclosed no confl ict of interest.Ikeda, Fuki ............................................. Disclosed no confl ict of interest.Ikeda, Haruka ........................................ Disclosed no confl ict of interest.Ikeda, Kaori ........................................... Disclosed no confl ict of interest.Ikeda, Takahide ..................................... Disclosed no confl ict of interest.Ikehara, Kayoko ..................................... Disclosed no confl ict of interest.Ikezaki, Hiroaki ...................................... Disclosed no confl ict of interest.Ikramuddin, Sayeed............................... Disclosed no confl ict of interest.Ilag, Liza L. ............................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Ilanne-Parikka, Pirjo .............................. Disclosed no confl ict of interest.Ilatovskaya, Daria.................................. Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases.Ilkayeva, Olga ........................................ Disclosed no confl ict of interest.Illuri, Vidhya D. ..................................... Disclosed no confl ict of interest.Imaeda, Kenro ....................................... Disclosed no confl ict of interest.Imamura, Haruki .................................... Disclosed no confl ict of interest.Imamura, Minako .................................. Disclosed no confl ict of interest.Imamura, Takeshi .................................. Disclosed no confl ict of interest.Imershein, Sarah G. .............................. Disclosed no confl ict of interest.Imes, Sharleen ...................................... Disclosed no confl ict of interest.Imholz, Ben ............................................ Disclosed no confl ict of interest.Imperatore, Giuseppina......................... Disclosed no confl ict of interest.Impronta, Flavia..................................... Disclosed no confl ict of interest.Imtiaz, Komal......................................... Disclosed no confl ict of interest.Inaba, Wataru ....................................... Disclosed no confl ict of interest.Inagaki, Akemi....................................... Disclosed no confl ict of interest.Inagaki, Nobuya .................................... Disclosed no confl ict of interest.Inashima, Kunikazu ............................... Disclosed no confl ict of interest.Inbakumari, Mercy ................................ Disclosed no confl ict of interest.Incalza, Maria Angela ........................... Disclosed no confl ict of interest.Ingelsson, Erik ....................................... Disclosed no confl ict of interest.Innes, Karen .......................................... Disclosed no confl ict of interest.Inoue, Gaku ........................................... Disclosed no confl ict of interest.Inoue, Kana ........................................... Disclosed no confl ict of interest.Inoue, Koji ............................................. Disclosed no confl ict of interest.Inoue, Noriyuki ...................................... Employee: Kowa Company, Ltd.Inoue, Shin-Ichi ..................................... Disclosed no confl ict of interest.Inoue, Tsuyoshi ...................................... Disclosed no confl ict of interest.Inoue, Yoshitaka .................................... Disclosed no confl ict of interest.Insogna, Carl ......................................... Disclosed no confl ict of interest.Inverardi, Luca ....................................... Disclosed no confl ict of interest.Invernizzi, Pietro Luigi ........................... Disclosed no confl ict of interest.Inzucchi, Silvio E. .................................. Board Member: Intarcia Therapeutics, Inc., Novo Nordisk Inc.;

Consultant: AstraZeneca, Boehringer Ingelheim GmbH,

Daiichi-Sankyo Co., Ltd., Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Merck & Co., Inc., Poxel Pharmaceutical Company, Sanofi U.S., TransTech Pharma, LLC.; Research Support: Takeda Pharmaceutical Company Limited.

Ioannidis, Ioannis .................................. Disclosed no confl ict of interest.Iovino, Salvatore ................................... Employee: Merck & Co., Inc.Iozzo, Patricia ........................................ Disclosed no confl ict of interest.Ip, Edward ............................................. Disclosed no confl ict of interest.Ipichart, Nantawan ............................... Disclosed no confl ict of interest.Iqbal, Ahmed ......................................... Disclosed no confl ict of interest.Iqbal, Nayyar ......................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Irace, Concetta ...................................... Disclosed no confl ict of interest.Ireland, Christopher............................... Disclosed no confl ict of interest.Irie, Junichiro ........................................ Disclosed no confl ict of interest.Irie, Shin ................................................ Disclosed no confl ict of interest.Irie, Shinichiro ....................................... Disclosed no confl ict of interest.Irmler, Martin ........................................ Disclosed no confl ict of interest.Isakova, Tamara .................................... Disclosed no confl ict of interest.Isaranuwatchai, Wanrudee ................... Disclosed no confl ict of interest.Isautier, Jennifer ................................... Disclosed no confl ict of interest.Isbell, James M. ................................... Disclosed no confl ict of interest.Ishida, Hitoshi ....................................... Disclosed no confl ict of interest.Ishigaki, Yasushi.................................... Disclosed no confl ict of interest.Ishihara, Hisamitsu ............................... Research Support: Astellas Pharma Inc., AstraZeneca, Daiichi-

Sankyo Co., Ltd., Eli Lilly Japan K.K., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi K.K., Taisho Pharmaceutical Co., Ltd.; Speaker’s Bureau: Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Novo Nordisk Inc., Sanofi K.K.

Ishii, Masaru ......................................... Disclosed no confl ict of interest.Ishii, Ryoko ............................................ Disclosed no confl ict of interest.Ishikado, Atsushi ................................... Disclosed no confl ict of interest.Ishikido, Michiya ................................... Disclosed no confl ict of interest.Ishizaki, Thales ...................................... Disclosed no confl ict of interest.Ishizawa, Masahiro ............................... Disclosed no confl ict of interest.Ishizawa, Sho ........................................ Disclosed no confl ict of interest.Ishizu, Katsura ....................................... Disclosed no confl ict of interest.Ishizuka, Tatsuo ..................................... Disclosed no confl ict of interest.Ishizuka, Tomoko ................................... Disclosed no confl ict of interest.Ismail, Amin .......................................... Disclosed no confl ict of interest.Ismail, Heba .......................................... Disclosed no confl ict of interest.Ismail-Beigi, Faramarz........................... Disclosed no confl ict of interest.Ismat, Fraz A. ........................................ Stock/Shareholder: Bristol-Myers Squibb Company.Isobe, Ken-Ichi....................................... Disclosed no confl ict of interest.Isogawa, Akihiro ................................... Disclosed no confl ict of interest.Isom, Scott ............................................ Disclosed no confl ict of interest.Israeli Yagev, Lital ................................. Disclosed no confl ict of interest.Ito, Akira ................................................ Disclosed no confl ict of interest.Ito, Hideki .............................................. Disclosed no confl ict of interest.Ito, Shunsuke......................................... Disclosed no confl ict of interest.Ito, Takeru .............................................. Disclosed no confl ict of interest.Ito, Toshimitsu ....................................... Disclosed no confl ict of interest.Itoh, Hiroshi ........................................... Board Member: NIPRO, SBI Pharma; Research Support:

AstraZeneca, Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Itoh, Yasuki ............................................ Disclosed no confl ict of interest.Iturralde, Esti ......................................... Disclosed no confl ict of interest.Iughetti, Lorenzo.................................... Disclosed no confl ict of interest.Ivandic, Marul ....................................... Disclosed no confl ict of interest.Ivanova, Jasmina .................................. Employee: Analysis Group, Boehringer Ingelheim

Pharmaceuticals, Inc. (Spouse/Partner); Research Support: Eli Lilly and Company.

Ivanyi, Tibor ........................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Iversen, Marjolein M. ........................... Disclosed no confl ict of interest.Ivey, Robert............................................ Disclosed no confl ict of interest.Ivovic, Alexander ................................... Disclosed no confl ict of interest.Iwabu, Masato ...................................... Disclosed no confl ict of interest.Iwabu, Miki ........................................... Disclosed no confl ict of interest.Iwai, Yukiko ........................................... Disclosed no confl ict of interest.Iwamoto, Yasuhiko ................................ Disclosed no confl ict of interest.Iwao, Yasushi ........................................ Disclosed no confl ict of interest.Iwaoka, Manami ................................... Disclosed no confl ict of interest.Iwasaki, Akinori..................................... Disclosed no confl ict of interest.Iwasaki, Hirotaka .................................. Disclosed no confl ict of interest.Iwasaki, Masayoshi .............................. Disclosed no confl ict of interest.Iwata, Hiroshi ........................................ Disclosed no confl ict of interest.Iwata, Shinpei ....................................... Disclosed no confl ict of interest.

A725


AU

THO

R D

ISCL

OSU

RE

Iwata, Wakiko ....................................... Disclosed no confl ict of interest.Iwaya-Ota, Chikayo ............................... Disclosed no confl ict of interest.Iyer, Malini S. ....................................... Disclosed no confl ict of interest.Iyer, Remya ............................................ Disclosed no confl ict of interest.Izaola, Olatz ........................................... Disclosed no confl ict of interest.Izumi, Kenichi ........................................ Disclosed no confl ict of interest.Izumiyama, Hajime ................................ Disclosed no confl ict of interest.Jaber, Yahya .......................................... Disclosed no confl ict of interest.Jabir Sayed, M.V. ................................. Disclosed no confl ict of interest.Jackson, Ronneshia .............................. Disclosed no confl ict of interest.Jackson, Samuel ................................... Disclosed no confl ict of interest.Jackson, Tourette .................................. Disclosed no confl ict of interest.Jacob, Robert F. .................................... Disclosed no confl ict of interest.Jacob, Saya ........................................... Disclosed no confl ict of interest.Jacobs, David R. ................................... Disclosed no confl ict of interest.Jacobs, Peter G. ................................... Disclosed no confl ict of interest.Jacobsen, Laura .................................... Disclosed no confl ict of interest.Jacobsen, Sanja Hald ........................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Jacobson, Alan M. ............................... Disclosed no confl ict of interest.Jacobson, David A. .............................. Disclosed no confl ict of interest.Jacobs-Tulleneers-Thevissen, Daniel ... Disclosed no confl ict of interest.Jacques, Paul F. .................................... Disclosed no confl ict of interest.Jacques, Richard ................................... Disclosed no confl ict of interest.Jacquier, Alexis ..................................... Disclosed no confl ict of interest.Jadhav, Vaishnavi ................................. Disclosed no confl ict of interest.Jaeckel, Elmar ....................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim GmbH,

Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharma AG, Novo Nordisk A/S, Roche Pharmaceuticals; Board Member: Eli Lilly and Company, Novo Nordisk A/S; Research Support: Biotest Pharmaceuticals, Federal Ministry of Education and Research, Germany, Fresenius SE & Co. KGaA, Gilead Sciences, Inc., Juvenile Diabetes Research Foundation, Miltenyi Biotech, Novartis Pharma AG, Novo Nordisk A/S, Roche Pharmaceuticals, VW-Stiftung, Wacker Chemie AG; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche Pharmaceuticals.

Jaffe, Iris ............................................... Research Support: American Heart Association, National Institutes of Health.

Jaganathan, Suganthi ........................... Disclosed no confl ict of interest.Jaggi, Shalini ........................................ Disclosed no confl ict of interest.Jaghutriz, Assad.................................... Disclosed no confl ict of interest.Jagielnicki, Maciej ................................ Disclosed no confl ict of interest.Jagu, Benoit .......................................... Disclosed no confl ict of interest.Jahansouz, Cyrus .................................. Disclosed no confl ict of interest.Jahn, Linda ............................................ Disclosed no confl ict of interest.Jahoor, Farook ....................................... Disclosed no confl ict of interest.Jain, Anand ........................................... Employee: Novo Nordisk A/S.Jain, Mohit ............................................ Disclosed no confl ict of interest.Jain, Mukul R. ...................................... Employee: Zydus Research Centre, Cadila Healthcare Limited,

Ahmedabad, India.Jain, Nidhi ............................................. Disclosed no confl ict of interest.Jain, Rahul ............................................ Employee: HealthCore.Jain, Rajeev........................................... Advisory Panel: Novo Nordisk Inc.; Consultant: Novo Nordisk

Inc.; Research Support: AstraZeneca, Johnson & Johnson, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Johnson & Johnson, Novo Nordisk Inc., Sanofi U.S.

Jain, Shalini .......................................... Disclosed no confl ict of interest.Jaiswal, Mamta .................................... Disclosed no confl ict of interest.Jakobsen, Poul E. ................................. Disclosed no confl ict of interest.Jakoby, Michael G. ............................... Speaker’s Bureau: Sanofi U.S.Jalaludin, Muhammad Yazid................. Disclosed no confl ict of interest.Jalou, Hasnaa E. .................................. Disclosed no confl ict of interest.Jałowiec, Irena...................................... Disclosed no confl ict of interest.James, Eddie A. ................................... Disclosed no confl ict of interest.James, Freyja D. ................................... Disclosed no confl ict of interest.James, Rose .......................................... Disclosed no confl ict of interest.Jamiołkowska, Milena .......................... Disclosed no confl ict of interest.Jamison, Braxton L. .............................. Disclosed no confl ict of interest.Jamnik, Veronica ................................... Disclosed no confl ict of interest.Janas, Izabela ....................................... Disclosed no confl ict of interest.Jandeleit-Dahm, Karin .......................... Disclosed no confl ict of interest.Janež, Andrej ........................................ Disclosed no confl ict of interest.Jang, Brian ............................................ Disclosed no confl ict of interest.Jang, Hak C. ......................................... Disclosed no confl ict of interest.Jang, Jung Eun...................................... Disclosed no confl ict of interest.Jang, Suk Yong...................................... Disclosed no confl ict of interest.Jang, Younghwan.................................. Disclosed no confl ict of interest.Janickova Zdarska, Denisa ................... Disclosed no confl ict of interest.Janisch, Hans-Dieter............................. Disclosed no confl ict of interest.Jank, Anne-Marie ................................. Disclosed no confl ict of interest.

Janovska, Petra ..................................... Disclosed no confl ict of interest.Janus, Charlotte .................................... Disclosed no confl ict of interest.Januszewski, Andrzej S. ...................... Disclosed no confl ict of interest.Jardine, Meg ......................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Janssen Pharmaceuticals, Inc.; Research Support: Gambaro; Speaker’s Bureau: Amgen Inc., Roche Pharmaceuticals.

Jaremko, Malgorzata ............................ Employee: Quest Diagnostics.Jarhyan, Prashant ................................. Disclosed no confl ict of interest.Jarlov, Henrik ........................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S, Novo Nordisk A/S (Spouse/Partner).Jarvelin, Marjo-Riitta ............................ Disclosed no confl ict of interest.Jaser, Sarah S. ..................................... Disclosed no confl ict of interest.Jastreboff, Ania M. .............................. Disclosed no confl ict of interest.Jayawardene, Dilshani ......................... Disclosed no confl ict of interest.Jayesh Kumar, P. .................................. Disclosed no confl ict of interest.Jayyousi, Amin ...................................... Disclosed no confl ict of interest.Jazbec, Anamarija................................. Disclosed no confl ict of interest.Jean-Baptiste, Eddy .............................. Disclosed no confl ict of interest.Jebakumar, Jebakaran .......................... Disclosed no confl ict of interest.Jedraszko, Aneta................................... Disclosed no confl ict of interest.Jee Young, You...................................... Disclosed no confl ict of interest.Jee, Jae Hwan ...................................... Disclosed no confl ict of interest.Jeffers, Jennifer M. ............................. Disclosed no confl ict of interest.Jeganathan, Ramesh ............................ Disclosed no confl ict of interest.Jelenik, Tomas ...................................... Disclosed no confl ict of interest.Jelley, David H. .................................... Disclosed no confl ict of interest.Jelsing, Jacob ....................................... Employee: Gubra; Stock/Shareholder: Gubra.Jendrike, Nina ....................................... Disclosed no confl ict of interest.Jenkins, Alicia J. .................................. Advisory Panel: Abbott Diabetes Care Inc.; Research Support:

Medtronic, Inc., Sanofi U.S.; Speaker’s Bureau: Animas Corporation, Medtronic, Inc.

Jenkins, Carol........................................ Disclosed no confl ict of interest.Jenkins, David J. .................................. Employee: Glycemic Index Laboratories (Spouse/Partner);

Research Support: Alpro Foundation, Canada Foundation for Innovation, Canada Research Chair, Ontario Research Fund, Peanut Institute, The International Tree Nut Council Nutrition Research & Education Foundation.

Jenkins, Erin C. ..................................... Disclosed no confl ict of interest.Jenkins-Jones, Sara.............................. Research Support: AstraZeneca, Merck & Co., Inc.Jenkinson, Celia .................................... Employee: Janssen Pharmaceuticals, Inc.Jenner, Helen ........................................ Disclosed no confl ict of interest.Jensen, Christian Z. ............................. Disclosed no confl ict of interest.Jensen, Dorte Møller ............................ Other Relationship: Eli Lilly and Company.Jensen, Elisa P. ..................................... Disclosed no confl ict of interest.Jensen, Jan ........................................... Disclosed no confl ict of interest.Jensen, Jorgen...................................... Disclosed no confl ict of interest.Jensen, Knud J. .................................... Consultant: Gubra; Stock/Shareholder: Gubra.Jensen, Magnus T. ............................... Disclosed no confl ict of interest.Jensen, Majken..................................... Employee: Steno Diabetes Center A/S; Research Support:

AstraZeneca; Stock/Shareholder: Novo Nordisk A/S.Jensen, Michael D. .............................. Disclosed no confl ict of interest.Jensen, Stina ........................................ Employee: Novo Nordisk A/S.Jensen, Thomas E. ............................... Disclosed no confl ict of interest.Jensterle, Mojca ................................... Disclosed no confl ict of interest.Jeon, Ja Young...................................... Disclosed no confl ict of interest.Jeon, Yun Kyung .................................... Disclosed no confl ict of interest.Jeong, Hana .......................................... Disclosed no confl ict of interest.Jeong, Kyung Hwan .............................. Disclosed no confl ict of interest.Jeong, Kyungah..................................... Disclosed no confl ict of interest.Jeong, Yoo Mi ....................................... Disclosed no confl ict of interest.Jeong, Yoomi......................................... Disclosed no confl ict of interest.Jepsen, Sara L. ..................................... Disclosed no confl ict of interest.Jermendy, Ádám L. ............................... Disclosed no confl ict of interest.Jermendy, György.................................. Speaker’s Bureau: 77 Electronics Co. Ltd.Jermutus, Lutz ....................................... Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Jerums, George ..................................... Disclosed no confl ict of interest.Jetten, Anton M. .................................. Disclosed no confl ict of interest.Jha, Jay C. ............................................ Disclosed no confl ict of interest.Jhingan, Ashok K. ................................ Disclosed no confl ict of interest.Ji, Linong ............................................... Advisory Panel: AstraZeneca; Consultant: Bayer HealthCare,

Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Novo Nordisk Inc., Roche Pharmaceuticals, Sanofi U.S., Takeda Pharmaceutical Company Limited; Research Support: Roche Pharmaceuticals, Sanofi U.S.

Ji, Myoung Jin ...................................... Disclosed no confl ict of interest.Ji, Qiuhe ................................................ Disclosed no confl ict of interest.Jia Yau, Doong ...................................... Disclosed no confl ict of interest.Jia, Guanghong ..................................... Disclosed no confl ict of interest.Jia, Jia................................................... Disclosed no confl ict of interest.Jia, Liu ................................................... Disclosed no confl ict of interest.Jia, Nan ................................................. Employee: Eli Lilly and Company.Jia, Weiping .......................................... Disclosed no confl ict of interest.Jia, Yumei .............................................. Disclosed no confl ict of interest.

A726


AU

THO

R D

ISCL

OSU

RE

Jiang, Bingbing ..................................... Disclosed no confl ict of interest.Jiang, Boyi............................................. Employee: Medtronic, Inc.Jiang, Dingfeng ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Jiang, Feng ............................................ Disclosed no confl ict of interest.Jiang, Haoyang ..................................... Disclosed no confl ict of interest.Jiang, Honghua ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Jiang, Lihong ......................................... Disclosed no confl ict of interest.Jiang, Lili ............................................... Disclosed no confl ict of interest.Jiang, Lin ............................................... Disclosed no confl ict of interest.Jiang, Qingling ...................................... Disclosed no confl ict of interest.Jiang, Qingwu ....................................... Disclosed no confl ict of interest.Jiang, Shaoning .................................... Disclosed no confl ict of interest.Jiang, Tao .............................................. Disclosed no confl ict of interest.Jiang, Wei ............................................. Disclosed no confl ict of interest.Jiang, Xiaozhen ..................................... Disclosed no confl ict of interest.Jiang, Xinyin.......................................... Disclosed no confl ict of interest.Jiang, Yong............................................ Disclosed no confl ict of interest.Jiang, Yunna .......................................... Disclosed no confl ict of interest.Jiang, Zhen Huan .................................. Disclosed no confl ict of interest.Jiang, Zhen Y. ....................................... Disclosed no confl ict of interest.Jin, Donna ............................................. Disclosed no confl ict of interest.Jin, Heung Yong .................................... Disclosed no confl ict of interest.Jin, Sang-Man....................................... Disclosed no confl ict of interest.Jin, Tianru.............................................. Disclosed no confl ict of interest.Jinbo, Hu ............................................... Disclosed no confl ict of interest.Jing, Danqing ........................................ Disclosed no confl ict of interest.Jing, Gu ................................................. Disclosed no confl ict of interest.Jirkovska, Alexandra ............................. Disclosed no confl ict of interest.Jo, Young-II ........................................... Disclosed no confl ict of interest.Jódar, Esteban ....................................... Advisory Panel: AstraZeneca, Eli Lilly and Company, FAES,

Janssen, Novo Nordisk A/S; Consultant: FAES, Merck Sharp & Dohme Corp.; Research Support: Amgen Inc., AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Pfi zer Inc.; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S.

Joensen, Lene E. .................................. Employee: Steno Diabetes Center A/S.Joergensen, John B. ............................ Disclosed no confl ict of interest.Joergensen, Niklas R. .......................... Disclosed no confl ict of interest.Joh, Takashi .......................................... Disclosed no confl ict of interest.Johal, Vikramdeep S. ........................... Disclosed no confl ict of interest.Johannsen, Darcy L. ............................. Disclosed no confl ict of interest.Johansen, Nanna B. ............................. Stock/Shareholder: Novo Nordisk A/S.Johansen, Odd Erik ............................... Employee: Boehringer Ingelheim GmbH.Johansen, Pierre ................................... Employee: The Swedish Institute for Health Economics.Johansen, Rakel F. ................................ Research Support: Eli Lilly and Company.Johansson, Carl-Christer....................... Stock/Shareholder: AstraZeneca.Johansson, Jan ..................................... Employee: Resverlogix Corp.; Stock/Shareholder: Resverlogix

Corp.Joharatnam, Jalini ................................ Disclosed no confl ict of interest.Johnsen, Søren P. ................................. Disclosed no confl ict of interest.Johnson Oakes, Diana .......................... Disclosed no confl ict of interest.Johnson, Andrew M. ............................ Disclosed no confl ict of interest.Johnson, Cassandra S. ......................... Employee: Good Measures, LLC.Johnson, Cathryn .................................. Disclosed no confl ict of interest.Johnson, Elizabeth ................................ Disclosed no confl ict of interest.Johnson, James D. ............................... Disclosed no confl ict of interest.Johnson, Jeffrey A. .............................. Disclosed no confl ict of interest.Johnson, June F. ................................... Disclosed no confl ict of interest.Johnson, Kevin B. ................................. Disclosed no confl ict of interest.Johnson, Kjell........................................ Consultant: Janssen Pharmaceuticals, Inc.Johnson, La-Shell.................................. Disclosed no confl ict of interest.Johnson, Leigh ...................................... Disclosed no confl ict of interest.Johnson, Matthew E. ........................... Disclosed no confl ict of interest.Johnson, Matthew L. ........................... Disclosed no confl ict of interest.Johnson, Nicole .................................... Disclosed no confl ict of interest.Johnson, Paul ........................................ Advisory Panel: Defymed, Diabetes Research and Wellness

Foundation, Dompé Pharmaceutical.Johnson, Randi K. ................................ Disclosed no confl ict of interest.Johnson, Richard J. .............................. Disclosed no confl ict of interest.Johnson, Sterling C. ............................. Research Support: AG027161, National Institutes of Health.Johnson, Suzanne B. ............................ Research Support: National Institutes of Health.Johnson, William D. ............................. Disclosed no confl ict of interest.Johnsson, Eva ....................................... Employee: AstraZeneca, AstraZeneca (Spouse/Partner); Stock/

Shareholder: AstraZeneca, AstraZeneca (Spouse/Partner).Johnsson, Kristina................................. Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Johnston, Adrian C. .............................. Disclosed no confl ict of interest.Johnston, Brian T. ................................ Disclosed no confl ict of interest.Johnston, Luke W. ................................ Disclosed no confl ict of interest.Johnston, Phillip C. .............................. Disclosed no confl ict of interest.Johnston, Stephen ................................ Employee: Truven Health Analytics, Inc.Jojima, Teruo ......................................... Disclosed no confl ict of interest.Joles, Jaap A. ...................................... Disclosed no confl ict of interest.

Joly, Erik ................................................ Disclosed no confl ict of interest.Jonas, Jean-Christophe ........................ Disclosed no confl ict of interest.Jones, Angus G. ................................... Disclosed no confl ict of interest.Jones, David.......................................... Disclosed no confl ict of interest.Jones, Sam............................................ Disclosed no confl ict of interest.Jones, Samuel E. .................................. Disclosed no confl ict of interest.Jones, Stedman T. ................................ Disclosed no confl ict of interest.Jones, Timothy W. ................................ Advisory Panel: Medtronic, Inc., Sanofi U.S., Takeda

Pharmaceutical Company Limited; Research Support: Medtronic, Inc.; Speaker’s Bureau: Lilly Deutschland GmbH, Medtronic, Inc., Sanofi U.S.

Jones-Leone, Angela ............................ Employee: GlaxoSmithKline; Stock/Shareholder: GlaxoSmithKline.

Jonsson, Anna....................................... Disclosed no confl ict of interest.Joosten, Maja ....................................... Disclosed no confl ict of interest.Jordan, Jens.......................................... Disclosed no confl ict of interest.Jordan, Olivia J. ................................... Disclosed no confl ict of interest.Jørgensen, Marit................................... Employee: Steno Diabetes Center A/S; Research Support:

AstraZeneca; Stock/Shareholder: Novo Nordisk A/S.Jorgensen, Nils B. ................................ Disclosed no confl ict of interest.Jørgensen, Peter G. .............................. Disclosed no confl ict of interest.Jörneskog, Gun ..................................... Disclosed no confl ict of interest.Jose Raj, M.G. ...................................... Disclosed no confl ict of interest.Jose, Arun P. ......................................... Disclosed no confl ict of interest.Joseph, Jamie W. ................................ Disclosed no confl ict of interest.Joseph, Joshua J. ................................ Disclosed no confl ict of interest.Joseph, Richard..................................... Disclosed no confl ict of interest.Joseph, Rosamma ................................. Disclosed no confl ict of interest.Joseph, Stacey ...................................... Disclosed no confl ict of interest.Joshi, Amrita ......................................... Disclosed no confl ict of interest.Joshi, Ashish V. .................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Joshi, Mamta ........................................ Disclosed no confl ict of interest.Joshi, Nisha .......................................... Disclosed no confl ict of interest.Joshi, Shashank R. ............................... Disclosed no confl ict of interest.Joshi, Shilpa S. .................................... Disclosed no confl ict of interest.Joshipura, Kaumudi J. ......................... Disclosed no confl ict of interest.Josien, Hubert ....................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Josse, Robert G. ................................... Research Support: Amgen Inc., AstraZeneca, Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc.

Jothydev, Sunitha.................................. Disclosed no confl ict of interest.Joubert, Michael ................................... Disclosed no confl ict of interest.Joubert, Pieter H. ................................. Consultant: Genmedica Therapeutics.Jouihan, Hani ........................................ Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Joung, Kyong Hye ................................. Disclosed no confl ict of interest.Jourdan, Tony ........................................ Disclosed no confl ict of interest.Joy, Nino G. .......................................... Disclosed no confl ict of interest.Ju, Mi K. ............................................... Employee: Yuhan Co.Ju, Sang Hyeon ..................................... Disclosed no confl ict of interest.Ju, Sang Hyun ....................................... Disclosed no confl ict of interest.Juang, Charity ....................................... Disclosed no confl ict of interest.Juang, Jyuhn-Huarng ............................ Disclosed no confl ict of interest.Judd, Robert L. ..................................... Disclosed no confl ict of interest.Judd, Ryan............................................. Disclosed no confl ict of interest.Juhl, Claus............................................. Disclosed no confl ict of interest.Jukema, J. Wouter ................................ Disclosed no confl ict of interest.Juliano, Rebecca A. ............................. Employee: Amarin Pharma, Inc.; Stock/Shareholder: Amarin

Pharma, Inc.Jumar, Agnes ........................................ Disclosed no confl ict of interest.Jun, Hee-Jin .......................................... Disclosed no confl ict of interest.Jun, Ji Eun............................................. Disclosed no confl ict of interest.Jun, Younghee....................................... Disclosed no confl ict of interest.Jundt, Dustin K. .................................... Disclosed no confl ict of interest.Jung, Chang Hee ................................... Disclosed no confl ict of interest.Jung, Chan-Hyeon ................................. Disclosed no confl ict of interest.Jung, Eunsoo ......................................... Disclosed no confl ict of interest.Jung, Hye Seung ................................... Disclosed no confl ict of interest.Jung, Hye Sook ..................................... Disclosed no confl ict of interest.Jung, II-Hoon ......................................... Employee: Dong-A ST.Jung, Jong Gab ..................................... Disclosed no confl ict of interest.Jung, Min-Ho ........................................ Disclosed no confl ict of interest.Jung, Peter ............................................ Disclosed no confl ict of interest.Jung, Sung Youb ................................... Disclosed no confl ict of interest.Junqueira, Yasmine............................... Disclosed no confl ict of interest.Jurczak, Michael ................................... Disclosed no confl ict of interest.Jurgen, Brittney..................................... Disclosed no confl ict of interest.Ka, Arun................................................. Disclosed no confl ict of interest.Kaakinen, Marika .................................. Disclosed no confl ict of interest.Kaar, Jill L. ............................................ Disclosed no confl ict of interest.Kabeya, Yusuke ..................................... Disclosed no confl ict of interest.Kabir, Golam .......................................... Disclosed no confl ict of interest.Kabir, Morvarid ...................................... Disclosed no confl ict of interest.Kabul, Samaneh .................................... Employee: Eli Lilly and Company.

A727


AU

THO

R D

ISCL

OSU

RE

Kaburagi, Yasushi.................................. Disclosed no confl ict of interest.Kachoria, Rashmi .................................. Disclosed no confl ict of interest.Kaczmar, Elizabeth ................................ Disclosed no confl ict of interest.Kadam, Rajesh ...................................... Disclosed no confl ict of interest.Kadaria, Dipen....................................... Disclosed no confl ict of interest.Kadayakkara, Deepak............................ Disclosed no confl ict of interest.Kaddis, John.......................................... Disclosed no confl ict of interest.Kadima, Webe C. ................................. Disclosed no confl ict of interest.Kado, Tomonobu .................................... Disclosed no confl ict of interest.Kadowaki, Takashi ................................ Advisory Panel: Boehringer Ingelheim GmbH, Daiichi-Sankyo

Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk A/S, Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Consultant: Boehringer Ingelheim GmbH, Merck Sharp & Dohme Corp.; Research Support: AstraZeneca, Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Merck Sharp & Dohme Corp., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Kady, Nermin ......................................... Disclosed no confl ict of interest.Kaga, Hideyosi ...................................... Disclosed no confl ict of interest.Kaga, Naoko .......................................... Disclosed no confl ict of interest.Kahn, Barbara B. .................................. Disclosed no confl ict of interest.Kahn, C. Ronald ..................................... Advisory Panel: Catabasis Pharmaceuticals, Inc., CohBar,

Inc., Dicerna Pharmaceuticals, Inc., Ember Therapeutics, Five Prime Therapeutics, Inc.; Research Support: Sanofi -Aventis Deutschland GmbH.

Kahn, Henry S. ...................................... Disclosed no confl ict of interest.Kahn, Peter ............................................ Disclosed no confl ict of interest.Kahn, Steven E. .................................... Disclosed no confl ict of interest.Kahraman, Sevim .................................. Disclosed no confl ict of interest.Kaigawa, Saori ...................................... Disclosed no confl ict of interest.Kaiyala, Karl .......................................... Disclosed no confl ict of interest.Kajita, Kazuo ......................................... Disclosed no confl ict of interest.Kakehi, Saori ......................................... Speaker’s Bureau: Merck Sharp & Dohme Corp.Kakei, Tsuyoshi ...................................... Disclosed no confl ict of interest.Kakino, Satomi ...................................... Disclosed no confl ict of interest.Kako-Komatsu, Shiho ............................ Disclosed no confl ict of interest.Kaku, Kohei ........................................... Research Support: Kowa Company, Ltd.Kalam, Suneetha ................................... Disclosed no confl ict of interest.Kalavalapalli, Srilaxmi .......................... Disclosed no confl ict of interest.Kallas-Koeman, Melissa ....................... Disclosed no confl ict of interest.Kalliokoski, Kari..................................... Disclosed no confl ict of interest.Kalra, Manik .......................................... Research Support: Parexel International.Kalra, Sanjay ......................................... Advisory Panel: Novo Nordisk Inc; Speaker’s Bureau:

AstraZeneca, Sanofi -Aventis Deutschland GmbH.Kalsbeek, Andries ................................. Disclosed no confl ict of interest.Kaltoft, Anne ......................................... Disclosed no confl ict of interest.Kaltoft, Margit S. ................................. Employee: Novo Nordisk A/S.Kalyani, Rita R. ..................................... Advisory Panel: AstraZeneca.Kalynska, Ludmyla................................. Disclosed no confl ict of interest.Kamada, Chiemi .................................... Disclosed no confl ict of interest.Kamar, Azanna Ahmad .......................... Disclosed no confl ict of interest.Kamaratos, Alexandros ......................... Disclosed no confl ict of interest.Kamaruddin, Nor Azmi .......................... Disclosed no confl ict of interest.Kamatani, Yoichiro ................................ Disclosed no confl ict of interest.Kamba, Aya ........................................... Disclosed no confl ict of interest.Kambar, S. ............................................ Disclosed no confl ict of interest.Kamecke, Ulrike .................................... Disclosed no confl ict of interest.Kamei, Shinji ......................................... Disclosed no confl ict of interest.Kamiya, Hideki ...................................... Research Support: Astellas Pharma Inc., Boehringer Ingelheim

Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson, Kyowa Hakko Kirin Co., Ltd., Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Eli Lilly Japan K.K., Merck & Co., Inc., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Sanofi K.K.

Kampmann, Ulla .................................... Disclosed no confl ict of interest.Kamps, Jodi........................................... Disclosed no confl ict of interest.Kanaguchi, Momoko ............................. Disclosed no confl ict of interest.Kanai, Yoshikatsu .................................. Research Support: Mitsubishi Tanabe Pharma Corporation.Kanasaki, Keizo ..................................... Consultant: Boehringer Ingelheim; Research Support:

Boehringer Ingelheim; Speaker’s Bureau: Astellas Pharma Inc., Boehringer Ingelheim, Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Sanofi .

Kanaya, Alka M. ................................... Disclosed no confl ict of interest.Kanazawa, Akio..................................... Speaker’s Bureau: Kissei Pharmaceutical Co., Ltd., Sanofi K.K.,

Takeda Pharmaceutical Company Limited.

Kanazawa, Ken...................................... Disclosed no confl ict of interest.Kanazawa, Yasushi ............................... Disclosed no confl ict of interest.Kanba, Aya ............................................ Disclosed no confl ict of interest.Kandaswamy, Prashanth ....................... Employee: Boehringer Ingelheim GmbH.Kandel, Daniel ....................................... Disclosed no confl ict of interest.Kandula, Namratha ............................... Disclosed no confl ict of interest.Kane, Naomi S. .................................... Disclosed no confl ict of interest.Kane, Robert R. .................................... Disclosed no confl ict of interest.Kaneko, Shizuka .................................... Advisory Panel: Astellas Pharma Inc., Eli Lilly Japan K.K.,

Novo Nordisk Inc., Taisho Pharmaceutical Co., Ltd.; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson Diabetes Institute, Kowa Company, Ltd., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Novo Nordisk Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Kaneko, Shuichi..................................... Disclosed no confl ict of interest.Kaneko, Terumi ...................................... Disclosed no confl ict of interest.Kaneto, Hideaki ..................................... Disclosed no confl ict of interest.Kang, Borami ......................................... Disclosed no confl ict of interest.Kang, Eun Seok ..................................... Disclosed no confl ict of interest.Kang, Hee Joon ..................................... Disclosed no confl ict of interest.Kang, Hong Soon................................... Disclosed no confl ict of interest.Kang, Hyeon-Ji ...................................... Disclosed no confl ict of interest.Kang, Hyojung ....................................... Disclosed no confl ict of interest.Kang, Ilho .............................................. Disclosed no confl ict of interest.Kang, Insug............................................ Disclosed no confl ict of interest.Kang, Li.................................................. Disclosed no confl ict of interest.Kang, Min-Cheol ................................... Disclosed no confl ict of interest.Kang, Shinae ......................................... Disclosed no confl ict of interest.Kang, Shin-Wook .................................. Disclosed no confl ict of interest.Kang, Sona ............................................ Disclosed no confl ict of interest.Kang, Sun Jung ..................................... Disclosed no confl ict of interest.Kang, Sun Woo ..................................... Disclosed no confl ict of interest.Kang, Yea Eum ...................................... Disclosed no confl ict of interest.Kang, Yeonjoo ....................................... Employee: Profi l Institute for Clinical Research, Inc.Kang, Yu Mi ........................................... Disclosed no confl ict of interest.Kang, Yup .............................................. Disclosed no confl ict of interest.Kanno, Shin-Ichiro ................................. Disclosed no confl ict of interest.Kano, Hugo ............................................ Disclosed no confl ict of interest.Kanott Lambert, Sheena ....................... Disclosed no confl ict of interest.Kansal, Anuraag R. ............................... Consultant: Boehringer Ingelheim GmbH.Kanter, Jenny E. ................................... Disclosed no confl ict of interest.Kanters, Jørgen ..................................... Disclosed no confl ict of interest.Kanzaki, Sayaka .................................... Disclosed no confl ict of interest.Kao, Anita L. ......................................... Disclosed no confl ict of interest.Kao, Chen-Wei ...................................... Disclosed no confl ict of interest.Kao, Shih Ling ....................................... Disclosed no confl ict of interest.Kapelios, Christos ................................. Disclosed no confl ict of interest.Kapeluto, Jordanna ............................... Disclosed no confl ict of interest.Kapitza, Christoph ................................. Advisory Panel: Sanofi U.S.; Research Support: ADOCIA,

AstraZeneca, Bioton SA, Boehringer Ingelheim GmbH, Dance Pharmaceuticals, Eli Lilly and Company, Gulf Pharmaceutical Industries, Johnson & Johnson, Marvel Lifesciences Ltd., MedImmune, LLC., Medtronic, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S., Senseonics, Inc., Zealand Pharma A/S; Speaker’s Bureau: Sanofi U.S.

Kaplan, Jennifer L. ............................... Disclosed no confl ict of interest.Kaplan, Lee M. ..................................... Advisory Panel: Fractyl, GI Dynamics, Inc., Janssen

Pharmaceuticals, Inc., MedImmune, LLC., Novo Nordisk A/S; Consultant: Fractyl, GI Dynamics, Inc., Janssen Pharmaceuticals, Inc., Novo Nordisk A/S.

Kaplan, Robert....................................... Disclosed no confl ict of interest.Kapoor, Ekta .......................................... Disclosed no confl ict of interest.Kappler, Lisa .......................................... Disclosed no confl ict of interest.Kapsokalyvas, Dimitris .......................... Disclosed no confl ict of interest.Kapur, Kavita ......................................... Employee: Steno Diabetes Center A/S.Karabay, Arzu Zeynep............................ Disclosed no confl ict of interest.Karaca, Anara........................................ Disclosed no confl ict of interest.Karachentsev, Iurii................................. Disclosed no confl ict of interest.Karadi, Istvan ........................................ Disclosed no confl ict of interest.Karahan, Tuna ....................................... Disclosed no confl ict of interest.Karakasilioti, Ismene............................. Disclosed no confl ict of interest.Karalliedde, Janaka .............................. Research Support: AstraZeneca; Speaker’s Bureau:

AstraZeneca, Boehringer Ingelheim, Janssen.Karanja, Kenneth................................... Disclosed no confl ict of interest.Karbage, Lia .......................................... Disclosed no confl ict of interest.Karbiener, Michael ................................ Disclosed no confl ict of interest.Karki, Shakun ........................................ Disclosed no confl ict of interest.Karkoszka, Henryk ................................. Disclosed no confl ict of interest.Karkula, Elizabeth.................................. Disclosed no confl ict of interest.Karlsson, Anders F. ............................... Disclosed no confl ict of interest.Karmacharya, Biraj M. ......................... Disclosed no confl ict of interest.Karmisholt, Jesper S. ........................... Disclosed no confl ict of interest.

A728


AU

THO

R D

ISCL

OSU

RE

Karnes, Lindsey ..................................... Disclosed no confl ict of interest.Karpinsky-Semper, Darla ....................... Disclosed no confl ict of interest.Karras, Spyridon .................................... Disclosed no confl ict of interest.Karsbøl, Julie Derving ........................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Karsdal, Morten A. ............................... Stock/Shareholder: Nordic Bioscience.Karunakaran, Coral................................ Disclosed no confl ict of interest.Karuppagounder, Vengadeshprabhu ..... Disclosed no confl ict of interest.Karvonen-Gutierrez, Carrie.................... Disclosed no confl ict of interest.Kashiwagi, Atsunori .............................. Board Member: Sunstar Dental Foundation; Consultant:

Astellas Pharma Inc.; Speaker’s Bureau: Astellas Pharma Inc.

Kashyap, Sangeeta R. .......................... Research Support: Ethicon Endo-Surgery, Inc.Kaspari, Rachael ................................... Disclosed no confl ict of interest.Kassa, Sentayehu.................................. Disclosed no confl ict of interest.Kassem, Mohamad ............................... Disclosed no confl ict of interest.Kasuga, Masato .................................... Disclosed no confl ict of interest.Kasumov, Takhar ................................... Disclosed no confl ict of interest.Kato, Asuka ........................................... Disclosed no confl ict of interest.Kato, Hideki ........................................... Disclosed no confl ict of interest.Kato, Jiro ............................................... Disclosed no confl ict of interest.Kato, Kiminori........................................ Disclosed no confl ict of interest.Kato, Koichi ........................................... Disclosed no confl ict of interest.Kato, Manabu........................................ Disclosed no confl ict of interest.Kato, Takehiro ....................................... Disclosed no confl ict of interest.Kato, Yoshiro ......................................... Disclosed no confl ict of interest.Katon, Jodie G. ..................................... Disclosed no confl ict of interest.Katopodi, Anastasia .............................. Disclosed no confl ict of interest.Katra, Barbara ....................................... Disclosed no confl ict of interest.Katsanos, Christos ................................ Disclosed no confl ict of interest.Katsilambros, Nicholas ......................... Disclosed no confl ict of interest.Katsogiannos, Petros ............................ Disclosed no confl ict of interest.Katsuki, Takeshi .................................... Disclosed no confl ict of interest.Katsumori, Kozo .................................... Disclosed no confl ict of interest.Katsuta, Hitoshi..................................... Disclosed no confl ict of interest.Kattan, Michael W. .............................. Research Support: Merck & Co., Inc., Novo Nordisk Inc.Katz, Arie ............................................... Employee: AstraZeneca Pharmaceuticals LP.Katz, Lois ............................................... Disclosed no confl ict of interest.Katz, Michelle L. ................................... Disclosed no confl ict of interest.Katz, Richard J. .................................... Disclosed no confl ict of interest.Katzman, Per ......................................... Disclosed no confl ict of interest.Kauffman, Audra L. .............................. Employee: Eli Lilly and Company.Kaufman, Elise ...................................... Research Support: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc.Kaufman, Francine R. ........................... Employee: Medtronic, Inc.Kaufman, Keith D. ................................ Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Kaufman, Steven ................................... Disclosed no confl ict of interest.Kauh, Anya ............................................ Employee: Merck & Co., Inc.Kaul, Kirti............................................... Disclosed no confl ict of interest.Kaul, Padma .......................................... Disclosed no confl ict of interest.Kaur, Amneet ......................................... Employee: Accenture; Other Relationship: Sanofi U.S., Inc.Kaur, Ishpreet ........................................ Disclosed no confl ict of interest.Kaur, Varinderpal ................................... Disclosed no confl ict of interest.Kauschke, Stefan G. ............................. Employee: Boehringer Ingelheim GmbH.Kavalkova, Petra.................................... Disclosed no confl ict of interest.Kavanaugh, Taylor E. ............................ Disclosed no confl ict of interest.Kawabe, Hiroshi .................................... Disclosed no confl ict of interest.Kawahara, Mamiko ............................... Disclosed no confl ict of interest.Kawai, Koichi ........................................ Disclosed no confl ict of interest.Kawai, Toshihide ................................... Research Support: Daiichi-Sankyo Co., Ltd.Kawakami, Yuko .................................... Disclosed no confl ict of interest.Kawamori, Dan...................................... Research Support: Astellas Pharma Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Shionogi Inc., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Takeda Pharmaceutical Company Limited.

Kawamori, Ryuzo................................... Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Merck & Co., Inc., Novartis Pharma K.K., Novo Nordisk Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Kawamoto, Ryuichi ............................... Disclosed no confl ict of interest.Kawamuki, Kosei................................... Employee: Astellas Pharma Inc.

Kawamura, Ryoichi ............................... Disclosed no confl ict of interest.Kawana, Hidetoshi ................................ Disclosed no confl ict of interest.Kawanabe, Haruka ................................ Employee: Ajinomoto Group.Kawanami, Daiji .................................... Disclosed no confl ict of interest.Kawanami, Takako ................................ Disclosed no confl ict of interest.Kawano, Seiko ...................................... Disclosed no confl ict of interest.Kawano, Yoshinaga............................... Disclosed no confl ict of interest.Kawasaki, Yukiko .................................. Disclosed no confl ict of interest.Kawase, Ryota ...................................... Disclosed no confl ict of interest.Kay, Linda .............................................. Disclosed no confl ict of interest.Kaya, Ecem ............................................ Disclosed no confl ict of interest.Kazda, Christof ...................................... Employee: Eli Lilly and Co. France; Stock/Shareholder: Eli Lilly

and Company.Kazierad, David J. ................................ Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc.Kazuta, Kenichi...................................... Employee: Astellas Pharma Inc.Ke, Weijian ............................................ Disclosed no confl ict of interest.Kearns, Caitlyn C. ................................. Disclosed no confl ict of interest.Kechris, Katerina ................................... Disclosed no confl ict of interest.Keckhafer, Abigail M. ........................... Disclosed no confl ict of interest.Kecskés, Ágnes ..................................... Employee: 77 Electronics Co., Ltd.Kedia, Rohit R. ...................................... Disclosed no confl ict of interest.Keenan, Hillary A. ................................ Disclosed no confl ict of interest.Keevil, Brian .......................................... Disclosed no confl ict of interest.Keil, Stefanie......................................... Employee: Sanofi -Aventis Deutschland GmbH.Keim, Kathryn S. ................................... Disclosed no confl ict of interest.Keim, Nancy L. ..................................... Disclosed no confl ict of interest.Keinänen-Kiukaanniemi, Sirkka ............ Disclosed no confl ict of interest.Keiran, Noelia ....................................... Disclosed no confl ict of interest.Keller, Amy C. ....................................... Disclosed no confl ict of interest.Kelley, Eric E. ........................................ Disclosed no confl ict of interest.Kellogg, Todd ......................................... Disclosed no confl ict of interest.Kelly, Andrea ......................................... Disclosed no confl ict of interest.Kelly, Clare B. ....................................... Disclosed no confl ict of interest.Kelly, Karen ........................................... Disclosed no confl ict of interest.Kelsey, Megan M. ................................ Disclosed no confl ict of interest.Kemmochi, Yusuke ................................ Disclosed no confl ict of interest.Kempa, Andrea...................................... Disclosed no confl ict of interest.Kempf, Kerstin....................................... Research Support: Boehringer Ingelheim GmbH.Kempker, Samantha .............................. Disclosed no confl ict of interest.Kendall, Cyril W. ................................... Disclosed no confl ict of interest.Kendall, Steven C. ................................ Consultant: PTS Diagnostics; Employee: eTrueNorth.Kennedy, Adele ..................................... Disclosed no confl ict of interest.Kennedy, Chris....................................... Disclosed no confl ict of interest.Kennedy, Lynn ....................................... Disclosed no confl ict of interest.Kent, David ............................................ Disclosed no confl ict of interest.Keogh, Jennifer ..................................... Disclosed no confl ict of interest.Kepaptsoglou, Olga ............................... Disclosed no confl ict of interest.Kerezoudis, Panagiotis .......................... Disclosed no confl ict of interest.Kergoat, Micheline................................ Other Relationship: Metabrain Research.Kern, Philip A. ....................................... Research Support: KinDex Pharmaceuticals.Kernan, Walter N. ................................ Research Support: Takeda Pharmaceutical Company Limited.Kerr, David ............................................. Disclosed no confl ict of interest.Kerr, Peter G. ........................................ Disclosed no confl ict of interest.Kerr-Conte, Julie A. .............................. Disclosed no confl ict of interest.Kerry, Chris ............................................ Disclosed no confl ict of interest.Kershaw, Erin ........................................ Disclosed no confl ict of interest.Kesavadev, Jothydev............................. Disclosed no confl ict of interest.Keshavan, Matcheri .............................. Disclosed no confl ict of interest.Keshawarz, Amena ............................... Disclosed no confl ict of interest.Keske, Michelle A. ............................... Disclosed no confl ict of interest.Kessinger, Haley .................................... Disclosed no confl ict of interest.Kessler, Laurence .................................. Research Support: Boehringer Ingelheim GmbH.Kessler, Romain ..................................... Disclosed no confl ict of interest.Ketchum, Kaitlin .................................... Disclosed no confl ict of interest.Kethireddy, Pooja .................................. Disclosed no confl ict of interest.Kevorkian, Jean-Philippe ...................... Disclosed no confl ict of interest.Keyes, Feenagh ..................................... Disclosed no confl ict of interest.Keymeulen, Bart .................................... Disclosed no confl ict of interest.Kgosidialwa, Oratile.............................. Disclosed no confl ict of interest.Khaja, Shamim ...................................... Disclosed no confl ict of interest.Khamaisi, Mogher ................................. Disclosed no confl ict of interest.Khan, Adnan .......................................... Disclosed no confl ict of interest.Khan, Farah ........................................... Disclosed no confl ict of interest.Khan, Nasir............................................ Disclosed no confl ict of interest.Khan, Salmaan A. ................................. Disclosed no confl ict of interest.Khan, Shara ........................................... Disclosed no confl ict of interest.Khan, Zoya............................................. Disclosed no confl ict of interest.Khandelwal, Abha ................................. Disclosed no confl ict of interest.Khandelwal, N. ..................................... Disclosed no confl ict of interest.Kharlampieva, Eugenia ......................... Disclosed no confl ict of interest.Khazrai, Yeganeh Manon ...................... Disclosed no confl ict of interest.Khemais-Benkhiat, Sonia ...................... Disclosed no confl ict of interest.Khokhar, Aditi ........................................ Disclosed no confl ict of interest.Khoo, Chin Meng................................... Disclosed no confl ict of interest.Khoo, Eric .............................................. Disclosed no confl ict of interest.Khowaja, Ameer A. .............................. Disclosed no confl ict of interest.

A729


AU

THO

R D

ISCL

OSU

RE

Khudsen, Janine.................................... Disclosed no confl ict of interest.Khunti, Kamlesh .................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim GmbH,

Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Consultant: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH.

Kibbey, Richard G. ................................ Disclosed no confl ict of interest.Kidron, Miriam ...................................... Board Member: Oramed Pharmaceuticals; Employee:

Oramed Pharmaceuticals; Stock/Shareholder: Oramed Pharmaceuticals.

Kiebish, Michael ................................... Disclosed no confl ict of interest.Kiens, Bente .......................................... Disclosed no confl ict of interest.Kievit, Paul ............................................ Research Support: Sanofi -Aventis Deutschland GmbH.Kikhtenko, N.A. .................................... Disclosed no confl ict of interest.Kikuchi, Tetsuhiro .................................. Disclosed no confl ict of interest.Kikuta, Junichi....................................... Disclosed no confl ict of interest.Kiljanski, Jacek ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Kilkus, Jennifer ..................................... Disclosed no confl ict of interest.Kilpatrick, Eric S. .................................. Disclosed no confl ict of interest.Kilvert, Jennifer Anne ........................... Disclosed no confl ict of interest.Kim Pak, Youngmi.................................. Disclosed no confl ict of interest.Kim, Bo Hyun ......................................... Disclosed no confl ict of interest.Kim, Byung Joon ................................... Disclosed no confl ict of interest.Kim, Byung-Gyu ..................................... Disclosed no confl ict of interest.Kim, Catherine....................................... Disclosed no confl ict of interest.Kim, Chul Hoon...................................... Disclosed no confl ict of interest.Kim, Dae Jin .......................................... Disclosed no confl ict of interest.Kim, Dae Jung ....................................... Disclosed no confl ict of interest.Kim, Daniel ............................................ Disclosed no confl ict of interest.Kim, Dohoon .......................................... Employee: Yuhan Co.Kim, Dongjoon ....................................... Research Support: Zealand Pharma A/S.Kim, Eun Heui ........................................ Disclosed no confl ict of interest.Kim, Eun Jung ....................................... Disclosed no confl ict of interest.Kim, Eun Ky ........................................... Disclosed no confl ict of interest.Kim, Eun Sook ....................................... Disclosed no confl ict of interest.Kim, Eunae ............................................ Disclosed no confl ict of interest.Kim, Grace ............................................. Disclosed no confl ict of interest.Kim, Gyuri .............................................. Disclosed no confl ict of interest.Kim, Hae Jin .......................................... Disclosed no confl ict of interest.Kim, Hee Young ..................................... Disclosed no confl ict of interest.Kim, Hoe Suk ......................................... Disclosed no confl ict of interest.Kim, Hong-Kyu....................................... Disclosed no confl ict of interest.Kim, Hun-Sung ...................................... Disclosed no confl ict of interest.Kim, Hyun Jin ........................................ Disclosed no confl ict of interest.Kim, In Joo ............................................ Disclosed no confl ict of interest.Kim, Jae Bum ........................................ Disclosed no confl ict of interest.Kim, Jae Hyeon ..................................... Disclosed no confl ict of interest.Kim, Jae Taek ........................................ Disclosed no confl ict of interest.Kim, Jason K. ....................................... Disclosed no confl ict of interest.Kim, Jennifer ......................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Kim, Jeong-A......................................... Disclosed no confl ict of interest.Kim, Ji Hyun .......................................... Disclosed no confl ict of interest.Kim, Ji Min ............................................ Disclosed no confl ict of interest.Kim, Jin Hee .......................................... Disclosed no confl ict of interest.Kim, Jin Young ...................................... Disclosed no confl ict of interest.Kim, Jong G. ......................................... Employee: Yuhan Co.Kim, Jong Ho ......................................... Disclosed no confl ict of interest.Kim, Jong Hun ....................................... Disclosed no confl ict of interest.Kim, Jong-II ........................................... Disclosed no confl ict of interest.Kim, Joon Young ................................... Disclosed no confl ict of interest.Kim, Jun H. ........................................... Employee: Yuhan Co.Kim, Jung Hee ....................................... Disclosed no confl ict of interest.Kim, Jung Kuk ....................................... Disclosed no confl ict of interest.Kim, Junghyun....................................... Disclosed no confl ict of interest.Kim, Keith .............................................. Disclosed no confl ict of interest.Kim, Kwang Joon .................................. Disclosed no confl ict of interest.Kim, Kwang-Won .................................. Disclosed no confl ict of interest.Kim, Kyeong Jin .................................... Disclosed no confl ict of interest.Kim, Kyoung Min ................................... Disclosed no confl ict of interest.Kim, Kyung Rae ..................................... Disclosed no confl ict of interest.Kim, Kyunga .......................................... Disclosed no confl ict of interest.Kim, Kyung-Soo ..................................... Disclosed no confl ict of interest.

Kim, Lee Kyung...................................... Disclosed no confl ict of interest.Kim, Mi-Kyung....................................... Employee: Dong-A ST.Kim, Min Jin .......................................... Disclosed no confl ict of interest.Kim, Min-Kyung..................................... Disclosed no confl ict of interest.Kim, Misung .......................................... Disclosed no confl ict of interest.Kim, Nahyun .......................................... Disclosed no confl ict of interest.Kim, Nam Ho ......................................... Disclosed no confl ict of interest.Kim, Nam Hoon ..................................... Disclosed no confl ict of interest.Kim, Nan Hee ........................................ Disclosed no confl ict of interest.Kim, Paul J. .......................................... Disclosed no confl ict of interest.Kim, Sang Soo ....................................... Disclosed no confl ict of interest.Kim, Sang Yong ..................................... Disclosed no confl ict of interest.Kim, Seoyoung C. ................................. Research Support: Eli Lilly and Company.Kim, Seung ............................................ Disclosed no confl ict of interest.Kim, Sin Gon.......................................... Disclosed no confl ict of interest.Kim, So Ra ............................................. Disclosed no confl ict of interest.Kim, Soo-Kyung ..................................... Disclosed no confl ict of interest.Kim, Stella P. ........................................ Disclosed no confl ict of interest.Kim, Su Yeon ......................................... Disclosed no confl ict of interest.Kim, Sun Hwa........................................ Disclosed no confl ict of interest.Kim, Sung Gyun ..................................... Disclosed no confl ict of interest.Kim, Sung Ho......................................... Disclosed no confl ict of interest.Kim, Sung Hoon..................................... Disclosed no confl ict of interest.Kim, Sung Woon ................................... Disclosed no confl ict of interest.Kim, Sungsu .......................................... Disclosed no confl ict of interest.Kim, Tae Ho ........................................... Disclosed no confl ict of interest.Kim, Tae Hyoung ................................... Employee: Dong-A ST.Kim, Tae Hyun ....................................... Disclosed no confl ict of interest.Kim, Tae Kyoon ...................................... Disclosed no confl ict of interest.Kim, Tae Nyun ....................................... Disclosed no confl ict of interest.Kim, Taekyoon ....................................... Disclosed no confl ict of interest.Kim, Teayoun ......................................... Disclosed no confl ict of interest.Kim, Woo Joong .................................... Disclosed no confl ict of interest.Kim, Yeong Seok ................................... Disclosed no confl ict of interest.Kim, Yong Ki .......................................... Disclosed no confl ict of interest.Kim, Yoona ............................................ Employee: Proteus Digital Health.Kim, You Jeong ..................................... Disclosed no confl ict of interest.Kim, Young Bum .................................... Disclosed no confl ict of interest.Kim, Young Hoon ................................... Disclosed no confl ict of interest.Kim, Young Seol .................................... Disclosed no confl ict of interest.Kim, Yu Jin ............................................ Disclosed no confl ict of interest.Kimata, Hiroe ........................................ Disclosed no confl ict of interest.Kimball, Andrew.................................... Disclosed no confl ict of interest.Kimball, Edward .................................... Employee: Novo Nordisk Inc.Kimbrell, Matthew R. ........................... Disclosed no confl ict of interest.Kimes, Teresa ........................................ Disclosed no confl ict of interest.Kimmel, Paul L. ..................................... Disclosed no confl ict of interest.Kimura, Hiroyuki .................................... Disclosed no confl ict of interest.Kimura, Moritsugu ................................ Disclosed no confl ict of interest.Kimura, Tomohiko .................................. Disclosed no confl ict of interest.Kimura, Yuki .......................................... Disclosed no confl ict of interest.Kinderman, Amanda.............................. Disclosed no confl ict of interest.Kineman, Rhonda D. ............................. Disclosed no confl ict of interest.King, George L. ..................................... Disclosed no confl ict of interest.King, Katherine S. ................................ Disclosed no confl ict of interest.King, Kourtney ....................................... Disclosed no confl ict of interest.King, Ryan ............................................. Disclosed no confl ict of interest.King, Sarah B. ....................................... Research Support: AstraZeneca, Bristol-Myers Squibb

Company, Eli Lilly and Company, Novartis AG.Kinney, Gregory L. ................................ Disclosed no confl ict of interest.Kinoshita, Tomoe ................................... Disclosed no confl ict of interest.Kinz, Elena ............................................. Disclosed no confl ict of interest.Kinzel, Laura S. ..................................... Disclosed no confl ict of interest.Kipnes, Mark ......................................... Disclosed no confl ict of interest.Kira, Yuri ................................................ Disclosed no confl ict of interest.Kirby, Jennifer L. .................................. Disclosed no confl ict of interest.Kircher, Robert ....................................... Employee: Dose Safety Inc.; Stock/Shareholder: Dose Safety

Inc.Kirchhoff, Brenda A. ............................. Disclosed no confl ict of interest.Kirchner, Thomas ................................... Employee: Janssen Pharmaceuticals, Inc.Kirk, Jessica B. ..................................... Disclosed no confl ict of interest.Kirkland, Cynthia L. .............................. Disclosed no confl ict of interest.Kirkman, M. Sue.................................... Research Support: Novo Nordisk Inc.Kirson, Noam Y. .................................... Research Support: AstraZeneca, Bristol-Myers Squibb

Company, Eli Lilly and Company, GlaxoSmithKline.Kirtland, Karen ...................................... Disclosed no confl ict of interest.Kirwan, Breda........................................ Disclosed no confl ict of interest.Kirwan, Brida......................................... Disclosed no confl ict of interest.Kirwan, John P. ..................................... Disclosed no confl ict of interest.Kîs, Sanja Giljanovic ............................. Employee: Eli Lilly and Company.Kishihara, Eriko ..................................... Disclosed no confl ict of interest.Kishimoto, Hiroshi ................................. Disclosed no confl ict of interest.Kishimoto, Ichiro ................................... Disclosed no confl ict of interest.Kishnani, Saniya.................................... Disclosed no confl ict of interest.Kislinger, Thomas .................................. Disclosed no confl ict of interest.Kislukhin, Alexander ............................. Employee: AmideBio.

A730


AU

THO

R D

ISCL

OSU

RE

Kissler, Stephan .................................... Disclosed no confl ict of interest.Kistner, Iris ............................................ Disclosed no confl ict of interest.Kitabchi, Abbas ..................................... Disclosed no confl ict of interest.Kitada, Yoshihiko................................... Disclosed no confl ict of interest.Kitagawa, Noriyuki................................ Disclosed no confl ict of interest.Kitahara, Atsuko.................................... Disclosed no confl ict of interest.Kitahara, Yoshiro ................................... Employee: Ajinomoto Group.Kitajima, Seiji ........................................ Employee: Ajinomoto Group.Kitamura, Tadahiro ................................ Disclosed no confl ict of interest.Kitazono, Takanari ................................. Disclosed no confl ict of interest.Kitio-Dschassi, Brice ............................. Employee: Sanofi .Kittelsrud, Julie M. .............................. Disclosed no confl ict of interest.Kivimäki, Mika....................................... Research Support: British Heart Foundation, Medical Research

Council, U.S. National Institutes of Health.Kiyohara, Yutaka ................................... Disclosed no confl ict of interest.Kjær, Troels ........................................... Disclosed no confl ict of interest.Kjellson, Maria ...................................... Consultant: Merck & Co., Inc.Kjems, Lise ............................................ Employee: Intarcia Therapeutics, Inc.Klabunde, Thomas................................. Employee: Sanofi .Klee, Philippe ........................................ Disclosed no confl ict of interest.Klein, Barbara E. ................................... Disclosed no confl ict of interest.Klein, David ........................................... Disclosed no confl ict of interest.Klein, Eric J. ......................................... Research Support: Asahi Kasei Corporation, AstraZeneca,

Catabasis Pharmaceuticals, Inc., Kissei Pharmaceutical Co., Ltd., Novo Nordisk Inc; Speaker’s Bureau: AstraZeneca, Janssen Pharmaceuticals, Inc.

Klein, Kerenaftali .................................. Disclosed no confl ict of interest.Klein, Oliver ........................................... Employee: Profi l Institut für Stoffwechselforschung GmbH.Klein, Richard ........................................ Disclosed no confl ict of interest.Klein, Thomas........................................ Employee: Boehringer Ingelheim GmbH.Kleiner, Amanda .................................... Disclosed no confl ict of interest.Kleinridders, Andre ............................... Disclosed no confl ict of interest.Klen, Jasna............................................ Disclosed no confl ict of interest.Klimentidis, Yann C. ............................. Disclosed no confl ict of interest.Klimontov, Vadim V. .............................. Disclosed no confl ict of interest.Kline, Susan .......................................... Disclosed no confl ict of interest.Klinepeter Bartz, Sara ........................... Disclosed no confl ict of interest.Klingensmith, Georgeanna J. ............... Disclosed no confl ict of interest.Klingler, Christian .................................. Disclosed no confl ict of interest.Klink, Andrew J. ................................... Employee: HealthCore.Klinkenberg, W. Dean ........................... Disclosed no confl ict of interest.Klonowska, Bozena ............................... Disclosed no confl ict of interest.Klouckova, Jana .................................... Disclosed no confl ict of interest.Klupa, Tomasz ....................................... Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly and

Company, Medtronic MiniMed, Inc., Roche Diagnostics; Employee: Bayer HealthCare (Spouse/Partner); Research Support: Bioton SA.

Knapp, Emily A. .................................... Disclosed no confl ict of interest.Knaub, Leslie A. ................................... Disclosed no confl ict of interest.Knebel, Birgit......................................... Disclosed no confl ict of interest.Knight, Elysse ........................................ Disclosed no confl ict of interest.Knop, Filip K. ........................................ Advisory Panel: AstraZeneca, Eli Lilly and Company, Novo

Nordisk A/S, Sanofi -Aventis Deutschland GmbH, Zealand Pharma A/S; Consultant: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Fractyl, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Zealand Pharma A/S; Research Support: Gubra, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH, Zealand Pharma A/S; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Gilead Sciences, Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH, Zealand Pharma A/S.

Knorr, Sine ............................................. Disclosed no confl ict of interest.Knowler, William C. ............................. Disclosed no confl ict of interest.Knox, Ryan P. ........................................ Disclosed no confl ict of interest.Knudsen, Carsten B. ............................. Employee: Zealand Pharma A/S.Knudsen, Jonas R. ................................ Disclosed no confl ict of interest.Knudsen, Sanne M. .............................. Disclosed no confl ict of interest.Knudsen, Sanne Møller......................... Employee: Gubra ApS.Knutsen, Chad ....................................... Employee: Pacifi c Diabetes Technologies, Inc.; Stock/

Shareholder: Pacifi c Diabetes Technologies, Inc.Knuuti, Juhani ....................................... Disclosed no confl ict of interest.Ko, Eunhyoung....................................... Disclosed no confl ict of interest.Ko, Gary T. ............................................ Disclosed no confl ict of interest.Ko, Kyung Soo ....................................... Disclosed no confl ict of interest.Ko, Seung-Hyun..................................... Disclosed no confl ict of interest.Kobayashi, Kiyoe ................................... Disclosed no confl ict of interest.Kobayashi, Takuya ................................. Research Support: Fujirebio.Inc., Sanwa Kagaku Kenkyusho

Co., Ltd.Kobayashi, Yuka .................................... Disclosed no confl ict of interest.Kobe, Sayuko......................................... Disclosed no confl ict of interest.Kober, Frank ........................................... Disclosed no confl ict of interest.Køber, Lars V. ........................................ Other Relationship: Novartis Pharmaceuticals Corporation,

Sanofi U.S., Servier.

Kobes, Sauko......................................... Disclosed no confl ict of interest.Kobes, Sayuko ....................................... Disclosed no confl ict of interest.Kocarnik, Beverly................................... Disclosed no confl ict of interest.Koch, Tina .............................................. Disclosed no confl ict of interest.Kocherlakota, Chaithanya Murthy ........ Disclosed no confl ict of interest.Koci, Zuzana .......................................... Disclosed no confl ict of interest.Kocna, Petr ............................................ Disclosed no confl ict of interest.Kodama, Keiichi .................................... Disclosed no confl ict of interest.Kodama, Satoru..................................... Disclosed no confl ict of interest.Kodama, Tatsuhiko ................................ Disclosed no confl ict of interest.Kodani, Noriko....................................... Disclosed no confl ict of interest.Koebnick, Corinna ................................. Disclosed no confl ict of interest.Koechlin, Alice ...................................... Disclosed no confl ict of interest.Koehorst, Martijn .................................. Disclosed no confl ict of interest.Koenigsrainer, Alfred ............................ Disclosed no confl ict of interest.Koezuka, Ryo ......................................... Disclosed no confl ict of interest.Kohara, Katsuhiko ................................. Disclosed no confl ict of interest.Kohara, Kenji ......................................... Disclosed no confl ict of interest.Kohashi, Kyoko ...................................... Disclosed no confl ict of interest.Kohrt, Wendy M. .................................. Disclosed no confl ict of interest.Koike, Hideo .......................................... Disclosed no confl ict of interest.Kojima, Takao ........................................ Disclosed no confl ict of interest.Koju, Rajendra P. .................................. Disclosed no confl ict of interest.Kojzar, Harald ........................................ Disclosed no confl ict of interest.Kokic, Slaven ......................................... Disclosed no confl ict of interest.Kokic, Visnja .......................................... Disclosed no confl ict of interest.Kokkinos, Alexander.............................. Disclosed no confl ict of interest.Kokkinos, Peter...................................... Disclosed no confl ict of interest.Kokoszka-Paszkot, Janina ..................... Disclosed no confl ict of interest.Kolesar, Libor ......................................... Disclosed no confl ict of interest.Koliaki, Chrysi........................................ Disclosed no confl ict of interest.Kolka, Cathryn ....................................... Disclosed no confl ict of interest.Kollman, Craig ....................................... Disclosed no confl ict of interest.Kolossváry, Márton ............................... Disclosed no confl ict of interest.Kolotkin, Ronnette................................. Advisory Panel: Janssen Pharmaceuticals, Inc., Novo Nordisk

Inc; Consultant: Eisai Co., Ltd., Novo Nordisk Inc., Orexigen Therapeutics, Inc.; Other Relationship: Duke University, Novo Nordisk Inc., Orexigen Therapeutics, Inc., Travel Support.

Kolterman, Orville ................................. Advisory Panel: NuSirt Biopharma; Consultant: NuSirt Biopharma.

Komba, Mitsuhiro.................................. Disclosed no confl ict of interest.Komiya, Chikara .................................... Disclosed no confl ict of interest.Komiya, Koji .......................................... Disclosed no confl ict of interest.Komuro, Manaho................................... Disclosed no confl ict of interest.Kondek, Dieter....................................... Board Member: InsulinNG; Employee: InsulinNG; Stock/

Shareholder: InsulinNG.Kondo, Manabu ..................................... Disclosed no confl ict of interest.Kondo, Masaki ...................................... Disclosed no confl ict of interest.Kondo, Seiya ......................................... Disclosed no confl ict of interest.Kondo, Takuma ...................................... Disclosed no confl ict of interest.Kondo, Yoshinobu.................................. Disclosed no confl ict of interest.Kong, Alice ............................................ Disclosed no confl ict of interest.Kong, Alvin ............................................ Disclosed no confl ict of interest.Kong, Lili................................................ Disclosed no confl ict of interest.Kong, Shengchun .................................. Disclosed no confl ict of interest.Königsrainer, Alfred .............................. Disclosed no confl ict of interest.Konishi, Masahiro ................................. Disclosed no confl ict of interest.Konkar, Anish ........................................ Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Kono, Saki ............................................. Disclosed no confl ict of interest.Konopka, Adam R. ................................ Disclosed no confl ict of interest.Koo, Bo Kyong ....................................... Disclosed no confl ict of interest.Kooner, Jaspal S. ................................. Disclosed no confl ict of interest.Kooptiwut, Suwattanee ........................ Disclosed no confl ict of interest.Kopecky, Jan ......................................... Disclosed no confl ict of interest.Koppensteiner, Renate .......................... Disclosed no confl ict of interest.Korach, Kenneth S. ............................... Disclosed no confl ict of interest.Korantzis, Asteris .................................. Disclosed no confl ict of interest.Kordium, Vitalii ...................................... Disclosed no confl ict of interest.Kordonouri, Olga ................................... Research Support: Sanofi ; Stock/Shareholder: DreaMed

Diabetes Ltd.Korman, Jeremy E. ............................... Disclosed no confl ict of interest.Korn, Marcus ......................................... Employee: Sanofi -Aventis Deutschland GmbH.Kornelius, Edy........................................ Disclosed no confl ict of interest.Korobelnik, Jean-François..................... Disclosed no confl ict of interest.Korolenko, Tatiana A. ........................... Disclosed no confl ict of interest.Korrer, Stephanie A. ............................. Disclosed no confl ict of interest.Korytkowski, Mary T. ............................ Disclosed no confl ict of interest.Kosak, Mikulas ...................................... Disclosed no confl ict of interest.Kosakai, Yoshinori ................................. Employee: Astellas Pharma Inc.Koseki, Masahiro .................................. Disclosed no confl ict of interest.Koshy, Ninan ......................................... Disclosed no confl ict of interest.Kosiborod, Mikhail ................................ Advisory Panel: Amgen Inc., AstraZeneca, Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Glytec, Inc., Sanofi -Aventis Deutschland GmbH, Takeda

A731


AU

THO

R D

ISCL

OSU

RE

Pharmaceutical Company Limited; Consultant: Amgen Inc., AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, ZS Pharma; Research Support: Amgen Inc., AstraZeneca Pharmaceuticals LP, Genentech, Inc., Gilead Sciences, Inc., Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: Amgen Inc.

Kosinski, Mary....................................... Employee: NuSirt Biopharma; Stock/Shareholder: NuSirt Biopharma.

Koss, Dave............................................. Disclosed no confl ict of interest.Kostaki, Stavroula ................................. Disclosed no confl ict of interest.Kostic, Aleksandar ................................ Disclosed no confl ict of interest.Koteneva, Yelena N. ............................. Disclosed no confl ict of interest.Kothare, Prajakti.................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Kothari, Vishal ....................................... Disclosed no confl ict of interest.Kotsa, Kalliopi ....................................... Advisory Panel: Merck Sharp & Dohme Corp., Sanofi K.K.;

Research Support: Novo Nordisk Inc.Kotzka, Jörg........................................... Disclosed no confl ict of interest.Koulajian, Khajag .................................. Disclosed no confl ict of interest.Kouru, Heikki ......................................... Employee: PerkinElmer Inc.Koutsovasilis, Anastasios ..................... Disclosed no confl ict of interest.Kouvelos, George .................................. Disclosed no confl ict of interest.Kovalik, Jean Paul ................................. Disclosed no confl ict of interest.Kovarnik, Tomas .................................... Disclosed no confl ict of interest.Kovatchev, Boris P. ............................... Advisory Panel: AstraZeneca, Becton, Dickinson and

Company, Sanofi U.S.; Research Support: Animas Inc., Becton, Dickinson and Company, Dexcom, Inc., Insulet Corporation, Roche Diagnostics, Sanofi U.S., Tandem Diabetes Care, Inc.; Stock/Shareholder: Inspark Technologies, Inc., TypeZero Technologies.

Koves, Timothy R. ................................. Disclosed no confl ict of interest.Kovil, Rajiv............................................. Disclosed no confl ict of interest.Kovzun, Olena........................................ Disclosed no confl ict of interest.Kowalski, Joseph .................................. Employee: Pacifi c Diabetes Technologies, Inc.; Stock/

Shareholder: Pacifi c Diabetes Technologies, Inc.Kowitt, Sarah ........................................ Disclosed no confl ict of interest.Koya, Daisuke........................................ Research Support: Astellas Pharma Inc., AstraZeneca, Bell

Medical Solutions, Boehringer Ingelheim, Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Japan Tabaco, Morinaga, Merck Sharp & Dohme Corp., Novartis, Sanofi , Sanwa Kagaku Kenkyusho Co., Ltd., Takeda, Tanabe-Mitsubishi; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Merck Sharp & Dohme Corp., Novartis, Sanofi , Tanabe-Mitsubishi.

Kozek, Elzbieta ...................................... Disclosed no confl ict of interest.Kozlovskaya, Veronika ........................... Disclosed no confl ict of interest.Kozlovski, Plamen.................................. Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG.Kraemer, Frederic .................................. Disclosed no confl ict of interest.Kraft, Guillaume .................................... Disclosed no confl ict of interest.Kraft, Peter ............................................ Disclosed no confl ict of interest.Krakoff, Jonathan.................................. Disclosed no confl ict of interest.Krall, Jodi .............................................. Disclosed no confl ict of interest.Kramer, Caroline K. .............................. Disclosed no confl ict of interest.Kramer, Christopher .............................. Disclosed no confl ict of interest.Kramer, Farah ........................................ Disclosed no confl ict of interest.Kramer, Mark H. ................................... Research Support: AstraZeneca, Boehringer Ingelheim GmbH,

Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH.Kraniou, Dionisis ................................... Disclosed no confl ict of interest.Krantz, James........................................ Disclosed no confl ict of interest.Krarup, Thure......................................... Advisory Panel: Sanofi -Aventis Deutschland GmbH.Krarup, Troels ........................................ Disclosed no confl ict of interest.Kratka, Zuzana....................................... Disclosed no confl ict of interest.Kraus, Amy ............................................ Disclosed no confl ict of interest.Kraus, Thomas....................................... Disclosed no confl ict of interest.Kraus, William E. .................................. Disclosed no confl ict of interest.Kravchun, Nonna ................................... Disclosed no confl ict of interest.Kravos, Nika .......................................... Disclosed no confl ict of interest.Krawczyk, Sarah .................................... Employee: Siemens Healthcare.Kremser, Sonja ...................................... Disclosed no confl ict of interest.Krentz, Andrew...................................... Disclosed no confl ict of interest.Krevenaite, Edita ................................... Disclosed no confl ict of interest.Kriebel, Jennifer.................................... Disclosed no confl ict of interest.Kripalani, Sunil ...................................... Stock/Shareholder: Bioscape Digital LLC.Krischer, Jeffrey P. ................................ Research Support: National Institutes of Health.Krishnamurthy, Rajesh .......................... Disclosed no confl ict of interest.Krishnamurthy, Ramkumar .................... Disclosed no confl ict of interest.Krishnan, Gopika ................................... Disclosed no confl ict of interest.Krishnan, Rahul ..................................... Disclosed no confl ict of interest.Kriska, Andrea M. ................................ Disclosed no confl ict of interest.Kristchevsky, Steve ............................... Disclosed no confl ict of interest.Kristensen, Jonas Møller ...................... Disclosed no confl ict of interest.Kristiansen, Viggo B. ............................ Disclosed no confl ict of interest.Krivova, Yuliya S. .................................. Disclosed no confl ict of interest.Kriz, Jan................................................. Disclosed no confl ict of interest.

Krizova, Jarmila..................................... Disclosed no confl ict of interest.Krnic, Mladen ........................................ Disclosed no confl ict of interest.Krogh, Sara S. ...................................... Disclosed no confl ict of interest.Krogvold, Lars........................................ Disclosed no confl ict of interest.Krolewski, Andrzej S. ........................... Disclosed no confl ict of interest.Kropff, Jort ............................................ Speaker’s Bureau: Senseonics, Inc.Krug, Alexander W. .............................. Employee: Merck & Co., Inc.Kruger, Davida F. ................................... Advisory Panel: Abbott Diabetes Care Inc.; Research Support:

Abbott Diabetes Care Inc.Krumholz, Harlan M. ............................ Research Support: Blue Cross Blue Shield, Food and Drug

Administration, Johnson & Johnson, Medtronic, Inc.Krupicka, Jan......................................... Disclosed no confl ict of interest.Kruse, Rikke........................................... Disclosed no confl ict of interest.Krustrup, Peter ...................................... Disclosed no confl ict of interest.Kshanti, Ida A. ...................................... Advisory Panel: Eli Lilly and Company, Novartis AG, Novo

Nordisk A/S, Sanofi -Aventis; Speaker’s Bureau: Becton, Dickinson and Company, Eli Lilly and Company, Novartis AG, Novo Nordisk A/S, Sanofi -Aventis, Servier.

Ku, Bon Jeong ....................................... Disclosed no confl ict of interest.Kuang, Lei.............................................. Disclosed no confl ict of interest.Kubik, Magdalena ................................. Disclosed no confl ict of interest.Kubinova, Sarka .................................... Disclosed no confl ict of interest.Kubisiak, Kristine .................................. Disclosed no confl ict of interest.Kubo, Kuniko ......................................... Disclosed no confl ict of interest.Kubo, Michiaki ...................................... Disclosed no confl ict of interest.Kubota, Eiji ............................................ Disclosed no confl ict of interest.Kubota, Naoto ....................................... Disclosed no confl ict of interest.Kubrak, Christina ................................... Disclosed no confl ict of interest.Küchler, Sebastian ................................ Disclosed no confl ict of interest.Kuda, Ondrej.......................................... Disclosed no confl ict of interest.Kudlicka, Jaroslav ................................. Disclosed no confl ict of interest.Kudva, Yogish ........................................ Disclosed no confl ict of interest.Kuhadiya, Nitesh D. ............................. Speaker’s Bureau: AstraZeneca.Kuhre, Rune E. ...................................... Disclosed no confl ict of interest.Kulasingam, Vathany ............................ Disclosed no confl ict of interest.Kulikowski, Ewelina .............................. Employee: Resverlogix Corp.; Stock/Shareholder: Resverlogix

Corp.Kulina, Georgia...................................... Disclosed no confl ict of interest.Kulkarni, Rohit N. ................................. Disclosed no confl ict of interest.Kullberg, Joel ........................................ Disclosed no confl ict of interest.Kullmann, Stephanie ............................. Disclosed no confl ict of interest.Kullo, Iftikhar J. .................................... Disclosed no confl ict of interest.Kulzer, Bernhard .................................... Advisory Panel: Abbott Diabetes Care Inc., Berlin-Chemie,

Novo Nordisk A/S, Roche Diagnostics; Research Support: Abbott Diabetes Care Inc., Berlin-Chemie, Roche Diagnostics, Ypsomed; Speaker’s Bureau: Abbott Diabetes Care Inc., Berlin-Chemie, Novo Nordisk A/S, Roche Diagnostics.

Kumagi, Teru ......................................... Disclosed no confl ict of interest.Kumah-Crystal, Yaa ............................... Disclosed no confl ict of interest.Kumar, Anil ............................................ Disclosed no confl ict of interest.Kumar, Anjali ......................................... Disclosed no confl ict of interest.Kumar, Harish ........................................ Advisory Panel: AstraZeneca; Speaker’s Bureau: Eli Lilly and

Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S.

Kumar, Pankaj ........................................ Disclosed no confl ict of interest.Kumar, Ravi ........................................... Disclosed no confl ict of interest.Kumar, Sudeep ...................................... Disclosed no confl ict of interest.Kumar, Sunil .......................................... Disclosed no confl ict of interest.Kumar, Vinay ......................................... Disclosed no confl ict of interest.Kumareswaran, Kavita .......................... Advisory Panel: Medtronic, Inc.; Speaker’s Bureau:

AstraZeneca Pharmaceuticals LP, Lilly Deutschland GmbH, Medtronic, Inc., Sanofi U.S.

Kumari, Manju....................................... Disclosed no confl ict of interest.Kumashiro, Naoki .................................. Research Support: Eli Lilly Japan K.K.Kundu, Nabanita ................................... Disclosed no confl ict of interest.Kunduru, Deepthi .................................. Disclosed no confl ict of interest.Kunii, Ilda S. ......................................... Disclosed no confl ict of interest.Kunka Mohanram, Ramkumar............... Disclosed no confl ict of interest.Kunkel, Steven ...................................... Disclosed no confl ict of interest.Kunos, George ....................................... Disclosed no confl ict of interest.Kuo, Chien-Hung ................................... Disclosed no confl ict of interest.Kuo, Gee-Hong ...................................... Employee: Janssen Pharmaceuticals, Inc.Kuo, Shihchen ....................................... Disclosed no confl ict of interest.Kupelian, Varant .................................... Disclosed no confl ict of interest.Kupfer, Stuart ........................................ Employee: Takeda Development Center Americas, Inc.Kurihara, Yoshio .................................... Disclosed no confl ict of interest.Kurisaki, Hironori................................... Disclosed no confl ict of interest.Kuriyama, Chiaki ................................... Employee: Mitsubishi Tanabe Pharma Corporation.Kurland, Irwin J. ................................... Disclosed no confl ict of interest.Kurlyandskaya, Raisa ............................ Employee: AstraZeneca.Kuroda, Akio .......................................... Speaker’s Bureau: Eli Lilly Japan K.K., Sanofi .Kuroda, Hisamoto.................................. Disclosed no confl ict of interest.Kuroha, Mutsumi................................... Disclosed no confl ict of interest.Kurose, Takeshi ..................................... Research Support: Eli Lilly Japan K.K., Merck Sharp & Dohme

Corp., Nippon Boehringer Ingelheim Co., Ltd., Novo

A732


AU

THO

R D

ISCL

OSU

RE

Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Takeda Pharmaceutical Company Limited, Teijin Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Daiichi-Sankyo Co., Ltd., Kaken Pharmaceutical Co., Ltd., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp & Dohme Corp., Nippon Boehringer Ingelheim Co., Ltd., Novo Nordisk Pharma Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Kurpad, A.V. .......................................... Disclosed no confl ict of interest.Kurtz, Natalie ........................................ Employee: Medtronic, Inc.; Stock/Shareholder: Medtronic, Inc.Kurzbach, Anica..................................... Disclosed no confl ict of interest.Kurzova, Ivana ....................................... Disclosed no confl ict of interest.Kusa, Temitope ...................................... Disclosed no confl ict of interest.Kushima, Hideki .................................... Disclosed no confl ict of interest.Kushner, Jake A. .................................. Advisory Panel: Lexicon Pharmaceuticals, Inc.; Research

Support: Merck & Co., Inc.Kusunoki, Masataka.............................. Disclosed no confl ict of interest.Kutalik, Zoltan ....................................... Disclosed no confl ict of interest.Kutoh, Eiji .............................................. Disclosed no confl ict of interest.Kuwata, Hitoshi..................................... Disclosed no confl ict of interest.Kuzhively, Jose ...................................... Disclosed no confl ict of interest.Kuznetsov, Andrey ................................. Disclosed no confl ict of interest.Kuzuya, Takeshi ..................................... Disclosed no confl ict of interest.Kvanbeck, Mary J. ................................ Disclosed no confl ict of interest.Kvapil, Milan ......................................... Disclosed no confl ict of interest.Kvist, Trine ............................................. Employee: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/

Partner); Stock/Shareholder: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/Partner).

Kwak, Kyoung Min ................................ Disclosed no confl ict of interest.Kwak, Soo-Heon.................................... Disclosed no confl ict of interest.Kwon, Hyuk-Sang .................................. Disclosed no confl ict of interest.Kwon, Min Jeong .................................. Disclosed no confl ict of interest.Kwon, Min-Jung.................................... Disclosed no confl ict of interest.Kwon, Obin ............................................ Disclosed no confl ict of interest.Kwon, Se Chang .................................... Employee: Hanmi Pharmaceutical Co., Ltd.Kwong, Yulanda .................................... Disclosed no confl ict of interest.Kyaw Tun, Tommy ................................. Disclosed no confl ict of interest.Kyoong, Andrew .................................... Disclosed no confl ict of interest.Kyriazis, Ioannis .................................... Disclosed no confl ict of interest.La Fleur, Susanne E. ............................. Disclosed no confl ict of interest.La Rosa, Stefano ................................... Disclosed no confl ict of interest.La Sala, Lucia ........................................ Disclosed no confl ict of interest.Labarbuta, Rossella............................... Disclosed no confl ict of interest.Labrie, Fernand...................................... Disclosed no confl ict of interest.Lacadie, Cheryl ...................................... Disclosed no confl ict of interest.Lacaya, Lyndon B. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Lachaud, Christian................................. Disclosed no confl ict of interest.Lachin, John .......................................... Consultant: AstraZeneca, Boehringer Ingelheim GmbH,

Eli Lilly and Company, Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation.

Lacinova, Zdenka................................... Disclosed no confl ict of interest.Lacombe, Veronique A. ........................ Disclosed no confl ict of interest.LaCouture, Michael ............................... Disclosed no confl ict of interest.LaCreta, Frank ....................................... Stock/Shareholder: Bristol-Myers Squibb Company.LaCroix, Andrea Z. ................................ Disclosed no confl ict of interest.Lacy, Mary E. ........................................ Disclosed no confl ict of interest.Ladenvall, Claes .................................... Disclosed no confl ict of interest.Ladha, Ali .............................................. Disclosed no confl ict of interest.Ladner, Danielle .................................... Disclosed no confl ict of interest.Ladouceur, Martin ................................. Disclosed no confl ict of interest.Laferrere, Blandine................................ Disclosed no confl ict of interest.Lafeuille, Marie-Hélène ........................ Research Support: Janssen Scientifi c Affairs, LLC.Laffel, Lori M. ....................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Dexcom, Inc., Eli Lilly and Company, Johnson & Johnson, Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S.; Consultant: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Dexcom, Inc., Eli Lilly and Company, Johnson & Johnson, Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S.

Lagakos, William S. ............................. Disclosed no confl ict of interest.Lagali, Neil ............................................ Disclosed no confl ict of interest.Lage, Maureen J. ................................. Disclosed no confl ict of interest.Lagerstedt, Jens O. .............................. Disclosed no confl ict of interest.Lagotte, Andrea E. ................................ Disclosed no confl ict of interest.Lai, Alessio ............................................ Disclosed no confl ict of interest.Lai, Eseng .............................................. Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Lai, Michelle.......................................... Disclosed no confl ict of interest.Lai, Shenghan........................................ Disclosed no confl ict of interest.Laing, Richard O. .................................. Disclosed no confl ict of interest.Laiteerapong, Neda............................... Disclosed no confl ict of interest.Lajer, Maria ........................................... Disclosed no confl ict of interest.Lak, Vincent ........................................... Disclosed no confl ict of interest.

Lake, Andrea ......................................... Disclosed no confl ict of interest.Lakeeva, T.S. ........................................ Disclosed no confl ict of interest.Lakey, Jonathan .................................... Disclosed no confl ict of interest.Lakshmipathi, Jayalakshmi ................... Disclosed no confl ict of interest.Lalaji, Maitree ....................................... Disclosed no confl ict of interest.Lalani, Sheliza ....................................... Disclosed no confl ict of interest.Lally, Jayasree....................................... Disclosed no confl ict of interest.Laloi-Michelin, Marie............................ Disclosed no confl ict of interest.Lam, Anna ............................................. Disclosed no confl ict of interest.Lam, Benjamin....................................... Disclosed no confl ict of interest.Lam, Carol J. ........................................ Disclosed no confl ict of interest.Lam, David............................................. Disclosed no confl ict of interest.Lam, Eric Chen Quin .............................. Employee: Eli Lilly and Company.Lam, Karen S. ....................................... Disclosed no confl ict of interest.Lam, Que ............................................... Disclosed no confl ict of interest.Lambers Heerspink, Hiddo J. ............... Consultant: AbbVie Inc., Astellas Pharma Inc., AstraZeneca,

Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., ZS Pharma.

Lambert, Danielle .................................. Disclosed no confl ict of interest.Lamendi, Carmen .................................. Disclosed no confl ict of interest.Lammertsma, Adriaan A. ..................... Disclosed no confl ict of interest.Lamontagne, Julien............................... Disclosed no confl ict of interest.Lamotte, Mark ....................................... Consultant: IMS Health Consulting.Lamounier, Rodrigo N. .......................... Disclosed no confl ict of interest.Lanba, Adhiraj ....................................... Disclosed no confl ict of interest.Landberg, Rikard ................................... Disclosed no confl ict of interest.Landgraf, Wolfgang .............................. Employee: Sanofi ; Stock/Shareholder: Sanofi .Lane, James T. ..................................... Research Support: AbbVie Inc., Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, EMD Serono, Inc., Genkyotex, Merck & Co., Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Pfi zer Inc., PhaseBio Pharmaceuticals, Inc., Sanofi -Aventis Deutschland GmbH, VM Biopharma.

Lane, Julie A. ....................................... Disclosed no confl ict of interest.Lang, Kathleen ...................................... Research Support: AstraZeneca; Boehringer Ingelheim

Pharmaceuticals, Inc.Lang, Wei .............................................. Disclosed no confl ict of interest.Lang, Wensheng ................................... Disclosed no confl ict of interest.Langbakke, Irene H. .............................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Lange, Leslie ......................................... Disclosed no confl ict of interest.Langefeld, Carl D. ................................. Disclosed no confl ict of interest.Langenberg, Claudia ............................. Disclosed no confl ict of interest.Langer, Jakob ........................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Langholz, Ebbe P. .................................. Advisory Panel: Janssen Pharmaceuticals, Inc.; Speaker’s

Bureau: AbbVie Inc.Langin, Dominique ................................ Disclosed no confl ict of interest.Langkilde, Anna Maria .......................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Langlais, Paul ........................................ Disclosed no confl ict of interest.Langman, Linda ..................................... Disclosed no confl ict of interest.Langslet, Gisle....................................... Consultant: Boehringer Ingelheim GmbH.Lankinen, Maria A. ............................... Disclosed no confl ict of interest.Lannoo, Matthias .................................. Research Support: Ethicon Endo-Surgery, Inc., Johnson &

Johnson.Lantier, Louise ....................................... Disclosed no confl ict of interest.Lanz, Christian ....................................... Disclosed no confl ict of interest.Lanza, Ian R. ......................................... Disclosed no confl ict of interest.Lapauw, Bruno....................................... Disclosed no confl ict of interest.Lapid, Kfi r .............................................. Disclosed no confl ict of interest.Lappas, Theodoros ................................ Disclosed no confl ict of interest.Lapuerta, Pablo ..................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc.Larco, Nancy.......................................... Disclosed no confl ict of interest.Larco, Philippe ....................................... Disclosed no confl ict of interest.Larkin, Amy............................................ Disclosed no confl ict of interest.Larrivee, Sandra .................................... Disclosed no confl ict of interest.Larsen Thorsted, Brian .......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Larsen, Bjarne Due ................................ Employee: Zealand Pharma A/S.Larsen, Olav........................................... Disclosed no confl ict of interest.Larsen, Philip Just ................................. Employee: Sanofi -Aventis Deutschland GmbH.Larsen, Sara A. ..................................... Disclosed no confl ict of interest.Larsen, Tricia D. .................................... Disclosed no confl ict of interest.Larson, Joseph J. ................................. Disclosed no confl ict of interest.Larsson, Christina.................................. Disclosed no confl ict of interest.Larsson, Helena Elding.......................... Disclosed no confl ict of interest.Lascar, Nadia ......................................... Research Support: Novo Nordisk Inc., The Binding Site.Lason, Izabela........................................ Disclosed no confl ict of interest.Lasseter, Kenneth .................................. Disclosed no confl ict of interest.Latham, Melanie ................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Latkovic, Erin ......................................... Disclosed no confl ict of interest.Lau Borjesson, Joey .............................. Disclosed no confl ict of interest.Lau, Clara Bik San ................................. Disclosed no confl ict of interest.

A733


AU

THO

R D

ISCL

OSU

RE

Lau, David C. ........................................ Advisory Panel: Amgen Inc., AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novartis AG, Novo Nordisk A/S, Roche Diagnostics, Sanofi U.S., Shire, Valeant Pharmaceuticals; Research Support: AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Novo Nordisk A/S; Speaker’s Bureau: Amgen Inc., AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Valeant Pharmaceuticals; Stock/Shareholder: Amgen Inc., Lilly.

Lau, Raymond G. .................................. Disclosed no confl ict of interest.Lau, Wayne ........................................... Disclosed no confl ict of interest.Laubner, Katharina ................................ Advisory Panel: Animas Corporation, GlaxoSmithKline,

Janssen Scientifi c Affairs, LLC; Research Support: Boehringer Ingelheim GmbH, GI Dynamics, Inc.; Speaker’s Bureau: Amgen Inc., AstraZeneca, Berlin-Chemie, GI Dynamics, Inc., Ipsen Bioscience, Inc., Novartis Pharma GmbH, Sanofi -Aventis Deutschland GmbH.

Laugesen, Esben ................................... Disclosed no confl ict of interest.Lauria Pantano, Angelo ......................... Disclosed no confl ict of interest.Lauria, Angelo ....................................... Disclosed no confl ict of interest.Laurie, Cathy ......................................... Disclosed no confl ict of interest.Laurin, Pierre ......................................... Board Member: ProMetic BioSciences Inc.; Employee:

ProMetic BioSciences Inc.; Stock/Shareholder: ProMetic Life Sciences Inc.

Lauritzen, Hans P. ................................. Disclosed no confl ict of interest.Lauritzen, Torsten .................................. Advisory Panel: AstraZeneca; Stock/Shareholder: Novo

Nordisk A/S.Lauro, Davide ........................................ Disclosed no confl ict of interest.Lautier, Corinne ..................................... Disclosed no confl ict of interest.Lautz, David B. ...................................... Advisory Panel: GI Windows; Stock/Shareholder: GI Windows.Laverdure, Alexandre ............................ Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Lavery, Lawrence A. ............................. Disclosed no confl ict of interest.Laviola, Luigi ......................................... Advisory Panel: AstraZeneca, Eli Lilly and Company, Johnson

& Johnson, Roche Diagnostics.Lawal, Muili O. ..................................... Disclosed no confl ict of interest.Lawrence, Debra F. ............................... Employee: HealthCore, Takeda Pharmaceutical Company

Limited.Lawrence, Jean M. .............................. Disclosed no confl ict of interest.Lawrence, Michael C. .......................... Disclosed no confl ict of interest.Lawson, Francesca C. ........................... Employee: Sanofi U.S.Layden, Brian T. .................................... Disclosed no confl ict of interest.Layne, Jennifer E. ................................. Employee: Insulet Corporation; Stock/Shareholder: Insulet

Corporation.Lazar, Jozef ............................................ Disclosed no confl ict of interest.Lazure, Patrice ....................................... Disclosed no confl ict of interest.Le Floch, Jean-Pierre............................. Disclosed no confl ict of interest.Le Joubioux, Florian .............................. Employee: Valbiotis.Le May, Cedric....................................... Disclosed no confl ict of interest.Le Pape, Gilles....................................... Disclosed no confl ict of interest.Le, Anne ................................................ Disclosed no confl ict of interest.Le, Yingying ........................................... Disclosed no confl ict of interest.Leal, Angela M. .................................... Disclosed no confl ict of interest.Leanza, Giulia ........................................ Disclosed no confl ict of interest.Leavitt, Ian M. ...................................... Research Support: Merck & Co., Inc.LeBlanc, Erin.......................................... Disclosed no confl ict of interest.Leblond, François A. ............................. Disclosed no confl ict of interest.Lebovitz, Harold E. ................................ Advisory Panel: Poxel Pharmaceutical Company.Lecher, Bernd ......................................... Disclosed no confl ict of interest.Lechner, Andreas ................................... Disclosed no confl ict of interest.Lecka-Czernik, Beata ............................. Disclosed no confl ict of interest.Leclercq, Alexandre............................... Disclosed no confl ict of interest.Leclercq, Laurent ................................... Employee: Janssen Pharmaceuticals, Inc.Lecube, Albert ....................................... Disclosed no confl ict of interest.Lecumberri, Edurne ............................... Disclosed no confl ict of interest.Ledesma, Migil...................................... Disclosed no confl ict of interest.Leduc, Martin ........................................ Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Lee, Aaron ............................................. Disclosed no confl ict of interest.Lee, Alexandra K. ................................. Disclosed no confl ict of interest.Lee, Andrew .......................................... Disclosed no confl ict of interest.Lee, Byung Wan .................................... Disclosed no confl ict of interest.Lee, Chia-Lin.......................................... Disclosed no confl ict of interest.Lee, Christine ........................................ Disclosed no confl ict of interest.Lee, Christopher .................................... Employee: Boehringer Ingelheim GmbH.Lee, Clare .............................................. Disclosed no confl ict of interest.Lee, Dae Ho ........................................... Disclosed no confl ict of interest.Lee, DaHae ............................................ Disclosed no confl ict of interest.Lee, Dicky K. ......................................... Disclosed no confl ict of interest.Lee, Dong-Sung ..................................... Disclosed no confl ict of interest.Lee, Eun Chong...................................... Disclosed no confl ict of interest.Lee, Eun Ju ............................................ Disclosed no confl ict of interest.Lee, Eun Sol........................................... Disclosed no confl ict of interest.Lee, Eun Young ...................................... Disclosed no confl ict of interest.

Lee, Gregory .......................................... Disclosed no confl ict of interest.Lee, Hak Mo .......................................... Disclosed no confl ict of interest.Lee, Heung Man .................................... Disclosed no confl ict of interest.Lee, Hon-Chi .......................................... Disclosed no confl ict of interest.Lee, Hong Kyu ....................................... Disclosed no confl ict of interest.Lee, Hsiao-Chen .................................... Disclosed no confl ict of interest.Lee, Hye Jin........................................... Disclosed no confl ict of interest.Lee, Hyoung Woo .................................. Disclosed no confl ict of interest.Lee, Hyun Jung...................................... Disclosed no confl ict of interest.Lee, Ina .................................................. Disclosed no confl ict of interest.Lee, In-Kyu............................................. Disclosed no confl ict of interest.Lee, Insup .............................................. Disclosed no confl ict of interest.Lee, I-Te ................................................. Disclosed no confl ict of interest.Lee, Jae Hyuk ........................................ Disclosed no confl ict of interest.Lee, Jae Min ......................................... Disclosed no confl ict of interest.Lee, Jenney ........................................... Disclosed no confl ict of interest.Lee, Jeongha ......................................... Employee: Dong-A ST.Lee, Ji Min ............................................ Disclosed no confl ict of interest.Lee, Ji Yeon ........................................... Disclosed no confl ict of interest.Lee, Ji Young ......................................... Disclosed no confl ict of interest.Lee, Jie-Eun........................................... Disclosed no confl ict of interest.Lee, Jin-Hee .......................................... Disclosed no confl ict of interest.Lee, Jong Han ....................................... Disclosed no confl ict of interest.Lee, Jong Suk ........................................ Disclosed no confl ict of interest.Lee, Joon Bok ........................................ Disclosed no confl ict of interest.Lee, Joonyub ......................................... Disclosed no confl ict of interest.Lee, Jun Young ...................................... Disclosed no confl ict of interest.Lee, Jung-Dong ..................................... Disclosed no confl ict of interest.Lee, Jung-Min ....................................... Disclosed no confl ict of interest.Lee, Ki Up .............................................. Disclosed no confl ict of interest.Lee, Ki Won ........................................... Disclosed no confl ict of interest.Lee, Kwan Woo ..................................... Disclosed no confl ict of interest.Lee, Kyung Pyo ...................................... Disclosed no confl ict of interest.Lee, Leonard .......................................... Disclosed no confl ict of interest.Lee, Lulu ................................................ Research Support: Kantar Health.Lee, Mackenzie ..................................... Disclosed no confl ict of interest.Lee, Mikang........................................... Disclosed no confl ict of interest.Lee, Min Kyung ..................................... Disclosed no confl ict of interest.Lee, Min Young ..................................... Disclosed no confl ict of interest.Lee, Minjin ............................................ Disclosed no confl ict of interest.Lee, Moon-Kyu ...................................... Disclosed no confl ict of interest.Lee, Nam Dong...................................... Disclosed no confl ict of interest.Lee, Paul C. ........................................... Disclosed no confl ict of interest.Lee, Phong Ching................................... Disclosed no confl ict of interest.Lee, Richard H. ..................................... Disclosed no confl ict of interest.Lee, Sang A. ......................................... Disclosed no confl ict of interest.Lee, Sang Bae ....................................... Disclosed no confl ict of interest.Lee, Sang-Hak ....................................... Disclosed no confl ict of interest.Lee, Scott .............................................. Employee: Medtronic, Inc.Lee, Seo Young...................................... Disclosed no confl ict of interest.Lee, Seung Eun...................................... Disclosed no confl ict of interest.Lee, Seung Ku ....................................... Disclosed no confl ict of interest.Lee, Seunghun P. .................................. Employee: Janssen Pharmaceuticals, Inc.Lee, Seung-Hwan .................................. Disclosed no confl ict of interest.Lee, Shaun W. ...................................... Disclosed no confl ict of interest.Lee, ShunFu ........................................... Disclosed no confl ict of interest.Lee, Sojin............................................... Disclosed no confl ict of interest.Lee, Sojung............................................ Disclosed no confl ict of interest.Lee, Soo Jin........................................... Disclosed no confl ict of interest.Lee, Soon Hee ....................................... Disclosed no confl ict of interest.Lee, Thomas .......................................... Disclosed no confl ict of interest.Lee, Vivien ............................................. Disclosed no confl ict of interest.Lee, Woo Je .......................................... Disclosed no confl ict of interest.Lee, Yau-Jiunn....................................... Disclosed no confl ict of interest.Lee, Yen-Chieh ...................................... Disclosed no confl ict of interest.Lee, Yi-Chien ......................................... Consultant: Novartis Pharmaceuticals Corporation, Sanofi U.S.Lee, Yong-Ho ......................................... Disclosed no confl ict of interest.Lee, Yoonkwang .................................... Disclosed no confl ict of interest.Lee, Young Mi ....................................... Employee: Hanmi Pharmaceutical Co., Ltd.Leelarathna, Lalantha ........................... Disclosed no confl ict of interest.Leening, Maarten J. ............................. Disclosed no confl ict of interest.Lefebvre, Patrick.................................... Research Support: Janssen Scientifi c Affairs, LLC.Lefèvre, Guillaume ................................ Disclosed no confl ict of interest.Leff, Todd ............................................... Consultant: Jiva Pharma Inc.Lefort, Corinne....................................... Disclosed no confl ict of interest.Legault, Laurent .................................... Advisory Panel: Eli Lilly Canada Inc.; Research Support: Merck

Canada, Novo Nordisk Inc.Lehmann, Anne ..................................... Employee: Sanofi -Aventis Deutschland GmbH.Lehmann, Lucine ................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Lehmann, Rainer ................................... Disclosed no confl ict of interest.Lehne, Benjamin.................................... Disclosed no confl ict of interest.Lehr, Stefan ........................................... Disclosed no confl ict of interest.Lehtonen, Marko ................................... Disclosed no confl ict of interest.Lei, Lanyu .............................................. Disclosed no confl ict of interest.Lei, Yan-Ping.......................................... Disclosed no confl ict of interest.

A734


AU

THO

R D

ISCL

OSU

RE

Leiherer, Andreas .................................. Disclosed no confl ict of interest.Leiria, Luiz O. ........................................ Disclosed no confl ict of interest.Leite, Inguna.......................................... Disclosed no confl ict of interest.Leite, Silmara A. ................................... Disclosed no confl ict of interest.Leiter, Lawrence A. .............................. Advisory Panel: Aegerion Pharmaceuticals, Inc., Amgen Inc.,

AstraZeneca, Eli Lilly and Company, Merck & Co., Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S.; Research Support: Amgen Inc., AstraZeneca, Eli Lilly and Company, Merck & Co., Inc., Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S.; Speaker’s Bureau: Amgen Inc., AstraZeneca, Merck & Co., Inc., Sanofi U.S., Valeant Pharmaceuticals.

Leitges, Michael.................................... Disclosed no confl ict of interest.Leith, Andrea ......................................... Disclosed no confl ict of interest.Lelouvier, Benjamin ............................... Employee: Vaiomer.Lemley, Kevin V. ................................... Disclosed no confl ict of interest.Lenchik, Nataliya I. ............................... Disclosed no confl ict of interest.Leng, Junhong ....................................... Disclosed no confl ict of interest.Lenhard, James ..................................... Speaker’s Bureau: Janssen Pharmaceuticals, Inc.Lentz, Stephen....................................... Disclosed no confl ict of interest.Leo, Michael.......................................... Disclosed no confl ict of interest.León, Fabián .......................................... Disclosed no confl ict of interest.Leonard, Anthony C. ............................. Disclosed no confl ict of interest.Leonard, James ..................................... Employee: Janssen Pharmaceuticals, Inc.Leonard, John........................................ Employee: Genzyme Corporation.Leonard, Michelle E. ............................ Disclosed no confl ict of interest.Leonardini, Anna ................................... Disclosed no confl ict of interest.Leone, Alessandro................................. Disclosed no confl ict of interest.Leone, Keri J. ....................................... Employee: Dexcom, Inc.; Stock/Shareholder: Dexcom, Inc.Leonetti, Donna L. ................................ Disclosed no confl ict of interest.Leong, Aaron ......................................... Disclosed no confl ict of interest.Leonova, Olga G. .................................. Disclosed no confl ict of interest.Leotta, Sergio ........................................ Disclosed no confl ict of interest.LePard, Kathy J. ................................... Disclosed no confl ict of interest.Lepifre, Franck ....................................... Disclosed no confl ict of interest.Lerner, Richard A. ................................. Stock/Shareholder: Zebra Biologics, Inc.Lernmark, Ake ....................................... Research Support: National Institutes of Health.LeRoith, Derek ....................................... Disclosed no confl ict of interest.Lesavre, Nathalie .................................. Disclosed no confl ict of interest.Leslie, Richard D. ................................. Disclosed no confl ict of interest.Lesmes, Luis .......................................... Board Member: Adaptive Sensory Technology, LLC; Employee:

Adaptive Sensory Technology, LLC; Other Relationship: Adaptive Sensory Technology, LLC; Stock/Shareholder: Adaptive Sensory Technology, LLC.

Lessan, Nader ....................................... Disclosed no confl ict of interest.LeStourgeon, Lauren M. ....................... Disclosed no confl ict of interest.Letierce, Alexia ..................................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi U.S.Leu, Hsin-Bang ...................................... Disclosed no confl ict of interest.Leung, Po Sing....................................... Disclosed no confl ict of interest.Lev, Vered .............................................. Disclosed no confl ict of interest.Levchenko, Vladislav ............................. Disclosed no confl ict of interest.Levi, Moshe ........................................... Disclosed no confl ict of interest.Levin, Ellis R. ........................................ Disclosed no confl ict of interest.Levin, Mariel ......................................... Disclosed no confl ict of interest.Levin, Philip ........................................... Advisory Panel: Novo Nordisk Inc., Sanofi U.S.; Consultant:

Novo Nordisk Inc., Sanofi U.S.; Research Support: Amylin Pharmaceuticals, LLC., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk Inc., Roche USA, Sanofi U.S.; Speaker’s Bureau: Amylin Pharmaceuticals, LLC., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi U.S.

Levine, Mark.......................................... Disclosed no confl ict of interest.Levine, S. Robert ................................... Disclosed no confl ict of interest.Levinson, Gideon ................................... Disclosed no confl ict of interest.Levister, Camilla .................................... Disclosed no confl ict of interest.Levitsky, Josh ........................................ Disclosed no confl ict of interest.Levitsky, Lynne ...................................... Disclosed no confl ict of interest.Levitt, Naomi ......................................... Disclosed no confl ict of interest.Levy, Brian ............................................. Employee: LifeScan, Inc.; Stock/Shareholder: Johnson &

Johnson.Levy, Carol ............................................. Advisory Panel: Janssen Pharmaceuticals, Inc.; Employee:

Allergan, Inc. (Spouse/Partner); Research Support: Lexicon Pharmaceuticals, Inc., Novo Nordisk Inc., Roche USA, Senseonics, Inc.

Levy, Matthew....................................... Disclosed no confl ict of interest.Levy, Shawn .......................................... Disclosed no confl ict of interest.Levy, Wendy L. ..................................... Disclosed no confl ict of interest.Lewis, Arthur ......................................... Disclosed no confl ict of interest.Lewis, Cora E. ....................................... Disclosed no confl ict of interest.Lewis, Eldrin F. ...................................... Consultant: Sanofi U.S. (Spouse/Partner); Research Support:

Amgen Inc., Novartis Pharmaceuticals Corporation, Sanofi U.S., Sanofi U.S. (Spouse/Partner).

Lewis, Gary F. ....................................... Disclosed no confl ict of interest.Leyva, Misti J. ...................................... Disclosed no confl ict of interest.

Li, Chen Guang ...................................... Disclosed no confl ict of interest.Li, Cheng-Hung ...................................... Disclosed no confl ict of interest.Li, Chun Jun........................................... Disclosed no confl ict of interest.Li, Chun.................................................. Disclosed no confl ict of interest.Li, Chung-Yi ........................................... Disclosed no confl ict of interest.Li, Chunlin.............................................. Disclosed no confl ict of interest.Li, Daiqing ............................................. Disclosed no confl ict of interest.Li, Dan ................................................... Disclosed no confl ict of interest.Li, Feng .................................................. Disclosed no confl ict of interest.Li, Guangwei ......................................... Disclosed no confl ict of interest.Li, Guo Dong .......................................... Disclosed no confl ict of interest.Li, Hai .................................................... Disclosed no confl ict of interest.Li, Haicheng........................................... Disclosed no confl ict of interest.Li, Haixia................................................ Disclosed no confl ict of interest.Li, Han ................................................... Disclosed no confl ict of interest.Li, Hong ................................................. Disclosed no confl ict of interest.Li, Hongyu.............................................. Disclosed no confl ict of interest.Li, Hua ................................................... Disclosed no confl ict of interest.Li, Hubert ............................................... Disclosed no confl ict of interest.Li, Hui .................................................... Disclosed no confl ict of interest.Li, Ji ....................................................... Disclosed no confl ict of interest.Li, Jia ..................................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Li, Jianping ............................................ Disclosed no confl ict of interest.Li, Jian-Wei ........................................... Disclosed no confl ict of interest.Li, Jibin .................................................. Disclosed no confl ict of interest.Li, Liang ................................................. Disclosed no confl ict of interest.Li, Lixin .................................................. Disclosed no confl ict of interest.Li, Lu ...................................................... Disclosed no confl ict of interest.Li, Lucy................................................... Disclosed no confl ict of interest.Li, Lujiao ................................................ Disclosed no confl ict of interest.Li, Manna .............................................. Disclosed no confl ict of interest.Li, Meng ................................................ Disclosed no confl ict of interest.Li, Mengyao........................................... Disclosed no confl ict of interest.Li, Min-Dian........................................... Disclosed no confl ict of interest.Li, Ming ................................................. Disclosed no confl ict of interest.Li, Mingyu.............................................. Disclosed no confl ict of interest.Li, Mingzhen .......................................... Disclosed no confl ict of interest.Li, Nan ................................................... Disclosed no confl ict of interest.Li, Pei ..................................................... Disclosed no confl ict of interest.Li, Ping ................................................... Disclosed no confl ict of interest.Li, Qian .................................................. Disclosed no confl ict of interest.Li, Qifu ................................................... Disclosed no confl ict of interest.Li, Qin .................................................... Disclosed no confl ict of interest.Li, Qing .................................................. Disclosed no confl ict of interest.Li, Rosemary .......................................... Disclosed no confl ict of interest.Li, Rui..................................................... Disclosed no confl ict of interest.Li, Shanshan .......................................... Disclosed no confl ict of interest.Li, Shengxu ............................................ Disclosed no confl ict of interest.Li, Tao .................................................... Disclosed no confl ict of interest.Li, Tsai-Chung ........................................ Disclosed no confl ict of interest.Li, Wan-Chun ......................................... Disclosed no confl ict of interest.Li, Wei ................................................... Disclosed no confl ict of interest.Li, Weiqin .............................................. Disclosed no confl ict of interest.Li, Wenhui ............................................. Disclosed no confl ict of interest.Li, Wen-Jie ............................................ Disclosed no confl ict of interest.Li, Xiaofeng ........................................... Disclosed no confl ict of interest.Li, Xiaojing............................................. Disclosed no confl ict of interest.Li, Xiaomei............................................. Disclosed no confl ict of interest.Li, Xiaoshan ........................................... Disclosed no confl ict of interest.Li, Xiaoyan N. ....................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Li, Xiaoying ............................................ Disclosed no confl ict of interest.Li, Xingsheng ......................................... Disclosed no confl ict of interest.Li, Xinmin............................................... Disclosed no confl ict of interest.Li, Xinyu ................................................. Disclosed no confl ict of interest.Li, Xuelin................................................ Disclosed no confl ict of interest.Li, Yan .................................................... Disclosed no confl ict of interest.Li, Yanbing ............................................. Disclosed no confl ict of interest.Li, Yanfeng............................................. Disclosed no confl ict of interest.Li, Yang .................................................. Employee: VeroScience, LLC.Li, Yanping ............................................. Disclosed no confl ict of interest.Li, Ya-Zhuo............................................. Research Support: Oramed Pharmaceuticals.Li, Yichong ............................................. Disclosed no confl ict of interest.Li, Yongguo ............................................ Disclosed no confl ict of interest.Li, Yu ...................................................... Disclosed no confl ict of interest.Li, Yu-Fen ............................................... Disclosed no confl ict of interest.Li, Yufeng ............................................... Disclosed no confl ict of interest.Li, Zhi ..................................................... Disclosed no confl ict of interest.Li, Zhu .................................................... Disclosed no confl ict of interest.Liang, Bing............................................. Disclosed no confl ict of interest.Liang, Guang ......................................... Disclosed no confl ict of interest.Liang, Hanyu.......................................... Disclosed no confl ict of interest.Liang, Hua ............................................. Disclosed no confl ict of interest.Liang, Jun .............................................. Disclosed no confl ict of interest.Liang, Li ................................................. Disclosed no confl ict of interest.

A735


AU

THO

R D

ISCL

OSU

RE

Liang, Lihuan ......................................... Employee: MedImmune, LLC.Liang, Luxi ............................................. Disclosed no confl ict of interest.Liang, Qingning ..................................... Disclosed no confl ict of interest.Liang, Sitai ............................................ Disclosed no confl ict of interest.Liang, Weiwen ...................................... Disclosed no confl ict of interest.Liang, Wen ............................................ Disclosed no confl ict of interest.Liang, Xinyue ......................................... Disclosed no confl ict of interest.Liang, Xiuci ............................................ Disclosed no confl ict of interest.Liang, Yin ............................................... Employee: Janssen Pharmaceuticals, Inc.Liang, Ying ............................................. Disclosed no confl ict of interest.Liang, Yongjun ....................................... Disclosed no confl ict of interest.Liao, Chen Di ......................................... Disclosed no confl ict of interest.Liao, Zhangping ..................................... Disclosed no confl ict of interest.Liaskos, Christos ................................... Disclosed no confl ict of interest.Liatis, Stavros........................................ Disclosed no confl ict of interest.Libby, Andrew........................................ Disclosed no confl ict of interest.Liberati, Ana Marija .............................. Disclosed no confl ict of interest.Libman De Gordon, Ingrid ..................... Disclosed no confl ict of interest.Liebl, Andreas ....................................... Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly and

Company, Medtronic, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S, Roche; Research Support: Dexcom, Inc., Eli Lilly and Company, Medtronic, Inc.; Speaker’s Bureau: AstraZeneca, Bayer HealthCare, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Eli Lilly and Company, Medtronic, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S, Roche.

Liebman, Rebecca ................................. Disclosed no confl ict of interest.Liem, Robert I. ...................................... Disclosed no confl ict of interest.Lier, Alexander ...................................... Disclosed no confl ict of interest.Liese, Angela D. ................................... Disclosed no confl ict of interest.Lieske, Stefanie..................................... Disclosed no confl ict of interest.Lieske, Steffi .......................................... Disclosed no confl ict of interest.Liew, Aaron ........................................... Advisory Panel: Novo Nordisk A/S; Research Support:

Dompé Pharmaceutical, Sanofi -Aventis Deutschland GmbH.

Liew, Chong Wee .................................. Disclosed no confl ict of interest.Lightner, Teresa ..................................... Board Member: Valley Baptist Legacy Foundation, RGVHIE.Ligthart, Symen ..................................... Disclosed no confl ict of interest.Lillie, Mark ............................................ Employee: IMS Health; Stock/Shareholder: Amgen,

AstraZeneca, Pfi zer.Lilly, Leslie C. ........................................ Employee: CeQur, Ltd.Lim, Boon Khim ..................................... Disclosed no confl ict of interest.Lim, Cadmon K. .................................... Disclosed no confl ict of interest.Lim, Chang Ki ........................................ Disclosed no confl ict of interest.Lim, Chee-Hau ....................................... Disclosed no confl ict of interest.Lim, Chin Hoong .................................... Disclosed no confl ict of interest.Lim, Gareth E. ....................................... Disclosed no confl ict of interest.Lim, Jung Chae...................................... Disclosed no confl ict of interest.Lim, Lee Ling ......................................... Disclosed no confl ict of interest.Lim, Seyoung ......................................... Employee: Yuhan Co.Lim, Shueh Lin ....................................... Disclosed no confl ict of interest.Lim, Soo................................................. Disclosed no confl ict of interest.Lim, Su Chi ............................................ Disclosed no confl ict of interest.Lim, Su M. ............................................ Disclosed no confl ict of interest.Lim, Sun-Young ..................................... Disclosed no confl ict of interest.Lim, Tae-Seok ........................................ Disclosed no confl ict of interest.Lin, Andrea ............................................ Disclosed no confl ict of interest.Lin, Cheng-Chieh ................................... Disclosed no confl ict of interest.Lin, Cheng-Mao ..................................... Disclosed no confl ict of interest.Lin, Ji ..................................................... Disclosed no confl ict of interest.Lin, Jou-Wei .......................................... Disclosed no confl ict of interest.Lin, Keke ................................................ Disclosed no confl ict of interest.Lin, Keyi ................................................. Disclosed no confl ict of interest.Lin, Kun.................................................. Disclosed no confl ict of interest.Lin, Mu .................................................. Disclosed no confl ict of interest.Lin, Shaoda............................................ Disclosed no confl ict of interest.Lin, Shih-Yi ............................................ Disclosed no confl ict of interest.Lin, Shuo................................................ Disclosed no confl ict of interest.Lin, Suvana ............................................ Disclosed no confl ict of interest.Lin, Tim .................................................. Consultant: AstraZeneca.Lin, Yao-Ping.......................................... Disclosed no confl ict of interest.Lin, Yi ..................................................... Disclosed no confl ict of interest.Lin, Yuhong ............................................ Disclosed no confl ict of interest.Lin, Yu-Tze ............................................. Disclosed no confl ict of interest.Lin, Ziwei ............................................... Disclosed no confl ict of interest.Linane, Hannah ..................................... Disclosed no confl ict of interest.Lincoff, A. Michael ................................ Research Support: AstraZeneca, Eli Lilly and Company,

Genentech, Inc., Roche USA, Takeda Development Center Americas, Inc.

Lind, Lars ............................................... Disclosed no confl ict of interest.Lind, Monica.......................................... Disclosed no confl ict of interest.Lindahl, Maria ....................................... Disclosed no confl ict of interest.Lindberg, Søren ..................................... Employee: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/

Partner).Linder, Barbara ...................................... Disclosed no confl ict of interest.Linder, Katarzyna ................................... Disclosed no confl ict of interest.

Linders, David R. .................................. Board Member: Podimetrics, Inc.; Employee: Podimetrics, Inc.; Stock/Shareholder: Podimetrics, Inc.

Lindquist, Ryan ...................................... Employee: Data Sciences International.Lindström, Jaana................................... Disclosed no confl ict of interest.Linetsky, Elina........................................ Disclosed no confl ict of interest.Linetzky, Bruno ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Ling, Wenhua ........................................ Disclosed no confl ict of interest.Ling, Ying ............................................... Disclosed no confl ict of interest.Lingvay, Ildiko ........................................ Advisory Panel: Novo Nordisk A/S; Board Member:

Janssen Pharmaceuticals, Inc.; Consultant: Novo Nordisk A/S; Other Relationship: Boehringer Ingelheim Pharmaceuticals, Inc., Novo Nordisk A/S, Sanofi U.S.; Research Support: GI Dynamics, Inc., Merck Serono, Novo Nordisk A/S, Pfi zer Inc.

Ling-Wang, Am ..................................... Disclosed no confl ict of interest.Linjawi, Sultan ...................................... Advisory Panel: Novo Nordisk Global, Novo Nordisk, Australia;

Speaker’s Bureau: Novo Nordisk Global.Link, Manuela........................................ Research Support: Senseonics, Inc.Linneberg, Allan .................................... Disclosed no confl ict of interest.Linnebjerg, Helle ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Linter, Katherine .................................... Disclosed no confl ict of interest.Lio, Adrian ............................................. Disclosed no confl ict of interest.Lipovich, Leonard .................................. Disclosed no confl ict of interest.Lipscombe, Lorraine L. ......................... Disclosed no confl ict of interest.Lipska, Kasia J. .................................... Research Support: National Institutes of Health.Liptak, Gregory ...................................... Disclosed no confl ict of interest.Lisi, Kristine........................................... Disclosed no confl ict of interest.Lisowicz, Lucyna.................................... Disclosed no confl ict of interest.Little, Randie ......................................... Consultant: Alere Inc.Littlejohn, Elizabeth............................... Disclosed no confl ict of interest.Littlewood, Kerry ................................... Disclosed no confl ict of interest.Littlewood, Zoe S. ................................ Disclosed no confl ict of interest.Liu, Aiqun .............................................. Disclosed no confl ict of interest.Liu, Bing................................................. Disclosed no confl ict of interest.Liu, Chengfeng ...................................... Disclosed no confl ict of interest.Liu, Ching-Ti........................................... Disclosed no confl ict of interest.Liu, Dan ................................................. Disclosed no confl ict of interest.Liu, Edwin .............................................. Disclosed no confl ict of interest.Liu, Edy .................................................. Disclosed no confl ict of interest.Liu, Fang ................................................ Disclosed no confl ict of interest.Liu, FangHui........................................... Disclosed no confl ict of interest.Liu, Feng ................................................ Disclosed no confl ict of interest.Liu, Guangjian ....................................... Disclosed no confl ict of interest.Liu, Hanlan ............................................ Employee: Genzyme Corporation.Liu, Hongtao .......................................... Disclosed no confl ict of interest.Liu, Huaying........................................... Disclosed no confl ict of interest.Liu, Huikun............................................. Disclosed no confl ict of interest.Liu, Hui-Qin............................................ Disclosed no confl ict of interest.Liu, Jason .............................................. Disclosed no confl ict of interest.Liu, Jia ................................................... Disclosed no confl ict of interest.Liu, Jianghua ......................................... Disclosed no confl ict of interest.Liu, Jiankang ......................................... Disclosed no confl ict of interest.Liu, Jianying .......................................... Employee: Janssen Pharmaceuticals, Inc.Liu, Jie ................................................... Employee: Merck & Co., Inc., Takeda Pharmaceutical Company

Limited; Stock/Shareholder: Merck & Co., Inc.Liu, Jinan ............................................... Employee: Merck & Co., Inc.Liu, Jing ................................................. Disclosed no confl ict of interest.Liu, Joey ................................................ Disclosed no confl ict of interest.Liu, Juan ................................................ Disclosed no confl ict of interest.Liu, Jun .................................................. Disclosed no confl ict of interest.Liu, Junjun ............................................. Disclosed no confl ict of interest.Liu, Kiang............................................... Disclosed no confl ict of interest.Liu, Liehua ............................................. Disclosed no confl ict of interest.Liu, Li-Fen .............................................. Disclosed no confl ict of interest.Liu, Ling ................................................. Disclosed no confl ict of interest.Liu, Lu .................................................... Disclosed no confl ict of interest.Liu, Meilian ........................................... Disclosed no confl ict of interest.Liu, Min ................................................. Disclosed no confl ict of interest.Liu, Ming ............................................... Disclosed no confl ict of interest.Liu, Nancy F. ......................................... Disclosed no confl ict of interest.Liu, Pei ................................................... Disclosed no confl ict of interest.Liu, Rong................................................ Employee: Eli Lilly and Company, Eli Lilly and Company


Liu, Rui................................................... Disclosed no confl ict of interest.Liu, Shanying ......................................... Disclosed no confl ict of interest.Liu, Shiwei............................................. Disclosed no confl ict of interest.Liu, Shuqian........................................... Disclosed no confl ict of interest.Liu, Shusen ............................................ Employee: Merck Sharp & Dohme Corp.Liu, Tao .................................................. Disclosed no confl ict of interest.Liu, Tiemin ............................................. Disclosed no confl ict of interest.Liu, Wei ................................................. Disclosed no confl ict of interest.Liu, Xiaodan........................................... Disclosed no confl ict of interest.Liu, Xiping.............................................. Employee: ConjuChem, LLC.

A736


AU

THO

R D

ISCL

OSU

RE

Liu, Xuwen............................................. Disclosed no confl ict of interest.Liu, Yan .................................................. Disclosed no confl ict of interest.Liu, YanMei ........................................... Disclosed no confl ict of interest.Liu, Yanping ........................................... Disclosed no confl ict of interest.Liu, Yanyan ............................................ Disclosed no confl ict of interest.Liu, Yilin ................................................. Disclosed no confl ict of interest.Liu, Ying ................................................. Disclosed no confl ict of interest.Liu, Yong ................................................ Disclosed no confl ict of interest.Liu, Yongqiang ....................................... Employee: Crown Bioscience, Inc.Liu, Yu .................................................... Disclosed no confl ict of interest.Liu, Yu .................................................... Research Support: Medtronic, Inc.Liu, Yuk-Fun ........................................... Disclosed no confl ict of interest.Liu, Yuyin ............................................... Disclosed no confl ict of interest.Liu, Zhen ................................................ Disclosed no confl ict of interest.Liu, Zhengshuai ..................................... Disclosed no confl ict of interest.Liu, Zhenhua .......................................... Disclosed no confl ict of interest.Liu, Zhenqi ............................................. Disclosed no confl ict of interest.Liu, Ziyi .................................................. Disclosed no confl ict of interest.Livingston, Mark.................................... Disclosed no confl ict of interest.Ljubic, Spomenka .................................. Disclosed no confl ict of interest.Ljungberg Pedersen, Søren ................... Employee: Gubra ApS.Llanos, Paola ......................................... Disclosed no confl ict of interest.Lo, Clement ........................................... Disclosed no confl ict of interest.Lo, Shih-Chang ...................................... Disclosed no confl ict of interest.Loader, Jordan ....................................... Disclosed no confl ict of interest.Loba, Jerzy ............................................ Speaker’s Bureau: Eli Lilly and Company.Lobo, Jennifer Mason ........................... Disclosed no confl ict of interest.Locasale, Jason..................................... Disclosed no confl ict of interest.Lock, John Paul ..................................... Disclosed no confl ict of interest.Lock, Leslie ............................................ Disclosed no confl ict of interest.Lockhart, Sam M. ................................. Disclosed no confl ict of interest.Lockhart, Samuel................................... Disclosed no confl ict of interest.Lodha, Abhay......................................... Disclosed no confl ict of interest.Lodi, Tiziana........................................... Disclosed no confl ict of interest.Loehn, Matthias .................................... Employee: Sanofi -Aventis Deutschland GmbH.Löfgren, Lars.......................................... Employee: AstraZeneca.Loganadan, Navin K. ............................ Disclosed no confl ict of interest.Loghin, Corina ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Loh, Margaret........................................ Disclosed no confl ict of interest.Lomanto, Davide ................................... Disclosed no confl ict of interest.Lombard, Carl ........................................ Disclosed no confl ict of interest.Lombardi, Angela .................................. Disclosed no confl ict of interest.Lombardo, Mauro .................................. Disclosed no confl ict of interest.Löndahl, Magnus................................... Disclosed no confl ict of interest.Lonergan, Michael ................................ Disclosed no confl ict of interest.Long, Long ............................................. Disclosed no confl ict of interest.Long, Min .............................................. Disclosed no confl ict of interest.Long, Molly............................................ Disclosed no confl ict of interest.Long, Qi ................................................. Disclosed no confl ict of interest.Long, Qinqiang ...................................... Disclosed no confl ict of interest.Long, S. Alice ........................................ Disclosed no confl ict of interest.Longo, Vincenzo .................................... Disclosed no confl ict of interest.Loo, Lawrence ....................................... Disclosed no confl ict of interest.Look, Howard ........................................ Employee: Tidepool; Stock/Shareholder: Dexcom, Inc.Looper, Lisa ........................................... Disclosed no confl ict of interest.Lopes, Claudia S. .................................. Disclosed no confl ict of interest.Lopes, Dominica .................................... Employee: Pfi zer Inc.Lopes-Virella, Maria F. ......................... Disclosed no confl ict of interest.Lopez Bastida, Julio .............................. Disclosed no confl ict of interest.López Cano, Marta ................................ Disclosed no confl ict of interest.Lopez Siguero, Juan Pedro.................... Consultant: Eli Lilly and Company.Lopez, Angel F. ...................................... Disclosed no confl ict of interest.Lopez, Bernard....................................... Disclosed no confl ict of interest.Lopez, Helen .......................................... Disclosed no confl ict of interest.Lopez-Acosta, Jose F. ........................... Disclosed no confl ict of interest.Lopez-Lopez, Ruben............................... Disclosed no confl ict of interest.Lopez-Mejia, Isabel C. .......................... Disclosed no confl ict of interest.López-Mezquita, Elena .......................... Disclosed no confl ict of interest.López-Murillo, Luis D. .......................... Disclosed no confl ict of interest.López-Navia, Ana .................................. Disclosed no confl ict of interest.Lopez-Ocejo, Omar ................................ Disclosed no confl ict of interest.Lorenz, Martin ....................................... Employee: Sanofi -Aventis Deutschland GmbH.Lorenzo, Carlos ...................................... Disclosed no confl ict of interest.Lorenzo, Petra I. .................................... Disclosed no confl ict of interest.Lorgeat, Viviane .................................... Disclosed no confl ict of interest.Los, Evan A. .......................................... Disclosed no confl ict of interest.Lotta, Luca ............................................. Disclosed no confl ict of interest.Lou, Qingqing ........................................ Disclosed no confl ict of interest.Lou, Qinlin ............................................. Disclosed no confl ict of interest.Loubato, Marilia L. ............................... Disclosed no confl ict of interest.Louche, Katie......................................... Disclosed no confl ict of interest.Loughlin, Anita M. ................................ Disclosed no confl ict of interest.Lovato, James ....................................... Disclosed no confl ict of interest.Lovblom, Leif Erik .................................. Disclosed no confl ict of interest.Lovejoy, Anne ........................................ Disclosed no confl ict of interest.

Lovell, Rebecca ..................................... Disclosed no confl ict of interest.Lovshin, Julie A. ................................... Disclosed no confl ict of interest.Lowe, Gordon D. ................................... Disclosed no confl ict of interest.Lowe, Lynn P. ........................................ Disclosed no confl ict of interest.Lowe, Robert ......................................... Disclosed no confl ict of interest.Lowe, William L. .................................. Disclosed no confl ict of interest.Loyd, Christine....................................... Disclosed no confl ict of interest.Löyttyniemi, Eliisa ................................. Disclosed no confl ict of interest.Lu, Bin.................................................... Disclosed no confl ict of interest.Lu, Christine .......................................... Disclosed no confl ict of interest.Lu, Danhong .......................................... Disclosed no confl ict of interest.Lu, Fengdi .............................................. Disclosed no confl ict of interest.Lu, Hongyun........................................... Disclosed no confl ict of interest.Lu, Huijuan ............................................ Disclosed no confl ict of interest.Lu, Jieli .................................................. Disclosed no confl ict of interest.Lu, Jing .................................................. Disclosed no confl ict of interest.Lu, Juming ............................................. Disclosed no confl ict of interest.Lu, Junxi ................................................ Disclosed no confl ict of interest.Lu, Liesheng .......................................... Disclosed no confl ict of interest.Lu, Sumei............................................... Disclosed no confl ict of interest.Lu, Tiantian ............................................ Disclosed no confl ict of interest.Lu, Tong ................................................. Disclosed no confl ict of interest.Lu, Wei .................................................. Disclosed no confl ict of interest.Lu, Xiang................................................ Disclosed no confl ict of interest.Lu, Yingli ................................................ Disclosed no confl ict of interest.Luan, Ju ................................................. Disclosed no confl ict of interest.Lubahn, Dennis B. ................................ Disclosed no confl ict of interest.Luc, Marie ............................................. Employee: Metabolys Inc.Lucchesi, Daniela .................................. Disclosed no confl ict of interest.Luchs, Robert......................................... Disclosed no confl ict of interest.Lucidi, Paola .......................................... Disclosed no confl ict of interest.Lucisano, Giuseppe ............................... Disclosed no confl ict of interest.Ludvigsson, Johnny ............................... Disclosed no confl ict of interest.Ludvik, Anton E. .................................... Disclosed no confl ict of interest.Ludwig-Galezowska, Agnieszka............ Disclosed no confl ict of interest.Luft, Vivian C. ....................................... Disclosed no confl ict of interest.Luiken, Joost ......................................... Disclosed no confl ict of interest.Luippold, Gerd ....................................... Employee: Boehringer Ingelheim GmbH.Luk, Andrea ........................................... Disclosed no confl ict of interest.Lukacs, Krisztina.................................... Disclosed no confl ict of interest.Lum, John W. ....................................... Disclosed no confl ict of interest.Luna, Genoveva F. ................................. Disclosed no confl ict of interest.Lunati, Maria Elena ............................... Disclosed no confl ict of interest.Lund, Asger ........................................... Disclosed no confl ict of interest.Lundboom, Jesper ................................. Disclosed no confl ict of interest.Lundgren, Julie...................................... Disclosed no confl ict of interest.Lundh, Morten ....................................... Disclosed no confl ict of interest.Lundkvist, Per ........................................ Disclosed no confl ict of interest.Lundquist, Christine .............................. Disclosed no confl ict of interest.Lundqvist, Kristin................................... Disclosed no confl ict of interest.Luo, Jin .................................................. Disclosed no confl ict of interest.Luo, Manyu............................................ Disclosed no confl ict of interest.Luo, Moulun .......................................... Disclosed no confl ict of interest.Luo, Shuqin............................................ Employee: VeroScience, LLC.Luo, Sihui............................................... Disclosed no confl ict of interest.Luo, Ting ................................................ Disclosed no confl ict of interest.Luo, Xi.................................................... Disclosed no confl ict of interest.Luo, Yan ................................................. Disclosed no confl ict of interest.Luo, Yili .................................................. Disclosed no confl ict of interest.Luo, Yingying ......................................... Disclosed no confl ict of interest.Luo, Yuqi ................................................ Disclosed no confl ict of interest.Luo, Yuwen ............................................ Disclosed no confl ict of interest.Lutes, Lesley.......................................... Disclosed no confl ict of interest.Lutomirsky, Mario Maldonado .............. Employee: Boehringer Ingelheim GmbH.Lutz, Cathleen........................................ Disclosed no confl ict of interest.Lutz, Céline ............................................ Disclosed no confl ict of interest.Lutz, Michael ......................................... Disclosed no confl ict of interest.Luzi, Livio ............................................... Advisory Panel: AstraZeneca, Johnson & Johnson; Consultant:

McKinsey & Company; Research Support: MOVI Group; Speaker’s Bureau: Eli Lilly and Company, Menarini Group, Novo Nordisk Inc., Sigma-Tau, Sunstar.

Lv, Jing .................................................. Disclosed no confl ict of interest.Lv, Wei ................................................... Disclosed no confl ict of interest.Lv, Xiafei ................................................ Disclosed no confl ict of interest.Ly, Trang T. ............................................ Research Support: Medtronic, Inc.Lybarger, Cindy ...................................... Disclosed no confl ict of interest.Lydic, Todd ............................................. Disclosed no confl ict of interest.Lykov, Alexander P. ............................... Disclosed no confl ict of interest.Lyles, Shannon ...................................... Disclosed no confl ict of interest.Lynch, Cheryl P. ..................................... Disclosed no confl ict of interest.Lynch, Elizabeth B. ............................... Disclosed no confl ict of interest.Lynch, Kristian ....................................... Research Support: National Institutes of Health.Lynes, Matthew D. ............................... Disclosed no confl ict of interest.Lyons, Jasmine G. ................................ Disclosed no confl ict of interest.Lyons, Timothy J. .................................. Disclosed no confl ict of interest.Lyssenko, Valeriya ................................. Employee: Steno Diabetes Center A/S.

A737


AU

THO

R D

ISCL

OSU

RE

Lytvyn, Yuliya ......................................... Disclosed no confl ict of interest.Lyu, Wanqing ........................................ Disclosed no confl ict of interest.Lyubetskaya, Anna ................................ Disclosed no confl ict of interest.M., Dinesha ........................................... Disclosed no confl ict of interest.Ma, Danjun............................................ Disclosed no confl ict of interest.Ma, Delin............................................... Disclosed no confl ict of interest.Ma, Jian-Xing........................................ Disclosed no confl ict of interest.Ma, Jun ................................................. Disclosed no confl ict of interest.Ma, Lin .................................................. Disclosed no confl ict of interest.Ma, Ronald C. ....................................... Disclosed no confl ict of interest.Ma, Shao Gang ..................................... Disclosed no confl ict of interest.Ma, Wei ................................................ Disclosed no confl ict of interest.Ma, Wenjie ........................................... Disclosed no confl ict of interest.Ma, Xiaojing .......................................... Disclosed no confl ict of interest.Ma, Xinliang .......................................... Disclosed no confl ict of interest.Ma, Yuelong .......................................... Disclosed no confl ict of interest.Ma, Yuhang ........................................... Disclosed no confl ict of interest.Ma, Zhulin ............................................. Employee: Novo Nordisk A/S.Maahs, David M. .................................. Advisory Panel: Insulet Corporation; Consultant: Abbott;

Research Support: Dexcom, Inc., Medtronic MiniMed, Inc., Roche Diagnostics.

Mabundo, Lilian .................................... Disclosed no confl ict of interest.Macaraeg, Greg .................................... Employee: AstraZeneca.Maccallini, Gustavo .............................. Disclosed no confl ict of interest.Macchi, Chiara ...................................... Disclosed no confl ict of interest.MacDonald, Patrick E. .......................... Disclosed no confl ict of interest.MacGregor, Grant R. ............................ Disclosed no confl ict of interest.Machann, Jürgen .................................. Disclosed no confl ict of interest.Machicao, Fausto .................................. Disclosed no confl ict of interest.Machineni, Sriram................................. Consultant: Ethicon Endo-Surgery, Inc.Machytka, Evžen ................................... Disclosed no confl ict of interest.MacIsaac, Richard J. ............................ Advisory Panel: AstraZeneca Pharmaceuticals LP; Other

Relationship: Novo Nordisk Inc; Research Support: Medtronic, Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP.

Mack, Laurin.......................................... Disclosed no confl ict of interest.MacKay, Adrienne ................................. Disclosed no confl ict of interest.Mackey, Aaron J. ................................. Disclosed no confl ict of interest.Mackintosh, Stephen ............................ Employee: LifeScan Scotland Ltd.MacLeod, Janice ................................... Employee: WellDoc, Inc.MacMillan, Lindy .................................. Disclosed no confl ict of interest.Macor, Marie ......................................... Disclosed no confl ict of interest.Macrì, Concetta..................................... Disclosed no confl ict of interest.Madala, Akshita .................................... Disclosed no confl ict of interest.Maddaloni, Ernesto ............................... Disclosed no confl ict of interest.Maddox, Thomas M. ............................ Disclosed no confl ict of interest.Maddux, Franklin................................... Disclosed no confl ict of interest.Mader, Julia K. ..................................... Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly and

Company, Merck Sharp & Dohme Corp., Sanofi -Aventis Deutschland GmbH; Consultant: Becton, Dickinson and Company; Speaker’s Bureau: Eli Lilly and Company, Nintamed GmbH&Co.KG, Roche Diagnostics, Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited.

Madiraju, Anila K. ................................ Disclosed no confl ict of interest.Madiraju, Murthy S. ............................. Disclosed no confl ict of interest.Madrigal, Jessica M. ........................... Disclosed no confl ict of interest.Madsbad, Sten ...................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Intarcia Therapeutics, Inc., Johnson & Johnson, MannKind Corporation, Merck Sharp & Dohme Corp., Novartis Pharma AG, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi -Aventis Deutschland GmbH, Zealand Pharma A/S; Speaker’s Bureau: AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi -Aventis Deutschland GmbH.

Madsen, Agnete B. .............................. Disclosed no confl ict of interest.Madsen, Henrik ..................................... Disclosed no confl ict of interest.Maeda, Hiromi ...................................... Disclosed no confl ict of interest.Maeda, Manami.................................... Disclosed no confl ict of interest.Maeda, Marie ....................................... Disclosed no confl ict of interest.Maeda, Shiro......................................... Disclosed no confl ict of interest.Maeda, Yasutaka .................................. Disclosed no confl ict of interest.Maegawa, Hiroshi................................. Research Support: Astellas Pharma Inc., Boehringer-

Mannheim, Merck Sharp & Dohme Corp., Ono Pharmaceutical Co., Ltd., Sanofi U.S., Takeda Pharmaceutical Company Limited.

Maekawa, Satoshi ................................ Disclosed no confl ict of interest.Maestroni, Anna ................................... Disclosed no confl ict of interest.Magadum, Ajit ...................................... Disclosed no confl ict of interest.Magalhaes Montenegro Jr., Renan ...... Research Support: Eli Lilly and Company.Magee, Michelle F. ............................... Disclosed no confl ict of interest.Maggioni, Aldo P. ................................. Other Relationship: Bayer HealthCare, Cardiorentis, Novartis

Pharmaceuticals Corporation; Research Support: Sanofi U.S.

Magi, Reedik ......................................... Disclosed no confl ict of interest.Magkos, Faidon ..................................... Disclosed no confl ict of interest.Magliano, Dianna J. ............................. Disclosed no confl ict of interest.Magnuson, Thomas............................... Disclosed no confl ict of interest.Magre, Jocelyne ................................... Disclosed no confl ict of interest.Maguire, Annie ..................................... Disclosed no confl ict of interest.Magyar, Kendra ..................................... Other Relationship: Tandem Diabetes Care, Inc.Mahabaleshwarkar, Rohan ................... Research Support: Merck Sharp & Dohme Corp.Mahadevan, Jana ................................. Disclosed no confl ict of interest.Mahajan, Anubha.................................. Disclosed no confl ict of interest.Mahajan, Hemant D. ............................ Disclosed no confl ict of interest.Mahantashetti, N. ................................ Disclosed no confl ict of interest.Maharjan, Babu Raja ............................ Disclosed no confl ict of interest.Mahendran, Yuvaraj .............................. Disclosed no confl ict of interest.Mahmud, Farid ...................................... Disclosed no confl ict of interest.Mahmud, Farina J. ............................... Disclosed no confl ict of interest.Mahon, Chantal..................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Maier, Bernhard .................................... Disclosed no confl ict of interest.Maier, Curtis C. .................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Maimon, Shiri........................................ Disclosed no confl ict of interest.Maislos, Maximo .................................. Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S,

Sanofi U.S.; Research Support: Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc., Sanofi U.S.; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S, Sanofi U.S.

Majidi, Shideh ....................................... Disclosed no confl ict of interest.Majkowska, Lilianna ............................. Disclosed no confl ict of interest.Majumdar, Neena ................................. Disclosed no confl ict of interest.Majumdar, Sumit R. ............................. Disclosed no confl ict of interest.Majumder, Anirban ............................... Disclosed no confl ict of interest.Majumder, Syamantak .......................... Disclosed no confl ict of interest.Makaci, Fatna........................................ Disclosed no confl ict of interest.Makadzange, Tariro ............................... Disclosed no confl ict of interest.Makaroff, Lydia E. ................................ Disclosed no confl ict of interest.Makary, Martin...................................... Disclosed no confl ict of interest.Makdissi, Antoine ................................. Disclosed no confl ict of interest.Makhlouf, Michel .................................. Disclosed no confl ict of interest.Makino, Chie ......................................... Disclosed no confl ict of interest.Makino, Hisashi .................................... Disclosed no confl ict of interest.Makita, Sumiko ..................................... Disclosed no confl ict of interest.Makrilakis, Konstantinos ...................... Disclosed no confl ict of interest.Malandrucco, Ilaria ............................... Disclosed no confl ict of interest.Malani, Anup......................................... Consultant: Precision Health Economics; Research Support:

AstraZeneca.Malcolm, Andrew.................................. Disclosed no confl ict of interest.Maldonado, Mario ................................ Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Malecki, Maciej T. ................................ Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly and

Company, Janssen Pharmaceuticals, Inc., Novo Nordisk A/S.

Malek, Goldis ........................................ Disclosed no confl ict of interest.Malhotra, Cheena ................................. Disclosed no confl ict of interest.Malik, Faisal S. ..................................... Disclosed no confl ict of interest.Malik, Jan ............................................. Disclosed no confl ict of interest.Malik, Nilma.......................................... Disclosed no confl ict of interest.Malik, Rayaz A. .................................... Disclosed no confl ict of interest.Malik, Saloni ......................................... Disclosed no confl ict of interest.Malin, Steven K. ................................... Disclosed no confl ict of interest.Malinska, Hana ..................................... Disclosed no confl ict of interest.Malinski, Tadeusz .................................. Disclosed no confl ict of interest.Malipeddi, Bhaskara Rao ...................... Disclosed no confl ict of interest.Malkani, Samir ...................................... Disclosed no confl ict of interest.Mallik, Ritwika ...................................... Disclosed no confl ict of interest.Mallisho, Abdullah ................................ Disclosed no confl ict of interest.Maloney, Maura .................................... Disclosed no confl ict of interest.Maloney, Patrick R. .............................. Disclosed no confl ict of interest.Mamidi, Rao Nvs................................... Employee: Janssen Pharmaceuticals, Inc.Mammen, Cherry................................... Disclosed no confl ict of interest.Mamykina, Lena .................................... Disclosed no confl ict of interest.Mamza, Jil B. ....................................... Disclosed no confl ict of interest.Man, Tengfei ......................................... Employee: Merck Sharp & Dohme Corp.Manabu, Okubo ..................................... Disclosed no confl ict of interest.Manda, Rodrigo..................................... Disclosed no confl ict of interest.Mandalapu, Rathna............................... Disclosed no confl ict of interest.Mandarino, Lawrence J. ...................... Disclosed no confl ict of interest.Mandrup-Poulsen, Thomas ................... Disclosed no confl ict of interest.Manduchi, Elisabetta ............................ Disclosed no confl ict of interest.Manfrini, Silvia...................................... Disclosed no confl ict of interest.Mangalea, Michael ............................... Disclosed no confl ict of interest.Mangan, Meg........................................ Disclosed no confl ict of interest.Manganiello, Vincent C. ....................... Disclosed no confl ict of interest.Mangat, Bhupinder ............................... Disclosed no confl ict of interest.Mangia, Silvia ....................................... Disclosed no confl ict of interest.Mangiafi co, Salvatore ........................... Disclosed no confl ict of interest.Mangione, Carol M. ............................. Disclosed no confl ict of interest.

A738


AU

THO

R D

ISCL

OSU

RE

Manhas, Janisha................................... Disclosed no confl ict of interest.Manicardi, Valeria ................................. Disclosed no confl ict of interest.Manjunatha, Rashmi ............................. Disclosed no confl ict of interest.Mann, David .......................................... Employee: Cellular Dynamics International.Manning, Alisa ...................................... Disclosed no confl ict of interest.Mannino, Gaia....................................... Disclosed no confl ict of interest.Mano, Fumika........................................ Disclosed no confl ict of interest.Manrique, Camila.................................. Research Support: National Institutes of Health.Manroa, Pooja ....................................... Disclosed no confl ict of interest.Manseau, Katherine.............................. Disclosed no confl ict of interest.Mansfi eld, Traci A. ............................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP.Manson, JoAnn ..................................... Disclosed no confl ict of interest.Mansour, Trina ...................................... Disclosed no confl ict of interest.Månsson, Marianne I. .......................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Mantravedi, Manasa G. ....................... Disclosed no confl ict of interest.Mantripragada, Sankaram .................... Employee: AntriaBio; Stock/Shareholder: AntriaBio.Mantzoros, Christos .............................. Disclosed no confl ict of interest.Manuguerra, Roberta ............................ Disclosed no confl ict of interest.Mao, Cuixiu ........................................... Disclosed no confl ict of interest.Mao, Dandan......................................... Disclosed no confl ict of interest.Mapes, Sheila ....................................... Disclosed no confl ict of interest.Marando, Alessandro............................ Disclosed no confl ict of interest.Maratos-Flier, Eleftheria ....................... Disclosed no confl ict of interest.Marc, Linda G. ...................................... Disclosed no confl ict of interest.Marcel, Michael .................................... Disclosed no confl ict of interest.Marchesi, Elisabetta ............................. Disclosed no confl ict of interest.Marchetti, Piero .................................... Disclosed no confl ict of interest.Marcos, Michael ................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Marcovecchio, Loredana ....................... Disclosed no confl ict of interest.Marcovina, Santica ............................... Disclosed no confl ict of interest.Marcucci, Melissa J. ............................ Disclosed no confl ict of interest.Marcus, Marsha D. .............................. Board Member: Weight Watchers International, Inc.; Research

Support: National Institutes of Health.Marechal, Xavier ................................... Disclosed no confl ict of interest.Marek, Kuzniwski .................................. Disclosed no confl ict of interest.Margaritis, Marios ................................ Disclosed no confl ict of interest.Margaron, Philippe................................ Employee: Novartis Pharma AG.Margolis, Karen L. ................................ Disclosed no confl ict of interest.Mari, Andrea ......................................... Disclosed no confl ict of interest.Maria, Zahra.......................................... Disclosed no confl ict of interest.Marin, Ivan ............................................ Disclosed no confl ict of interest.Marina, Michela.................................... Disclosed no confl ict of interest.Marinelli Andreoli, Anna....................... Disclosed no confl ict of interest.Mark, Michael ....................................... Employee: Boehringer Ingelheim GmbH.Markgraf, Daniel ................................... Disclosed no confl ict of interest.Markley, Sara C. ................................... Disclosed no confl ict of interest.Markova, Kateryna ................................ Disclosed no confl ict of interest.Markowitz, Benjamin ............................ Disclosed no confl ict of interest.Marks, Jennifer B. ................................ Disclosed no confl ict of interest.Marques, Jefferson L. .......................... Disclosed no confl ict of interest.Marquez, Alberto .................................. Disclosed no confl ict of interest.Marra, Camillo ...................................... Disclosed no confl ict of interest.Marrano, Nicola .................................... Disclosed no confl ict of interest.Marre, Michel ....................................... Advisory Panel: Intarcia Therapeutics, Inc., Novo Nordisk A/S,

Servier.Marshall, Andrew ................................. Disclosed no confl ict of interest.Marshall, Cassondra ............................. Disclosed no confl ict of interest.Marshall, Nicole.................................... Disclosed no confl ict of interest.Marso, Steven P. .................................. Consultant: Novo Nordisk Inc., St. Jude Medical; Research

Support: Abbott, Amylin Pharmaceuticals, LLC., Novo Nordisk Inc., Terumo Corporation, The Medicines Company.

Martchenko, Alexandre......................... Disclosed no confl ict of interest.Martelli, Elizabeth E. ............................ Disclosed no confl ict of interest.Martí, Luc .............................................. Consultant: Genmedica Therapeutics; Stock/Shareholder:

Genmedica Therapeutics.Martin, Corby K. ................................... Disclosed no confl ict of interest.Martin, Emily ......................................... Disclosed no confl ict of interest.Martin, Guy ........................................... Board Member: Metabolys Inc.; Stock/Shareholder:

Metabolys Inc.Martin, Maximiliano ............................. Disclosed no confl ict of interest.Martin, Stephan .................................... Advisory Panel: Almased Wellness GmbH, Boehringer

Ingelheim GmbH; Research Support: Almased Wellness GmbH, Boehringer Ingelheim GmbH.

Martin, Tonya ........................................ Employee: Janssen Pharmaceuticals, Inc.Martinborough, Esther .......................... Employee: Receptos.Martinez, Diana H. ............................... Disclosed no confl ict of interest.Martinez, Esperanza.............................. Disclosed no confl ict of interest.Martinez, J. Alfredo .............................. Disclosed no confl ict of interest.Martinez, Jenny A. ............................... Disclosed no confl ict of interest.Martinez, Joseph .................................. Employee: Valeritas.Martinez, Micaela ................................. Disclosed no confl ict of interest.Martinez, Rachel ................................... Disclosed no confl ict of interest.Martinez, Robert ................................... Disclosed no confl ict of interest.

Martínez-Abundis, Esperanza ............... Disclosed no confl ict of interest.Martinez-Lemus, Luis ............................ Disclosed no confl ict of interest.Martin-Montalvo, Alejandro ................. Disclosed no confl ict of interest.Martyn-Nemeth, Pamela....................... Disclosed no confl ict of interest.Maruthur, Nisa ...................................... Disclosed no confl ict of interest.Maruyama, Koutatsu............................. Disclosed no confl ict of interest.Maruyama, Takako ................................ Disclosed no confl ict of interest.Marvel, Skylar ....................................... Disclosed no confl ict of interest.Marwaha, N. ........................................ Disclosed no confl ict of interest.Marwitz, Kathryn................................... Disclosed no confl ict of interest.Maryniuk, Melinda D. .......................... Disclosed no confl ict of interest.Mascary, Marie-Christine ..................... Disclosed no confl ict of interest.Maser, Raelene E. ................................ Disclosed no confl ict of interest.Masharani, Umesh ................................ Disclosed no confl ict of interest.Mashek, Douglas G. ............................. Disclosed no confl ict of interest.Mashek, Mara ....................................... Disclosed no confl ict of interest.Masierek, Malgorzata ........................... Employee: Bioton SA.Masindova, Ivica ................................... Disclosed no confl ict of interest.Mason, Graeme..................................... Disclosed no confl ict of interest.Mason, Jane ......................................... Disclosed no confl ict of interest.Mason, R. Preston ................................. Research Support: Financial Support, Pfi zer Inc.Masone Iacobucci, Giovanna ................ Disclosed no confl ict of interest.Mastick, Cynthia Corley ........................ Disclosed no confl ict of interest.Maston, Glenn A. ................................. Employee: Quest Diagnostics.Mastrominas, Minas ............................. Disclosed no confl ict of interest.Masucci, John ....................................... Disclosed no confl ict of interest.Masuda, Daisaku .................................. Research Support: Sanwa Kagaku Kenkyusho Co., Ltd.Masuya, Rie .......................................... Disclosed no confl ict of interest.Mat Adenan, Noor Azmi ....................... Disclosed no confl ict of interest.Mat Husin, Haliza.................................. Disclosed no confl ict of interest.Matejko, Bartłomiej .............................. Disclosed no confl ict of interest.Mateo, Lourdes ..................................... Disclosed no confl ict of interest.Mather, Kieren J. ................................. Research Support: Abbott, Merck & Co., Inc., Novo Nordisk

Inc., Sanofi U.S.Matheson, Della.................................... Disclosed no confl ict of interest.Matheson, Don...................................... Employee: Dose Safety Inc.; Stock/Shareholder: Dose Safety

Inc.Mathew, Anu......................................... Disclosed no confl ict of interest.Mathews, Clayton E. ............................ Disclosed no confl ict of interest.Mathiassen, Ole N. .............................. Disclosed no confl ict of interest.Mathiesen, Elisabeth R. ....................... Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S.Mathieu, Chantal .................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, AstraZeneca

Pharmaceuticals LP, Eli Lilly and Company, Hanmi Pharmaceutical Co., Ltd., Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Pfi zer Inc.; Research Support: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Merck Sharp & Dohme Corp., NOVA Biomedical, Novartis AG, Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH.

Matika, Tafadzwa .................................. Disclosed no confl ict of interest.Matoba, Keiichiro.................................. Disclosed no confl ict of interest.Matoba, Reie......................................... Disclosed no confl ict of interest.Matonti, Gerardina................................ Disclosed no confl ict of interest.Matosz, Sabrina .................................... Disclosed no confl ict of interest.Matsagos, Spiridon ............................... Disclosed no confl ict of interest.Matsagos, Spiros .................................. Disclosed no confl ict of interest.Matsen, Miles ....................................... Disclosed no confl ict of interest.Matsuba, Ikuro ...................................... Research Support: Eli Lilly and Company.Matsubara, Hajime ............................... Disclosed no confl ict of interest.Matsubara, Madoka.............................. Disclosed no confl ict of interest.Matsubayashi, Yasuhiro........................ Research Support: Kowa Company, Ltd. (Spouse/Partner).Matsuda, Hibiki ..................................... Disclosed no confl ict of interest.Matsuda, Masafumi.............................. Disclosed no confl ict of interest.Matsuhashi, Yuki ................................... Disclosed no confl ict of interest.Matsuhisa, Munehide ........................... Research Support: Astellas Pharma Inc., Biomedicalnet,

Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd. (Spouse/Partner), Nihon Unisys, Nikkiso, Tanabe-Mitsubishi (Spouse/Partner); Speaker’s Bureau: Astellas Pharma Inc. (Spouse/Partner), Eli Lilly Japan K.K., Novo Nordisk Inc. (Spouse/Partner), Sanofi , Takeda.

Matsui, Kenichi ..................................... Disclosed no confl ict of interest.Matsui, Masahiko ................................. Disclosed no confl ict of interest.Matsuki, Kota ........................................ Disclosed no confl ict of interest.Matsumoto, Itsuka ................................ Disclosed no confl ict of interest.Matsumoto, Koji.................................... Disclosed no confl ict of interest.Matsumoto, Michihiro .......................... Disclosed no confl ict of interest.Matsumoto, Shinobu............................. Disclosed no confl ict of interest.Matsumura, Koki ................................... Disclosed no confl ict of interest.Matsunaga, Satoshi .............................. Disclosed no confl ict of interest.Matsuo, Miki ......................................... Disclosed no confl ict of interest.Matsuoka, Taka-Aki .............................. Research Support: Astellas Pharma Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim

A739


AU

THO

R D

ISCL

OSU

RE

Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Shionogi Inc., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Matsushita, Maiko ................................ Disclosed no confl ict of interest.Matsushita, Mutsuyoshi ....................... Disclosed no confl ict of interest.Matsushita, Yumi .................................. Disclosed no confl ict of interest.Matsuura, Bunzo ................................... Disclosed no confl ict of interest.Matsuyama, Yutaka .............................. Disclosed no confl ict of interest.Matsuzaki, Motoko ............................... Disclosed no confl ict of interest.Matter, Hans ......................................... Employee: Sanofi -Aventis Deutschland GmbH.Matthaei, Stephan ................................ Advisory Panel: Abbott Diabetes Care Inc., AstraZeneca,

Boehringer Ingelheim GmbH, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Roche Pharmaceuticals, Ypsomed; Speaker’s Bureau: Abbott Diabetes Care Inc., AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk A/S, Roche Pharmaceuticals, Sanofi -Aventis Deutschland GmbH, Ypsomed.

Mattheus, Michaela.............................. Employee: Boehringer Ingelheim GmbH.Matthew, Annie C. ............................... Disclosed no confl ict of interest.Matthews, Jeffrey ................................ Disclosed no confl ict of interest.Mattingly, Megan.................................. Disclosed no confl ict of interest.Matveyenko, Aleksey ............................ Disclosed no confl ict of interest.Maugard, Thierry................................... Board Member: Valbiotis.Maurizi, Anna Rita ................................ Disclosed no confl ict of interest.Maurovich-Horvat, Pál .......................... Disclosed no confl ict of interest.Mauseth, Richard .................................. Employee: Dose Safety Inc.; Stock/Shareholder: Dose Safety

Inc.Mauvais-Jarvis, Franck ......................... Consultant: Pfi zer Inc.; Research Support: Pfi zer Inc.Mawani, Minaz ..................................... Disclosed no confl ict of interest.Maxwell, Alexander P. ......................... Disclosed no confl ict of interest.May, Coral S. ........................................ Consultant: PTS Diagnostics; Employee: eTrueNorth.May, Michael A. ................................... Disclosed no confl ict of interest.Mayberry, Lindsay S. ............................ Disclosed no confl ict of interest.Mayer-Davis, Elizabeth J. .................... Disclosed no confl ict of interest.Mayoux, Eric W. ................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Mazidi, Moshen .................................... Disclosed no confl ict of interest.Mazur, Artur .......................................... Disclosed no confl ict of interest.Mbanya, Armand................................... Disclosed no confl ict of interest.McAullay, Daniel ................................... Disclosed no confl ict of interest.McBride, Jeffrey D. .............................. Disclosed no confl ict of interest.McCall, Anthony L. ............................... Disclosed no confl ict of interest.McCallum, Richard W. ......................... Disclosed no confl ict of interest.McCance, David .................................... Disclosed no confl ict of interest.McCann, Erika ....................................... Disclosed no confl ict of interest.McCann, Maximilian ............................. Disclosed no confl ict of interest.McCarthy, Mark I. ................................. Disclosed no confl ict of interest.McCarthy, Timothy J. ........................... Employee: Pfi zer Inc.McClain, Donald A. .............................. Disclosed no confl ict of interest.McClain, Richard ................................... Disclosed no confl ict of interest.McCoin, Colin ........................................ Disclosed no confl ict of interest.McCommis, Kyle S. .............................. Disclosed no confl ict of interest.McConahey, Brent ................................. Disclosed no confl ict of interest.McConnell, Daniel................................. Disclosed no confl ict of interest.McCoy, Rozalina G. .............................. Research Support: Mayo Clinic Kern Center for the Science of

Health Care Delivery.McDaniel, Kristen ................................. Disclosed no confl ict of interest.McDermott, Brenda............................... Employee: ALPCO.McDermott, John .................................. Disclosed no confl ict of interest.McDonald, Mary ................................... Employee: Janssen Pharmaceuticals, Inc.McDonald, Nicole ................................. Disclosed no confl ict of interest.McDonald, Patricia................................ Disclosed no confl ict of interest.McDonald, William G. .......................... Employee: Metabolic Solutions Development Company, LLC.;

Stock/Shareholder: Metabolic Solutions Development Company, LLC.

McDonnell, Lauren ................................ Disclosed no confl ict of interest.McDowell, Ruth E. ............................... Disclosed no confl ict of interest.McEntee, Michael ................................. Consultant: PTS Diagnostics; Employee: eTrueNorth.McEwan, Phil ........................................ Research Support: AstraZeneca, Bristol-Myers Squibb

Company, GlaxoSmithKline, Lilly Deutschland GmbH, Novo Nordisk A/S, Sanofi U.S.

Mcfarland, Raymie ................................ Disclosed no confl ict of interest.McFayden, Caitlin ................................. Disclosed no confl ict of interest.McGavock, Jonathan ............................ Disclosed no confl ict of interest.McGill, Janet B. ................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Eli Lilly and Company, Janssen Pharmaceuticals,

Inc., Merck & Co., Inc., Novo Nordisk Inc; Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.; Research Support: Dexcom, Inc., Intarcia Therapeutics, Inc., Lexicon Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Pfi zer Inc.; Speaker’s Bureau: Janssen Pharmaceuticals, Inc.

McGinty, James .................................... Disclosed no confl ict of interest.McGough, Peter .................................... Disclosed no confl ict of interest.McGovern, Andrew P. ........................... Research Support: Eli Lilly and Company.McGowan, Barbara M. ......................... Disclosed no confl ict of interest.McGrail, Kieran ..................................... Disclosed no confl ict of interest.McGrath, Maureen T. ........................... Disclosed no confl ict of interest.McGrath, Rachel ................................... Disclosed no confl ict of interest.McGraw, Timothy E. ............................. Disclosed no confl ict of interest.McGregor, Brett A. ............................... Disclosed no confl ict of interest.McGuire, Darren K. .............................. Consultant: Janssen Pharmaceuticals, Inc., Merck Sharp

& Dohme Corp., Novo Nordisk Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S.; Other Relationship: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Takeda Development Center Americas, Inc.

McGurnaghan, Stuart............................ Disclosed no confl ict of interest.McKay, Siripoom V. .............................. Disclosed no confl ict of interest.McKeever, Edward ................................ Disclosed no confl ict of interest.McKeigue, Paul ..................................... Disclosed no confl ict of interest.McKnight, Amy J. ................................. Disclosed no confl ict of interest.McKusick, Michael A. .......................... Disclosed no confl ict of interest.McLaughlin, Tracey L. .......................... Advisory Panel: AstraZeneca; Consultant: Eiger

Biopharmaceuticals; Stock/Shareholder: Eiger Biophparmaceuticals.

McLeese, Rebecca ................................ Disclosed no confl ict of interest.Mclellan, Katia ...................................... Disclosed no confl ict of interest.McLennan, Susan.................................. Disclosed no confl ict of interest.McMahon, Chantal M. ......................... Employee: Medtronic, Inc.McManus, Ruth M. .............................. Disclosed no confl ict of interest.McMullen, William ............................... Disclosed no confl ict of interest.McMurray, John J. ............................... Other Relationship: Duke University, GlaxoSmithKline, Merck

& Co., Inc., Novartis Pharmaceuticals Corporation, Oxford University, Theracos, Inc.; Research Support: Sanofi U.S.

McNair, Andrew .................................... Disclosed no confl ict of interest.McNamara, Coleen A. .......................... Disclosed no confl ict of interest.McNeill, Ann Marie .............................. Employee: Merck & Co., Inc.McPhaul, Michael J. ............................ Employee: Quest Diagnostics.McPhillips, Sarah E. ............................. Disclosed no confl ict of interest.McQueen, Matthew .............................. Disclosed no confl ict of interest.McQueen, Robert B. ............................. Consultant: AstraZeneca Pharmaceuticals LP; Research

Support: AstraZeneca Pharmaceuticals LP.McTigue, Kathleen M. .......................... Disclosed no confl ict of interest.Mdaki, Kennedy S. ............................... Disclosed no confl ict of interest.Mdingi, Colleen E. ................................ Employee: Senseonics, Inc.Meadows, Aaron S. ............................. Disclosed no confl ict of interest.Medici, Valentina .................................. Disclosed no confl ict of interest.Medina, Jesús....................................... Employee: AstraZeneca.Medina, José L. .................................... Disclosed no confl ict of interest.Medline, Alan........................................ Disclosed no confl ict of interest.Meegalla, Sanath.................................. Employee: Janssen Pharmaceuticals, Inc.Meehan, Colette ................................... Disclosed no confl ict of interest.Meek, Shon ........................................... Disclosed no confl ict of interest.Megard, Catherine ................................ Employee: Sanofi -Aventis Deutschland GmbH.Megret, Claire ....................................... Employee: ADOCIA.Megro, Shu............................................ Disclosed no confl ict of interest.Mehana, Amir E. .................................. Disclosed no confl ict of interest.Mehra, Rakesh ...................................... Disclosed no confl ict of interest.Mehrotra, Rajeev .................................. Disclosed no confl ict of interest.Mehta, Aditya ....................................... Disclosed no confl ict of interest.Mehta, Amee ........................................ Employee: Marvel Life Sciences Ltd.Mehta, Cyrus R. .................................... Employee: Cytel Inc.Mehta, Rajnikant................................... Disclosed no confl ict of interest.Mehta, Roopa........................................ Advisory Panel: Amgen Inc., AstraZeneca, Boehringer

Ingelheim GmbH, Janssen Pharmaceuticals, Inc., Novo Nordisk A/S; Speaker’s Bureau: Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk A/S.

Mehta, Sanjeev N. ............................... Disclosed no confl ict of interest.Meier, Anja ............................................ Disclosed no confl ict of interest.Meier, Daniel ......................................... Disclosed no confl ict of interest.Meier, Juris J. ...................................... Advisory Panel: AstraZeneca, Bristol-Myers Squibb Company,

Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Board Member: AstraZeneca, Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Research Support: Eli Lilly and Company, Merck Sharp &

A740


AU

THO

R D

ISCL

OSU

RE

Dohme Corp., Novartis Pharma GmbH, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: AstraZeneca, Berlin-Chemie, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk Inc., Roche Pharmaceuticals, Sanofi -Aventis Deutschland GmbH.

Meiffren, Grégory.................................. Employee: ADOCIA; Stock/Shareholder: ADOCIA.Meigs, James B. .................................. Disclosed no confl ict of interest.Meincke, Henrik H. ............................... Employee: Novo Nordisk A/S.Meininger, Gary ..................................... Employee: Janssen Research & Development, LLC.Meininger, Gerald ................................. Disclosed no confl ict of interest.Mejia, Roberto ...................................... Disclosed no confl ict of interest.Melander, Olle ....................................... Disclosed no confl ict of interest.Melidonis, Andreas ............................... Disclosed no confl ict of interest.Melior, Anita ......................................... Disclosed no confl ict of interest.Mellati, Mahnaz .................................... Disclosed no confl ict of interest.Melton, Stephanie T. ............................ Disclosed no confl ict of interest.Mende, Christian................................... Speaker’s Bureau: AstraZeneca.Méndez Pérez, María ............................ Employee: Sanofi -Aventis Deutschland GmbH.Mendez, Carlos E. ................................ Disclosed no confl ict of interest.Mendivil, Carlos O. ............................... Advisory Panel: Janssen Pharmaceuticals, Inc., Merck &

Co., Inc., Novo Nordisk A/S; Speaker’s Bureau: Janssen Pharmaceuticals, Inc., Merck Serono, Novo Nordisk A/S.

Mendola, Pauline .................................. Disclosed no confl ict of interest.Mendonca, Christine ............................. Disclosed no confl ict of interest.Mendoza, Helen A. ............................... Disclosed no confl ict of interest.Meneghini, Luigi F. ............................... Advisory Panel: Novo Nordisk Inc., Sanofi U.S.; Consultant:

Novo Nordisk Inc., Sanofi U.S.Meneilly, Graydon ................................. Disclosed no confl ict of interest.Meng, Fantao ........................................ Disclosed no confl ict of interest.Meng, Jie .............................................. Consultant: Amgen Inc., Sanofi U.S.Meng, Ling Ling..................................... Disclosed no confl ict of interest.Meng, Lingjin ........................................ Disclosed no confl ict of interest.Meng, Shu ............................................. Disclosed no confl ict of interest.Meng, Wen ........................................... Disclosed no confl ict of interest.Menichetti, Francesco........................... Disclosed no confl ict of interest.Menjivar, Marta .................................... Disclosed no confl ict of interest.Menke, Andy ......................................... Disclosed no confl ict of interest.Menoni, Maria C. ................................. Disclosed no confl ict of interest.Mensberg, Pernille ................................ Disclosed no confl ict of interest.Mentz, Robert........................................ Consultant: Janssen Pharmaceuticals, Inc., Novartis

Pharmaceuticals Corporation, ResMed; Research Support: Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline, National Institutes of Health, Novartis Pharmaceuticals Corporation, Otsuka Pharmaceutical Co., Ltd., ResMed.

Meoli, Luca............................................ Research Support: Eli Lilly and Company.Mercado, Carla I. .................................. Disclosed no confl ict of interest.Mercado-Matos, Jose........................... Disclosed no confl ict of interest.Merchant, Anwar .................................. Disclosed no confl ict of interest.Merenda, Christine ............................... Disclosed no confl ict of interest.Mereu, Laurie ........................................ Research Support: Merck & Co., Inc.Merino, Maria ....................................... Disclosed no confl ict of interest.Merioud, Badreddine ............................ Disclosed no confl ict of interest.Merjaneh, Lina ...................................... Disclosed no confl ict of interest.Merkel, Janie ........................................ Disclosed no confl ict of interest.Merkely, Béla ........................................ Disclosed no confl ict of interest.Merlotti, Claudia ................................... Disclosed no confl ict of interest.Merrins, Matthew J. ............................ Disclosed no confl ict of interest.Mersereau, Margaret............................ Disclosed no confl ict of interest.Merton, Katherine ................................. Employee: Janssen Scientifi c Affairs, LLC.Mesa, Jordi ........................................... Disclosed no confl ict of interest.Messer, Laurel H. ................................. Disclosed no confl ict of interest.Messier, Virginie ................................... Disclosed no confl ict of interest.Messiniti, Valentina .............................. Disclosed no confl ict of interest.Metspalu, Andres.................................. Disclosed no confl ict of interest.Metzger, Boyd E. .................................. Disclosed no confl ict of interest.Meulemans, Ann ................................... Disclosed no confl ict of interest.Meurer, John ......................................... Disclosed no confl ict of interest.Meyer, Barbara J. ................................. Disclosed no confl ict of interest.Meyer, Laurent ...................................... Disclosed no confl ict of interest.Meyers, Juliana .................................... Other Relationship: RTI Health Solutions, Sanofi U.S.Mezuk, Briana ....................................... Disclosed no confl ict of interest.Mezza, Teresa ....................................... Disclosed no confl ict of interest.Miao, Dongmei...................................... Disclosed no confl ict of interest.Miarka, Przemysław .............................. Disclosed no confl ict of interest.Mical, Marie.......................................... Employee: Sanofi .Miccoli, Roberto .................................... Disclosed no confl ict of interest.Michaeli, Shalom .................................. Disclosed no confl ict of interest.Michaliszyn, Sara F. ............................. Disclosed no confl ict of interest.Michels, Aaron W. ............................... Disclosed no confl ict of interest.Middleton, Timothy L. .......................... Research Support: Merck Sharp & Dohme Corp.Midyett, Kurt ......................................... Advisory Panel: Abbott Diabetes Care Inc.; Research Support:

Abbott Diabetes Care Inc.Miernik, Jadwiga .................................. Disclosed no confl ict of interest.

Miftaraj, Mervete.................................. Disclosed no confl ict of interest.Migliano, M. ......................................... Disclosed no confl ict of interest.MiJeong, Kim ........................................ Disclosed no confl ict of interest.Mikami, Dean ........................................ Disclosed no confl ict of interest.Mikami, Takahisa .................................. Disclosed no confl ict of interest.Mikeladze, Maia ................................... Disclosed no confl ict of interest.Miki, Akane ........................................... Disclosed no confl ict of interest.Miki, Tetsuro ......................................... Disclosed no confl ict of interest.Mikkelsen, Kristian H. .......................... Disclosed no confl ict of interest.Mikkelsen, Tarjei ................................... Employee: 10X Genomics.Milanov, Valentin .................................. Disclosed no confl ict of interest.Milenkovic, Tatjana ............................... Disclosed no confl ict of interest.Miles, John M. ..................................... Advisory Panel: Sanofi U.S.Miles, Kevin .......................................... Disclosed no confl ict of interest.Milicevic, Zvonko .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Milinovich, Alex .................................... Research Support: Merck & Co., Inc., Novo Nordisk Inc.Millan-Ferro, Andreina .......................... Disclosed no confl ict of interest.Miller, Bernard V. .................................. Disclosed no confl ict of interest.Miller, David .......................................... Disclosed no confl ict of interest.Miller, Kellee M. .................................. Disclosed no confl ict of interest.Miller, Lesley ......................................... Employee: LifeScan, Inc.Miller, Michael ...................................... Consultant: AstraZeneca; Employee: Merck & Co., Inc; Stock/

Shareholder: Merck & Co., Inc.Miller, Rachel G. ................................... Disclosed no confl ict of interest.Miller, Susan H. .................................... Employee: PTS Diagnostics.Miller, William P. .................................. Disclosed no confl ict of interest.Mills, Deirdre ........................................ Disclosed no confl ict of interest.Milne, Michele ...................................... Disclosed no confl ict of interest.Milne, Roberta E. ................................. Disclosed no confl ict of interest.Min, Jea Young ..................................... Disclosed no confl ict of interest.Min, Kyung Wan ................................... Disclosed no confl ict of interest.Min, Se Hee .......................................... Disclosed no confl ict of interest.Minagawa, Shinya ................................ Disclosed no confl ict of interest.Minami, Hisaka ..................................... Disclosed no confl ict of interest.Minami, Isao ......................................... Disclosed no confl ict of interest.Minamoto, Mayu................................... Disclosed no confl ict of interest.Mine, Keiichiro ...................................... Disclosed no confl ict of interest.Mine, Yusuke ......................................... Disclosed no confl ict of interest.Minervini, Gianmaria ............................ Employee: AstraZeneca.Ming, Jie ............................................... Disclosed no confl ict of interest.Mingrone, Geltrude ............................... Consultant: Fractyl, Novo Nordisk A/S; Research Support:

AstraZeneca, Fractyl, MetaCure Inc.Miranda, Érique J. ................................ Disclosed no confl ict of interest.Mirasol, Roberto ................................... Advisory Panel: AstraZeneca, Eli Lilly and Company, Genzyme

Corporation, Merck & Co., Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S; Research Support: Eli Lilly and Company.

Mirmira, Raghavendra G. ..................... Disclosed no confl ict of interest.Mirrahimi, Arash ................................... Disclosed no confl ict of interest.Mishra, Ina ............................................ Disclosed no confl ict of interest.Mishra, Keerteshwrya........................... Disclosed no confl ict of interest.Mishra, Nitish ....................................... Disclosed no confl ict of interest.Misnikova, Inna V. ................................ Disclosed no confl ict of interest.Misra, Shivani ....................................... Disclosed no confl ict of interest.Mistretta, Frederic ................................ Disclosed no confl ict of interest.Mita, Tomoya ........................................ Research Support: Merck & Co., Inc., Takeda Pharmaceutical

Company Limited.Mitchell, Madeline................................ Disclosed no confl ict of interest.Mitchell, Todd W. ................................. Disclosed no confl ict of interest.Mitri, Joanna......................................... Disclosed no confl ict of interest.Mitsumatsu, Takako .............................. Disclosed no confl ict of interest.Mittman, Neal ....................................... Disclosed no confl ict of interest.Miura, Masaki ....................................... Research Support: Eli Lilly Japan K.K., Novartis Pharma K.K.,

Taisho Pharmaceutical Co., Ltd.Miura, Yoshiko ...................................... Disclosed no confl ict of interest.Miyachi, Yasutaka ................................. Disclosed no confl ict of interest.Miyada, Kayoko..................................... Disclosed no confl ict of interest.Miyagi, Masahiko ................................. Disclosed no confl ict of interest.Miyajima, Katsuhiro .............................. Disclosed no confl ict of interest.Miyake, Kana ........................................ Disclosed no confl ict of interest.Miyake, Teruki ....................................... Disclosed no confl ict of interest.Miyake, Yoshihiro.................................. Disclosed no confl ict of interest.Miyakoshi, Takahiro .............................. Disclosed no confl ict of interest.Miyamura, Keitaro ................................ Disclosed no confl ict of interest.Miyaoka, Hiroaki ................................... Disclosed no confl ict of interest.Miyashita, Naoko .................................. Disclosed no confl ict of interest.Miyashita, Shizuka ................................ Disclosed no confl ict of interest.Miyata, Ichiro ........................................ Disclosed no confl ict of interest.Miyatsuka, Takeshi ............................... Research Support: Eli Lilly Japan K.K., Novartis Pharma K.K.,

Taisho Pharmaceutical Co., Ltd.Miyoshi, Hideaki ................................... Disclosed no confl ict of interest.Miyoshi, Masashi.................................. Disclosed no confl ict of interest.Mizgier, Maria L. .................................. Disclosed no confl ict of interest.Mizubayashi, Ryuichi ............................ Disclosed no confl ict of interest.Mizukami, Hiroki ................................... Disclosed no confl ict of interest.

A741


AU

THO

R D

ISCL

OSU

RE

Mizuno, Ken .......................................... Employee: Kowa Company, Ltd.Mizutani, Humio .................................... Disclosed no confl ict of interest.Mlynarchik, Andrew .............................. Disclosed no confl ict of interest.Mo, Cecilia ............................................ Disclosed no confl ict of interest.Mo, Yongzhen........................................ Disclosed no confl ict of interest.Mobarrez, Fariborz ................................ Disclosed no confl ict of interest.Mody, Nimesh ....................................... Disclosed no confl ict of interest.Moeller, Jan K. ..................................... Disclosed no confl ict of interest.Moffa, Simona ...................................... Disclosed no confl ict of interest.Moffat, Scott D. ................................... Disclosed no confl ict of interest.Mogre, Saie........................................... Employee: Berg Health; Stock/Shareholder: Berg Health.Mohamad Hanapi, Nur Sulwana .......... Disclosed no confl ict of interest.Mohamed Ismail, Nor Azlin .................. Disclosed no confl ict of interest.Mohamed, Muhammad......................... Disclosed no confl ict of interest.Mohamed, Wael ................................... Disclosed no confl ict of interest.Mohamedagic, Cynthia ......................... Disclosed no confl ict of interest.Mohammad, Rima A. ........................... Disclosed no confl ict of interest.Mohammed, Sahar D. .......................... Disclosed no confl ict of interest.Mohammedi, Kamel .............................. Other Relationship: Boehringer Ingelheim Pharmaceuticals,

Inc., Eli Lilly and Company, Novo Nordisk A/S; Speaker’s Bureau: Merck Sharp & Dohme Corp., Novo Nordisk A/S.

Mohan, Sailesh ..................................... Disclosed no confl ict of interest.Mohan, Viswanathan ............................ Disclosed no confl ict of interest.Mohanraj, Rajesh .................................. Disclosed no confl ict of interest.Mohanty, Alina ...................................... Disclosed no confl ict of interest.Mohd Shariff, Zalilah ............................ Disclosed no confl ict of interest.Mohd Yusof, Barakatun Nisak .............. Disclosed no confl ict of interest.Moheet, Amir ........................................ Disclosed no confl ict of interest.Moin, Tannaz ......................................... Disclosed no confl ict of interest.Moineddin, Rahim ................................. Disclosed no confl ict of interest.Moinet, Gérard ...................................... Stock/Shareholder: Metabolys Inc.Moises, Regina C. ................................ Disclosed no confl ict of interest.Mojiminiyi, Olusegun ............................ Disclosed no confl ict of interest.Mojonnier, Alex ..................................... Disclosed no confl ict of interest.Mokhashi, Moinuddin H. ...................... Disclosed no confl ict of interest.Moldovan, Leni...................................... Disclosed no confl ict of interest.Mol da, Piotr.......................................... Disclosed no confl ict of interest.Molinari, Claudia................................... Disclosed no confl ict of interest.Molitch, Mark E. ................................... Consultant: Ipsen Bioscience, Inc., Janssen Biotech, Inc.,

Merck & Co., Inc., Novartis AG, Novo Nordisk Inc., Pfi zer Inc., Takeda Pharmaceutical Company Limited; Research Support: Bayer HealthCare, Ipsen Bioscience, Inc., Johnson & Johnson, Novartis AG, Novo Nordisk Inc.

Møller, Niels .......................................... Disclosed no confl ict of interest.Molven, Anders ..................................... Disclosed no confl ict of interest.Molyneaux, Lynda ................................. Disclosed no confl ict of interest.Monbaliu, Diethard ............................... Disclosed no confl ict of interest.Mondesir, Debbie .................................. Disclosed no confl ict of interest.Mondragon, Angeles............................. Disclosed no confl ict of interest.Monnier, Louis ....................................... Disclosed no confl ict of interest.Monson, Rebecca S. ............................ Disclosed no confl ict of interest.Montaigne, David.................................. Disclosed no confl ict of interest.Montanucci, Pia .................................... Disclosed no confl ict of interest.Montaser, Eslam ................................... Disclosed no confl ict of interest.Montedoro, Anna .................................. Disclosed no confl ict of interest.Monteiro Carvalho Mori Cunha, Joao Paulo........................................ Disclosed no confl ict of interest.Monteiro, Pedro .................................... Advisory Panel: Bristol-Myers Squibb Company, Boehringer

Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Pfi zer Inc.; Consultant: AstraZeneca, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Pfi zer Inc.; Employee: Coimbra University Hospital and Medical School; Research Support: Bayer HealthCare, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Pfi zer Inc.

Montejano, Leslie ................................. Employee: Truven Health Analytics.Montenegro, Ana Paula ........................ Disclosed no confl ict of interest.Montenegro Jr., Renan ......................... Disclosed no confl ict of interest.Montesano, Anna.................................. Disclosed no confl ict of interest.Montgomery, Joshua ............................ Disclosed no confl ict of interest.Montgomery, Vicki ................................ Disclosed no confl ict of interest.Montufar-Robles, Isela ......................... Disclosed no confl ict of interest.Moody, Alan .......................................... Disclosed no confl ict of interest.Moon, Jae Hoon.................................... Disclosed no confl ict of interest.Moon, Mi Jin......................................... Disclosed no confl ict of interest.Moon, Min Kyong.................................. Disclosed no confl ict of interest.Moon, Sun Joon .................................... Disclosed no confl ict of interest.Moon, Sung Dae ................................... Disclosed no confl ict of interest.Moon, Woo-Kyung ................................ Disclosed no confl ict of interest.Mooney, Elizabeth Ann ......................... Disclosed no confl ict of interest.Moonsammy, Akisha ............................. Disclosed no confl ict of interest.Moore, Daniel J. .................................. Disclosed no confl ict of interest.Moore, Joshua A. ................................. Disclosed no confl ict of interest.Moore, Kathryn ..................................... Disclosed no confl ict of interest.Moore, Kelly .......................................... Disclosed no confl ict of interest.Moore, L. Merkle................................... Disclosed no confl ict of interest.

Moore, Mary Courtney .......................... Disclosed no confl ict of interest.Moosavi, Mandana ............................... Disclosed no confl ict of interest.Mor, Anil ................................................ Disclosed no confl ict of interest.Moraes, Ana C. .................................... Disclosed no confl ict of interest.Moraes-Vieira, Pedro M. ...................... Disclosed no confl ict of interest.Morahan, Grant ..................................... Disclosed no confl ict of interest.Moran, Antoinette................................. Advisory Panel: Caladrius Biosciences, Medtronic, Inc.,

Novo Nordisk Inc., Vertex; Consultant: CordUse, Debiopharm Group, Pfi zer Inc.; Research Support: Novartis Pharmaceuticals Corporation, Pfi zer Inc., Prochymal, Tolerx.

Moran, Brett A. .................................... Disclosed no confl ict of interest.Moran, John .......................................... Employee: Pro Metic Bio Sciences Inc.; Stock/Shareholder: Pro

Metic Bio Sciences Inc.Morariu, Elena....................................... Disclosed no confl ict of interest.Morawska, Iwona ................................. Disclosed no confl ict of interest.Mordes, John P. .................................... Disclosed no confl ict of interest.Moreira, Gabriela V. ............................. Disclosed no confl ict of interest.Morel, Didier R. .................................... Employee: Becton, Dickinson and Company; Stock/

Shareholder: Becton, Dickinson and Company.Moreno, Cesar....................................... Disclosed no confl ict of interest.Moreno, Veronica .................................. Employee: Janssen Pharmaceuticals, Inc.Morford, Jamie ..................................... Disclosed no confl ict of interest.Morgan, Christopher L. ........................ Research Support: Abbott, AstraZeneca, Novartis

Pharmaceuticals Corporation, Pfi zer Inc.Morgan, Katherine A. ........................... Disclosed no confl ict of interest.Morgan, Nadine N. .............................. Disclosed no confl ict of interest.Morgan-Bathke, Maria.......................... Disclosed no confl ict of interest.Mori, Yusaku ......................................... Disclosed no confl ict of interest.Morieri, Mario-Luca .............................. Research Support: Hearst Foundation.Morigny, Pauline ................................... Disclosed no confl ict of interest.Morikawa, Shuntaro ............................. Disclosed no confl ict of interest.Morino, Katsutaro ................................. Disclosed no confl ict of interest.Morita, Hiroyuki .................................... Disclosed no confl ict of interest.Morita, Naru.......................................... Disclosed no confl ict of interest.Morita, Tomoko ..................................... Disclosed no confl ict of interest.Moriya, Chihiro Tsukagoshi ................... Disclosed no confl ict of interest.Moriya, Tatsumi .................................... Disclosed no confl ict of interest.Moro, Cedric.......................................... Disclosed no confl ict of interest.Morris, Andrew ..................................... Disclosed no confl ict of interest.Morris, E. Matthew ............................... Disclosed no confl ict of interest.Morris, Heather L. ................................ Disclosed no confl ict of interest.Morris, Kristin ....................................... Employee: Pacifi c Diabetes Technologies, Inc.; Stock/

Shareholder: Pacifi c Diabetes Technologies, Inc.Morrisey, Robin ..................................... Disclosed no confl ict of interest.Morrison, Alanna C. ............................. Disclosed no confl ict of interest.Morrow, Connie C. ............................... Disclosed no confl ict of interest.Morrow, Linda ....................................... Employee: Profi l Institute for Clinical Research, Inc.Morton, Daniel ...................................... Disclosed no confl ict of interest.Morton, Gregory J. ............................... Disclosed no confl ict of interest.Morton-Eggleston, Emma B. ................ Disclosed no confl ict of interest.Moscardó, Vanessa ............................... Disclosed no confl ict of interest.Mosinski, J. David................................. Disclosed no confl ict of interest.Moss, Larry G. ...................................... Disclosed no confl ict of interest.Moss, Neil ............................................. Disclosed no confl ict of interest.Mostello, Dorothea J. .......................... Disclosed no confl ict of interest.Mostoller, Kate ...................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Mota, Eugen .......................................... Disclosed no confl ict of interest.Mota, Maria .......................................... Disclosed no confl ict of interest.Mota, Vanessa ...................................... Disclosed no confl ict of interest.Motabar, Ali .......................................... Disclosed no confl ict of interest.Motala, Ayesha A. ............................... Disclosed no confl ict of interest.Motegi, Mikio........................................ Disclosed no confl ict of interest.Motiani, Kumail K. ............................... Disclosed no confl ict of interest.Motoki, Takanori ................................... Disclosed no confl ict of interest.Motsinger-Reif, Alison A. .................... Disclosed no confl ict of interest.Mottalib, Adham ................................... Disclosed no confl ict of interest.Mottl, Amy K. ....................................... Disclosed no confl ict of interest.Mottola, Michelle ................................. Disclosed no confl ict of interest.Mouritzen, Ulrik..................................... Employee: Zealand Pharma A/S.Mousa, Aya ........................................... Disclosed no confl ict of interest.Mousiolis, Athanasios C. ..................... Disclosed no confl ict of interest.Moutaouakil, Abdeljalil......................... Disclosed no confl ict of interest.Moutengou, Elodie ................................ Disclosed no confl ict of interest.Moyama, Shota ..................................... Disclosed no confl ict of interest.Mozdzan, Michal ................................... Disclosed no confl ict of interest.Mrad, Georges ...................................... Disclosed no confl ict of interest.Mraz, Milos ........................................... Disclosed no confl ict of interest.Mrozinska, Sandra ................................ Disclosed no confl ict of interest.Mruk, Magdalena.................................. Disclosed no confl ict of interest.Msallaty, Zaher ..................................... Disclosed no confl ict of interest.Mu, Panwei ........................................... Disclosed no confl ict of interest.Mu, Yiming ............................................ Disclosed no confl ict of interest.Mu, Yiming ............................................ Research Support: Medtronic, Inc.Muccio, Donald ..................................... Disclosed no confl ict of interest.

A742


AU

THO

R D

ISCL

OSU

RE

Mudaliar, Sunder ................................... Disclosed no confl ict of interest.Muehlbauer, Michael ............................ Disclosed no confl ict of interest.Mueller, Heidi ........................................ Disclosed no confl ict of interest.Mueller, Noel T. .................................... Disclosed no confl ict of interest.Muendlein, Axel .................................... Disclosed no confl ict of interest.Muessig, Karsten .................................. Disclosed no confl ict of interest.Mugabo, Yves ....................................... Disclosed no confl ict of interest.Muhamedagic, Cynthia A. .................... Disclosed no confl ict of interest.Mujahed, Ayman ................................... Disclosed no confl ict of interest.Mujahed, Osama ................................... Disclosed no confl ict of interest.Muka, Taulant ....................................... Disclosed no confl ict of interest.Mukai, Naoko ........................................ Disclosed no confl ict of interest.Mukane, Maija ...................................... Disclosed no confl ict of interest.Mukans, Maksims ................................. Disclosed no confl ict of interest.Mukherjee, Jayanti ............................... Employee: Bristol-Myers Squibb Company; Stock/Shareholder:

Bristol-Myers Squibb Company.Mulchan, Siddika .................................. Disclosed no confl ict of interest.Muller, Carole ........................................ Disclosed no confl ict of interest.Muller, Sarah ......................................... Disclosed no confl ict of interest.Muller, Yunhua ...................................... Disclosed no confl ict of interest.Müller-Wieland, Dirk ............................ Advisory Panel: AstraZeneca, Merck & Co., Inc., Novartis AG,

Sanofi U.S.; Consultant: AstraZeneca, Merck & Co., Inc., Novartis AG, Sanofi U.S.; Speaker’s Bureau: Amgen Inc., AstraZeneca, Merck Sharp & Dohme Corp., Novartis AG, Sanofi U.S.

Multsyn, Darya ...................................... Disclosed no confl ict of interest.Mulukutla, Surya N. ............................. Disclosed no confl ict of interest.Mulvaney, Ashling................................. Employee: AstraZeneca Pharmaceuticals LP.Mulvaney, Shelagh A. .......................... Disclosed no confl ict of interest.Mulya, Anny .......................................... Disclosed no confl ict of interest.Mundi, Manpreet .................................. Disclosed no confl ict of interest.Mune, Tomoatsu ................................... Disclosed no confl ict of interest.Munir, Iqbal ........................................... Disclosed no confl ict of interest.Muniyappa, Ranganath ......................... Disclosed no confl ict of interest.Muñoz-Torres, Francisco J. .................. Disclosed no confl ict of interest.Munro, Neil M. ..................................... Research Support: Eli Lilly and Company.Muntner, Paul ........................................ Research Support: Amgen Inc.Münzel, Thomas .................................... Research Support: Boehringer Ingelheim GmbH.Muoio, Deborah M. .............................. Disclosed no confl ict of interest.Murakami, Hiroshi................................. Disclosed no confl ict of interest.Murakami, Masanori............................. Disclosed no confl ict of interest.Muralidharan, Kumar K. ....................... Employee: Biogen Idec; Stock/Shareholder: Biogen Idec,

Merck & Co., Inc.Murano, Shunichi .................................. Disclosed no confl ict of interest.Murashima, Toshitaka ........................... Disclosed no confl ict of interest.Murdock, Ben ........................................ Disclosed no confl ict of interest.Murotani, Kenta .................................... Disclosed no confl ict of interest.Murphy, Angela ..................................... Advisory Panel: Novartis AG; Speaker’s Bureau: Novo Nordisk

A/S, Sanofi -Aventis, Servier.Murphy, Helen R. .................................. Disclosed no confl ict of interest.Murphy, Holly M. .................................. Disclosed no confl ict of interest.Murphy, Rinki ........................................ Disclosed no confl ict of interest.Murray, Anna......................................... Disclosed no confl ict of interest.Murray, Joseph A. ................................ Disclosed no confl ict of interest.Murray, Suzanne ................................... Disclosed no confl ict of interest.Murray, William .................................... Disclosed no confl ict of interest.Murrey, Darren ...................................... Disclosed no confl ict of interest.Murthy, Narasimha ............................... Disclosed no confl ict of interest.Musani, Solomon K. ............................. Disclosed no confl ict of interest.Musen, Gail ........................................... Disclosed no confl ict of interest.Musi, Nicolas ........................................ Disclosed no confl ict of interest.Muskiet, Marcel H. .............................. Disclosed no confl ict of interest.Musser, Bret .......................................... Employee: Merck & Co., Inc.Müssig, Karsten .................................... Disclosed no confl ict of interest.Musso, Carla ......................................... Disclosed no confl ict of interest.Mustafa, Norlaila .................................. Disclosed no confl ict of interest.Muthusamy, Arivalagan ........................ Disclosed no confl ict of interest.Myakina, Natalia E. .............................. Disclosed no confl ict of interest.Mychaleckyj, Josyf C. .......................... Disclosed no confl ict of interest.Myers, Candice A. ................................ Disclosed no confl ict of interest.Myers, Martin G. .................................. Research Support: Novo Nordisk Inc.Mynatt, Randall L. ................................ Disclosed no confl ict of interest.Na, Ki-Ryang ......................................... Disclosed no confl ict of interest.Nabben, Miranda .................................. Disclosed no confl ict of interest.Nabrdalik, Katarzyna ............................. Disclosed no confl ict of interest.Nackiewicz, Dominika ........................... Disclosed no confl ict of interest.Nadalin, Silvio ....................................... Disclosed no confl ict of interest.Nadeau, Kristen J. ............................... Disclosed no confl ict of interest.Naderali, Ebrahim ................................. Employee: Eli Lilly and Company.Naderpoor, Negar .................................. Disclosed no confl ict of interest.Naga Prasad, Sathyamangla V. ............ Disclosed no confl ict of interest.Nagafuchi, Seiho................................... Disclosed no confl ict of interest.Nagai, Yasuki ........................................ Disclosed no confl ict of interest.Nagai, Yosuke ....................................... Disclosed no confl ict of interest.Nagamori, Shushi.................................. Disclosed no confl ict of interest.Naganawa, Mika................................... Disclosed no confl ict of interest.

Nagano, Gaku........................................ Disclosed no confl ict of interest.Nagashimada, Mayumi ......................... Disclosed no confl ict of interest.Nagata, Masaharu ................................ Disclosed no confl ict of interest.Nagata, Naoto....................................... Disclosed no confl ict of interest.Nagayama, Daiji.................................... Disclosed no confl ict of interest.Nagel, Corey.......................................... Disclosed no confl ict of interest.Nagumo, Ayako ..................................... Disclosed no confl ict of interest.Nagy, Attila ........................................... Employee: 77 Electronics Co., Ltd.Naik, Amol............................................. Disclosed no confl ict of interest.Naik, Kunal ............................................ Disclosed no confl ict of interest.Naik, Rakhi P. ........................................ Disclosed no confl ict of interest.Naik, Ramachandra ............................... Employee: LifeScan, Inc.; Stock/Shareholder: Johnson &

Johnson.Nair, Anup ............................................. Disclosed no confl ict of interest.Nair, K. Sreekumaran ............................ Disclosed no confl ict of interest.Nair, Kavita V. ....................................... Research Support: AstraZeneca Pharmaceuticals LP.Nair, Shailesh ........................................ Disclosed no confl ict of interest.Nair, Sreejayan ...................................... Disclosed no confl ict of interest.Najafi , Bijan........................................... Research Support: Podimetrics, Inc.Naji, Joseph R. ..................................... Disclosed no confl ict of interest.Nakae, Jun ............................................ Disclosed no confl ict of interest.Nakagami, Tomoko ................................ Disclosed no confl ict of interest.Nakagawa, Aya ..................................... Disclosed no confl ict of interest.Nakagawa, Riyuki ................................. Disclosed no confl ict of interest.Nakagawa, Takashi ............................... Disclosed no confl ict of interest.Nakaji, Shigeyuki .................................. Disclosed no confl ict of interest.Nakajima, Hiro ...................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Nakajima, Hiromu ................................. Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Nakajima, Katsuyuki ............................. Disclosed no confl ict of interest.Nakajima, Osamu .................................. Disclosed no confl ict of interest.Nakaki, Ryo ........................................... Disclosed no confl ict of interest.Nakamura, Ichiro ................................... Employee: Astellas Pharma Inc.Nakamura, Jiro...................................... Research Support: Astellas Pharma Inc., Boehringer Ingelheim

Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson, Kyowa Hakko Kirin Co., Ltd., Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., Eli Lilly Japan K.K., Kyowa Hakko Kirin Co., Ltd., Merck & Co., Inc., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Pfi zer Japan Inc., Sanofi K.K., Shionogi & Co. Ltd., Taisho Pharmaceutical Co., Ltd.

Nakamura, Katherine ............................ Employee: Dexcom, Inc.Nakamura, Masahiro ............................ Disclosed no confl ict of interest.Nakamura, Naoto .................................. Disclosed no confl ict of interest.Nakamura, Takao .................................. Disclosed no confl ict of interest.Nakamura, Yui ....................................... Disclosed no confl ict of interest.Nakano, Miyuki ..................................... Disclosed no confl ict of interest.Nakano, Yujiro ....................................... Disclosed no confl ict of interest.Nakao, Ikko............................................ Employee: Astellas Pharma Inc.Nakao, Kazuwa ..................................... Disclosed no confl ict of interest.Nakao, Takayuki .................................... Disclosed no confl ict of interest.Nakasone, Yasuto ................................. Disclosed no confl ict of interest.Nakatani, Kazuhiro ................................ Disclosed no confl ict of interest.Nakatou, Tatsuaki ................................. Disclosed no confl ict of interest.Nakaya, Yuki .......................................... Disclosed no confl ict of interest.Nakayama, Hitomi................................. Disclosed no confl ict of interest.Nakayama, Morio.................................. Disclosed no confl ict of interest.Nakhle, Samer....................................... Speaker’s Bureau: Eli Lilly and Company, Janssen

Pharmaceuticals, Inc., Novo Nordisk Inc.Naliato, Erika C. ................................... Disclosed no confl ict of interest.Nallamshetty, Shriram .......................... Disclosed no confl ict of interest.Nam, Chung Mo .................................... Disclosed no confl ict of interest.Nam, Ji Sun........................................... Disclosed no confl ict of interest.Nam, Joo Young .................................... Disclosed no confl ict of interest.Nam, Juha ............................................. Disclosed no confl ict of interest.Nam, Moonsuk ...................................... Disclosed no confl ict of interest.Nam, Soohyun ....................................... Disclosed no confl ict of interest.Nam, Su Y. ............................................ Employee: Yuhan Co.Namiki, Hidenori ................................... Disclosed no confl ict of interest.Nanayakkara, Natalie ........................... Disclosed no confl ict of interest.Nangaku, Masaomi ............................... Disclosed no confl ict of interest.Nankervis, Alison .................................. Disclosed no confl ict of interest.Nano, Jana ............................................ Disclosed no confl ict of interest.Napier, David ......................................... Consultant: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/

Partner); Research Support: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/Partner).

Naples, Mark......................................... Disclosed no confl ict of interest.Napoli, Nicola ....................................... Disclosed no confl ict of interest.Narain, Niven R. ................................... Board Member: Berg Health; Employee: Berg Health; Stock/

Shareholder: Berg Health.Naranjo, Diana ...................................... Disclosed no confl ict of interest.Naraparaju, Gayathri............................. Disclosed no confl ict of interest.

A743


AU

THO

R D

ISCL

OSU

RE

Narayan, K.M. Venkat ........................... Disclosed no confl ict of interest.Narayanan, Ram Prakash ...................... Disclosed no confl ict of interest.Narayanasamy, Murugesan .................. Disclosed no confl ict of interest.Nargis, Syeda ........................................ Disclosed no confl ict of interest.Naruse, Keiko ........................................ Disclosed no confl ict of interest.Nashatker, Katherine L. ........................ Disclosed no confl ict of interest.Nasir, Khurram ...................................... Advisory Panel: Quest Diagnostics; Consultant: Regeneron

Pharmaceuticals, Inc.Nasiri, Ali R. ......................................... Disclosed no confl ict of interest.Nasiroglu Imga, Narin ........................... Disclosed no confl ict of interest.Nassar, Carine ....................................... Disclosed no confl ict of interest.Natali, Andrea ....................................... Disclosed no confl ict of interest.Natalicchio, Annalisa ............................ Disclosed no confl ict of interest.Natarajan, Sundaram ............................ Disclosed no confl ict of interest.Nathan, Aviva G. .................................. Disclosed no confl ict of interest.Nathan, Brandon M. ............................. Research Support: Medtronic, Inc.Natsume, Yukie ..................................... Disclosed no confl ict of interest.Naughton, Bartholomew J. .................. Disclosed no confl ict of interest.Navarro González, David ....................... Disclosed no confl ict of interest.Navarro Sanz, Sergi .............................. Disclosed no confl ict of interest.Navitskaya, Svetlana ............................ Disclosed no confl ict of interest.Navratil, Kamil ...................................... Disclosed no confl ict of interest.Nawaz, Allah ......................................... Disclosed no confl ict of interest.Nawrotek, Jolanta ................................ Disclosed no confl ict of interest.Nawroth, Peter ...................................... Disclosed no confl ict of interest.Naylor, Jacqueline ................................ Employee: MedImmune, LLC.Naylor, Rochelle .................................... Disclosed no confl ict of interest.Naziruddin, Bashoo ............................... Disclosed no confl ict of interest.Nederveen, Aart J. ............................... Disclosed no confl ict of interest.Needleman, Bradley.............................. Disclosed no confl ict of interest.Neema, Pranay K. ................................. Disclosed no confl ict of interest.Negrato, Carlos ..................................... Disclosed no confl ict of interest.Nehus, Edward J. ................................. Disclosed no confl ict of interest.Neinstein, Aaron B. .............................. Advisory Panel: Tidepool; Other Relationship: Cisco,

Medscape.Neisius, Abby ........................................ Disclosed no confl ict of interest.Nelakurthi, Arun Reddy ......................... Disclosed no confl ict of interest.Nelson, Bryce A. ................................... Disclosed no confl ict of interest.Nelson, David A. .................................. Disclosed no confl ict of interest.Nelson, James ...................................... Employee: Truven Health Analytics, Inc.Nelson, Karin M. .................................. Disclosed no confl ict of interest.Nelson, Lyndsay A. ............................... Disclosed no confl ict of interest.Nelson, Robert G. ................................. Disclosed no confl ict of interest.Nemcova, Andrea.................................. Disclosed no confl ict of interest.Nero, Damion ........................................ Other Relationship: Sanofi U.S., Inc., Truven Health Analytics,

Inc.Nery, Márcia.......................................... Disclosed no confl ict of interest.Neslusan, Cheryl ................................... Employee: Janssen Global Services, LLC.Neubauer, Katharina M. ....................... Disclosed no confl ict of interest.Neugebauer, Romain ............................. Disclosed no confl ict of interest.Neuhouser, Marian L. ........................... Disclosed no confl ict of interest.Neumann, Dietbert................................ Disclosed no confl ict of interest.Neumann-Haefelin, Christoph .............. Disclosed no confl ict of interest.Neupane, Sankalpa ............................... Research Support: Senseonics, Inc.Neuwahl, Simon J. ............................... Disclosed no confl ict of interest.Neves, Celestino ................................... Disclosed no confl ict of interest.Neves, João S. ..................................... Disclosed no confl ict of interest.Newby, Brittney N. ............................... Disclosed no confl ict of interest.Newcomer, Bradley R. .......................... Disclosed no confl ict of interest.Newgard, Christopher B. ...................... Disclosed no confl ict of interest.Newman, Susan .................................... Disclosed no confl ict of interest.Ng, Cedric K. ........................................ Disclosed no confl ict of interest.Ng, Dominic........................................... Disclosed no confl ict of interest.Ng, Kai Xin ............................................ Disclosed no confl ict of interest.Ng, Li Whye Cindy................................. Disclosed no confl ict of interest.Ng, Martin K. ........................................ Disclosed no confl ict of interest.Ng, Yvonne ............................................ Disclosed no confl ict of interest.Ngo, Doan T. ......................................... Disclosed no confl ict of interest.Ngoc Dang, Mary Ann........................... Disclosed no confl ict of interest.Ngufor, Che G. ...................................... Disclosed no confl ict of interest.Nguyen, Andrew ................................... Disclosed no confl ict of interest.Nguyen, Anh-Khoi ................................. Disclosed no confl ict of interest.Nguyen, Ha............................................ Disclosed no confl ict of interest.Nguyen, Hiep......................................... Employee: AstraZeneca Pharmaceuticals LP.Nguyen, Huong-Lan............................... Disclosed no confl ict of interest.Nguyen, Nhung ..................................... Disclosed no confl ict of interest.Nguyen, Phuong Nga ............................ Disclosed no confl ict of interest.Nguyen, Tuong-Vi .................................. Disclosed no confl ict of interest.Ni, Chang-Lin......................................... Disclosed no confl ict of interest.Niazi, Zahid Rasul ................................. Disclosed no confl ict of interest.Nichols, Alita......................................... Disclosed no confl ict of interest.Nichols, Charles .................................... Disclosed no confl ict of interest.Nichols, Gregory A. .............................. Research Support: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Incyte Corporation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation.

Nicholson, Luke ..................................... Disclosed no confl ict of interest.

Nicholson, Wanda ................................. Disclosed no confl ict of interest.Nicolaus, Leonard ................................. Disclosed no confl ict of interest.Nicoloro, Sarah M. ............................... Disclosed no confl ict of interest.Nicolucci, Antonio ................................. Advisory Panel: AstraZeneca, Novo Nordisk; Research

Support: Artsana, Novo Nordisk.Nie, Song............................................... Disclosed no confl ict of interest.Niedermeier, Katja ................................ Advisory Panel: Sanofi -Aventis Deutschland GmbH.Nielsen, Jens N. ................................... Disclosed no confl ict of interest.Nielsen, Jens S. ................................... Disclosed no confl ict of interest.Nielsen, Signe ....................................... Disclosed no confl ict of interest.Nielsen, Søren....................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk Inc;

Research Support: Eli Lilly and Company.Niemoeller, Elisabeth ............................ Employee: Sanofi .Nies, Vera .............................................. Disclosed no confl ict of interest.Niess, Andreas ...................................... Disclosed no confl ict of interest.Niessen, Louis W. ................................ Disclosed no confl ict of interest.Niessen, Markus ................................... Disclosed no confl ict of interest.Nieuwdorp, Max ................................... Disclosed no confl ict of interest.Nieuwoudt, Stephan ............................. Disclosed no confl ict of interest.Niewczas, Monika................................. Disclosed no confl ict of interest.Niiya, Tetsuji ......................................... Disclosed no confl ict of interest.Nikkel, Carla .......................................... Employee: Valeritas; Speaker’s Bureau: Valeritas; Stock/

Shareholder: Valeritas.Nikolayeva, Antonina B. ....................... Disclosed no confl ict of interest.Nikonova, Elena .................................... Other Relationship: Artech Information Systems, LLC, Sanofi

U.S., Inc.Nikoulina, Svetlana ............................... Stock/Shareholder: Satiogen Pharmaceuticals, Inc.Nilsson, Andreas ................................... Employee: The Swedish Institute for Health Economics.Ning, Guang .......................................... Disclosed no confl ict of interest.Nino, Antonio ........................................ Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Ninomiya, Naoko................................... Disclosed no confl ict of interest.Ninomiya, Toshiharu ............................. Disclosed no confl ict of interest.Nischal, Kanwal .................................... Disclosed no confl ict of interest.Nischal, Ken K. ..................................... Disclosed no confl ict of interest.Nishida, Makoto.................................... Disclosed no confl ict of interest.Nishida, Wataru .................................... Disclosed no confl ict of interest.NIshihara, Harumi ................................. Disclosed no confl ict of interest.Nishimiya, Tatsuya ................................ Disclosed no confl ict of interest.Nishimura, Akiko ................................... Disclosed no confl ict of interest.Nishimura, Erica .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S, Novo Nordisk A/S (Spouse/Partner).Nishino, Tomoya .................................... Disclosed no confl ict of interest.Nissen, Anne ......................................... Disclosed no confl ict of interest.Nissen, Steven E. ................................. Research Support: AstraZeneca, Eli Lilly and Company, Novo

Nordisk Inc., Pfi zer Inc., Takeda Development Center Americas, Inc.

Nistala, Ravi .......................................... Disclosed no confl ict of interest.Niswender, Kevin .................................. Research Support: NuSirt Biopharma.Nithi, Ajantha ........................................ Disclosed no confl ict of interest.Niwa, Hiroyuki....................................... Disclosed no confl ict of interest.Niyyati, Mahtab .................................... Disclosed no confl ict of interest.Nizza, Jael ............................................. Disclosed no confl ict of interest.Njolstad, Pal R. ..................................... Disclosed no confl ict of interest.Nk, Thulaseedharan .............................. Disclosed no confl ict of interest.Noble, Janelle A. ................................. Disclosed no confl ict of interest.Nocon, Allison ....................................... Disclosed no confl ict of interest.Noctor, Eoin ........................................... Employee: Steno Diabetes Center A/S.Noda, Saeko .......................................... Disclosed no confl ict of interest.Nodzenski, Michael............................... Disclosed no confl ict of interest.Noguchi, Constance Tom ...................... Employee: National Institute of Diabetes and Digestive and

Kidney Diseases.Nogueira, Keith ..................................... Disclosed no confl ict of interest.Noh, Hye-Lim......................................... Disclosed no confl ict of interest.Noh, Junghyun ...................................... Disclosed no confl ict of interest.Noh, Yun-Hee ........................................ Disclosed no confl ict of interest.Nojima, Jun ........................................... Disclosed no confl ict of interest.Nolan, John ........................................... Employee: Steno Diabetes Center A/S; Research Support:

Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S.Nomiyama, Takashi ............................... Research Support: Eli Lilly Japan K.K.Norby, Barbara ...................................... Disclosed no confl ict of interest.Nordaby, Matias.................................... Employee: Boehringer Ingelheim GmbH.Nordin, Elise .......................................... Disclosed no confl ict of interest.Nørgaard, Kirsten .................................. Advisory Panel: Abbott Diabetes Care Inc., Medtronic, Inc.,

Novo Nordisk A/S; Consultant: Medtronic, Inc., Roche Diagnostics; Speaker’s Bureau: Medtronic, Inc., Novo Nordisk A/S, Roche Diagnostics; Stock/Shareholder: Novo Nordisk A/S, Roche Diagnostics.

Noria, Sabrena ...................................... Disclosed no confl ict of interest.Normand, Christophe ............................ Disclosed no confl ict of interest.Norquay, Lisa D. ................................... Employee: Janssen Pharmaceuticals, Inc.Nørrelund, Helene ................................. Disclosed no confl ict of interest.Norris, Jill.............................................. Disclosed no confl ict of interest.Norris, Olga C. ...................................... Disclosed no confl ict of interest.Norton, James....................................... Research Support: Merck Sharp & Dohme Corp.Norton, Luke .......................................... Disclosed no confl ict of interest.

A744


AU

THO

R D

ISCL

OSU

RE

Norvell, J.P. .......................................... Disclosed no confl ict of interest.Norwood, Arnita F. ............................... Disclosed no confl ict of interest.Norwood, Paul....................................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Medtronic, Inc., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH.

Nosek, Leszek........................................ Disclosed no confl ict of interest.Noser, Amy ............................................ Disclosed no confl ict of interest.Not, Didier ............................................. Disclosed no confl ict of interest.Noumi, Yukinobu ................................... Disclosed no confl ict of interest.Nouvong, Aksone .................................. Disclosed no confl ict of interest.Nov, Sovanndany................................... Disclosed no confl ict of interest.Novara, Francesca................................. Disclosed no confl ict of interest.Novodvorksy, Peter................................ Disclosed no confl ict of interest.Nowak, Christoph.................................. Disclosed no confl ict of interest.Nowotny, Bettina .................................. Disclosed no confl ict of interest.Nowotny, Peter...................................... Disclosed no confl ict of interest.Noya, Carolina....................................... Disclosed no confl ict of interest.Nozaki, Yuichi ........................................ Disclosed no confl ict of interest.Nubiola, Andreu .................................... Consultant: Almirall, AstraZeneca, Eli Lilly and Company,

Esteve, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis, Novo Nordisk Inc., Sanofi -Aventis; Research Support: Janssen Pharmaceuticals, Inc. (Spouse/Partner), Merck Sharp & Dohme Corp. (Spouse/Partner), Novartis (Spouse/Partner), Sanofi -Aventis (Spouse/Partner); Speaker’s Bureau: Almirall (Spouse/Partner).

Nugent, Ailish ....................................... Disclosed no confl ict of interest.Numasawa, Masuyuki .......................... Disclosed no confl ict of interest.Nunes, Anthony P. ................................ Disclosed no confl ict of interest.Nunez, Marinelle V. .............................. Disclosed no confl ict of interest.Nuñez-Roa, Catalina ............................. Disclosed no confl ict of interest.Nunlee-Bland, Gail ................................ Disclosed no confl ict of interest.Nunley, Karen A. .................................. Disclosed no confl ict of interest.Nyby, Signe ........................................... Disclosed no confl ict of interest.Nyirjesy, Sarah ...................................... Disclosed no confl ict of interest.Nylen, Eric ............................................. Disclosed no confl ict of interest.Nystrup Husemoen, Lise Lotte .............. Employee: Novo Nordisk A/S.Oakes, Diana ......................................... Disclosed no confl ict of interest.Oba, Kenzo ............................................ Disclosed no confl ict of interest.Obata, Atsushi....................................... Disclosed no confl ict of interest.Obata, Yoko ........................................... Disclosed no confl ict of interest.Oberholzer, Jose .................................... Disclosed no confl ict of interest.Obeyesekere, Varuni ............................. Disclosed no confl ict of interest.Obialo, Elizabeth E. .............................. Disclosed no confl ict of interest.Obora, Akihiro ....................................... Disclosed no confl ict of interest.O’Boyle, Colm ........................................ Disclosed no confl ict of interest.Obregon-Henao, Andres........................ Disclosed no confl ict of interest.O’Brien, Duncan .................................... Employee: Janssen Global Services, LLC.O’Brien, Matthew J. ............................. Disclosed no confl ict of interest.O’Brien, Phillipe..................................... Disclosed no confl ict of interest.O’Brien, Shannon .................................. Disclosed no confl ict of interest.O’Brien, Siobhan ................................... Employee: MedImmune, LLC.O’Brien, Tracy P. .................................... Disclosed no confl ict of interest.O’Bryant, Sid ......................................... Disclosed no confl ict of interest.Ocampo, Alejandra................................ Disclosed no confl ict of interest.O’Connell, Jennifer Fiori ....................... Disclosed no confl ict of interest.O’Connor, Patrick J. .............................. Disclosed no confl ict of interest.Oda, Kenzaburou ................................... Disclosed no confl ict of interest.O’Day, Terrence ..................................... Employee: MedImmune, LLC.O’Doherty, Robert M. ........................... Disclosed no confl ict of interest.Oduori, Okechi S. .................................. Disclosed no confl ict of interest.Oelze, Matthias ..................................... Disclosed no confl ict of interest.Oestreicher, Karen ................................. Disclosed no confl ict of interest.Ofsthun, Norma ..................................... Disclosed no confl ict of interest.Ogaku, Sei-Ichiro ................................... Disclosed no confl ict of interest.Ogawa, Shimpei .................................... Employee: Ajinomoto Group.Ogawa, Shuichiro .................................. Disclosed no confl ict of interest.Ogawa, Yoshihiro .................................. Disclosed no confl ict of interest.Ogden, Jimmie D. ................................. Disclosed no confl ict of interest.Ogihara, Takeshi .................................... Disclosed no confl ict of interest.Ogimori, Yasuyo .................................... Disclosed no confl ict of interest.Ogle, Graham ........................................ Disclosed no confl ict of interest.Oguchi, Hideomi .................................... Disclosed no confl ict of interest.Ogunmoroti, Oluseye............................. Disclosed no confl ict of interest.Oguntolu, Victor .................................... Disclosed no confl ict of interest.Ogurtsova, Katherine ............................ Disclosed no confl ict of interest.Oh, Byung-Mo ....................................... Disclosed no confl ict of interest.Oh, Chang-Myung ................................. Disclosed no confl ict of interest.Oh, Da Young......................................... Disclosed no confl ict of interest.Oh, Eriko ................................................ Disclosed no confl ict of interest.Oh, Eunjin .............................................. Disclosed no confl ict of interest.Oh, Hyun Seo Robin .............................. Disclosed no confl ict of interest.Oh, Jee-Young ....................................... Disclosed no confl ict of interest.Oh, Kook-Hwan ..................................... Disclosed no confl ict of interest.Oh, Seungjoon ....................................... Disclosed no confl ict of interest.

Oh, Tae Jung ......................................... Disclosed no confl ict of interest.Oh, Takkeun ........................................... Disclosed no confl ict of interest.Ohama, Tohru ........................................ Disclosed no confl ict of interest.Ohama, Toshihiko .................................. Disclosed no confl ict of interest.Ohara, Makoto ...................................... Disclosed no confl ict of interest.Ohara, Nohirhiko ................................... Disclosed no confl ict of interest.Ohara, Norihiko ..................................... Disclosed no confl ict of interest.Ohara, Tomoyuki .................................... Disclosed no confl ict of interest.Ohashi, Jun ........................................... Disclosed no confl ict of interest.Ohashi, Natsuko .................................... Disclosed no confl ict of interest.Ohashi, Yasuo........................................ Disclosed no confl ict of interest.Ohata, Yoko ........................................... Disclosed no confl ict of interest.Ohgaki, Ryuichi...................................... Disclosed no confl ict of interest.Ohira, Akeo............................................ Disclosed no confl ict of interest.Ohira, Lisa ............................................. Disclosed no confl ict of interest.Ohira, Masahiro .................................... Disclosed no confl ict of interest.Ohkawa, Naoto ..................................... Disclosed no confl ict of interest.Ohl, Maddie........................................... Disclosed no confl ict of interest.Öhman, Peter......................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Ohmayer, Uli .......................................... Disclosed no confl ict of interest.Ohmura, Chie......................................... Disclosed no confl ict of interest.Ohno, Haruya......................................... Disclosed no confl ict of interest.Ohri, Anupam ........................................ Disclosed no confl ict of interest.Ohsawa, Nakaaki .................................. Disclosed no confl ict of interest.Ohsumi, Koji .......................................... Employee: Ajinomoto Group.Ohta, Takeshi ......................................... Disclosed no confl ict of interest.Ohtsuka, Yoshie..................................... Disclosed no confl ict of interest.Ohyagi, Yasumasa ................................. Disclosed no confl ict of interest.Oii, Chuan Ng ........................................ Disclosed no confl ict of interest.Oikawa, Yoichi....................................... Disclosed no confl ict of interest.Oikemus, Sarah ..................................... Disclosed no confl ict of interest.Okabe, Atsushi ...................................... Disclosed no confl ict of interest.Okabe, Keisuke...................................... Disclosed no confl ict of interest.Okada, Norio ......................................... Disclosed no confl ict of interest.Okada, Takeshi ...................................... Disclosed no confl ict of interest.Okada, Yosuke ....................................... Research Support: Bayer HealthCare, Kowa Company, Ltd.,

Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Merck & Co., Inc., Ono Pharmaceutical Co., Ltd.

Okahata, Sumie ..................................... Disclosed no confl ict of interest.Okamoto, Ai........................................... Disclosed no confl ict of interest.Okano, Satoshi ...................................... Disclosed no confl ict of interest.Okauchi, Seizo ....................................... Disclosed no confl ict of interest.Okawa, Tetsuji ....................................... Disclosed no confl ict of interest.Okawara, Miho...................................... Disclosed no confl ict of interest.Okayama, Naotsuka .............................. Disclosed no confl ict of interest.O’Keefe-Rosetti, Maureen .................... Disclosed no confl ict of interest.Oki, Kenji ............................................... Disclosed no confl ict of interest.Okitsu, Akira .......................................... Employee: Astellas Pharma Inc.Okubo, Manabu ..................................... Disclosed no confl ict of interest.Okubo, Yoshiaki ..................................... Disclosed no confl ict of interest.Okuda, Inaha ......................................... Employee: GlaxoSmithKline.Okuda, Suguru ....................................... Disclosed no confl ict of interest.Okuno, Misako ...................................... Disclosed no confl ict of interest.Oladunjoye, Adeolu ............................... Disclosed no confl ict of interest.Olateju, Tolulope O. .............................. Disclosed no confl ict of interest.Olde Damink, Steven W. ...................... Disclosed no confl ict of interest.Oldham, Stephanie................................ Employee: MedImmune, LLC.O’Leary, Kevin........................................ Disclosed no confl ict of interest.Olefsky, Jerrold M. ............................... Disclosed no confl ict of interest.Olesen, Kasper ...................................... Employee: Steno Diabetes Center A/S.Oliva Moreno, Juan............................... Disclosed no confl ict of interest.Oliveira, Denise S. ................................ Disclosed no confl ict of interest.Oliveira, Ramon G. ............................... Disclosed no confl ict of interest.Oliveira, Sofi a ........................................ Disclosed no confl ict of interest.Oliver, Nick S. ....................................... Disclosed no confl ict of interest.Oliveri, Mary C. .................................... Disclosed no confl ict of interest.Olmos, Pablo ......................................... Disclosed no confl ict of interest.Olofsson, Charlotta ............................... Employee: AstraZeneca (Spouse/Partner).Olowoyeye, Omodele ............................ Disclosed no confl ict of interest.Olsen, Gayle .......................................... Disclosed no confl ict of interest.Olsen, Grith S. ...................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Olsen, Sjurdur F. ................................... Disclosed no confl ict of interest.Olshansky, Ellen .................................... Disclosed no confl ict of interest.Olson, Ann L. ........................................ Disclosed no confl ict of interest.Olson, David .......................................... Research Support: Novo Nordisk Inc.Olsza ska, Ewa ...................................... Disclosed no confl ict of interest.Olvera, Angela C. ................................. Disclosed no confl ict of interest.Omar, Mak ............................................. Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S;

Speaker’s Bureau: Eli Lilly and Company, LifeScan, Inc., Novo Nordisk A/S, Sanofi -Aventis.

Omar, Siti Zawiah .................................. Disclosed no confl ict of interest.Omura, Eiji ............................................. Disclosed no confl ict of interest.O’Neal, David N. .................................. Advisory Panel: Abbott Diabetes Care Inc., Firefl y Bioworks,

Inc., Medtronic, Inc.; Research Support: Medtronic, Inc.,

A745


AU

THO

R D

ISCL

OSU

RE

Sanofi U.S.; Speaker’s Bureau: Medtronic, Inc., Novo Nordisk Inc., Sanofi U.S.

O’Neill, Brian T. .................................... Disclosed no confl ict of interest.O’Neill, Edward A. ................................ Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Onen, Mehmet ...................................... Disclosed no confl ict of interest.Onengut-Gumuscu, Suna ...................... Disclosed no confl ict of interest.Onishi, Tetsuro ...................................... Disclosed no confl ict of interest.Onishi, Yukiko ........................................ Disclosed no confl ict of interest.Onji, Morikazu ....................................... Disclosed no confl ict of interest.Onodera, Masafumi .............................. Disclosed no confl ict of interest.Onuma, Hiroshi...................................... Disclosed no confl ict of interest.Onuma, Hirotoshi .................................. Disclosed no confl ict of interest.Oram, Richard A. .................................. Disclosed no confl ict of interest.Orchard, Trevor J. ................................. Advisory Panel: Eli Lilly and Company.Ordelheide, Anna-Maria ....................... Disclosed no confl ict of interest.Ørgaard, Anne ....................................... Disclosed no confl ict of interest.Orho-Melander, Marju .......................... Disclosed no confl ict of interest.Orlando, Giorgio .................................... Disclosed no confl ict of interest.Orlando, Laurent.................................... Disclosed no confl ict of interest.Orlov, Nikolay B. ................................... Disclosed no confl ict of interest.Orlova, Marija ....................................... Disclosed no confl ict of interest.Orme, Michelle Elaine........................... Consultant: AstraZeneca, Bristol-Myers Squibb.Ornstein, Amy Y. ................................... Disclosed no confl ict of interest.Orozco-Beltran, Domingo ...................... Disclosed no confl ict of interest.Orr Walker, Brandon .............................. Disclosed no confl ict of interest.Orsenigo, Elena ..................................... Disclosed no confl ict of interest.Orsi, Emanuela ...................................... Disclosed no confl ict of interest.Ortega, Maite ........................................ Disclosed no confl ict of interest.Ortiz, Angel............................................ Disclosed no confl ict of interest.Ortiz, Edward ......................................... Disclosed no confl ict of interest.Ortiz, Hallie............................................ Disclosed no confl ict of interest.Ortiz, Marjorie R. .................................. Disclosed no confl ict of interest.Ortiz-López, María G. ........................... Disclosed no confl ict of interest.Ortiz-Rubio, Paulina............................... Disclosed no confl ict of interest.Osaka, Mizuko ....................................... Disclosed no confl ict of interest.Osaka, Takafumi .................................... Disclosed no confl ict of interest.Osama, Hamdy ...................................... Disclosed no confl ict of interest.Osawa, Haruhiko ................................... Disclosed no confl ict of interest.Osborn, Chandra Y. ............................... Disclosed no confl ict of interest.Osborne, Melissa .................................. Disclosed no confl ict of interest.Osei, Kwame ......................................... Disclosed no confl ict of interest.Oseid, Elizabeth..................................... Disclosed no confl ict of interest.Oshida, Yoshiharu ................................. Disclosed no confl ict of interest.Oshiro, Chie ........................................... Disclosed no confl ict of interest.Oskolkov, Nikolay .................................. Disclosed no confl ict of interest.Osondu, Chukwuemeka......................... Disclosed no confl ict of interest.Osterberg, Lars ...................................... Consultant: Proteus Digital Health.Østergaard, Jakob A. ........................... Research Support: Novo Nordisk Foundation.Østergaard, Lauge ................................. Disclosed no confl ict of interest.O’Sullivan, Eoin P. ................................. Advisory Panel: Novo Nordisk Inc; Other Relationship: Merck

& Co., Inc.O’Sullivan, Esther S. ............................. Advisory Panel: Medtronic, Inc.O-Sullivan, InSug................................... Disclosed no confl ict of interest.O’Sullivan, John F. ................................ Disclosed no confl ict of interest.Ota, Kazuki ............................................ Disclosed no confl ict of interest.Ota, Tsuguhito ....................................... Disclosed no confl ict of interest.Otabe, Shuichi ....................................... Disclosed no confl ict of interest.Otake, Hiroyuki ...................................... Disclosed no confl ict of interest.Otokozawa, Seiko.................................. Disclosed no confl ict of interest.Otsuka, Yinhua Hanako ......................... Disclosed no confl ict of interest.Ott, Christian ......................................... Disclosed no confl ict of interest.Otto, Erik................................................ Employee: InSpark Technologies, Inc.; Stock/Shareholder:

InSpark Technologies, Inc.Oturai, Peter .......................................... Disclosed no confl ict of interest.Otvos, James......................................... Disclosed no confl ict of interest.Ouchi, Hiromi......................................... Disclosed no confl ict of interest.Ouchi, Motoshi ...................................... Disclosed no confl ict of interest.Ouellette, Miranda ................................ Disclosed no confl ict of interest.Oulhaj, Abderrahim ............................... Disclosed no confl ict of interest.Ouwens, Margriet ................................. Disclosed no confl ict of interest.Ouwerkerk, Ronald ................................ Disclosed no confl ict of interest.Ouyang, Fanqian.................................... Disclosed no confl ict of interest.Ouyang, Qin ........................................... Disclosed no confl ict of interest.Ouyang, Xiaojun .................................... Disclosed no confl ict of interest.Ovalle, Fernando ................................... Disclosed no confl ict of interest.Overbergh, Lut ....................................... Disclosed no confl ict of interest.Owei, Ibiye ............................................ Disclosed no confl ict of interest.Owen, Katharine ................................... Disclosed no confl ict of interest.Owens, David R. ................................... Consultant: Boehringer Ingelheim, Eli Lilly and Company,

Roche Diagnostics, Sanofi , Takeda; Speaker’s Bureau: Boehringer Ingelheim, Eli Lilly and Company, Roche Diagnostics, Sanofi , Takeda.

Owens, Lisa A. ..................................... Disclosed no confl ict of interest.Owyang, Chung ..................................... Disclosed no confl ict of interest.Oya, Junko............................................. Disclosed no confl ict of interest.

Oyedokun, Festus .................................. Disclosed no confl ict of interest.Oz, Gulin ................................................ Disclosed no confl ict of interest.Oza-Frank, Reena .................................. Disclosed no confl ict of interest.Ozakca, Isil ............................................ Disclosed no confl ict of interest.Ozaki, Riza ............................................. Disclosed no confl ict of interest.Paananen, Jussi .................................... Disclosed no confl ict of interest.Pacaud, Danièle .................................... Disclosed no confl ict of interest.Pace, Romina......................................... Disclosed no confl ict of interest.Pacheco, Julian A. ................................ Disclosed no confl ict of interest.Pacifi ci, Francesca ................................. Disclosed no confl ict of interest.Pacini, Giovanni..................................... Disclosed no confl ict of interest.Pacora, Percy N. ................................... Disclosed no confl ict of interest.Paddock, Ethan ...................................... Disclosed no confl ict of interest.Padgett, Lindsey E. ............................... Disclosed no confl ict of interest.Padilla, Jaume....................................... Disclosed no confl ict of interest.Padilla, Nathalia.................................... Disclosed no confl ict of interest.Padmanabhan, Sandosh........................ Disclosed no confl ict of interest.Padua, Elvira.......................................... Disclosed no confl ict of interest.Pagacova, Libuse................................... Disclosed no confl ict of interest.Pagán Banchs, Pedro A. ....................... Disclosed no confl ict of interest.Paganoti, Cristiane F. ............................ Disclosed no confl ict of interest.Page, Melissa M. ................................. Disclosed no confl ict of interest.Paglialunga, Sabina .............................. Employee: Celerion, Inc.Pagnini, Manuela .................................. Disclosed no confl ict of interest.Pai, Chih-Wen ....................................... Disclosed no confl ict of interest.Paini, Stefano ........................................ Disclosed no confl ict of interest.Paiva, Tanya .......................................... Disclosed no confl ict of interest.Pak, Youngmi K. .................................... Disclosed no confl ict of interest.Palaia, Thomas ...................................... Disclosed no confl ict of interest.Palcza, John .......................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Paldánius, Päivi M. ............................... Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG.Palermo, Andrea.................................... Disclosed no confl ict of interest.Palik, Eva ............................................... Disclosed no confl ict of interest.Pall, Allison ........................................... Disclosed no confl ict of interest.Pallai, Shillo .......................................... Disclosed no confl ict of interest.Pallardo, L. Felipe .................................. Disclosed no confl ict of interest.Palmer, Colin ......................................... Disclosed no confl ict of interest.Palmer, Jerry P. ..................................... Disclosed no confl ict of interest.Palmer, Nicholette D. ........................... Disclosed no confl ict of interest.Palmieri, Eva.......................................... Disclosed no confl ict of interest.Palmiter, Richard D. .............................. Disclosed no confl ict of interest.Palta, Priya ............................................ Disclosed no confl ict of interest.Palygin, Oleg ......................................... Research Support: National Kidney Foundation.Pamar, Vijayveer S. .............................. Disclosed no confl ict of interest.Pambianco, Georgia .............................. Disclosed no confl ict of interest.Pan, Fong Cheng.................................... Disclosed no confl ict of interest.Pan, Hui ................................................. Disclosed no confl ict of interest.Pan, Qing ............................................... Disclosed no confl ict of interest.Pan, Xiaoping ........................................ Disclosed no confl ict of interest.Panagiotopoulos, Constadina ............... Disclosed no confl ict of interest.Panajotu, Alexisz ................................... Disclosed no confl ict of interest.Panburana, Punyu.................................. Disclosed no confl ict of interest.Panczel, Pal ........................................... Disclosed no confl ict of interest.Panduru, Nicolae M. ............................ Disclosed no confl ict of interest.Pang, Terence ........................................ Disclosed no confl ict of interest.Panosian, Jennifer ................................ Disclosed no confl ict of interest.Panse, Madhura .................................... Disclosed no confl ict of interest.Pantalone, Kevin M. ............................. Consultant: Eli Lilly and Company, Merck & Co., Inc., Novo

Nordisk Inc; Research Support: Merck & Co., Inc., Novo Nordisk Inc; Speaker’s Bureau: AstraZeneca, Merck & Co., Inc., Novo Nordisk Inc.

Pantos, Anastasios................................ Disclosed no confl ict of interest.Pantos, Konstantinos ............................ Disclosed no confl ict of interest.Papachristoforou, Eleftheria ................. Disclosed no confl ict of interest.Papadaki, Despina................................. Disclosed no confl ict of interest.Papademetriou, Vasilios ....................... Disclosed no confl ict of interest.Papadopoulou, Maria ............................ Disclosed no confl ict of interest.Papaoikonomou, Stavroula ................... Disclosed no confl ict of interest.Papazafi ropoulou, Athanasia ................ Disclosed no confl ict of interest.Papp, Sára ............................................. Disclosed no confl ict of interest.Pappa, Maria ......................................... Disclosed no confl ict of interest.Pappas, Stavros..................................... Disclosed no confl ict of interest.Paramalingam, Nirubasini..................... Disclosed no confl ict of interest.Paramasivam, Sharmila Sunita ............. Disclosed no confl ict of interest.Paratore, Giorgia ................................... Disclosed no confl ict of interest.Pare, Guillaume ..................................... Disclosed no confl ict of interest.Paredes, Laura....................................... Disclosed no confl ict of interest.Parets, Sasha E. ................................... Disclosed no confl ict of interest.Parihar, Richa ........................................ Disclosed no confl ict of interest.Parikh, Lisa ............................................ Disclosed no confl ict of interest.Parikh, Neehar....................................... Disclosed no confl ict of interest.Parise, Jason ......................................... Employee: Janssen Pharmaceuticals, Inc.Park, Bo-Yoon ........................................ Disclosed no confl ict of interest.Park, Byung Soon .................................. Disclosed no confl ict of interest.

A746


AU

THO

R D

ISCL

OSU

RE

Park, Chang ........................................... Disclosed no confl ict of interest.Park, Cheol-Young ................................. Disclosed no confl ict of interest.Park, Chorong ........................................ Disclosed no confl ict of interest.Park, Ga Bin ........................................... Disclosed no confl ict of interest.Park, Hansu ........................................... Employee: Dong-A ST.Park, Hye Jeong .................................... Disclosed no confl ict of interest.Park, Hye Sun ........................................ Disclosed no confl ict of interest.Park, Hyo Eun ........................................ Disclosed no confl ict of interest.Park, Hyoungchun.................................. Disclosed no confl ict of interest.Park, Ie Byung........................................ Disclosed no confl ict of interest.Park, Jeong Hyun .................................. Disclosed no confl ict of interest.Park, Jeong Woon ................................. Disclosed no confl ict of interest.Park, Jong Suk....................................... Disclosed no confl ict of interest.Park, Joong-Yeol ................................... Disclosed no confl ict of interest.Park, Ju Young....................................... Employee: Yuhan Co.Park, Jung Eun....................................... Disclosed no confl ict of interest.Park, Keun-Gyu ...................................... Disclosed no confl ict of interest.Park, Kyong Soo .................................... Disclosed no confl ict of interest.Park, Kyoungmin.................................... Disclosed no confl ict of interest.Park, Meeyoung .................................... Disclosed no confl ict of interest.Park, Minsun ......................................... Disclosed no confl ict of interest.Park, Seo Jin ......................................... Disclosed no confl ict of interest.Park, Seok Won ..................................... Disclosed no confl ict of interest.Park, So Yeon ........................................ Disclosed no confl ict of interest.Park, So Youn ........................................ Disclosed no confl ict of interest.Park, So Young ...................................... Disclosed no confl ict of interest.Park, Sun Hee ........................................ Disclosed no confl ict of interest.Park, Sung Ha ........................................ Disclosed no confl ict of interest.Park, Sung Hee ...................................... Employee: Hanmi Pharmaceutical Co., Ltd.Park, Sung Woo ..................................... Disclosed no confl ict of interest.Park, Tae Sun ......................................... Disclosed no confl ict of interest.Park, Wook Ha ....................................... Disclosed no confl ict of interest.Park, Yong-Moon ................................... Disclosed no confl ict of interest.Park, Yongsoo ........................................ Disclosed no confl ict of interest.Park, Young Jin...................................... Disclosed no confl ict of interest.Park, Young-Min .................................... Disclosed no confl ict of interest.Parker, Kathryn ...................................... Disclosed no confl ict of interest.Parker, Melissa M. ............................... Disclosed no confl ict of interest.Parker, Stephen C. ................................ Disclosed no confl ict of interest.Parkin, Christopher G. .......................... Consultant: Dexcom, Inc., Insulet Corporation, Roche USA,

Sanofi U.S.Parkinson, Joanna ................................. Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Parlin, Ursula W. .................................. Disclosed no confl ict of interest.Parravano, Maria Cristina ..................... Disclosed no confl ict of interest.Parrinello, Christina............................... Disclosed no confl ict of interest.Parsa, Rahul .......................................... Disclosed no confl ict of interest.Parsons, Bruce....................................... Employee: Pfi zer Inc.Parsons, Janet A. ................................. Disclosed no confl ict of interest.Parvaresh Rizi, Ehsan ............................ Disclosed no confl ict of interest.Parving, Hans-Henrik............................. Disclosed no confl ict of interest.Paschoal, Vivian A. ............................... Disclosed no confl ict of interest.Pasek, Raymond C. ............................... Disclosed no confl ict of interest.Pasquale, Margaret............................... Disclosed no confl ict of interest.Pasqualetti, Patrizio .............................. Disclosed no confl ict of interest.Pasquali, Christian ................................ Employee: Vifor Pharma.Pasquel, Francisco................................. Disclosed no confl ict of interest.Passos, Valéria ...................................... Disclosed no confl ict of interest.Paster, Igor ............................................ Disclosed no confl ict of interest.Pastore, Donatella................................. Disclosed no confl ict of interest.Pastrana-Delgado, Juan........................ Disclosed no confl ict of interest.Pastukh, Viktor ...................................... Disclosed no confl ict of interest.Pasupathy, Shanker ............................... Disclosed no confl ict of interest.Patek, Stephen D. ................................. Research Support: Eli Lilly and Company; Stock/Shareholder:

TypeZero Technologies.Patel, Barry ............................................ Disclosed no confl ict of interest.Patel, Eva............................................... Disclosed no confl ict of interest.Patel, Jay............................................... Disclosed no confl ict of interest.Patel, Niral J. ....................................... Disclosed no confl ict of interest.Patel, Pankaj R. .................................... Board Member: Cadila Healthcare Limited; Employee: Cadila

Healthcare Limited.Patel, Vipulkumar .................................. Disclosed no confl ict of interest.Paterson, Andrea................................... Disclosed no confl ict of interest.Paterson, Andrew D. ............................ Disclosed no confl ict of interest.Paterson, Martha .................................. Disclosed no confl ict of interest.Päth, Günter .......................................... Disclosed no confl ict of interest.Pathan, Faruque .................................... Advisory Panel: Novo Nordisk A/S; Board Member:

Eli Lilly and Company, Novo Nordisk A/S, Sanofi -Aventis; Employee: BIRDEM General Hospital; Research Support: Novartis AG, Novo Nordisk A/S, Sanofi -Aventis; Speaker’s Bureau: Eli Lilly and Company, LifeScan, Inc., Novartis AG, Novo Nordisk A/S, Sanofi -Aventis.

Pathan, Hafsa ........................................ Disclosed no confl ict of interest.Pathan, Sameer ..................................... Disclosed no confl ict of interest.Patil, Shivajirao ..................................... Disclosed no confl ict of interest.Patinkin, Zachary ................................... Disclosed no confl ict of interest.

Patiño-Laguna, Anayeli J. .................... Disclosed no confl ict of interest.Patorno, Elisabetta ................................ Consultant: Aetion, Inc.Pattar, Guruprasad R. ........................... Disclosed no confl ict of interest.Patterson, Barron .................................. Disclosed no confl ict of interest.Patterson, Bruce .................................... Disclosed no confl ict of interest.Patterson, Chris C. ................................ Disclosed no confl ict of interest.Patterson, Christa.................................. Disclosed no confl ict of interest.Patti, Mary-Elizabeth............................. Consultant: Diasome Pharmaceuticals, Inc., ExpertConnect,

Magnolia Innovation, Triangle Insights Group, LLC; Research Support: AstraZeneca, MedImmune, LLC., Novo Foundation, Nuclea Biotechnologies, Sanofi U.S., Xeris Pharmaceuticals, Inc.

Patton, Susana R. ................................. Disclosed no confl ict of interest.Pattou, François..................................... Disclosed no confl ict of interest.Paty, Breay W. ...................................... Disclosed no confl ict of interest.Paul, Dirk ............................................... Disclosed no confl ict of interest.Paul, Margaret M. ................................ Disclosed no confl ict of interest.Paul, Narinder ....................................... Disclosed no confl ict of interest.Paul, Sanjoy........................................... Consultant: Amylin Pharmaceuticals, LLC., AstraZeneca,

Genentech, Inc., GI Dynamics, Inc., Novo Nordisk A/S; Research Support: Amylin Pharmaceuticals, LLC., AstraZeneca, Merck & Co., Inc., Novo Nordisk A/S, Pfi zer Inc.; Speaker’s Bureau: AstraZeneca.

Paul, Sudeshna...................................... Disclosed no confl ict of interest.Paul, Terri .............................................. Disclosed no confl ict of interest.Paulmurugan, Ramasamy...................... Disclosed no confl ict of interest.Pavkov, Meda E. ................................... Disclosed no confl ict of interest.Pavo, Imre.............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Pawlak, Sylvester .................................. Employee: Pfi zer Inc.Payne, Dawn ......................................... Disclosed no confl ict of interest.Peach, Robert ........................................ Employee: Receptos.Pearson, Ewan....................................... Disclosed no confl ict of interest.Pedersen, Andreas James .................... Disclosed no confl ict of interest.Pedersen, Anne G. ................................ Disclosed no confl ict of interest.Pedersen, Brian A. ................................ Disclosed no confl ict of interest.Pedersen, Lars ....................................... Disclosed no confl ict of interest.Pedersen, Oluf ....................................... Disclosed no confl ict of interest.Pedersen, Søren L. ............................... Employee: Gubra.Pedersen-Bjergaard, Ulrik ..................... Disclosed no confl ict of interest.Pedley, Carolyn ...................................... Disclosed no confl ict of interest.Pedone, Claudio .................................... Disclosed no confl ict of interest.Peeples, Malinda .................................. Employee: WellDoc, Inc.Peer, Nasheeta ...................................... Disclosed no confl ict of interest.Peeters, Anna ........................................ Disclosed no confl ict of interest.Pegelow, Katrin ..................................... Employee: Sanofi -Aventis Deutschland GmbH.Peil, Barbara .......................................... Employee: Boehringer Ingelheim GmbH.Peiris, Timothy ....................................... Disclosed no confl ict of interest.Pek, Sharon Li Ting ................................ Disclosed no confl ict of interest.Peleckis, Amy ........................................ Disclosed no confl ict of interest.Pelikanova, Terezie ................................ Disclosed no confl ict of interest.Peltier, Sébastien L. ............................. Employee: Valbiotis.Peltz, Maya............................................ Employee: Intarcia Therapeutics, Inc.Pena, Javier D. ..................................... Disclosed no confl ict of interest.Pena, Jose F. ......................................... Disclosed no confl ict of interest.Peña-Espinoza, Bárbara Itzel................. Disclosed no confl ict of interest.Penalo, Pedro J. ................................... Disclosed no confl ict of interest.Pendergrass, Merri................................ Disclosed no confl ict of interest.Pendharkar, Sayali ................................. Disclosed no confl ict of interest.Pendlebury, David.................................. Disclosed no confl ict of interest.Penfornis, Alfred ................................... Disclosed no confl ict of interest.Peng, Chuan .......................................... Disclosed no confl ict of interest.Peng, Hangya ........................................ Disclosed no confl ict of interest.Peng, Liang ............................................ Disclosed no confl ict of interest.Peng, Limin ............................................ Disclosed no confl ict of interest.Peng, Yanyu ........................................... Employee: AmideBio.Peng, Yongde......................................... Disclosed no confl ict of interest.Pennathur, Subramaniam ...................... Disclosed no confl ict of interest.Penniman, Christie ................................ Disclosed no confl ict of interest.Penno, Giuseppe ................................... Disclosed no confl ict of interest.Pennoni, Ilaria ....................................... Disclosed no confl ict of interest.Penque, Brent A. .................................. Disclosed no confl ict of interest.Peragallo-Dittko, Virginia ...................... Disclosed no confl ict of interest.Perakakis, Nikolaos ............................... Disclosed no confl ict of interest.Percy, Carol............................................ Disclosed no confl ict of interest.Perdomo, German.................................. Disclosed no confl ict of interest.Pereira, Alexandre C. ........................... Disclosed no confl ict of interest.Pereira, Maria J. .................................. Disclosed no confl ict of interest.Pereira, Miguel...................................... Disclosed no confl ict of interest.Pereira, Renata O. ................................ Disclosed no confl ict of interest.Pereira, Rosa ......................................... Disclosed no confl ict of interest.Perel, Cecilia ......................................... Disclosed no confl ict of interest.Pérez Cáceres, David............................. Disclosed no confl ict of interest.Pérez Manghi, Federico C. ................... Disclosed no confl ict of interest.Perez, Mercedes.................................... Disclosed no confl ict of interest.Perez-Colon, Sheila ............................... Disclosed no confl ict of interest.

A747


AU

THO

R D

ISCL

OSU

RE

Perez-Nieves, Magaly ........................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Pérez-Rubio, Karina G. ......................... Disclosed no confl ict of interest.Perez-Tilve, Diego.................................. Research Support: Calibrium LLC.Perkins, Bruce A. .................................. Consultant: NeuroMetrix, Inc.; Research Support: Boehringer

Ingelheim Pharmaceuticals, Inc., Medtronic, Inc.; Speaker’s Bureau: GlaxoSmithKline, Johnson & Johnson, Medtronic, Inc., Novo Nordisk Inc., Novo Nordisk Inc., Roche Pharmaceuticals, Sanofi U.S.

Perkins, Susan ....................................... Disclosed no confl ict of interest.Perkovic, Vlado ...................................... Consultant: AbbVie Inc., Astellas Pharma Inc., Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Inc.; Speaker’s Bureau: Baxter International, Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc., Pfi zer Inc.

Permpikul, Chairat ................................. Disclosed no confl ict of interest.Pernet, Andrew ..................................... Disclosed no confl ict of interest.Peroni, Odile D. .................................... Disclosed no confl ict of interest.Perrea, Despoina ................................... Disclosed no confl ict of interest.Perreault, Leigh ..................................... Disclosed no confl ict of interest.Perreault, Mylene.................................. Employee: Pfi zer Inc.Perrin, Allison ........................................ Consultant: Amgen Inc., Novartis Pharmaceuticals

Corporation, Sanofi U.S.Perrin, Alysa J. ..................................... Disclosed no confl ict of interest.Perrin, Anne Elisabeth........................... Disclosed no confl ict of interest.Perrini, Sebastio .................................... Disclosed no confl ict of interest.Perron, Patrice ....................................... Disclosed no confl ict of interest.Perry, Daniel .......................................... Disclosed no confl ict of interest.Perry, Rachel J. ..................................... Disclosed no confl ict of interest.Persson, Frederik ................................... Advisory Panel: AstraZeneca, Merck Sharp & Dohme Corp.;

Employee: Steno Diabetes Center A/S; Research Support: AstraZeneca, Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis AG, Novo Nordisk A/S.

Pery, Billy ............................................... Employee: LabStyle Innovations, Ltd.Pescara, Teresa ..................................... Disclosed no confl ict of interest.Pesquera, Carlos ................................... Consultant: Novo Nordisk A/S; Speaker’s Bureau: Eli Lilly and

Company.Pessin, Jeffrey E. .................................. Disclosed no confl ict of interest.Pesta, Dominik ...................................... Disclosed no confl ict of interest.Peter, Patricia R. ................................... Disclosed no confl ict of interest.Peters, Anne L. ..................................... Consultant: Abbott Diabetes Care, Amgen, AstraZeneca,

Becton, Dickinson and Company, Biodel, Boehringer Ingelheim, Bristol-Myers Squibb, CVS/Caremark, Eli Lilly and Company, Janssen, Lexicon, Medtronic, Merck, Novo Nordisk, OptumRx, Sanofi , Takeda, Thermalin; Research Support: Abbott Diabetes Care, Amgen, AstraZeneca, Becton, Dickinson and Company, Biodel, Boehringer Ingelheim, Bristol-Myers Squibb, CVS/Caremark, Eli Lilly and Company, Janssen, Lexicon, Medtronic, Merck, Novo Nordisk, OptumRx, Sanofi , Takeda, Thermalin; Speaker’s Bureau: Abbott Diabetes Care, Amgen, AstraZeneca, Becton, Dickinson and Company, Biodel, Boehringer Ingelheim, Bristol-Myers Squibb, CVS/Caremark, Eli Lilly and Company, Janssen, Lexicon, Medtronic, Merck, Novo Nordisk, OptumRx, Sanofi , Takeda, Thermalin.

Peters, Michael J. ................................ Disclosed no confl ict of interest.Petersen, Brian J. ................................. Employee: Podimetrics, Inc.; Stock/Shareholder: Podimetrics,

Inc.Petersen, Kitt F. .................................... Disclosed no confl ict of interest.Petersen, Laura A. ................................ Disclosed no confl ict of interest.Petersen, Lonnie G. .............................. Disclosed no confl ict of interest.Petersen, Max C. .................................. Disclosed no confl ict of interest.Petersen, Mira M. ................................ Employee: Steno Diabetes Center A/S.Peterson, Eric ........................................ Consultant: AstraZeneca, Bayer HealthCare, Janssen

Pharmaceuticals, Inc., Sanofi U.S.; Research Support: Eli Lilly and Company, Janssen Pharmaceuticals, Inc.

Peterson, Magnus ................................. Disclosed no confl ict of interest.Peterson, Ryan ...................................... Disclosed no confl ict of interest.Peterson-Burch, Frances ....................... Disclosed no confl ict of interest.Petit, Marie-Hélène............................... Disclosed no confl ict of interest.Petr, Tomas ............................................ Disclosed no confl ict of interest.Petrak, Ondrej........................................ Disclosed no confl ict of interest.Petric, Marin.......................................... Disclosed no confl ict of interest.Petrie, John ........................................... Disclosed no confl ict of interest.Petrosino, Joseph.................................. Disclosed no confl ict of interest.Petrou, Mario ........................................ Disclosed no confl ict of interest.Petrov, Max ........................................... Disclosed no confl ict of interest.Petrov, Nikolay ...................................... Disclosed no confl ict of interest.Petruso, Holly ........................................ Research Support: Merck Sharp & Dohme Corp.Petruželková, Lenka............................... Disclosed no confl ict of interest.Petry, Stefan .......................................... Employee: Sanofi -Aventis Deutschland GmbH.Pettis, Ronald J. ................................... Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.

Peyrot, Mark .......................................... Advisory Panel: Novo Nordisk and Roche; Consultant: Amylin, Genentech, Eli Lilly and Company, MannKind, Medtronic and Novo Nordisk; Research Support: Novo Nordisk; Speaker’s Bureau: Novo Nordisk.

Peyrou, Marion ...................................... Disclosed no confl ict of interest.Pezzolesi, Marcus G. ............................ Disclosed no confl ict of interest.Pfeffer, Marc A. .................................... Advisory Panel: Sanofi ; Consultant: Amgen, Astra Zeneca,

Bayer, Celladon, GenZyme Corp., Lilly U.S., MedImmune, Medtronic, Merck, Novartis, Novo Nordisk, Relypsa, Roche, Salix, Sanderling, Takeda, Teva, The Medicines Company, Thrasos, Vericel; Research Support: Sanofi .

Pfeifer, Michael ..................................... Employee: Johnson & Johnson, PAREXEL International Corp. (Spouse/Partner).

Pfenninger, Anja .................................... Employee: Sanofi -Aventis Deutschland GmbH.Pfl imlin, Elsa .......................................... Employee: Sanofi -Aventis Deutschland GmbH.Pfohl, Martin ......................................... Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly and

Company, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH.

Pfützner, Andreas .................................. Advisory Panel: Novo Nordisk A/S, Sanofi Diabetes; Board Member: InsulinNG; Consultant: Insuline Medical Ltd., LifeCare, Sanofi Diabetes, TempraMed; Employee: Pfützner Science & Health Institute; Research Support: Bayer HealthCare, Boehringer Ingelheim GmbH, Eli Lilly and Company, Genkyotex, Insuline Medical Ltd., Johnson & Johnson, Lexicon Pharmaceuticals, Inc., Pfi zer Inc., Unomedical; Speaker’s Bureau: Berlin-Chemie, Insuline Medical Ltd., Novo Nordisk A/S.

Pfützner, Anke H. .................................. Research Support: Insuline Medical Ltd., LifeCare, Roche Diagnostics.

Phadake, Uday....................................... Disclosed no confl ict of interest.Pham, Hoang ......................................... Disclosed no confl ict of interest.Pham-Hua, Dana ................................... Disclosed no confl ict of interest.Phan, Anh-Danh T. ................................ Disclosed no confl ict of interest.Philbrick, William .................................. Disclosed no confl ict of interest.Philip, Jannel......................................... Disclosed no confl ict of interest.Philip, Sephy.......................................... Employee: Amarin Pharma, Inc.; Stock/Shareholder: Amarin

Pharma, Inc.Philips, Paula ......................................... Disclosed no confl ict of interest.Philipson, Louis H. ................................ Disclosed no confl ict of interest.Philis-Tsimikas, Athena ......................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Dexcom,

Inc., Eli Lilly and Company, Novo Nordisk Inc., Sanofi U.S.; Employee: Ionis Pharmaceuticals (Spouse/Partner); Research Support: Eli Lilly and Company, Lexicon Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi U.S.; Stock/Shareholder: Ionis Pharmaceuticals (Spouse/Partner).

Phillips, Claire ....................................... Disclosed no confl ict of interest.Phillips, Lawrence S. ............................ Advisory Panel: Author, Janssen Pharmaceuticals, Inc., Profi l

Institute for Clinical Research, Inc.; Research Support: AstraZeneca, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Novo Nordisk Inc.

Phillips, Neil .......................................... Disclosed no confl ict of interest.Phillips, Nelson B. ................................ Disclosed no confl ict of interest.Phillips, Stuart ....................................... Employee: LifeScan scotland Ltd.Piaggesi, Alberto ................................... Disclosed no confl ict of interest.Piaggi, Paolo.......................................... Disclosed no confl ict of interest.Piatti, Piermarco .................................... Disclosed no confl ict of interest.Piccin, Barbara ...................................... Disclosed no confl ict of interest.Piccirilli, Sara ........................................ Disclosed no confl ict of interest.Picconi, Fabiana .................................... Disclosed no confl ict of interest.Pich, Sara .............................................. Disclosed no confl ict of interest.Piche, Claude A. ................................... Employee: Locemia Solutions; Stock/Shareholder: Locemia

Solutions.Pichette, Vincent ................................... Disclosed no confl ict of interest.Pichu, Sivakamasundari ........................ Disclosed no confl ict of interest.Pick, Rebecca ........................................ Employee: Janssen Pharmaceuticals, Inc.Pieber, Thomas ...................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-

Myers Squibb Company, Eli Lilly and Company, Novo Nordisk Inc., Roche Diagnostics; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Novo Nordisk Inc., Roche Diagnostics.

Piercy, James ........................................ Research Support: Merck & Co., Inc.Piermarini, Francesca ............................ Disclosed no confl ict of interest.Pierre-Damien, Denechaud ................... Disclosed no confl ict of interest.Pietropaolo, Massimo ........................... Disclosed no confl ict of interest.Piganelli, Jon D. ................................... Disclosed no confl ict of interest.Pihlajamäki, Jussi ................................. Disclosed no confl ict of interest.Pihoker, Catherine ................................. Disclosed no confl ict of interest.Pike, Julie .............................................. Disclosed no confl ict of interest.Pikulska-Chrobak, Ewa .......................... Disclosed no confl ict of interest.Pileggi, Antonello .................................. Disclosed no confl ict of interest.Pileti , Milivoj ........................................ Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S.Pilette, Claire......................................... Disclosed no confl ict of interest.Piljac, Ante ............................................ Disclosed no confl ict of interest.Pillai, Sreekumar G. .............................. Employee: Eli Lilly and Company, ICON, Plc. (Spouse/Partner).

A748


AU

THO

R D

ISCL

OSU

RE

Pilon, Dominic ....................................... Research Support: Janssen Scientifi c Affairs, LLC.Pimentel, Grégory.................................. Disclosed no confl ict of interest.Pimentel, Mauro S. .............................. Disclosed no confl ict of interest.Pimkova, Miroslava ............................... Disclosed no confl ict of interest.Pingel, Ronnie ....................................... Disclosed no confl ict of interest.Pinna, Ferdinando.................................. Disclosed no confl ict of interest.Pinney, Sara E. ...................................... Disclosed no confl ict of interest.Pino, Gemma M. ................................... Disclosed no confl ict of interest.Pinsker, Jordan E. ................................. Disclosed no confl ict of interest.Pintaudi, Basilio .................................... Disclosed no confl ict of interest.Pinto, Angela ......................................... Disclosed no confl ict of interest.Pinto, Bruno B. ...................................... Disclosed no confl ict of interest.Pipolo, Giselda ...................................... Disclosed no confl ict of interest.Pirenne, Jacques ................................... Disclosed no confl ict of interest.Pirisi, Mario ........................................... Disclosed no confl ict of interest.Piropato, Andrew R. ............................. Disclosed no confl ict of interest.Piske, Micah .......................................... Disclosed no confl ict of interest.Piston, David W. ................................... Disclosed no confl ict of interest.Pi-Sunyer, Xavier ................................... Disclosed no confl ict of interest.Pitchaimani, Vigneshwaran .................. Disclosed no confl ict of interest.Pitocco, Dario ........................................ Disclosed no confl ict of interest.Pittas, Anastassios G. .......................... Disclosed no confl ict of interest.Pittman, David ....................................... Disclosed no confl ict of interest.Pizzi, Gianluigi ....................................... Disclosed no confl ict of interest.Plam, Misha .......................................... Board Member: AmideBio; Stock/Shareholder: AmideBIo.Plank, Johannes .................................... Research Support: Novo Nordisk A/S.Platt, Bettina ......................................... Disclosed no confl ict of interest.Player, Mark .......................................... Employee: Janssen Pharmaceuticals, Inc.Plengvidhya, Nattachet ......................... Disclosed no confl ict of interest.Plesser, Mitchell .................................... Disclosed no confl ict of interest.Pleus, Stefan ......................................... Disclosed no confl ict of interest.Pleva, Melissa ....................................... Disclosed no confl ict of interest.Plucinska, Kaja ...................................... Disclosed no confl ict of interest.Plum-Mörschel, Leona .......................... Employee: Profi l Mainz GmbH & Co. KG.Pober, David .......................................... Disclosed no confl ict of interest.Pocai, Alessandro.................................. Employee: Janssen Pharmaceuticals, Inc.Pocock, Stuart J. .................................. Advisory Panel: AstraZeneca; Consultant: AstraZeneca.Podell, Brendan K. ................................ Disclosed no confl ict of interest.Podeschwa, Michael ............................. Employee: Sanofi -Aventis Deutschland GmbH.Poettler, Tina ......................................... Disclosed no confl ict of interest.Poffenberger, Greg ................................ Disclosed no confl ict of interest.Pogach, Leonard .................................... Disclosed no confl ict of interest.Pogwizd, Steven .................................... Disclosed no confl ict of interest.Pohlig, Ryan T. ...................................... Disclosed no confl ict of interest.Polak, Jan .............................................. Disclosed no confl ict of interest.Polanco, Georgina G. ............................ Disclosed no confl ict of interest.Polgreen, Linnea.................................... Disclosed no confl ict of interest.Polgreen, Philip ..................................... Disclosed no confl ict of interest.Polidori, David C. .................................. Employee: Johnson & Johnson; Stock/Shareholder: Johnson

& Johnson.Pollack, Pia S. ....................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Pollock, Carol......................................... Disclosed no confl ict of interest.Pollom, Robyn K. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Polonsky, William H. ............................ Consultant: Abbott, Boehringer Ingelheim GmbH, Dexcom,

Inc., Eli Lilly and Company, Johnson & Johnson, Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S., Taisho Pharmaceutical Co., Ltd.

Polozova, Lubov ..................................... Disclosed no confl ict of interest.Polsky, Sarit ........................................... Research Support: Dexcom, Inc.Pongratz, Rebecca L. ............................ Disclosed no confl ict of interest.Ponte, Clarisse ...................................... Disclosed no confl ict of interest.Pontiroli, Antonio E. ............................. Disclosed no confl ict of interest.Pontremoli, Roberto .............................. Disclosed no confl ict of interest.Poole, Aaron .......................................... Disclosed no confl ict of interest.Popa, Simona Georgiana G. ................. Disclosed no confl ict of interest.Pop-Busui, Rodica ................................. Disclosed no confl ict of interest.Popescu, Miro ....................................... Disclosed no confl ict of interest.Popp, Daniel .......................................... Disclosed no confl ict of interest.Porcellati, Francesca ............................. Advisory Panel: Eli Lilly and Company; Board Member: Sanofi -

Aventis Deutschland GmbH; Consultant: Eli Lilly and Company.

Porksen, Niels K. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Port, John .............................................. Disclosed no confl ict of interest.Porter, James E. ................................... Disclosed no confl ict of interest.Portha, Bernard ..................................... Disclosed no confl ict of interest.Portillo Sanchez, Paola.......................... Disclosed no confl ict of interest.Posch, Maximillian G. .......................... Consultant: Sanofi -Aventis Deutschland GmbH; Research

Support: Sanofi -Aventis Deutschland GmbH.Pothier, Claire ........................................ Disclosed no confl ict of interest.Potier, Louis ........................................... Disclosed no confl ict of interest.Potoski, Laura ........................................ Disclosed no confl ict of interest.Potter, James ........................................ Disclosed no confl ict of interest.Potzel, Anne .......................................... Disclosed no confl ict of interest.Poudel, Anil ........................................... Disclosed no confl ict of interest.

Poulos, John .......................................... Disclosed no confl ict of interest.Poulsen, Elisa ........................................ Other Relationship: Industrial PHD, Novo Nordisk A/S.Poulsen, Per L. ...................................... Disclosed no confl ict of interest.Poulsen, Steen S. ................................. Disclosed no confl ict of interest.Poulter, Neil ........................................... Consultant: Amgen Inc., Novo Nordisk Inc., Servier; Research

Support: Servier.Poursharifi , Pegah ................................. Disclosed no confl ict of interest.Povlsen, Gro K. ..................................... Employee: Novo Nordisk A/S.Powe, Camille E. .................................. Disclosed no confl ict of interest.Powell, A. Blair...................................... Disclosed no confl ict of interest.Powell, Jeffrey ...................................... Disclosed no confl ict of interest.Powell, Rachel....................................... Employee: Receptos (Celgene).Powell, Theresa L. ................................ Disclosed no confl ict of interest.Powell, Winter ...................................... Disclosed no confl ict of interest.Powers, Alvin C. ................................... Advisory Panel: American Diabetes Association, Endocrine

Society, Helmsley Charitable Trust, Juvenile Diabetes Research Foundation, National Institutes of Health; Board Member: American Diabetes Association; Research Support: Juvenile Diabetes Research Foundation, National Institutes of Health, Veterans Administration.

Powers, Margaret A. ............................ Disclosed no confl ict of interest.Pozo, David ............................................ Disclosed no confl ict of interest.Pozzilli, Paolo......................................... Research Support: Eli Lilly and Company; Speaker’s Bureau: Eli

Lilly and Company.Prabhakar, Prakash ................................ Employee: Intarcia Therapeutics, Inc.Prabhakaran, Dorairaj ........................... Disclosed no confl ict of interest.Pradel, Vincent ...................................... Disclosed no confl ict of interest.Prado, Kayorrany ................................... Disclosed no confl ict of interest.Praet, Marleen ...................................... Disclosed no confl ict of interest.Pralong, François P. .............................. Disclosed no confl ict of interest.Prasad, Nripesh ..................................... Disclosed no confl ict of interest.Pratley, Richard E. ................................ Consultant: Amylin Pharmaceuticals, LLC., AstraZeneca,

Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eisai Co., Ltd., Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline, ICON Clinical Research Inc., Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Ligand Pharmaceuticals, Inc., MannKind Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Profi l Institute for Clinical Research, Inc., Sanofi U.S., Takeda; Research Support: Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline, MannKind Corporation, Merck & Co., Inc., Novo Nordisk Inc., Pfi zer Inc., Takeda; Speaker’s Bureau: Boehringer Ingelheim GmbH, Merck & Co., Inc., Novo Nordisk Inc., Takeda.

Prazny, Martin ....................................... Disclosed no confl ict of interest.Preblick, Ronald..................................... Employee: Sanofi U.S.Predieri, Barbara ................................... Disclosed no confl ict of interest.Preechasuk, Lukana............................... Disclosed no confl ict of interest.Preissl, Hubert ....................................... Disclosed no confl ict of interest.Premakumar, Indu .................................. Disclosed no confl ict of interest.Prenni, Jessica ...................................... Disclosed no confl ict of interest.Prentice, Kacey J. ................................. Disclosed no confl ict of interest.Prentki, Marc ......................................... Disclosed no confl ict of interest.Presley, Caroline A. .............................. Disclosed no confl ict of interest.Prewitt, Todd ......................................... Employee: Humana Inc.Priaulx, Jennifer .................................... Employee: AstraZeneca.Price, David A. ...................................... Employee: Dexcom, Inc.; Stock/Shareholder: Dexcom, Inc.Prieur, Xavier ......................................... Disclosed no confl ict of interest.Prince, Lynne ......................................... Disclosed no confl ict of interest.Printz, Richard L. ................................... Disclosed no confl ict of interest.Prinz, Nicole .......................................... Disclosed no confl ict of interest.Probstfi eld, Jeffrey L. ........................... Advisory Panel: Sanofi ; Research Support: Sanofi .Prokopenko, Inga ................................... Disclosed no confl ict of interest.Proshchina, Alexandra E. ..................... Disclosed no confl ict of interest.Proskorovsky, Irina................................. Consultant: Boehringer Ingelheim GmbH.Prosser, Hamish C. ............................... Disclosed no confl ict of interest.Protopsaltis, John ................................. Disclosed no confl ict of interest.Provenzano, Francesca .......................... Disclosed no confl ict of interest.Provenzano, Vincenzo ............................ Disclosed no confl ict of interest.Pruett, Timothy ...................................... Disclosed no confl ict of interest.Psaltopoulou, Theodora ........................ Disclosed no confl ict of interest.Pscherer, Stefan .................................... Advisory Panel: Novartis AG, Sanofi -Aventis Deutschland

GmbH; Research Support: Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: AstraZeneca, Berlin-Chemie, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG, Sanofi -Aventis Deutschland GmbH.

Ptacek, Peggy ........................................ Disclosed no confl ict of interest.Pucci, Laura ........................................... Disclosed no confl ict of interest.Puelles, Jorge........................................ Employee: Takeda Development Centre Europe Ltd.Puerta Quintero, Jorge .......................... Disclosed no confl ict of interest.Puffi ng, Adelheid ................................... Disclosed no confl ict of interest.Pugliese, Alberto ................................... Disclosed no confl ict of interest.Pugliese, Giuseppe................................ Disclosed no confl ict of interest.

A749


AU

THO

R D

ISCL

OSU

RE

Puig Domingo, Manuel.......................... Advisory Panel: Eli Lilly and Company, Sanofi ; Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novo Nordisk, Sanofi .

Pujadas, Gemma ................................... Disclosed no confl ict of interest.Punthakee, Zubin................................... Research Support: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk Inc., Sanofi U.S.

Purnell, Jonathan Q. ............................. Disclosed no confl ict of interest.Pusec, Carolina M. ............................... Disclosed no confl ict of interest.Püttgen, Sonja ....................................... Disclosed no confl ict of interest.Pyatak, Elizabeth ................................... Disclosed no confl ict of interest.Pyke, Charles ......................................... Employee: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/


Pyle, Laura ............................................. Disclosed no confl ict of interest.Pyrzak, Beata ......................................... Disclosed no confl ict of interest.Qaisar, Natasha ..................................... Disclosed no confl ict of interest.Qi, Jenson ............................................. Employee: Janssen Pharmaceuticals, Inc.Qi, Jianshen .......................................... Disclosed no confl ict of interest.Qi, Lu ..................................................... Disclosed no confl ict of interest.Qi, Qibin................................................. Disclosed no confl ict of interest.Qi, Weier ............................................... Disclosed no confl ict of interest.Qi, Xiaoyan ............................................ Disclosed no confl ict of interest.Qi, Yue ................................................... Disclosed no confl ict of interest.Qian, Can ............................................... Disclosed no confl ict of interest.Qian, Wei-Jun ....................................... Disclosed no confl ict of interest.Qiang, Guifen ........................................ Disclosed no confl ict of interest.Qiao, Hong............................................. Disclosed no confl ict of interest.Qiao, Jiqiu ............................................. Employee: Crown Bioscience, Inc.Qiao, Qing.............................................. Employee: AstraZeneca.Qiao, Wei .............................................. Employee: Converge Biotech, Inc.Qiao, Zhengdong ................................... Disclosed no confl ict of interest.Qin, Lei .................................................. Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Qiu, Liling .............................................. Disclosed no confl ict of interest.Qiu, Rong ............................................... Employee: Janssen Research & Development, LLC.Qiu, Yunping .......................................... Disclosed no confl ict of interest.Qu, Shen ................................................ Disclosed no confl ict of interest.Quaggin, Susan E. ................................ Advisory Panel: Aerpio Pharmaceuticals; Research Support: Eli

Lilly and Company.Quan, Nanhu ......................................... Disclosed no confl ict of interest.Quartuccio, Michael W. ....................... Disclosed no confl ict of interest.Quayle, Annette .................................... Disclosed no confl ict of interest.Queiroz, Marcia Silva ............................ Disclosed no confl ict of interest.Quek, Jonathan Caleb You Xing............ Disclosed no confl ict of interest.Quesenberry, Charles P. ........................ Disclosed no confl ict of interest.Quick, Alycia.......................................... Disclosed no confl ict of interest.Quimbo, Ralph ....................................... Other Relationship: HealthCore, Inc., Sanofi U.S. Inc.Quinlan, Aaron R. ................................. Disclosed no confl ict of interest.Quinn, Lauretta...................................... Disclosed no confl ict of interest.Quinn, Laurie ......................................... Disclosed no confl ict of interest.Quinn, Maryanne................................... Disclosed no confl ict of interest.Quinn, Michael T. ................................. Disclosed no confl ict of interest.Quinones, Ana ....................................... Disclosed no confl ict of interest.Quintana, Fernando G. ......................... Disclosed no confl ict of interest.Quintero Carrasco, Maria José ............. Disclosed no confl ict of interest.Quirós, Carmen...................................... Disclosed no confl ict of interest.R., Chandni ............................................ Disclosed no confl ict of interest.Rabasa-Lhoret, Rémi ............................. Consultant: Abbott, Amgen Inc., AstraZeneca, Boehringer

Ingelheim Pharmaceuticals, Inc., Carlina Technologie, Eli Lilly Canada Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Medtronic, Inc., Merck & Co., Inc., Neomed, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Roche Diagnostics, Sanofi Aventis, Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals; Research Support: Eli Lilly Canada Inc., Medtronic, Inc.

Rabbani, Zaheen ................................... Disclosed no confl ict of interest.Raccah, Dennis...................................... Advisory Panel: AstraZeneca, Eli Lilly and Company, Novartis

Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S.

Racek, Mary O. ..................................... Disclosed no confl ict of interest.Rachek, Lyudmila .................................. Disclosed no confl ict of interest.Rackelmann, Nils .................................. Employee: Sanofi -Aventis Deutschland GmbH.Rademaker, Alfred ................................. Disclosed no confl ict of interest.Radford, Caitlin ..................................... Disclosed no confl ict of interest.Radford, Elizabeth ................................. Disclosed no confl ict of interest.Radhakrishnan, Chandni ....................... Disclosed no confl ict of interest.Radhakrishnan, Suma ........................... Disclosed no confl ict of interest.Radican, Larry........................................ Employee: Merck & Co., Inc.Radkowski, Piotr.................................... Disclosed no confl ict of interest.Radovick, Sally ...................................... Disclosed no confl ict of interest.

Rady, Brian ............................................ Employee: Janssen Pharmaceuticals, Inc.Raeder, Helge ........................................ Disclosed no confl ict of interest.Rafkin, Lisa ............................................ Disclosed no confl ict of interest.Raghavan, Arun ..................................... Disclosed no confl ict of interest.Raghinaru, Dan...................................... Disclosed no confl ict of interest.Ragolia, Louis ........................................ Disclosed no confl ict of interest.Rahelic, Dario ........................................ Disclosed no confl ict of interest.Rahimi, Behruz ...................................... Disclosed no confl ict of interest.Rahman, Anissa .................................... Disclosed no confl ict of interest.Rahman, M.D. Azizur............................. Disclosed no confl ict of interest.Rahman, Maisara .................................. Disclosed no confl ict of interest.Rahman, Rabia S. ................................. Disclosed no confl ict of interest.Rahme, Elham ....................................... Disclosed no confl ict of interest.Rahmouni, Kamal .................................. Disclosed no confl ict of interest.Rai, Preet Ekta ....................................... Disclosed no confl ict of interest.Raikhel, Marina ..................................... Disclosed no confl ict of interest.Railkar, Radha ....................................... Employee: Merck & Co., Inc.Raimondo, Anne .................................... Disclosed no confl ict of interest.Raja, Manisha ....................................... Disclosed no confl ict of interest.Raja, Praveen ........................................ Employee: Proteus Digital Health.Rajagopalan, Harith .............................. Board Member: Fractyl; Employee: Fractyl.Rajan, Bharat......................................... Disclosed no confl ict of interest.Rajan, Suja ............................................ Disclosed no confl ict of interest.Rajaobelina, Kalina ............................... Disclosed no confl ict of interest.Rajasekeran, Harindra........................... Disclosed no confl ict of interest.Rajendran, Rajesh ................................. Disclosed no confl ict of interest.Rajpathak, Swapnil ............................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Rakshit, Kuntol ...................................... Disclosed no confl ict of interest.Ralston, Evelyn ...................................... Disclosed no confl ict of interest.Ram, Ramesh ........................................ Disclosed no confl ict of interest.Ramachandran, Ambady ....................... Advisory Panel: AstraZeneca, Merck Sharp & Dohme Corp.;

Consultant: Bayer HealthCare, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc; Research Support: Merck Sharp & Dohme Corp.

Ramachandran, Sabarinathan............... Disclosed no confl ict of interest.Ramachandran, Vinitha ......................... Disclosed no confl ict of interest.Ramdass, Vyandra ................................. Disclosed no confl ict of interest.Ramesh, Venkat .................................... Disclosed no confl ict of interest.Rami-Merhar, Birgit ............................... Disclosed no confl ict of interest.Ramirez, Agustin ................................... Disclosed no confl ict of interest.Ramirez-Perez, Francisco I. .................. Disclosed no confl ict of interest.Ramirez-Rincon, Alex ............................ Disclosed no confl ict of interest.Ramírez-Rodríguez, Alejandra M. ........ Disclosed no confl ict of interest.Ramljak, Sanja ...................................... Disclosed no confl ict of interest.Ramos, Carlos ....................................... Disclosed no confl ict of interest.Ramos, Julia.......................................... Disclosed no confl ict of interest.Rampakakis, Emmanouil ....................... Consultant: Locemia Solutions.Rampersad, Sharvan ............................. Disclosed no confl ict of interest.Ramracheya, Reshma D. ...................... Disclosed no confl ict of interest.Ramsey, Bonnie ..................................... Disclosed no confl ict of interest.Ramsey, David J. .................................. Disclosed no confl ict of interest.Ramsey, Katrina .................................... Disclosed no confl ict of interest.Ramshaw, Hayley S. ............................. Disclosed no confl ict of interest.Ramsuchit, Bhupaul .............................. Disclosed no confl ict of interest.Ran, Nina............................................... Disclosed no confl ict of interest.Ran, Xingwu .......................................... Research Support: Medtronic, Inc.Rana, Jamal S. ..................................... Disclosed no confl ict of interest.Ranade, Prajakta ................................... Disclosed no confl ict of interest.Ranasinha, Sanjeeva............................. Disclosed no confl ict of interest.Randazzo, Caroline ................................ Disclosed no confl ict of interest.Randeva, Harpal S. ............................... Disclosed no confl ict of interest.Randolph, John F. ................................. Disclosed no confl ict of interest.Randrianarisoa, Landy........................... Disclosed no confl ict of interest.Ranjan, Ajenthen................................... Disclosed no confl ict of interest.Ranjan, Jyoti ......................................... Employee: Berg Health; Stock/Shareholder: Berg Health.Rankin, Matthew M. ............................ Employee: Janssen Pharmaceuticals, Inc.Ranson, Aymeric ................................... Employee: ADOCIA; Stock/Shareholder: ADOCIA.Rao, Ganesh .......................................... Disclosed no confl ict of interest.Rao, Paturi V. ........................................ Employee: DiabetOmics, Inc.; Research Support: Eli Lilly and

Company, Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: USV Pharma, India; Stock/Shareholder: DiabetOmics, Inc.

Rao, R. Harsha....................................... Disclosed no confl ict of interest.Rao, Ranganatha ................................... Disclosed no confl ict of interest.Rapaport, Robert ................................... Disclosed no confl ict of interest.Raphael, Rachel .................................... Disclosed no confl ict of interest.Rappaport, Eric F. .................................. Disclosed no confl ict of interest.Rapti, Eleni ............................................ Disclosed no confl ict of interest.Rasa, Ingvars ......................................... Disclosed no confl ict of interest.Rask-Madsen, Christian ........................ Research Support: Novo Nordisk Inc.Rasmussen, Lars M. ............................. Disclosed no confl ict of interest.Raspovic, Katherine M. ........................ Disclosed no confl ict of interest.Rastogi, Ravi ......................................... Employee: Senseonics, Inc.Rasulnia, Mazi....................................... Disclosed no confl ict of interest.

A750


AU

THO

R D

ISCL

OSU

RE

Rath, Akshyaya...................................... Employee: Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, India.

Rathjen, Thomas ................................... Employee: Novo Nordisk A/S.Rathore, Ali ........................................... Disclosed no confl ict of interest.Ratnasingam, Jeyakantha..................... Disclosed no confl ict of interest.Ratner, Robert E. .................................. Disclosed no confl ict of interest.Rattigan, Stephen ................................. Disclosed no confl ict of interest.Ratzki-Leewing, Alexandria .................. Other Relationship: Sanofi Canada.Rausch, Joseph ..................................... Disclosed no confl ict of interest.Raussell-Palamos, Francisco................. Disclosed no confl ict of interest.Ravn, Peter ............................................ Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Ravussin, Eric ........................................ Disclosed no confl ict of interest.Rawal, Shristi ........................................ Disclosed no confl ict of interest.Rawlings, Andreea ................................ Disclosed no confl ict of interest.Ray, Joel G. .......................................... Disclosed no confl ict of interest.Ray, Michael.......................................... Disclosed no confl ict of interest.Ray, Ranjan............................................ Disclosed no confl ict of interest.Ray, Subir .............................................. Disclosed no confl ict of interest.Rayman, Gerry ....................................... Advisory Panel: Abbott Diabetes Care Inc.; Speaker’s Bureau:

Abbott Diabetes Care Inc.Rayman, Gerry ....................................... Disclosed no confl ict of interest.Raymond, Jennifer K. ........................... Disclosed no confl ict of interest.Raynal, Sophie ...................................... Disclosed no confl ict of interest.Rayner, Nigel W. .................................. Disclosed no confl ict of interest.Razjouyan, Javad .................................. Disclosed no confl ict of interest.Rea, Silvia ............................................. Disclosed no confl ict of interest.Reddy, K. Srinath ................................... Disclosed no confl ict of interest.Reddy, Ravi ............................................ Disclosed no confl ict of interest.Redekop, Ken W. .................................. Disclosed no confl ict of interest.Redel, Jacob M. ................................... Disclosed no confl ict of interest.Redondo, Maria J. ................................ Disclosed no confl ict of interest.Reeds, Dominic ..................................... Disclosed no confl ict of interest.Reehl, Sarah M. ................................... Disclosed no confl ict of interest.Reers, Christina ..................................... Employee: Evotec.Rees, Jennifer ....................................... Disclosed no confl ict of interest.Reeves, Michael.................................... Advisory Panel: Novo Nordisk A/S; Research Support:

Boehringer Ingelheim Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Novo Nordisk A/S, Sanofi .

Reeves, Neil .......................................... Disclosed no confl ict of interest.Rege, Nischay K. .................................. Disclosed no confl ict of interest.Regelmann, Molly ................................. Disclosed no confl ict of interest.Regensteiner, Judith G. ........................ Research Support: Merck & Co., Inc.Regev, Arie ............................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Regnault, Nolwenn ............................... Disclosed no confl ict of interest.Reiber, Gayle E. .................................... Disclosed no confl ict of interest.Reich, Heather....................................... Disclosed no confl ict of interest.Reichert, Sonja ...................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Novo Nordisk Inc., Sanofi U.S.; Consultant: Novo Nordisk Inc., Sanofi U.S., Servier; Other Relationship: Canadian Diabetes Association, Heart and Stroke Foundation of Canada; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Canadian Institutes of Health Research, Novo Nordisk Inc; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc.

Reichetzeder, Christoph ........................ Disclosed no confl ict of interest.Reider, Jodie A. .................................... Disclosed no confl ict of interest.Reif, Sabrina.......................................... Disclosed no confl ict of interest.Reifsnider, Odette ................................. Consultant: Boehringer Ingelheim GmbH.Reimann, Frank...................................... Disclosed no confl ict of interest.Reimer, André ........................................ Disclosed no confl ict of interest.Rein, Philipp .......................................... Disclosed no confl ict of interest.Reiner, Alexander P. ............................. Disclosed no confl ict of interest.Reinhart, Glenn A. ................................ Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Reinhart, Greg ....................................... Employee: Receptos/Celgene.Reinke, Julia.......................................... Disclosed no confl ict of interest.Reis, Andre F. ........................................ Disclosed no confl ict of interest.Reiser, Joe ............................................. Stock/Shareholder: Cure DM Inc.Reisetter, Anna ...................................... Disclosed no confl ict of interest.Reissaus, Christopher A. ...................... Disclosed no confl ict of interest.Reiterer, Florian ..................................... Disclosed no confl ict of interest.Remedi, Maria S. ................................. Disclosed no confl ict of interest.Remus, Kerstin ...................................... Disclosed no confl ict of interest.Remvig, Line .......................................... Employee: HypoSafe A/S.Ren, Guang ............................................ Disclosed no confl ict of interest.Ren, Jenny L. ........................................ Disclosed no confl ict of interest.Ren, Jimmy............................................ Employee: Janssen Scientifi c Affairs, LLC.Ren, Jun ................................................ Disclosed no confl ict of interest.Ren, Qian ............................................... Disclosed no confl ict of interest.Ren, Shuang .......................................... Disclosed no confl ict of interest.Ren, Wenqian ........................................ Disclosed no confl ict of interest.Renard, Eric ........................................... Disclosed no confl ict of interest.Renda, Andrew...................................... Employee: Humana Inc.; Consultant: Novo Nordisk Inc.

Rendell, Marc ........................................ Other Relationship: Merck & Co., Inc; Research Support: Merck & Co., Inc.

Rengarajan, S. ...................................... Disclosed no confl ict of interest.Reno, Candace M. ................................ Disclosed no confl ict of interest.Resalat, Navid ....................................... Disclosed no confl ict of interest.Resi, Veronica ....................................... Disclosed no confl ict of interest.Retnakaran, Ravi ................................... Consultant: Novo Nordisk Inc., Sanofi U.S., Takeda

Development Center Americas, Inc.; Research Support: Novo Nordisk Inc.

Reub, Oliver ........................................... Employee: Boehringer Ingelheim GmbH.Reusch, Jane E.B. ................................. Research Support: Bristol-Myers Squibb Company, Merck &

Co., Inc.Reutrakul, Sirimon................................. Speaker’s Bureau: Medtronic MiniMed, Inc., Novo Nordisk

Inc., Sanofi U.S.Reviriego, Jesus .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Rewers, Arleta ...................................... Disclosed no confl ict of interest.Rewers, Marian..................................... Research Support: National Institutes of Health.Rey, Victor L. ......................................... Disclosed no confl ict of interest.Reyes, David.......................................... Disclosed no confl ict of interest.Reyes-Umpierrez, David ........................ Disclosed no confl ict of interest.Reynolds, James T. .............................. Disclosed no confl ict of interest.Reynolds, Kristi ..................................... Disclosed no confl ict of interest.Reynolds, Rebecca ................................ Disclosed no confl ict of interest.Reyzelman, Alexander M. .................... Research Support: Podimetrics, Inc.Rezanejadbardeji, Habib ....................... Disclosed no confl ict of interest.Rezende, Effi ley M. .............................. Disclosed no confl ict of interest.Rezki, Amel............................................ Disclosed no confl ict of interest.Rezvani, Geoffrey .................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP.Rhee, Byung Doo ................................... Disclosed no confl ict of interest.Rhee, Dong Keun................................... Disclosed no confl ict of interest.Rhee, Eun-Jung ..................................... Disclosed no confl ict of interest.Rhee, Jae W. ........................................ Disclosed no confl ict of interest.Rhee, Jinnie J. ..................................... Disclosed no confl ict of interest.Rhee, Mary ............................................ Disclosed no confl ict of interest.Rhee, Nicolai A. ................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Rhee, Sang Youl .................................... Disclosed no confl ict of interest.Riccardi, Gabriele .................................. Disclosed no confl ict of interest.Rich, Stephen S. ................................... Disclosed no confl ict of interest.Richard, Allison J. ................................ Disclosed no confl ict of interest.Richards, Stephen M. ........................... Disclosed no confl ict of interest.Richards, William .................................. Disclosed no confl ict of interest.Richey, Joyce M. .................................. Disclosed no confl ict of interest.Richman, Jeremy G. ............................. Disclosed no confl ict of interest.Richter, Erik A. ...................................... Disclosed no confl ict of interest.Rickels, Michael R. ............................... Consultant: Johnson & Johnson; Research Support: Merck &

Co., Inc.Ricklefs-Johnson, Kristin ...................... Disclosed no confl ict of interest.Ricks, Madia.......................................... Disclosed no confl ict of interest.Ricordi, Camillo ..................................... Disclosed no confl ict of interest.Riddell, Michael .................................... Disclosed no confl ict of interest.Ridderstråle, Martin .............................. Advisory Panel: Medtronic, Inc., Novo Nordisk A/S;

Consultant: Boehringer Ingelheim GmbH; Employee: Steno Diabetes Center A/S; Speaker’s Bureau: AstraZeneca.

Riddle, Matthew C. .............................. Advisory Panel: Astra Zeneca, Sanofi ; Consultant: Biodel, Elcelyx, Valeritas; Research Support: Astra Zeneca, Eli Lilly and Company, Novo Nordisk, Sanofi .

Riddlesworth, Tonya D. ........................ Disclosed no confl ict of interest.Rider, Nicholas ...................................... Disclosed no confl ict of interest.Ridolfi , Valentina ................................... Disclosed no confl ict of interest.Riedel, Gernot ....................................... Disclosed no confl ict of interest.Riedel, Jens........................................... Employee: Sanofi -Aventis Deutschland GmbH.Rigalleau, Vincent ................................. Disclosed no confl ict of interest.Rigbolt, Kristoffer .................................. Employee: Gubra.Rigby, Alan S. ....................................... Disclosed no confl ict of interest.Riley, Keith ............................................ Disclosed no confl ict of interest.Rimar, Joan M. ..................................... Other Relationship: Strata Decision Technology.Rimawi, Fatimah ................................... Disclosed no confl ict of interest.Rimbault, Mathieu ................................ Employee: Sanofi -Aventis Deutschland GmbH.Rinehart, Jesse ..................................... Disclosed no confl ict of interest.Ringham, Brandy ................................... Disclosed no confl ict of interest.Rinn, Sarah ............................................ Disclosed no confl ict of interest.Rios, Jackie S. ...................................... Disclosed no confl ict of interest.Rios, Jahazania ..................................... Disclosed no confl ict of interest.Risérus, Ulf ............................................ Disclosed no confl ict of interest.Rista, Lucas ........................................... Research Support: Eli Lilly and Company.Ritthaler, Julia ....................................... Disclosed no confl ict of interest.Ritzel, Robert A. ................................... Consultant: AstraZeneca, Merck Sharp & Dohme, Novo

Nordisk, Sanofi ; Speaker’s Bureau: AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Merck Sharp & Dohme, Novartis, Novo Nordisk, Sanofi .

Ritzén, Hanna ........................................ Disclosed no confl ict of interest.Rius, Ferran ........................................... Disclosed no confl ict of interest.Riva, Alberto.......................................... Disclosed no confl ict of interest.

A751


AU

THO

R D

ISCL

OSU

RE

Rivas, Lourdes ....................................... Disclosed no confl ict of interest.Riveline, Jean-Pierre ............................. Disclosed no confl ict of interest.Rivellese, Angela A. ............................. Disclosed no confl ict of interest.Riviera, Federico.................................... Disclosed no confl ict of interest.Rizza, Robert A. .................................... Disclosed no confl ict of interest.Rizzuto, Rosario ..................................... Disclosed no confl ict of interest.Roat, Regan ........................................... Disclosed no confl ict of interest.Robacker, Maire .................................... Disclosed no confl ict of interest.Robbins, David ...................................... Disclosed no confl ict of interest.Robbins, Raymond................................. Disclosed no confl ict of interest.Roberts, Brian K. .................................. Employee: AntriaBio; Stock/Shareholder: AntriaBio.Robertson, Kenneth E. .......................... Employee: Eli Lilly and Company.Robertson, Morgan A. .......................... Disclosed no confl ict of interest.Robertson, R. Paul ................................. Disclosed no confl ict of interest.Robertson, Stacy ................................... Disclosed no confl ict of interest.Robinson, Anthony ................................ Disclosed no confl ict of interest.Robinson, Matthew M. ........................ Disclosed no confl ict of interest.Robinson, Michelle D. .......................... Disclosed no confl ict of interest.Rocha, Rafaela C. ................................. Disclosed no confl ict of interest.Roche, Kelly........................................... Disclosed no confl ict of interest.Rockenbach, Gabriele ........................... Disclosed no confl ict of interest.Rockette-Wagner, Bonny ...................... Disclosed no confl ict of interest.Rodbard, David ...................................... Consultant: Dexcom, Inc.Rodbard, Helena.................................... Advisory Panel: AstraZeneca, Biodel Inc., Janssen

Pharmaceuticals, Inc., Lilly, Merck, Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc., Sanofi ; Consultant: AstraZeneca, Biodel Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Lilly, Merck, Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc., Sanofi ; Research Support: AstraZeneca, Biodel Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Halozyme Therapeutics, Janssen Pharmaceuticals, Inc., Lilly, Merck, Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc., Sanofi ; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Lilly, Merck, Novo Nordisk A/S, Sanofi .

Roden, Michael ..................................... Advisory Panel: Eli Lilly and Company, GI Dynamics, Inc., Novo Nordisk Inc., Poxel Pharmaceutical Company; Board Member: Eli Lilly and Company, GI Dynamics, Inc., Novo Nordisk Inc., Poxel Pharmaceutical Company; Consultant: Genentech, Inc., GI Dynamics, Inc., Merck & Co., Inc., Sanofi -Aventis Deutschland GmbH; Other Relationship: AstraZeneca (Spouse/Partner), Boehringer Ingelheim GmbH (Spouse/Partner), Eli Lilly and Company, Novartis Pharma GmbH (Spouse/Partner); Research Support: Boehringer Ingelheim GmbH, Danone, Inc., Novartis Pharma GmbH, Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk Inc.

Rodezno, Wilfredo................................. Employee: Medtronic, Inc.Rodgers, Lauren R. ............................... Disclosed no confl ict of interest.Rodney, Allistiar .................................... Disclosed no confl ict of interest.Rodriguez, Alena ................................... Disclosed no confl ict of interest.Rodriguez, Angel ................................... Employee: Eli Lilly and Company.Rodriguez, Henry ................................... Disclosed no confl ict of interest.Rodriguez, Kellie ................................... Consultant: Bayer HealthCare.Rodriguez, Leonardo.............................. Research Support: Fractyl.Rodriguez, Patricia ................................ Research Support: Fractyl.Rodriguez-Diaz, Rayner ......................... Disclosed no confl ict of interest.Roe, Michael W. ................................... Disclosed no confl ict of interest.Roeder, Pia ............................................ Disclosed no confl ict of interest.Roehling, Martin ................................... Disclosed no confl ict of interest.Roehrig, Karin........................................ Disclosed no confl ict of interest.Roell, William C. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Roenneberg, Till .................................... Disclosed no confl ict of interest.Rogers, Brian ......................................... Disclosed no confl ict of interest.Rogers, Heather M. .............................. Employee: National Institute of Diabetes and Digestive and

Kidney Diseases.Rogers, James....................................... Research Support: Eli Lilly and Company.Rogers, Olivia ........................................ Disclosed no confl ict of interest.Rogozinska, Izabela ............................... Disclosed no confl ict of interest.Rogulina, Svetlana ................................ Disclosed no confl ict of interest.Rohde, Ulrich ......................................... Disclosed no confl ict of interest.Röhling, Martin ..................................... Disclosed no confl ict of interest.Rohrs, Henry .......................................... Disclosed no confl ict of interest.Rojas, Jennifer ...................................... Disclosed no confl ict of interest.Rojas, Jose A. ...................................... Disclosed no confl ict of interest.Rojas, Yuliana ........................................ Disclosed no confl ict of interest.Rojo de la Vega, Montserrat ................. Disclosed no confl ict of interest.Rokitta, Ilka ........................................... Disclosed no confl ict of interest.Rolandsson, Olov................................... Disclosed no confl ict of interest.Rolka, Deborah ...................................... Disclosed no confl ict of interest.Roman, Richard J. ................................ Disclosed no confl ict of interest.Romano, Maria...................................... Disclosed no confl ict of interest.

Romanova, Iryna.................................... Disclosed no confl ict of interest.Romenskaia, Irina.................................. Disclosed no confl ict of interest.Romero, Beverly .................................... Consultant: ICON, Plc.Romero, Enrique .................................... Disclosed no confl ict of interest.Romero, Fabiola .................................... Disclosed no confl ict of interest.Romero, Odile........................................ Disclosed no confl ict of interest.Romero-Ibarguengoitia, Maria Elena.... Disclosed no confl ict of interest.Romijn, Johannes A. ............................ Disclosed no confl ict of interest.Ron, Eyal................................................ Disclosed no confl ict of interest.Rondags, Stefanie MPA ........................ Disclosed no confl ict of interest.Rondinelli, Maurizio .............................. Disclosed no confl ict of interest.Rondinone, Cristina ............................... Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Ronn, Jonas........................................... Disclosed no confl ict of interest.Rønn, Pernille F. .................................... Employee: Novo Nordisk A/S (Spouse/Partner).Ronneby, Helle ...................................... Disclosed no confl ict of interest.Ronsin, Olivia ........................................ Disclosed no confl ict of interest.Ronsley, Claire....................................... Disclosed no confl ict of interest.Ronsley, Rebecca .................................. Disclosed no confl ict of interest.Rooney, William .................................... Disclosed no confl ict of interest.Rorsman, Patrik ..................................... Disclosed no confl ict of interest.Rosales, Lizet ........................................ Disclosed no confl ict of interest.Rosas-Arellano, Patricia........................ Disclosed no confl ict of interest.Rose, Ludger.......................................... Advisory Panel: AstraZeneca, Lilly, Novo Nordisk A/S;

Research Support: AstraZeneca, Lilly, Novo Nordisk A/S.Rosen, Evan ........................................... Disclosed no confl ict of interest.Rosendahl, Mary S. .............................. Employee: AntriaBio; Stock/Shareholder: AntriaBio.Rosenfeld, Nora .................................... Disclosed no confl ict of interest.Rosengren, Anders ................................ Disclosed no confl ict of interest.Rosenkilde, Mette M. .......................... Disclosed no confl ict of interest.Rosenstock, Julio .................................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, GlaxoSmithKline, Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., MannKind Corporation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited; Research Support: Amylin Pharmaceuticals, LLC., AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, GlaxoSmithKline, Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., MannKind Corporation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Pfi zer Inc., Roche Pharmaceuticals, Sanofi U.S., Takeda Pharmaceutical Company Limited.

Rosenthal, Meredith B. ........................ Disclosed no confl ict of interest.Rosenthal, Miranda............................... Disclosed no confl ict of interest.Rosenthal, Stephen M. ........................ Disclosed no confl ict of interest.Roshandel, Delnaz................................. Disclosed no confl ict of interest.Rosikiewicz, Marta................................ Disclosed no confl ict of interest.Rosman, Paul......................................... Advisory Panel: LabStyle Innovations, Ltd; Consultant:

LabStyle Innovations, Ltd.Rosner, Bernard ..................................... Disclosed no confl ict of interest.Ross, Cassie .......................................... Disclosed no confl ict of interest.Ross, Glynis P. ...................................... Disclosed no confl ict of interest.Ross, Joseph S. .................................... Research Support: Blue Cross Blue Shield, Food and Drug

Administration, Johnson & Johnson, Medtronic, Inc.Ross-Degnan, Dennis ............................ Disclosed no confl ict of interest.Rosselot, Carolina ................................. Disclosed no confl ict of interest.Rossetti, Paolo ...................................... Disclosed no confl ict of interest.Rossi, Alessandra.................................. Employee: MedImmune, LLC.Rossi, Maria .......................................... Disclosed no confl ict of interest.Rossing, Peter ....................................... Other Relationship: Astellas Pharma Inc., AstraZeneca,

Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis AG; Research Support: Abbott, Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S.

Rossulek, Michelle ................................ Disclosed no confl ict of interest.Rotberg, Britt ......................................... Employee: Novo Nordisk A/S.Rotem, Avi ............................................. Disclosed no confl ict of interest.Roth, Christian L. .................................. Disclosed no confl ict of interest.Roth, Roswith L. ................................... Research Support: National Institutes of Health.Roth, Shena ........................................... Disclosed no confl ict of interest.Rothberg, Amy E. .................................. Board Member: ADA Clinical Professional Practice Committee

(Spouse/Partner), Endocrine Society; Other Relationship: Lexicon Pharmaceuticals, Inc. (Spouse/Partner), Merck & Co., Inc; Research Support: Nestlé.

Rothe, Maik ........................................... Disclosed no confl ict of interest.Rothenberg, Gary M. ............................ Research Support: Podimetrics, Inc.Rother, Kristina ...................................... Disclosed no confl ict of interest.Rothman, Douglas ................................. Disclosed no confl ict of interest.Rotroff, Daniel ....................................... Disclosed no confl ict of interest.Rotter, Jerome ....................................... Disclosed no confl ict of interest.Rougier, Marie-Bénédicte ..................... Disclosed no confl ict of interest.Roumie, Christianne L. ......................... Disclosed no confl ict of interest.

A752


AU

THO

R D

ISCL

OSU

RE

Round, Elizabeth.................................... Employee: Merck & Co., Inc., Novartis Pharmaceuticals Corporation (Spouse/Partner); Stock/Shareholder: Merck & Co., Inc.

Rouse, Michael ..................................... Disclosed no confl ict of interest.Rousseau, Michel F. ............................. Disclosed no confl ict of interest.Roussel, Ronan...................................... Board Member: Janssen Pharmaceuticals, Inc., Merck Sharp

& Dohme Corp., Novo Nordisk A/S, Sanofi Pasteur; Research Support: Sanofi Pasteur; Speaker’s Bureau: AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly and Company.

Roust, Lori R. ........................................ Disclosed no confl ict of interest.Roustit, Matthieu .................................. Disclosed no confl ict of interest.Rovers, Maroeska M. ........................... Disclosed no confl ict of interest.Rowe, Glenn .......................................... Disclosed no confl ict of interest.Roy, Anirban .......................................... Employee: Medtronic, Inc.Roy, Nilotpal .......................................... Disclosed no confl ict of interest.Roy, Sayon ............................................. Research Support: Zealand Pharma A/S.Ruan, Hong ............................................ Disclosed no confl ict of interest.Ruan, Yue .............................................. Disclosed no confl ict of interest.Ruan, Yuting .......................................... Disclosed no confl ict of interest.Ruanpeng, Darin.................................... Disclosed no confl ict of interest.Rubenstein, Ronald C. .......................... Disclosed no confl ict of interest.Rubin, Daniel J. .................................... Disclosed no confl ict of interest.Rubino, Domenica M. ........................... Advisory Panel: Eisai, Inc.; Consultant: Novo Nordisk A/S;

Other Relationship: Novo Nordisk; Speaker’s Bureau: Eisai, Inc., Novo Nordisk A/S.

Rubino, Francesco ................................. Consultant: Fractyl; Speaker’s Bureau: Sanofi U.S.Rubinstein, Debra Nan .......................... Disclosed no confl ict of interest.Ruchko, Mykhailo .................................. Disclosed no confl ict of interest.Rudijanto, Achmad ................................ Board Member: Indonesian College of Internal Medicine;

Employee: Faculty of Medicine, Brawijaya University; Other Relationship: Project WDF 11-586; 2011-2015 (Diabetes Nurses and Educators course); Research Support: Novo Nordisk A/S.

Rudijanto, Ahmad.................................. Disclosed no confl ict of interest.Rudivich, Natalia ................................... Disclosed no confl ict of interest.Rueppel, Diether ................................... Employee: Sanofi .Ruffolo, Antonio .................................... Employee: Boehringer Ingelheim GmbH.Rufi ange, Marianne............................... Consultant: Locemia Solutions.Ruggiero, Laurie .................................... Other Relationship: Johnson & Johnson Diabetes Institute.Ruggles, James A. ............................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Rui, Liangyou ......................................... Disclosed no confl ict of interest.Rui, Xianliang ........................................ Disclosed no confl ict of interest.Ruiz, Henry ............................................ Disclosed no confl ict of interest.Ruiz, Monica.......................................... Disclosed no confl ict of interest.Ruiz-Nava, Josefi na .............................. Disclosed no confl ict of interest.Ruiz-Palomar, José Manuel .................. Consultant: Sanofi -Aventis.Ruman, Joanna ..................................... Disclosed no confl ict of interest.Rumora, Amy ......................................... Disclosed no confl ict of interest.Rumpler, Markus ................................... Disclosed no confl ict of interest.Rungby, Jørgen...................................... Disclosed no confl ict of interest.Runge, Heike ......................................... Disclosed no confl ict of interest.Runion, Asher ........................................ Disclosed no confl ict of interest.Rupnow, Marcia F. ................................ Employee: Janssen Scientifi c Affairs, LLC; Stock/Shareholder:

Johnson & Johnson.Rurali, Erica ........................................... Disclosed no confl ict of interest.Rush, William A. .................................. Disclosed no confl ict of interest.Russell, Kate ......................................... Disclosed no confl ict of interest.Russell, Ryan D. ................................... Disclosed no confl ict of interest.Russell, Steven J. ................................. Advisory Panel: Campanion Medical, Campanion Medical,

Tandem Diabetes Care, Inc., Tandem Diabetes Care, Inc.; Consultant: Sanofi U.S., Sanofi U.S.; Other Relationship: Abbott Diabetes Care Inc., Abbott Diabetes Care Inc., Beta Bionics, Beta Bionics, Dexcom, Inc., Dexcom, Inc., Eli Lilly and Company, Eli Lilly and Company, Insulet Corporation, Insulet Corporation, International Biomedical, International Biomedical, Medtronic MiniMed, Inc., Medtronic MiniMed, Inc., Sanofi U.S., Sanofi U.S., Tandem Diabetes Care, Inc., Tandem Diabetes Care, Inc.

Russell, William .................................... Disclosed no confl ict of interest.Russell-Jones, David............................. Advisory Panel: AstraZeneca, Lilly Deutschland GmbH, Novo

Nordisk A/S, Sanofi ; Board Member: AstraZeneca, Lilly Deutschland GmbH, Novo Nordisk A/S, Sanofi ; Consultant: AstraZeneca, Lilly Deutschland GmbH, Lilly Deutschland GmbH, Novo Nordisk A/S, Sanofi , Sanofi -Aventis Deutschland GmbH; Research Support: AstraZeneca, Lilly Deutschland GmbH, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: AstraZeneca, Lilly Deutschland GmbH, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi .

Russkikh, G.S. ....................................... Disclosed no confl ict of interest.Russo, Alessandro................................. Disclosed no confl ict of interest.Russo, Eleonora..................................... Disclosed no confl ict of interest.Russo, Thiago L. ................................... Disclosed no confl ict of interest.Ruth, Kate.............................................. Disclosed no confl ict of interest.

Ruth, Katherine ..................................... Disclosed no confl ict of interest.Rutter, Guy A. ....................................... Disclosed no confl ict of interest.Rutter, Martin ........................................ Consultant: Roche Pharmaceuticals; Research Support:

GlaxoSmithKline, Novo Nordisk Inc; Stock/Shareholder: GlaxoSmithKline.

Ryan, Alexander J. ............................... Disclosed no confl ict of interest.Ryan, Bridget L. .................................... Disclosed no confl ict of interest.Ryan, Catlin ........................................... Disclosed no confl ict of interest.Ryan, Glennice ...................................... Disclosed no confl ict of interest.Rychlik, Karen........................................ Disclosed no confl ict of interest.Ryden, Mikael ....................................... Disclosed no confl ict of interest.Rydén-Bergsten, Tina ............................ Employee: AstraZeneca.Ryder, Robert E. .................................... Disclosed no confl ict of interest.Rydin, Anna ........................................... Disclosed no confl ict of interest.Ryou, Marvin ......................................... Advisory Panel: GI Windows; Board Member: GI Windows;

Stock/Shareholder: GI Windows.Rys, Przemyslaw.................................... Consultant: Medtronic, Inc.Ryszawy, Jakub ..................................... Disclosed no confl ict of interest.Rytter, Ane ............................................. Disclosed no confl ict of interest.Saad, Farid ............................................ Employee: Bayer HealthCare; Stock/Shareholder: Bayer

HealthCare.Saad, Sonia ........................................... Disclosed no confl ict of interest.Sabadine, Maria Augusta ..................... Disclosed no confl ict of interest.Sabaratnam, Rugivan ............................ Disclosed no confl ict of interest.Sabek, Omaima ..................................... Disclosed no confl ict of interest.Sabo, John P. ........................................ Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Saboo, Banshi ....................................... Disclosed no confl ict of interest.Sabroe, Ian ............................................ Disclosed no confl ict of interest.Sacchetti, Massimo .............................. Disclosed no confl ict of interest.Sacco, Vanessa ..................................... Disclosed no confl ict of interest.Sachsenheimer, Daniela ....................... Disclosed no confl ict of interest.Sacks, David B. ..................................... Disclosed no confl ict of interest.Sacks, Frank M. .................................... Disclosed no confl ict of interest.Sacksner, Jamie .................................... Disclosed no confl ict of interest.Sadagurski, Marianna ........................... Disclosed no confl ict of interest.Sadasivan Pillai, Pradeep Babu ............ Disclosed no confl ict of interest.Sadosky, Alesia ..................................... Employee: Pfi zer Inc.Sadoune, Aziz ........................................ Consultant: Locemia Solutions.Saeki, Akio ............................................ Disclosed no confl ict of interest.Saely, Christoph H. ............................... Disclosed no confl ict of interest.Saengnipanthkul, Suchaorn .................. Disclosed no confl ict of interest.Saetung, Sunee ..................................... Disclosed no confl ict of interest.Safai, Narges ........................................ Employee: Steno Diabetes Center A/S.Safar, Pavel ........................................... Employee: Sanofi U.S.Safo, Sandra.......................................... Disclosed no confl ict of interest.Safranow, Krzysztof............................... Disclosed no confl ict of interest.Sagara, Masaaki ................................... Disclosed no confl ict of interest.Sagathelian, Alan.................................. Disclosed no confl ict of interest.Sagum, Jonathan .................................. Disclosed no confl ict of interest.Sahin, Alper........................................... Disclosed no confl ict of interest.Sahota, Daljit ........................................ Disclosed no confl ict of interest.Saiki, Atsuhito ....................................... Disclosed no confl ict of interest.Sailau, Zhanbolat S. ............................. Disclosed no confl ict of interest.Sailer, Corinna ....................................... Disclosed no confl ict of interest.Sairanen, Mikko .................................... Employee: PerkinElmer Inc.Sairyo, Masami ..................................... Research Support: Sanwa Kagaku Kenkyusho Co., Ltd.Saito, Isao ............................................. Disclosed no confl ict of interest.Saito, Maki ............................................ Disclosed no confl ict of interest.Saito, Rintaro ........................................ Disclosed no confl ict of interest.Saito, Toshihiko ..................................... Disclosed no confl ict of interest.Sajan, Mini P. ....................................... Disclosed no confl ict of interest.Saji, Hideo ............................................. Disclosed no confl ict of interest.Sajuthi, Satria ....................................... Disclosed no confl ict of interest.Sakaguchi, Masaji................................. Disclosed no confl ict of interest.Sakai, Juro ............................................ Disclosed no confl ict of interest.Sakai, Takenori ...................................... Disclosed no confl ict of interest.Sakai, Tohru ........................................... Disclosed no confl ict of interest.Sakamoto, Fumie................................... Disclosed no confl ict of interest.Sakamoto, Kentaro................................ Disclosed no confl ict of interest.Sakamoto, Yuka ..................................... Disclosed no confl ict of interest.Sakashita, Anna .................................... Disclosed no confl ict of interest.Sakata, Yasushi ..................................... Disclosed no confl ict of interest.Sakr, Mahmoud ..................................... Disclosed no confl ict of interest.Sakurai, Yoshitaka................................. Disclosed no confl ict of interest.Sakuta, Hidenari.................................... Disclosed no confl ict of interest.Sala, Margarita ..................................... Disclosed no confl ict of interest.Salami, Joseph A. ................................ Disclosed no confl ict of interest.Salari, Hamid......................................... Employee: MedImmune, LLC.Salas, Eduardo ...................................... Disclosed no confl ict of interest.Salas, Tiffanie ....................................... Disclosed no confl ict of interest.Salastekar, Ninad .................................. Disclosed no confl ict of interest.Salata, Roseann J. ............................... Disclosed no confl ict of interest.Salaye, Lipika ........................................ Disclosed no confl ict of interest.Salazar, Tatiana ..................................... Disclosed no confl ict of interest.Salbaum, Michael ................................. Disclosed no confl ict of interest.Saleh, Farrah ......................................... Disclosed no confl ict of interest.

A753


AU

THO

R D

ISCL

OSU

RE

Salehi, Albert ........................................ Disclosed no confl ict of interest.Salem, Rany .......................................... Disclosed no confl ict of interest.Sales, Ana Paula ................................... Disclosed no confl ict of interest.Sales, Vicencia M. ............................... Disclosed no confl ict of interest.Salgado, P. ............................................ Disclosed no confl ict of interest.Salhin, Amna ......................................... Disclosed no confl ict of interest.Salihovic, Samira .................................. Disclosed no confl ict of interest.Salkind, Sara ......................................... Disclosed no confl ict of interest.Sallam, Hanaa ....................................... Disclosed no confl ict of interest.Salle, Laurence...................................... Disclosed no confl ict of interest.Salomaa, Veikko .................................... Disclosed no confl ict of interest.Salsali, Afshin ....................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Salsberg, Veronica ................................ Disclosed no confl ict of interest.Salutini, Elisabetta ................................ Disclosed no confl ict of interest.Samala, Niharika................................... Disclosed no confl ict of interest.Samantray, Julie ................................... Disclosed no confl ict of interest.Samarasekera, Tanya ............................ Disclosed no confl ict of interest.Samii, Leyla ........................................... Disclosed no confl ict of interest.Samingan, Nurshadia............................ Disclosed no confl ict of interest.Samkani, Amirsalar ............................... Disclosed no confl ict of interest.Sampol, Gabriel..................................... Disclosed no confl ict of interest.Sampson, Mike ..................................... Disclosed no confl ict of interest.Samuel, Rita .......................................... Employee: Regeneron Pharmaceuticals, Inc.; Stock/

Shareholder: Regeneron Pharmaceuticals, Inc.Samuel, Varman T. ............................... Disclosed no confl ict of interest.Samuel-Hodge, Carmen ........................ Disclosed no confl ict of interest.Sanal, Geethu........................................ Disclosed no confl ict of interest.Sánchez, Enric ....................................... Disclosed no confl ict of interest.Sanchez, Ramiro.................................... Disclosed no confl ict of interest.Sanchez, Rosalia ................................... Disclosed no confl ict of interest.Sánchez-Infantes, David ....................... Disclosed no confl ict of interest.Sánchez-Iñigo, Laura ............................. Disclosed no confl ict of interest.Sánchez-Pozos, Katy ............................. Disclosed no confl ict of interest.Sancho-Bornez, Veronica ...................... Disclosed no confl ict of interest.Sandberg, Jonathan .............................. Disclosed no confl ict of interest.Sandholm, Niina.................................... Disclosed no confl ict of interest.Sandoval, Darleen A. ........................... Research Support: Boehringer Ingelheim GmbH, Ethicon Endo-

Surgery, Inc., Novo Nordisk A/S, Sanofi U.S.Sandre-Banon, Dorian ........................... Disclosed no confl ict of interest.Sands, Arthur T. .................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc.Sands, Keith .......................................... Disclosed no confl ict of interest.Sandy, Phillip ......................................... Disclosed no confl ict of interest.Sanger, Debora ...................................... Disclosed no confl ict of interest.Sangnes, Dag A. ................................... Disclosed no confl ict of interest.Sangtian, Jutarat .................................. Disclosed no confl ict of interest.Sankar, Adhithya ................................... Disclosed no confl ict of interest.Sankaranarayanan, Sailesh .................. Disclosed no confl ict of interest.Sanna, Fabio.......................................... Disclosed no confl ict of interest.Sano, Hiroyuki ....................................... Disclosed no confl ict of interest.Sano, Kohei ........................................... Disclosed no confl ict of interest.Sano, Madoka ....................................... Disclosed no confl ict of interest.Santamaria-Fernandez, Sonia ............... Disclosed no confl ict of interest.Santaren, Ingrid D. ............................... Disclosed no confl ict of interest.Santi, Lorenza........................................ Disclosed no confl ict of interest.Santini, Noel O. .................................... Disclosed no confl ict of interest.Santoni, Federico .................................. Disclosed no confl ict of interest.Santos, Aritania S. ............................... Disclosed no confl ict of interest.Santos, Debora F. ................................. Disclosed no confl ict of interest.Santos, Guilherme................................. Disclosed no confl ict of interest.Santos, Jose L. ..................................... Disclosed no confl ict of interest.Santos, Julia M. ................................... Disclosed no confl ict of interest.Santos, Laila R. .................................... Disclosed no confl ict of interest.Santos, M. Dolores ............................... Disclosed no confl ict of interest.Santos, Rosa F. ..................................... Disclosed no confl ict of interest.Sanz-Ortega, Julian............................... Disclosed no confl ict of interest.Sanz-Velasco, Alberto ........................... Disclosed no confl ict of interest.Sarac, Fulden......................................... Disclosed no confl ict of interest.Sarac, Sefa ............................................ Disclosed no confl ict of interest.Sarangarajan, Rangaprasad.................. Employee: Berg Health; Stock/Shareholder: Berg Health.Saravanan, Ponnusamy ......................... Disclosed no confl ict of interest.Sargin, Mehmet .................................... Disclosed no confl ict of interest.Sari, Ramazan ....................................... Disclosed no confl ict of interest.Sarkar, Bansari ...................................... Disclosed no confl ict of interest.Sarosiek, Irene ...................................... Disclosed no confl ict of interest.Sarra-Bournet, François ........................ Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Sarron, Tulio .......................................... Disclosed no confl ict of interest.Sartipy, Peter ......................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Sasahara, Yuriko ................................... Disclosed no confl ict of interest.Sasaki, Hiroyuki..................................... Disclosed no confl ict of interest.Sasaki, Osamu....................................... Disclosed no confl ict of interest.Sasaki, Satoru ....................................... Disclosed no confl ict of interest.Sasaki, Shugo........................................ Disclosed no confl ict of interest.Sasase, Tomohiko ................................. Disclosed no confl ict of interest.Saseen, Joseph ..................................... Research Support: AstraZeneca Pharmaceuticals LP.

Sasikumar, Meera ................................. Disclosed no confl ict of interest.Satake, Eiichiro ..................................... Disclosed no confl ict of interest.Sathyapalan, Thozhukat ........................ Disclosed no confl ict of interest.Sato, Ai.................................................. Disclosed no confl ict of interest.Sato, Daisuke ........................................ Disclosed no confl ict of interest.Sato, Eri ................................................. Disclosed no confl ict of interest.Sato, Junko ........................................... Speaker’s Bureau: Novartis Pharmaceuticals Corporation,

Novo Nordisk Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Sato, Koji ............................................... Disclosed no confl ict of interest.Sato, Minoru ......................................... Disclosed no confl ict of interest.Sato, Teruko .......................................... Disclosed no confl ict of interest.Sato, Yuka ............................................. Disclosed no confl ict of interest.Sato, Yuta .............................................. Disclosed no confl ict of interest.Satoh, Hiroaki........................................ Research Support: Abbott, Asahi Kasei Corporation,

Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eisai Co., Ltd., Genzyme Corporation, Otsuka Pharmaceutical Co., Ltd., Terumo Corporation, Torii Pharmaceutical Co., Ltd.; Speaker’s Bureau: AstraZeneca, Eli Lilly Japan K.K., Kowa Company, Ltd., Novartis Pharma AG, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Satoh, Jo ............................................... Disclosed no confl ict of interest.Satoh, Shinobu ...................................... Disclosed no confl ict of interest.Sattar, Naveed ...................................... Disclosed no confl ict of interest.Sattari, Maryam .................................... Disclosed no confl ict of interest.Satyarengga, Medha............................. Disclosed no confl ict of interest.Sauder, Katherine A. ............................ Disclosed no confl ict of interest.Sauder, Matthew A. ............................. Disclosed no confl ict of interest.Sauerwein, Tom J. ............................... Disclosed no confl ict of interest.Saulnier, Pierre-Jean ............................. Disclosed no confl ict of interest.Saunavaara, Virva ................................. Disclosed no confl ict of interest.Saunders, Diane .................................... Disclosed no confl ict of interest.Saura, Gabriella .................................... Disclosed no confl ict of interest.Sauter, Jerry .......................................... Disclosed no confl ict of interest.Savage, George ..................................... Employee: Proteus Digital Health.Savari, Omid .......................................... Disclosed no confl ict of interest.Savas, Sumru E. ................................... Disclosed no confl ict of interest.Saveliev, Sergey V. ............................... Disclosed no confl ict of interest.Savoca, Margaret R. ............................ Disclosed no confl ict of interest.Savolainen, Anna M. ............................ Disclosed no confl ict of interest.Savopoulos, Christos............................. Disclosed no confl ict of interest.Savoye, Mary ........................................ Disclosed no confl ict of interest.Savu, Anamaria ..................................... Disclosed no confl ict of interest.Sawa, Samantha ................................... Employee: Receptos (Celgene).Sawada, Kaori ....................................... Disclosed no confl ict of interest.Sawaguchi, Tatsuya .............................. Disclosed no confl ict of interest.Sawano, Shoko ..................................... Disclosed no confl ict of interest.Sawase, Kenji ....................................... Disclosed no confl ict of interest.Saydah, Sharon ..................................... Disclosed no confl ict of interest.Sayeed, Rana ........................................ Disclosed no confl ict of interest.Sbraccia, Paolo...................................... Disclosed no confl ict of interest.Scarabello, Victoria ............................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Scardo, James A. ................................. Disclosed no confl ict of interest.Scarlett, Jarrad ..................................... Disclosed no confl ict of interest.Scarpitta, Antonietta Maria .................. Disclosed no confl ict of interest.Scarr, Daniel .......................................... Disclosed no confl ict of interest.Scelsi, Amanda R. ................................ Disclosed no confl ict of interest.Schaan, Beatriz D. ................................ Disclosed no confl ict of interest.Schaap, Frank G. .................................. Disclosed no confl ict of interest.Schaefer, Ernst ...................................... Employee: Boston Heart Diagnostics.Schaffer, Jean E. .................................. Disclosed no confl ict of interest.Schaller, Matthew ................................. Disclosed no confl ict of interest.Schallom, Marilyn E. ............................ Disclosed no confl ict of interest.Schamarek, Imke ................................... Disclosed no confl ict of interest.Schanuel, Liz ......................................... Employee: AmideBio.Schaper, Nicolaas ................................. Research Support: Novo Nordisk Inc., Sanofi U.S.Scharf, Mauro ....................................... Disclosed no confl ict of interest.Scharfmann, Raphael ............................ Disclosed no confl ict of interest.Schatz, Desmond A. ............................. Disclosed no confl ict of interest.Schauder, Chrystal ................................ Disclosed no confl ict of interest.Schauer, Philip R. ................................. Research Support: Ethicon Endo-Surgery, Inc.Schaupp, Lukas ..................................... Disclosed no confl ict of interest.Scheen, Andre ....................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Research Support: Novo Nordisk Inc; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH.

Scheerer, Marcus F. .............................. Employee: AstraZeneca.

A754


AU

THO

R D

ISCL

OSU

RE

Scheffl er, Klaus ..................................... Disclosed no confl ict of interest.Scheideler, Marcel ................................ Disclosed no confl ict of interest.Schenck, Lindsay ................................... Disclosed no confl ict of interest.Scherlag, Benjamin ............................... Disclosed no confl ict of interest.Schernthaner, Gerit ............................... Disclosed no confl ict of interest.Schernthaner, Guntram ......................... Board Member: Amgen Inc., Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.

Schick, Fritz ........................................... Disclosed no confl ict of interest.Schiermeyer, Katherine ......................... Disclosed no confl ict of interest.Schiff, Jeff............................................. Disclosed no confl ict of interest.Schile, Andrew ...................................... Disclosed no confl ict of interest.Schini-Kerth, Valerie ............................. Research Support: Boehringer Ingelheim GmbH.Schirmbeck, Reinhold............................ Disclosed no confl ict of interest.Schleger, Franziska ................................ Disclosed no confl ict of interest.Schleicher, Erwin ................................... Disclosed no confl ict of interest.Schleifer, Nicole .................................... Disclosed no confl ict of interest.Schlensak, Matthias ............................. Disclosed no confl ict of interest.Schmerold, Luke .................................... Employee: Analysis Group; Research Support: Eli Lilly and

Company.Schmid, Vera ......................................... Disclosed no confl ict of interest.Schmidt, Adam ...................................... Disclosed no confl ict of interest.Schmidt, Ann Marie .............................. Disclosed no confl ict of interest.Schmidt, Brian A. ................................. Disclosed no confl ict of interest.Schmidt, Christian ................................. Disclosed no confl ict of interest.Schmidt, Kathleen ................................. Disclosed no confl ict of interest.Schmidt, Maria Inês .............................. Research Support: Eli Lilly and Company.Schmieder, Roland E. ........................... Advisory Panel: Boehringer Ingelheim GmbH; Board Member:

Boehringer Ingelheim GmbH; Research Support: AstraZeneca; Speaker’s Bureau: Boehringer Ingelheim GmbH.

Schmitt, Andreas J. .............................. Disclosed no confl ict of interest.Schmitt, Patricia .................................... Disclosed no confl ict of interest.Schmittdiel, Julie A. ............................. Disclosed no confl ict of interest.Schnall, Adrian M. ............................... Research Support: AstraZeneca Pharmaceuticals LP, Novo

Nordisk Inc.Schnauder, Günter ................................. Disclosed no confl ict of interest.Schneeweib, Patrick.............................. Disclosed no confl ict of interest.Schneeweiss, Sebastian ....................... Consultant: Aetion, Inc., Whiscon, LLC.; Research Support:

Boehringer-Ingelheim, Federal Drug Administration, The National Heart, Lung, and Blood Institute Novartis, Patient-Centered Outcomes Research Institute.

Schneider, Jennifer ............................... Employee: Livongo Health; Stock/Shareholder: Livongo Heath.Schneider, Margaret ............................. Disclosed no confl ict of interest.Schneider, Mark .................................... Disclosed no confl ict of interest.Schneider, Michael ............................... Employee: Boehringer Ingelheim GmbH.Schneiderman, Neil............................... Disclosed no confl ict of interest.Schoenberg, Benjamen E. .................... Disclosed no confl ict of interest.Schoiswohl, Gabriele ............................ Disclosed no confl ict of interest.Scholl, Theresa...................................... Disclosed no confl ict of interest.Scholtens, Denise ................................. Disclosed no confl ict of interest.Schoof, Erwin ........................................ Disclosed no confl ict of interest.Schooneman, Marieke G. ..................... Disclosed no confl ict of interest.Schramm, Jill F. .................................... Disclosed no confl ict of interest.Schreiter, Kay ........................................ Disclosed no confl ict of interest.Schrieks, Ilse C. .................................... Disclosed no confl ict of interest.Schroeder, Kristin L. ............................. Disclosed no confl ict of interest.Schroeder, Melanie ............................... Employee: Janssen-Cilag Ltd.Schubert, Agata .................................... Employee: Janssen Poland.Schuler, Michele ................................... Disclosed no confl ict of interest.Schultz, Alan T. ..................................... Disclosed no confl ict of interest.Schultz, James ...................................... Disclosed no confl ict of interest.Schulz, Christina-Alexandra .................. Disclosed no confl ict of interest.Schulz, Eberhard.................................... Disclosed no confl ict of interest.Schulz, Tim ............................................ Disclosed no confl ict of interest.Schuman, Brooke .................................. Disclosed no confl ict of interest.Schürmann, Annette ............................. Disclosed no confl ict of interest.Schuster, Cornelia ................................. Disclosed no confl ict of interest.Schuster, Dara ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Schutta, Mark........................................ Disclosed no confl ict of interest.Schwab, Phil.......................................... Disclosed no confl ict of interest.Schwacha, Henning .............................. Disclosed no confl ict of interest.Schwartz, Ann V. .................................. Advisory Panel: Janssen Pharmaceuticals, Inc.Schwartz, David D. ............................... Disclosed no confl ict of interest.Schwartz, Gary J. ................................. Disclosed no confl ict of interest.Schwartz, Gregory G. ........................... Research Support: Cerenis Therapeutics Inc., Reseverlogix,

Roche Pharmaceuticals, Sanofi U.S., The Medicines Company.

Schwartz, Michael W. .......................... Disclosed no confl ict of interest.Schwarz, Cynthia D. ............................. Disclosed no confl ict of interest.Schwarzfuchs, Dan................................ Disclosed no confl ict of interest.

Schweitzer, Michael .............................. Disclosed no confl ict of interest.Schwitzgebel, Valerie ........................... Disclosed no confl ict of interest.Scifres, Christina ................................... Disclosed no confl ict of interest.Sconocchia, Giuseppe ........................... Disclosed no confl ict of interest.Scorsone, Alessandro ........................... Disclosed no confl ict of interest.Scott, Adrian ......................................... Disclosed no confl ict of interest.Scott, Anne............................................ Disclosed no confl ict of interest.Scott, Donald K. ................................... Disclosed no confl ict of interest.Scott, Emma S. ..................................... Disclosed no confl ict of interest.Scott, Fiona ........................................... Employee: Receptos.Scott, Mark S. ...................................... Disclosed no confl ict of interest.Scott, Melanie....................................... Disclosed no confl ict of interest.Scott, Robert ......................................... Disclosed no confl ict of interest.Scribner, Richard ................................... Disclosed no confl ict of interest.Scudder, Mellisa ................................... Disclosed no confl ict of interest.Sealls, Whitney J. ................................ Disclosed no confl ict of interest.Seaquist, Elizabeth R. .......................... Disclosed no confl ict of interest.Sears, Cynthia ....................................... Disclosed no confl ict of interest.Seay, Howard R. ................................... Disclosed no confl ict of interest.Sebastiani, Guido .................................. Disclosed no confl ict of interest.Seborg, Dale E. ..................................... Disclosed no confl ict of interest.Secchi, Antonio ..................................... Disclosed no confl ict of interest.Sedjo, Rebecca...................................... Disclosed no confl ict of interest.Seeger, John ......................................... Employee: Optum, Inc.Seeley, Randy J. ................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Circuit Therapeutics, Daiichi-Sankyo Co., Ltd., Ethicon Endo-Surgery, Inc., Nestlé, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited; Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Circuit Therapeutics, Daiichi-Sankyo Co., Ltd., Ethicon Endo-Surgery, Inc., Nestlé, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Ethicon Endo-Surgery, Inc., Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: Ethicon Endo-Surgery, Inc.

Seelig, Amber........................................ Disclosed no confl ict of interest.Seested, Torben .................................... Employee: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/


Seghieri, Giuseppe ................................ Disclosed no confl ict of interest.Sehra, Sudhish ...................................... Disclosed no confl ict of interest.Sehrt, Liane ........................................... Disclosed no confl ict of interest.Seidemann, Ericka................................. Disclosed no confl ict of interest.Seifeldin, Raafat ................................... Employee: Takeda Development Center Americas, Inc.; Stock/

Shareholder: Takeda Development Center Americas, Inc.Seifert, Jennifer .................................... Disclosed no confl ict of interest.Seino, Susumu ...................................... Research Support: Astellas Pharma Inc., Astellas Pharma

Inc., Daiichi Sankyo Company and Limited, Dainippon Sumitomo Pharma Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp & Dohme Corp., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation, Sumimoto Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Limited.

Seino, Yusuke ........................................ Research Support: Kowa Company, Ltd.Seino, Yutaka ........................................ Consultant: Becton, Dickinson and Company, Intarcia

Therapeutics, Inc., Kao Corporation, Kyowa Hakko Kirin Co., Ltd., Novo Nordisk Pharma Inc., Taisho Pharmaceutical Co., Ltd.; Research Support: Eli Lilly and Company, Merck Sharp & Dohme Corp., Nippon Boehringer Ingelheim, Taisho Toyama Pharmaceutical Co., Ltd.; Speaker’s Bureau: Astellas Pharma Inc., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Kyowa Hakko Kirin Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Novo Nordisk Pharma Inc., Sanofi K.K., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Seissler, Jochen .................................... Disclosed no confl ict of interest.Sejling, Anne-Sophie ............................ Disclosed no confl ict of interest.Sekimoto, Shinjiro ................................. Disclosed no confl ict of interest.Selagamsetty, Raj ................................. Disclosed no confl ict of interest.Selagamsetty, Rajendranath ................. Disclosed no confl ict of interest.Sellami-Mnif, Houda ............................. Disclosed no confl ict of interest.Sellers, Elizabeth................................... Disclosed no confl ict of interest.Sellmeyer, Deborah E. .......................... Disclosed no confl ict of interest.Sellors, Lianne....................................... Disclosed no confl ict of interest.Seltman, Howard .................................. Disclosed no confl ict of interest.Selvarajah, Dinesh ................................ Disclosed no confl ict of interest.Selveindran, Nalini M. ......................... Disclosed no confl ict of interest.Selvin, Elizabeth .................................... Disclosed no confl ict of interest.Semnani-Azad, Zhila ............................. Disclosed no confl ict of interest.Semplici, Francesca .............................. Disclosed no confl ict of interest.

A755


AU

THO

R D

ISCL

OSU

RE

Semzezem, Cintia .................................. Disclosed no confl ict of interest.Sen Gupta, Piya ..................................... Disclosed no confl ict of interest.Sen, Sabyasachi .................................... Disclosed no confl ict of interest.Senba, Hidenori..................................... Disclosed no confl ict of interest.Senesi, Pamela...................................... Disclosed no confl ict of interest.Senicki, Sheri ........................................ Disclosed no confl ict of interest.Senior, Peter A. .................................... Advisory Panel: Abbott, AstraZeneca, Bayer, Eli Lilly and

Company, Genzyme, GlaxoSmithKline, Janssen, Medtronic, Novo Nordisk, Sanofi , Servier; Board Member: Abbott, AstraZeneca, Bayer, Eli Lilly and Company Genzyme, GlaxoSmithKline, Janssen, Medtronic, Novo Nordisk, Sanofi , Servier; Consultant: Abbott, AstraZeneca, Bayer, Eli Lilly and Company, Genzyme, GlaxoSmithKline, Janssen, Medtronic, Novo Nordisk, Sanofi , Servier; Research Support: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Prometic, Servier; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Lifescan, Novartis, Novo Nordisk, Sanofi , Valeant.

Seo, Dongju ........................................... Disclosed no confl ict of interest.Seo, Ji A. .............................................. Disclosed no confl ict of interest.Seo, Ji Hye ............................................ Disclosed no confl ict of interest.Seo, Minji .............................................. Employee: Yuhan Co.Seok, Hannah ........................................ Disclosed no confl ict of interest.Sequeira Duarte, João .......................... Disclosed no confl ict of interest.Serafi n-Dokhan, Sara ............................ Disclosed no confl ict of interest.Serafi ni, Paolo ....................................... Disclosed no confl ict of interest.Serban, Carmen..................................... Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG.Sereika, Susan M. ................................ Disclosed no confl ict of interest.Serena, Carolina.................................... Disclosed no confl ict of interest.Sergaliev, Talgat S. .............................. Disclosed no confl ict of interest.Sergentanis, Theodoros ........................ Disclosed no confl ict of interest.Serifovski, Nermin................................. Advisory Panel: Bayer HealthCare; Research Support: Roche

Diagnostics; Speaker’s Bureau: Roche Diagnostics.Serlie, Mireille J. ................................. Disclosed no confl ict of interest.Sermadiras, Isabelle ............................. Employee: MedImmune, LLC.Serne, Erik H. ........................................ Disclosed no confl ict of interest.Serrano Muñoz, Marta .......................... Employee: Genmedica Therapeutics.Serrano-Moreno, Clara ......................... Disclosed no confl ict of interest.Serreze, David V. .................................. Disclosed no confl ict of interest.Serusclat, Pierre .................................... Board Member: Novo Nordisk; Research Support: Eli Lilly and

Company, Novo Nordisk, Sanofi .Servant, Florence .................................. Employee: Vaiomer.Serwold, Thomas .................................. Disclosed no confl ict of interest.Sessa, Fausto ........................................ Disclosed no confl ict of interest.Setford, Steven J. ................................ Employee: LifeScan Scotland Ltd; Stock/Shareholder: LifeScan

Scotland Ltd.Seth, Asha ............................................. Employee: MedImmune, LLC.Seufert, Jochen ..................................... Advisory Panel: Amgen Inc., AstraZeneca, Bayer HealthCare,

Berlin-Chemie, Boehringer Ingelheim GmbH, GI Dynamics, Inc., GlaxoSmithKline, Ipsen Bioscience, Inc., Janssen Scientifi c Affairs, LLC, Lilly Deutschland GmbH, Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk Inc., Novo Nordisk Inc., Pfi zer Inc., Roche Diagnostics, Sanofi -Aventis Deutschland GmbH, Takeda Development Center Americas, Inc.; Research Support: Amgen Inc., Boehringer Ingelheim GmbH, GI Dynamics, Inc., GlaxoSmithKline, Intarcia Therapeutics, Inc., Ipsen Bioscience, Inc., Janssen Scientifi c Affairs, LLC, Lilly Deutschland GmbH, Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk Inc., Pfi zer Inc., Roche Diagnostics, Sanofi -Aventis Deutschland GmbH, Servier, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Amgen Inc., AstraZeneca, Bayer HealthCare, Berlin-Chemie, Boehringer Ingelheim GmbH, GlaxoSmithKline, Ipsen Bioscience, Inc., Janssen Scientifi c Affairs, LLC, LifeScan, Inc., Lilly Deutschland GmbH, Merck & Co., Inc., Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk Inc., Omnia-Med, Ltd., Pfi zer Inc., Roche Diagnostics, Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited.

Seyoum, Berhane .................................. Disclosed no confl ict of interest.Sforza, Alessandra ................................ Disclosed no confl ict of interest.Sgouros, Konstantinos .......................... Disclosed no confl ict of interest.Sgroi, Dennis C. .................................... Disclosed no confl ict of interest.Shabbir, Asim ........................................ Disclosed no confl ict of interest.Shabeer, Muhammed ............................ Disclosed no confl ict of interest.Shaefer, Charles .................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Lilly Pharmaceuticals, Sanofi U.S., Sanofi -Aventis Deutschland GmbH; Consultant: Sanofi U.S., Sanofi -Aventis Deutschland GmbH; Research Support: Eli Lilly and Company, Sanofi U.S.; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Lilly Pharmaceuticals, Sanofi U.S.

Shah, Amy S. ........................................ Disclosed no confl ict of interest.Shah, Baiju R. ....................................... Disclosed no confl ict of interest.Shah, Hetal............................................ Disclosed no confl ict of interest.Shah, Keval ........................................... Disclosed no confl ict of interest.Shah, Kiran ............................................ Disclosed no confl ict of interest.Shah, Nihar ........................................... Disclosed no confl ict of interest.Shah, Nilay D. ...................................... Research Support: AHRQ.Shah, Nishit........................................... Disclosed no confl ict of interest.Shah, Poonam S. .................................. Disclosed no confl ict of interest.Shah, Ravi ............................................. Disclosed no confl ict of interest.Shah, Sanjiv .......................................... Disclosed no confl ict of interest.Shah, Shashank S. ............................... Research Support: Johnson & Johnson.Shah, Vallabh ........................................ Disclosed no confl ict of interest.Shah, Viral N. ....................................... Disclosed no confl ict of interest.Shahraz, Saeid ...................................... Disclosed no confl ict of interest.Shai, Iris ................................................ Disclosed no confl ict of interest.Shakeev, Kairat T. ................................. Disclosed no confl ict of interest.Shaler, Donna ........................................ Disclosed no confl ict of interest.Shalev, Anath ........................................ Disclosed no confl ict of interest.Shalev, Nurit.......................................... Disclosed no confl ict of interest.Shambilova, Natalya A. ....................... Disclosed no confl ict of interest.Shamoon, Harry..................................... Disclosed no confl ict of interest.Shamsi, Farnaz ...................................... Disclosed no confl ict of interest.Shang, Shuhua ...................................... Employee: Sanofi .Shankar, Arun ........................................ Disclosed no confl ict of interest.Shankar, Ravi ......................................... Employee: Eli Lilly and Company (Spouse/Partner), Merck

Sharp & Dohme Corp.Shankar, Sudha S. ................................ Employee: Eli Lilly and Company, Merck & Co., Inc. (Spouse/

Partner); Stock/Shareholder: Eli Lilly and Company, Merck & Co., Inc. (Spouse/Partner).

Shankarappa, Manjunatha.................... Disclosed no confl ict of interest.Shao, Shiying ........................................ Disclosed no confl ict of interest.Shao, Weijuan ....................................... Disclosed no confl ict of interest.Shapira, Amit ........................................ Disclosed no confl ict of interest.Shapiro Manning, Linda ........................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Shapiro, A. James ................................. Disclosed no confl ict of interest.Shapiro, Alan......................................... Disclosed no confl ict of interest.Shapiro, Allison L. ................................ Disclosed no confl ict of interest.Shapiro, James ..................................... Disclosed no confl ict of interest.Sharifi , Amin.......................................... Disclosed no confl ict of interest.Sharma, Andrea J. ............................... Disclosed no confl ict of interest.Sharma, Andria ..................................... Disclosed no confl ict of interest.Sharma, Anu.......................................... Disclosed no confl ict of interest.Sharma, Arun ........................................ Employee: MedImmune, LLC.Sharma, Jugal K. .................................. Disclosed no confl ict of interest.Sharma, Kumar...................................... Advisory Panel: Boehringer Ingelheim GmbH, Merck Sharp

& Dohme Corp.; Consultant: ClinMet; Research Support: Boehringer Ingelheim GmbH; Stock/Shareholder: ClinMet.

Sharma, Neeraj ..................................... Disclosed no confl ict of interest.Sharma, Rajiv ........................................ Disclosed no confl ict of interest.Sharma, Sanjeev ................................... Disclosed no confl ict of interest.Sharma, Susan ...................................... Disclosed no confl ict of interest.Sharma, Yogesh .................................... Disclosed no confl ict of interest.Sharp, Lisa............................................. Disclosed no confl ict of interest.Sharrett, A. Richey ................................ Disclosed no confl ict of interest.Shatskov, Alla........................................ Employee: AstraZeneca.Shaunik, Alka ........................................ Employee: AstraZeneca.Shaw, James ......................................... Other Relationship: Novo Nordisk A/S; Research Support:

Dompé Pharmaceutical; Speaker’s Bureau: Lilly Deutschland GmbH.

Shaw, Jonathan E. ............................... Advisory Panel: Abbott, AstraZeneca, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH.

Shaw, Leslie M. .................................... Disclosed no confl ict of interest.Shay, Christina ...................................... Disclosed no confl ict of interest.She, Jin-Xiong ....................................... Research Support: National Institutes of Health.Shea, Jacqueline J. .............................. Disclosed no confl ict of interest.Shearer, David ....................................... Employee: LifeScan, Inc.; Stock/Shareholder: Johnson &

Johnson.Shearer, Kirsty ....................................... Disclosed no confl ict of interest.Sheehan, John J. ................................. Employee: AstraZeneca Pharmaceuticals LP, Bristol-Myers

Squibb Company (Spouse/Partner).Sheehan, Patricia .................................. Disclosed no confl ict of interest.Sheetz, Joshua B. ................................. Disclosed no confl ict of interest.Sheffi eld, Annan.................................... Disclosed no confl ict of interest.Sheikh, Saba ......................................... Disclosed no confl ict of interest.Shelley, Lisa Raynelle ........................... Disclosed no confl ict of interest.Shen, Hong ............................................ Disclosed no confl ict of interest.Shen, Jian ............................................. Disclosed no confl ict of interest.Shen, Liya .............................................. Disclosed no confl ict of interest.Shen, Wen-Jun ..................................... Disclosed no confl ict of interest.Shen, Xia ............................................... Disclosed no confl ict of interest.Sheng, Chunjun ..................................... Disclosed no confl ict of interest.Sheng, Hui ............................................. Disclosed no confl ict of interest.

A756


AU

THO

R D

ISCL

OSU

RE

Sheng, Liang.......................................... Disclosed no confl ict of interest.Shenkman, Betsy................................... Disclosed no confl ict of interest.Shepherd, Peter R. ............................... Disclosed no confl ict of interest.Shepherd, Sam O. ................................ Disclosed no confl ict of interest.Sherban, Alex ........................................ Disclosed no confl ict of interest.Sheridan, Paul J. .................................. Disclosed no confl ict of interest.Sheriff, Alexandra ................................. Disclosed no confl ict of interest.Sherman, Arthur S. ............................... Disclosed no confl ict of interest.Sherr, Jennifer L. .................................. Disclosed no confl ict of interest.Sherratt, Samuel C. .............................. Disclosed no confl ict of interest.Sherwin, Robert S. ............................... Consultant: AstraZeneca; Other Relationship: Merck & Co.,

Inc., Novo Nordisk Inc., Sanofi U.S.; Research Support: Merck & Co., Inc.

Sheskey, Sarah R. ................................. Disclosed no confl ict of interest.Shestakova, Marina V. ......................... Advisory Panel: AstraZeneca; Research Support: Novartis,

Sanofi ; Speaker’s Bureau: Merck, Sharp & Dohme, Novartis, Novo Nordisk.

Shetty, Sharash ..................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Sheu, Wayne Huey-Herng ..................... Disclosed no confl ict of interest.Shevchenko, Alla V. .............................. Disclosed no confl ict of interest.Shevchenko, Ivan .................................. Disclosed no confl ict of interest.Shi, Hang ............................................... Disclosed no confl ict of interest.Shi, Lei................................................... Disclosed no confl ict of interest.Shi, Leon................................................ Disclosed no confl ict of interest.Shi, Lizheng ........................................... Disclosed no confl ict of interest.Shi, Lu.................................................... Disclosed no confl ict of interest.Shi, Qian ................................................ Disclosed no confl ict of interest.Shi, Sen ................................................. Disclosed no confl ict of interest.Shi, Wen ................................................ Disclosed no confl ict of interest.Shi, Xiaoqin ........................................... Disclosed no confl ict of interest.Shiba, Kumiko ....................................... Disclosed no confl ict of interest.Shiba, Teruo .......................................... Speaker’s Bureau: Daiichi-Sankyo Co., Ltd., Kowa Company,

Ltd., Merck Sharp & Dohme Corp., Pfi zer Japan Inc., Shionogi & Co. Ltd.

Shibata, Mao......................................... Disclosed no confl ict of interest.Shibata, Saori........................................ Disclosed no confl ict of interest.Shieh, Christine ..................................... Disclosed no confl ict of interest.Shields, Beverley M. ............................ Disclosed no confl ict of interest.Shigeoka, Toru ....................................... Disclosed no confl ict of interest.Shigeta, Ayako ...................................... Disclosed no confl ict of interest.Shigiyama, Fumika ................................ Disclosed no confl ict of interest.Shiinoki, Kikuko ..................................... Disclosed no confl ict of interest.Shillo, Pallai .......................................... Disclosed no confl ict of interest.Shiloach, Joseph ................................... Disclosed no confl ict of interest.Shim, Min-Jung..................................... Disclosed no confl ict of interest.Shimada, Akira ...................................... Speaker’s Bureau: Eli Lilly Japan K.K., Novo Nordisk Inc.,

Sanofi K.K.Shimada, Satoshi .................................. Disclosed no confl ict of interest.Shimada, Takashi .................................. Disclosed no confl ict of interest.Shimazu, Noriko .................................... Disclosed no confl ict of interest.Shimizu, Akira ....................................... Disclosed no confl ict of interest.Shimizu, Jyunichi .................................. Disclosed no confl ict of interest.Shimizu, Tomoaki .................................. Disclosed no confl ict of interest.Shimizu-Hirota, Ryoko ........................... Disclosed no confl ict of interest.Shimoda, Kazuya ................................... Disclosed no confl ict of interest.Shimoda, Masashi ................................ Disclosed no confl ict of interest.Shimomura, Iichiro ................................ Research Support: Astellas Pharma Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Shionogi Inc., Takeda Pharmaceutical Company Limited.

Shin, Andrew C. ................................... Disclosed no confl ict of interest.Shin, Chol .............................................. Disclosed no confl ict of interest.Shin, Jang-Yel ....................................... Disclosed no confl ict of interest.Shin, John ............................................. Employee: Medtronic, Inc.Shin, Shyi Jang ..................................... Disclosed no confl ict of interest.Shinde, Rituparna S. ............................ Disclosed no confl ict of interest.Shinde, Suresh N. ................................ Disclosed no confl ict of interest.Shinmura, Kyoko ................................... Disclosed no confl ict of interest.Shinoda, Junji ....................................... Disclosed no confl ict of interest.Shinohara, Masami ............................... Disclosed no confl ict of interest.Shiojima, Ichiro ..................................... Disclosed no confl ict of interest.Shiota, Masakazu.................................. Disclosed no confl ict of interest.Shiotani, Masaharu............................... Employee: Mitsubishi Tanabe Pharma Corporation.Shiraga, Nobuyuki ................................. Disclosed no confl ict of interest.Shirai, Kohji ........................................... Disclosed no confl ict of interest.Shirakawa, Jun ..................................... Disclosed no confl ict of interest.Shiramoto, Masanari ............................ Disclosed no confl ict of interest.Shivappa, Nitin...................................... Disclosed no confl ict of interest.Shivaswamy, Vijay ................................ Research Support: Novo Nordisk Inc., Pfi zer Inc.Shoelson, Steven E. ............................. Consultant: Catabasis Pharmaceuticals, Inc., Merck & Co., Inc.Shojima, Nobuhiro ................................ Disclosed no confl ict of interest.

Shojima, Sonei ...................................... Disclosed no confl ict of interest.Shonkwiler, Cheryl ................................ Disclosed no confl ict of interest.Shoo, Haika ........................................... Disclosed no confl ict of interest.Shook, Brian .......................................... Employee: Janssen Pharmaceuticals, Inc.Short, Megan ........................................ Disclosed no confl ict of interest.Shostak, Alena ...................................... Disclosed no confl ict of interest.Shrestha, Archana................................. Disclosed no confl ict of interest.Shrestha, Deepika ................................. Disclosed no confl ict of interest.Shrestha, Sachita M. ........................... Disclosed no confl ict of interest.Shrestha, Sundar................................... Disclosed no confl ict of interest.Shu, Hua ................................................ Disclosed no confl ict of interest.Shu, Yu-Hsiang ...................................... Disclosed no confl ict of interest.Shubina, Maria...................................... Disclosed no confl ict of interest.Shubrook, Jay........................................ Consultant: AstraZeneca Pharmaceuticals LP, Eli Lilly and

Company, GlaxoSmithKline, Novo Nordisk Inc; Research Support: Sanofi U.S.

Shukare, Mengistu Lemecha ................ Disclosed no confl ict of interest.Shulman, Gerald I. ................................ Disclosed no confl ict of interest.Shultz, Leonard D. ................................ Disclosed no confl ict of interest.Shuster, Jonathan J. ............................ Disclosed no confl ict of interest.Shuto, Emi ............................................. Disclosed no confl ict of interest.Sibai, Zakaria ........................................ Disclosed no confl ict of interest.Sibomana, Laurien ................................ Disclosed no confl ict of interest.Sicard, Eric ............................................ Consultant: Locemia Solutions.Siddall, James....................................... Disclosed no confl ict of interest.Siddiqui , Nazrul I. ................................ Disclosed no confl ict of interest.Sidibé, Assa .......................................... Disclosed no confl ict of interest.Sidibeh, Cherno O. ............................... Disclosed no confl ict of interest.Sieber, Jochen ....................................... Employee: Sanofi -Aventis Deutschland GmbH.Siegel, Karen R. .................................... Disclosed no confl ict of interest.Siegel-Axel, Dorothea I. ....................... Disclosed no confl ict of interest.Siegle, Greg J. ...................................... Disclosed no confl ict of interest.Siejka, Slawomir ................................... Disclosed no confl ict of interest.Sieniawska, Joanna .............................. Disclosed no confl ict of interest.Sievenpiper, John L. ............................. Board Member: Dompé Pharmaceutical; Consultant: Abbott

Laboratories, C3 for Health, Canadian Nutrition Society, Dairy Farmers of Canada, Dr. Pepper Snapple Group, mdBriefcase, Nutrition Foundation of Italy, Perkins Coie LLP, Tate & Lyle, The Coca Cola Company, White Wave Foods, Winston Strawn LLP; Other Relationship: American Society for Nutrition, Canadian Diabetes Association, European Association for the Study of Diabetes, and Canadian Cardiovascular Society. (Spouse/Partner) Research Support: American Society for Nutrition, Calorie Control Council, Canadian Diabetes Association, Canadian Institutes of Health Research, Dr. Pepper Snapple Group, International Tree Nut Council Nutrition Research & Education Foundation, PSI Foundation, The Coca Cola Company.

Siford, Gerri L. ...................................... Disclosed no confl ict of interest.Sigal, Ronald J. .................................... Research Support: Alberta Innovates-Health Solutions.Sihag, Bhupender .................................. Disclosed no confl ict of interest.Sijbrands, Eric J. .................................. Disclosed no confl ict of interest.Sikirica, Mirko ....................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Silbernagel, Guenther ........................... Disclosed no confl ict of interest.Silink, Martin......................................... Disclosed no confl ict of interest.Sill, Heinz .............................................. Disclosed no confl ict of interest.Silva, Aline P. ........................................ Disclosed no confl ict of interest.Silva, Maria Elizabeth ........................... Disclosed no confl ict of interest.Silva, Maria Regina S. ......................... Disclosed no confl ict of interest.Silva, Pâmella G. .................................. Disclosed no confl ict of interest.Silva, Paolo S. ...................................... Disclosed no confl ict of interest.Silverstein, Janet .................................. Disclosed no confl ict of interest.Silvius, Bianca ....................................... Disclosed no confl ict of interest.Simac, Petra .......................................... Disclosed no confl ict of interest.Simha, Vinaya ....................................... Disclosed no confl ict of interest.Siminerio, Linda M. .............................. Disclosed no confl ict of interest.Simmons, David .................................... Disclosed no confl ict of interest.Simmons, Debra L. ............................... Board Member: American Diabetes Association; Research

Support: Bristol-Meyers Squibb Company, National Institutes of Health, Novo Nordisk Inc.

Simmons, Jill H. ................................... Disclosed no confl ict of interest.Simmons, Jon........................................ Disclosed no confl ict of interest.Simmons, Kimber M. ............................ Disclosed no confl ict of interest.Simó, Rafael .......................................... Disclosed no confl ict of interest.Simon, Marie-Christine ......................... Disclosed no confl ict of interest.Simonaviciute, Dovile ........................... Disclosed no confl ict of interest.Simonsen, Lene ..................................... Disclosed no confl ict of interest.Simonson, Donald C. ............................ Advisory Panel: GI Windows; Stock/Shareholder: GI Windows.Simos, Anna .......................................... Disclosed no confl ict of interest.Simo-Servat, Olga ................................. Disclosed no confl ict of interest.Simpson, Richard W. ............................ Board Member: Novo Nordisk Inc; Research Support:

AstraZeneca, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Pfi zer Inc., Sanofi U.S.

Simpson, Ronda L. ................................ Disclosed no confl ict of interest.

A757


AU

THO

R D

ISCL

OSU

RE

Simpson, Scot H. .................................. Disclosed no confl ict of interest.Sims, Deborah ....................................... Disclosed no confl ict of interest.Sims, Emily K. ....................................... Disclosed no confl ict of interest.Sims, Jerrell .......................................... Disclosed no confl ict of interest.Sinclair, Alan ......................................... Consultant: Eli Lilly and Company, Merck Sharp & Dohme

Corp., Novartis Pharmaceuticals Corporation, Takeda.Sing, Krystal .......................................... Disclosed no confl ict of interest.Singh, Kiran Pal ..................................... Disclosed no confl ict of interest.Singh, Mugdha ...................................... Disclosed no confl ict of interest.Singh, Satbir K. .................................... Disclosed no confl ict of interest.Singh, Vikesh ......................................... Consultant: Novo Nordisk Inc.Sinha, Madhumita................................. Disclosed no confl ict of interest.Sinha, Manasi ....................................... Disclosed no confl ict of interest.Sinha, Rajita .......................................... Disclosed no confl ict of interest.Sinha, Sourabh ...................................... Disclosed no confl ict of interest.Sinkin, Jeremy C. ................................. Disclosed no confl ict of interest.Sinner, Frank .......................................... Disclosed no confl ict of interest.Sipos, Bence.......................................... Disclosed no confl ict of interest.Sippl, Rachel ......................................... Disclosed no confl ict of interest.Sipter, Emese ........................................ Disclosed no confl ict of interest.Sipula, Ian ............................................. Disclosed no confl ict of interest.Sirek, Adam ........................................... Disclosed no confl ict of interest.Sirota, Marina ....................................... Disclosed no confl ict of interest.Sirvent, Pascal....................................... Board Member: Valbiotis.Sisson, Erin M. ..................................... Disclosed no confl ict of interest.Sitthananun, Chaiyuth........................... Disclosed no confl ict of interest.Sivaprasad, Sobha ................................ Consultant: Allergan, Inc., Bayer HealthCare, Novartis

Pharmaceuticals Corporation; Research Support: Allergan, Inc., Bayer HealthCare, Novartis Pharmaceuticals Corporation.

Siwakoti, Krishmita ............................... Disclosed no confl ict of interest.Sixsmith, Judith .................................... Disclosed no confl ict of interest.Sjöstrand, Mikaela ................................ Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Sjöström, C. David................................. Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Skelton, Graham.................................... Disclosed no confl ict of interest.Skibova, Jelena ..................................... Disclosed no confl ict of interest.Skidmore, Jessica ................................. Disclosed no confl ict of interest.Skinner, Allie ......................................... Disclosed no confl ict of interest.Skolnik, Neil .......................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim,

Lilly, Novartis, Sanofi U.S., Teva; Speaker’s Bureau: AstraZeneca.

Skovlund, Søren .................................... Employee: Novo Nordisk A/S.Skovsø, Søs ........................................... Disclosed no confl ict of interest.Skrha, Jan ............................................. Disclosed no confl ict of interest.Skrha Jr., Jan ........................................ Disclosed no confl ict of interest.Skrtic, Stanko ........................................ Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Skupien, Jan.......................................... Research Support: Juvenile Diabetes Research Foundation.Skyler, Jay S. ........................................ Disclosed no confl ict of interest.Skytte, Mads J. .................................... Disclosed no confl ict of interest.Sladek, Robert ....................................... Disclosed no confl ict of interest.Slama, Michael ..................................... Disclosed no confl ict of interest.Sledzinski, Maciej ................................. Disclosed no confl ict of interest.Slee, April.............................................. Employee: Axio Research.Slentz, Dorothy H. ................................ Disclosed no confl ict of interest.Slingerland, Annabelle S. .................... Disclosed no confl ict of interest.Sloan, Lance .......................................... Disclosed no confl ict of interest.Sloane, Richard ..................................... Disclosed no confl ict of interest.Sloop, Joseph........................................ Disclosed no confl ict of interest.Slover, Robert ........................................ Research Support: Medtronic, Inc.Smailovic, Almira .................................. Disclosed no confl ict of interest.Smaldone, Arlene.................................. Disclosed no confl ict of interest.Small, Lewin.......................................... Disclosed no confl ict of interest.Smiles, Adam M. .................................. Disclosed no confl ict of interest.Smiley, Dawn D. ................................... Disclosed no confl ict of interest.Smiley, Janelia ...................................... Disclosed no confl ict of interest.Smiraglia, Massimiliana ....................... Disclosed no confl ict of interest.Smircic-Duvnjak, Lea............................. Disclosed no confl ict of interest.Smit, Roelof........................................... Disclosed no confl ict of interest.Smith, Alicia K. ..................................... Disclosed no confl ict of interest.Smith, Barbara ...................................... Disclosed no confl ict of interest.Smith, Brenda........................................ Disclosed no confl ict of interest.Smith, Carly ........................................... Disclosed no confl ict of interest.Smith, David M. ................................... Employee: AstraZeneca.Smith, Emily D. ..................................... Disclosed no confl ict of interest.Smith, Kathi B. ..................................... Disclosed no confl ict of interest.Smith, Laura .......................................... Disclosed no confl ict of interest.Smith, Lisa G. ....................................... Disclosed no confl ict of interest.Smith, Marta ......................................... Disclosed no confl ict of interest.Smith, Nancy ......................................... Disclosed no confl ict of interest.Smith, Nicholas ..................................... Disclosed no confl ict of interest.Smith, Raymond L. ............................... Disclosed no confl ict of interest.Smith, Richard D. ................................. Disclosed no confl ict of interest.Smith, Robert J. ................................... Disclosed no confl ict of interest.Smith, Steven R. ................................... Consultant: Arena Pharmaceuticals, Inc., AstraZeneca,

Boehringer Ingelheim GmbH, Eisai Co., Ltd., Elcelyx Therapeutics, Inc., Eli Lilly and Company, Five Prime

Therapeutics, Inc., GlaxoSmithKline U.S. Processing/Genpact AP, NGM Biopharmaceuticals, Novo Nordisk A/S, Orexigen Therapeutics, Inc., Piramal Life Sciences, Takeda, Takeda Global Research and Development Inc., Zafgen; Research Support: Amylin Pharmaceuticals, LLC., Eli Lilly and Company, Takeda; Stock/Shareholder: Jenrin Discovery, Zafgen.

Smits, Mark M. .................................... Disclosed no confl ict of interest.Smulders, Yvo M. ................................. Disclosed no confl ict of interest.Smyda, Garry W. .................................. Disclosed no confl ict of interest.Smyrniotis, Colleen ............................... Disclosed no confl ict of interest.Snackey Alvarez, Kristin........................ Disclosed no confl ict of interest.Sneddon, Claire C. ................................ Disclosed no confl ict of interest.Sneider, Michael B. .............................. Disclosed no confl ict of interest.Snelgrove, Rebecca K. ......................... Disclosed no confl ict of interest.Snell-Bergeon, Janet K. ....................... Research Support: LipoScience, Inc.; Stock/Shareholder:

GlaxoSmithKline.Snetselaar, Linda G. ............................. Disclosed no confl ict of interest.Snoek, Frank J. ..................................... Advisory Panel: Roche Diagnostics, Sanofi -Aventis

Deutschland GmbH; Speaker’s Bureau: Eli Lilly and Company, Sanofi -Aventis Deutschland GmbH.

Snow, Kathy .......................................... Disclosed no confl ict of interest.So, Jimmy Bok Yan................................ Disclosed no confl ict of interest.So, Marvin ............................................. Disclosed no confl ict of interest.So, Wing Yan......................................... Disclosed no confl ict of interest.So, Wing Yee......................................... Disclosed no confl ict of interest.Soare, Andreea ..................................... Disclosed no confl ict of interest.Soares, Holly ......................................... Employee: Bristol-Myers Squibb Company.Sobers, Kevamae C. ............................. Disclosed no confl ict of interest.Soderberg, Stefan ................................. Disclosed no confl ict of interest.Soe, Kyaw ............................................. Disclosed no confl ict of interest.Soeters, Maarten R. ............................. Disclosed no confl ict of interest.Soewondo, Pradana .............................. Disclosed no confl ict of interest.Sofer, Tamar .......................................... Disclosed no confl ict of interest.Søfteland, Eirik ...................................... Consultant: AstraZeneca, Boehringer Ingelheim GmbH, Eli

Lilly and Company, Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk Inc., Sanofi ; Employee: Haukeland University Hospital.

Softic, Samir.......................................... Disclosed no confl ict of interest.Soh, Lip Min .......................................... Disclosed no confl ict of interest.Sohn, Min-Woong ................................. Disclosed no confl ict of interest.Sohn, Tae Seo ....................................... Disclosed no confl ict of interest.Solà-Adell, Cristina ............................... Disclosed no confl ict of interest.Solano, Francis ...................................... Disclosed no confl ict of interest.Solar, Chelsey ........................................ Disclosed no confl ict of interest.Soldatos, Georgia.................................. Disclosed no confl ict of interest.Soleymani, Taraneh ............................... Disclosed no confl ict of interest.Solez, Kim.............................................. Disclosed no confl ict of interest.Solheim, Marie H. ................................ Disclosed no confl ict of interest.Soliman, Catherine................................ Disclosed no confl ict of interest.Solomina, Julia ..................................... Disclosed no confl ict of interest.Solomon, Scott D. ................................ Research Support: Sanofi U.S.Somayaji, Veena ................................... Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc.Someya, Yuki ......................................... Disclosed no confl ict of interest.Sommer, Nora N. .................................. Disclosed no confl ict of interest.Søndergaard, Bo.................................... Disclosed no confl ict of interest.Søndergaard, Esben .............................. Disclosed no confl ict of interest.Sone, Hirohito ....................................... Research Support: Kowa Company, Ltd.Song, Kexiu ........................................... Disclosed no confl ict of interest.Song, Lili................................................ Disclosed no confl ict of interest.Song, Shijie ........................................... Disclosed no confl ict of interest.Song, Tae Hun ....................................... Disclosed no confl ict of interest.Song, Xue .............................................. Other Relationship: Sanofi U.S., Truven Health Analytics.Song, Ye ................................................ Disclosed no confl ict of interest.Song, Yiqing .......................................... Disclosed no confl ict of interest.Song, Young Shin .................................. Disclosed no confl ict of interest.Song, Zhuolun ....................................... Disclosed no confl ict of interest.Soni, Hiral.............................................. Disclosed no confl ict of interest.Sonne, David P. ..................................... Disclosed no confl ict of interest.Sood, Ajay ............................................. Research Support: Novo Nordisk Inc.Sorensen, Charlotte M. ........................ Disclosed no confl ict of interest.Sorensen, Ditte ..................................... Disclosed no confl ict of interest.Sørensen, Henrik T. .............................. Disclosed no confl ict of interest.Sorhede Winzell, Maria ........................ Employee: AstraZeneca.Soria, Bernat ......................................... Disclosed no confl ict of interest.Sorice, Gian Pio ..................................... Disclosed no confl ict of interest.Sorli, Christopher H. ............................. Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S;

Research Support: Eli Lilly and Company, Johnson & Johnson, MannKind Corporation, Merck Sharp & Dohme Corp., Roche Pharmaceuticals, Sanofi -Aventis Deutschland GmbH; Speaker’s Bureau: Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk A/S.

Soroka, Orysya ...................................... Disclosed no confl ict of interest.Sorrenson, Brie...................................... Disclosed no confl ict of interest.Sosenko, Jay M. ................................... Disclosed no confl ict of interest.

A758


AU

THO

R D

ISCL

OSU

RE

Sosina, Olukayode................................. Disclosed no confl ict of interest.Sotiropoulos, Alexios ............................ Disclosed no confl ict of interest.Souhami, Elisabeth ............................... Employee: Sanofi France; Stock/Shareholder: Sanofi .Soula, Olivier ......................................... Employee: Adocia; Stock/Shareholder: Adocia.Soula, Rémi ........................................... Employee: Adocia; Stock/Shareholder: Adocia.Soumerai, Stephen................................ Disclosed no confl ict of interest.Soumillon, Magali ................................. Employee: Berkeley Lights.Soupal, Jan ........................................... Disclosed no confl ict of interest.Sourij, Harald ........................................ Advisory Panel: Amgen Inc., AstraZeneca Pharmaceuticals

LP, Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis Pharma AG, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH; Employee: Center for Biomarker Research in Medicine CBmed; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Merck Sharp & Dohme Corp.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis AG, Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited.

Sousa, Maysa........................................ Disclosed no confl ict of interest.Soutelo, Jimena .................................... Disclosed no confl ict of interest.Souza, Ana Crla ..................................... Disclosed no confl ict of interest.Souza, Arnaldo H. ................................. Disclosed no confl ict of interest.Souza, Luana ......................................... Disclosed no confl ict of interest.Sowers, James R. ................................ Research Support: National Institutes of Health, Veterans

Affairs Merit System.Soysal-Atile, Neslihan .......................... Disclosed no confl ict of interest.Spadafranca, Angela............................. Disclosed no confl ict of interest.Spaeth, Jason ....................................... Disclosed no confl ict of interest.Spaic, Tamara ........................................ Disclosed no confl ict of interest.Spano, Lucia .......................................... Disclosed no confl ict of interest.Spanou, Marianna................................. Disclosed no confl ict of interest.Spat, Stephan........................................ Disclosed no confl ict of interest.Spatz, Erica S. ...................................... Disclosed no confl ict of interest.Spatz, Jan.............................................. Disclosed no confl ict of interest.Speake, Cate ......................................... Disclosed no confl ict of interest.Speck, Madeleine ................................. Disclosed no confl ict of interest.Speight, Jane ........................................ Advisory Panel: Roche Diagnostics; Consultant: AstraZeneca

Pharmaceuticals LP, Roche Diagnostics, Sanofi U.S.; Research Support: AstraZeneca Pharmaceuticals LP, Roche Diagnostics, Sanofi U.S.; Speaker’s Bureau: Johnson & Johnson, Roche Diagnostics, Sanofi U.S.

Spencer, Netanya Y. ............................. Disclosed no confl ict of interest.Sperl-Hillen, JoAnn M. ........................ Disclosed no confl ict of interest.Sperling, Laurence S. ........................... Disclosed no confl ict of interest.Spigelman, Aliya ................................... Disclosed no confl ict of interest.Spigoni, Valentina ................................. Disclosed no confl ict of interest.Spimpolo, Jennifer ................................ Disclosed no confl ict of interest.Spinas, Giatgen A. ............................... Disclosed no confl ict of interest.Spiro, Kim .............................................. Disclosed no confl ict of interest.Spiropoulou, Panagiota ......................... Disclosed no confl ict of interest.Spranger, Joachim ................................ Disclosed no confl ict of interest.Spreafi co, Emanuele ............................. Disclosed no confl ict of interest.Springer, Lee B. .................................... Employee: PTS Diagnostics.Sprouse, Maran..................................... Disclosed no confl ict of interest.Spruijt-Metz, Donna .............................. Disclosed no confl ict of interest.Spurling, Sarah...................................... Disclosed no confl ict of interest.Spyropoulos, Jelena S. ........................ Disclosed no confl ict of interest.Sreedhar, Remya ................................... Disclosed no confl ict of interest.Sreenan, Seamus .................................. Disclosed no confl ict of interest.Srichaikul, Korbua ................................. Disclosed no confl ict of interest.Srisai, Dollada ....................................... Disclosed no confl ict of interest.Sriussadaporn, Sutin ............................. Disclosed no confl ict of interest.Srivastava, Rahul .................................. Disclosed no confl ict of interest.Sriwijitkamol, Apiradee ........................ Disclosed no confl ict of interest.Sroka, Agnieszka ................................... Disclosed no confl ict of interest.St. Clair, Joshua .................................... Disclosed no confl ict of interest.Stacey, Holly M. ................................... Disclosed no confl ict of interest.Staels, Bart............................................ Disclosed no confl ict of interest.Stafford, Jeanette ................................. Disclosed no confl ict of interest.Stager, William ..................................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi U.S.Stahre, Christina ................................... Employee: AstraZeneca.Staiger, Harald ...................................... Disclosed no confl ict of interest.Staimez, Lisa R. .................................... Disclosed no confl ict of interest.Stampfer, Meir ...................................... Disclosed no confl ict of interest.Stanek, Kelly ......................................... Disclosed no confl ict of interest.Stanhope, Kimber.................................. Disclosed no confl ict of interest.Stanley, Katharine ................................. Disclosed no confl ict of interest.Stano, Sarah.......................................... Disclosed no confl ict of interest.Stanton, Robert C. ................................ Disclosed no confl ict of interest.Stark Casagrande, Sarah ...................... Disclosed no confl ict of interest.Starling, Anne P. ................................... Disclosed no confl ict of interest.Staruschenko, Alexander ...................... Research Support: American Diabetes Association, American

Heart Association, National Institutes of Health.Stasinopoulos, Marilyn ......................... Disclosed no confl ict of interest.

Staten, Myrlene .................................... Disclosed no confl ict of interest.Stathi, Chryssoula ................................. Disclosed no confl ict of interest.Stauber, Melanie ................................... Disclosed no confl ict of interest.Staudacher, Carlo .................................. Disclosed no confl ict of interest.Staudenmaier, Paige J. ........................ Disclosed no confl ict of interest.Steck, Andrea ........................................ Disclosed no confl ict of interest.Steck, Susan.......................................... Disclosed no confl ict of interest.Steele, Kimberley .................................. Disclosed no confl ict of interest.Steers, W. Neil ...................................... Disclosed no confl ict of interest.Stefan, Bornstein R. ............................. Disclosed no confl ict of interest.Stefan, Norbert ..................................... Disclosed no confl ict of interest.Stefanadis, Christodoulos ..................... Disclosed no confl ict of interest.Stefanovic-Racic, Maja ......................... Disclosed no confl ict of interest.Stefanovski, Darko ................................ Disclosed no confl ict of interest.Steffen, Brian T. ................................... Disclosed no confl ict of interest.Steffensen, Rudi.................................... Disclosed no confl ict of interest.Steffes, Michael W. ............................. Disclosed no confl ict of interest.Steg, Philippe Gabriel ........................... Disclosed no confl ict of interest.Stehle, Peter.......................................... Disclosed no confl ict of interest.Steil, Garry M. ...................................... Disclosed no confl ict of interest.Stein, Ellen ............................................ Disclosed no confl ict of interest.Stein, Roland W. .................................. Disclosed no confl ict of interest.Steinbring, Jochen ................................ Disclosed no confl ict of interest.Steinbusch, Laura.................................. Disclosed no confl ict of interest.Steiner, Derek ........................................ Employee: Janssen Pharmaceuticals, Inc.Steinhardt, Xenia .................................. Disclosed no confl ict of interest.Steinman, Michael A. .......................... Disclosed no confl ict of interest.Stella, Peter........................................... Employee: Sanofi .Stender-Petersen, Kirstine .................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novartis

Pharmaceuticals Corporation.Stener-Victorin, Elisabet ....................... Disclosed no confl ict of interest.Stenkula, Karin G. ................................ Disclosed no confl ict of interest.Stentz, Frankie B. ................................. Disclosed no confl ict of interest.Stephens, Jacqueline M. ..................... Disclosed no confl ict of interest.Stephens, Jeffrey W. ........................... Disclosed no confl ict of interest.Stephens, Lancer D. ............................. Disclosed no confl ict of interest.Stephens, Sam ...................................... Disclosed no confl ict of interest.Sterl, Karin ............................................ Disclosed no confl ict of interest.Steven, Sarah ........................................ Disclosed no confl ict of interest.Steven, Sebastian ................................. Disclosed no confl ict of interest.Stevens, Robert ..................................... Disclosed no confl ict of interest.Stewart, John........................................ Employee: Sanofi ; Stock/Shareholder: Sanofi .Stewart, Zoe A. .................................... Disclosed no confl ict of interest.Steyn, Krisela ........................................ Disclosed no confl ict of interest.Stifter, Katja .......................................... Disclosed no confl ict of interest.Stillman, Issac ....................................... Disclosed no confl ict of interest.Stilp, Adrienne ...................................... Disclosed no confl ict of interest.Stitzel, Michael L. ................................ Disclosed no confl ict of interest.Stivers, David ........................................ Employee: Alere Inc.Stocker, Jacqui ...................................... Disclosed no confl ict of interest.Stockmann, Martin................................ Disclosed no confl ict of interest.Stoeckel, Maggie .................................. Disclosed no confl ict of interest.Stoffers, Doris A. .................................. Consultant: Amylin Pharmaceuticals, LLC., Correlagen, Eli Lilly

and Company; Research Support: Johnson & Johnson.Stohr, Oliver ........................................... Disclosed no confl ict of interest.Stolze, Merel S. .................................... Disclosed no confl ict of interest.Stone, Michael ...................................... Employee: Medtronic, Inc.Stone, Stephen I. .................................. Research Support: National Institutes of Health, Pediatric

Endocrine Society.Stoneburner, Ashley .............................. Disclosed no confl ict of interest.Stoner, Julie .......................................... Disclosed no confl ict of interest.St-Onge, Luc .......................................... Disclosed no confl ict of interest.Storgaard, Heidi .................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim GmbH;

Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim GmbH, Merck Sharp & Dohme Corp.

Storkholm, Jan H. ................................. Disclosed no confl ict of interest.Storm, Petter ......................................... Disclosed no confl ict of interest.Stowell, Michael ................................... Board Member: AmideBio.Straetener, Jan ...................................... Disclosed no confl ict of interest.Strain, William D. ................................. Advisory Panel: Janssen Pharmaceuticals, Inc., Novartis

Pharma AG, Novo Nordisk A/S; Employee: Novo Nordisk A/S (Spouse/Partner); Speaker’s Bureau: Janssen Pharmaceuticals, Inc., Novartis Pharma AG, Novo Nordisk A/S.

Strandberg, Charlotte............................ Disclosed no confl ict of interest.Strange, Poul ......................................... Consultant: AstraZeneca, Valeritas; Stock/Shareholder:

Valeritas.Strassburger, Klaus ............................... Disclosed no confl ict of interest.Stricker-Krongrad, Alain ........................ Disclosed no confl ict of interest.Stricklin, Olivia E. ................................. Disclosed no confl ict of interest.Strobel, Marjorie ................................... Disclosed no confl ict of interest.Strohmeyer, Christine ............................ Disclosed no confl ict of interest.Strollo, Patrick ....................................... Disclosed no confl ict of interest.Strollo, Rocky ........................................ Disclosed no confl ict of interest.Strom, Alexander .................................. Disclosed no confl ict of interest.Strotmeyer, Elsa S. ............................... Disclosed no confl ict of interest.

A759


AU

THO

R D

ISCL

OSU

RE

Struemph, Taylor ................................... Disclosed no confl ict of interest.Strum, Matthew .................................... Disclosed no confl ict of interest.Strumph, Paul S. ................................... Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc.Strycker, Lisa ......................................... Disclosed no confl ict of interest.Strzinek, Robert ..................................... Disclosed no confl ict of interest.Stuckey, Heather L. .............................. Disclosed no confl ict of interest.Sturchler, Emmanuel ............................. Disclosed no confl ict of interest.Stylopoulos, Nicholas ........................... Research Support: Eli Lilly and Company.Su, Haoran............................................. Disclosed no confl ict of interest.Su, Junlei .............................................. Disclosed no confl ict of interest.Su, Maxwell .......................................... Disclosed no confl ict of interest.Su, Meifang........................................... Disclosed no confl ict of interest.Su, Xin ................................................... Disclosed no confl ict of interest.Su, Yu-Wen ........................................... Disclosed no confl ict of interest.Suarez, Helena ...................................... Disclosed no confl ict of interest.Subaran, Sharmila C. ........................... Disclosed no confl ict of interest.Subbaiah, Papasani V. .......................... Disclosed no confl ict of interest.Subramanian, Savitha ........................... Disclosed no confl ict of interest.Suckow, Arthur T. ................................. Employee: MedImmune, LLC.Sudo, Nobuyuki ..................................... Disclosed no confl ict of interest.Suehs, Brandon ..................................... Consultant: Novo Nordisk Inc.Suetsugu, Mariko .................................. Disclosed no confl ict of interest.Sugamori, Haruko.................................. Employee: Astellas Pharma Inc.Suganami, Hideki .................................. Employee: Kowa Company, Ltd.Suganuma, Hiroyuki .............................. Disclosed no confl ict of interest.Sugawara, Kenji .................................... Disclosed no confl ict of interest.Sugimoto, Danny H. ............................. Disclosed no confl ict of interest.Sugino, Masakazu ................................. Disclosed no confl ict of interest.Suh, Sunghwan ..................................... Disclosed no confl ict of interest.Sui, Xuemei ........................................... Disclosed no confl ict of interest.Sujjitjoon, Jatuporn............................... Disclosed no confl ict of interest.Suka, Machi .......................................... Disclosed no confl ict of interest.Sullivan, Ashley..................................... Disclosed no confl ict of interest.Sullivan, Brooke A. ............................... Disclosed no confl ict of interest.Sullivan, Cierra ...................................... Disclosed no confl ict of interest.Sullivan, Mark ....................................... Disclosed no confl ict of interest.Sulpice, Thierry ..................................... Employee: Physiogenex.Sum, Chee Fang .................................... Disclosed no confl ict of interest.Sumino, Yasukiyo .................................. Disclosed no confl ict of interest.Sumitani, Yoshikazu .............................. Disclosed no confl ict of interest.Summers, Adria..................................... Disclosed no confl ict of interest.Sumner, Anne ........................................ Disclosed no confl ict of interest.Sun, Alice Vinsin ................................... Disclosed no confl ict of interest.Sun, Bei ................................................. Disclosed no confl ict of interest.Sun, Danny ............................................ Disclosed no confl ict of interest.Sun, Dianjianyi ...................................... Disclosed no confl ict of interest.Sun, Guangyong .................................... Disclosed no confl ict of interest.Sun, Guofeng......................................... Employee: Crown Bioscience, Inc.Sun, Hang .............................................. Disclosed no confl ict of interest.Sun, Jennifer K. .................................... Advisory Panel: Allergan, Inc., Eleven Biotherapeutics,

Novartis Pharmaceuticals Corporation, Regeneron Pharmaceuticals, Inc.; Consultant: Kowa Company, Ltd.; Other Relationship: Bayer HealthCare; Research Support: Adaptive Sensory Technology, LLC, Boston Micromachines, Genentech, Inc., KalVista Pharmaceuticals Inc., Optovue.

Sun, Jia ................................................. Disclosed no confl ict of interest.Sun, Jian ............................................... Disclosed no confl ict of interest.Sun, Jiangming ..................................... Disclosed no confl ict of interest.Sun, Jiayu.............................................. Disclosed no confl ict of interest.Sun, Jinhong ......................................... Disclosed no confl ict of interest.Sun, Kai ................................................. Disclosed no confl ict of interest.Sun, Lei.................................................. Disclosed no confl ict of interest.Sun, Lirong ............................................ Disclosed no confl ict of interest.Sun, Qi ................................................... Disclosed no confl ict of interest.Sun, Wanqing ........................................ Disclosed no confl ict of interest.Sun, Wei ................................................ Disclosed no confl ict of interest.Sun, Xiaojing ......................................... Disclosed no confl ict of interest.Sun, Yijun .............................................. Disclosed no confl ict of interest.Sun, Yixuan ........................................... Disclosed no confl ict of interest.Sun, Yuxiang .......................................... Disclosed no confl ict of interest.Sun, Zhaoli ............................................ Disclosed no confl ict of interest.Sun, Zhe ................................................ Disclosed no confl ict of interest.Sun, Zhen .............................................. Disclosed no confl ict of interest.Sun, Zhongjie ........................................ Disclosed no confl ict of interest.Sun, Zi Lin.............................................. Disclosed no confl ict of interest.Sundaram, Selvam ................................ Disclosed no confl ict of interest.Sundaresan, Aditi.................................. Disclosed no confl ict of interest.Sundbom, Magnus ................................ Disclosed no confl ict of interest.Sundstrom, Jeffrey M. ......................... Disclosed no confl ict of interest.Sundström, Johan ................................. Disclosed no confl ict of interest.Sung, Jennifer ....................................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi .Sung, Joohun ........................................ Disclosed no confl ict of interest.Sung, Yeon-Ah....................................... Disclosed no confl ict of interest.Suppli, Malte P. .................................... Disclosed no confl ict of interest.

Suraci, Concetta .................................... Disclosed no confl ict of interest.Surani, Saherish .................................... Disclosed no confl ict of interest.Surani, Salim H. ................................... Disclosed no confl ict of interest.Surani, Zoya .......................................... Disclosed no confl ict of interest.Surmont, Filip ........................................ Employee: AstraZeneca.Surovtseva, Yulia V. .............................. Disclosed no confl ict of interest.Suryana, Eurwin .................................... Disclosed no confl ict of interest.Suryawanshi, Shailaja .......................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Sussman, Matthew ............................... Research Support: Boston Health Economics, Inc.Sustarich, Jake...................................... Disclosed no confl ict of interest.Sutcliffe, Harvey.................................... Disclosed no confl ict of interest.Sutherland, Jeff .................................... Disclosed no confl ict of interest.Suto, Chikako ........................................ Disclosed no confl ict of interest.Sutton, David......................................... Consultant: Valeritas; Speaker’s Bureau: Valeritas.Suwansaksri, Nattakarn........................ Disclosed no confl ict of interest.Suzuki, Hirofumi .................................... Disclosed no confl ict of interest.Suzuki, Hiromichi................................... Disclosed no confl ict of interest.Suzuki, Hiroshi....................................... Disclosed no confl ict of interest.Suzuki, Junichi ...................................... Disclosed no confl ict of interest.Suzuki, Ken ............................................ Disclosed no confl ict of interest.Suzuki, Kenji .......................................... Disclosed no confl ict of interest.Suzuki, Kunihiro..................................... Disclosed no confl ict of interest.Suzuki, Reiko ......................................... Disclosed no confl ict of interest.Suzuki, Ruriko ........................................ Disclosed no confl ict of interest.Suzuki, Ryo ............................................ Research Support: Eli Lilly Japan K.K., Novo Nordisk Inc.,

Sanofi K.K.Suzuki, Takashi ...................................... Disclosed no confl ict of interest.Suzuki, Tatsuya ...................................... Disclosed no confl ict of interest.Sv, Nikhil ............................................... Disclosed no confl ict of interest.Svane, Maria S. .................................... Disclosed no confl ict of interest.Svare, Jens A. ...................................... Disclosed no confl ict of interest.Svatkova, Alena .................................... Disclosed no confl ict of interest.Svendsen, Berit ..................................... Disclosed no confl ict of interest.Svendsen, Lars B. ................................. Disclosed no confl ict of interest.Svendstrup, Mathilde............................ Disclosed no confl ict of interest.Svensson, Ann-Marie............................ Disclosed no confl ict of interest.Svensson, Elisabeth .............................. Disclosed no confl ict of interest.Swanson, Lawrence J. ......................... Disclosed no confl ict of interest.Swanson, Ronald .................................. Employee: Janssen Pharmaceuticals, Inc.Swasey, Krystal Kapi’Olani ................... Disclosed no confl ict of interest.Sweeney, Mike...................................... Employee: Resverlogix Corp.; Stock/Shareholder: Resverlogix

Corp.Sweet, Ian R. ........................................ Disclosed no confl ict of interest.Sweeting, Arianne N. ........................... Disclosed no confl ict of interest.Swensen, Monica H. ............................ Employee: Alere Inc.Sycova-Krivanova, Lenka ...................... Disclosed no confl ict of interest.Syed, Farooq.......................................... Disclosed no confl ict of interest.Syed, Ismail ........................................... Disclosed no confl ict of interest.Syed, Samreen K. ................................. Employee: Eli Lilly and Company.Sykova, Eva ........................................... Disclosed no confl ict of interest.Sylow, Lykke .......................................... Disclosed no confl ict of interest.Sylvetsky, Allison C. ............................. Disclosed no confl ict of interest.Szalecki, Mieczysław ............................ Disclosed no confl ict of interest.Szapacs, Matthew E. ........................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Szarf, Gilberto ....................................... Disclosed no confl ict of interest.Szendrödi, Julia..................................... Disclosed no confl ict of interest.Szkudlinska, Magdalena ....................... Disclosed no confl ict of interest.Szopa, Magdalena ................................ Disclosed no confl ict of interest.Szu-Hua, Chen ....................................... Disclosed no confl ict of interest.Szymanska-Garbacz, Elektra ................. Advisory Panel: Eli Lilly and Company, Medtronic, Inc., Merck

Sharp & Dohme Corp., Novo Nordisk A/S; Speaker’s Bureau: Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp.

Szymanski, Keith A. .............................. Employee: Takeda Pharmaceutical Company Limited.Szypowska, Agnieszka .......................... Disclosed no confl ict of interest.Tabak, Adam G. .................................... Disclosed no confl ict of interest.Tabak, Rachel G. ................................... Disclosed no confl ict of interest.Tabara, Yasuharu ................................... Disclosed no confl ict of interest.Tabata, Mitsuhisa ................................. Disclosed no confl ict of interest.Tabung, Fred .......................................... Disclosed no confl ict of interest.Taccioli, Christian .................................. Disclosed no confl ict of interest.Tachendorff, Andrew ............................. Disclosed no confl ict of interest.Tack, Cees J. ........................................ Advisory Panel: AstraZeneca, Eli Lilly and Company, Janssen

Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S; Research Support: AstraZeneca, Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S.

Tackett, Lixuan ...................................... Disclosed no confl ict of interest.Tadinada, Satya M. .............................. Disclosed no confl ict of interest.Tae, Wonil ............................................. Disclosed no confl ict of interest.Tafreshi, Maryam .................................. Consultant: Locemia Solutions.Taghizadeh, Farnaz ................................ Disclosed no confl ict of interest.Taguchi, Koichiro ................................... Disclosed no confl ict of interest.Tahara, Yumiko ...................................... Disclosed no confl ict of interest.Taher, Jennifer ...................................... Disclosed no confl ict of interest.

A760


AU

THO

R D

ISCL

OSU

RE

Tahsin, Bettina ...................................... Disclosed no confl ict of interest.Tai, E. Shyong ........................................ Disclosed no confl ict of interest.Taira, Makiko ......................................... Disclosed no confl ict of interest.Tajima, Naoko ....................................... Disclosed no confl ict of interest.Tajima, Toshihiro ................................... Disclosed no confl ict of interest.Tajiri, Yuji ............................................... Disclosed no confl ict of interest.Takács, Róbert ....................................... Disclosed no confl ict of interest.Takada, Yoshihisa .................................. Disclosed no confl ict of interest.Takahashi, Atsushi ................................ Disclosed no confl ict of interest.Takahashi, Harumi ................................. Disclosed no confl ict of interest.Takahashi, Hideyuki .............................. Employee: Astellas Pharma Inc.Takahashi, Hilton K. ............................. Disclosed no confl ict of interest.Takahashi, Hirokazu .............................. Disclosed no confl ict of interest.Takahashi, Hiroshi ................................. Disclosed no confl ict of interest.Takahashi, Hiroyuki ............................... Disclosed no confl ict of interest.Takahashi, Ippei .................................... Disclosed no confl ict of interest.Takahashi, Kanako ................................ Disclosed no confl ict of interest.Takahashi, Kazuhisa .............................. Disclosed no confl ict of interest.Takahashi, Kazuto ................................. Disclosed no confl ict of interest.Takahashi, Kiyohito ............................... Speaker’s Bureau: Astellas Pharma Inc., Boehringer Ingelheim

Pharmaceuticals, Inc., Eisai Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Shionogi & Co. Ltd., Takeda Pharmaceutical Company Limited.

Takahashi, Tomomi ................................ Disclosed no confl ict of interest.Takahashi, Yoshihiko ............................. Disclosed no confl ict of interest.Takami, Akane ....................................... Employee: Sanofi .Takamoto, Iseki ..................................... Disclosed no confl ict of interest.Takano, Ayumi ....................................... Disclosed no confl ict of interest.Takao, Toshiko ....................................... Disclosed no confl ict of interest.Takata, Yasunori .................................... Disclosed no confl ict of interest.Takatani, Tomozumi ............................... Disclosed no confl ict of interest.Takayama, Michiyo ............................... Disclosed no confl ict of interest.Takeda, Jun ........................................... Disclosed no confl ict of interest.Takeda, Yusuke ...................................... Disclosed no confl ict of interest.Takeno, Kageumi ................................... Speaker’s Bureau: Eli Lilly Japan K.K., Takeda Pharmaceutical

Company Limited.Takenoshita, Hiromadsa ........................ Disclosed no confl ict of interest.Takeuchi, Takato .................................... Disclosed no confl ict of interest.Takikawa, Akiko .................................... Disclosed no confl ict of interest.Takiyama, Yumi ..................................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Eli Lilly Japan K.K., Taisho Pharmaceutical Co., Ltd.; Speaker’s Bureau: Daiichi-Sankyo Co., Ltd., Novartis Pharma K.K., Sanofi K.K.

Takizawa, Tomoharu .............................. Disclosed no confl ict of interest.Talal, Talal K. ........................................ Disclosed no confl ict of interest.Tam, Charmaine .................................... Disclosed no confl ict of interest.Tam, Ching Ching .................................. Disclosed no confl ict of interest.Tam, Claudia H. .................................... Disclosed no confl ict of interest.Tam, Wing Hung .................................... Disclosed no confl ict of interest.Tamaki, Motoyuki .................................. Disclosed no confl ict of interest.Tamanaha, Tamiko ................................ Disclosed no confl ict of interest.Tamarina, Natalia .................................. Disclosed no confl ict of interest.Tamborlane, William V. ........................ Consultant: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited.

Tamhane, Shirikant ............................... Disclosed no confl ict of interest.Tamiya, Junko ....................................... Employee: Receptos (Celgene).Tamura, Haruka ..................................... Disclosed no confl ict of interest.Tamura, Yoshifumi ................................. Speaker’s Bureau: AstraZeneca, Eli Lilly Japan K.K., Kissei

Pharmaceutical Co., Ltd., Merck & Co., Inc., Takeda Pharmaceutical Company Limited.

Tamvakos, Charalampos ....................... Disclosed no confl ict of interest.Tamvakos, Ilias ...................................... Disclosed no confl ict of interest.Tan, Alexander Tong Boon .................... Disclosed no confl ict of interest.Tan, Alvin Wai Kit ................................. Disclosed no confl ict of interest.Tan, Beesan ........................................... Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc.Tan, Bernice ........................................... Disclosed no confl ict of interest.Tan, Chun Hai ........................................ Disclosed no confl ict of interest.Tan, Florence Hui Sieng ........................ Disclosed no confl ict of interest.Tan, Guat K. .......................................... Disclosed no confl ict of interest.Tan, Hiangkiat (Jason) ........................... Employee: HealthCore.Tan, Hong Chang ................................... Disclosed no confl ict of interest.Tan, Joanne T. ...................................... Disclosed no confl ict of interest.Tan, Kelly ............................................... Disclosed no confl ict of interest.Tan, Maudrene L. ................................. Disclosed no confl ict of interest.Tan, Meng ............................................. Other Relationship: Eli Lilly and Company.Tan, Peng Chiong ................................... Disclosed no confl ict of interest.Tan, Shixiong ......................................... Disclosed no confl ict of interest.Tan, Wee Boon ...................................... Disclosed no confl ict of interest.Tan, Yi .................................................... Disclosed no confl ict of interest.Tan, Ying ................................................ Disclosed no confl ict of interest.Tanabe, Akihito ..................................... Disclosed no confl ict of interest.

Tanabe, Jutaro ...................................... Disclosed no confl ict of interest.Tanabe, Katsuya .................................... Disclosed no confl ict of interest.Tanaka, Akira ......................................... Disclosed no confl ict of interest.Tanaka, Kayo ......................................... Disclosed no confl ict of interest.Tanaka, Keiko ........................................ Disclosed no confl ict of interest.Tanaka, Masami .................................... Disclosed no confl ict of interest.Tanaka, Masatoshi ................................ Disclosed no confl ict of interest.Tanaka, Muhei ....................................... Disclosed no confl ict of interest.Tanaka, Naomi ...................................... Disclosed no confl ict of interest.Tanaka, Sachiko .................................... Disclosed no confl ict of interest.Tanaka, Satoshi ..................................... Disclosed no confl ict of interest.Tanaka, Shiro ......................................... Disclosed no confl ict of interest.Tanaka, Shou ......................................... Disclosed no confl ict of interest.Tanaka, Shunichi ................................... Disclosed no confl ict of interest.Tanaka, Tomoko ..................................... Disclosed no confl ict of interest.Tanaka, Toshiaki .................................... Disclosed no confl ict of interest.Tanamas, Stephanie K. ........................ Disclosed no confl ict of interest.Tandon, Nikhil ....................................... Disclosed no confl ict of interest.Taneichi, Haruhito ................................. Disclosed no confl ict of interest.Tanenbaum, Molly L. ............................ Disclosed no confl ict of interest.Tanenberg, Robert J. ............................ Disclosed no confl ict of interest.Tang, Bocai ............................................ Disclosed no confl ict of interest.Tang, Fan ............................................... Disclosed no confl ict of interest.Tang, Huilin ........................................... Disclosed no confl ict of interest.Tang, Junling ......................................... Disclosed no confl ict of interest.Tang, Patrick Y. ..................................... Disclosed no confl ict of interest.Tang, Sunyinyan .................................... Disclosed no confl ict of interest.Tang, Weifeng ....................................... Stock/Shareholder: AstraZeneca.Tang, Wenjuan ...................................... Disclosed no confl ict of interest.Tang, Yuexin .......................................... Employee: Merck & Co., Inc.Tang, Yun-Zhao ...................................... Disclosed no confl ict of interest.Tangjittipokin, Watip ............................. Disclosed no confl ict of interest.Tanigawa, Takeshi ................................. Disclosed no confl ict of interest.Taniguchi, Satoshi ................................. Disclosed no confl ict of interest.Taniguchi, Yukiko ................................... Disclosed no confl ict of interest.Tanizawa, Yukio ..................................... Disclosed no confl ict of interest.Tao, Ling ................................................ Disclosed no confl ict of interest.Tao, Rongya ........................................... Disclosed no confl ict of interest.Tao-Chun, Lee ........................................ Disclosed no confl ict of interest.Taplin, Craig E. ..................................... Disclosed no confl ict of interest.Taraoune, Ibrahim ................................. Disclosed no confl ict of interest.Tardif, Jean-Claude ............................... Other Relationship: AstraZeneca, Cerenis Therapeutics Inc.,

Eli Lilly and Company, MedImmune, LLC., Merck & Co., Inc., Pfi zer Inc., Roche Pharmaceuticals, Sanofi U.S., Servier, Thrasos Therapeutics; Research Support: Sanofi U.S.

Tárnoki, Ádám D. .................................. Disclosed no confl ict of interest.Tárnoki, Dávid L. ................................... Disclosed no confl ict of interest.Tarnow, Lise .......................................... Advisory Panel: Merck Sharp & Dohme Corp., Novo Nordisk

A/S; Other Relationship: Boehringer Ingelheim GmbH, Merck Sharp & Dohme Corp., Novo Nordisk A/S, ReApplix, ResMed; Stock/Shareholder: Novo Nordisk A/S.

Tascini, Carlo ......................................... Disclosed no confl ict of interest.Tastanova, Gulzhan M. ......................... Disclosed no confl ict of interest.Tat, Timothy ........................................... Employee: Janssen Pharmaceuticals, Inc.Tate, Donna B. ...................................... Disclosed no confl ict of interest.Tateda, Tetsuyuki .................................. Disclosed no confl ict of interest.Tatosian, Daniel .................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Tatsumi, Yasuaki ................................... Disclosed no confl ict of interest.Tatsuno, Ichiro ....................................... Disclosed no confl ict of interest.Tavakoli, Mitra ...................................... Disclosed no confl ict of interest.Tavares Bello, Carlos ............................. Disclosed no confl ict of interest.Tavintharan, Subramaniam ................... Disclosed no confl ict of interest.Tawaramoto, Kazuhito .......................... Disclosed no confl ict of interest.Tayeb, Khaled A. .................................. Disclosed no confl ict of interest.Taylor, Angela ........................................ Disclosed no confl ict of interest.Taylor Jr., Charles G. ............................ Disclosed no confl ict of interest.Taylor, Gordon J. .................................. Disclosed no confl ict of interest.Taylor, Gretchen .................................... Disclosed no confl ict of interest.Taylor, Hugh S. ..................................... Disclosed no confl ict of interest.Taylor, Roy ............................................. Speaker’s Bureau: Eli Lilly and Company, Novartis,

NovoNordisk.Taylor, Shannon ..................................... Disclosed no confl ict of interest.Taylor, Simeon I. ................................... Disclosed no confl ict of interest.te Groen, Maarten................................. Disclosed no confl ict of interest.Teague, April M. ................................... Disclosed no confl ict of interest.Teder-Laving, Maris............................... Disclosed no confl ict of interest.Tedeschi, Anna ...................................... Disclosed no confl ict of interest.Teede, Helena ....................................... Disclosed no confl ict of interest.Teh, Ming Ming ..................................... Disclosed no confl ict of interest.Teh, Rachel ............................................ Disclosed no confl ict of interest.Tehrani, Sara ......................................... Disclosed no confl ict of interest.Teichert, Lenore ..................................... Employee: Sanofi -Aventis Deutschland GmbH.Teigland, Tonje ...................................... Disclosed no confl ict of interest.Teixeira, Mônica .................................... Disclosed no confl ict of interest.

A761


AU

THO

R D

ISCL

OSU

RE

Tekin, Zehra ........................................... Disclosed no confl ict of interest.Telford, Onala ........................................ Disclosed no confl ict of interest.Telo, Gabriela H. ................................... Disclosed no confl ict of interest.Temple, Rosemary ................................. Disclosed no confl ict of interest.Templin, Andrew T. ............................... Disclosed no confl ict of interest.Templin, Megan .................................... Research Support: Merck Sharp & Dohme Corp.Ten Have, Gabriella A. ......................... Disclosed no confl ict of interest.Tenen, Danielle ..................................... Disclosed no confl ict of interest.Tennagels, Norbert ................................ Employee: Sanofi -Aventis Deutschland GmbH.Tentolouris, Nicholas ............................ Disclosed no confl ict of interest.Teo, Adrian K. ....................................... Disclosed no confl ict of interest.Teo, Chaur Lee ....................................... Disclosed no confl ict of interest.Teo, Yvonne ........................................... Disclosed no confl ict of interest.Teplitsky, Lena ....................................... Disclosed no confl ict of interest.Tepper, Edward R. ................................ Disclosed no confl ict of interest.Ter Horst, Kasper W. ............................ Disclosed no confl ict of interest.Terai, Ai ................................................. Research Support: Boehringer Ingelheim Japan Inc., Merck

Sharp & Dohme Corp., Novo Nordisk Inc.Terasaki, Michishige ............................. Disclosed no confl ict of interest.Terauchi, Yasuo ..................................... Other Relationship: Astellas Pharma Inc., AstraZeneca,

Bayer Yakuhin, Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp & Dohme Corp., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Pfi zer Japan Inc., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Shionogi & Co. Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Bayer Yakuhin, Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp & Dohme Corp., Nippon Boehringer Ingelheim Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Shionogi & Co. Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Terawaki, Yuichi .................................... Disclosed no confl ict of interest.Terruzzi, Ileana ...................................... Speaker’s Bureau: Soremartec.Tersey, Sarah ......................................... Disclosed no confl ict of interest.Tesauro, Manfredi ................................. Disclosed no confl ict of interest.Tesfaye, Solomon .................................. Research Support: ImpetoMedical, Neurometrix.Teshima, Miho ....................................... Disclosed no confl ict of interest.Tesse, Angela ........................................ Disclosed no confl ict of interest.Testa, Marcia A. ................................... Disclosed no confl ict of interest.Teudt, Frederik ....................................... Disclosed no confl ict of interest.Tezza, Sara ............................................ Disclosed no confl ict of interest.Tfayli, Hala ............................................ Disclosed no confl ict of interest.Thabit, Hood .......................................... Disclosed no confl ict of interest.Thacker, Hemant ................................... Disclosed no confl ict of interest.Thakur, Deepika ..................................... Research Support: Parexel International.Thakur, Vikram ....................................... Disclosed no confl ict of interest.Tham, Elaine.......................................... Disclosed no confl ict of interest.Tham, Jill............................................... Disclosed no confl ict of interest.Tham, Kwang Wei ................................. Disclosed no confl ict of interest.Tham, Lai San........................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Thangiah, Geetha .................................. Disclosed no confl ict of interest.Thanyaphon, Thanita............................. Disclosed no confl ict of interest.Thapa, Prabin ........................................ Disclosed no confl ict of interest.Thatcher, Natalie J. .............................. Disclosed no confl ict of interest.Thayer, Sarah ........................................ Employee: Optum; Other Relationship: Janssen; Stock/

Shareholder: Optum.Thazin, Ma............................................. Disclosed no confl ict of interest.Theckedath, Boby .................................. Disclosed no confl ict of interest.Theis, Stefan ......................................... Employee: Sanofi -Aventis Deutschland GmbH.Theodosis-Georgilas, Anastasios ......... Disclosed no confl ict of interest.Therasse, Ashley ................................... Disclosed no confl ict of interest.Thevenet, Julien.................................... Disclosed no confl ict of interest.Theverkalam, Geetha ............................ Disclosed no confl ict of interest.Thiel, Steffen......................................... Disclosed no confl ict of interest.Thiele Isip Tan, Iris ................................ Other Relationship: Sanofi ; Speaker’s Bureau: Merck Sharp &

Dohme Corp., Sanofi .Thiery, Joachim ..................................... Disclosed no confl ict of interest.Thieu, Vivian .......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Thimme, Robert ..................................... Disclosed no confl ict of interest.Thomakos, Petros .................................. Disclosed no confl ict of interest.Thomas, Andreas .................................. Employee: Medtronic Deutschland.Thomas, Anthony P. .............................. Disclosed no confl ict of interest.Thomas, Celeste.................................... Disclosed no confl ict of interest.Thomas, Fred ......................................... Disclosed no confl ict of interest.

Thomas, Hilary R. ................................. Disclosed no confl ict of interest.Thomas, John F. .................................... Disclosed no confl ict of interest.Thomas, Kirsten L. ................................ Disclosed no confl ict of interest.Thomas, Melissa K. .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Thomas, Nick M. .................................. Disclosed no confl ict of interest.Thomas, Nihal ....................................... Disclosed no confl ict of interest.Thompson, Bithika................................. Disclosed no confl ict of interest.Thompson, Christopher C. .................... Advisory Panel: Covidien, Fractyl, USGI Medical Inc.;

Consultant: Apollo Endosurgery, Covidien, Olympus, USGI Medical Inc.; Research Support: Apollo Endosurgery, Aspire Bariatrics, Olympus, USGI Medical Inc.; Stock/Shareholder: GI Windows.

Thompson, David M. ............................ Disclosed no confl ict of interest.Thompson, Deborah .............................. Disclosed no confl ict of interest.Thompson, Michael J. .......................... Disclosed no confl ict of interest.Thompson, Sharon E. ........................... Disclosed no confl ict of interest.Thompson, Vivian .................................. Disclosed no confl ict of interest.Thomsen, Reimar W. ............................ Disclosed no confl ict of interest.Thomsen, Soren K. ............................... Disclosed no confl ict of interest.Thong, Ken Y. ........................................ Disclosed no confl ict of interest.Thongtang, Nuntakorn .......................... Disclosed no confl ict of interest.Thonusin, Chanisa ................................. Disclosed no confl ict of interest.Thorel, Fabrizio ...................................... Disclosed no confl ict of interest.Thorn, Peter ........................................... Disclosed no confl ict of interest.Thorner, Lauren ..................................... Disclosed no confl ict of interest.Thorsteinsson, Birger ............................ Disclosed no confl ict of interest.Thukuntla, Shwetha .............................. Disclosed no confl ict of interest.Thulaseedharan, N.K. ........................... Disclosed no confl ict of interest.Thurheimer-Cacciotti, Jennifer L. ........ Disclosed no confl ict of interest.Thurmond, Debbie ................................. Disclosed no confl ict of interest.Thyfault, John ....................................... Disclosed no confl ict of interest.Tian, Dan ............................................... Disclosed no confl ict of interest.Tian, Lili ................................................. Disclosed no confl ict of interest.Tibudan, Martin ..................................... Disclosed no confl ict of interest.Tiemeier, Henning ................................. Disclosed no confl ict of interest.Tierney, Edward ..................................... Disclosed no confl ict of interest.Tillner, Joachim ..................................... Employee: Sanofi -Aventis Deutschland GmbH; Stock/

Shareholder: Sanofi -Aventis Deutschland GmbH.Timony, Gregg........................................ Employee: Receptos (Celgene).Tinahones, Francisco J. ........................ Advisory Panel: AstraZeneca, Boehringer Ingelheim GmbH,

Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novartis Pharma GmbH, Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Board Member: Boehringer Ingelheim GmbH, Sanofi U.S.

Tinkoff, Stacey....................................... Disclosed no confl ict of interest.Tinsley, Liane ......................................... Disclosed no confl ict of interest.Tio, Joseph ............................................ Disclosed no confl ict of interest.Tippu, Zayd ............................................ Disclosed no confl ict of interest.Tirado, Sandra ....................................... Disclosed no confl ict of interest.Tirucherai, Giridhar S. .......................... Stock/Shareholder: Bristol-Myers Squibb Company.Titan, Silvia Maria de Oliveira .............. Disclosed no confl ict of interest.Titchenell, Paul M. ............................... Disclosed no confl ict of interest.Titus, Courtney ...................................... Disclosed no confl ict of interest.Tiwari, Akankasha ................................. Disclosed no confl ict of interest.Tjørnhøj-Thomsen, Tine......................... Disclosed no confl ict of interest.Tobe, Kazuyuki ....................................... Research Support: Astellas Pharma Inc., Boehringer Ingelheim

Pharmaceuticals, Inc., Fuji Chemical Industries Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Merck Sharp & Dohme Corp., Pfi zer Japan Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca, Takeda Pharmaceutical Company Limited.

Tobias, Deirdre K. ................................. Disclosed no confl ict of interest.Tobin, Victoria ....................................... Disclosed no confl ict of interest.Tochiya, Mayu ....................................... Disclosed no confl ict of interest.Toda, Hitoshi ......................................... Disclosed no confl ict of interest.Toda, Kyoko ........................................... Disclosed no confl ict of interest.Todd, Jennifer N. .................................. Disclosed no confl ict of interest.Todkar, Jayashree S. ............................ Research Support: Johnson & Johnson.Toft-Nielsen, Mai-Britt .......................... Disclosed no confl ict of interest.Toh, Sue-Anne ....................................... Disclosed no confl ict of interest.Tokumoto, Shinsuke .............................. Disclosed no confl ict of interest.Toledano, Yoel ....................................... Research Support: Eli Lilly and Company.Tollefsen, Sherida ................................. Disclosed no confl ict of interest.Tomasi, Franco ...................................... Disclosed no confl ict of interest.Tomer, Yaron .......................................... Disclosed no confl ict of interest.Tomic, Martina ...................................... Disclosed no confl ict of interest.Tomita, Masuomi .................................. Disclosed no confl ict of interest.Tomita, Tsutomu .................................... Disclosed no confl ict of interest.Tomonaga, Osamu ................................. Disclosed no confl ict of interest.Tomoyasu, Masako ............................... Disclosed no confl ict of interest.Tomsa, Anca .......................................... Disclosed no confl ict of interest.Tomuta, Nora ......................................... Disclosed no confl ict of interest.Ton, Thanh ............................................. Research Support: AstraZeneca.

A762


AU

THO

R D

ISCL

OSU

RE

Tong, Chin Voon..................................... Disclosed no confl ict of interest.Tong, Jenny ........................................... Disclosed no confl ict of interest.Tong, Liyue ............................................ Employee: Sanofi U.S.Tong, Xin ................................................ Disclosed no confl ict of interest.Toni, Sonia ............................................. Disclosed no confl ict of interest.Tonneijck, Lennart ................................. Disclosed no confl ict of interest.Tonnesen, Morten F. ............................. Employee: Novo Nordisk A/S.Toorawa, Robert .................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Tooze, Janet .......................................... Disclosed no confl ict of interest.Topcuoglu, Canan .................................. Disclosed no confl ict of interest.Toppari, Jorma ...................................... Research Support: National Institutes of Health.Toppila, Iiro ............................................ Disclosed no confl ict of interest.Toräng, Signe ........................................ Disclosed no confl ict of interest.Torekov, Signe S. .................................. Stock/Shareholder: Novo Nordisk A/S.Torisu, Masamoto ................................. Disclosed no confl ict of interest.Tornabene, Talia .................................... Disclosed no confl ict of interest.Toropova, Olena .................................... Disclosed no confl ict of interest.Torres, Jackson A. ................................ Disclosed no confl ict of interest.Torrey, Heather ...................................... Disclosed no confl ict of interest.Tosaki, Takahiro ..................................... Research Support: Daiichi-Sankyo Co., Ltd., Mitsubishi

Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Corporation.

Toti, Florence ......................................... Disclosed no confl ict of interest.Totomirova, Tzvetelina .......................... Disclosed no confl ict of interest.Toumadje, Arazdordi ............................. Disclosed no confl ict of interest.Toumaniantz, Gilles ............................... Disclosed no confl ict of interest.Tountas, Christos ................................... Disclosed no confl ict of interest.Toural, Elvira .......................................... Research Support: Boehringer Ingelheim GmbH.Tousoulis, Dimitris ................................. Disclosed no confl ict of interest.Touyz, Rhian .......................................... Disclosed no confl ict of interest.Towers, Meghan ................................... Employee: Janssen Pharmaceuticals, Inc.Townsend, Clay V. ................................ Disclosed no confl ict of interest.Townsend, Raymond ............................. Advisory Panel: Janssen; Consultant: Janssen.Toyoda, Kentaro .................................... Disclosed no confl ict of interest.Toyoda, Masao ...................................... Disclosed no confl ict of interest.Tracey, Gregory ...................................... Disclosed no confl ict of interest.Tracey, Irene .......................................... Disclosed no confl ict of interest.Trachta, Pavel ........................................ Disclosed no confl ict of interest.Traina, Shana ........................................ Employee: Janssen Global Services, LLC.Traish, Abdulmaged .............................. Disclosed no confl ict of interest.Tran, Bao Chau ...................................... Disclosed no confl ict of interest.Tran, Brian ............................................. Disclosed no confl ict of interest.Tran, Julia .............................................. Disclosed no confl ict of interest.Tran, Lee ................................................ Disclosed no confl ict of interest.Traurig, Michael .................................... Disclosed no confl ict of interest.Trautmann, Michael .............................. Advisory Panel: Merck & Co., Inc; Consultant: Merck & Co.,

Inc., Servier; Stock/Shareholder: Eli Lilly and Company.Travers, Jasmine ................................... Disclosed no confl ict of interest.Travia, Daniela ...................................... Disclosed no confl ict of interest.Traylor, Louise ....................................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi U.S.Trefts, Elijah .......................................... Disclosed no confl ict of interest.Tremblay, Mikaël ................................... Employee: ProMetic BioSciences Inc.; Stock/Shareholder:

ProMetic Life Sciences Inc.Trescoli, Ana .......................................... Disclosed no confl ict of interest.Trescoli, Carlos ...................................... Disclosed no confl ict of interest.Trevaskis, James ................................... Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Trico’, Domenico .................................... Disclosed no confl ict of interest.Trief, Paula M. ...................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases.Trieschman, Erich .................................. Research Support: AstraZeneca, Bristol-Myers Squibb

Company, Eli Lilly and Company.Triest, Myriam ....................................... Employee: Locemia Solutions; Stock/Shareholder: Locemia

Solutions.Trifi rò, Silvia .......................................... Disclosed no confl ict of interest.Trikallinou, Aikaterini ............................ Disclosed no confl ict of interest.Tripathy, Devjit ...................................... Consultant: Sanofi .Triplitt, Curtis ......................................... Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc.Trivedi, Chitrang .................................... Employee: Zydus Research Centre, Cadila Healthcare Limited,

Ahmedabad, India.Troelsen, Lone N. ................................. Employee: Novo Nordisk A/S.Trofi movksy, Elina .................................. Disclosed no confl ict of interest.Trombatore, Cesare ............................... Disclosed no confl ict of interest.Trombetta, Maddalena .......................... Disclosed no confl ict of interest.Tronko, Mykola ...................................... Disclosed no confl ict of interest.Troup, John ............................................ Employee: Metagenics, Inc.Trouvas, Dimitrios ................................. Disclosed no confl ict of interest.True, Mark W. ....................................... Disclosed no confl ict of interest.Trujillo, Jennifer M. .............................. Advisory Panel: Sanofi U.S.Trujillo, Maria E. ................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Tryggestad, Jeanie B. ........................... Disclosed no confl ict of interest.Trznadel-Morawska, Iwona ................... Disclosed no confl ict of interest.

Tsai, Ailin ............................................... Disclosed no confl ict of interest.Tsai, Katherine ...................................... Employee: MedImmune, LLC.Tsai, Michael ......................................... Disclosed no confl ict of interest.Tsai, Shih-Tzer ....................................... Advisory Panel: Boehringer Ingelheim, Novo Nordisk, Sanofi ;

Other Relationship: AstraZeneca.Tsang, Michael ...................................... Disclosed no confl ict of interest.Tsaousidou, Eva ..................................... Disclosed no confl ict of interest.Tschopp, Oliver ...................................... Disclosed no confl ict of interest.Tse, Hubert M. ...................................... Disclosed no confl ict of interest.Tsekmekidou, Xanthippi ........................ Disclosed no confl ict of interest.Tseng, Chin-Lin ...................................... Disclosed no confl ict of interest.Tseng, Eva ............................................. Disclosed no confl ict of interest.Tseng, Yu-Hua ....................................... Disclosed no confl ict of interest.Tsiakou, Afroditi .................................... Disclosed no confl ict of interest.Tsirigotis, Dimitrios ............................... Disclosed no confl ict of interest.Tso, Annette W. .................................... Disclosed no confl ict of interest.Tsopozidi, Maria .................................... Disclosed no confl ict of interest.Tsoukas, George M. ............................. Advisory Panel: Eli Lilly and Company, Merck & Co., Inc;

Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk Inc.

Tsoukas, Michael .................................. Consultant: Eli Lilly and Company, Novo Nordisk A/S.Tsuboi, Maho ......................................... Employee: GlaxoSmithKline.Tsubonaka, Kaori ................................... Disclosed no confl ict of interest.Tsuchida, Hiromi .................................... Disclosed no confl ict of interest.Tsuchiya, Kyoichiro ................................ Disclosed no confl ict of interest.Tsujikawa, Laura ................................... Employee: Resverlogix Corp.; Stock/Shareholder: Resverlogix

Corp.Tsujita, Kenichi ...................................... Disclosed no confl ict of interest.Tsunekawa, Shin ................................... Disclosed no confl ict of interest.Tsuneyama, Koichi ................................ Disclosed no confl ict of interest.Tsuprykov, Oleg ..................................... Disclosed no confl ict of interest.Tsuruta, Fujiko ....................................... Disclosed no confl ict of interest.Tsuruta, Megumi ................................... Disclosed no confl ict of interest.Tsuruta, Munehisa ................................ Disclosed no confl ict of interest.Tsutsumi, Shuichi .................................. Disclosed no confl ict of interest.Tu, Hongbin ........................................... Disclosed no confl ict of interest.Tu, Lichuan ............................................ Disclosed no confl ict of interest.Tu, Yingmei ............................................ Employee: Merck Sharp & Dohme Corp.Tuca, Alexandru ..................................... Disclosed no confl ict of interest.Tuchman, Michael M. .......................... Disclosed no confl ict of interest.Tuka, Vladimir ........................................ Disclosed no confl ict of interest.Tuke, Marcus ......................................... Disclosed no confl ict of interest.Tulia, Jerome ......................................... Disclosed no confl ict of interest.Tulloch-Reid, Marshall K. ..................... Disclosed no confl ict of interest.Tully, Natalie ......................................... Disclosed no confl ict of interest.Tumurbaatar, Batbayar .......................... Disclosed no confl ict of interest.Tunceli, Kaan ......................................... Employee: Merck & Co., Inc.Tunduguru, Ragadeepthi ....................... Disclosed no confl ict of interest.Tuomainen, Tomi-Pekka ........................ Disclosed no confl ict of interest.Tuomilehto, Jaakko ............................... Other Relationship: Novo Nordisk A/S, Sanofi -Aventis

Deutschland GmbH; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Sanofi -Aventis Deutschland GmbH; Stock/Shareholder: Orion.

Tura, Andrea .......................................... Disclosed no confl ict of interest.Turaihi, Alexander H. ............................ Disclosed no confl ict of interest.Turan, Ozhan .......................................... Disclosed no confl ict of interest.Turchin, Alexander ................................ Advisory Panel: Monarch Medical Technologies, Novo Nordisk

Inc; Research Support: Merck Sharp & Dohme Corp., Sanofi U.S.

Turk, Norman ......................................... Disclosed no confl ict of interest.Turkistani, Sarah Anwar ........................ Disclosed no confl ict of interest.Turksoy, Kamuran .................................. Disclosed no confl ict of interest.Turnbull, Philip ....................................... Employee: Receptos (Celgene).Turnbull, Randall ................................... Disclosed no confl ict of interest.Turner, Tod ............................................. Employee: Pfi zer Inc.Turnovcova, Karolina ............................. Disclosed no confl ict of interest.Tutino, Greg E. ...................................... Stock/Shareholder: Merck & Co., Inc.Tutkunkardas, Deniz .............................. Employee: Novo Nordisk A/S.Tuttle, Edward ....................................... Consultant: Intarcia Therapeutics, Inc.Twigg, Stephen M. ............................... Disclosed no confl ict of interest.Tyan, Nadezda V. .................................. Disclosed no confl ict of interest.Tyner, Tracy ............................................ Disclosed no confl ict of interest.Tyrberg, Björn ........................................ Employee: AstraZeneca.Tyrrell, Jessica ...................................... Disclosed no confl ict of interest.Tziomalos, Konstantinos ....................... Disclosed no confl ict of interest.Uccella, Silvia........................................ Disclosed no confl ict of interest.Uchida, Junko........................................ Disclosed no confl ict of interest.Uchida, Toyoyoshi ................................. Disclosed no confl ict of interest.Uchigata, Yasuko................................... Research Support: Astellas Pharma Inc., AstraZeneca,

Boehringer Ingelheim Pharmaceuticals, Inc., Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Novo Nordisk Inc.,

A763


AU

THO

R D

ISCL

OSU

RE

Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pfi zer Japan Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited, Terumo Corporation; Speaker’s Bureau: Eli Lilly Japan K.K., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Uchino, Hiroshi ...................................... Disclosed no confl ict of interest.Udahogora, Margaret............................ Disclosed no confl ict of interest.Udler, Miriam ........................................ Disclosed no confl ict of interest.Ueda, Nobuhisa..................................... Disclosed no confl ict of interest.Ueda, Noriko ......................................... Disclosed no confl ict of interest.Ueda, Teruhisa ...................................... Disclosed no confl ict of interest.Ueda, Youhei ......................................... Disclosed no confl ict of interest.Ueki, Kohjiro .......................................... Research Support: Boehringer Ingelheim Japan Inc., Merck

Sharp & Dohme Corp., Novo Nordisk Inc.Ueno, Kazuyuki ...................................... Disclosed no confl ict of interest.Ueno, Miki ............................................. Disclosed no confl ict of interest.Ueta, Kiichiro......................................... Employee: Mitsubishi Tanabe Pharma Corporation.Ueyama, Eiji .......................................... Employee: Astellas Pharma Inc.Ugi, Satoshi ........................................... Disclosed no confl ict of interest.Ugur-Altun, Betül .................................. Disclosed no confl ict of interest.Uhley, Virginia ....................................... Disclosed no confl ict of interest.Ukropcova, Barbara ............................... Disclosed no confl ict of interest.Ukropec, Jozef....................................... Disclosed no confl ict of interest.Ulloa, Johanna ...................................... Disclosed no confl ict of interest.Ullrich, Susanne .................................... Disclosed no confl ict of interest.Umapathy, Dhamodharan...................... Disclosed no confl ict of interest.Umapathysivam, Mahesh M. ............... Disclosed no confl ict of interest.Umekwu, Nkiru...................................... Disclosed no confl ict of interest.Umezu, Junko ........................................ Disclosed no confl ict of interest.Umpaichitra, Vatcharapan .................... Disclosed no confl ict of interest.Umpierrez, Guillermo E. ....................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S.; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.

Unger, Jeff ............................................. Advisory Panel: Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Novo Nordisk Inc; Other Relationship: Lippincott; Research Support: Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc., Proteus Digital Health, Sanofi U.S., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Teva Pharmaceutical Industries Ltd.; Stock/Shareholder: Novo Nordisk Inc.

Ungprasert, Patompong ........................ Disclosed no confl ict of interest.Unnikrishnan, Ranjit .............................. Disclosed no confl ict of interest.Unoki-Kubota, Hiroyuki ......................... Disclosed no confl ict of interest.Unterman, Terry G. ............................... Disclosed no confl ict of interest.Untermann, Anette................................ Disclosed no confl ict of interest.Uong, Cecilia ......................................... Disclosed no confl ict of interest.Upham, Lori ........................................... Stock/Shareholder: Cure DM Inc.Urakami, Tatsuhiko ................................ Advisory Panel: Novo Nordisk Inc., Sanofi K.K.; Speaker’s

Bureau: Novo Nordisk Inc., Sanofi K.K.Urano, Fumihiko .................................... Research Support: Amarantus BioScience Holdings, Inc.,

American Diabetes Association, Juvenile Diabetes Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases, Ono Pharmaceutical Co., Ltd.

Uranus, Fumi ......................................... Disclosed no confl ict of interest.Urasaki, Yoko......................................... Disclosed no confl ict of interest.Uratsu, Connie S. ................................. Disclosed no confl ict of interest.Uribe, Claudia........................................ Consultant: Novo Nordisk Inc.Urrutia, M. Agustina ............................. Disclosed no confl ict of interest.Usherwood, Tim .................................... Disclosed no confl ict of interest.Ushida, Yusuke ...................................... Disclosed no confl ict of interest.Ushigome, Emi ...................................... Disclosed no confl ict of interest.Usmani-Brown, Sahar ........................... Disclosed no confl ict of interest.Usuelli, Vera .......................................... Disclosed no confl ict of interest.Usui, Isao............................................... Disclosed no confl ict of interest.Usui, Shuki ............................................ Disclosed no confl ict of interest.Usui, Taro .............................................. Disclosed no confl ict of interest.Utsunomiya, Kazunori ........................... Disclosed no confl ict of interest.Utzschneider, Kristina M. ..................... Disclosed no confl ict of interest.Uusitupa, Matti ..................................... Disclosed no confl ict of interest.Uwaifo, Gabriel ..................................... Disclosed no confl ict of interest.Vaaben, Christoffer ............................... Disclosed no confl ict of interest.Vaag, Allan ............................................ Disclosed no confl ict of interest.Vaala, Sarah E. ..................................... Disclosed no confl ict of interest.Vacante, Fernanda ................................ Disclosed no confl ict of interest.Vadakekalam, Jacob ............................. Disclosed no confl ict of interest.Vaddady, Pavan ..................................... Employee: Merck & Co., Inc.Vaduganathan, Muthiah ....................... Disclosed no confl ict of interest.Vafai, Scott B. ...................................... Consultant: Metavention; Stock/Shareholder: Metavention.

Vaidehi, Nagarajan ............................... Disclosed no confl ict of interest.Vaitaitis, Gisela ..................................... Disclosed no confl ict of interest.Valabhji, Jonathan ................................ Disclosed no confl ict of interest.Valcarce, Carmen .................................. Employee: vTv Therapeutics LLC.Valdez, Ivan A. ...................................... Disclosed no confl ict of interest.Valencia, Willy Marcos ......................... Disclosed no confl ict of interest.Valensi, Paul .......................................... Advisory Panel: AstraZeneca, GlaxoSmithKline, Lilly

Deutschland GmbH, Merck Sharp & Dohme Corp., Novo Nordisk Inc., Sanofi -Aventis Deutschland GmbH; Board Member: Abbott, AstraZeneca, Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., GlaxoSmithKline, Merck & Co., Inc., Novo Nordisk Inc.

Valent, David J. .................................... Disclosed no confl ict of interest.Valentine, Joseph M. ........................... Disclosed no confl ict of interest.Valentini, Umberto ................................ Disclosed no confl ict of interest.Valera, Jose Manuel ............................. Disclosed no confl ict of interest.Valeri, Marta ......................................... Disclosed no confl ict of interest.Valero-Elizondo, Javier ......................... Disclosed no confl ict of interest.Valinotti, Elizabeth ................................ Disclosed no confl ict of interest.Valo, Erkka A. ....................................... Disclosed no confl ict of interest.Vambergue, Anne .................................. Disclosed no confl ict of interest.Van Brunt, Kate ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.van de Bunt, Martijn ............................. Disclosed no confl ict of interest.Van de Velde, Frederique ...................... Disclosed no confl ict of interest.Van der Ende, Miranda ......................... Disclosed no confl ict of interest.van der Meulen, Talitha ........................ Disclosed no confl ict of interest.Van der Schueren, Bart ......................... Disclosed no confl ict of interest.van der Valk, Fleur M. .......................... Disclosed no confl ict of interest.van Deursen, Jan .................................. Disclosed no confl ict of interest.Van Gaal, Luc ........................................ Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi ; Research Support: Hepadip + Resolve Consortium; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi .

van Herpt, Thijs T. ................................ Disclosed no confl ict of interest.van Hinsbergh, Victor ............................ Disclosed no confl ict of interest.Van Houten, Holly K. ............................ Disclosed no confl ict of interest.van Leeuwen, Michiel C. ...................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S.Van Name, Michelle ............................. Disclosed no confl ict of interest.Van Ness, Peter H. ............................... Disclosed no confl ict of interest.van Niel-Staakman, Judith ................... Disclosed no confl ict of interest.van Nierop, Samuel............................... Disclosed no confl ict of interest.Van Nieuwenhove, Yves ....................... Disclosed no confl ict of interest.Van Pelt, Rachael .................................. Disclosed no confl ict of interest.van Poelgeest, Erik M. ......................... Disclosed no confl ict of interest.van Raalte, Daniël H. ........................... Research Support: AstraZeneca.Van Simaeys, Dimitri ............................. Disclosed no confl ict of interest.van Steen, Sigrid C. .............................. Disclosed no confl ict of interest.van Tulder, Maurits W. ......................... Disclosed no confl ict of interest.van Witteloostuijn, Søren B. ................ Employee: Gubra; Stock/Shareholder: Novo Nordisk A/S.Van Wyk, Eugene .................................. Disclosed no confl ict of interest.van Zuydam, Natalie R. ........................ Disclosed no confl ict of interest.Vanderlinden, Lauren ............................ Disclosed no confl ict of interest.VanderWeele, Jennifer ......................... Disclosed no confl ict of interest.VanDeusen, Halena R. ......................... Disclosed no confl ict of interest.Vandommelen, Kyle .............................. Disclosed no confl ict of interest.Vangen, Bente ....................................... Employee: Boehringer Ingelheim GmbH.Vangoitsenhoven, Roman ..................... Disclosed no confl ict of interest.Vannasaeng, Sathit ............................... Disclosed no confl ict of interest.Vannest, Jennifer .................................. Disclosed no confl ict of interest.Vanucchi, Jesse .................................... Disclosed no confl ict of interest.Vardhman, Rakyan K. ........................... Disclosed no confl ict of interest.Vargas, Alfonso ..................................... Disclosed no confl ict of interest.Varghese, Ron T. ................................... Disclosed no confl ict of interest.Varming, Annemarie ............................. Employee: Steno Diabetes Center A/S.Varol, Nebibe ........................................ Employee: AstraZeneca.Varsavsky, Andrea ................................. Disclosed no confl ict of interest.Vasan, Soumini ..................................... Disclosed no confl ict of interest.Vasavada, Rupangi ................................ Disclosed no confl ict of interest.Vasconcelos, Carlos .............................. Disclosed no confl ict of interest.Vasconcelos, Izabella ............................ Disclosed no confl ict of interest.Vasconcelos, Livia Y. ............................ Disclosed no confl ict of interest.Vatner, Daniel F. ................................... Disclosed no confl ict of interest.

A764


AU

THO

R D

ISCL

OSU

RE

Vatner, Dorothy E. ................................. Disclosed no confl ict of interest.Vatner, Stephen F. ................................ Disclosed no confl ict of interest.Vauchelles, Romain ............................... Disclosed no confl ict of interest.Vaudel, Marc ......................................... Disclosed no confl ict of interest.Vaz, Frederic .......................................... Disclosed no confl ict of interest.Vazirani, Reema .................................... Disclosed no confl ict of interest.Vazquez Benitez, Gabriela ..................... Disclosed no confl ict of interest.Vázquez, Clotilde ................................... Disclosed no confl ict of interest.Vázquez, Luis A. ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Vedtofte, Louise .................................... Research Support: Novo Nordisk A/S.Veedfald, Simon .................................... Disclosed no confl ict of interest.Veettil, Sona .......................................... Disclosed no confl ict of interest.Veeze, Henk J. ...................................... Consultant: Medtronic, Inc.Vega, Rosa N. ....................................... Disclosed no confl ict of interest.Vehí, Josep ............................................ Disclosed no confl ict of interest.Vehik, Kendra ........................................ Disclosed no confl ict of interest.Veidal, Sanne S. ................................... Disclosed no confl ict of interest.Veijola, Riitta ......................................... Disclosed no confl ict of interest.Veit, Ralf ................................................ Disclosed no confl ict of interest.Velado, Kevin ........................................ Employee: Medtronic, Inc.Velasco-Gonzalez, Cruz ......................... Disclosed no confl ict of interest.Vélayoudom-Céphize, Fritz-Line ............ Disclosed no confl ict of interest.Veleba, Jiri ............................................ Disclosed no confl ict of interest.Veledar, Emir ......................................... Disclosed no confl ict of interest.Velez-Garza, Jorge ................................ Disclosed no confl ict of interest.Velho, Gilberto ...................................... Disclosed no confl ict of interest.Vella, Adrian .......................................... Disclosed no confl ict of interest.Vellanki, Priyathama ............................. Disclosed no confl ict of interest.Venditti, Elizabeth M. ........................... Board Member: Aastrom Biosciences, Inc.; Research Support:

National Institute of Diabetes and Digestive and Kidney Diseases.

Venditti, Mario ...................................... Disclosed no confl ict of interest.Vendrell, Joan ....................................... Disclosed no confl ict of interest.Venkataraman, Hema ............................ Disclosed no confl ict of interest.Venn, Karri ............................................. Disclosed no confl ict of interest.Ventrelle, Jennifer ................................ Disclosed no confl ict of interest.Vera, Diego ............................................ Disclosed no confl ict of interest.Vera, Nicholas ....................................... Disclosed no confl ict of interest.Veras, Katherine .................................... Disclosed no confl ict of interest.Verchere, Bruce ..................................... Disclosed no confl ict of interest.Vergani, Andrea .................................... Disclosed no confl ict of interest.Vergari, Elisa ......................................... Disclosed no confl ict of interest.Vergères, Guy ........................................ Disclosed no confl ict of interest.Vergidou, Paraskevi ............................... Disclosed no confl ict of interest.Vernillet, Laurent ................................... Employee: Boehringer Ingelheim GmbH.Vernon, Ashley ...................................... Disclosed no confl ict of interest.Verras, Chris .......................................... Disclosed no confl ict of interest.Verras, Christos ..................................... Disclosed no confl ict of interest.Versteeg, Ruth I. ................................... Disclosed no confl ict of interest.Vesco, Kimberly ..................................... Disclosed no confl ict of interest.Vestergaard, Henrik .............................. Disclosed no confl ict of interest.Vethakkan, Shireene R. ........................ Disclosed no confl ict of interest.Vethe, Heidrun ...................................... Disclosed no confl ict of interest.Veves, Aristidis ..................................... Disclosed no confl ict of interest.Viale, Edi ............................................... Disclosed no confl ict of interest.Viana, Ricardo ....................................... Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG.Vích, Daniel ........................................... Disclosed no confl ict of interest.Vickery, Ellen ......................................... Disclosed no confl ict of interest.Victor, Hendriena ................................... Disclosed no confl ict of interest.Vidal, Josep ........................................... Disclosed no confl ict of interest.Vidal-Trécan, Tiphaine ........................... Disclosed no confl ict of interest.Vidigal, Pedro ........................................ Disclosed no confl ict of interest.Vidrio Velazquez, Maricela.................... Disclosed no confl ict of interest.Vieira-de-Abreu, Adriana ...................... Disclosed no confl ict of interest.Vieira-Potter, Victoria J. ....................... Disclosed no confl ict of interest.Vienberg, Sara G. ................................. Employee: Novo Nordisk A/S.Viera De Abreu, Adriana ....................... Disclosed no confl ict of interest.Vierra, Nicholas C. ............................... Disclosed no confl ict of interest.Vigen, Cheryl ......................................... Disclosed no confl ict of interest.Vigersky, Robert .................................... Employee: Medtronic, Inc.; Research Support: Dexcom, Inc.Vignati, Laila ......................................... Disclosed no confl ict of interest.Vignolo, Paulina .................................... Research Support: Fractyl.Vigo, Liliana ........................................... Disclosed no confl ict of interest.Viguerie, Nathalie ................................. Disclosed no confl ict of interest.Vijapurkar, Ujjwala ................................ Employee: Janssen Research & Development, LLC.Vijayakumar, Archana ........................... Disclosed no confl ict of interest.Vijayakumar, Pavithra ............................ Disclosed no confl ict of interest.Vikulova, Olga ....................................... Advisory Panel: Sanofi U.S.; Research Support: AstraZeneca;

Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Sanofi U.S., Servier.

Vilallonga, Ramon ................................. Disclosed no confl ict of interest.Vileikyte, Loretta ................................... Disclosed no confl ict of interest.Villalba, Nidia ........................................ Disclosed no confl ict of interest.Villalba, Rosa ........................................ Disclosed no confl ict of interest.

Villarroya, Francesc ............................... Disclosed no confl ict of interest.Villega, Renata ...................................... Disclosed no confl ict of interest.Vilmann, Peter ....................................... Consultant: Mediglobe GmbH; Research Support: Arvid

Nilsons Foundation, Pentax.Vilsbøll, Tina .......................................... Advisory Panel: Amgen Inc., AstraZeneca, Boehringer

Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi K.K., Takeda Pharmaceutical Company Limited; Consultant: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi K.K., Takeda Pharmaceutical Company Limited; Research Support: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi K.K., Takeda Pharmaceutical Company Limited.

Vincent, Maya ....................................... Employee: Sanofi ; Stock/Shareholder: Sanofi .Vind, Birgitte F. ..................................... Disclosed no confl ict of interest.Vine, Sara .............................................. Disclosed no confl ict of interest.Vine, Seanna ......................................... Research Support: AstraZeneca.Vinik, Aaron ........................................... Board Member: Medscape; Consultant: Alnylam, Astellas

Pharma Inc., Hydra Biosciences, Isis Pharmaceuticals, Inc., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, NeuroMetrix, Inc., Pamlab, Inc., Pfi zer Inc.; Research Support: American Diabetes Association, Daiichi-Sankyo Co., Ltd., Impeto Medical, Intarcia Therapeutics, Inc., National Institutes of Health, Novo Nordisk Inc., Pfi zer Inc., Tercica, VeroScience, LLC, ViroMed Laboratories Inc.; Speaker’s Bureau: Merck & Co., Inc., Pamlab, Inc.

Vintila, Madalina ................................... Disclosed no confl ict of interest.Vintimilla, Raul ...................................... Disclosed no confl ict of interest.Viñuela, Ana .......................................... Disclosed no confl ict of interest.Viollet, Benoit ........................................ Disclosed no confl ict of interest.Vionnet, Nathalie .................................. Disclosed no confl ict of interest.Virani, Salim S. ..................................... Disclosed no confl ict of interest.Virdi, Naunihal ...................................... Employee: Proteus Digital Health.Virostko, John M. ................................. Disclosed no confl ict of interest.Virtanen, Jyrki ....................................... Disclosed no confl ict of interest.Virtanen, Kirsi A. .................................. Disclosed no confl ict of interest.Visalli, Natalia ....................................... Disclosed no confl ict of interest.Visaria, Jay ............................................ Employee: HealthCore.Viscoli, Catherine M. ............................ Disclosed no confl ict of interest.Vishnu, Abhishek ................................... Disclosed no confl ict of interest.Vishnudas, Vivek K. .............................. Employee: Berg Health; Stock/Shareholder: Berg Health.Visser, Gerard H. .................................. Disclosed no confl ict of interest.Vistisen, Dorte ....................................... Employee: Steno Diabetes Center A/S; Stock/Shareholder:

Novo Nordisk A/S.Viswanathan, Shankar .......................... Disclosed no confl ict of interest.Vitale, Marilena .................................... Disclosed no confl ict of interest.Vitek, Libor ............................................ Disclosed no confl ict of interest.Vitolins, Mara Z. ................................... Disclosed no confl ict of interest.Vittinghoff, Eric ..................................... Disclosed no confl ict of interest.Vivar Aguirre, Jorge .............................. Disclosed no confl ict of interest.Vlachopoulou, Efthymia ........................ Disclosed no confl ict of interest.Vlachová, Zuzana .................................. Disclosed no confl ict of interest.Vo, Michelle .......................................... Disclosed no confl ict of interest.Voiriot, Pascal ....................................... Consultant: Sanofi -Aventis Deutschland GmbH; Research

Support: Sanofi -Aventis Deutschland GmbH.Voirol, Marie-Jeanne ............................ Disclosed no confl ict of interest.Volkening, Lisa ...................................... Disclosed no confl ict of interest.Volkmann, Anna .................................... Consultant: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/

Partner); Research Support: Novo Nordisk A/S, Novo Nordisk A/S (Spouse/Partner).

von Ah, Ueli ........................................... Disclosed no confl ict of interest.Von Deylen, Alison C. ........................... Disclosed no confl ict of interest.von Eynatten, Maximillian .................... Employee: Boehringer Ingelheim GmbH.von Feilitzsch, Maximilian..................... Disclosed no confl ict of interest.Von Figura, Guido .................................. Disclosed no confl ict of interest.Von Herrath, Matthias G. ..................... Employee: Novo Nordisk Inc.von Loeffelholz, Christian...................... Disclosed no confl ict of interest.von Oettingen, Julia E. ......................... Disclosed no confl ict of interest.von Websky, Karoline ............................ Disclosed no confl ict of interest.Vonbank, Alexander .............................. Disclosed no confl ict of interest.Vonberg, Andrew .................................. Disclosed no confl ict of interest.Vongbunyong, Kenny ............................. Disclosed no confl ict of interest.Vora, Jiten P. ......................................... Advisory Panel: AstraZeneca, Eli Lilly and Company, Merck

Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited.

Vörös, Szilárd ........................................ Employee: Global Genomics Group, LLC; Stock/Shareholder: Global Genomics Group, LLC.

A765


AU

THO

R D

ISCL

OSU

RE

Voska, Ludek ......................................... Disclosed no confl ict of interest.Voss, Bernd ........................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Voutilainen, Sari .................................... Disclosed no confl ict of interest.Vrang, Niels ........................................... Employee: Gubra; Stock/Shareholder: Gubra.Vriesendorp, Titia M. ............................ Disclosed no confl ict of interest.Vu, Maihan ............................................ Disclosed no confl ict of interest.Vucic Lovrencic, Marijana ..................... Disclosed no confl ict of interest.Vue-Her, Houa ....................................... Disclosed no confl ict of interest.Wabitsch, Martin .................................. Disclosed no confl ict of interest.Wachal, Angela L. ................................ Disclosed no confl ict of interest.Wada, Asuka ......................................... Disclosed no confl ict of interest.Wada, Seiki ........................................... Disclosed no confl ict of interest.Wada, Youichiro .................................... Disclosed no confl ict of interest.Wadhwa, Navneet ................................ Disclosed no confl ict of interest.Wadhwani, Pallavi ................................ Disclosed no confl ict of interest.Wadien, Tanja ....................................... Disclosed no confl ict of interest.Wadwa, R. Paul ..................................... Consultant: Medtronic MiniMed, Inc.; Research Support:

Lexicon Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi U.S.

Wagenknecht, Lynne E. ........................ Disclosed no confl ict of interest.Wagh, Vilas ........................................... Disclosed no confl ict of interest.Wagner, Bridget .................................... Disclosed no confl ict of interest.Wagner, David H. ................................. Stock/Shareholder: Op-T-Mune, Inc.Wagner, Kelly A. .................................. Disclosed no confl ict of interest.Wagner, Michael J. .............................. Disclosed no confl ict of interest.Wagner, Robert ..................................... Disclosed no confl ict of interest.Wago, Takehiko ..................................... Disclosed no confl ict of interest.Waheed, Salman ................................... Disclosed no confl ict of interest.Waheed, Sehrish ................................... Disclosed no confl ict of interest.Waid, Dan ............................................. Disclosed no confl ict of interest.Wakabayashi, Ken-Ichi ......................... Disclosed no confl ict of interest.Wake, Kenjiro ........................................ Disclosed no confl ict of interest.Wakeman, Christian .............................. Disclosed no confl ict of interest.Waki, Hironori ....................................... Research Support: Merck Sharp & Dohme Corp., Novartis

Pharma K.K., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca, Kissei Pharmaceutical Co., Ltd.

Walczyk, Allison R. ............................... Disclosed no confl ict of interest.Waldeck, Barbara .................................. Employee: Boehringer Ingelheim GmbH.Waldman, Lindsey ................................. Disclosed no confl ict of interest.Walenta, Evelyn .................................... Disclosed no confl ict of interest.Walker, Ashby F. ................................... Disclosed no confl ict of interest.Walker, Chris ......................................... Disclosed no confl ict of interest.Walker, Jeremy ..................................... Disclosed no confl ict of interest.Walker, Susan ....................................... Employee: Federal Drug Administration.Walker, Tomas ....................................... Employee: Dexcom, Inc.; Stock/Shareholder: Dexcom, Inc.Wallace, Nathaniel ............................... Employee: Janssen Pharmaceuticals, Inc.Wallén, Håkan ....................................... Disclosed no confl ict of interest.Wallendorf, Michael ............................. Disclosed no confl ict of interest.Wallia, Amisha ...................................... Research Support: Johnson & Johnson, Merck Sharp &

Dohme Corp.Wallston, Kenneth A. ........................... Disclosed no confl ict of interest.Wallstrom, Garrick ................................ Disclosed no confl ict of interest.Walsh, Christi ........................................ Disclosed no confl ict of interest.Walter, Mary ......................................... Disclosed no confl ict of interest.Walter, Peter J. .................................... Disclosed no confl ict of interest.Walus-Miarka, Malgorzata ................... Disclosed no confl ict of interest.Wan Mohamud, Wan Nazaimoon ........ Disclosed no confl ict of interest.Wan, Gang ............................................ Disclosed no confl ict of interest.Wan, Jim ............................................... Disclosed no confl ict of interest.Wan, Lijuan ........................................... Disclosed no confl ict of interest.Wan, Xuesi ............................................ Disclosed no confl ict of interest.Wandall, Erik P. .................................... Disclosed no confl ict of interest.Wang, Anping ....................................... Disclosed no confl ict of interest.Wang, Bin Hui ....................................... Disclosed no confl ict of interest.Wang, Bing ............................................ Employee: Genzyme Corporation.Wang, Bingdi ......................................... Employee: Crown Bioscience, Inc.Wang, Chi Chiu ..................................... Disclosed no confl ict of interest.Wang, Chun ........................................... Disclosed no confl ict of interest.Wang, Congrong ................................... Disclosed no confl ict of interest.Wang, Dan ............................................ Disclosed no confl ict of interest.Wang, Gang .......................................... Disclosed no confl ict of interest.Wang, Guang ........................................ Disclosed no confl ict of interest.Wang, Hai-Lan ...................................... Disclosed no confl ict of interest.Wang, Heng .......................................... Disclosed no confl ict of interest.Wang, Hongjun ..................................... Disclosed no confl ict of interest.Wang, Hongwei .................................... Employee: Sanofi U.S.Wang, Hongyin ...................................... Disclosed no confl ict of interest.Wang, Hui ............................................. Employee: Crown Bioscience, Inc.Wang, Hye Jin ....................................... Disclosed no confl ict of interest.Wang, Jennifer P. ................................. Disclosed no confl ict of interest.Wang, Jie .............................................. Disclosed no confl ict of interest.Wang, Jing ............................................ Disclosed no confl ict of interest.Wang, Jingjing ...................................... Disclosed no confl ict of interest.Wang, Jinping ....................................... Disclosed no confl ict of interest.

Wang, Lan ............................................. Disclosed no confl ict of interest.Wang, Le ............................................... Disclosed no confl ict of interest.Wang, Leishen ...................................... Disclosed no confl ict of interest.Wang, Li ................................................ Disclosed no confl ict of interest.Wang, Liangchen .................................. Disclosed no confl ict of interest.Wang, Lili .............................................. Disclosed no confl ict of interest.Wang, Limin .......................................... Disclosed no confl ict of interest.Wang, Lin .............................................. Disclosed no confl ict of interest.Wang, Ling ............................................ Disclosed no confl ict of interest.Wang, Linhong ...................................... Disclosed no confl ict of interest.Wang, Manman .................................... Disclosed no confl ict of interest.Wang, Ming .......................................... Disclosed no confl ict of interest.Wang, Mingyue ..................................... Disclosed no confl ict of interest.Wang, Ningjian ..................................... Disclosed no confl ict of interest.Wang, Peili ............................................ Disclosed no confl ict of interest.Wang, Peng ........................................... Disclosed no confl ict of interest.Wang, Qi ............................................... Disclosed no confl ict of interest.Wang, Qian ........................................... Disclosed no confl ict of interest.Wang, Qing ........................................... Disclosed no confl ict of interest.Wang, Qunan ........................................ Disclosed no confl ict of interest.Wang, Ruifeng ...................................... Disclosed no confl ict of interest.Wang, Shari .......................................... Disclosed no confl ict of interest.Wang, Shudong ..................................... Disclosed no confl ict of interest.Wang, Simeng ....................................... Disclosed no confl ict of interest.Wang, Songyan ..................................... Disclosed no confl ict of interest.Wang, Tiange ........................................ Disclosed no confl ict of interest.Wang, Tiansheng .................................. Disclosed no confl ict of interest.Wang, Tingfeng ..................................... Disclosed no confl ict of interest.Wang, Tongtong .................................... Employee: Merck & Co., Inc.Wang, Weiqing ..................................... Disclosed no confl ict of interest.Wang, Xiaoli .......................................... Employee: Crown Bioscience, Inc.Wang, Xiaoming .................................... Disclosed no confl ict of interest.Wang, Xiaoqin ....................................... Disclosed no confl ict of interest.Wang, Xiaoqing ..................................... Disclosed no confl ict of interest.Wang, Xiaoyong .................................... Disclosed no confl ict of interest.Wang, Xingang ...................................... Disclosed no confl ict of interest.Wang, Xingchun .................................... Disclosed no confl ict of interest.Wang, Xuanchun ................................... Disclosed no confl ict of interest.Wang, Xuejiao ....................................... Disclosed no confl ict of interest.Wang, Xueyan ....................................... Employee: AntriaBio; Stock/Shareholder: AntriaBio.Wang, Xun ............................................. Disclosed no confl ict of interest.Wang, Yadi ............................................ Disclosed no confl ict of interest.Wang, Yajing ......................................... Disclosed no confl ict of interest.Wang, Yamin ......................................... Disclosed no confl ict of interest.Wang, Yaohui ........................................ Disclosed no confl ict of interest.Wang, Yi ................................................ Disclosed no confl ict of interest.Wang, Ying ............................................ Disclosed no confl ict of interest.Wang, Yixin (Jim) .................................. Employee: Crown Bioscience, Inc.Wang, Yu ............................................... Disclosed no confl ict of interest.Wang, Yuanping .................................... Employee: Janssen Pharmaceuticals, Inc.Wang, Yueqian ...................................... Disclosed no confl ict of interest.Wang, Yuexi .......................................... Consultant: STATinMED Research.Wang, Yufan .......................................... Disclosed no confl ict of interest.Wang, Zhenyuan ................................... Employee: Quest Diagnostics.Wanitcharoenkul, Ekasitt ...................... Disclosed no confl ict of interest.Wanner, Christoph ................................ Advisory Panel: Amgen Inc., Boehringer Ingelheim GmbH,

Sanofi -Aventis Deutschland GmbH; Consultant: Boehringer Ingelheim GmbH, GlaxoSmithKline; Research Support: Genzyme Corporation.

Ward, Alison ......................................... Research Support: AstraZeneca.Ward, Glenn .......................................... Research Support: Medtronic, Inc.Ward, W.K. ........................................... Board Member: Pacifi c Diabetes Technologies, Inc.; Employee:

Pacifi c Diabetes Technologies, Inc.; Stock/Shareholder: Pacifi c Diabetes Technologies, Inc.

Wardian, Jana L. .................................. Disclosed no confl ict of interest.Wareham, Nicholas .............................. Disclosed no confl ict of interest.Warfel, Jaycob D. ................................ Disclosed no confl ict of interest.Warner, Justin T. .................................. Disclosed no confl ict of interest.Warnock, Alicia ..................................... Research Support: Dexcom, Inc.Warren, Bethany ................................... Disclosed no confl ict of interest.Warren, Daniel ...................................... Disclosed no confl ict of interest.Warren, Jonathan L. ............................ Disclosed no confl ict of interest.Warren, Michael ................................... Disclosed no confl ict of interest.Warren, Robert V. ................................. Disclosed no confl ict of interest.Wartha, Julia ........................................ Disclosed no confl ict of interest.Wasiak, Sylwia ..................................... Employee: Resverlogix Corp.; Stock/Shareholder: Resverlogix

Corp.Wasserfall, Clive ................................... Disclosed no confl ict of interest.Wasserman, David H. .......................... Disclosed no confl ict of interest.Wasserman, Rachel M. ........................ Disclosed no confl ict of interest.Watada, Hirotaka .................................. Other Relationship: Merck & Co., Inc., Takeda Pharmaceutical

Company Limited; Research Support: Astellas Pharma Inc., AstraZeneca, Benefi t One Healthcare K.K., Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly Japan K.K., Kyowa Hakko Kirin Co., Ltd., Merck

A766


AU

THO

R D

ISCL

OSU

RE

& Co., Inc., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nittoubouseki K.K., Novartis Pharma K.K., Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Pfi zer Japan Inc., Sanofi K.K., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Terumo Corporation; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Dainippon Sumitomo Pharma Co., Ltd., Kowa Company, Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharma K.K., Novo Nordisk Inc., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Watanabe, Kenichi ................................ Disclosed no confl ict of interest.Watanabe, Kentaro ............................... Disclosed no confl ict of interest.Watanabe, Nobuyuki ............................ Disclosed no confl ict of interest.Watanabe, Rena ................................... Disclosed no confl ict of interest.Watanabe, Richard M. ......................... Disclosed no confl ict of interest.Watanabe, Ryusuke .............................. Disclosed no confl ict of interest.Watanabe, Takayuki .............................. Disclosed no confl ict of interest.Watanabe, Takehito .............................. Disclosed no confl ict of interest.Watanabe, Takuya ................................ Disclosed no confl ict of interest.Watanabe, Yasuhiro .............................. Disclosed no confl ict of interest.Waters, Alexa ....................................... Disclosed no confl ict of interest.Watkins, Elaine ..................................... Employee: Profi l Institute for Clinical Research, Inc.; Other

Relationship: AstraZeneca.Watkins, Renecia .................................. Disclosed no confl ict of interest.Watson, Nina ........................................ Disclosed no confl ict of interest.Watson, Sara ........................................ Disclosed no confl ict of interest.Watson, Shoan ...................................... Disclosed no confl ict of interest.Watters, Scott ....................................... Employee: VeroScience, LLC.Waugh, Kathleen C. ............................. Disclosed no confl ict of interest.Weatherall, James ................................ Employee: Novo Nordisk Inc; Stock/Shareholder: Novo

Nordisk Inc.Weaver, Mark ........................................ Disclosed no confl ict of interest.Webb, Joseph L. .................................. Disclosed no confl ict of interest.Webb-Robertson, Bobbie-Jo ................. Disclosed no confl ict of interest.Weber, Katharina S. ............................. Disclosed no confl ict of interest.Weber-Born, Sonja A. .......................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Webster, Carl ........................................ Disclosed no confl ict of interest.Webster-Bogaert, Susan ....................... Other Relationship: Sanofi .Weedon, Michael .................................. Speaker’s Bureau: Ipsen Bioscience, Inc.Weerarathna, Thilak Priyantha ............. Disclosed no confl ict of interest.Weets, Ilse ............................................ Disclosed no confl ict of interest.Wefers, Jakob ....................................... Disclosed no confl ict of interest.Wei, Cheryl ............................................ Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Wei, Ling ............................................... Disclosed no confl ict of interest.Wei, Maggie ......................................... Disclosed no confl ict of interest.Wei, Wenhui ......................................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi U.S.Weibmann, Jörg .................................... Employee: Roche Diagnostics.Weidling, John ...................................... Disclosed no confl ict of interest.Weigert, Cora ........................................ Disclosed no confl ict of interest.Weil, E. Jennifer ................................... Disclosed no confl ict of interest.Weill, Alain ........................................... Disclosed no confl ict of interest.Weinert, Stefan ..................................... Employee: Roche Diabetes Care Inc.Weinglass, Adam .................................. Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Weinstock, Ruth S. ............................... Research Support: Calibra Medical Inc., Intarcia Therapeutics,

Inc., Joslin Diabetes Center, Juvenile Diabetes Research Foundation, Leona M. and Harry B. Helmsley Charitable Trust, Medtronic, Inc., Mylan, National Institute of Diabetes and Digestive and Kidney Diseases, Novo Nordisk Inc., Sanofi U.S.

Weinzimer, Stuart ................................. Research Support: Medtronic, Inc.Weir, Gordon C. .................................... Advisory Panel: Semma Therpeutics.Weir, Natalie L. .................................... Disclosed no confl ict of interest.Weisman, Alanna .................................. Disclosed no confl ict of interest.Weisnagel, S. John ............................... Disclosed no confl ict of interest.Weiss, Jürgen ....................................... Disclosed no confl ict of interest.Weiss, Michael A. ................................ Disclosed no confl ict of interest.Weissberg-Benchell, Jill ....................... Speaker’s Bureau: Roche Diagnostics.Weitgasser, Raimund ............................ Advisory Panel: Amgen Inc., AstraZeneca, Boehringer

Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi -Aventis Deutschland GmbH, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Allergan, Inc., AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Medtronic MiniMed, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S, Roche Pharmaceuticals, Schülke, Takeda Pharmaceutical Company Limited.

Weitlauf, Julie C. ................................. Disclosed no confl ict of interest.Weldon, Steven M. .............................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc.Wellenius, Gregory A. .......................... Disclosed no confl ict of interest.Wells, Andrew D. ................................. Disclosed no confl ict of interest.Wells, Brian J. ...................................... Research Support: Merck & Co., Inc., Novo Nordisk Inc.Welly, Rebecca J. ................................. Disclosed no confl ict of interest.

Welscher, Alecia ................................... Disclosed no confl ict of interest.Welsh, John B. ..................................... Employee: Medtronic MiniMed, Inc.Welsh, Nicholas .................................... Disclosed no confl ict of interest.Wen, Chunmiao ..................................... Disclosed no confl ict of interest.Wen, Gebo ............................................ Disclosed no confl ict of interest.Wen, Qing ............................................. Disclosed no confl ict of interest.Wendt, Sabrina L. ................................ Employee: Zealand Pharma A/S.Weng, Jianping ..................................... Disclosed no confl ict of interest.Wens, Johan ......................................... Advisory Panel: AstraZeneca, Bristol-Myers Squibb, Eli Lilly

and Company, Novo Nordisk.Wentworth, John M. ............................ Disclosed no confl ict of interest.Werner, Ulrich ....................................... Employee: Sanofi -Aventis Deutschland GmbH.Wernstedt Asterholm, Ingrid ................ Disclosed no confl ict of interest.Wessel, Jennifer ................................... Disclosed no confl ict of interest.Westacott, Matthew ............................. Disclosed no confl ict of interest.Westerhout, Cynthia M. ....................... Disclosed no confl ict of interest.Westfall, Emily ...................................... Disclosed no confl ict of interest.Westphal, Sören ................................... Disclosed no confl ict of interest.Wetzel, Amy .......................................... Disclosed no confl ict of interest.Wewalka, Marlene ............................... Disclosed no confl ict of interest.Wewer Albrectsen, Nicolai J. .............. Disclosed no confl ict of interest.Whaley, Jean ........................................ Employee: Janssen Pharmaceuticals, Inc.Whaley-Connell, Adam ......................... Disclosed no confl ict of interest.Whang Kong, Hyerim ............................ Disclosed no confl ict of interest.Wharam, James Frank .......................... Disclosed no confl ict of interest.Wheeler, Eleanor ................................... Disclosed no confl ict of interest.Wheeler, Michael B. ............................ Disclosed no confl ict of interest.Wheeler, Sarah ..................................... Disclosed no confl ict of interest.Wheelock, Kevin ................................... Disclosed no confl ict of interest.Whelan, Mary ....................................... Disclosed no confl ict of interest.Whelan, Sheila...................................... Disclosed no confl ict of interest.White, Brad ........................................... Disclosed no confl ict of interest.White, Morris F. .................................... Disclosed no confl ict of interest.White, Neil H. ...................................... Disclosed no confl ict of interest.White, Peter .......................................... Disclosed no confl ict of interest.White, Sean .......................................... Disclosed no confl ict of interest.White, William B. ................................. Other Relationship: Takeda Development Center Americas,

Inc.Whitener, Robert L. .............................. Stock/Shareholder: MacroGenics, Inc.Whitham, Dana ..................................... Disclosed no confl ict of interest.Whitson, Amy........................................ Employee: Intarcia Therapeutics, Inc.Whittaker, Jonathan ............................. Disclosed no confl ict of interest.Whittemore, Robin ................................ Disclosed no confl ict of interest.Whyte, Martin ....................................... Disclosed no confl ict of interest.Wiber, Stuart C. .................................... Disclosed no confl ict of interest.Wice, Burton M. ................................... Disclosed no confl ict of interest.Wichmann, Carmen............................... Disclosed no confl ict of interest.Wicklow, Brandy ................................... Disclosed no confl ict of interest.Wickramanayake, Anneka .................... Disclosed no confl ict of interest.Wilding, John P. ................................... Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Bristol-Myers Squibb, Janssen Pharmaceuticals, Inc., Merck Sharp & Dohme Corp., Novo Nordisk A/S, Sanofi ; Consultant: Pfi zer Inc.; Research Support: AstraZeneca, Bristol-Myers Squibb, Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Janssen Pharmaceuticals, Inc., Lilly, Novo Nordisk A/S.

Wiles, Micheal ...................................... Disclosed no confl ict of interest.Wiles, Timothy A. ................................. Disclosed no confl ict of interest.Wilhelm, Joshua ................................... Disclosed no confl ict of interest.Wilinska, Malgorzata E. ....................... Consultant: Becton, Dickinson and Company.Wilkins, Nick ......................................... Research Support: Merck Sharp & Dohme Corp.Wilkinson, Iain ...................................... Disclosed no confl ict of interest.Will, Sarah ............................................ Employee: MedImmune, LLC.; Stock/Shareholder:

AstraZeneca.Willaing, Ingrid...................................... Employee: Novo Nordisk A/S, Steno Diabetes Center A/S.Willard, Joshua R. ................................ Disclosed no confl ict of interest.Willett, Michael .................................... Disclosed no confl ict of interest.Willett, Walter ...................................... Disclosed no confl ict of interest.Willette, Auriel A. ................................ Research Support: AG047282, National Institutes of Health.Willi, Steven M. ................................... Disclosed no confl ict of interest.Williams, Ashley S. .............................. Disclosed no confl ict of interest.Williams, Dafydd................................... Employee: Pharmatelligence.Williams, Jean ...................................... Employee: Merck & Co., Inc.Williams, Jennifer L. ............................ Disclosed no confl ict of interest.Williams, Joel E. .................................. Disclosed no confl ict of interest.Williams, Jonathan M. ........................ Disclosed no confl ict of interest.Williams, Kevin Jon .............................. Stock/Shareholder: Hygieia.Williams, Laura K. ................................ Disclosed no confl ict of interest.Williams, Mark E. ................................. Advisory Panel: Bayer HealthCare.Williams, Paul F. ................................... Disclosed no confl ict of interest.Williams, Phillip .................................... Disclosed no confl ict of interest.Williams, Sandi ..................................... Other Relationship: Medtronic, Inc.; Speaker’s Bureau: Abbott.Williams, Scott...................................... Disclosed no confl ict of interest.Williamson, Donald A. ......................... Disclosed no confl ict of interest.Willis, Michael ...................................... Employee: The Swedish Institute for Health Economics.

A767


AU

THO

R D

ISCL

OSU

RE

Willmann, Katrin ................................... Disclosed no confl ict of interest.Willmes, Diana M. ............................... Disclosed no confl ict of interest.Wilson, Craig......................................... Employee: Takeda Development Center Americas, Inc.Wilson, Darrell M. ................................ Disclosed no confl ict of interest.Wilson, Glenn........................................ Disclosed no confl ict of interest.Wilson, Gregory A. ............................... Disclosed no confl ict of interest.Wilson, James ...................................... Disclosed no confl ict of interest.Wilson, Julie ......................................... Employee: Receptos.Wilson, Timothy H. ............................... Employee: GlaxoSmithKline, PAREXEL International Corp.;

Stock/Shareholder: GlaxoSmithKline.Windham, B. Gwen ............................... Disclosed no confl ict of interest.Windham, Samuel T. ............................ Disclosed no confl ict of interest.Windsor, John ....................................... Disclosed no confl ict of interest.Winkelmayer, Wolfgang C. .................. Disclosed no confl ict of interest.Winnay, Jonathon N. ........................... Disclosed no confl ict of interest.Winnick, Jason J. ................................. Disclosed no confl ict of interest.Winocour, Peter ..................................... Disclosed no confl ict of interest.Winter, William E. ................................ Disclosed no confl ict of interest.Wintergerst, Kupper.............................. Advisory Panel: Tandem Diabetes Care, Inc.Winterstein, Jeff ................................... Advisory Panel: Abbott, AstraZeneca, Boehringer Ingelheim

GmbH, Eli Lilly Canada Inc., Janssen Pharmaceuticals, Inc., Sanofi -Aventis Deutschland GmbH, Valeant Pharmaceuticals; Research Support: AstraZeneca, Eli Lilly and Company, Janssen Pharmaceuticals, Inc.; Speaker’s Bureau: Abbott, AstraZeneca, BD Medical-Diabetes Care, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Sanofi -Aventis Deutschland GmbH.

Winthrop, Kevin .................................... Disclosed no confl ict of interest.Wirth, Michael ...................................... Disclosed no confl ict of interest.Wirtz, Veronika J. ................................. Disclosed no confl ict of interest.Wise, Brittany ....................................... Disclosed no confl ict of interest.Wise, Robert ......................................... Consultant: MannKind Corporation, Sanofi U.S.Wise, Ryan J. ....................................... Disclosed no confl ict of interest.Wisherd, Chris....................................... Employee: ALPCO.Wismann, Pernille ................................. Employee: Gubra ApS.Wisniewski, Scott N. ........................... Disclosed no confl ict of interest.Wisnu, Wismandari .............................. Other Relationship: Novo Nordisk A/S.Witek, Przemyslaw................................ Disclosed no confl ict of interest.Witkin, Linda ......................................... Disclosed no confl ict of interest.Witkowski, Piotr .................................... Disclosed no confl ict of interest.Witsch, Michael .................................... Disclosed no confl ict of interest.Witt, Edward A. .................................... Consultant: Merck Sharp & Dohme Corp.Witte, Daniel ......................................... Research Support: Danish Diabetes Academy; Stock/

Shareholder: Novo Nordisk A/S.Wittmann, April H. ............................... Disclosed no confl ict of interest.Wladyslaw, Sulowicz ............................ Disclosed no confl ict of interest.Wod, Mette ........................................... Disclosed no confl ict of interest.Woerle, Hans J. ................................... Employee: Boehringer Ingelheim GmbH.Woerner, Stephanie E. ......................... Disclosed no confl ict of interest.Wohlfart, Paulus ................................... Employee: Sanofi -Aventis Deutschland GmbH.Wohlstadter, Jacob N. ......................... Disclosed no confl ict of interest.Wojciechowski, Barbara ....................... Disclosed no confl ict of interest.Wójcik, Jakub........................................ Disclosed no confl ict of interest.Wojeciechowski, Piotr .......................... Disclosed no confl ict of interest.Wojtaszewski, Jørgen Frank Pind ......... Disclosed no confl ict of interest.Wolanin, Oktawia ................................. Disclosed no confl ict of interest.Wolf Greenstein, Abigail ...................... Disclosed no confl ict of interest.Wolff, Antonio ....................................... Disclosed no confl ict of interest.Wolff, Michael ...................................... Employee: Boehringer Ingelheim GmbH.Wolff, Rosa ........................................... Disclosed no confl ict of interest.Wölfl er, Albert ....................................... Disclosed no confl ict of interest.Wolkow, Pawel ..................................... Disclosed no confl ict of interest.Wollam, Joshua .................................... Disclosed no confl ict of interest.Wolpert, Howard A. ............................. Advisory Panel: Abbott Diabetes Care Inc., Glooko, Insulet

Corporation; Consultant: Dexcom, Inc.; Research Support: Abbott Diabetes Care Inc., Dexcom, Inc.

Wolpin, Brian ........................................ Disclosed no confl ict of interest.Wolsk, Emil ........................................... Disclosed no confl ict of interest.Wolski, Kathy ........................................ Disclosed no confl ict of interest.Wondisford, Fredric E. .......................... Disclosed no confl ict of interest.Wondrak, Georg T. ................................ Disclosed no confl ict of interest.Wong, Evelyn ........................................ Disclosed no confl ict of interest.Wong, Jencia ........................................ Research Support: Merck Sharp & Dohme Corp., Novo Nordisk

A/S; Speaker’s Bureau: AstraZeneca, Merck Sharp & Dohme Corp., Novo Nordisk A/S.

Wong, Jennifer L. ................................. Disclosed no confl ict of interest.Wong, Michael ...................................... Disclosed no confl ict of interest.Wong, Nathan D. ................................. Disclosed no confl ict of interest.Wong, Nathan K. .................................. Disclosed no confl ict of interest.Wong, Norman C. ................................. Employee: Resverlogix Corp.; Research Support: Resverlogix

Corp.; Stock/Shareholder: Resverlogix Corp.Wong, Pak Kin ....................................... Disclosed no confl ict of interest.Wong, Tien Y. ....................................... Disclosed no confl ict of interest.Woo, Connie Wai .................................. Disclosed no confl ict of interest.Woo, Dong Ho ....................................... Disclosed no confl ict of interest.

Woo, Jeong Taek .................................. Disclosed no confl ict of interest.Woo, Jungtaek ...................................... Disclosed no confl ict of interest.Woo, Vincent C. ................................... Advisory Panel: Lilly, Novo Nordisk A/S, Sanofi U.S.; Speaker’s

Bureau: Lilly, Novo Nordisk A/S, Sanofi K.K.Woo, Yu-Cho ......................................... Disclosed no confl ict of interest.Wood, Andrew ...................................... Disclosed no confl ict of interest.Wood, Colleen L. .................................. Disclosed no confl ict of interest.Wood, Jamie R. .................................... Disclosed no confl ict of interest.Wood, Richard S. ................................. Disclosed no confl ict of interest.Wood, Ruth ........................................... Disclosed no confl ict of interest.Woodford, Makenzie L. ........................ Disclosed no confl ict of interest.Woodley, Wendy D. ............................. Employee: BD Technologies; Stock/Shareholder: Becton,

Dickinson and Company.Woodman, Anthony .............................. Disclosed no confl ict of interest.Woods, Nancy F. ................................... Disclosed no confl ict of interest.Woodward, Brad ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Woodwyk, Alyssa .................................. Disclosed no confl ict of interest.Woolcott, Orison O. .............................. Disclosed no confl ict of interest.Woolf, Brittany ...................................... Disclosed no confl ict of interest.Woontner, Michael ............................... Disclosed no confl ict of interest.Worm, Jesper ........................................ Employee: Novo Nordisk A/S.Worme, Amanda M. ............................. Disclosed no confl ict of interest.Worthington, Anne ................................ Disclosed no confl ict of interest.Woskova, Veronika................................ Disclosed no confl ict of interest.Wotherspoon, Amy C. .......................... Disclosed no confl ict of interest.Wright, Christopher V. .......................... Disclosed no confl ict of interest.Wright, Davene ..................................... Disclosed no confl ict of interest.Wright, Eugene E. ................................ Advisory Panel: Abbott Diabetes Care Inc., Amgen Inc.,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Voluntis; Research Support: Abbott Diabetes Care Inc.; Speaker’s Bureau: Abbott Diabetes Care Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company.

Wright, Fiona J. .................................... Disclosed no confl ict of interest.Wright, Valerie ...................................... Disclosed no confl ict of interest.Wroblewski, Kristen.............................. Disclosed no confl ict of interest.Wronkowitz, Nina ................................. Disclosed no confl ict of interest.Wu, Chao ............................................... Disclosed no confl ict of interest.Wu, Chen Guang ................................... Disclosed no confl ict of interest.Wu, Donghai ......................................... Disclosed no confl ict of interest.Wu, Eric ................................................. Employee: Analysis Group, Inc.Wu, Haidi .............................................. Disclosed no confl ict of interest.Wu, Hao ................................................ Disclosed no confl ict of interest.Wu, Hong .............................................. Disclosed no confl ict of interest.Wu, Hongju ........................................... Disclosed no confl ict of interest.Wu, I-Hsien ........................................... Disclosed no confl ict of interest.Wu, Jun ................................................. Disclosed no confl ict of interest.Wu, Licheng .......................................... Disclosed no confl ict of interest.Wu, Li-Chiu ............................................ Disclosed no confl ict of interest.Wu, Lin .................................................. Disclosed no confl ict of interest.Wu, Meifen ........................................... Disclosed no confl ict of interest.Wu, Ming-Ju ......................................... Disclosed no confl ict of interest.Wu, Qi ................................................... Disclosed no confl ict of interest.Wu, Qiang ............................................. Disclosed no confl ict of interest.Wu, Shijuan ........................................... Employee: ConjuChem, LLC.Wu, Ted ................................................. Research Support: Merck Sharp & Dohme Corp.Wu, Wei-Dang ...................................... Research Support: Oramed Pharmaceuticals.Wu, Wen-Chih ....................................... Disclosed no confl ict of interest.Wu, Wenjun .......................................... Disclosed no confl ict of interest.Wu, Wudelehu ...................................... Disclosed no confl ict of interest.Wu, Xiaoyin ........................................... Disclosed no confl ict of interest.Wu, Yanling ........................................... Disclosed no confl ict of interest.Wu, Yixi ................................................. Disclosed no confl ict of interest.Wu, Yuan ............................................... Disclosed no confl ict of interest.Wu, Yujun .............................................. Employee: Sanofi -Aventis U.S.Wukich, Dane K. ................................... Disclosed no confl ict of interest.Wulff Kampmann, Bengta ..................... Disclosed no confl ict of interest.Wunderlich, Frank Thomas ................... Disclosed no confl ict of interest.Wurtz, Elisabeth .................................... Disclosed no confl ict of interest.Wyckoff, Jennifer.................................. Disclosed no confl ict of interest.Wyne, Kathleen..................................... Disclosed no confl ict of interest.Wysham, Carol H. ................................ Advisory Panel: AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Dance Biopharm, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Sanofi U.S.; Consultant: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Sanofi U.S.; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Intarcia Therapeutics, Inc., Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk Inc., Sanofi U.S.

Wysocka-Mincewicz, Marta ................. Disclosed no confl ict of interest.Wystrychowski, Antoni ......................... Other Relationship: Roche Pharmaceuticals.

A768


AU

THO

R D

ISCL

OSU

RE

Wystrychowski, Grzegorz ...................... Other Relationship: Abbott, Roche Pharmaceuticals.Wystrychowski, Wojciech ..................... Disclosed no confl ict of interest.Xhaard, Ilham ........................................ Disclosed no confl ict of interest.Xia, Qianghua ........................................ Disclosed no confl ict of interest.Xia, Yu ................................................... Disclosed no confl ict of interest.Xiang, Anny H. ...................................... Disclosed no confl ict of interest.Xiao, Changting ..................................... Disclosed no confl ict of interest.Xiao, Hui ................................................ Disclosed no confl ict of interest.Xiao, Jianzhong ..................................... Disclosed no confl ict of interest.Xiao, Xiaoqiu ......................................... Disclosed no confl ict of interest.Xiao, Xinhua .......................................... Disclosed no confl ict of interest.Xiao, Yong Fu......................................... Employee: Crown Bioscience, Inc.Xie, Jia .................................................. Disclosed no confl ict of interest.Xie, Lin................................................... Consultant: STATinMED Research.Xie, Ting................................................. Disclosed no confl ict of interest.Xie, Xinni ............................................... Disclosed no confl ict of interest.Xie, Yan Yan .......................................... Disclosed no confl ict of interest.Xin, Xiaoban .......................................... Disclosed no confl ict of interest.Xin, Xiaohui ........................................... Disclosed no confl ict of interest.Xing, Junhui .......................................... Disclosed no confl ict of interest.Xiong, Keming ....................................... Disclosed no confl ict of interest.Xiong, Qin .............................................. Disclosed no confl ict of interest.Xiong, Shanshan ................................... Disclosed no confl ict of interest.Xiong, Yan ............................................. Disclosed no confl ict of interest.Xiong, Yi ................................................ Disclosed no confl ict of interest.Xu, Ai Min ............................................. Disclosed no confl ict of interest.Xu, Baihui .............................................. Disclosed no confl ict of interest.Xu, Beibei .............................................. Disclosed no confl ict of interest.Xu, Canxin ............................................. Disclosed no confl ict of interest.Xu, Cheng .............................................. Disclosed no confl ict of interest.Xu, Elaine .............................................. Disclosed no confl ict of interest.Xu, Fei.................................................... Disclosed no confl ict of interest.Xu, Fen................................................... Disclosed no confl ict of interest.Xu, Fengmei........................................... Disclosed no confl ict of interest.Xu, Guanlan ........................................... Disclosed no confl ict of interest.Xu, Guowang ......................................... Disclosed no confl ict of interest.Xu, Guozhang ........................................ Employee: Janssen Pharmaceuticals, Inc.Xu, Haixia .............................................. Disclosed no confl ict of interest.Xu, Hongliang ........................................ Disclosed no confl ict of interest.Xu, Hufeng............................................. Disclosed no confl ict of interest.Xu, Jian ................................................. Disclosed no confl ict of interest.Xu, Jiaren .............................................. Disclosed no confl ict of interest.Xu, John ................................................ Employee: AstraZeneca; Stock/Shareholder: AstraZeneca.Xu, June ................................................ Employee: Janssen Pharmaceuticals, Inc.Xu, Lei.................................................... Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Xu, Liang................................................ Disclosed no confl ict of interest.Xu, Lu..................................................... Disclosed no confl ict of interest.Xu, Michael M. ..................................... Disclosed no confl ict of interest.Xu, Min .................................................. Disclosed no confl ict of interest.Xu, Mingjiang ........................................ Disclosed no confl ict of interest.Xu, Mingxin ........................................... Disclosed no confl ict of interest.Xu, Ping ................................................. Disclosed no confl ict of interest.Xu, Shaoyong ........................................ Disclosed no confl ict of interest.Xu, Weiwei ............................................ Disclosed no confl ict of interest.Xu, Wen ................................................. Disclosed no confl ict of interest.Xu, Wencan ........................................... Disclosed no confl ict of interest.Xu, X. Jian ............................................. Disclosed no confl ict of interest.Xu, Yang ................................................ Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.Xu, Yihua ............................................... Disclosed no confl ict of interest.Xu, Yiting ............................................... Disclosed no confl ict of interest.Xu, Yong ................................................ Disclosed no confl ict of interest.Xu, Yongjiang ........................................ Disclosed no confl ict of interest.Xu, Yu .................................................... Disclosed no confl ict of interest.Xu, Yuan ................................................ Disclosed no confl ict of interest.Xu, Zheng .............................................. Disclosed no confl ict of interest.Xu, Zhonggao ........................................ Disclosed no confl ict of interest.Xu, Ziqian .............................................. Disclosed no confl ict of interest.Xue, Bing ............................................... Disclosed no confl ict of interest.Xue, Bingzhong...................................... Disclosed no confl ict of interest.Xue, Ruidan ........................................... Disclosed no confl ict of interest.Xuejie, Dong .......................................... Disclosed no confl ict of interest.Yabe, Daisuke........................................ Research Support: Eli Lilly and Company, Merck Sharp &

Dohme Corp., Nippon Boehringer Ingelheim, Taisho Toyama Pharmaceutical Co., Ltd.; Speaker’s Bureau: Eli Lilly Japan K.K., Merck Sharp & Dohme Corp., Nippon Boehringer Ingelheim, Novo Nordisk Pharma Ltd., Sanofi K.K., Taisho Toyama Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited.

Yadagiri, Mahender............................... Disclosed no confl ict of interest.Yaghootkar, Hanieh ............................... Disclosed no confl ict of interest.Yagi, Kazumasa ..................................... Disclosed no confl ict of interest.Yagi, Takashi ......................................... Disclosed no confl ict of interest.Yagi, Tomoko ......................................... Disclosed no confl ict of interest.Yagihashi, Soroku.................................. Disclosed no confl ict of interest.

Yaksh, Dipti ........................................... Disclosed no confl ict of interest.Yakusigami, Eri ...................................... Disclosed no confl ict of interest.Yalamanchi, Swaytha............................ Disclosed no confl ict of interest.Yale, Jean-François ............................... Advisory Panel: Abbott, AstraZeneca, Boehringer Ingelheim,

Eli Lilly and Company, Janssen, Medtronic, Merck, Novo Nordisk, Sanofi , Takeda; Research Support: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Medtronic, Merck, Sanofi ; Speaker’s Bureau: Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Medtronic, Merck, Novo Nordisk, Sanofi , Takeda.

Yamada, Kazunori.................................. Employee: Mitsubishi Tanabe Pharma Corporation.Yamada, Kentaro ................................... Disclosed no confl ict of interest.Yamada, Kouji ....................................... Disclosed no confl ict of interest.Yamada, Nobuhiro................................. Disclosed no confl ict of interest.Yamada, Satoru ..................................... Disclosed no confl ict of interest.Yamada, Tomohide ................................ Disclosed no confl ict of interest.Yamada, Yuichiro ................................... Disclosed no confl ict of interest.Yamaguchi, Iyo ...................................... Disclosed no confl ict of interest.Yamaguchi, Riku .................................... Disclosed no confl ict of interest.Yamaguchi, Shinobu.............................. Disclosed no confl ict of interest.Yamaguchi, Susumu .............................. Employee: Astellas Pharma Inc.Yamaguchi, Takashi ............................... Disclosed no confl ict of interest.Yamamoto, Hirotaka.............................. Disclosed no confl ict of interest.Yamamoto, Naomune............................ Disclosed no confl ict of interest.Yamamoto, Rain .................................... Disclosed no confl ict of interest.Yamamoto, Saki .................................... Disclosed no confl ict of interest.Yamamoto, Shin .................................... Disclosed no confl ict of interest.Yamamoto, Takeshi ............................... Disclosed no confl ict of interest.Yamamoto, Takuya ................................ Disclosed no confl ict of interest.Yamamoto, Tsunehiko ........................... Disclosed no confl ict of interest.Yamamoto, Yuka.................................... Disclosed no confl ict of interest.Yamashita, Fumio .................................. Disclosed no confl ict of interest.Yamashita, Kaoru .................................. Disclosed no confl ict of interest.Yamashita, Shinichi............................... Disclosed no confl ict of interest.Yamashita, Shizuya ............................... Advisory Panel: Sanwa Kagaku Kenkyusho Co., Ltd.Yamauchi, Keishi ................................... Research Support: Sanwa Kagaku Kenkyusho; Speaker’s

Bureau: Astellas Pharma Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Japan, Merck Sharp & Dohme Corp., Sanofi Japan.

Yamauchi, Masahiro ............................. Disclosed no confl ict of interest.Yamauchi, Toshimasa ............................ Research Support: Daiichi-Sankyo Co., Ltd., Mitsubishi

Tanabe Pharma Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Merck Sharp & Dohme Corp., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Yamazaki, Tamae ................................... Disclosed no confl ict of interest.Yan, Amy ............................................... Disclosed no confl ict of interest.Yan, Hai ................................................. Employee: REMD Biotherapeutics, Inc; Stock/Shareholder:

REMD Biotherapeutics, Inc.Yan, Jinhua............................................ Disclosed no confl ict of interest.Yan, Qingwu .......................................... Disclosed no confl ict of interest.Yan, Tian-Tian ........................................ Disclosed no confl ict of interest.Yan, Tingjian .......................................... Other Relationship: HealthCore, Inc., Sanofi U.S. Inc.Yan, Wen ............................................... Employee: Janssen Pharmaceuticals, Inc.Yan, Wenjun .......................................... Disclosed no confl ict of interest.Yan, Xiaoqing ........................................ Disclosed no confl ict of interest.Yan, Yan................................................. Employee: TechData Service LLC.Yan, Yuanqing ........................................ Disclosed no confl ict of interest.Yan, Yun ................................................. Disclosed no confl ict of interest.Yan, Zihan.............................................. Disclosed no confl ict of interest.Yanagi, Kazunori.................................... Disclosed no confl ict of interest.Yanagimachi, Miyuki ............................. Disclosed no confl ict of interest.Yanagisawa, Hiroyuki............................ Disclosed no confl ict of interest.Yanase, Toshihiko .................................. Disclosed no confl ict of interest.Yang, Burton B. ..................................... Disclosed no confl ict of interest.Yang, Chengwei .................................... Disclosed no confl ict of interest.Yang, Chieh-Hsin ................................... Disclosed no confl ict of interest.Yang, Daizhi........................................... Disclosed no confl ict of interest.Yang, Dan .............................................. Disclosed no confl ict of interest.Yang, Guang-Ran................................... Disclosed no confl ict of interest.Yang, Hae Kyung ................................... Disclosed no confl ict of interest.Yang, Hongbo ........................................ Employee: Analysis Group, Inc.Yang, Huabing ....................................... Disclosed no confl ict of interest.Yang, Ivana V. ....................................... Disclosed no confl ict of interest.Yang, Jae Sung ..................................... Employee: Dong-A ST.Yang, Jae Wook .................................... Disclosed no confl ict of interest.Yang, Jihui Anne ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.Yang, Jingkui ......................................... Research Support: Medtronic, Inc.

A769


AU

THO

R D

ISCL

OSU

RE

Yang, Juan............................................. Disclosed no confl ict of interest.Yang, Kevin............................................ Disclosed no confl ict of interest.Yang, Kyung Mo .................................... Disclosed no confl ict of interest.Yang, Li-Jun........................................... Disclosed no confl ict of interest.Yang, Min .............................................. Disclosed no confl ict of interest.Yang, Ning ............................................. Disclosed no confl ict of interest.Yang, Peixin ........................................... Disclosed no confl ict of interest.Yang, Peng............................................. Disclosed no confl ict of interest.Yang, Penghua....................................... Disclosed no confl ict of interest.Yang, Qin ............................................... Disclosed no confl ict of interest.Yang, Qinglin ......................................... Disclosed no confl ict of interest.Yang, Shumin ........................................ Disclosed no confl ict of interest.Yang, Tae Young .................................... Disclosed no confl ict of interest.Yang, Tao ............................................... Disclosed no confl ict of interest.Yang, Wenjia ......................................... Disclosed no confl ict of interest.Yang, Wenying ...................................... Disclosed no confl ict of interest.Yang, Xi L. ............................................. Disclosed no confl ict of interest.Yang, Xiaoping ...................................... Disclosed no confl ict of interest.Yang, Xiaoyong...................................... Disclosed no confl ict of interest.Yang, Xilin ............................................. Disclosed no confl ict of interest.Yang, Xin ............................................... Disclosed no confl ict of interest.Yang, XuBin ........................................... Disclosed no confl ict of interest.Yang, Xuexian........................................ Disclosed no confl ict of interest.Yang, Yan............................................... Disclosed no confl ict of interest.Yang, Yeoree ......................................... Disclosed no confl ict of interest.Yang, Yi-Sun .......................................... Disclosed no confl ict of interest.Yang, Yunfan ......................................... Disclosed no confl ict of interest.Yang, Yunou ........................................... Disclosed no confl ict of interest.Yang, Zhihong........................................ Disclosed no confl ict of interest.Yang, Zhongnan..................................... Disclosed no confl ict of interest.Yanjin, Hu .............................................. Disclosed no confl ict of interest.Yano, Hideki .......................................... Disclosed no confl ict of interest.Yao, Bin ................................................. Disclosed no confl ict of interest.Yao, Qiang X. ........................................ Employee: ConjuChem, LLC.Yao, Xiaoxi............................................. Disclosed no confl ict of interest.Yao, Zhiwen........................................... Employee: ConjuChem, LLC.Yap, Chui Sun ........................................ Disclosed no confl ict of interest.Yapp, Rhiannon ..................................... Research Support: AstraZeneca.Yarchoan, Mark ..................................... Disclosed no confl ict of interest.Yasuda, Satoshi..................................... Disclosed no confl ict of interest.Yasui, Akira ........................................... Disclosed no confl ict of interest.Yavelberg, Loren.................................... Disclosed no confl ict of interest.Yavuz, Metin.......................................... Disclosed no confl ict of interest.Yazar, Zeliha .......................................... Disclosed no confl ict of interest.Yazawa, Masako ................................... Disclosed no confl ict of interest.Yazid, Nursyafi qah A. ........................... Disclosed no confl ict of interest.Yderstræde, Knud B. ............................ Disclosed no confl ict of interest.Ye, Cheng .............................................. Disclosed no confl ict of interest.Ye, Fen ................................................... Employee: TechData Service, LLC; Other Relationship: Sanofi

U.S., Inc.Ye, Jieping............................................. Disclosed no confl ict of interest.Ye, Kaitai ............................................... Disclosed no confl ict of interest.Ye, Qin ................................................... Employee: AstraZeneca Pharmaceuticals LP.Ye, Weiwei ............................................ Employee: Crown Bioscience, Inc.Ye, Wen ................................................. Disclosed no confl ict of interest.Yeadon, Jim........................................... Disclosed no confl ict of interest.Yeager, Adam ........................................ Disclosed no confl ict of interest.Yeager, Mark ......................................... Disclosed no confl ict of interest.Yearwood, Rosana ................................ Disclosed no confl ict of interest.Yee, Christine ........................................ Disclosed no confl ict of interest.Yeh, Hsin-Chieh ..................................... Disclosed no confl ict of interest.Yeh, Wen-I ............................................. Disclosed no confl ict of interest.Yenchitsomanus, Pa-Thai ...................... Disclosed no confl ict of interest.Yeo, Chia Rou ........................................ Disclosed no confl ict of interest.Yeo, Sulun Aaron................................... Disclosed no confl ict of interest.Yeoh, Ester ............................................ Disclosed no confl ict of interest.Yeoh, Lee Ying ....................................... Disclosed no confl ict of interest.Yeow, Toh Peng ..................................... Research Support: Novartis Corporation.Yepes Cortés, Carlos Augusto............... Employee: Hospital Universitario Clínica San Rafael; Research

Support: Novo Nordisk A/S; Speaker’s Bureau: Eli Lilly Interamérica, Medtronic, Inc., Novo Nordisk A/S.

Yi, Weiwei ............................................. Employee: Crown Bioscience, Inc.Yi, Zhengping ........................................ Disclosed no confl ict of interest.Yi-Frazier, Joyce P. ................................ Disclosed no confl ict of interest.Yilmaz Oral, Didem ................................ Disclosed no confl ict of interest.Yilmaz, Enis ........................................... Disclosed no confl ict of interest.Yin, Guoshu ........................................... Disclosed no confl ict of interest.Yin, Jun ................................................. Disclosed no confl ict of interest.Yin, Lei ................................................... Disclosed no confl ict of interest.Yin, Ruonan ........................................... Disclosed no confl ict of interest.Yin, Shinan ............................................ Disclosed no confl ict of interest.Ylli, Dorina............................................. Disclosed no confl ict of interest.Yochum, Laura ....................................... Disclosed no confl ict of interest.Yokoi, Norihide ...................................... Disclosed no confl ict of interest.Yokomizo, Hisashi ................................. Disclosed no confl ict of interest.Yokota, Tamotsu .................................... Disclosed no confl ict of interest.

Yokote, Koutaro ..................................... Other Relationship: Merck Sharp & Dohme Corp.; Research Support: Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca, Daiichi-Sankyo Co., Ltd., Kowa Company, Ltd., Kyowa Hakko Kirin Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Merck Sharp & Dohme Corp., Ono Pharmaceutical Co., Ltd., Pfi zer Japan Inc., Shionogi & Co. Ltd., Takeda Pharmaceutical Company Limited.

Yoneda, Masayasu ................................ Disclosed no confl ict of interest.Yonemoto, Koji ...................................... Disclosed no confl ict of interest.Yoneyama, Hiroyuki............................... Disclosed no confl ict of interest.Yoo, Hye Jin .......................................... Disclosed no confl ict of interest.Yoo, Janet ............................................. Disclosed no confl ict of interest.Yoo, Soon-Jib ........................................ Disclosed no confl ict of interest.Yoon, Jeong-Hwa .................................. Disclosed no confl ict of interest.Yoon, Ji Won ......................................... Disclosed no confl ict of interest.Yoon, Kun-Ho......................................... Disclosed no confl ict of interest.Yoon, Sun Ae ......................................... Disclosed no confl ict of interest.Yoona, Kim ............................................ Disclosed no confl ict of interest.Yorek, Mark ........................................... Disclosed no confl ict of interest.Yoshida, Mami ...................................... Disclosed no confl ict of interest.Yoshida, Masasuke ............................... Disclosed no confl ict of interest.Yoshida, Masayuki ................................ Disclosed no confl ict of interest.Yoshida, Osamu..................................... Disclosed no confl ict of interest.Yoshida, Sakiko ..................................... Disclosed no confl ict of interest.Yoshida, Satoshi.................................... Employee: Astellas Pharma Inc.Yoshida, Shigeru ................................... Disclosed no confl ict of interest.Yoshida, Yuki ......................................... Disclosed no confl ict of interest.Yoshihara, Kazufumi.............................. Disclosed no confl ict of interest.Yoshikai, Yasunobu ............................... Disclosed no confl ict of interest.Yoshimatsu, Gumpei ............................. Disclosed no confl ict of interest.Yoshimitsu, Tamami .............................. Disclosed no confl ict of interest.Yoshimoto, Takanobu ............................ Disclosed no confl ict of interest.Yoshimura, Yukio ................................... Disclosed no confl ict of interest.Yoshinaga, Yasunari .............................. Disclosed no confl ict of interest.Yoshino, Hiroshi .................................... Disclosed no confl ict of interest.Yoshinobu, Satoko................................. Disclosed no confl ict of interest.Yoshitomi, Tomomi ................................ Disclosed no confl ict of interest.Yoshizawa, Sakiko................................. Disclosed no confl ict of interest.You, Bo Ram .......................................... Disclosed no confl ict of interest.You, Ji Hong .......................................... Disclosed no confl ict of interest.You, Seohee .......................................... Employee: Janssen Pharmaceuticals, Inc.Younes, Naji .......................................... Disclosed no confl ict of interest.Young, Andrew ...................................... Stock/Shareholder: Satiogen Pharmaceuticals, Inc.Young, Cacina........................................ Disclosed no confl ict of interest.Young, Ian S. ........................................ Disclosed no confl ict of interest.Young, Jamey D. .................................. Disclosed no confl ict of interest.Young, Kendra ....................................... Disclosed no confl ict of interest.Young, Laura A. .................................... Research Support: Bayer HealthCare, Eli Lilly and Company,

GI Dynamics, Inc., Halozyme Therapeutics, Johnson & Johnson, Lexicon Pharmaceuticals, Inc., Medtronic, Inc., Novo Nordisk Inc., Orexigen Therapeutics, Inc., PhaseBio Pharmaceuticals, Inc., Sanofi U.S., Scion NeuroStim LLC, Takeda Pharmaceutical Company Limited, ToleRx.

Young, Lawrence H. ............................. Research Support: Merck & Co., Inc, Mifcor.Young, Martin........................................ Disclosed no confl ict of interest.Young, Steven L. ................................... Disclosed no confl ict of interest.Younge, Phin.......................................... Disclosed no confl ict of interest.Younk, Lisa M. ...................................... Disclosed no confl ict of interest.Yu Hung, Chang ..................................... Disclosed no confl ict of interest.Yu, Bo .................................................... Disclosed no confl ict of interest.Yu, Chack-Yung ...................................... Disclosed no confl ict of interest.Yu, Changhong ...................................... Research Support: Merck & Co., Inc., Novo Nordisk Inc.Yu, Christine .......................................... Employee: Sanofi .Yu, Demin .............................................. Disclosed no confl ict of interest.Yu, Hengchi ........................................... Disclosed no confl ict of interest.Yu, Jae Myung ...................................... Disclosed no confl ict of interest.Yu, Jeremy ............................................. Disclosed no confl ict of interest.Yu, Ji Hee .............................................. Disclosed no confl ict of interest.Yu, Jing .................................................. Disclosed no confl ict of interest.Yu, Liping ............................................... Disclosed no confl ict of interest.Yu, Maria ............................................... Employee: Eli Lilly Canada Inc.; Stock/Shareholder: Eli Lilly

and Company.Yu, Miao ................................................ Disclosed no confl ict of interest.Yu, Na .................................................... Disclosed no confl ict of interest.Yu, Ping .................................................. Disclosed no confl ict of interest.Yu, Seung Hee ....................................... Disclosed no confl ict of interest.Yu, Shujie .............................................. Disclosed no confl ict of interest.Yu, Sung Hoon ....................................... Disclosed no confl ict of interest.Yu, Tae Yang .......................................... Disclosed no confl ict of interest.Yu, Tzu-Yun ............................................ Disclosed no confl ict of interest.Yu, Yun ................................................... Disclosed no confl ict of interest.Yu, Zhijie ................................................ Disclosed no confl ict of interest.Yuan, Ming-Xia ...................................... Disclosed no confl ict of interest.

A770


AU

THO

R D

ISCL

OSU

RE

Yuan, Shen-Yuan ................................... Disclosed no confl ict of interest.Yuan, Xiaohong ..................................... Disclosed no confl ict of interest.Yuan, Xu ................................................ Disclosed no confl ict of interest.Yuan, Yang ............................................. Disclosed no confl ict of interest.Yudkin, John S. ..................................... Disclosed no confl ict of interest.Yue, Dennis K. ...................................... Disclosed no confl ict of interest.Yue, Kevin K. ........................................ Disclosed no confl ict of interest.Yue, Lin .................................................. Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.Yuen, Michele M. ................................. Disclosed no confl ict of interest.Yuksel, Arif ............................................ Disclosed no confl ict of interest.Yuksel, Esma ......................................... Disclosed no confl ict of interest.Yun, Jae-Seung ..................................... Disclosed no confl ict of interest.Yun, Mijin .............................................. Disclosed no confl ict of interest.Yuqian, Bao ........................................... Disclosed no confl ict of interest.Yussman, Martin ................................... Disclosed no confl ict of interest.Yusuf Solaiman, Ahmad ........................ Disclosed no confl ict of interest.Yuting Kao, Christi ................................. Employee: Eli Lilly and Company.Yuzefovych, Larysa ................................ Disclosed no confl ict of interest.Zaal, Kristien J. .................................... Disclosed no confl ict of interest.Zabeen, Bedowra .................................. Disclosed no confl ict of interest.Zaharieva, Dessi.................................... Disclosed no confl ict of interest.Zahr, Roula ............................................ Disclosed no confl ict of interest.Zain, Fuziah M. ..................................... Disclosed no confl ict of interest.Zajac, Jeffrey D. ................................... Disclosed no confl ict of interest.Zakaria, Ahmed S. ................................ Disclosed no confl ict of interest.Zaky, Amgad .......................................... Disclosed no confl ict of interest.Zaldivar, Frank ....................................... Disclosed no confl ict of interest.Zaman Huri, Hasniza ............................. Disclosed no confl ict of interest.Zambrowicz, Brian P. ............................ Employee: Lexicon Pharmaceuticals, Inc.; Stock/Shareholder:

Lexicon Pharmaceuticals, Inc.Zamudio, Cindy D. ................................ Disclosed no confl ict of interest.Zane, Doris T. ....................................... Disclosed no confl ict of interest.Zang, Mengwei ..................................... Research Support: American Diabetes Association, National

Institute of Diabetes and Digestive and Kidney Diseases.Zani, Fabiana ......................................... Disclosed no confl ict of interest.Zannad, Faiez ........................................ Other Relationship: Air Liquide, Bayer HealthCare, Biomérieux,

Biotronik, Boston Scientifi c, CardioRenal Diagnostics, CVRx, Janssen Pharmaceuticals, Inc., Mitsubishi, Novartis AG, Pfi zer Inc., ResMed, Sanofi U.S., Servier, St. Jude Medical, Takeda Development Center Americas, Inc.; Research Support: Roche Diagnostics.

Zanoboni, Luna ...................................... Disclosed no confl ict of interest.Zanolin, Daniela .................................... Disclosed no confl ict of interest.Zarra, Emanuela .................................... Disclosed no confl ict of interest.Zarrella, Bianca ..................................... Disclosed no confl ict of interest.Zasadny, Frederick................................. Disclosed no confl ict of interest.Zavaroni, Donatella ............................... Disclosed no confl ict of interest.Zavaroni, Ivana ...................................... Disclosed no confl ict of interest.Zazzeron, Laura ..................................... Disclosed no confl ict of interest.Zebisch, Armin ...................................... Disclosed no confl ict of interest.Zee, Benny............................................. Disclosed no confl ict of interest.Zeiger, Michael ..................................... Disclosed no confl ict of interest.Zeiter, Lauren ........................................ Disclosed no confl ict of interest.Zeitler, Philip ......................................... Disclosed no confl ict of interest.Zelada, Henry ........................................ Disclosed no confl ict of interest.Zelenko, Zara......................................... Disclosed no confl ict of interest.Zeller, Cordula ....................................... Employee: Boehringer Ingelheim GmbH.Zelnick, Leila ......................................... Disclosed no confl ict of interest.Zemel, Michael B. ................................ Board Member: NuSirt Biopharma; Employee: NuSirt

Biopharma; Stock/Shareholder: NuSirt Biopharma.Zemlyanitsyna, Olga.............................. Disclosed no confl ict of interest.Zender, Robynn ...................................... Disclosed no confl ict of interest.Zeng, Jun............................................... Disclosed no confl ict of interest.Zeng, Kejing .......................................... Disclosed no confl ict of interest.Zeng, Longyi .......................................... Disclosed no confl ict of interest.Zeng, Rong ............................................ Research Support: Oramed Pharmaceuticals.Zeng, Wen ............................................. Disclosed no confl ict of interest.Zenz, Sabine .......................................... Disclosed no confl ict of interest.Zgibor, Janice ........................................ Disclosed no confl ict of interest.Zhang, Bichen........................................ Disclosed no confl ict of interest.Zhang, Bo .............................................. Disclosed no confl ict of interest.Zhang, Chen .......................................... Employee: Gubra.Zhang, Cuilin ......................................... Disclosed no confl ict of interest.Zhang, Dandan ...................................... Disclosed no confl ict of interest.Zhang, Deling ........................................ Disclosed no confl ict of interest.Zhang, Deqiang ..................................... Disclosed no confl ict of interest.Zhang, Di ............................................... Disclosed no confl ict of interest.Zhang, Dong .......................................... Disclosed no confl ict of interest.Zhang, Dongwei .................................... Disclosed no confl ict of interest.Zhang, Dongyan .................................... Disclosed no confl ict of interest.Zhang, Donna D. ................................... Disclosed no confl ict of interest.Zhang, Fang ........................................... Disclosed no confl ict of interest.Zhang, Feifei.......................................... Disclosed no confl ict of interest.Zhang, Fuyang ....................................... Disclosed no confl ict of interest.Zhang, Ge .............................................. Disclosed no confl ict of interest.

Zhang, Hong .......................................... Disclosed no confl ict of interest.Zhang, Hongkai ..................................... Disclosed no confl ict of interest.Zhang, Huabing ..................................... Disclosed no confl ict of interest.Zhang, Huashi ....................................... Disclosed no confl ict of interest.Zhang, Jennifer Q. ................................ Disclosed no confl ict of interest.Zhang, Jian-Dong .................................. Disclosed no confl ict of interest.Zhang, Jie.............................................. Disclosed no confl ict of interest.Zhang, Kaisi........................................... Disclosed no confl ict of interest.Zhang, Lei .............................................. Disclosed no confl ict of interest.Zhang, Lihong ........................................ Disclosed no confl ict of interest.Zhang, Lihua .......................................... Disclosed no confl ict of interest.Zhang, Lu ............................................... Disclosed no confl ict of interest.Zhang, Manna ....................................... Disclosed no confl ict of interest.Zhang, Mei ............................................ Other Relationship: Consultant working for Sanofi U.S., Inc.Zhang, Michelle X. ............................... Employee: Eli Lilly Canada Inc.; Stock/Shareholder: Eli Lilly

and Company.Zhang, Mingliang .................................. Disclosed no confl ict of interest.Zhang, Ming-Zhi .................................... Disclosed no confl ict of interest.Zhang, Nan ............................................ Employee: Eli Lilly and Company.Zhang, Nianxian .................................... Employee: Sanofi .Zhang, Ning ........................................... Disclosed no confl ict of interest.Zhang, Peng........................................... Disclosed no confl ict of interest.Zhang, Pengyuan ................................... Disclosed no confl ict of interest.Zhang, Pengzi ........................................ Disclosed no confl ict of interest.Zhang, Pilli............................................. Disclosed no confl ict of interest.Zhang, Ping............................................ Disclosed no confl ict of interest.Zhang, Puhong....................................... Disclosed no confl ict of interest.Zhang, Qian ........................................... Disclosed no confl ict of interest.Zhang, Qun ............................................ Disclosed no confl ict of interest.Zhang, Rianna ....................................... Disclosed no confl ict of interest.Zhang, Rong .......................................... Disclosed no confl ict of interest.Zhang, Rui ............................................. Disclosed no confl ict of interest.Zhang, Ruzhi .......................................... Disclosed no confl ict of interest.Zhang, Shuang ...................................... Disclosed no confl ict of interest.Zhang, Simin ......................................... Disclosed no confl ict of interest.Zhang, Tao ............................................. Disclosed no confl ict of interest.Zhang, Ting ............................................ Disclosed no confl ict of interest.Zhang, Weiming .................................... Employee: Amgen Inc. (Spouse/Partner).Zhang, Wenwei ..................................... Disclosed no confl ict of interest.Zhang, Xiangmin ................................... Disclosed no confl ict of interest.Zhang, Xian-Man................................... Disclosed no confl ict of interest.Zhang, Xiaoli ......................................... Disclosed no confl ict of interest.Zhang, Xiaoyan...................................... Disclosed no confl ict of interest.Zhang, Xiong ......................................... Disclosed no confl ict of interest.Zhang, Xiuying....................................... Disclosed no confl ict of interest.Zhang, Xuanping ................................... Disclosed no confl ict of interest.Zhang, Xue-Lian .................................... Disclosed no confl ict of interest.Zhang, Yahong....................................... Employee: VeroScience, LLC.Zhang, Yan............................................. Disclosed no confl ict of interest.Zhang, Yanqing...................................... Disclosed no confl ict of interest.Zhang, Yanwei....................................... Disclosed no confl ict of interest.Zhang, Yao............................................. Disclosed no confl ict of interest.Zhang, Yi ............................................... Disclosed no confl ict of interest.Zhang, Yinan ......................................... Disclosed no confl ict of interest.Zhang, Ying ........................................... Disclosed no confl ict of interest.Zhang, Yingmei ..................................... Disclosed no confl ict of interest.Zhang, Yong........................................... Disclosed no confl ict of interest.Zhang, Yuan ........................................... Disclosed no confl ict of interest.Zhang, Yun ............................................. Disclosed no confl ict of interest.Zhang, Zhengyu ..................................... Disclosed no confl ict of interest.Zhang, Zhiguo........................................ Disclosed no confl ict of interest.Zhang, Zhiyin ......................................... Disclosed no confl ict of interest.Zhang, Zhiyong ...................................... Disclosed no confl ict of interest.Zhao, Bin ............................................... Employee: Merck Sharp & Dohme Corp.Zhao, Chen ............................................ Employee: Analysis Group; Research Support: Eli Lilly and

Company.Zhao, Guiyu ........................................... Disclosed no confl ict of interest.Zhao, Jing.............................................. Employee: Analysis Group, Inc.Zhao, Liping ........................................... Disclosed no confl ict of interest.Zhao, Shangang .................................... Disclosed no confl ict of interest.Zhao, Shihao ......................................... Disclosed no confl ict of interest.Zhao, Shuyuan....................................... Employee: Janssen Pharmaceuticals, Inc.Zhao, Wenhua ....................................... Disclosed no confl ict of interest.Zhao, Xiaohui ........................................ Disclosed no confl ict of interest.Zhao, YiNan ........................................... Disclosed no confl ict of interest.Zhao, Yu ................................................. Disclosed no confl ict of interest.Zhao, Yueshui ........................................ Disclosed no confl ict of interest.Zhao, Zhenping...................................... Disclosed no confl ict of interest.Zhao, Zhiyuan ........................................ Disclosed no confl ict of interest.Zhe, Jie.................................................. Disclosed no confl ict of interest.Zheng, Chao .......................................... Disclosed no confl ict of interest.Zheng, Chen .......................................... Disclosed no confl ict of interest.Zheng, Chengzhu ................................... Disclosed no confl ict of interest.Zheng, Hongting .................................... Disclosed no confl ict of interest.Zheng, Hui ............................................. Disclosed no confl ict of interest.Zheng, Jia.............................................. Disclosed no confl ict of interest.

A771


AU

THO

R D

ISCL

OSU

RE

Zheng, Jie.............................................. Disclosed no confl ict of interest.Zheng, Taishan ...................................... Disclosed no confl ict of interest.Zheng, Xianyun...................................... Disclosed no confl ict of interest.Zheng, Xiaobin ...................................... Disclosed no confl ict of interest.Zheng, Xueying...................................... Disclosed no confl ict of interest.Zheng, Yan............................................. Disclosed no confl ict of interest.Zheng, Ying ........................................... Consultant: Boehringer Ingelheim GmbH; Employee: Eli Lilly and

Company (Spouse/Partner).Zheng, Yinggan ..................................... Disclosed no confl ict of interest.Zheng, Yuanchao ................................... Disclosed no confl ict of interest.Zhong, Alex ........................................... Employee: Medtronic, Inc.Zhong, Ni ............................................... Disclosed no confl ict of interest.Zhong, Victor ......................................... Research Support: Sanofi U.S.Zhong, Yi ............................................... Disclosed no confl ict of interest.Zhou, Anna Y. ....................................... Disclosed no confl ict of interest.Zhou, Bi ................................................. Disclosed no confl ict of interest.Zhou, Bin ............................................... Disclosed no confl ict of interest.Zhou, Donglei ........................................ Disclosed no confl ict of interest.Zhou, Hongwen ..................................... Disclosed no confl ict of interest.Zhou, Joe............................................... Disclosed no confl ict of interest.Zhou, Joseph ......................................... Disclosed no confl ict of interest.Zhou, Kaixin........................................... Disclosed no confl ict of interest.Zhou, Lingli ............................................ Disclosed no confl ict of interest.Zhou, Maigeng ...................................... Disclosed no confl ict of interest.Zhou, Qiong ........................................... Disclosed no confl ict of interest.Zhou, Rong ............................................ Disclosed no confl ict of interest.Zhou, Shiwen ........................................ Disclosed no confl ict of interest.Zhou, Shiyi............................................. Disclosed no confl ict of interest.Zhou, Shuyue......................................... Disclosed no confl ict of interest.Zhou, Steve ........................................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi U.S.Zhou, Tianyue ........................................ Employee: Sanofi .Zhou, Xianghai ...................................... Disclosed no confl ict of interest.Zhou, Xilin ............................................. Disclosed no confl ict of interest.Zhou, Yanhua......................................... Disclosed no confl ict of interest.Zhou, YingSheng ................................... Disclosed no confl ict of interest.Zhou, You............................................... Disclosed no confl ict of interest.Zhou, Zhou............................................. Employee: Analysis Group, Inc.Zhu, Beibei ............................................ Disclosed no confl ict of interest.Zhu, Bilian ............................................. Disclosed no confl ict of interest.Zhu, Cuiling ........................................... Disclosed no confl ict of interest.Zhu, Cyrus.............................................. Employee: Medtronic MiniMed, Inc.Zhu, Dalong ........................................... Research Support: Medtronic, Inc.Zhu, Dongshan ...................................... Disclosed no confl ict of interest.Zhu, Jia.................................................. Disclosed no confl ict of interest.Zhu, Jie.................................................. Disclosed no confl ict of interest.Zhu, Kavin.............................................. Disclosed no confl ict of interest.Zhu, Liang-Xiang ................................... Disclosed no confl ict of interest.Zhu, Ling ................................................ Disclosed no confl ict of interest.Zhu, Wanling ......................................... Disclosed no confl ict of interest.Zhu, Xiaohui .......................................... Disclosed no confl ict of interest.Zhu, Xiaolin ........................................... Employee: Merck Sharp & Dohme Corp.Zhu, Xiaoxue.......................................... Disclosed no confl ict of interest.Zhu, Yan Juan........................................ Disclosed no confl ict of interest.Zhu, Yeyi ................................................ Disclosed no confl ict of interest.Zhu, Yu-Ping .......................................... Disclosed no confl ict of interest.Zhuang, Ning ......................................... Disclosed no confl ict of interest.Zhuang, Yongzhong ............................... Disclosed no confl ict of interest.Zhuge, Fen ............................................. Disclosed no confl ict of interest.Zhumabekova, Baglan K. ...................... Disclosed no confl ict of interest.Zhuo, Shu .............................................. Disclosed no confl ict of interest.Zhuo, Xiaohui ........................................ Employee: Merck & Co., Inc; Stock/Shareholder: Merck & Co.,

Inc.

Zhuplatov, Sergey.................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/Shareholder: AstraZeneca Pharmaceuticals LP.

Ziccardi, Lucia ....................................... Disclosed no confl ict of interest.Zidon, Terese M. .................................. Disclosed no confl ict of interest.Ziegler, Anette ....................................... Research Support: National Institutes of Health.Ziegler, Dan ........................................... Disclosed no confl ict of interest.Ziegler, Ralph ........................................ Disclosed no confl ict of interest.Ziegler, Thomas R. ................................ Disclosed no confl ict of interest.Ziemer, David C. ................................... Other Relationship: Quintiles Inc.; Research Support: American

Diabetes Association.Ziemssen, Focke .................................... Consultant: Alimera, Allergan, Inc., Bayer HealthCare, Novartis

Pharma AG; Research Support: Allergan, Inc., Novartis Pharma AG; Speaker’s Bureau: Alcon, Alimera, Allergan, Inc., Bayer HealthCare, Heidelberg Engineering, Novartis Pharma AG.

Zierfuss, Bernhard ................................. Disclosed no confl ict of interest.Zijlstra, Eric ........................................... Other Relationship: Dance Biopharm, Novo Nordisk A/S;

Speaker’s Bureau: Roche Diagnostics.Zilov, Alexey .......................................... Consultant: Novartis, Novo-Nordisk and Merck; Research

Support: Novartis, Novo-Nordisk and Merck; Speaker’s Bureau: Novartis, Novo-Nordisk and Merck.

Zimbudzi, Edward .................................. Disclosed no confl ict of interest.Zimermann, Baruch ............................... Disclosed no confl ict of interest.Zimmerman, Robert S. ......................... Consultant: Novo Nordisk Inc; Research Support: Merck &

Co., Inc., Novo Nordisk Inc; Speaker’s Bureau: Johnson & Johnson, Merck & Co., Inc.

Zinke-Cerwenka, Wilma........................ Disclosed no confl ict of interest.Zinman, Bernard .................................... Advisory Panel: Abbott, AstraZeneca, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Consultant: Abbott, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S.; Research Support: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Novo Nordisk Inc.

Zinn, Kelly K. ........................................ Disclosed no confl ict of interest.Zirie, Mahmoud ..................................... Disclosed no confl ict of interest.Zisser, Howard C. ................................. Employee: Insulet Corporation; Stock/Shareholder: Insulet

Corporation.Zong, Haihong ....................................... Disclosed no confl ict of interest.Zorrilla, Lilian ........................................ Disclosed no confl ict of interest.Zorzano, Antonio ................................... Stock/Shareholder: Genmedica Therapeutics.Zoso, Alessia ......................................... Disclosed no confl ict of interest.Zou, Baiming ......................................... Disclosed no confl ict of interest.Zou, Hongyun ........................................ Disclosed no confl ict of interest.Zoungas, Sophia.................................... Disclosed no confl ict of interest.Zoupas, Christos.................................... Disclosed no confl ict of interest.Zraick, Vivien ......................................... Employee: Calibra Medical; Stock/Shareholder: Johnson &

Johnson.Zraika, Sakeneh..................................... Disclosed no confl ict of interest.Zsombok, Andrea .................................. Disclosed no confl ict of interest.Zuellig, Richard A. ................................ Disclosed no confl ict of interest.Zuffardi, Orsetta .................................... Disclosed no confl ict of interest.Zugaib, Marcelo .................................... Disclosed no confl ict of interest.Zuin, Massimo....................................... Disclosed no confl ict of interest.Zukowska-Szczechowska, Ewa ............. Other Relationship: Roche Pharmaceuticals.Zullo, Andrew R. ................................... Research Support: National Institutes of Health.Zuñiga, Laura......................................... Disclosed no confl ict of interest.Zusi, Chiara ........................................... Disclosed no confl ict of interest.

ABSTRACT AUTHOR DISCLOSURE INFORMATION · ABSTRACT AUTHOR DISCLOSURE INFORMATION All...

Documents

Transcript of ABSTRACT AUTHOR DISCLOSURE INFORMATION · ABSTRACT AUTHOR DISCLOSURE INFORMATION All...